[
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "非甾体抗炎药抗炎的作用机制是",
    "options": {
      "A": "抑制炎症部位前列腺素的合成",
      "B": "促进 P 物质的释放",
      "C": "作用于下丘脑体温调节中枢, 扩张外周血管",
      "D": "促进前列腺素合成",
      "E": "对抗 cAMP 直接引起的作用"
    },
    "answer": "A",
    "explanation": "本题考查解热、镇痛、抗炎药的临床用药评价。非甾体抗炎药(NSAIDs)主要通过抑制炎症细胞的花生四烯酸代谢过程中的环氧化酶，减少炎症介质，从而抑制前列腺素和血栓素的合成。当环氧化酶被NSAIDs抑制后，各类前列腺素的合成减少，临床炎症得以改善。故本题答案为A。",
    "source_note": "",
    "question_id": "901328fe1410ee2732074fb570403eca7aedec23",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于中枢性镇咳药的是",
    "options": {
      "A": "福尔可定",
      "B": "喷托维林",
      "C": "依普拉酮",
      "D": "苯丙哌林",
      "E": "那可丁"
    },
    "answer": "A",
    "explanation": "本题考查镇咳药的分类与作用机制。中枢性镇咳药有：福尔可定、二氧丙嗪、右美沙芬、可待因、双氢可待因。故本题答案为 A。苯丙哌林、喷托维林、依普拉酮为兼具中枢及外周作用的镇咳药。那可丁为外周性镇咳药。",
    "source_note": "",
    "question_id": "f1198c03d07d89a5c4bd595faad0e172feb358ce",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "兰索拉唑用于治疗胃及十二指肠溃疡的机制是",
    "options": {
      "A": "中和胃酸，升高胃内 \\mathrm{pH}",
      "B": "保护胃黏膜",
      "C": "拮抗 \\mathrm{H}_{2} 受体",
      "D": "抑制 \\mathrm{H}^{+}, \\mathrm{K}^{+}-ATP 酶",
      "E": "拮抗胆碱M受体"
    },
    "answer": "D",
    "explanation": "本题考查质子泵抑制剂（PPI）的临床用药评价。PPI与 \\mathrm{H}+, \\mathrm{K}+-ATP酶（又称质子泵）结合形成复合物，抑制 \\mathrm{H}+, \\mathrm{K}+-ATP酶的活性，使壁细胞内的 \\mathrm{H}+ 不能转运到胃腔中，阻断了胃酸分泌的最后步骤，使胃液中的胃酸量大大减少，表现出较高的选择性、专一性、不可逆性和持久性。故本题答案为D。",
    "source_note": "",
    "question_id": "6cdd4703f2a7008466cd72d46bcf056e43d25ef1",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "苯二氮草类镇静催眠药按作用持续时间分为：短效药、中效药和长效药。按顺序分属这三类药物的是",
    "options": {
      "A": "三唑仑、氟西泮、劳拉西泮",
      "B": "替马西泮、三唑仑、夸西泮",
      "C": "三唑仑、艾司唑仑、地西泮",
      "D": "夸西泮、劳拉西泮、三唑仑",
      "E": "替马西泮、地西泮、三唑仑"
    },
    "answer": "C",
    "explanation": "本题考查镇静催眠药的分类与作用机制。苯二氮草类镇静催眠药包括短效类（三唑仑）、中效类（艾司唑仑、劳拉西泮、替马西泮）、长效类（地西泮、氟西泮、夸西泮）。故本题答案为 C。",
    "source_note": "",
    "question_id": "49f54195533ed3e4e1dafa0116fe3440cae9070c",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于 I c 类钠通道阻滞剂的药物是",
    "options": {
      "A": "胺碘酮",
      "B": "普罗帕酮",
      "C": "苯妥英钠",
      "D": "利多卡因",
      "E": "普鲁卡因胺"
    },
    "answer": "B",
    "explanation": "本题考查抗心律失常药的分类与作用机制。普罗帕酮属于 Ic 类钠通道阻滞剂。故本题答案为 B。胺碘酮属于钾通道阻滞剂。苯妥英钠和利多卡因属于 Ib 类钠通道阻滞剂。普鲁卡因胺属于 Ia 类钠通道阻滞剂。",
    "source_note": "",
    "question_id": "a83829a224802be5df2bf6ce6790eb903c8b6d54",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于维生素K拮抗剂，能够抑制凝血因子Ⅱ、Ⅶ、Ⅸ、X合成的抗凝血药是",
    "options": {
      "A": "蒂莫司他",
      "B": "华法林",
      "C": "那屈肝素钙",
      "D": "甲萘氢醌",
      "E": "达比加群酯"
    },
    "answer": "B",
    "explanation": "本题考查抗血栓药的分类与代表药品。维生素K是肝脏合成四种凝血因子（Ⅱ、Ⅶ、Ⅸ、X）、必不可少的辅因子。华法林属于维生素K拮抗剂，可抑制维生素K环氧化物还原酶复合体1（VKOR1），阻断维生素K的再生循环，进而影响凝血因子Ⅱ、Ⅶ、Ⅸ、X的合成过程。故本题答案为B。",
    "source_note": "",
    "question_id": "eb2d12a2074114d60a0dc2ede36899231f14c867",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "不属于呋塞米典型不良反应的是",
    "options": {
      "A": "耳毒性",
      "B": "磺胺样过敏反应",
      "C": "血钙升高",
      "D": "高尿酸血症",
      "E": "水和电解质紊乱"
    },
    "answer": "C",
    "explanation": "本题考查袢利尿药的临床用药评价。呋塞米属于袢利尿药，典型不良反应有：①水与电解质紊乱：低血容量（低血压）、低血钾、低血钙、低血镁、低血钠、 低氯性代谢性碱血症、高尿酸血症、高血糖、高血脂；②耳毒性呈剂量依赖性，依他尼酸最易引起，布美他尼、托拉塞米耳毒性较小；③呋塞米、布美他尼、托拉塞米有磺胺样过敏反应，依他尼酸无磺胺样过敏反应。呋塞米临床可用于治疗高钾血症及高钙血症。故本题答案为C。",
    "source_note": "explanation_range_detected",
    "question_id": "5847adf8f337242b4a03f36a0b2623dedc9014bc",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第1节下丘脑-垂体激素及相关药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于重组人生长激素适应证的是",
    "options": {
      "A": "严重急性食管静脉曲张出血",
      "B": "严重急性胃或十二指肠溃疡出血",
      "C": "糖尿病酮症酸中毒的辅助治疗",
      "D": "重度烧伤的治疗",
      "E": "胰腺外科术后并发症的预防和治疗"
    },
    "answer": "D",
    "explanation": "本题考查重组人生长激素的临床用药评价。重组人生长激素用于：①因 内源性生长激素缺乏所引起的儿童生长缓慢；②儿童慢性肾功能不全导致的生长障碍；③成人生长激素缺乏症；特纳氏综合征；④重度烧伤治疗、手术、创伤后高代谢状态（负氮平衡），脓毒败血症；⑤已明确的下丘脑-垂体疾病所致的生长激素缺乏症和经至少2周不同的生长激素刺激试验确诊的生长激素显著缺乏症。故本题答案为D。严重急性食管静脉曲张出血、严重急性胃或十二指肠溃疡出血、糖尿病酮症酸中毒的辅助治疗、胰腺外科术后并发症的预防和治疗属于生长抑素的适应证。",
    "source_note": "explanation_range_detected",
    "question_id": "12d28405cea7ef8c430a0fd01a35c437049f5964",
    "section_no": 1,
    "section_title": "下丘脑-垂体激素及相关药物",
    "section_norm": "第一节 下丘脑-垂体激素及相关药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第1节抗菌药物总论",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "抗菌药物与细菌短暂接触后，细菌受到非致 死性损伤，当药物清除后，细菌生长繁殖仍然持续受到抑制的效应是",
    "options": {
      "A": "耐受性",
      "B": "耐药性",
      "C": "抗菌谱",
      "D": "抗菌活性",
      "E": "抗生素后效应"
    },
    "answer": "E",
    "explanation": "本题考查抗菌药物的常用术语。抗生素后效应指抗菌药物与细菌短暂接触后，细菌受到非致死性损伤，当药物清除后，细菌生长繁殖仍然持续受到抑制的效应。故本题答案为 E。",
    "source_note": "",
    "question_id": "15c4a8f50c8244be233812eae8d11a69c02b9ce9",
    "section_no": 1,
    "section_title": "抗菌药物总论",
    "section_norm": "第一节 抗菌药物总论"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "多用于非小细胞肺癌的治疗且骨髓抑制不良反应最严重的药物是",
    "options": {
      "A": "博来霉素",
      "B": "奥沙利铂",
      "C": "卡铂",
      "D": "羟喜树碱",
      "E": "长春新碱"
    },
    "answer": "C",
    "explanation": "本题考查破坏 DNA 的铂类化合物的临床用药评价。卡铂抗肿瘤谱与顺铂相似, 多用于非小细胞肺癌、头颈部及食管癌、卵巢癌等。铂类化合物中, 顺铂引起恶心、呕吐、肾毒性和耳毒性的不良反应最严重; 卡铂引起骨髓抑制的不良反应最严重; 奥沙利铂的神经毒性强。故本题答案为 C。",
    "source_note": "",
    "question_id": "0dd69d8c91fb5a2a08a0a2ac928486ad83c873ea",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第1节体外杀寄生虫与皮肤感染治疗药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "具有局部麻醉的作用，可外用于皮肤瘙痒的药物是",
    "options": {
      "A": "甲氧沙林",
      "B": "莫匹罗星",
      "C": "克林霉素",
      "D": "克罗米通",
      "E": "伊曲康唑"
    },
    "answer": "D",
    "explanation": "本题考查体外杀寄生虫与皮肤感染治疗药的代表药品与临床用药评价。克罗米通有局部麻醉作用, 可治疗各型瘙痒症, 还有特异性杀灭疥螨的作用, 作用于疥螨神经系统, 使疥螨麻痹而死亡, 可用于治疗疥疮。故本题答案为 D。",
    "source_note": "",
    "question_id": "baa22f4dbe5cb06edb2dad8401f8f024240650ca",
    "section_no": 1,
    "section_title": "体外杀寄生虫与皮肤感染治疗药",
    "section_norm": "第一节 体外杀寄生虫与皮肤感染治疗药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "属于高度选择性 COX-2 抑制剂的是",
    "options": {
      "A": "阿司匹林",
      "B": "布洛芬 对乙酰氨基酚",
      "C": "塞来昔布",
      "D": "弓喉美辛"
    },
    "answer": "C",
    "explanation": "本题考查解热、镇痛、抗炎药的分类与作用机制。选择性 COX-2 抑制剂有：① 高度选择性 COX-2 抑制剂：塞来昔布、依托考昔、帕瑞昔布、伐地考昔、艾瑞昔布；② 部分选择性 COX-2 抑制剂：美洛昔康、尼美舒利。故本题答案为 C。",
    "source_note": "explanation_range_detected",
    "question_id": "34b3548ad88af54633038d8570dc590d24b050d3",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "使用后应避免从事高空作业、驾驶汽车等有危险性的机械操作的镇咳药是",
    "options": {
      "A": "沙丁胺醇",
      "B": "可待因",
      "C": "阿司匹林",
      "D": "塞托溴铵",
      "E": "氨溴索"
    },
    "answer": "B",
    "explanation": "本题考查镇咳药的临床用药评价。可待因为中枢性镇咳药，服用后可出现嗜睡，故服药期间不得驾驶车、船，从事高空作业、机械作业及操作精密仪器。故本题答案为 B。",
    "source_note": "",
    "question_id": "4898f0a466ce2e2b923eae562e7e33adef4dfe3a",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "下列有关质子泵抑制剂的叙述，错误的是",
    "options": {
      "A": "口服必须采用肠溶剂型，餐前 30 \\sim 60 \\mathrm{~min} 整粒或整片吞服",
      "B": "大多数 PPI 的主要代谢酶是 CYP2C19 或 CYP3A4",
      "C": "为确保溶液 \\mathrm{pH} 维持在弱碱性, 可在辅料中加入 EDTA",
      "D": "可用于幽门螺杆菌的根除治疗",
      "E": "可用于胃、十二指肠溃疡，消化性溃疡急性出血"
    },
    "answer": "C",
    "explanation": "本题考查质子泵抑制剂（PPI）的临床用药评价。PPI 遇酸会快速分解，口服必须采用肠溶剂型（整粒或整片餐前 30 \\sim 60 \\mathrm{~min} 吞服，不可咀嚼、压碎）。PPI 注射剂型的辅料中加入氢氧化钠，确保稀释后溶液呈碱性，增强其稳定性。PPI 可用于胃、十二指肠溃疡等酸相关性疾病，还可以与抗菌药物合用治疗幽门螺杆菌相关性消化性溃疡。故本题答案为 C。",
    "source_note": "",
    "question_id": "f27440e4b0daac3b031469812d7a15a0a7db9b99",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "下列镇静催眠药中属于非苯二氮草类的是",
    "options": {
      "A": "佐匹克隆",
      "B": "地西泮",
      "C": "劳拉西泮",
      "D": "阿普唑仑",
      "E": "三唑仑"
    },
    "answer": "A",
    "explanation": "本题考查镇静催眠药的分类与作用机制。佐匹克隆为环吡咯酮类镇静催眠药，是非苯二氮草类药物。故本题答案为A。地西泮、劳拉西泮、阿普唑仑、三唑仑属于苯二氮草类药物。",
    "source_note": "",
    "question_id": "58037b81f8da530abe8bec4d01de3db10581a307",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "不属于作用于心血管系统离子通道的抗心律失常药是",
    "options": {
      "A": "普罗帕酮",
      "B": "苯妥英钠",
      "C": "奎尼丁",
      "D": "地尔硫革",
      "E": "美托洛尔"
    },
    "answer": "E",
    "explanation": "本题考查抗心律失常药的分类与作用机制。抗心律失常药包括：（1）钠通道阻滞剂：① I a 类适度（中等）阻滞钠通道：奎尼丁、普鲁卡因胺；② I b 类轻度（较弱）阻滞钠通道：利多卡因、苯妥英钠、美西律；③ I c 类明显（较强）阻滞钠通道：普罗帕酮。（2）钾通道阻滞剂（III类抗心律失常药）：胺碘酮、索他洛尔。（3）钙通道阻滞剂（IV类抗心律失常药）：维拉帕米、地尔硫草。（4）β受体拮抗剂（II类抗心律失常药）：普萘洛尔、美托洛尔等。其中I类、III类、IV类属于作用于心血管系统离子通道的药物。故本题答案为E。",
    "source_note": "explanation_range_detected",
    "question_id": "e40accbd2e705101744255fd33eb9c34290a4813",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "下列药物中属于直接凝血酶抑制剂的是",
    "options": {
      "A": "达比加群酯",
      "B": "阿昔单抗",
      "C": "依诺肝素钠",
      "D": "阿哌沙班",
      "E": "华法林"
    },
    "answer": "A",
    "explanation": "本题考查抗血栓药的分类与代表药品。直接凝血酶抑制剂的代表药品有达比加群酯（口服）、比伐芦定、阿加曲班、水蛭素、重组水蛭素。故本题答案为 A。",
    "source_note": "",
    "question_id": "5922e8a77d8509e97d76559213b5297f8692636f",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "主要作用于远曲小管近端，直接抑制远曲小管近端的 \\mathrm{Na}^{+}-\\mathrm{Cl}^{-}共转运体的利尿药是",
    "options": {
      "A": "阿米洛利",
      "B": "氢氯噻嗪",
      "C": "依他尼酸",
      "D": "氨苯蝶啶",
      "E": "乙酰唑胺"
    },
    "answer": "B",
    "explanation": "本题考查利尿药的分类与作用部位。噻嗪类与类噻嗪类利尿药（氢氯噻嗪、吲达帕胺）作用于远曲小管近端，直接抑制远曲小管近端的 \\mathrm{Na} + -\\mathrm{Cl} 共转运子。故本题答案为 B。留钾利尿药（螺内酯、氨苯蝶啶、阿米洛利）作用于远曲小管末端和皮质集合管。乙酰唑胺作用于近曲（球）小管。",
    "source_note": "",
    "question_id": "854fc3d2203122ad8326452ead34b9c9dd112bc2",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第1节下丘脑-垂体激素及相关药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可减少胰腺的外分泌和内分泌，用于预防和治疗胰腺外科手术后并发症的药物是",
    "options": {
      "A": "胰岛素",
      "B": "胰高血糖素",
      "C": "重组人生长激素",
      "D": "促皮质素",
      "E": "生长抑素"
    },
    "answer": "E",
    "explanation": "本题考查生长抑素的临床用药评价。生长抑素可用于：①可抑制胃泌素和胃酸以及胃蛋白酶的分泌，从而治疗上消化道出血；②可以明显减少内脏器官的血流量，又不引起体循环动脉血压的显著变化，因而在治疗食管静脉曲张出血方面有一定的临床价值；③可减少胰腺的内分泌和外分泌，用于预防和治疗胰腺外科手术后并发症；④可以抑制胰高血糖素的分泌，从而有效地治疗糖尿病酮症酸中毒。故本题答案为E。",
    "source_note": "explanation_range_detected",
    "question_id": "16135bc81ec74ed7712ae5204382443e7bf4914a",
    "section_no": 1,
    "section_title": "下丘脑-垂体激素及相关药物",
    "section_norm": "第一节 下丘脑-垂体激素及相关药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第1节抗菌药物总论",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "根据药动学/药效学（PK/PD）的特点，评估指数是血浆药物峰浓度与最低抑菌浓度比值(C_{\\mathrm{max}} / \\mathrm{MIC}) 的药物是",
    "options": {
      "A": "青霉素",
      "B": "阿奇霉素",
      "C": "亚胺培南",
      "D": "万古霉素"
    },
    "answer": "B",
    "explanation": "本题考查抗菌药物的药代动力学/药效学。浓度依赖性的药物有氨基糖苷类（链霉素、阿米卡星、奈替米星等）、氟喹诺酮类（环丙沙星、氧氟沙星、诺氟沙星等）、达托霉素、多黏菌素、硝基咪唑类（甲硝唑、替硝唑、奥硝唑），评估指数为Cmax/MIC或AUCO～24/MIC。故本题答案为B。时间依赖性且抗菌作用时间短的药物有β-内酰胺类（包括青霉素类、头孢菌素类、碳青霉烯类如亚胺培南等）、红霉素、林可霉素类，评估指数为%T>MIC。时间依赖性且抗菌作用时间长的药物有四环素类、阿奇霉素、替加环素、利奈唑胺、糖肽类（如万古霉素等），评估指数为AUCO～24/MIC（利奈唑胺还包括%T>MIC）。",
    "source_note": "",
    "question_id": "a3233d67729b31d05e4907190c624f4fea48153e",
    "section_no": 1,
    "section_title": "抗菌药物总论",
    "section_norm": "第一节 抗菌药物总论"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第1节糖类、盐类、酸碱平衡调节药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可用于解救镁盐中毒的药物是",
    "options": {
      "A": "氯化钙",
      "B": "氯化铵",
      "C": "乳酸钠",
      "D": "氯化钾"
    },
    "answer": "A",
    "explanation": "本题考查氯化钙的临床用药评价。氯化钙可用于: ① 甲状腺功能亢进症术后“骨饥饿综合征”; ② 低钙血症、高钾血症、高镁血症、钙通道阻滞剂中毒; ③ 血钙过 低引起的手足抽搐、肠绞痛、输尿管绞痛等; ④解救镁盐中毒; ⑤过敏性疾病; ⑥作为强心剂, 用于心脏复苏。故本题答案为 A。",
    "source_note": "explanation_range_detected",
    "question_id": "7887b73cab1876fe515a744c08aa95a46e32a0b3",
    "section_no": 1,
    "section_title": "糖类、盐类、酸碱平衡调节药",
    "section_norm": "第一节 糖类、盐类、酸碱平衡调节药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第1节体外杀寄生虫与皮肤感染治疗药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可用于细菌性结膜炎、眼睑炎、沙眼的四环素类药物是",
    "options": {
      "A": "克罗米通",
      "B": "克霉唑",
      "C": "硫黄",
      "D": "金霉素",
      "E": "异维A酸"
    },
    "answer": "D",
    "explanation": "本题考查体外杀寄生虫与皮肤感染治疗药的代表药品与临床用药评价。金霉素属于四环素类抗菌药物，眼膏可用于细菌性结膜炎、眼睑炎，也用于治疗沙眼。 故本题答案为D。",
    "source_note": "",
    "question_id": "e32fcdaf5e945dec55f10e4ae8daaa443ca3bc03",
    "section_no": 1,
    "section_title": "体外杀寄生虫与皮肤感染治疗药",
    "section_norm": "第一节 体外杀寄生虫与皮肤感染治疗药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "下列不属于阿司匹林不良反应的是",
    "options": {
      "A": "胃肠道反应",
      "B": "凝血障碍",
      "C": "过敏反应",
      "D": "水杨酸反应",
      "E": "心血管事件"
    },
    "answer": "E",
    "explanation": "本题考查解热、镇痛、抗炎药的临床用药评价。阿司匹林的不良反应包括：①胃肠道反应，溃疡病患者禁用；②凝血障碍，严重肝损害、低凝血酶原血症及维生素K缺乏者禁用；③过敏反应，包括“阿司匹林哮喘”和血管神经性水肿；⑤水杨酸反应；⑥瑞夷综合征。故本题答案为E。",
    "source_note": "explanation_range_detected",
    "question_id": "12b2e6e3919bdbdcb03532989f794d2cd750ba67",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "镇咳作用较强，无成瘾性，具有罂粟碱样平滑肌解痉作用的药物是",
    "options": {
      "A": "苯丙哌林",
      "B": "双氢可待因",
      "C": "福尔可定",
      "D": "可待因",
      "E": "右美沙芬"
    },
    "answer": "A",
    "explanation": "本题考查镇咳药的临床用药评价。苯丙哌林镇咳作用较强, 为可待因的 2 \\sim 4 倍, 无麻醉作用, 不抑制呼吸, 无成瘾性, 具有罂粟碱样平滑肌解痉作用。故本题答案为 A。",
    "source_note": "",
    "question_id": "a9c3e9c2b7ce3fcb1e80e822bffa38e906e01bd7",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "下列药物中可引起剥脱性皮疹的是",
    "options": {
      "A": "苯巴比妥",
      "B": "地西泮",
      "C": "唑吡坦",
      "D": "佐匹克隆",
      "E": "氟西泮"
    },
    "answer": "A",
    "explanation": "本题考查巴比妥类的临床用药评价。服用巴比妥类药物可引起剥脱性皮疹, 严重可致死。一旦出现皮疹等皮肤反应, 应立即停药。故本题答案为 A。",
    "source_note": "",
    "question_id": "63d35d1675dd4bc6187d1437567afc99ccc9faa0",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "可拮抗β肾上腺素能受体，降低交感神经效应，减慢窦性节律、心房和房室结传导的药物是",
    "options": {
      "A": "胺碘酮",
      "B": "美托洛尔",
      "C": "苯妥英钠",
      "D": "利多卡因",
      "E": "维拉帕米"
    },
    "answer": "B",
    "explanation": "本题考查抗心律失常药的分类与作用机制。β受体拮抗剂（如美托洛尔）可拮抗β肾上腺素能受体, 降低交感神经效应, 从而减慢窦性节律, 减慢心房和房室结的传导, 延长房室结的功能性不应期, 因此可用于治疗心律失常。故本题答案为B。",
    "source_note": "",
    "question_id": "0f9aa91e2013ae654d11489c0c23390659dad311",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "通过抑制磷酸二酯酶而产生抗血小板作用的药品是",
    "options": {
      "A": "阿司匹林",
      "B": "氯吡格雷 噻氯匹定",
      "C": "西洛他唑",
      "D": "替罗非班"
    },
    "answer": "C",
    "explanation": "本题考查抗血栓药的分类与代表药品。西洛他唑通过抑制磷酸二酯酶活性使血小板内环磷酸腺苷（cAMP）浓度上升，抑制血小板聚集，并可使血管平滑肌细胞内的 cAMP 浓度上升，使血管扩张，增加末梢动脉血流量。故本题答案为 C。",
    "source_note": "",
    "question_id": "d6cfa259337c32452fa7fafe9f47d29f0f9db6d3",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "下列关于依普利酮的叙述，错误的是",
    "options": {
      "A": "属于盐皮质激素受体拮抗剂, 治疗与醛固酮升高相关的水肿效果显著",
      "B": "常与袢利尿药或噻嗪类利尿药合用, 既可增加利尿水平, 也能保持正常的血钾水平",
      "C": "具有心脏保护作用, 可提高心力衰竭患者的生活质量和生存率",
      "D": "与含钾药物、ACEI、ARB 及肾素抑制剂合用增加高钾血症发生的风险",
      "E": "对雄激素受体亲和力较高, 易引起男性乳房发育, 性欲减退"
    },
    "answer": "E",
    "explanation": "本题考查留钾利尿药的临床用药评价。依普利酮对肾上腺盐皮质激素受体有更高的选择性，而对雄激素和孕激素受体的亲和力远低于螺内酯，故对性激素的影响小于螺内酯，不良反应更少（如男性乳房女性化），耐受性更好。故本题答案为E。",
    "source_note": "",
    "question_id": "f8d25042b063bda20f25e9db6198448fa5cf161a",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第1节下丘脑-垂体激素及相关药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "可维持肾上腺正常的形态与功能，促进肾上腺皮质细胞增生，并兴奋肾上腺皮质细胞合成和分泌激素，长期使用可出现医源性库欣综合征以及痤疮和多毛的药物是",
    "options": {
      "A": "肾上腺糖皮质激素",
      "B": "肾上腺盐皮质激素",
      "C": "促皮质素",
      "D": "促性腺激素",
      "E": "促肾上腺皮质激素释放激素"
    },
    "answer": "C",
    "explanation": "本题考查促皮质素（ACTH）的临床用药评价。促皮质素是维持肾上腺正常的形态与功能的重要激素，可促进肾上腺皮质细胞增生，并兴奋肾上腺皮质细胞合成和分泌肾上腺皮质激素，长期使用可产生糖皮质激素的副作用，出现医源性库欣综合征。促皮质素因刺激雄激素分泌可出现痤疮和多毛。故本题答案为C。",
    "source_note": "",
    "question_id": "baf14cf65b1c8ae179f847184159a27e11327ddc",
    "section_no": 1,
    "section_title": "下丘脑-垂体激素及相关药物",
    "section_norm": "第一节 下丘脑-垂体激素及相关药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "用药后可出现肺毒性，严重肺部疾患及严重弥漫性肺纤维化者禁用的药物是",
    "options": {
      "A": "卡铂",
      "B": "顺铂",
      "C": "长春新碱",
      "D": "博来霉素",
      "E": "羟喜树碱"
    },
    "answer": "D",
    "explanation": "本题考查破坏 DNA 的抗生素的临床用药评价。博来霉素具有肺毒性,可导致间质性肺炎, 严重肺部疾患及严重弥漫性肺纤维化者禁用。故本题答案为 D。",
    "source_note": "",
    "question_id": "ac30ed2dda20fdb3a35026559d4796357f181263",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第1节糖类、盐类、酸碱平衡调节药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "静脉滴注氯化钾可引起局部剧烈疼痛，且有心脏停搏的危险，因此静脉补钾的浓度及滴速不宜超过",
    "options": {
      "A": "40\\mathrm{mmol} / \\mathrm{L}, 750\\mathrm{mg / h}",
      "B": "40 \\mathrm{mmol} / \\mathrm{L}, 800 \\mathrm{mg} / \\mathrm{h}",
      "C": "50 \\mathrm{mmol} / \\mathrm{L}, 750 \\mathrm{mg} / \\mathrm{h}",
      "D": "50 \\mathrm{mmol} / \\mathrm{L}, 800 \\mathrm{mg} / \\mathrm{h}",
      "E": "60mmol/L, 750\\mathrm{mg / h}"
    },
    "answer": "A",
    "explanation": "本题考查氯化钾的临床用药评价。静脉滴注氯化钾之前需要先加入 5 \\% 葡萄糖注射液中稀释, 不能直接滴注与推注给药。静脉补钾浓度一般不宜超过 40 \\mathrm{mmol} / \\mathrm{L} (0.3%), 滴速不宜超过 750 \\mathrm{mg} / \\mathrm{h} (10mmol/h), 否则可引起局部剧烈疼痛, 且有导致心脏停搏的危险。故本题答案为 A。",
    "source_note": "",
    "question_id": "92acc8e12080f18a4b0621b34e4542ffdc3d90d8",
    "section_no": 1,
    "section_title": "糖类、盐类、酸碱平衡调节药",
    "section_norm": "第一节 糖类、盐类、酸碱平衡调节药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "毛果芸香碱对眼的药理作用不包括",
    "options": {
      "A": "缩小瞳孔",
      "B": "收缩睫状肌",
      "C": "降低眼压",
      "D": "减少房水分泌",
      "E": "调节麻痹"
    },
    "answer": "E",
    "explanation": "本题考查眼科用药的临床用药评价。毛果芸香碱属于胆碱能受体激动剂, 可使瞳孔括约肌和睫状肌收缩, 从而使瞳孔缩小, 同时可部分减少房水分泌, 降低眼压, 并有调节痉挛 (视近物清楚, 看远物模糊) 等作用。故本题答案为 E。",
    "source_note": "",
    "question_id": "d08adb848a03e4964764ea90610003510aa07c51",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第1节体外杀寄生虫与皮肤感染治疗药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "儿童优选的局部杀疥虫药物是",
    "options": {
      "A": "苯甲酸苄酯",
      "B": "壬二酸",
      "C": "莫匹罗星",
      "D": "克罗米通",
      "E": "硫黄"
    },
    "answer": "D",
    "explanation": "本题考查体外杀寄生虫与皮肤感染治疗药的代表药品与临床用药评价。克罗米通无刺激性, 为儿童优选的局部杀疥虫药物, 硫磺为非优选。故本题答案为 D。",
    "source_note": "",
    "question_id": "740834a02f9868d9ec7c1e38098961154ddddf44",
    "section_no": 1,
    "section_title": "体外杀寄生虫与皮肤感染治疗药",
    "section_norm": "第一节 体外杀寄生虫与皮肤感染治疗药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "可待因为前药，约 15\\% 代谢为吗啡，参与该代谢有关的肝药酶是",
    "options": {
      "A": "CYP3A4",
      "B": "CYP2C19",
      "C": "CYP2C9",
      "D": "CYP2D6",
      "E": "CYP1A2"
    },
    "answer": "D",
    "explanation": "本题考查镇咳药的临床用药评价。可待因为前药，约 15\\% 经 CYP2D6 代谢为吗啡，有四种代谢类型：超快型、快速型、正常型和缓慢代谢型，若为超快代谢型基因，易出现嗜睡、呼吸困难，中毒甚至致死，因此已知为 CYP2D6 超快代谢者禁用。故本题答案为 D。",
    "source_note": "",
    "question_id": "431b11aa658c7f259b6f0ed8b9621b5060233519",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "下列关于苯二氮草类镇静催眠药的叙述，不正确的是",
    "options": {
      "A": "地西泮半衰期较长",
      "B": "用药期间避免驾车、操纵机器和高空作业",
      "C": "突然停药可发生撤药症状",
      "D": "三唑仑属于短效药",
      "E": "长期应用不会产生依赖性"
    },
    "answer": "E",
    "explanation": "本题考查苯二氮草类的临床用药评价。苯二氮草类镇静催眠药长期使用易产生依赖性。常见嗜睡、精神依赖性、步履蹒跚、共济失调。故本题答案为 E。",
    "source_note": "",
    "question_id": "61de7e56fb907eb480369b617106830f1dae1679",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "氯吡格雷抗血小板作用的机制是",
    "options": {
      "A": "抑制凝血酶",
      "B": "拮抗血小板糖蛋白 II b/ III a 受体",
      "C": "抑制环氧化酶",
      "D": "拮抗 \\mathrm{P}2\\mathrm{Y}_{12} 受体",
      "E": "抑制磷酸二酯酶"
    },
    "answer": "D",
    "explanation": "本题考查抗血栓药的分类与代表药品。氯吡格雷属于 P2Y12 受体拮抗剂, 通过选择性、不可逆地结合 P2Y12 受体, 进而拮抗 ADP 介导的血小板聚集。故本题答案为 D。",
    "source_note": "",
    "question_id": "1e8c9af08f3ca9c148798271d2b8aa8dc6385e50",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "下列药物中利尿作用最强的药物是",
    "options": {
      "A": "味塞米",
      "B": "氢氯噻嗪",
      "C": "弓达帕胺",
      "D": "氨苯蝶啶",
      "E": "阿米洛利"
    },
    "answer": "A",
    "explanation": "本题考查袢利尿药的临床用药评价。袢利尿药是目前使用的最强的一类利尿药物，其代表药物有呋塞米、托拉塞米、依他尼酸、布美他尼。故本题答案为A。",
    "source_note": "",
    "question_id": "3855e7a417cdca45c2b4fd9e330702f80ade3bb0",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第1节下丘脑-垂体激素及相关药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "可用于治疗中枢性尿崩症和夜间遗尿症的药物是",
    "options": {
      "A": "促皮质素",
      "B": "醋酸去氨加压素",
      "C": "重组人生长激素",
      "D": "生长抑素",
      "E": "糖皮质激素"
    },
    "answer": "B",
    "explanation": "本题考查醋酸去氨加压素的临床用药评价。醋酸去氨加压素具有较强的抗利尿作用及较弱的加压作用，临床用于治疗中枢性尿崩症、夜间遗尿症（6岁或以上的患者）。故本题答案为B。",
    "source_note": "",
    "question_id": "914e7e3560520ef23e37f1dfda7c6edb410f7e4b",
    "section_no": 1,
    "section_title": "下丘脑-垂体激素及相关药物",
    "section_norm": "第一节 下丘脑-垂体激素及相关药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "属于破坏 DNA 的烷化剂的药物是",
    "options": {
      "A": "羟喜树碱",
      "B": "丝裂霉素",
      "C": "顺铂",
      "D": "塞替派",
      "E": "依托泊苷"
    },
    "answer": "D",
    "explanation": "本题考查直接影响 DNA 结构和功能的药物的分类与代表药品。破坏 DNA 的烷化剂有: 氮芥、环磷酰胺、塞替派、白消安、替莫唑胺。故本题答案为 D。羟喜树碱属于拓扑异构酶 I 抑制剂。丝裂霉素属于破坏 DNA 的抗生素。顺铂属于破坏 DNA 的铂类化合物。依托泊苷属于拓扑异构酶 II 抑制剂。",
    "source_note": "",
    "question_id": "bf391bd14a40421401d0bf79990729e80429711a",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "属于收敛腐蚀与促进吸收药，可辅助治疗玻璃体混浊的药物是",
    "options": {
      "A": "妥布霉素",
      "B": "左氧氟沙星",
      "C": "普罗碘铵",
      "D": "雷珠单抗",
      "E": "曲伏前列素"
    },
    "answer": "C",
    "explanation": "本题考查眼科用药的分类与代表药品。收敛腐蚀与促进吸收药可辅助治疗玻璃体混浊，促进组织内病理沉着物的吸收和慢性炎症的消散，代表药物为普罗碘铵、氨碘肽、卵磷脂络合碘。故本题答案为C。",
    "source_note": "",
    "question_id": "02b53fce48edf7c4ddea7bb0212ec4d59cd1bd4b",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第1节体外杀寄生虫与皮肤感染治疗药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "适用于各种细菌性皮肤感染，主要用于革兰阳性球菌引起的脓疱、疖肿、毛囊炎的药物是",
    "options": {
      "A": "莫匹罗星",
      "B": "苯甲酸苄酯",
      "C": "克罗米通",
      "D": "阿达帕林",
      "E": "克霉唑"
    },
    "answer": "A",
    "explanation": "本题考查体外杀寄生虫与皮肤感染治疗药的代表药品与临床用药评价。莫匹罗星属于皮肤感染治疗药, 在低浓度时起抑菌作用, 在高浓度时起杀菌作用, 适用于各种细菌性皮肤感染, 主要用于革兰阳性球菌引起的脓疱、疖肿、毛囊炎等。故本题答案为 A。",
    "source_note": "",
    "question_id": "a9a434ad362bb07a0916c9fea59212f18e157b81",
    "section_no": 1,
    "section_title": "体外杀寄生虫与皮肤感染治疗药",
    "section_norm": "第一节 体外杀寄生虫与皮肤感染治疗药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "属于部分选择性COX-2抑制剂的是",
    "options": {
      "A": "布洛芬",
      "B": "呃哚美辛 阿司匹林",
      "C": "双氯芬酸钠",
      "D": "尼美舒利"
    },
    "answer": "D",
    "explanation": "本题考查解热、镇痛、抗炎药的分类与作用机制。部分选择性COX-2抑制剂的代表药物有：美洛昔康、尼美舒利。故本题答案为D。布洛芬、吲哚美辛、双氯芬酸钠、阿司匹林属于非选择性COX抑制剂。",
    "source_note": "",
    "question_id": "6ee3cda3d6f415a3028c4780331ff97b237a9f08",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "关于苯丙哌林作用特点的说法，正确的是",
    "options": {
      "A": "可抑制呼吸",
      "B": "可引起胆道和十二指肠痉挛",
      "C": "易产生耐受性",
      "D": "镇咳作用为可待因的 2\\sim 4 倍，无麻醉作用",
      "E": "可引起便秘"
    },
    "answer": "D",
    "explanation": "本题考查镇咳药的临床用药评价。苯丙哌林镇咳作用较强, 为可待因的 2 \\sim 4 倍。无麻醉作用, 不抑制呼吸, 不引起胆道和十二指肠痉挛, 不引起便秘, 无成瘾性, 未发现耐受性。故本题答案为 D。",
    "source_note": "",
    "question_id": "a62f94ba73d191a2b3d21e2a49de627ebaf4a7b7",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "PPI长期使用易导致",
    "options": {
      "A": "高钠血症",
      "B": "高钙血症",
      "C": "低镁血症",
      "D": "高镁血症",
      "E": "高钾血症"
    },
    "answer": "C",
    "explanation": "本题考查质子泵抑制剂（PPI）的临床用药评价。长期应用 PPI 可引起高胃泌素血症、骨折、低镁血症、维生素 B12 缺乏。故本题答案为 C。",
    "source_note": "",
    "question_id": "c71f72f2856eba418a3d096b90c5708b080dc276",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "维拉帕米的适应证不包括",
    "options": {
      "A": "变异型心绞痛",
      "B": "原发性高血压",
      "C": "阵发性室上性心动过速",
      "D": "左心室特发性室性心动过速",
      "E": "二度或三度房室传导阻滞"
    },
    "answer": "E",
    "explanation": "本题考查钙通道阻滞剂的临床用药评价。维拉帕米（1）口服 ① 心绞痛：变异型心绞痛、不稳定型心绞痛、慢性稳定型心绞痛；② 心律失常：与地高辛合用控制慢性心房颤动和（或）心房扑动时的心室率；预防阵发性室上性心动过速的反复发作；③ 原发性高血压。（2）静脉注射用于终止阵发性室上性心动过速和左心室特发性室性心动过速。由于维拉帕米主要减慢窦房结的自律性和抑制房室结传导，故病态窦房结综合征患者和二度或三度房室传导阻滞患者禁用，窦性心动过缓和一度房室传导阻滞患者慎用。故本题答案为 E。",
    "source_note": "explanation_range_detected",
    "question_id": "4f6b7e075300774e3a9947b8be5e97f125b0ab85",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "可口服的直接凝血酶抑制剂是",
    "options": {
      "A": "达肝素钠",
      "B": "达比加群酯",
      "C": "利伐沙班",
      "D": "比伐芦定",
      "E": "华法林"
    },
    "answer": "B",
    "explanation": "本题考查抗血栓药的分类与代表药品。直接凝血酶抑制剂的代表药品有达比加群酯、水蛭素、重组水蛭素、比伐芦定, 其中达比加群酯是可口服的, 水蛭素、重组水蛭素、比伐芦定均需注射给药。故本题答案为 B。",
    "source_note": "",
    "question_id": "0caa3ef4822df694e29a826999b794e5d54ebcdd",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "吲达帕胺用于治疗原发性高血压时，最好的给药时间是",
    "options": {
      "A": "每日早晨给药1次",
      "B": "每日睡前给药1次",
      "C": "每日早晚给药2次",
      "D": "每日餐前给药3次",
      "E": "每日餐后给药3次"
    },
    "answer": "A",
    "explanation": "本题考查噻嗪与类噻嗪类利尿药的临床用药评价。吲达帕胺通常早上给药，一日1次，可有效避免夜间起夜而影响睡眠。故本题答案为A。",
    "source_note": "",
    "question_id": "7551ee7e86f62ae119bc18ef90fd08b24f096e10",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第1节下丘脑-垂体激素及相关药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "下列关于重组人生长激素的描述，错误的是",
    "options": {
      "A": "重组人生长激素为 191 个氨基酸构成的肽类激素",
      "B": "可用于重度烧伤的治疗",
      "C": "可引起一过性高血糖现象",
      "D": "罹患肿瘤或近2年内有恶性肿瘤病史者禁用",
      "E": "可用于因内源性生长激素缺乏或骨骺过早闭合所引起的儿童生长缓慢"
    },
    "answer": "E",
    "explanation": "本题考查重组人生长激素的临床用药评价。生长激素为 191 个氨基酸构成的肽类激素, 重组人生长激素氨基酸含量及序列与生长激素完全相同, 可用于因内源性生长激素缺乏所引起的儿童生长缓慢, 以及重度烧伤的治疗, 但禁用于骨骺已经闭合的儿童。故本题答案为 E。生长激素可引起一过性的高血糖现象, 通常随着用药时间延长或停药后恢复正常。罹患肿瘤或近 2 年内有恶性肿瘤病史者禁用。",
    "source_note": "",
    "question_id": "c585b4ebce9e0e7dc88dfa9e7932884a43c0fcac",
    "section_no": 1,
    "section_title": "下丘脑-垂体激素及相关药物",
    "section_norm": "第一节 下丘脑-垂体激素及相关药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "可透过血-脑屏障，为脑瘤的首选用药的是",
    "options": {
      "A": "奥沙利铂",
      "B": "顺铂",
      "C": "依托泊苷",
      "D": "替尼泊苷",
      "E": "羟喜树碱"
    },
    "answer": "D",
    "explanation": "本题考查拓扑异构酶抑制剂的临床用药评价。替尼泊苷脂溶性高，可透过血-脑屏障，为颅脑肿瘤的首选用药，依托泊苷的化疗指数高，为小细胞肺癌的首选用药。故本题答案为 D。",
    "source_note": "",
    "question_id": "94216fb230304217a690a099e918f1f0fe877891",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "属于毛果芸香碱适应证的是",
    "options": {
      "A": "青光眼",
      "B": "白内障",
      "C": "视网膜黄斑变性",
      "D": "散瞳验光"
    },
    "answer": "A",
    "explanation": "本题考查眼科用药的临床用药评价。毛果芸香碱可用于治疗原发性青光眼，包括开角型青光眼与闭角型青光眼。故本题答案为A。",
    "source_note": "",
    "question_id": "3a69cc2f5433182e262d4a691e82654c486c968e",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "关于镇咳药作用特点的说法，正确的是",
    "options": {
      "A": "喷托维林镇咳作用强度约为可待因的2倍",
      "B": "福尔可定缓解干咳的效果弱于可待因",
      "C": "儿童对福尔可定耐受性好，无成瘾性，不引起便秘或消化功能紊乱",
      "D": "可待因适用于伴有胸痛的剧烈干咳",
      "E": "右美沙芬口服吸收缓慢，无镇痛作用"
    },
    "answer": "D",
    "explanation": "本题考查镇咳药的临床用药评价。可待因镇咳作用强而迅速，约为吗啡的 1 / 4 ，适用于各种原因引起的剧烈干咳和刺激性咳嗽，尤其适合于伴有胸痛的剧烈干咳，但具有成瘾性。故本题答案为 D。喷托维林镇咳作用强度约为可待因的 1 / 3 。福尔可定具有与可待因相似的镇咳、镇痛作用，缓解干咳的效果比可待因好，成瘾性比可待因小，呼吸抑制较吗啡弱，儿童对福尔可定耐受性较好，不引起便秘或消化功能紊乱。 右美沙芬口服吸收迅速，治疗剂量不抑制呼吸，长期应用未见耐受性和成瘾性，无镇痛作用。",
    "source_note": "",
    "question_id": "fb69aeee5dd8d37cb10439fab851b22a33132cd5",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "可竞争性结合质子泵的钾离子结合位点，阻止 \\mathsf{K}^{+} 的跨膜转运，抑制胃酸分泌，用于反流性食管炎的药物是",
    "options": {
      "A": "米索前列醇",
      "B": "吉法酯",
      "C": "兰索拉唑",
      "D": "西米替丁"
    },
    "answer": "B",
    "explanation": "本题考查钾离子竞争性酸阻滞剂（P-CABs）的临床用药评价。伏诺拉生属于钾离子竞争性酸阻滞剂，通过竞争性结合质子泵的钾离子结合位点，阻止 \\mathsf{K}+ 的跨膜转运，能够对质子泵产生可逆性的抑制，从而抑制胃酸分泌，主要用于反流性食管炎的治疗。故本题答案为B。米索前列醇属于前列腺素类抑酸剂。兰索拉唑属于质子泵抑制剂。西咪替丁属于H2受体拮抗剂。吉法酯属于胃黏膜保护药。",
    "source_note": "",
    "question_id": "438a20b7c30310313316425341b2b9afb591b823",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "老年人对苯二氮草类药较为敏感，用药后可致平衡功能失调，觉醒后可发生步履蹒跚、思维迟钝等症状，在临床上被称为",
    "options": {
      "A": "震颤麻痹综合征",
      "B": "老年期痴呆",
      "C": "“宿醉”现象",
      "D": "戒断综合征",
      "E": "锥体外系反应"
    },
    "answer": "C",
    "explanation": "本题考查苯二氮草类的临床用药评价。老年人对苯二氮草类药物较为敏感, 服用本类药物后, 可产生过度镇静、肌肉松弛作用, 觉醒后可发生震颤、思维迟缓、运动障碍、认知功能障碍、步履蹒跚、肌无力等 “宿醉” 现象。故本题答案为 C。",
    "source_note": "",
    "question_id": "33e0e1341175a1e04e9bb08afcaeb1a97d69f54b",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "可引起角膜色素沉着的抗心律失常药是",
    "options": {
      "A": "利多卡因",
      "B": "索他洛尔",
      "C": "维拉帕米",
      "D": "胺碘酮",
      "E": "普鲁卡因胺"
    },
    "answer": "D",
    "explanation": "本题考查钾通道阻滞剂的临床用药评价。胺碘酮的典型不良反应有光敏感性、角膜色素沉着、甲状腺功能障碍等。故本题答案为 D。",
    "source_note": "",
    "question_id": "9a8268e26c89b6425b4a43628a1da16068faca42",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "属于直接 Xa 抑制剂的是",
    "options": {
      "A": "依诺肝素钠",
      "B": "替格瑞洛",
      "C": "华法林",
      "D": "利伐沙班",
      "E": "达比加群酯"
    },
    "answer": "D",
    "explanation": "本题考查抗血栓药的分类与代表药品。直接 Xa 抑制剂的代表药品有利伐沙班、阿哌沙班、艾多沙班。故本题答案为 D。",
    "source_note": "",
    "question_id": "b9662fecd2e6bd7abc6c34e9a9092f8c628393f8",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "留钾利尿药中作用最强的药物是",
    "options": {
      "A": "螺内酯",
      "B": "依普利酮",
      "C": "氨苯蝶啶",
      "D": "阿米洛利",
      "E": "非奈利酮"
    },
    "answer": "D",
    "explanation": "本题考查留钾利尿药的临床用药评价。阿米洛利为留钾利尿药作用最强的药物，作用强度是氨苯蝶啶的10倍。故本题答案为D。",
    "source_note": "",
    "question_id": "02edc92706fa3c86a21e75ab8bd82ce85fa2e1ba",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第1节下丘脑-垂体激素及相关药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "促皮质素的不良反应不包括",
    "options": {
      "A": "水钠潴留",
      "B": "低血钾",
      "C": "骨质疏松",
      "D": "低血糖反应",
      "E": "痤疮、多毛"
    },
    "answer": "D",
    "explanation": "本题考查促皮质素（ACTH）的临床用药评价。促皮质素可导致高血糖，糖尿病患者需调整、增加降血糖药用量。故本题答案为D。",
    "source_note": "",
    "question_id": "cd5ba6be2cbb69c3f13ad24c3850f77c0f00e179",
    "section_no": 1,
    "section_title": "下丘脑-垂体激素及相关药物",
    "section_norm": "第一节 下丘脑-垂体激素及相关药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "会加重奥沙利铂所致的严重神经系统毒性（感觉障碍、痉挛）的行为是",
    "options": {
      "A": "温泉浴",
      "B": "日光浴",
      "C": "冷水浴",
      "D": "饮用热饮",
      "E": "接触塑料制品"
    },
    "answer": "C",
    "explanation": "本题考查破坏 DNA 的铂类化合物的临床用药评价。奥沙利铂神经毒性强, 神经毒性（包括感觉性周围神经病）是剂量依赖性的, 遇冷可加重, 静脉滴注期间不可食用冷食和饮用冷水, 并避免接触冰冷的物体。故本题答案为 C。",
    "source_note": "",
    "question_id": "9059037d19ee7b82b689200d58675cb041936566",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "关于环氧化酶（COX）和前列腺素（PG）的生理作用及相互关系的说法，错误的是",
    "options": {
      "A": "PGs 可增强该处受损组织痛觉的敏感度,构成炎症部位肿痛炎症的症状",
      "B": "COX 是 PG 合成的必需酶, 也是 PG 初始合成步骤中的关键限速酶",
      "C": "COX-2 可抑制 PG 的生成，减少炎症反应",
      "D": "COX-1 参与血管舒缩、血小板聚集、胃黏膜血流、胃黏液分泌及肾功能等的调节",
      "E": "COX包括COX-1和COX-2两种异构体"
    },
    "answer": "C",
    "explanation": "本题考查解热、镇痛、抗炎药的作用机制。环氧化酶是前列腺素（PG）合成所必需的酶，也是 PG 合成初始步骤中的关键性限速酶；目前发现环氧化酶有 COX-1 和 COX-2 两种异构体，前者主要存在于血管、胃、肾等组织中，参与血管舒缩、血小板聚集、胃黏膜血流、胃黏液分泌及肾功能等的调节，其功能与保护胃肠黏膜、调节血小板聚集、调节外周血管的阻力和调节肾血流量分布有关。后者主要在损伤或炎症部位表达，并合成 PGs 类物质，PGs 可增强该处受损组织痛觉的敏感度，构成炎症部位肿痛炎症的症状。故本题答案为 C。",
    "source_note": "",
    "question_id": "f2ddc3c4b44e856ee14924052f3ed3e894a10d34",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "关于镇咳药作用强度的比较，正确的是",
    "options": {
      "A": "右美沙芬 \\geqslant 可待因 > 喷托维林 > 苯丙哌林",
      "B": "可待因 > 苯丙哌林 > 喷托维林 > 右美沙芬",
      "C": "苯丙哌林 > 右美沙芬 \\geqslant 可待因 > 喷托维林",
      "D": "喷托维林 > 右美沙芬 > 可待因 > 苯丙哌林",
      "E": "苯丙哌林 > 喷托维林 > 右美沙芬 \\geqslant 可待因"
    },
    "answer": "C",
    "explanation": "本题考查镇咳药的临床用药评价。苯丙哌林的镇咳作用较强，为可待因的 2 \\sim 4 倍，右美沙芬镇咳强度与可待因相等或略强，喷托维林镇咳作用强度约为可待因的 1 / 3 。因此镇咳作用强度的比较顺序为：苯丙哌林 > 右美沙芬 \\geqslant 可待因 > 喷托维林。故本题答案为 C。",
    "source_note": "",
    "question_id": "d7851cc6ea7c923621eb313367cecfa9355bc0ea",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "属于组胺 \\mathrm{H}_{2} 受体拮抗剂的是",
    "options": {
      "A": "伏诺拉生",
      "B": "雷尼替丁",
      "C": "米索前列醇",
      "D": "甲硝唑",
      "E": "奥美拉唑"
    },
    "answer": "B",
    "explanation": "本题考查抑酸剂的分类与代表药品。H2 受体拮抗剂包括雷尼替丁、法莫替丁、西咪替丁等。故本题答案为 B。",
    "source_note": "",
    "question_id": "a3741ca88e5207d7c0590fe8a886bbede62a8939",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "适应证为仅用于治疗失眠的药物是",
    "options": {
      "A": "地西泮",
      "B": "佐匹克隆",
      "C": "卡马西平",
      "D": "氟西汀",
      "E": "吗啡"
    },
    "answer": "B",
    "explanation": "本题考查非苯二氮草类的临床用药评价。佐匹克隆的适应证：用于各种失眠症。故本题答案为 B。",
    "source_note": "",
    "question_id": "c1720f54a12bb4f7bd61f9797770f94aefe3c5d7",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "与钠通道解离时间长，对钠通道抑制作用强的药物是",
    "options": {
      "A": "奎尼丁",
      "B": "利多卡因",
      "C": "普罗帕酮",
      "D": "索他洛尔",
      "E": "维拉帕米"
    },
    "answer": "C",
    "explanation": "本题考查抗心律失常药的分类与作用机制。普罗帕酮属于 Ic 类抗心律失常药，阻滞钠通道失活，与钠通道解离时间长，抑制钠通道作用强。故本题答案为 C。",
    "source_note": "",
    "question_id": "f8cb0653f3d5ff691068350fdc7bc6f1f4c1ccff",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "下列药物中，不属于抗血小板药的是",
    "options": {
      "A": "氯吡格雷",
      "B": "阿司匹林",
      "C": "双嘧达莫",
      "D": "阿替普酶",
      "E": "阿昔单抗"
    },
    "answer": "D",
    "explanation": "本题考查抗血栓药的分类与代表药品。阿替普酶属于溶栓药。故本题答案为D。",
    "source_note": "",
    "question_id": "14637656c73f7da9d5923d808c0909bb55adef32",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "是加压素受体选择性拮抗药，可以在不损失电解质的情况下增加水的排泄，临床用于治疗抗利尿激素分泌失调综合征引起的低钠血症的药物是",
    "options": {
      "A": "托伐普坦",
      "B": "乙酰唑胺",
      "C": "甘露醇",
      "D": "达格列净",
      "E": "氨苯蝶啶"
    },
    "answer": "A",
    "explanation": "本题考查加压素受体拮抗剂的临床用药评价。托伐普坦是血管加压素 V2 受体选择性拮抗药, 也被称为排水利尿药, 可以在不损失电解质的情况下增加水的排泄 (脱水), 临床用于治疗低钠血症, 尤其是抗利尿激素分泌失调综合征等多种原因引起的低钠血症。故本题答案为 A。",
    "source_note": "",
    "question_id": "2f914353a9ca70b67e3f7026d7695e8f1d0d1996",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第1节下丘脑-垂体激素及相关药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "由腺垂体分泌，在人血浆中具有规律性昼夜节律变化，早晨睡醒前及后1h内达最高峰，下午 6\\sim 11 点最低的是",
    "options": {
      "A": "促皮质素",
      "B": "生长激素",
      "C": "生长抑素",
      "D": "糖皮质激素",
      "E": "去氨加压素"
    },
    "answer": "A",
    "explanation": "本题考查促皮质素（ACTH）的临床用药评价。人血浆中促皮质素（ACTH）水平具有规律性昼夜节律变化，一般睡眠后 3 \\sim 5 \\mathrm{~h} 分泌频率增加，早晨睡醒前及后 1 \\mathrm{~h} 内达最高峰，以后渐减，下午 6 \\sim 11 点最低。故本题答案为 A。",
    "source_note": "",
    "question_id": "b739729febd6475f118ad8e1947ad81907c1eeb7",
    "section_no": 1,
    "section_title": "下丘脑-垂体激素及相关药物",
    "section_norm": "第一节 下丘脑-垂体激素及相关药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "能干扰拓扑异构酶 I 的活性, 从而阻止 DNA 复制及抑制 RNA 合成的药物是",
    "options": {
      "A": "紫杉醇",
      "B": "羟喜树碱",
      "C": "丝裂霉素",
      "D": "奥沙利铂",
      "E": "阿糖胞苷"
    },
    "answer": "B",
    "explanation": "本题考查直接影响 DNA 结构和功能的药物的分类与代表药品。拓扑异构酶 I 抑制剂的代表药物有伊立替康、拓扑替康、羟喜树碱。故本题答案为 B。",
    "source_note": "",
    "question_id": "e479d551d601ea43ee3056982effa5138e59610f",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "属于 \\alpha_{2} 受体激动药的降眼压药是",
    "options": {
      "A": "左布诺洛尔",
      "B": "毛果芸香碱",
      "C": "消旋山莨菪碱",
      "D": "溴莫尼定",
      "E": "布林佐胺"
    },
    "answer": "D",
    "explanation": "本题考查眼科用药的分类与代表药品。α2受体激动药的代表药物为溴莫尼定。故本题答案为D。左布诺洛尔属于β受体拮抗药。毛果芸香碱属于胆碱能受体激动药。消旋山莨菪碱属于散瞳药。布林佐胺属于碳酸酐酶抑制药。",
    "source_note": "",
    "question_id": "bad9622a79fcd9432d93a43c7a959f57d22b87f7",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "长期使用可能增加严重心血管血栓性不良事件的非甾体抗炎药是",
    "options": {
      "A": "阿司匹林",
      "B": "双氯芬酸",
      "C": "塞来昔布",
      "D": "弓喉美辛",
      "E": "布洛芬"
    },
    "answer": "C",
    "explanation": "本题考查解热、镇痛、抗炎药的临床用药评价。塞来昔布为选择性COX-2抑制剂，抑制血管内皮的前列腺素生成，使血管内的前列腺素和血小板中的血栓素动态平衡失调，导致血栓素升高，促进血栓形成，因而存在心血管不良反应风险。长期使用塞来昔布可能增加严重心血管血栓性不良事件、心肌梗死和卒中的风险，其风险可能是致命的。故本题答案为C",
    "source_note": "",
    "question_id": "24aa75f03fb272d92d8ee9e4458e1c4f5f1d37ce",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "关于可待因临床应用的说法，错误的是",
    "options": {
      "A": "通常还具有较强的镇痛、镇静作用",
      "B": "不抑制呼吸，无抑制支气管腺体分泌作用，痰多黏稠患者不宜单独使用",
      "C": "重复给药可产生耐受性, 久用有成瘾性",
      "D": "18 岁以下儿童和青少年禁用含有可待因的咳嗽感冒药",
      "E": "服药期间不得驾驶车、船, 或从事高空作业"
    },
    "answer": "B",
    "explanation": "本题考查镇咳药的临床用药评价。可待因为中枢性镇咳药，可选择性地抑制延髓的咳嗽中枢，抑制支气管腺体的分泌，产生中枢性镇咳作用，剂量过大可抑制呼吸。痰多黏稠患者不宜单独使用。故本题答案为 B。",
    "source_note": "",
    "question_id": "163fcc34bc28adc360d2236be185886275c98928",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "西咪替丁易透过血-脑屏障，老年人常见的不良反应是",
    "options": {
      "A": "低镁血症",
      "B": "眼压升高",
      "C": "高钾血症",
      "D": "定向力障碍",
      "E": "Q-T间期延长"
    },
    "answer": "D",
    "explanation": "本题考查 H2 受体拮抗剂的临床用药评价。H2 受体拮抗剂（如西咪替丁）可透过血-脑屏障，引起定向力障碍（头晕、乏力、神志不清、精神异常、行为异常、幻觉、激动、失眠等）。故本题答案为 D。",
    "source_note": "",
    "question_id": "ee6e2142e20c39c4f19596f1a0fc4c83cb9d03bc",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "关于唑吡坦作用特点的说法，错误的是",
    "options": {
      "A": "属于 \\gamma- 氨基丁酸 A 型受体激动剂",
      "B": "具有镇静催眠、抗焦虑作用",
      "C": "口服后消化道吸收迅速",
      "D": "血浆蛋白结合率高",
      "E": "含有咪唑并吡啶结构"
    },
    "answer": "B",
    "explanation": "本题考查非苯二氮草类的临床用药评价。唑吡坦为含有咪唑并吡啶结构的 \\gamma-氨基丁酸 A 型（GABAA）受体激动剂，仅具有镇静催眠作用，而无抗焦虑、肌肉 松弛和抗惊厥等作用。故本题答案为B。唑吡坦口服后消化道吸收迅速，血浆蛋白结合率高，主要经肝脏代谢，经肾脏排出。",
    "source_note": "",
    "question_id": "e89277f71c39732d7a26100d0a89c8786f369554",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "属于丝氨酸蛋白酶抑制剂的抗凝血药是",
    "options": {
      "A": "华法林",
      "B": "阿哌沙班",
      "C": "蒂莫司他",
      "D": "达比加群酯",
      "E": "磺达肝癸钠"
    },
    "answer": "C",
    "explanation": "本题考查抗血栓药的分类与代表药品。抗凝血药包括：①维生素K拮抗剂（华法林）；②肝素类药物（如肝素钠、磺达肝癸钠）；③直接凝血酶（IIa）抑制剂（如达比加群酯）；④直接Xa抑制剂（如阿哌沙班）；⑤丝氨酸蛋白酶抑制剂（萘莫司他）。故本题答案为C。",
    "source_note": "explanation_range_detected",
    "question_id": "2c079716e616cd22d4d21e2d23752d2dccd93bd6",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "既可用于各种原因引起的水肿，也可用于治疗肾性尿崩症的药物是",
    "options": {
      "A": "依普利酮",
      "B": "氢氯噻嗪",
      "C": "布美他尼",
      "D": "阿米洛利",
      "E": "味塞米"
    },
    "answer": "B",
    "explanation": "本题考查噻嗪类与类噻嗪类利尿药的临床用药评价。氢氯噻嗪具有利 尿作用，可用于治疗各种原因引起的水肿，对轻、中度心源性水肿疗效较好；还具有抗利尿作用，可用于治疗肾性尿崩症及中枢性尿崩症。故本题答案为B。",
    "source_note": "",
    "question_id": "d02122d1a3e971d62b510b37431f70ab170dd71a",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "奥沙利铂作为常用抗肿瘤药物，首选用于治疗",
    "options": {
      "A": "慢性淋巴细胞性白血病",
      "B": "非小细胞肺癌",
      "C": "纤维瘤",
      "D": "结直肠癌",
      "E": "脂肪瘤"
    },
    "answer": "D",
    "explanation": "本题考查破坏 DNA 的铂类化合物的临床用药评价。奥沙利铂是胃肠道癌的常用药, 是结直肠癌的首选药之一。故本题答案为 D。",
    "source_note": "",
    "question_id": "32af99b8a4a24bd31046ab295c2b5b1ed0ed727c",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "具有抑制碳酸酐酶，降低眼内压作用，常用于青光眼治疗的药物是",
    "options": {
      "A": "味塞米",
      "B": "螺内酯",
      "C": "乙酰唑胺",
      "D": "氢氯噻嗪",
      "E": "甘油果糖"
    },
    "answer": "C",
    "explanation": "本题考查眼科用药的分类与代表药品。乙酰唑胺为碳酸酐酶抑制药,可以减少房水的生成，降低眼内压，主要用于治疗青光眼。故本题答案为 C。",
    "source_note": "",
    "question_id": "a9c3cbe9d83d932824ebba83e803cb42142eae99",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "镇咳作用约为可待因的1/3，口服易吸收，禁用于2岁以下儿童的药物是",
    "options": {
      "A": "右美沙芬",
      "B": "氯化铵",
      "C": "可待因",
      "D": "喷托维林",
      "E": "苯丙哌林"
    },
    "answer": "D",
    "explanation": "本题考查镇咳药的临床用药评价。喷托维林的镇咳作用约为可待因的 1 / 3,口服易吸收, 在 20 \\sim 30 分钟内起效, 一次给药镇咳作用可维持 4 \\sim 6 小时, 禁用于 2 岁以下儿童。故本题答案为 D。",
    "source_note": "",
    "question_id": "36b9a4372610ec5a35b522cd1956a8925b85e143",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "对褪黑素受体有高亲和力，可用于失眠的短期治疗，且无催眠副作用的药物是",
    "options": {
      "A": "水合氯醛",
      "B": "唑吡坦",
      "C": "三唑仑",
      "D": "雷美替胺",
      "E": "苯巴比妥"
    },
    "answer": "D",
    "explanation": "本题考查褪黑素类的临床用药评价。雷美替胺为褪黑素受体激动剂，对褪黑素受体有高亲和力，通常用于失眠的短期治疗。与非苯二氮草类或苯二氮草类药物相比，雷美替胺的副作用较少，没有催眠副作用、戒断反应和反跳性失眠，并且依赖性小。故本题答案为 D。",
    "source_note": "",
    "question_id": "75031d37f8f2db94d4ebb084fea8246f0ad9f282",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "关于铂类药物的描述，错误的是",
    "options": {
      "A": "作用机制是破坏 DNA 的结构和功能",
      "B": "为细胞增殖周期非特异性抑制剂",
      "C": "卡铂和奥沙利铂在葡萄糖溶液中稳定",
      "D": "顺铂是结直肠癌的首选药之一",
      "E": "奥沙利铂与顺铂、卡铂无交叉耐药性"
    },
    "answer": "D",
    "explanation": "本题考查破坏 DNA 的铂类化合物的临床用药评价。铂类化合物可与 DNA 结合, 破坏其结构与功能, 为细胞周期非特异性抑制剂。奥沙利铂是结直肠癌的首选药之一, 与顺铂、卡铂无交叉耐药性。故本题答案为 D。",
    "source_note": "",
    "question_id": "79cb2213dfa499f28119da463d2fe81998b2ba88",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "通过阻断由血管内皮生长因子介导的信号传递，抑制病变新生血管的生长，治疗多种眼底新生血管疾病，如湿性年龄相关性黄斑变 性的药物是",
    "options": {
      "A": "阿昔洛韦",
      "B": "庆大霉素滴",
      "C": "玻璃酸钠",
      "D": "康柏西普"
    },
    "answer": "D",
    "explanation": "本题考查眼科用药的分类与代表药品。康柏西普为抗血管内皮生长因子药, 通过阻断由血管内皮生长因子介导的信号传递, 抑制病变新生血管的生长, 治疗多种眼底新生血管疾病, 包括湿性年龄相关性黄斑变性、糖尿病黄斑水肿、视网膜静脉阻塞、新生血管性青光眼及虹膜新生血管等。故本题答案为 D。",
    "source_note": "",
    "question_id": "f3d23f2b2036db580f8296a13e741834c3cf4ea5",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "关于 \\mathsf{H}_2 受体拮抗剂作用特点及药物相互作用的说法，错误的是",
    "options": {
      "A": "与胃壁细胞上 \\mathrm{H}_{2} 受体结合, 抑制组胺刺激引起的胃酸分泌",
      "B": "法莫替丁具有较强抗雄激素作用，会导致男性乳房女性化",
      "C": "睡前服用 \\mathrm{H}_{2} 受体拮抗剂能有效抑制夜间基础胃酸分泌",
      "D": "雷尼替丁主要以原型通过肾脏清除",
      "E": "西咪替丁结构中的咪唑环与肝药酶有较强的亲和力, 能影响肝药酶的活性"
    },
    "answer": "B",
    "explanation": "本题考查 H2 受体拮抗剂的临床用药评价。H2 受体拮抗剂能竞争性地拮抗组胺与胃壁细胞上的 H2 受体结合, 抑制组胺刺激后引起的胃酸分泌。西咪替丁含有咪唑环结构, 对肝药酶有较强的抑制作用。西咪替丁具有轻度抗雄激素作用, 法莫替丁和雷尼替丁对性激素的影响较轻。西咪替丁和拉呋替丁主要经肝脏代谢清除, 而法莫替丁、雷尼替丁、尼扎替丁、罗沙替丁主要以原型经肾脏清除, 肾功能不全者可能需调整剂量。故本题答案为 B。",
    "source_note": "",
    "question_id": "15a368c4526538c4862228a9a0262f65b6b08cd6",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "半衰期短，几乎不会出现宿醉现象，故可作为入睡困难者首选的药物是",
    "options": {
      "A": "地西泮",
      "B": "佐匹克隆",
      "C": "苯巴比妥",
      "D": "唑吡坦",
      "E": "扎来普隆"
    },
    "answer": "E",
    "explanation": "本题考查非苯二氮草类的临床用药评价。扎来普隆是入睡困难者的首选用药，但不宜长期使用。半衰期短，几乎不会出现宿醉现象。故本题答案为E。",
    "source_note": "",
    "question_id": "f1ffaaca750656e162cbccb6cf4d03114c36a409",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "华法林是临床常用的口服抗凝药物。关于华法林合理使用的说法，正确的是",
    "options": {
      "A": "华法林对已经合成的凝血因子无抑制作用，抗凝作用要待功能正常的凝血因子消耗后才显现，因此起效缓慢",
      "B": "华法林代谢较快, 一般停药后凝血功能便可恢复, 适用于择期手术患者",
      "C": "肾功能不全者禁用华法林",
      "D": "华法林的抗凝作用能被维生素 \\mathbb{K}_1 所拮抗，因此在用药期间避免进食富含维生素\\mathbb{K}_1 的绿色果蔬",
      "E": "华法林不易通过胎盘屏障，为妊娠期首选的抗凝药"
    },
    "answer": "A",
    "explanation": "本题考查维生素 K 拮抗剂的临床用药评价。华法林对已经合成的凝血因子无抑制作用，抗凝作用要待功能正常的凝血因子消耗后才显现，因此起效缓慢，需要几天才能达到所需药效。故本题答案为 A。华法林疗效个体差异较大，治疗期间应根据凝血酶原时间 INR 值调整用量，药效维持时间较长，用药期间应避免不必要的手术操作，择期手术者应停药 7 日。华法林几乎完全通过肝脏代谢失活，肾功能不全患者不必调整华法林的剂量。食物中维生素 K 的含量可能会影响华法林的治疗作用。建议服用华法林的患者保持正常均衡饮食，以保持维生素 K 的稳定摄入量。华法林能透过胎盘屏障，妊娠期要禁用（具有高血栓栓塞风险的机械心脏瓣膜的妊娠期女性除外）。",
    "source_note": "",
    "question_id": "a34564ae30f69fb6c3a8ae5fece8b9479d2bb56f",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "下列利尿药中，与同类药物相比耳毒性更大，因此临床使用受到限制的是",
    "options": {
      "A": "吹塞米",
      "B": "阿米洛利",
      "C": "托拉塞米",
      "D": "依他尼酸",
      "E": "吟达帕胺"
    },
    "answer": "D",
    "explanation": "本题考查袢利尿药的临床用药评价。袢利尿药（如呋塞米、布美他尼、依他尼酸、托拉塞米）具有耳毒性, 与其他袢利尿药相比, 依他尼酸耳毒性更大,因此临床使用受到限制, 主要用作对含磺酰胺基团、磺胺类药物过敏或不耐受患者的替代药物。故本题答案为 D。",
    "source_note": "",
    "question_id": "8b76d6df5b7ee5457f24a0f2da46f431153dca3e",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "由于分子结构上的差异，导致三种铂类化合物的各自毒性亦有所区别，有显著的肾毒性、血液毒性、神经毒性的药物分别是",
    "options": {
      "A": "卡铂、顺铂、奥沙利铂",
      "B": "顺铂、奥沙利铂、卡铂",
      "C": "奥沙利铂、卡铂、顺铂",
      "D": "顺铂、卡铂、奥沙利铂",
      "E": "卡铂、奥沙利铂、顺铂"
    },
    "answer": "D",
    "explanation": "本题考查破坏 DNA 的铂类化合物的临床用药评价。由于分子结构上的差异, 导致三种铂类化合物的各自毒性亦有所区别, 顺铂有显著的胃肠道反应和肾毒性; 卡铂的血液毒性显著, 可导致骨髓抑制; 奥沙利铂有显著的神经毒性。故本题答案为 D。",
    "source_note": "",
    "question_id": "52ea08eef48ccd9bb49e4e9aabe54def5d7fa4db",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "通过拮抗 \\beta 受体，减少睫状体的房水生成而降低眼压的药物是",
    "options": {
      "A": "托吡卡胺",
      "B": "噬吗洛尔",
      "C": "溴莫尼定",
      "D": "醋甲唑胺",
      "E": "毛果芸香碱"
    },
    "answer": "B",
    "explanation": "本题考查眼科用药的分类与代表药品。B 受体拮抗药通过减少睫状体的房水生成而降低眼压, 代表药物有噻吗洛尔、倍他洛尔、卡替洛尔、左布诺洛尔。故本题答案为 B。",
    "source_note": "",
    "question_id": "d4d1419e0d1f8a215308053ea15be8cf6fe64199",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "既可用于治疗由NSAID引起的消化性溃疡，也可与米非司酮序贯联合用于终止早孕的药物是",
    "options": {
      "A": "替戈拉生",
      "B": "米索前列醇",
      "C": "西地那非",
      "D": "利托君",
      "E": "十一酸睾酮"
    },
    "answer": "B",
    "explanation": "本题考查前列腺素类抑酸剂的临床用药评价。米索前列醇属于前列腺素类抑酸剂, 可用于治疗由 NSAID 引起的消化性溃疡, 也可与米非司酮序贯联合使用,用于终止停经 49 日内的早期妊娠。故本题答案为 B。",
    "source_note": "",
    "question_id": "42b3094c475750302f0b8f03443460b1c68ddf48",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "属于非苯二氮草类，可用于多发性硬化症所引起的严重但可逆的肌肉痉挛的药物是",
    "options": {
      "A": "地西泮",
      "B": "佐匹克隆",
      "C": "苯巴比妥",
      "D": "巴氯芬",
      "E": "苯妥英钠"
    },
    "answer": "D",
    "explanation": "本题考查中枢肌松药的临床用药评价。巴氯芬属于非苯二氮草类中枢肌松药，临床用于多发性硬化症所引起的严重但可逆的肌肉痉挛。故本题答案为 D。佐匹克隆仅用于治疗失眠。",
    "source_note": "",
    "question_id": "2eff6c5cd7bf5e5126f97dfb2c4fd9224797ec21",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "华法林是消旋体，由S-对映体和R-对映体组成，关于二者的抗凝作用，说法正确的是",
    "options": {
      "A": "S-对映体的抗凝作用较R-对映体强",
      "B": "消旋体的作用强于二者",
      "C": "二者抗凝作用等效",
      "D": "二者抗凝作用关系不确定"
    },
    "answer": "A",
    "explanation": "本题考查维生素 K 拮抗剂的临床用药评价。华法林是消旋体, 由 S-对映体和 R-对映体组成，前者的抗凝作用约是后者的 3 \\sim 5 倍。故本题答案为 A。",
    "source_note": "",
    "question_id": "9473a4df7b8b56d6e955956886b5306f22f0e176",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "可直接阻断远曲小管末端和集合管管腔膜上的 \\mathrm{Na}^{+}通道的利尿药是",
    "options": {
      "A": "美托拉宗",
      "B": "依普利酮",
      "C": "布美他尼",
      "D": "氨苯蝶啶",
      "E": "甘露醇"
    },
    "answer": "D",
    "explanation": "本题考查利尿药的分类与作用机制。肾小管上皮细胞Na+通道抑制药的代表药物有氨苯蝶啶和阿米洛利，主要作用于远曲小管末端与集合管，可直接阻断管腔膜上的Na+通道而减少Na+的重吸收，由此降低了肾小管管腔内驱动K+分泌的负电位从而减少K+的排泌，抑制了Na+-K+的交换，从而产生排Na+、利尿、保K+的作用。故本题答案为D。",
    "source_note": "",
    "question_id": "e68c559a93954ece25280feb198d2671fc523119",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "可用于干眼症和各种原因引起的角膜病变的促角膜修复类药是",
    "options": {
      "A": "人干扰素 \\alpha 1\\mathrm{b}",
      "B": "牛碱性成纤维细胞生长因子",
      "C": "雷珠单抗",
      "D": "卵磷脂络合碘",
      "E": "毛果芸香碱"
    },
    "answer": "B",
    "explanation": "本题考查眼科用药的分类与代表药品。牛碱性成纤维细胞生长因子属于促角膜修复类药，可用于各种原因引起的角膜上皮缺损和点状角膜病变，也可用于轻中度干眼症。故本题答案为B。",
    "source_note": "",
    "question_id": "065823f99d3fbd70b11b937de12e40227be85f1e",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 12,
    "stem": "常与抗菌药物、铋剂合用治疗幽门螺杆菌（Hp）相关性消化性溃疡的药物是",
    "options": {
      "A": "硫糖铝",
      "B": "奥美拉唑",
      "C": "西咪替丁",
      "D": "山莨菪碱",
      "E": "多潘立酮"
    },
    "answer": "B",
    "explanation": "本题考查质子泵抑制剂（PPI）的临床用药评价。质子泵抑制剂（如奥美拉唑）可用于胃、十二指肠溃疡、消化性溃疡急性出血、反流性食管炎、卓-艾综合征，还可与抗菌药物、铋剂合用治疗幽门螺杆菌（Hp）相关性消化性溃疡。故本题答案为 B。",
    "source_note": "",
    "question_id": "45862354401f7794d97992d638fdc3d7545af75a",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 12,
    "stem": "可逆性地抑制血小板 COX-1，减少 \\mathrm{TXA}_2 的合成，使血小板无法聚集的药物是",
    "options": {
      "A": "阿司匹林",
      "B": "氯吡格雷",
      "C": "替罗非班",
      "D": "呵喲布芬",
      "E": "双嘧达莫"
    },
    "answer": "D",
    "explanation": "本题考查血栓素 A2 (TXA2) 抑制剂的临床用药评价。阿司匹林、吲哚布芬属于血栓素 A2 (TXA2) 抑制剂, 可抑制环氧化酶-1 (COX-1), 减少血栓素 A2 (TXA2) 合成, 使血小板无法聚集。其中, 咽哚布芬对血小板 COX-1 的抑制作用可逆。故本题答案为 D。阿司匹林对血小板 COX-1 的抑制作用不可逆。",
    "source_note": "",
    "question_id": "f539aa669415446627a1c05b6b9abb8b9b5a1d8f",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 13,
    "stem": "伏诺拉生的主要代谢酶是",
    "options": {
      "A": "CYP1A2",
      "B": "CYP2C19",
      "C": "CYP2D6",
      "D": "CYP3A4",
      "E": "CYP2C9"
    },
    "answer": "D",
    "explanation": "本题考查钾离子竞争性酸阻滞剂的临床用药评价。钾离子竞争性酸阻滞剂的代表药品包括伏诺拉生、替戈拉生、凯普拉生, 主要代谢酶均是 CYP3A4。故 本题答案为D。",
    "source_note": "",
    "question_id": "fee42ac12d49d6734b2cf6fde52d4b01d4e4b157",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 13,
    "stem": "肝素的抗凝作用特点是",
    "options": {
      "A": "体内、体外均有效",
      "B": "仅在体内有效",
      "C": "必须有维生素K辅助",
      "D": "作用缓慢",
      "E": "仅在体外有效"
    },
    "answer": "A",
    "explanation": "本题考查肝素类的临床用药评价。肝素在体内和体外均有强大的抗凝作用。肝素以起效迅速, 在体内外均有抗凝作用。故本题答案为 A。",
    "source_note": "",
    "question_id": "667833748e5e0c7849114ee2acdf2300a1ebb2ae",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "单项选择题",
    "qno": 13,
    "stem": "可提高血浆渗透压，使组织间液向血浆转移，产生组织脱水作用，从而减轻组织水肿，降低眼内压、颅内压的药物是",
    "options": {
      "A": "甘露醇",
      "B": "布美他尼",
      "C": "呵达帕胺",
      "D": "依普利酮",
      "E": "味塞米"
    },
    "answer": "A",
    "explanation": "本题考查渗透性利尿药的临床用药评价。甘露醇属于渗透性利尿药,作为高渗溶液静脉给药后，随着药物在血浆中浓度增加，血浆的渗透压也会增加，使组织间液向血浆转移而产生组织脱水作用，并降低颅内压和眼内压。故本题答案为 A。",
    "source_note": "",
    "question_id": "5dfc6beba1c64053237f9dd403a531b46fe0da6e",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 14,
    "stem": "属于胃黏膜保护药的是",
    "options": {
      "A": "胶体果胶铋",
      "B": "胰酶",
      "C": "奥美拉唑",
      "D": "莫沙必利",
      "E": "谷胱甘肽"
    },
    "answer": "A",
    "explanation": "本题考查胃黏膜保护药的分类与代表药品。胶体果胶铋为胃黏膜保护药, 用于治疗胃、十二指肠溃疡, 急、慢性胃炎, 以及 Hp 感染的根除治疗。故本题答案为 A。",
    "source_note": "",
    "question_id": "0e9b5ab997e1472940d26f43f49c718b473b2673",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 14,
    "stem": "下列关于肝素的描述，错误的是",
    "options": {
      "A": "来源自猪肠黏膜提取的硫酸氨基葡聚糖",
      "B": "作用靶点是抗凝血酶III（AT-III）",
      "C": "可皮下注射、静脉注射给药",
      "D": "具有纤溶活性, 能裂解已有的血凝块",
      "E": "可用于血液标本的抗凝处理"
    },
    "answer": "D",
    "explanation": "本题考查肝素类的临床用药评价。肝素在体内和体外都能抑制导致血液凝结和血纤维蛋白凝块形成的反应, 能预防血栓发生, 但肝素不具有纤溶活性, 不能裂解已有的血凝块, 不是溶栓药。故本题答案为 D。",
    "source_note": "",
    "question_id": "2aa5024014f8e4538fd6112ca32859d119007309",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 15,
    "stem": "口服后可直接中和胃酸，快速改善反酸、烧心和胃部不适症状，但药效持续的时间较短，空腹服用仅约30分钟的药物是",
    "options": {
      "A": "多潘立酮",
      "B": "匹维溴铵",
      "C": "铝碳酸镁",
      "D": "米索前列醇",
      "E": "淬托拉唑"
    },
    "answer": "C",
    "explanation": "本题考查抗酸药的临床用药评价。铝碳酸镁为抗酸药, 可在胃内直接中和胃酸, 能够快速有效地缓解反酸、胃痛等不适症状, 但不能抑制胃酸分泌, 且药效持续的时间很短, 空腹服用仅约 30 分钟, 餐后服用可有效延长。故本题答案为 C。",
    "source_note": "",
    "question_id": "bf72063205fcf443fda6911a237cce80b423c6ff",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 15,
    "stem": "属于无活性的前体药物的是",
    "options": {
      "A": "替格瑞洛",
      "B": "阿司匹林",
      "C": "双嘧达莫",
      "D": "替罗非班",
      "E": "氯吡格雷"
    },
    "answer": "E",
    "explanation": "本题考查（ADP）P2Y12 受体拮抗剂的临床用药评价。氯吡格雷、噻 氯匹定是无活性的前体药物。故本题答案为E。",
    "source_note": "",
    "question_id": "6b06eab9076029257b98ce6cb8a3b68e8614cfe0",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 16,
    "stem": "锥剂常见的不良反应不包括",
    "options": {
      "A": "便秘",
      "B": "高血压",
      "C": "黑便",
      "D": "口中带氨味",
      "E": "神经病变"
    },
    "answer": "B",
    "explanation": "本题考查胃黏膜保护药的临床用药评价。铋剂的不良反应: ①恶心、呕吐、便秘及腹泻; ②服药期间口中可能带有氨味, 舌苔及大便呈灰黑色, 牙齿短暂变色, 停药后能自行消失; ③有肾毒性, 长期用药肾功能不全者可出现铋蓄积, 易导致神经病变、脑病。故本题答案为 B。",
    "source_note": "explanation_range_detected",
    "question_id": "7394e08d38b686e2c4698010ecc2ca71f7f9fd9e",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 16,
    "stem": "低分子量肝素发挥抗凝作用中，受到抑制作用最强的凝血因子是",
    "options": {
      "A": "凝血因子IIa",
      "B": "凝血因子IX a",
      "C": "凝血因子X a",
      "D": "凝血因子XI a",
      "E": "凝血因子XII a"
    },
    "answer": "C",
    "explanation": "本题考查肝素类的临床用药评价。低分子量肝素主要通过对抗因子Xa发挥抗凝作用。故本题答案为C。",
    "source_note": "",
    "question_id": "49bc7a207108c9dfc9a85bcb3ffb0a8575d64e23",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 17,
    "stem": "关于枸橼酸铋钾临床应用的说法，错误的是",
    "options": {
      "A": "前3次于三餐餐前0.5h，第4次于晚餐后2h服用",
      "B": "应避免与牛奶同服",
      "C": "可与碳酸氢钠同服增强疗效",
      "D": "可见恶心、呕吐、便秘及腹泻",
      "E": "服用后口中可能有氨味"
    },
    "answer": "C",
    "explanation": "本题考查胃黏膜保护药的临床用药评价。抗酸药（如碳酸氢钠）可干扰枸橼酸铋钾（在酸性环境中疗效增强）的作用, 两药不能同时服用。故本题答案为 C。",
    "source_note": "",
    "question_id": "06e279acb9aa1941ee5c7efc5b2c5cb387212165",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 17,
    "stem": "肝素和华法林均可用于",
    "options": {
      "A": "弥散性血管内凝血",
      "B": "血小板减少症",
      "C": "防治血栓栓塞性疾病",
      "D": "脑出血",
      "E": "体外循环抗凝"
    },
    "answer": "C",
    "explanation": "本题考查维生素 K 拮抗剂与肝素类的临床用药评价。肝素和华法林同为抗凝药, 均可用于血栓栓塞性疾病的预防和治疗。本题答案为 C。",
    "source_note": "",
    "question_id": "b1c1e7440fc6718b0e62897e813b760629140322",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 18,
    "stem": "能直接中和胃酸，迅速缓解反酸、胃灼伤、胃痛等症状的药物是",
    "options": {
      "A": "法莫替丁",
      "B": "硫糖铝",
      "C": "枸橼酸铋钾",
      "D": "碳酸钙",
      "E": "雷贝拉唑"
    },
    "answer": "D",
    "explanation": "本题考查抗酸药的临床用药评价。抗酸药有碳酸钙、氢氧化铝、铝碳酸镁、三硅酸镁等; 可直接中和胃酸, 迅速缓解反酸、胃灼伤、胃痛等症状。故本题答案为 D。",
    "source_note": "",
    "question_id": "8cf98953ab8917c8da595c54d475bb5f3ec86f60",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 18,
    "stem": "肝素抗凝血治疗过程中引起的自发性出血，宜用的抢救药物是",
    "options": {
      "A": "氨甲环酸",
      "B": "维生素K",
      "C": "硫酸鱼精蛋白",
      "D": "氨基己酸",
      "E": "硫酸亚铁"
    },
    "answer": "C",
    "explanation": "本题考查肝素类的临床用药评价。硫酸鱼精蛋白适用于肝素过量引起的出血。故本题答案为C。",
    "source_note": "",
    "question_id": "2e8e5126a27483cadb3dec89a2aff9c3cd40f7fb",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 19,
    "stem": "可使用硫酸鱼精蛋白迅速逆转其出血作用，效果最好的是",
    "options": {
      "A": "肝素钠",
      "B": "达肝素钠",
      "C": "依诺肝素钠",
      "D": "那屈肝素钙",
      "E": "贝米肝素钠"
    },
    "answer": "A",
    "explanation": "本题考查肝素类的临床用药评价。可使用硫酸鱼精蛋白迅速逆转普通肝素（肝素钠）的作用。故本题答案为A。鱼精蛋白也能部分中和低分子量肝素（如达肝素钠、依诺肝素钠、那屈肝素钙、贝米肝素钠)，但效果可能不佳。",
    "source_note": "",
    "question_id": "660c418ea871b0eaca4975f7458997917ce07654",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 20,
    "stem": "不易导致便秘或腹泻不良反应的抗酸药是",
    "options": {
      "A": "硫糖铝",
      "B": "氢氧化铝",
      "C": "氢氧化镁",
      "D": "铝碳酸镁",
      "E": "碳酸钙"
    },
    "answer": "D",
    "explanation": "本题考查抗酸药的临床用药评价。铝离子可松弛胃平滑肌引起胃排空延迟和便秘, 而镁有导泻作用, 因此铝碳酸镁对胃排空和小肠功能影响很小, 降低了便秘和腹泻的发生风险。故本题答案为 D。",
    "source_note": "",
    "question_id": "b24e06829ed89d9ab5bed0caf86df760ab2897ab",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 20,
    "stem": "治疗窗窄，实现充分抗凝又不发生出血的难度较大的是",
    "options": {
      "A": "肝素钠",
      "B": "达肝素钠",
      "C": "依诺肝素钠",
      "D": "那屈肝素钙",
      "E": "贝米肝素钠"
    },
    "answer": "A",
    "explanation": "本题考查肝素类的临床用药评价。普通肝素（肝素钠）治疗窗窄, 实现充分抗凝又不发生出血的难度较大, 需要频繁进行实验室监测。低分子量肝素（达肝素钠、依诺肝素钠、那屈肝素钙、贝米肝素钠）剂量与抗凝反应之间的相关性更好, 可以固定剂量给药, 无需实验室监测。故本题答案为 A。",
    "source_note": "",
    "question_id": "9d2d95d51a3f8e624c72f37629f581bd7deb1928",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "单项选择题",
    "qno": 21,
    "stem": "可碱化尿液，且可调节体内酸碱平衡的抗酸药是",
    "options": {
      "A": "碳酸钙",
      "B": "碳酸氢钠 兰索拉唑",
      "C": "硫糖铝",
      "D": "铝碳酸镁"
    },
    "answer": "B",
    "explanation": "本题考查抗酸药的临床用药评价。碳酸氢钠口服具有调节体内酸碱平衡和碱化尿液的作用。故本题答案为B。",
    "source_note": "",
    "question_id": "898c116801405b9cf20b9dcc722a976a6715a856",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 22,
    "stem": "联合使用会降低达比加群酯血药浓度的药物是",
    "options": {
      "A": "利福平",
      "B": "胺碘酮",
      "C": "维拉帕米",
      "D": "克拉霉素",
      "E": "奎尼丁"
    },
    "answer": "A",
    "explanation": "本题考查直接抗凝药的临床用药评价。达比加群酯是 P-gp 的底物,与强效 P-gp 抑制剂（如胺碘酮、维拉帕米、克拉霉素、决奈达隆、奎尼丁）联合使用会导致达比加群血药浓度升高。与 P-gp 诱导物（利福平、卡马西平或苯妥英等）联合使用会降低达比加群血药浓度。故本题答案为 A。",
    "source_note": "",
    "question_id": "540a8188ae3b309f89fbdb8d96d0073601fff697",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 23,
    "stem": "依达赛珠单抗可用来解救",
    "options": {
      "A": "阿哌沙班过量所致出血",
      "B": "华法林过量所致出血",
      "C": "达比加群酯过量所致出血",
      "D": "肝素过量所致出血",
      "E": "利伐沙班过量所致出血"
    },
    "answer": "C",
    "explanation": "本题考查直接抗凝药的临床用药评价。达比加群酯的解救药为依达赛珠单抗, 能拮抗达比加群的抗凝作用。故本题答案为 C。",
    "source_note": "",
    "question_id": "76b703b3c5deb57cd6daea6733648b8a85ca521b",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 24,
    "stem": "15\\mathrm{mg} 或 20\\mathrm{mg} 剂量的片剂与食物同服可提高其生物利用度的药物是",
    "options": {
      "A": "替格瑞洛",
      "B": "阿哌沙班",
      "C": "利伐沙班",
      "D": "达比加群酯",
      "E": "替罗非班"
    },
    "answer": "C",
    "explanation": "本题考查直接抗凝药的临床用药评价。15mg或20mg的利伐沙班片剂与食物同服后，与空腹服药相比，平均AUC和Cmax均提高，故15mg或20mg的利伐沙班片剂应与食物同服；进食对10mg剂量的利伐沙班无明显影响。故本题答案为C。阿哌沙班无需与食物同服。",
    "source_note": "",
    "question_id": "659109ae9242342eb27110b9320e3218e8e3b55a",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 25,
    "stem": "为减少手术中和手术后出血风险，择期手术前需提前停用阿司匹林",
    "options": {
      "A": "1 \\sim 3 日",
      "B": "4 \\sim 6 日",
      "C": "7 \\sim 10 日",
      "D": "11\\sim 15 日",
      "E": "16 \\sim 20 日"
    },
    "answer": "C",
    "explanation": "本题考查血栓素A2（TXA2）抑制剂的临床用药评价。由于阿司匹林对血小板聚集的抑制作用可持续数日，可能导致手术中或手术后增加出血，为减少出血风险，需提前停用阿司匹林 7 \\sim 10 日。故本题答案为C。",
    "source_note": "",
    "question_id": "2be32c3521e46cf99af2651d92f59ddeb713f9c5",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 26,
    "stem": "可与甲氨蝶呤竞争血浆蛋白，减少甲氨蝶呤的肾清除，增加其血液毒性的药物是",
    "options": {
      "A": "氯吡格雷",
      "B": "西洛他唑",
      "C": "替罗非班",
      "D": "双嘧达莫",
      "E": "阿司匹林"
    },
    "answer": "E",
    "explanation": "本题考查血栓素A2（TXA2）抑制剂的临床用药评价。水杨酸和甲氨蝶呤与血浆蛋白竞争结合，减少甲氨蝶呤的肾清除，从而增加甲氨蝶呤的血液毒性，因此当甲氨蝶呤每周剂量 \\geqslant 15\\mathrm{mg} 时，应避免使用阿司匹林。故本题答案为E。",
    "source_note": "",
    "question_id": "f3ce7245c0716b2bc9fee70a887f66e1a0f68e00",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 27,
    "stem": "对氯吡格雷活性影响最大的酶是",
    "options": {
      "A": "酯酶",
      "B": "CYP3A4",
      "C": "CYP2C19",
      "D": "CYP1A2",
      "E": "CYP2B6"
    },
    "answer": "C",
    "explanation": "本题考查（ADP）P2Y12 受体拮抗剂的临床用药评价。氯吡格雷是前药, 经 CYP3A4 或 CYP2C19 2 个代谢途径, 分别转化为非活性代谢物和有抗体小板活性的活性代谢物, 故 CYP2C19 代谢能力对氯吡格雷活性影响最大。故本题答案为 C。",
    "source_note": "",
    "question_id": "5e7658eee976f1d15291dba39ce9712f7c766641",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 28,
    "stem": "属于可逆性（ADP）\\mathrm{P2Y}_{12} 受体拮抗剂的药物是",
    "options": {
      "A": "噻氯匹定",
      "B": "替格瑞洛 双嘧达莫",
      "C": "阿司匹林",
      "D": "西洛他唑"
    },
    "answer": "B",
    "explanation": "本题考查（ADP）P2Y12 受体拮抗剂的临床用药评价。替格瑞洛不需经肝脏代谢而直接作用于 P2Y12 受体, 且其拮抗 P2Y12 受体的作用可逆。故本题答案为 B。噻氯匹定对血小板 P2Y12 受体的拮抗是不可逆的。",
    "source_note": "",
    "question_id": "36ff8b7ddbf95b17d7b3a690be1f51f1c2e7a6e5",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 29,
    "stem": "常用溶栓药物中，血浆消除半衰期最长的药物是",
    "options": {
      "A": "尿激酶",
      "B": "阿替普酶",
      "C": "重组链激酶",
      "D": "替奈普酶",
      "E": "重组人尿激酶原"
    },
    "answer": "E",
    "explanation": "本题考查溶栓药（溶栓酶）的临床用药评价。溶栓药血浆消除半衰 期: 尿激酶 \\leqslant 20 \\mathrm{~min}; 重组链激酶 5 \\sim 30 \\mathrm{~min}; 阿替普酶 4 \\sim 5 \\mathrm{~min}; 瑞替普酶 14 \\sim 16 \\mathrm{~min};替奈普酶 20 \\sim 24 \\mathrm{~min}; 50 \\mathrm{mg} 重组人尿激酶原 0.67 \\mathrm{~h} (非线性)。故本题答案为 \\mathrm{E} 。",
    "source_note": "",
    "question_id": "a61010d67606ce214a7c2bedc2b66b1415cc19b7",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 30,
    "stem": "与阿替普酶相比，对纤维蛋白原的消耗更小的溶栓药是",
    "options": {
      "A": "尿激酶",
      "B": "重组链激酶",
      "C": "替奈普酶",
      "D": "肌酸激酶",
      "E": "瑞替普酶"
    },
    "answer": "C",
    "explanation": "本题考查溶栓药（溶栓酶）的临床用药评价。尿激酶、重组链激酶属于非特异性纤溶酶原激活剂，明显消耗纤维蛋白原。阿替普酶、瑞替普酶、替奈普酶、重组人尿激酶原属于特异性纤溶酶原激活剂，其中替奈普酶极小消耗纤维蛋白原。阿替普酶轻度消耗纤维蛋白原。瑞替普酶中度消耗纤维蛋白原。故本题答案为C。",
    "source_note": "",
    "question_id": "184e505e093774e5d3f88934371b11ab8e3f101a",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 32,
    "stem": "可能导致牙龈出血的药物是",
    "options": {
      "A": "拉西地平",
      "B": "依诺肝素钠",
      "C": "普伐他汀",
      "D": "普萘洛尔",
      "E": "味塞米"
    },
    "answer": "B",
    "explanation": "本题考查肝素类的临床用药评价。肝素用药过量可出现自发性出血,表现为各种黏膜出血、齿龈出血、肾出血、卵巢出血、腹膜后出血、肾上腺出血、月经量增多、关节积血和伤口出血等。故本题答案为 B。",
    "source_note": "",
    "question_id": "c639a0a75cce8698919ab50a6169878bc5646e1b",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 33,
    "stem": "可能与奥美拉唑发生相互作用而致血栓风险增高的是",
    "options": {
      "A": "华法林",
      "B": "肝素",
      "C": "氯吡格雷",
      "D": "达比加群酯",
      "E": "利伐沙班"
    },
    "answer": "C",
    "explanation": "本题考查（ADP）P2Y12受体拮抗剂的临床用药评价。氯吡格雷部分由CYP2C19代谢为活性产物，合用抑制此酶活性的药物将导致氯吡格雷活性代谢产物水平降低并降低临床有效性，奥美拉唑属于CYP2C19抑制剂。故本题答案为C。",
    "source_note": "",
    "question_id": "ce032e52d08c8a4378f721096e9f3e8b1a0b7f9e",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 35,
    "stem": "是重组人组织纤维蛋白溶酶原激活剂，需持续静脉滴注给药的溶栓药是",
    "options": {
      "A": "达比加群酯",
      "B": "替罗非班",
      "C": "阿替普酶",
      "D": "瑞替普酶",
      "E": "替奈普酶"
    },
    "answer": "C",
    "explanation": "本题考查溶栓药（溶栓酶）的临床用药评价。阿替普酶是重组人组织纤维蛋白溶酶原激活剂，具有纤维蛋白特异性，血浆消除半衰期短（4～5min），需持续静脉滴注给药。故本题答案为C。",
    "source_note": "",
    "question_id": "5c938c990e89b8a67bc194daa9aec3a81550e5b3",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "单项选择题",
    "qno": 36,
    "stem": "华法林的剂量调整需考虑的基因多态性有",
    "options": {
      "A": "CYP2C9、VKORC1",
      "B": "CYP2D6、VKORC1",
      "C": "CYP2C9、CYP3A4",
      "D": "CYP1A2、CYP3A4",
      "E": "CYP2C19、CYP1A2"
    },
    "answer": "A",
    "explanation": "本题考查维生素K拮抗剂的临床用药评价。不同患者的华法林钠片 初始剂量差异很大，影响初始剂量的因素包括年龄、种族、体重、性别、伴随用药和伴随疾病等临床因素，以及 CYP2C9 和 VKORC1 基因型等遗传因素。故本题答案为 A。",
    "source_note": "",
    "question_id": "13a73a9fc0238ab8aa24c5ed6e24c8e8619871dd",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第1节抗菌药物总论",
    "qtype": "配伍选择题",
    "qno": 3,
    "stem": "作用于依赖于DNA的RNA多聚酶，抑制细菌RNA合成的药物是",
    "options": {
      "A": "阿莫西林",
      "B": "环丙沙星",
      "C": "磺胺嘧啶",
      "D": "利福平"
    },
    "answer": "D",
    "explanation": "本组题考查抗菌药物的分类与作用机制。 ①利福平属于广谱抗菌药，可与依赖于DNA的RNA多聚酶的β亚单位牢固结合，抑制细菌RNA的合成。故本题答案为D。",
    "source_note": "",
    "question_id": "c68ff0bc7aff6398b8104c6a2d6d742423252ffa",
    "section_no": 1,
    "section_title": "抗菌药物总论",
    "section_norm": "第一节 抗菌药物总论"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第1节抗菌药物总论",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "干扰细菌细胞壁黏肽合成，激活细菌的自溶酶，引起细菌破裂溶解的药物是",
    "options": {
      "A": "阿莫西林",
      "B": "环丙沙星",
      "C": "磺胺嘧啶",
      "D": "利福平"
    },
    "answer": "A",
    "explanation": "本组题考查抗菌药物的分类与作用机制。 ②阿莫西林为青霉素类药物，属于β-内酰胺类药物，可与细菌细胞内膜上的青霉素结合蛋白（PBPs）结合，干扰细菌细胞壁黏肽合成，进而起抗菌作用。故本题答案为A。阿米卡星属于氨基糖苷类，通过与细菌核糖体30S结合，抑制细菌蛋白质合成。磺胺嘧啶属于二氢叶酸合成酶抑制剂。环丙沙星的抗菌机制为抑制细菌DNA的合成。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "f8d990d974cf3b9b7ea77b60d9fba545bdf97790",
    "section_no": 1,
    "section_title": "抗菌药物总论",
    "section_norm": "第一节 抗菌药物总论"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第1节抗菌药物总论",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "属于时间依赖性，抗菌作用时间短的药物是",
    "options": {
      "A": "红霉素",
      "B": "阿奇霉素",
      "C": "莫西沙星",
      "D": "多黏菌素",
      "E": "链霉素"
    },
    "answer": "A",
    "explanation": "本组题考查抗菌药物的药代动力学/药效学。 ① \\beta-内酰胺类（如青霉素、头孢菌素）、林可霉素、红霉素属于抗菌作用时间短的时间依赖性抗菌药物。故本题答案为 A。",
    "source_note": "",
    "question_id": "3d6d41d61c44302435e3d046d11a6177d7fc251c",
    "section_no": 1,
    "section_title": "抗菌药物总论",
    "section_norm": "第一节 抗菌药物总论"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第1节抗菌药物总论",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "属于时间依赖性, 抗菌作用时间长的药物是",
    "options": {
      "A": "红霉素",
      "B": "阿奇霉素",
      "C": "莫西沙星",
      "D": "多黏菌素",
      "E": "链霉素"
    },
    "answer": "B",
    "explanation": "本组题考查抗菌药物的药代动力学/药效学。 ②替加环素、利奈唑胺、阿奇霉素、克拉霉素、四环素类、糖肽类属于抗菌作用时间长的时间依赖性抗菌药物。故本题答案为 B。莫西沙星、多黏菌素、链霉素属于浓度依赖性抗菌药物。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "79b5db407616aecf6c8f76197f47056e67cfd863",
    "section_no": 1,
    "section_title": "抗菌药物总论",
    "section_norm": "第一节 抗菌药物总论"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第1节糖类、盐类、酸碱平衡调节药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "可用于急性黄疸性肝炎、肝细胞功能不全和急、慢性肝炎的辅助治疗的药物是 [8 \\sim 9] A. 氯化铵 B. 氯化钠 C. 乳酸钠 D. 氯化钾 E. 葡萄糖 8. 可用于治疗洋地黄中毒引起的频发性、多源性期前收缩或快速型心律失常的药物是 9.可用于高钾血症或普鲁卡因胺引起的心律失常伴有酸血症者的药物是",
    "options": {
      "A": "葡萄糖",
      "B": "门冬氨酸钾镁",
      "C": "维生素",
      "D": "脂肪乳",
      "E": "氨基酸"
    },
    "answer": "B",
    "explanation": "①本题考查门冬氨酸钾镁的临床用药评价。门冬氨酸钾镁的适应证低钾血症、低钾及洋地黄中毒引起的心律失常; 心肌代谢障碍所致的心绞痛、心肌梗死、心肌炎后遗症, 慢性心功能不全; 急性黄疸性肝炎、肝细胞功能不全和急、慢性肝炎的辅助治疗。故本题答案为 B。",
    "source_note": "",
    "question_id": "59ccab7847e40f1feb8c06899ac38442c0fe204a",
    "section_no": 1,
    "section_title": "糖类、盐类、酸碱平衡调节药",
    "section_norm": "第一节 糖类、盐类、酸碱平衡调节药"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第1节糖类、盐类、酸碱平衡调节药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "可用于降低眼压，还可维持和调节腹膜透析液渗透压的药物是",
    "options": {
      "A": "葡萄糖",
      "B": "门冬氨酸钾镁",
      "C": "维生素",
      "D": "脂肪乳",
      "E": "氨基酸"
    },
    "answer": "A",
    "explanation": "②本题考查葡萄糖的临床用药评价。50%葡萄糖注射液可用于维持和调节腹膜透析液渗透压, 25%/50%葡萄糖注射液可用于降低眼压及因颅压增加引起的各种病症。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c9503343da0703d6dda3acf6a9bc5a472e723f46",
    "section_no": 1,
    "section_title": "糖类、盐类、酸碱平衡调节药",
    "section_norm": "第一节 糖类、盐类、酸碱平衡调节药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第1节下丘脑-垂体激素及相关药物",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "可用于治疗活动性风湿病、类风湿关节炎等结缔组织病的药物是",
    "options": {
      "A": "生长激素",
      "B": "生长抑素",
      "C": "促皮质素",
      "D": "醋酸去氨加压素",
      "E": "胰岛素"
    },
    "answer": "C",
    "explanation": "【 8 \\sim 9】 ①本题考查促皮质素（ACTH）的临床用药评价。促皮质素可用于活动性风湿病、类风湿关节炎等结缔组织病。故本题答案为 C。",
    "source_note": "",
    "question_id": "6a3b3bc1467497ce6101e056591f1e300132d420",
    "section_no": 1,
    "section_title": "下丘脑-垂体激素及相关药物",
    "section_norm": "第一节 下丘脑-垂体激素及相关药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第1节下丘脑-垂体激素及相关药物",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "既可用于治疗食管静脉曲张出血，又可用于糖尿病酮症酸中毒辅助治疗的药物是",
    "options": {
      "A": "生长激素",
      "B": "生长抑素",
      "C": "促皮质素",
      "D": "醋酸去氨加压素",
      "E": "胰岛素"
    },
    "answer": "B",
    "explanation": "【 8 \\sim 9】 ②本题考查生长抑素的临床用药评价。生长抑素可明显减少内脏器官的血流量，治疗食管静脉曲张出血，还可抑制胰高血糖素的分泌，用于糖尿病酮症酸中毒的辅助治疗。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "52eb70def6ac7cca9533561fcc2f845182ad6ada",
    "section_no": 1,
    "section_title": "下丘脑-垂体激素及相关药物",
    "section_norm": "第一节 下丘脑-垂体激素及相关药物"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第1节糖类、盐类、酸碱平衡调节药",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "可用于甲状旁腺功能亢进症术后的“骨饥饿综合征”的药物是",
    "options": {
      "A": "氯化钠",
      "B": "硫酸镁",
      "C": "氯化钙",
      "D": "乳酸钠",
      "E": "门冬氨酸钾镁"
    },
    "answer": "C",
    "explanation": "【 10 \\sim 11】 ①本题考查氯化钙的临床用药评价。氯化钙可用于甲状旁腺功能亢进症术后“骨饥饿综合征”。故本题答案为 C。",
    "source_note": "",
    "question_id": "267f6aeac34826365c9b66ac0b036fdbbdb2834d",
    "section_no": 1,
    "section_title": "糖类、盐类、酸碱平衡调节药",
    "section_norm": "第一节 糖类、盐类、酸碱平衡调节药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "为麻醉药品，具有成瘾性，颅脑外伤者慎用的镇咳药是",
    "options": {
      "A": "那可丁",
      "B": "氯化铵",
      "C": "喷托维林",
      "D": "可待因",
      "E": "氟替卡松"
    },
    "answer": "D",
    "explanation": "【 11 \\sim 12】 ①本题考查镇咳药的临床用药评价。可待因为麻醉药品, 具有成瘾性, 采购、运输、储存、处方开具、使用等环节必须遵守麻醉药品相关规定; 可引起颅内高压, 故颅脑损伤或颅内病变者慎用。故本题答案为 D。",
    "source_note": "",
    "question_id": "cb059dc5423d4ba2db68b43db5c4c16eac2306a5",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "属于 I b 类钠通道阻滞剂的抗心律失常药是",
    "options": {
      "A": "利多卡因",
      "B": "普鲁卡因胺 去乙酰毛花苷",
      "C": "胺碘酮",
      "D": "维拉帕米"
    },
    "answer": "A",
    "explanation": "【 11 \\sim 12】本组题考查抗心律失常药的分类与作用机制。 ①属于 I b 类钠通道阻滞剂的抗心律失常药有利多卡因、苯妥英钠、美西律。故本题答案为 A。",
    "source_note": "",
    "question_id": "4cb8d416474e815ad368a98a1dd49b4ded11eebb",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "依托泊苷注射液的溶媒选择要求是",
    "options": {
      "A": "用氯化钠注射液稀释",
      "B": "用 5 \\% 葡萄糖注射液稀释",
      "C": "先用乳酸钠注射液溶解, 再用氯化钠注射液或 5 \\% 葡萄糖注射液进一步稀释",
      "D": "先用氯化钠注射液溶解, 再用 5 \\% 葡萄糖注射液进一步稀释",
      "E": "先用氯化钠注射液溶解, 再用氯化钠注射液或 5 \\% 葡萄糖注射液进一步稀释"
    },
    "answer": "A",
    "explanation": "本组题考查典型抗肿瘤药物的溶剂要求。 ①依托泊苷静脉滴注: 应用 0.9\\% 氯化钠注射液稀释, 浓度不超过 0.25 \\mathrm{mg} / \\mathrm{ml} 。故本题答案为 A。",
    "source_note": "",
    "question_id": "8e28e88616dd289d7fdaf5c59f162f73c96c837d",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第1节糖类、盐类、酸碱平衡调节药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "可用于各种原因所致的低渗性、等渗性和高渗性失水的药物是",
    "options": {
      "A": "氯化钠",
      "B": "硫酸镁",
      "C": "氯化钙",
      "D": "乳酸钠",
      "E": "门冬氨酸钾镁"
    },
    "answer": "A",
    "explanation": "【 10 \\sim 11】 ②本题考查氯化钠的临床用药评价。氯化钠可用于各种原因所致的低渗性、等渗性和高渗性失水。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "d3a998a266b709a4db702bb38f64fc011033991a",
    "section_no": 1,
    "section_title": "糖类、盐类、酸碱平衡调节药",
    "section_norm": "第一节 糖类、盐类、酸碱平衡调节药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "可引起肝损伤，12岁以下儿童禁用的非甾体抗炎药是",
    "options": {
      "A": "双氯芬酸",
      "B": "布洛芬",
      "C": "弓喉美辛",
      "D": "尼美舒利",
      "E": "对乙酰氨基酚"
    },
    "answer": "D",
    "explanation": "本组题考查解热、镇痛、抗炎药的临床用药评价。 ①尼美舒利属于部分选择性COX-2抑制剂, 可引起肝损伤, 12岁以下儿童禁用。故本题答案为D。",
    "source_note": "",
    "question_id": "630fec19170c544a6b2bf00ffd3d85256a0900d5",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "属于外周性镇咳药，可抑制咳嗽反射弧上的牵张感受器，发挥止咳作用的药物是",
    "options": {
      "A": "那可丁",
      "B": "氯化铵",
      "C": "喷托维林",
      "D": "可待因",
      "E": "氟替卡松"
    },
    "answer": "A",
    "explanation": "【 11 \\sim 12】 ②本题考查镇咳药的分类与作用机制。那可丁属于外周性镇咳药, 可与咳嗽反射弧上的咳嗽感受器、传入神经、传出神经及效应器部位受体结合而产生镇咳作用。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "7facece21074745dbc4a25a4d4efb2e9866ef095",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "可用于小儿高热、破伤风及子痫引起的惊厥，但大剂量可抑制心肌收缩力的镇静催眠药是",
    "options": {
      "A": "扎来普隆",
      "B": "佐匹克隆",
      "C": "雷美替胺",
      "D": "唑吡坦",
      "E": "水合氯醛"
    },
    "answer": "E",
    "explanation": "①本题考查醛类的临床用药评价。醛类催眠作用温和, 可缩短睡眠潜伏期, 但不缩短快动眼睡眠期 (REMS) 睡眠时间, 脂溶性高。可用于小儿高热、破伤风及子痫引起的惊厥。大剂量抑制心肌收缩力、抑制延髓呼吸中枢, 引起昏迷、麻醉甚至死亡。故本题答案为 E。",
    "source_note": "",
    "question_id": "dbfdb1d8a41845cc900ed604b6c0055b1015704b",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "属于钙通道阻滞剂的抗心律失常药是",
    "options": {
      "A": "利多卡因",
      "B": "普鲁卡因胺 去乙酰毛花苷",
      "C": "胺碘酮",
      "D": "维拉帕米"
    },
    "answer": "D",
    "explanation": "【 11 \\sim 12】本组题考查抗心律失常药的分类与作用机制。 ②属于钙通道阻滞剂的抗心律失常药有维拉帕米、地尔硫草。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "821aaddde65e2737615f2bf06b973fb5a5866544",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "注射用奥沙利铂的溶媒选择要求是",
    "options": {
      "A": "用氯化钠注射液稀释",
      "B": "用 5 \\% 葡萄糖注射液稀释",
      "C": "先用乳酸钠注射液溶解, 再用氯化钠注射液或 5 \\% 葡萄糖注射液进一步稀释",
      "D": "先用氯化钠注射液溶解, 再用 5 \\% 葡萄糖注射液进一步稀释",
      "E": "先用氯化钠注射液溶解, 再用氯化钠注射液或 5 \\% 葡萄糖注射液进一步稀释"
    },
    "answer": "B",
    "explanation": "本组题考查典型抗肿瘤药物的溶剂要求。 ②奥沙利铂与氯化钠和碱性溶液之间存在配伍禁忌, 在葡萄糖溶液中稳定, 使用中应采用 5 \\% 葡萄糖注射液溶解输注。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "0fa347ca2a942c12b333e0c170bcd328700cd8e3",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "不良反应大，不作为治疗关节炎的首选药，仅在其他非甾体抗炎药无效时才考虑使用的药物是",
    "options": {
      "A": "双氯芬酸",
      "B": "布洛芬",
      "C": "弓喉美辛",
      "D": "尼美舒利",
      "E": "对乙酰氨基酚"
    },
    "answer": "C",
    "explanation": "本组题考查解热、镇痛、抗炎药的临床用药评价。 ②吲哚美辛可兴奋中枢, 加重癫痫、帕金森、精神病病情, 不良反应较大, 治疗关节炎已不作为首选用药, 仅在其他非甾体抗炎药无效时才考虑使用。故本题答案为C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c6920adcf97f9f11cba4c5a298253b583a5db7dc",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "对入睡困难型失眠比睡眠维持型失眠更有效，但可能发生泌乳素水平升高和睾酮水平下降的镇静催眠药是",
    "options": {
      "A": "扎来普隆",
      "B": "佐匹克隆",
      "C": "雷美替胺",
      "D": "唑吡坦",
      "E": "水合氯醛"
    },
    "answer": "C",
    "explanation": "②本题考查褪黑素类的临床用药评价。雷美替胺属于褪黑素类镇静催眠药, 通常用于失眠的短期治疗, 对入睡困难型失眠比睡眠维持型失眠更有效, 其不良反应常见嗜睡、头晕等, 还可能发生泌乳素水平升高和睾酮水平下降。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c2ecebe0c776b0b86b6767c9a3464587b671efb3",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "属于第 I 类抗心律失常药的是",
    "options": {
      "A": "利多卡因",
      "B": "索他洛尔",
      "C": "美托洛尔",
      "D": "硝酸甘油",
      "E": "维拉帕米"
    },
    "answer": "A",
    "explanation": "本组题考查抗心律失常药的分类与作用机制。 ① 抗心律失常药包括四类: 钠通道阻滞剂 (I 类抗心律失常药)、β 受体拮抗剂 (II 类抗心律失常药)、钾通道阻滞剂 (III 类抗心律失常药)、钙通道阻滞剂 (IV 类抗心律失常药)。I 类抗心律失常药又可细分为: a. I a 类适度 (中等) 阻滞钠通道: 奎尼丁、普鲁卡因胺; b. I b 类轻度 (较弱) 阻滞钠通道: 利多卡因、苯妥英钠、美西律; c. I c 类明显 (较强) 阻滞钠通道: 普罗帕酮。故本题答案为 A。",
    "source_note": "",
    "question_id": "3fc70319618a5549703aaa3e7362f148229fcb23",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "与奥沙利铂可协同抗肿瘤，但因存在配伍禁忌，禁止通过同一静脉途径给药的是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "头孢噻吩",
      "C": "氟尿嘧啶",
      "D": "味塞米",
      "E": "丙磺舒"
    },
    "answer": "C",
    "explanation": "本组题考查破坏 DNA 的铂类化合物的临床用药评价。 ①因与氯化钠和碱性溶液（特别是氟尿嘧啶）之间存在配伍禁忌，奥沙利铂禁止与上述制剂混合或通过同一静脉途径给药。故本题答案为 C。",
    "source_note": "",
    "question_id": "3625d2277f0ca445e15585e0f99047333f336de2",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "属于人工泪液，可用于治疗干眼症的药物是",
    "options": {
      "A": "玻璃酸钠",
      "B": "弓哚菁绿",
      "C": "红霉素",
      "D": "毛果芸香碱"
    },
    "answer": "A",
    "explanation": "本组题考查眼科用药的分类与代表药品。 ②人工泪液可用于治疗干眼症, 代表药物有: 玻璃酸钠、甲基纤维素、聚乙烯醇、卡波姆940。故本题答案为A。红霉素为抗眼部细菌感染药, 用于治疗细菌性结膜炎。毛果芸香碱为胆碱能受体激动药。阿昔洛韦属于抗病毒药。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "4393a8a61876666206b410785a1595056a1f4d56",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "主要用于解热镇痛，但几乎没有抗炎作用的药物是",
    "options": {
      "A": "双氯芬酸钠",
      "B": "阿司匹林",
      "C": "弓喉美辛",
      "D": "塞来昔布",
      "E": "对乙酰氨基酚"
    },
    "answer": "E",
    "explanation": "本组题考查解热、镇痛、抗炎药的临床用药评价。 ①对乙酰氨基酚解热、镇痛作用强, 主要用于普通感冒或流行性感冒引起的发热, 也用于缓解轻至中度疼痛, 但几乎没有抗炎作用。故本题答案为 E。",
    "source_note": "",
    "question_id": "4e649c71252ca1037a27472ebc36e648cbcfafd8",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "属于第Ⅲ类抗心律失常药的是",
    "options": {
      "A": "利多卡因",
      "B": "索他洛尔",
      "C": "美托洛尔",
      "D": "硝酸甘油",
      "E": "维拉帕米"
    },
    "answer": "B",
    "explanation": "本组题考查抗心律失常药的分类与作用机制。 ② 胺碘酮、索他洛尔属于钾通道阻滞剂 (III 类抗心律失常药)。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "a0ec0be47fd87e244aad312683371b59ff6798bd",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "味塞米发挥利尿作用的部位在",
    "options": {
      "A": "肾小球",
      "B": "近曲小管",
      "C": "远曲小管近端",
      "D": "髓袢升支粗段",
      "E": "远曲小管末端和皮质集合管"
    },
    "answer": "D",
    "explanation": "【 14 \\sim 15】本组题考查利尿药的分类与作用部位。 ①呋塞米属于袢利尿药, 主要作用于髓袢升支粗段。故本题答案为 D。",
    "source_note": "",
    "question_id": "0e3cc6c2340859f2791c809c353c7d59e0c811cf",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "与顺铂合用可增加耳毒性的药物是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "头孢噻吩",
      "C": "氟尿嘧啶",
      "D": "味塞米",
      "E": "丙磺舒"
    },
    "answer": "D",
    "explanation": "本组题考查破坏 DNA 的铂类化合物的临床用药评价。 ②顺铂与氯霉素、呋塞米或依他尼酸合用，增加耳毒性。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "0316a42fa984a9bfce777f2ef67cc8a36077659d",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "直接作用于 M 胆碱受体而引起缩瞳，降低眼压的药物是",
    "options": {
      "A": "毒扁豆碱",
      "B": "依可碘酯",
      "C": "溴莫尼定",
      "D": "醋甲唑胺",
      "E": "毛果芸香碱"
    },
    "answer": "E",
    "explanation": "本组题考查眼科用药的分类与代表药品。 ①毛果芸香碱为胆碱能受体激动药, 直接作用于 M 胆碱受体, 引起缩瞳, 眼压下降, 并有调节痉挛等作用。故本题答案为 E。",
    "source_note": "",
    "question_id": "583c2fb8a2e6d6ba347cac1294deb6417d0fb0a0",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "可抑制血栓素 \\mathrm{A}_2 （\\mathrm{TXA}_2）的合成，预防心肌梗死复发的药物是",
    "options": {
      "A": "双氯芬酸钠",
      "B": "阿司匹林",
      "C": "弓喉美辛",
      "D": "塞来昔布",
      "E": "对乙酰氨基酚"
    },
    "answer": "B",
    "explanation": "本组题考查解热、镇痛、抗炎药的临床用药评价。 ②阿司匹林以共价结合的方式不可逆的抑制 COX, 阻止血小板生物合成血栓素 A2 (TXA2), 可预防心肌梗死复发。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "8d98379d198a0152f0aae7b0d4bad1cb8fb31f92",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "具有与可待因相似的镇咳、镇痛作用，1岁幼儿可以使用的药物是",
    "options": {
      "A": "喷托维林",
      "B": "苯丙哌林",
      "C": "右美沙芬",
      "D": "福尔可定",
      "E": "氨溴索"
    },
    "answer": "D",
    "explanation": "本组题考查镇咳药的临床用药评价。 ①福尔可定具有与可待因相似的镇咳、镇痛作用, 缓解干咳的效果比可待因好。成瘾性比可待因小, 呼吸抑制较吗啡弱, 儿童对福尔可定耐受性较好, 不引起便秘或消化功能紊乱, 1 岁幼儿可以使用。故本题答案为 D。",
    "source_note": "",
    "question_id": "0bd5c87e7cc1a7dc04c64ad30cc938414b3299c8",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "脂溶性低，中枢抑制作用慢，属于巴比妥类药物的是",
    "options": {
      "A": "阿普唑仑",
      "B": "异戊巴比妥",
      "C": "苯巴比妥",
      "D": "佐匹克隆",
      "E": "地西泮"
    },
    "answer": "C",
    "explanation": "②本题考查巴比妥类的临床用药评价。药物的脂溶性可决定其进入脑组织的快慢, 脂溶性低的药物 (如苯巴比妥) 出现中枢抑制作用慢。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "fb796a8830502d4c9500338e2442e39abe46b1eb",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "属于第IV类抗心律失常药的是",
    "options": {
      "A": "利多卡因",
      "B": "索他洛尔",
      "C": "美托洛尔",
      "D": "硝酸甘油",
      "E": "维拉帕米"
    },
    "answer": "E",
    "explanation": "本组题考查抗心律失常药的分类与作用机制。 ③ 维拉帕米、地尔硫草属于钙通道阻滞剂 (IV 类抗心律失常药)。故本题答案为 E。硝酸甘油属于抗心绞痛药物。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c1c091bc96a0145c92ca238834ed82cb0e4ca52c",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "氨苯蝶啶发挥利尿作用的部位在",
    "options": {
      "A": "肾小球",
      "B": "近曲小管",
      "C": "远曲小管近端",
      "D": "髓袢升支粗段",
      "E": "远曲小管末端和皮质集合管"
    },
    "answer": "E",
    "explanation": "【 14 \\sim 15】本组题考查利尿药的分类与作用部位。 ②氨苯蝶啶属于留钾利尿药, 主要作用于远曲小管末端和皮质集合管。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "413d11858c5dadde5699578a911d2a7cd1ad74b1",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "可逆性抑制胆碱酯酶的药物是",
    "options": {
      "A": "毒扁豆碱",
      "B": "依可碘酯",
      "C": "溴莫尼定",
      "D": "醋甲唑胺",
      "E": "毛果芸香碱"
    },
    "answer": "A",
    "explanation": "本组题考查眼科用药的分类与代表药品。 ②可逆性胆碱酯酶抑制药可与酶结合形成易于解离的复合物, 不破坏胆碱酯酶, 经过一段时间后释放出胆碱酯酶恢复其活性, 代表药物为毒扁豆碱。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "cc239c4c68b558df1c9affa367898e94be83bd61",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "属于非麻醉性镇咳药，嚼碎服用可引起口腔麻木的药物是",
    "options": {
      "A": "喷托维林",
      "B": "苯丙哌林",
      "C": "右美沙芬",
      "D": "福尔可定",
      "E": "氨溴索"
    },
    "answer": "B",
    "explanation": "本组题考查镇咳药的临床用药评价。 ②苯丙哌林属于非麻醉性镇咳药, 无成瘾性, 兼具中枢性和外周性镇咳作用, 并具有罂粟碱样平滑肌解痉作用; 服用时需整粒吞服, 切勿嚼碎, 以免引起口腔麻木。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c296b95d6314b6aedb8daf709d51145a5811a18f",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "脂溶性高，中枢抑制作用快，属于巴比妥类药物的是",
    "options": {
      "A": "阿普唑仑",
      "B": "异戊巴比妥",
      "C": "苯巴比妥",
      "D": "佐匹克隆",
      "E": "地西泮"
    },
    "answer": "B",
    "explanation": "③本题考查巴比妥类的临床用药评价。脂溶性高的药物 (如硫喷妥钠、异戊巴比妥) 出现中枢抑制作用快。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "fb076f1839babcf83a16a8184697d78e98e5d0c9",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "阻滞钠通道，对短动作电位时程的心房肌无效，仅用于治疗室性心律失常的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "利多卡因 普罗帕酮",
      "C": "索他洛尔",
      "D": "地尔硫草"
    },
    "answer": "B",
    "explanation": "【 16\\sim 18 】 ①本题考查作用于钠通道药物的临床用药评价。利多卡因属于I b类抗心律失常药，轻度（较弱）阻滞钠通道，对短动作电位时程的心房肌无效，仅用于室性心律失常。故本题答案为B。",
    "source_note": "",
    "question_id": "ce489c1d8ab3ecd5156226e9ef5b1af257f77032",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "早期通过利尿而降压，长期用药通过扩外周血管而降压的药物是",
    "options": {
      "A": "吹塞米",
      "B": "阿米洛利",
      "C": "乙酰唑胺",
      "D": "氢氣塞嗪",
      "E": "依他尼酸"
    },
    "answer": "D",
    "explanation": "①本题考查噻嗪与类噻嗪类利尿药的临床用药评价。氢氯噻嗪属于噻嗪类利尿药, 用药早期通过利尿、减少血容量而降压, 长期用药则通过扩张外周血管而降压。故本题答案为 D。",
    "source_note": "",
    "question_id": "54ad8b5b3b627f6616aac02f39a295e232cdbba2",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "不可逆性抑制胆碱酯酶的药物是",
    "options": {
      "A": "毒扁豆碱",
      "B": "依可碘酯",
      "C": "溴莫尼定",
      "D": "醋甲唑胺",
      "E": "毛果芸香碱"
    },
    "answer": "B",
    "explanation": "本组题考查眼科用药的分类与代表药品。 ③不可逆性胆碱酯酶抑制药与胆碱酯酶牢固结合, 使酶老化失活, 代表药物为依可碘酯。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "16eb0300d69745da9c90a41caf9d70f7d1d96cbd",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "患儿，男，5岁，流行性感冒，伴有鼻塞流涕，体温 38^{\\circ}C ，宜选用的退烧药是",
    "options": {
      "A": "阿司匹林",
      "B": "吗啡",
      "C": "呕替啶",
      "D": "塞来昔布",
      "E": "对乙酰氨基酚"
    },
    "answer": "E",
    "explanation": "【 16\\sim 17 】本组题考查解热、镇痛、抗炎药的临床用药评价。 ②对乙酰氨基酚可用于普通感冒或流行性感冒引起的发热，也用于缓解轻至中度疼痛。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "57cd79dde200bd1c770cbee0b07047cb94883419",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "镇咳强度与可待因相等或略强，无镇痛作用，主要用于干咳的药物是",
    "options": {
      "A": "苯丙哌林",
      "B": "右美沙芬",
      "C": "可待因",
      "D": "喷托维林",
      "E": "氯化铵"
    },
    "answer": "B",
    "explanation": "本组题考查镇咳药的临床用药评价。 ①右美沙芬镇咳强度与可待因相等或略强, 无镇痛作用, 主要用于干咳。故本题答案为 B。",
    "source_note": "",
    "question_id": "a527de2c12f66698c3d2b96833d58ee15eb7fca2",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "阻滞钙通道，降低窦房结自律性，可用于控制房颤和房扑的心室率的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "利多卡因 普罗帕酮",
      "C": "索他洛尔",
      "D": "地尔硫草"
    },
    "answer": "D",
    "explanation": "【 16\\sim 18 】 ②本题考查钙通道阻滞剂的临床用药评价。维拉帕米、地尔硫草为IV类抗心律失常药，选择性阻断钙通道，可减慢房室结传导速度、减低窦房结自律性从而减慢心率，可用于控制房颤和房扑的心室率，减慢窦速。故本题答案为D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "948cc85cc2a89a37fd206efb452983e002cce647",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "长期使用会引起血钾升高的药物是",
    "options": {
      "A": "吹塞米",
      "B": "阿米洛利",
      "C": "乙酰唑胺",
      "D": "氢氣塞嗪",
      "E": "依他尼酸"
    },
    "answer": "B",
    "explanation": "②本题考查留钾利尿药的临床用药评价。螺内酯、氨苯蝶啶、阿米洛利属于留钾利尿药, 长期使用会引起血钾升高。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "f3d5d24c194d485cf489bc8d42ee3238c1fd37e2",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "用药后可增加虹膜棕色色素的数量而逐渐引 起眼睛颜色改变的药物是",
    "options": {
      "A": "曲伏前列素",
      "B": "塞吗洛尔",
      "C": "奥布卡因",
      "D": "红霉素"
    },
    "answer": "A",
    "explanation": "①本题考查眼科用药的临床用药评价。前列腺素类似物会增加虹膜棕色色素的数量而逐渐引起眼睛颜色改变, 单侧治疗可导致永久性的虹膜异色症,代表药物有拉坦前列素、曲伏前列素、他氟前列素、贝美前列素。故本题答案为 A。",
    "source_note": "",
    "question_id": "30abafd133c6fc9700422d82a27f8bef370b53eb",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "可导致瑞夷综合征，病毒感染性发烧的儿童须禁用的药物是",
    "options": {
      "A": "阿司匹林",
      "B": "对乙酰氨基酚",
      "C": "弓喉美辛",
      "D": "塞来昔布",
      "E": "布洛芬"
    },
    "answer": "A",
    "explanation": "本组题考查解热、镇痛、抗炎药的临床用药评价。 ①阿司匹林可导致瑞夷综合征, 患病毒感染性疾病发烧的儿童须禁用。故本题答案为 A。",
    "source_note": "",
    "question_id": "0d4a41fb627537c16d6095d14c811d5cade6ad79",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "适用于各种原因引起的剧烈干咳和刺激性咳嗽，也可用于中度以上疼痛的药物是",
    "options": {
      "A": "苯丙哌林",
      "B": "右美沙芬",
      "C": "可待因",
      "D": "喷托维林",
      "E": "氯化铵"
    },
    "answer": "C",
    "explanation": "本组题考查镇咳药的临床用药评价。 ②可待因适用于各种原因引起的剧烈干咳和刺激性咳嗽, 尤其适合于伴有胸痛的剧烈干咳, 也具有镇痛作用, 可用于中度以上疼痛。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "3a2299c55b5525dea70ade5dd7915ce14a9a1b52",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "阻滞钾通道，延长动作电位时程，同时兼有 \\beta 受体拮抗作用的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "利多卡因 普罗帕酮",
      "C": "索他洛尔",
      "D": "地尔硫草"
    },
    "answer": "C",
    "explanation": "【 16\\sim 18 】 ③本题考查作用于钾通道药物的临床用药评价。胺碘酮、索他洛尔为III类抗心律失常药，抑制多种钾通道，其中索他洛尔同时兼有Ⅱ类抗心律失常药的β受体拮抗作用。故本题答案为C。普萘洛尔为β受体拮抗剂，可降低交感神经效应，减慢窦性节律和心房、房室结传导。普罗帕酮为Ic类抗心律失常药，明显（较强）阻滞钠通道，适用于室上性和室性心律失常的治疗。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "5991b081ea6b94bfea5bd46cfa961ff95192be84",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "是症状性心力衰竭治疗基石的药物是",
    "options": {
      "A": "味塞米",
      "B": "氢氯噻嗪",
      "C": "甘露醇",
      "D": "氨苯蝶啶",
      "E": "螺内酯"
    },
    "answer": "A",
    "explanation": "①本题考查袢利尿药的临床用药评价。心力衰竭常引起肺水肿, 神利尿药由于具有强效的利尿作用被写入国内外心力衰竭治疗指南中, 是症状性心力衰竭治疗的基石。故本题答案为 A。",
    "source_note": "",
    "question_id": "81c11f3cf3fbd8c466d8d47d6fb5cd284240e497",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "大剂量长期使用可引起视神经炎或视神经乳头炎的药物是",
    "options": {
      "A": "曲伏前列素",
      "B": "塞吗洛尔",
      "C": "奥布卡因",
      "D": "红霉素"
    },
    "answer": "B",
    "explanation": "②本题考查眼科用药的临床用药评价。氯霉素大剂量长期使用可引起视神经炎或视神经乳头炎 (特别是小儿)。故本题答案为 B。",
    "source_note": "",
    "question_id": "cfc9df5c589988197b0de5a6b9cd46e482ee330c",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "可导致类磺胺过敏反应，对磺胺类药物过敏者须禁用的药物是",
    "options": {
      "A": "阿司匹林",
      "B": "对乙酰氨基酚",
      "C": "弓喉美辛",
      "D": "塞来昔布",
      "E": "布洛芬"
    },
    "answer": "D",
    "explanation": "本组题考查解热、镇痛、抗炎药的临床用药评价。 ②塞来昔布可导致类磺胺过敏反应, 出现皮疹、瘙痒、荨麻疹, 严重者出现史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症, 故对磺胺类药物过敏者禁用。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "40749a1a844e6cb7948fd4023aff552c1a0470d7",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "因其注射液中含有苯甲醇，禁用于儿童肌内注射的药物是",
    "options": {
      "A": "胺碘酮",
      "B": "苯妥英钠",
      "C": "普鲁卡因胺",
      "D": "维拉帕米",
      "E": "普罗帕酮"
    },
    "answer": "A",
    "explanation": "①本题考查钾通道阻滞剂的临床用药评价。胺碘酮注射液禁用于 3 岁以下儿童, 因含有苯甲醇, 禁用于儿童肌内注射。故本题答案为 A。",
    "source_note": "",
    "question_id": "2fd6f18fd981ece6eaf4ae6950fbb5770fb66bc4",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "为肝硬化腹水初始治疗首选的药物是",
    "options": {
      "A": "味塞米",
      "B": "氢氯噻嗪",
      "C": "甘露醇",
      "D": "氨苯蝶啶",
      "E": "螺内酯"
    },
    "answer": "E",
    "explanation": "②本题考查留钾利尿药的临床用药评价。肝硬化患者的醛固酮水平通常会升高, 使用袢利尿药治疗时, 会发生利尿药抵抗, 而螺内酯和依普利酮由于其抗醛固酮作用, 成为肝硬化腹水初始治疗的首选药物。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "eea2e7036cf188c83709fb7b70866afb49daf213",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "可用于外眼手术和简单的内眼手术的表面麻醉药是",
    "options": {
      "A": "曲伏前列素",
      "B": "塞吗洛尔",
      "C": "奥布卡因",
      "D": "红霉素"
    },
    "answer": "C",
    "explanation": "③本题考查眼科用药的分类与代表药品。奥布卡因为眼科表面麻醉药, 可用于外眼手术和简单的内眼手术的麻醉。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "3f11df2c74c3baf014ae9121a4c5bfc0250006a7",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 20,
    "stem": "长期使用可能出现狼疮样综合征的药物是",
    "options": {
      "A": "胺碘酮",
      "B": "苯妥英钠",
      "C": "普鲁卡因胺",
      "D": "维拉帕米",
      "E": "普罗帕酮"
    },
    "answer": "C",
    "explanation": "②本题考查作用于钠通道药物的临床用药评价。普鲁卡因胺属于广谱抗心律失常药, 长期使用可能出现狼疮样综合征, 已很少使用。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "5d977b93e5bddbbc92ca9187f912b6345206c509",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 20,
    "stem": "可用于高钙血症、高钾血症、稀释性低钠血症的药物是",
    "options": {
      "A": "吹塞米",
      "B": "氢氯噻嗪",
      "C": "甘露醇",
      "D": "螺内酯",
      "E": "托伐普坦"
    },
    "answer": "A",
    "explanation": "①本题考查袢利尿药的临床用药评价。呋塞米属于袢利尿药，可用于：高钙血症、高钾血症、稀释性低钠血症；急性药物、毒物中毒；抗利尿激素分泌过多综合征等。故本题答案为A。",
    "source_note": "",
    "question_id": "d169df88688b06d3629628efe5b0b41127ff0aac",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 21,
    "stem": "连续应用可能出现咳嗽、呼吸困难和肺纤维化的药物是",
    "options": {
      "A": "胺碘酮",
      "B": "苯妥英钠",
      "C": "普鲁卡因胺",
      "D": "维拉帕米",
      "E": "普罗帕酮"
    },
    "answer": "A",
    "explanation": "③本题考查作用于钾通道药物的临床用药评价。胺碘酮可引起肺毒性, 起病隐匿, 最早表现为咳嗽, 但病情发展时可出现发热和呼吸困难, 表现为急性肺炎, 还可能引起慢性肺间质纤维化。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "488a9a64697e9c3fd981d26681db6c51a9b10140",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 21,
    "stem": "可用于钙性肾结石、特发性高钙尿症的药物是",
    "options": {
      "A": "吹塞米",
      "B": "氢氯噻嗪",
      "C": "甘露醇",
      "D": "螺内酯",
      "E": "托伐普坦"
    },
    "answer": "B",
    "explanation": "②本题考查噻嗪类与类噻嗪类利尿药的临床用药评价。氢氯噻嗪属于噻嗪类利尿药，通过增加钙离子在远曲小管的重吸收，减少尿钙排泄，可用于治疗钙性肾结石、特发性高钙尿症、预防骨质疏松症。故本题答案为B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "4929ad3aa40cfa2e320145d1c23d0bf1cca75762",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "配伍选择题",
    "qno": 22,
    "stem": "不能直接抑制质子泵，需在胃壁细胞旁的酸性微环境中转化为次磺酰基代谢物，通过二硫键与质子泵结合，抑制胃酸分泌的药物是",
    "options": {
      "A": "伏诺拉生",
      "B": "西咪替丁",
      "C": "米索前列醇",
      "D": "枸橼酸铋钾",
      "E": "雷贝拉唑"
    },
    "answer": "E",
    "explanation": "①本题考查质子泵抑制剂（PPI）的临床用药评价。在胃壁细胞微管的酸性环境中，经酸催化为次磺酰基代谢物，通过二硫键与质子泵的巯基呈不可逆的结合，抑制 \\mathrm{H}+，\\mathrm{K}+-ATP酶的活性，使壁细胞内的 \\mathrm{H}+ 不能转运到胃腔中，阻断了胃酸分泌的最后步骤。故本题答案为E。",
    "source_note": "",
    "question_id": "97483f26c75e41b8a50658c07186626651113c38",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "综合分析题",
    "qno": 22,
    "stem": "可用于原发性醛固酮增多症的诊断和治疗，也可用于特发性水肿的药物是",
    "options": {
      "A": "吹塞米",
      "B": "氢氯噻嗪",
      "C": "甘露醇",
      "D": "螺内酯",
      "E": "托伐普坦"
    },
    "answer": "D",
    "explanation": "③本题考查留钾利尿药的临床用药评价。螺内酯可用于原发性醛固酮增多症的诊断和治疗，也可用于特发性水肿（周期性水钠潴留症）的治疗。故本题答案为D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "qtype_raw": "配伍选择题",
    "question_id": "0ae457c80fb6299df029fde984e7feac9333ebaf",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "配伍选择题",
    "qno": 23,
    "stem": "无需体内转化，通过阻止 \\mathsf{K}^+ 的跨膜转运，发挥抑酸作用，可空腹或餐后服用的药物是",
    "options": {
      "A": "伏诺拉生",
      "B": "西咪替丁",
      "C": "米索前列醇",
      "D": "枸橼酸铋钾",
      "E": "雷贝拉唑"
    },
    "answer": "A",
    "explanation": "②本题考查钾离子竞争性酸阻滞剂（P-CABs）的临床用药评价。钾离子竞争性酸阻滞剂无需体内转化，可直接通过竞争性结合质子泵的钾离子结合位点，阻止 \\mathrm{K}+ 的跨膜转运，对质子泵产生可逆性的抑制，从而抑制胃酸分泌，食物不影响其吸收，故空腹和餐后服药均可。故本题答案为A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "27d12d3e6652c8bca39c2af6818e0659500536e0",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "配伍选择题",
    "qno": 23,
    "stem": "具有抗癫痫作用，还具有抗心律失常作用的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "维拉帕米",
      "C": "利多卡因",
      "D": "胺碘酮"
    },
    "answer": "B",
    "explanation": "②本题考查抗心律失常药的分类与作用机制。苯妥英钠属于Ib类钠通道阻滞剂，可使传导减慢，Q-Tc间期缩短。苯妥英钠还具有抗癫痫作用，可用于癫痫强直-阵挛性发作、单纯及复杂部分性发作、继发性全面发作、癫痫持续状态的治疗。故本题答案为B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "3e2538c360f9aedd1d3ab9a0abcce5d6d1b4d039",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 23,
    "stem": "中效利尿药中效价最强的药物是",
    "options": {
      "A": "氯噻酮",
      "B": "氢氯噻嗪",
      "C": "布美他尼",
      "D": "味塞米",
      "E": "阿米洛利"
    },
    "answer": "A",
    "explanation": "①本题考查噻嗪类与类噻嗪类利尿药的临床用药评价。中效利尿药的最大利尿作用相同, 只是利尿作用效价强度不同, 效价强度排序为氯噻酮 > 呋达帕胺 > 氢氯噻嗪 > 氯噻嗪。故本题答案为 A。",
    "source_note": "",
    "question_id": "fcce9c0446a8a69c0e2d4085baad2b1ef645ecd1",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "配伍选择题",
    "qno": 24,
    "stem": "制成肠溶制剂，餐前空腹整片吞服，不得嚼碎或压碎的抑酸剂是",
    "options": {
      "A": "雷尼替丁",
      "B": "枸橼酸铋钾",
      "C": "沪托拉唑",
      "D": "吉法酯",
      "E": "铝碳酸镁"
    },
    "answer": "C",
    "explanation": "①本题考查质子泵抑制剂（PPI）的临床用药评价。泮托拉唑为质子泵抑制剂, 可抑制胃酸分泌, 遇酸快速分解, 为增强其口服制剂的稳定性, 须制成肠溶制剂 (片或胶囊), 服用时应以整片 (粒) 餐前 30 \\sim 60 \\mathrm{~min} 吞服, 不得咀嚼和压碎。故本题答案为 C。",
    "source_note": "",
    "question_id": "e55970921daab92d147286a2d4eb3e949696147c",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 24,
    "stem": "强效利尿药中效价最强的药物是",
    "options": {
      "A": "氯噻酮",
      "B": "氢氯噻嗪",
      "C": "布美他尼",
      "D": "味塞米",
      "E": "阿米洛利"
    },
    "answer": "C",
    "explanation": "②本题考查袢利尿药的临床用药评价。对强效利尿药利尿作用的效价进行排序, 具体顺序是: 布美他尼 > 托拉塞米 > 呋塞米 > 依他尼酸。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "6969022e9bc6926164b7bb13acbd2de6a1f69582",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "配伍选择题",
    "qno": 25,
    "stem": "抑制夜间酸分泌作用强，可于清晨和睡前服用，且8岁以下儿童禁用",
    "options": {
      "A": "雷尼替丁",
      "B": "枸橼酸铋钾",
      "C": "沪托拉唑",
      "D": "吉法酯",
      "E": "铝碳酸镁"
    },
    "answer": "A",
    "explanation": "②本题考查 H2 受体拮抗剂的临床用药评价。雷尼替丁为 H2 受体拮抗剂, 抑制夜间酸分泌作用强, 治疗消化性溃疡时, 可于清晨和睡前服用, 且 8 岁以下儿童禁用。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "92a3259f11bf3af60bad23ae874aa0a2bde96c75",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 25,
    "stem": "属于碳酸酐酶抑制剂，可降低眼内压，常用于青光眼治疗的药物是",
    "options": {
      "A": "味塞米",
      "B": "甘露醇",
      "C": "乙酰唑胺",
      "D": "氢氯噻嗪"
    },
    "answer": "C",
    "explanation": "本组题考查利尿药的分类与临床用药评价。 ①乙酰唑胺为碳酸酐酶抑制剂, 利尿作用弱而持久, 可以减少房水的生成, 降低眼内压, 主要用于治疗青光眼。故本题答案为 C。",
    "source_note": "",
    "question_id": "14e6a028c6068d98d81e8c76eb7f7f778fd8c39d",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 26,
    "stem": "属于盐皮质激素受体拮抗剂，不需分泌到管腔便可发挥利尿作用的药物是",
    "options": {
      "A": "味塞米",
      "B": "甘露醇",
      "C": "乙酰唑胺",
      "D": "氢氯噻嗪"
    },
    "answer": "B",
    "explanation": "本组题考查利尿药的分类与临床用药评价。 ②非奈利酮属于盐皮质激素受体拮抗药, 通过与特异性盐皮质激素受体 (MR) 结合, 竞争性抑制了醛固酮的作用, 由于此类药物不与管腔受体结合,仅与细胞质靶点结合, 因此它们是唯一不需要分泌到管腔发挥作用的利尿药。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "53b363893cb14fd3ae0b651862a31c5c1ab9777f",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 27,
    "stem": "布美他尼能增加尿中 \\mathrm{Na}^{+}、\\mathrm{Cl}^{-}排泄而产生利尿作用的主要部位是",
    "options": {
      "A": "肾脏远曲小管末端和集合管",
      "B": "肾脏远曲小管近端",
      "C": "肾小球",
      "D": "肾脏近曲小管"
    },
    "answer": "B",
    "explanation": "本组题考查利尿药的分类与作用部位。 ①布美他尼属于袢利尿药, 通过抑制分布在髓袢升支粗段管腔膜上的 \\mathrm{Na}+, \\mathrm{K}++2 \\mathrm{Cl}- 共转运体, 增加尿中 \\mathrm{Na}+ 、 \\mathrm{Cl}- 排泄而产生利尿作用。故本题答案为 B。",
    "source_note": "",
    "question_id": "748257be7a8cf67733a3978c3e9e2b0ecf6cbbde",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "配伍选择题",
    "qno": 28,
    "stem": "对 \\mathrm{H}^{+}, \\mathrm{K}^{+}-ATP 酶产生不可逆的抑制作用, 单次抑酸作用可维持 12 小时以上的药物是",
    "options": {
      "A": "伏诺拉生",
      "B": "雷尼替丁 呼仑西平",
      "C": "米索前列醇",
      "D": "兰索拉唑"
    },
    "answer": "D",
    "explanation": "①本题考查质子泵抑制剂（PPI）的临床用药评价。兰索拉唑属于质子泵抑制剂，为前药，经酸催化转换为活性形式，然后通过二硫键与质子泵的巯基呈不可逆性的结合，从而抑制 \\mathrm{H}+，\\mathrm{K}+-ATP 酶的活性；对质子泵的抑制作用是不可逆的， 但单次抑酸作用时间可维持 12 小时以上。故本题答案为 D。",
    "source_note": "",
    "question_id": "5564c925ec53172e9684c3dbfd6141f7c21eea63",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 28,
    "stem": "依普利酮能拮抗醛固酮受体而产生利尿作用的主要部位是",
    "options": {
      "A": "肾脏远曲小管末端和集合管",
      "B": "肾脏远曲小管近端",
      "C": "肾小球",
      "D": "肾脏近曲小管"
    },
    "answer": "A",
    "explanation": "本组题考查利尿药的分类与作用部位。 ②依普利酮是醛固酮受体拮抗药, 作用于远曲小管末端和集合管, 调控 \\mathrm{Na}+ 和 \\mathrm{K}+ 转运。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "90e275b685e11dcce6fdcb47c61b7f545866ecf8",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "配伍选择题",
    "qno": 29,
    "stem": "可降低胃壁细胞的胃酸分泌，还可增强黏膜的防御机制，增加碳酸氢盐和黏液分泌的药物是",
    "options": {
      "A": "伏诺拉生",
      "B": "雷尼替丁 呼仑西平",
      "C": "米索前列醇",
      "D": "兰索拉唑"
    },
    "answer": "C",
    "explanation": "②本题考查前列腺素类抑酸剂的临床用药评价。米索前列醇为前列腺素类抑酸剂，可降低胃壁细胞的胃酸分泌，还可增强黏膜的防御机制，增加碳酸氢盐和黏液分泌，同时也是终止早孕药。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "e62a0b6e98020c5ce8b928fc2c94f96de0588535",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "配伍选择题",
    "qno": 29,
    "stem": "可用于治疗创伤性脑损伤和脑水肿后颅内压升高的药物是",
    "options": {
      "A": "布美他尼",
      "B": "依他尼酸",
      "C": "甘露醇",
      "D": "氨苯蝶啶",
      "E": "氢氯噻嗪"
    },
    "answer": "C",
    "explanation": "①本题考查渗透性利尿药（甘露醇）的临床用药评价。甘露醇作为组织脱水药, 用于治疗各种原因引起的脑水肿, 降低颅内压, 降低眼内压; 对某些药物过量或毒物中毒 (如巴比妥类药物、锂、水杨酸盐和溴化物等), 可促进其排泄,并防止肾毒性。故本题答案为 C。",
    "source_note": "",
    "question_id": "53bd642e83c975901fda579073246c5f7f1c1b56",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "配伍选择题",
    "qno": 30,
    "stem": "口服后有中和胃酸的作用，长期应用可致腹泻的药物是",
    "options": {
      "A": "氢氧化铝",
      "B": "氢氧化镁",
      "C": "枸橼酸铋钾",
      "D": "碳酸氢钠",
      "E": "奥美拉唑"
    },
    "answer": "B",
    "explanation": "①本题考查抗酸药的临床用药评价。氢氧化镁、氢氧化铝、碳酸氢钠为抗酸药，是碱性物质，可在胃内直接中和胃酸，能够快速有效地缓解反酸、胃痛等不适症状，其中氢氧化镁可致腹泻，氢氧化铝可致便秘。故本题答案为B。",
    "source_note": "",
    "question_id": "f1da32275b2ea57cf966b30f526fb23c8b7cfb3b",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "配伍选择题",
    "qno": 31,
    "stem": "服药期间，口中可能带有氨味并可使舌苔及大便呈灰黑色的药物是",
    "options": {
      "A": "氢氧化铝",
      "B": "氢氧化镁",
      "C": "枸橼酸铋钾",
      "D": "碳酸氢钠",
      "E": "奥美拉唑"
    },
    "answer": "C",
    "explanation": "②本题考查胃黏膜保护药的临床用药评价。枸橼酸铋钾的不良反应可见恶心、呕吐、便秘及腹泻，偶见轻度过敏反应；服药期间，口中可能带有氨味并可使舌苔及大便呈灰黑色。故本题答案为C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "06497c5d37ede4099947caa76cf6b6122e3d4977",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 37,
    "stem": "属于口服直接Xa抑制剂的是",
    "options": {
      "A": "利伐沙班",
      "B": "比伐芦定",
      "C": "依达肝素",
      "D": "双嘧达莫",
      "E": "达比加群酯"
    },
    "answer": "A",
    "explanation": "本组题考查抗血栓药的分类与代表药品。 ①利伐沙班、阿哌沙班、艾多沙班均属于口服直接 Xa 抑制剂。故本题答案为 A。",
    "source_note": "",
    "question_id": "47e604803c0c8b63a7fce24aeab3e7b8811fbf7e",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 38,
    "stem": "属于直接凝血酶抑制剂，但需注射给药的是",
    "options": {
      "A": "利伐沙班",
      "B": "比伐芦定",
      "C": "依达肝素",
      "D": "双嘧达莫",
      "E": "达比加群酯"
    },
    "answer": "B",
    "explanation": "本组题考查抗血栓药的分类与代表药品。 ②达比加群酯、水蛭素、重组水蛭素和比伐芦定属于直接凝血酶抑制剂, 其中水蛭素、重组水蛭素和比伐芦定需注射给药。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "a0b1935618656ea9a761551ee453086395838cb6",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 39,
    "stem": "属于血栓素 \\mathrm{A}_2 （TXA）抑制剂的是",
    "options": {
      "A": "阿司匹林",
      "B": "替格瑞洛",
      "C": "阿昔单抗",
      "D": "替罗非班",
      "E": "噬氯匹定"
    },
    "answer": "A",
    "explanation": "①本题考查抗血栓药的分类与代表药品。阿司匹林属于血栓素A2（TXA2）抑制。故本题答案为A。",
    "source_note": "",
    "question_id": "ff1b64ac0ff035c09480811e3f6d897fa9b85dc2",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 40,
    "stem": "属于不可逆性血小板糖蛋白（GP）II b/III a 受体拮抗剂的是",
    "options": {
      "A": "阿司匹林",
      "B": "替格瑞洛",
      "C": "阿昔单抗",
      "D": "替罗非班",
      "E": "噬氯匹定"
    },
    "answer": "C",
    "explanation": "②本题考查抗血栓药的分类与代表药品。阿昔单抗、替罗非班属于血小板糖蛋白（GP）IIb/IIIa受体拮抗剂，阿昔单抗作用不可逆，替罗非班作用可逆。故本题答案为C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "2947d69b009ca523a925ed9181bb2be0aacda0e8",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 41,
    "stem": "属于噻吩并吡啶类 \\mathrm{P2Y}_{12} 受体拮抗剂的是",
    "options": {
      "A": "阿司匹林",
      "B": "替格瑞洛",
      "C": "阿昔单抗",
      "D": "替罗非班",
      "E": "噬氯匹定"
    },
    "answer": "E",
    "explanation": "③本题考查P2Y12受体拮抗剂的临床用药评价。噻氯匹定属于噻吩并吡啶类P2Y12受体拮抗剂。故本题答案为E。",
    "source_note": "",
    "question_id": "102021e3d4272e546274374614cfbd653dea50ae",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 42,
    "stem": "沙格雷酯属于",
    "options": {
      "A": "前列环素受体激动剂",
      "B": "\\mathrm{P2Y}_{12} 受体拮抗剂",
      "C": "血小板糖蛋白 II b/ III a 受体拮抗剂",
      "D": "血栓素 \\mathrm{A}_{2} ( \\mathrm{TXA}_{2} ) 抑制剂",
      "E": "5-羟色胺受体拮抗剂"
    },
    "answer": "E",
    "explanation": "本组题考查抗血栓药的分类与代表药品。 ①沙格雷酯属于5-羟色胺受体拮抗剂。故本题答案为E。",
    "source_note": "",
    "question_id": "92e66cf9d1b42ca8f4e27b9ff38029a786c940dc",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 43,
    "stem": "贝前列素钠属于",
    "options": {
      "A": "前列环素受体激动剂",
      "B": "\\mathrm{P2Y}_{12} 受体拮抗剂",
      "C": "血小板糖蛋白 II b/ III a 受体拮抗剂",
      "D": "血栓素 \\mathrm{A}_{2} ( \\mathrm{TXA}_{2} ) 抑制剂",
      "E": "5-羟色胺受体拮抗剂"
    },
    "answer": "A",
    "explanation": "本组题考查抗血栓药的分类与代表药品。 ②贝前列素钠属于前列环素受体激动剂。故本题答案为A。P2Y12受体拮抗剂的代表药品有噻氯匹定、氯吡格雷、替格瑞洛。血小板糖蛋白IIb/IIIa受体拮抗剂的代表药品有阿昔单抗、替罗非班、依替巴肽。血栓素A2（TXA2）抑制剂的代表药品有阿司匹林、吲哚布芬。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "dc6603eb496ffc4b7801b82b3303abb4e89f4391",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 44,
    "stem": "第一个 \\mathrm{P2Y_{12}} 受体拮抗剂是",
    "options": {
      "A": "噬氯匹定",
      "B": "肝素",
      "C": "阿替普酶",
      "D": "阿司匹林",
      "E": "瑞普替酶"
    },
    "answer": "A",
    "explanation": "①本题考查（ADP）P2Y12受体拮抗剂的临床用药评价。噻氯匹定是第一个P2Y12受体拮抗剂。故本题答案为A。",
    "source_note": "",
    "question_id": "7abe1350bf8977c5d294a84db54e850cfae1f219",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 45,
    "stem": "小剂量连日服用，可用于冠心病的一、二级预防的是",
    "options": {
      "A": "噬氯匹定",
      "B": "肝素",
      "C": "阿替普酶",
      "D": "阿司匹林",
      "E": "瑞普替酶"
    },
    "answer": "D",
    "explanation": "②本题考查血栓素A2（TXA2）抑制剂的临床用药评价。阿司匹林临床上小剂量连日服用，一般用于冠心病的一、二级预防。故本题答案为D。",
    "source_note": "",
    "question_id": "f39aa7002d8c0cf87fe7c4c93fbe83c87debff1a",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 46,
    "stem": "因抑制 CYP2C19 的活性，可导致氯吡格雷活性代谢物转化减少，降低氯吡格雷的临床有效性的药物是",
    "options": {
      "A": "达比加群酯",
      "B": "兰索拉唑",
      "C": "甲氨蝶呤",
      "D": "布洛芬",
      "E": "奥美拉唑"
    },
    "answer": "E",
    "explanation": "①本题考查P2Y12受体拮抗剂的临床用药评价。氯吡格雷为前药，需经CYP2C19代谢为有抗血小板活性的代谢物，而奥美拉唑和艾司奥美拉唑能明显抑制CYP2C19活性，影响氯吡格雷的抗血小板药效，因此氯吡格雷应避免与奥美拉唑和艾司奥美拉唑合用。故本题答案为E。",
    "source_note": "",
    "question_id": "704215d71787828dc8d78fa11b4b0e8b11e356ff",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 47,
    "stem": "可干扰阿司匹林对血小板的抑制作用，降低阿司匹林的心血管保护作用的药物是",
    "options": {
      "A": "达比加群酯",
      "B": "兰索拉唑",
      "C": "甲氨蝶呤",
      "D": "布洛芬",
      "E": "奥美拉唑"
    },
    "answer": "D",
    "explanation": "②本题考查血栓素A2（TXA2）抑制剂的临床 用药评价。布洛芬会干扰阿司匹林对血小板的不可逆抑制作用，降低阿司匹林的心血管保护作用，应避免合用。故本题答案为D。",
    "source_note": "",
    "question_id": "664c287db16422179fe4ab3e95995bb43d9cef22",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 48,
    "stem": "为P-gp的底物，应避免与P-gp抑制剂如胺碘酮联合应用的药物是",
    "options": {
      "A": "达比加群酯",
      "B": "兰索拉唑",
      "C": "甲氨蝶呤",
      "D": "布洛芬",
      "E": "奥美拉唑"
    },
    "answer": "A",
    "explanation": "③本题考查直接口服抗凝药的临床用药评价。达比加群酯为P-gp的底物，与强效P-gp抑制剂（胺碘酮、维拉帕米、奎尼丁、克拉霉素）合用，可导致达比加群的血药浓度升高，应避免合用。故本题答案为A。",
    "source_note": "",
    "question_id": "81d322611c19e72c7b06b2bdcafadfd11a22f9a9",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 49,
    "stem": "可竞争性、可逆性拮抗GPIIb/IIIa受体的药物是",
    "options": {
      "A": "阿昔单抗",
      "B": "替罗非班",
      "C": "氯吡格雷",
      "D": "替格瑞洛",
      "E": "西洛他唑"
    },
    "answer": "B",
    "explanation": "①本题考查抗血栓药的分类与代表药品。血小板糖蛋白IIb/IIIa受体拮抗剂可分为2类：a.作用可逆：替罗非班、依替巴肽；b.作用不可逆：阿昔单抗。故本题答案为B。",
    "source_note": "",
    "question_id": "a765f91e5e7fc7f231c3820ea7d5fbbe1ef33042",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 50,
    "stem": "可直接作用于 \\mathsf{P2Y}_{12} 受体，且其拮抗 \\mathsf{P2Y}_{12} 受体的作用可逆的药物是",
    "options": {
      "A": "阿昔单抗",
      "B": "替罗非班",
      "C": "氯吡格雷",
      "D": "替格瑞洛",
      "E": "西洛他唑"
    },
    "answer": "D",
    "explanation": "②本题考查（ADP）P2Y12受体拮抗剂的临床用药评价。氯吡格雷、替格瑞洛属于P2Y12受体拮抗剂，其中替格瑞洛可直接作用于P2Y12受体，且其拮抗P2Y12受体的作用可逆。故本题答案为D。氯吡格雷是无活性的前药，代谢为活性代谢物后，通过选择性、不可逆地结合P2Y12受体，进而阻断ADP等激活剂诱导的血小板聚集。",
    "source_note": "",
    "question_id": "2ec83a7b5b5fd54c9ca6e9761ebdb711158fa038",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 51,
    "stem": "影响华法林的总体抗凝作用的肝药酶是",
    "options": {
      "A": "CYP1A2",
      "B": "CYP2D6",
      "C": "CYP3A4",
      "D": "CYP2C9",
      "E": "CYP2C19"
    },
    "answer": "D",
    "explanation": "①本题考查维生素 K 拮抗剂的临床用药评价。华法林是消旋体,由 S-对映体和 R-对映体组成, 前者的抗凝作用约是后者的 3 \\sim 5 倍, 两者主要代谢酶也不同, S-对映体主要经 CYP2C9 代谢, R-对映体经 CYP1A2 和 CYP3A4 代谢。因此, 华法林的总体抗凝作用可能更受 CYP2C9 酶的代谢能力影响。故本题答案为 D。",
    "source_note": "",
    "question_id": "4bc89cb42bf45605cae10c22705f709e1d865bf1",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 52,
    "stem": "参与利伐沙班代谢的肝药酶是",
    "options": {
      "A": "CYP1A2",
      "B": "CYP2D6",
      "C": "CYP3A4",
      "D": "CYP2C9",
      "E": "CYP2C19"
    },
    "answer": "C",
    "explanation": "②本题考查直接抗凝药的临床用药评价。利伐沙班主要通过 CYP3A4、CYP2J2 和不依赖 CYP450 酶系的途径代谢。故本题答案为 C。",
    "source_note": "",
    "question_id": "019744658c0c4d9be66c93416b27772d9ebd0a30",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 53,
    "stem": "为非特异性纤溶酶原激活剂，易导致全身性 纤溶状态，增加出血风险的溶栓药是",
    "options": {
      "A": "阿替普酶",
      "B": "瑞替普酶",
      "C": "替奈普酶",
      "D": "尿激酶",
      "E": "重组人尿激酶原"
    },
    "answer": "D",
    "explanation": "本组题考查溶栓药（溶栓酶）的临床用药评价。 ①尿激酶、重组链激酶属于非特异性纤溶酶原激活剂，使用过程中，容易过度消耗循环中的纤维蛋白原，导致全身性纤溶状态，增加出血的发生风险。故本题答案为D。",
    "source_note": "",
    "question_id": "99814f9002f4b689227cba50fb25935c7e86560a",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 54,
    "stem": "为重组人组织型纤溶酶原激酶衍生物，用于急性心肌梗死症状发生后12小时以内，可间隔30min静脉注射2次的溶栓药是",
    "options": {
      "A": "阿替普酶",
      "B": "瑞替普酶",
      "C": "替奈普酶",
      "D": "尿激酶",
      "E": "重组人尿激酶原"
    },
    "answer": "B",
    "explanation": "本组题考查溶栓药（溶栓酶）的临床用药评价。 ②瑞替普酶是重组人组织型纤溶酶原激酶衍生物，具有一定的纤维蛋白特异性，血浆清除半衰期为14～16min，使用时静脉注射2次即可，两剂之间间隔30min。故本题答案为B。",
    "source_note": "",
    "question_id": "0ce4fcb57c2b23cda4cb1cbf5fe90cb109f7fb59",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 55,
    "stem": "血浆清除半衰期为 14 \\sim 16 \\mathrm{~min}，静脉注射2次即可的溶栓药是",
    "options": {
      "A": "阿哌沙班",
      "B": "瑞替普酶",
      "C": "华法林",
      "D": "替奈普酶",
      "E": "达比加群酯"
    },
    "answer": "B",
    "explanation": "本组题考查溶栓药(溶栓酶)的临床用药评价。 ①瑞替普酶血浆清除半衰期为 14 \\sim 16 \\mathrm{~min}, 比阿替普酶长, 静脉注射 2 次即可。故本题答案为 B。",
    "source_note": "",
    "question_id": "1123f80d5d956e634b7e3c1630823c52d221b6f8",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 56,
    "stem": "血浆清除半衰期 20 \\sim 24 \\mathrm{~min}, 半衰期更长, 单次注射给药即可的溶栓药是",
    "options": {
      "A": "阿哌沙班",
      "B": "瑞替普酶",
      "C": "华法林",
      "D": "替奈普酶",
      "E": "达比加群酯"
    },
    "answer": "D",
    "explanation": "本组题考查溶栓药(溶栓酶)的临床用药评价。 ②替奈普酶血浆清除半衰期 20 \\sim 24 \\mathrm{~min}, 半衰期更长, 单次注射给药即可。故本题答案为 D。",
    "source_note": "",
    "question_id": "b491e35ac12b78534084e94999927a73d9e30a93",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 57,
    "stem": "阿司匹林发挥抗血小板聚集作用的靶点是",
    "options": {
      "A": "GP II b/ III a 受体",
      "B": "COX-1",
      "C": "\\mathrm{P} 2 \\mathrm{Y}_{12}",
      "D": "磷酸二酯酶",
      "E": "COX-2"
    },
    "answer": "B",
    "explanation": "①本题考查血栓素A2（TXA2）抑制剂的临床用药评价。阿司匹 林不可逆地抑制环氧化酶-1（COX-1），减少血栓素A2（TXA2）合成，使血小板无法聚集。故本题答案为B。",
    "source_note": "",
    "question_id": "1250ab37127cf3193199e5769e80d5a4908b5cd2",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 58,
    "stem": "替格瑞洛的作用靶点是",
    "options": {
      "A": "GP II b/ III a 受体",
      "B": "COX-1",
      "C": "\\mathrm{P} 2 \\mathrm{Y}_{12}",
      "D": "磷酸二酯酶",
      "E": "COX-2"
    },
    "answer": "C",
    "explanation": "②本题考查抗血栓药的分类与代表药品。替格瑞洛直接作用于P2Y12受体，且其拮抗P2Y12受体的作用可逆。故本题答案为C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "554c957381a560f775a0ddb72cc9fc22a3db19a3",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "配伍选择题",
    "qno": 59,
    "stem": "替罗非班的作用靶点是",
    "options": {
      "A": "GP II b/ III a 受体",
      "B": "COX-1",
      "C": "\\mathrm{P} 2 \\mathrm{Y}_{12}",
      "D": "磷酸二酯酶",
      "E": "COX-2"
    },
    "answer": "A",
    "explanation": "③本题考查抗血栓药的分类与代表药品。替罗非班属于GP II b/IIIa受体拮抗剂，通过与II b/IIIa受体结合，抑制血小板聚集。故本题答案为A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "ba2fc9c99fedefc1b068028e731e1e4a35aa4537",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，男，17岁。因双眼畏光、流泪、异物感、烧灼感一周就诊，诊断为沙眼，该患者不宜选用的药物是",
    "options": {
      "A": "氯霉素滴眼液",
      "B": "红霉素眼膏",
      "C": "左氧氟沙星滴眼液",
      "D": "四环素可的松眼膏",
      "E": "利巴韦林滴眼液"
    },
    "answer": "E",
    "explanation": "本题考查眼科用药的临床用药评价。抗眼部细菌感染药用于敏感菌引起的结膜炎、角膜炎、沙眼等眼部感染，代表药物有氯霉素、红霉素、左氧氟沙星、四环素等。利巴韦林滴眼液为抗眼部病毒感染药。故本题答案为E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "c0ce46460a542500a7c034c9e70f8bb3b5716790",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第1节直接影响DNA结构和功能的药物",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "患者，男，36岁，诊断为恶性淋巴瘤，正在接受环磷酰胺治疗，患者用药期间需重点关注的不良反应是",
    "options": {
      "A": "神经毒性",
      "B": "耳毒性 剥脱性皮炎",
      "C": "甲状腺功能障碍",
      "D": "出血性膀胱炎"
    },
    "answer": "D",
    "explanation": "本题考查破坏 DNA 的烷化剂的临床用药评价。使用异环磷酰胺及大剂量环磷酰胺时会出现出血性膀胱炎, 这是由代谢物丙烯醛所致 (可用美司钠预防或乙酰半胱氨酸解救)。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "31840a70517422e4eb6567a46235b9b8fb7d0786",
    "section_no": 1,
    "section_title": "直接影响DNA结构和功能的药物",
    "section_norm": "第一节 直接影响DNA结构和功能的药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "患者，男，56岁，既往有动脉粥样硬化血栓病史，服用氯吡格雷做抗血栓治疗，近日出现腹部疼痛，诊断为胃溃疡，应避免合用的药物是",
    "options": {
      "A": "兰索拉唑",
      "B": "铝碳酸镁",
      "C": "硫糖铝",
      "D": "淬托拉唑",
      "E": "奥美拉唑"
    },
    "answer": "E",
    "explanation": "本题考查质子泵抑制剂（PPI）的临床用药评价。氯吡格雷为前药，需经 CYP2C19 代谢为有抗血小板活性的代谢物，而奥美拉唑和艾司奥美拉唑能明显抑制 CYP2C19 活性，影响氯吡格雷的抗血小板药效，因此氯吡格雷应避免与奥美拉唑和艾司奥美拉唑合用。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "35c782ff91548e8704f685d48b6a10a2765992aa",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "患者，女，36岁，癫痫病史3年，长期使用苯巴比妥治疗，伴轻度肝功能不全。近期由于天气变化，出现发热，患者避免使用的退热药物是",
    "options": {
      "A": "布洛芬",
      "B": "双氯芬酸",
      "C": "对乙酰氨基酚",
      "D": "依那西普",
      "E": "依托考昔"
    },
    "answer": "C",
    "explanation": "本题考查解热、镇痛、抗炎药的临床用药评价。苯巴比妥属于肝药酶诱导剂，与对乙酰氨基酚合用，导致对乙酰氨基酚代谢加快，疗效降低，代谢产物 N-乙酰对苯醌亚胺堆积，肝毒性增加。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "3eb9a2f2360e4d642600e3550f7986cd819f0c69",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "患者，女，36岁，近期经常上腹灼烧痛、反酸，疼痛多出现在上午10点及下午4点，有时夜间痛醒，进食后缓解，X线钡餐诊断为十二指肠溃疡，该患者宜使用的治疗药物是",
    "options": {
      "A": "颠茄",
      "B": "莫沙必利",
      "C": "奥美拉唑",
      "D": "甲氧氯普胺"
    },
    "answer": "C",
    "explanation": "本题考查质子泵抑制剂（PPI）的临床用药评价。奥美拉唑属于抑酸剂，临床可用于胃、十二指肠溃疡的治疗。故本题答案为C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "e5926c577a11c3e6f75d09bb0ad271be9d405339",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第1节抗心律失常药",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "室性心律失常患者若伴有左室功能不全，轻度传导系统病变可首选的药物是",
    "options": {
      "A": "胺碘酮",
      "B": "维拉帕米",
      "C": "苯妥英钠",
      "D": "利多卡因",
      "E": "美西律"
    },
    "answer": "E",
    "explanation": "本题考查I类抗心律失常药的临床用药评价。美西律为Ib类轻度（较弱）阻滞钠通道的抗心律失常药，对短动作电位时程的心房肌无效，仅用于室性心律失常。美西律对室性心律失常的疗效虽不太高，但具有负性肌力作用轻微，促心律失常作用发生率低等优点。室性心律失常患者若伴有左室功能不全，轻度传导系统病变应首选美西律。故本题答案为E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "35b5d8096a174e93ebe64c5df145ee5c15aa38d4",
    "section_no": 1,
    "section_title": "抗心律失常药",
    "section_norm": "第一节 抗心律失常药"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第1节糖类、盐类、酸碱平衡调节药",
    "qtype": "综合分析题",
    "qno": 5,
    "stem": "患者，女，55岁。慢性心力衰竭3年，正在 服用地高辛治疗，近期出现明显肺水肿，采用 20\\% 甘露醇联合 50\\% 葡萄糖注射液用于组织脱水，期间患者应注意补充的电解质是",
    "options": {
      "A": "钙",
      "B": "铝",
      "C": "钾",
      "D": "锂",
      "E": "锌"
    },
    "answer": "C",
    "explanation": "本题考查葡萄糖的临床用药评价。大量葡萄糖进入体内后, 暂时不被利用的葡萄糖在合成糖原时需要消耗钾, 可致血钾降低, 从而诱发或加重强心苷类（如地高辛）中毒, 故在应用地高辛或其他强心苷期间输入葡萄糖（特别是大剂量）时应注意同时补钾。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "9db84911463de4935f0bf00717dfe0fadaa792a5",
    "section_no": 1,
    "section_title": "糖类、盐类、酸碱平衡调节药",
    "section_norm": "第一节 糖类、盐类、酸碱平衡调节药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第1节眼科用药",
    "qtype": "综合分析题",
    "qno": 6,
    "stem": "青光眼及前列腺增生患者禁用",
    "options": {
      "A": "毛果芸香碱滴眼液",
      "B": "噬吗洛尔滴眼液",
      "C": "曲伏前列素滴眼液",
      "D": "聚乙二醇滴眼液",
      "E": "硫酸阿托品眼用凝胶"
    },
    "answer": "E",
    "explanation": "本题考查眼科用药的临床用药评价。阿托品拮抗 M 胆碱受体, 使瞳孔括约肌和睫状肌松弛, 导致去甲肾上腺素能神经支配的瞳孔扩大肌的功能占优势, 从而使瞳孔散大, 引起眼压升高; 同时阿托品可松弛膀胱逼尿肌, 加重前列腺增生导致的排尿困难, 故青光眼及前列腺增生患者禁用硫酸阿托品眼用凝胶。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "baaa8534a51949c8d2306d23f5f9cf8a2d9ffec3",
    "section_no": 1,
    "section_title": "眼科用药",
    "section_norm": "第一节 眼科用药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "综合分析题",
    "qno": 9,
    "stem": "患者，女，45岁，因强直性脊柱炎住院，同时伴有胃溃疡、高血压及糖尿病，不宜使用的药品是",
    "options": {
      "A": "硝苯地平",
      "B": "双氯芬酸钠",
      "C": "雷尼替丁",
      "D": "格列齐特",
      "E": "二甲双胍"
    },
    "answer": "B",
    "explanation": "本题考查解热、镇痛、抗炎药的临床用药评价。双氯芬酸钠属于非选择性 COX 抑制剂，常见胃肠道不良反应，消化性溃疡患者应用可加重溃疡性出血症状。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "24a0519812e2e13db4087e4bb623b3bf751f86c0",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "综合分析题",
    "qno": 9,
    "stem": "患者，男，58岁，使用阿司匹林后出现上腹部疼痛，自行使用西咪替丁治疗。服药期间，该患者需要特别关注的不良反应是",
    "options": {
      "A": "溶血性贫血",
      "B": "高钾血症",
      "C": "低镁血症",
      "D": "男性乳房肿胀",
      "E": "低磷血症"
    },
    "answer": "D",
    "explanation": "本题考查 H2 受体拮抗剂的临床用药评价。H2 受体拮抗剂可透过血-脑屏障, 引起定向力障碍, 表现为头晕、乏力、神志不清、精神异常、失眠等, 西咪替丁具有轻度抗雄性激素作用, 长期用药可出现男性乳房肿胀、胀痛以及女性溢乳等。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "965428937dcef6b6278e3000c533964075c9cc04",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "综合分析题",
    "qno": 9,
    "stem": "必须根据患者用药后的国际标准化比率 (INR)水平调整给药剂量和疗程的药物是",
    "options": {
      "A": "肝素",
      "B": "华法林",
      "C": "依诺肝素钠",
      "D": "达比加群酯",
      "E": "氯吡格雷"
    },
    "answer": "B",
    "explanation": "本题考查维生素 K 拮抗剂的临床用药评价。所有接受华法林钠治疗的患者应定期监测国际标准化比率（INR），根据各适应证对应的 INR 目标值范围，结合患者用药后 INR 水平和临床情况，对剂量和疗程进行调整。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "7902cfe0c1767b24104581f650206e84a5e641ae",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "综合分析题",
    "qno": 9,
    "stem": "患者，男，55岁，慢性心力衰竭，长期用药 物规律治疗，近期出现乳房胀痛且异常发育，引起该不良反应的药物是",
    "options": {
      "A": "味塞米",
      "B": "依普利酮 氨苯蝶啶",
      "C": "螺内酯",
      "D": "氢氯噻嗪"
    },
    "answer": "C",
    "explanation": "本题考查留钾利尿药的临床用药评价。螺内酯和依普利酮具有心脏保护作用，可有效减少心衰患者醛固酮生成和活性增加造成的心脏损伤，提高轻、中、重度心衰患者生活质量和生存率。螺内酯与雄激素受体亲和力高，抑制作用强，长期用药可出现男性乳房发育、性欲减退等不良反应，依普利酮对性激素影响较轻，不良反应更少。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "ff672f5873e3d421c1ebee8ad57b98779221e9b3",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "综合分析题",
    "qno": 10,
    "stem": "消化道溃疡和胃肠道出血高风险患者可以选用的药物是",
    "options": {
      "A": "双氯芬酸钠",
      "B": "吡罗昔康",
      "C": "弓喉美辛",
      "D": "塞来昔布",
      "E": "对乙酰氨基酚"
    },
    "answer": "D",
    "explanation": "本组题考查解热、镇痛、抗炎药的临床用药评价。 ①塞来昔布属于选择性 COX-2 抑制剂, 可避免胃肠道的损害, 消化道溃疡和胃肠道出血高风险患者可以选用, 但存在心血管不良反应风险, 有心肌梗死病史者禁用塞来昔布。故本题答案为 D。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "59a1dd8e44d8f1dec7249a8837c62f7c1c80b374",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "综合分析题",
    "qno": 11,
    "stem": "癫痫、帕金森病及精神疾病患者避免使用的药物是",
    "options": {
      "A": "双氯芬酸钠",
      "B": "吡罗昔康",
      "C": "弓喉美辛",
      "D": "塞来昔布",
      "E": "对乙酰氨基酚"
    },
    "answer": "C",
    "explanation": "本组题考查解热、镇痛、抗炎药的临床用药评价。 ②吲哚美辛的不良反应较大, 治疗关节炎一般已不作为首选用药, 且可以兴奋中枢,可加重癫痫、帕金森病和精神病病情, 有此类疾病的患者避免使用吲哚美辛。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "021748842602b0445b0b305adc9d7e7f8b7180fd",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "综合分析题",
    "qno": 12,
    "stem": "患者，女，58岁，既往有磺胺类药物过敏史，诊断为充血性心力衰竭，为减轻患者明显液体潴留，可选择的药物是",
    "options": {
      "A": "味塞米",
      "B": "依他尼酸",
      "C": "氢氯噻嗪",
      "D": "布美他尼",
      "E": "吟达帕胺"
    },
    "answer": "B",
    "explanation": "本题考查袢利尿药的临床用药评价。利尿药可以改善水肿症状，是心衰治疗中唯一能够控制体液潴留的药物，患者既往有磺胺过敏史，禁止使用有磺酰胺（脲）基团的药物，包括①袢利尿药（呋塞米、布美他尼）；②噻嗪类和类噻嗪类利尿药（氢氯噻嗪、吲达帕胺）。而依他尼酸不含磺酰胺（脲）基团，不会引起磺胺样过敏反应。故本题答案为B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords) | explanation_range_detected",
    "question_id": "24878b24b60aa99067da887963fe50296cf7c51a",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "综合分析题",
    "qno": 13,
    "stem": "以白天咳嗽为主的患者较适用的镇咳药物是",
    "options": {
      "A": "福尔可定",
      "B": "羧甲司坦",
      "C": "可待因",
      "D": "右美沙芬",
      "E": "苯丙哌林"
    },
    "answer": "E",
    "explanation": "本组题考查镇咳药的临床用药评价。 ①苯丙哌林属于兼具中枢及外周作用的镇咳药, 镇咳作用较强, 为可待因的 2 \\sim 4 倍, 适用于白天咳嗽为主的患者。 故本题的正确答案为 E。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "bf99d3c99ae48182f799b81a908cab344e451825",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第1节镇咳药",
    "qtype": "综合分析题",
    "qno": 14,
    "stem": "以夜间咳嗽为主的患者较适用的镇咳药物是",
    "options": {
      "A": "福尔可定",
      "B": "羧甲司坦",
      "C": "可待因",
      "D": "右美沙芬",
      "E": "苯丙哌林"
    },
    "answer": "D",
    "explanation": "本组题考查镇咳药的临床用药评价。 ②右美沙芬属于中枢性镇咳药，口服吸收迅速，镇咳强度与可待因相等或略强，适用于夜间咳嗽为主的患者。故本题的正确答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "62d9802813a803a1c497d389b9cf5251529e43cd",
    "section_no": 1,
    "section_title": "镇咳药",
    "section_norm": "第一节 镇咳药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第1节镇静催眠药、中枢肌松药",
    "qtype": "综合分析题",
    "qno": 14,
    "stem": "为非苯二氮草类，重症肌无力患者禁用的药物是",
    "options": {
      "A": "阿普唑仑",
      "B": "异戊巴比妥",
      "C": "苯巴比妥",
      "D": "佐匹克隆",
      "E": "地西泮"
    },
    "answer": "D",
    "explanation": "①本题考查非苯二氮草类的临床用药评价。佐匹克隆是非苯二氮草结构的杂环类镇静催眠药, 重症肌无力患者禁用。故本题答案为 D。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "35ae12b7075107e8dc4bbe6e902947a97cb2bc7b",
    "section_no": 1,
    "section_title": "镇静催眠药、中枢肌松药",
    "section_norm": "第一节 镇静催眠药、中枢肌松药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第1节解热、镇痛、抗炎药",
    "qtype": "综合分析题",
    "qno": 16,
    "stem": "患者，女，68岁，既往有心肌梗死病史，不宜选用的药物是",
    "options": {
      "A": "阿司匹林",
      "B": "吗啡",
      "C": "呕替啶",
      "D": "塞来昔布",
      "E": "对乙酰氨基酚"
    },
    "answer": "D",
    "explanation": "【 16\\sim 17 】本组题考查解热、镇痛、抗炎药的临床用药评价。 ①塞来昔布属于选择性COX-2抑制剂，可升高血管内的血栓素，促进血栓形成，存在心血管不良风险，禁用于有心肌梗死病史或脑卒中病史者。亦禁用于冠状动脉旁路移植手术围手术期疼痛的治疗。故本题答案为D。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "6b2f595e7f89a4638eadfac6285897c99057df77",
    "section_no": 1,
    "section_title": "解热、镇痛、抗炎药",
    "section_norm": "第一节 解热、镇痛、抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第1节抑酸剂、抗酸药与胃黏膜保护药",
    "qtype": "综合分析题",
    "qno": 19,
    "stem": "患者，男，30岁，有长期便秘病史，因胃痛就医，诊断为胃溃疡，该患者治疗胃溃疡应避免使用的药物是",
    "options": {
      "A": "西米替丁",
      "B": "氢氧化铝",
      "C": "奥美拉唑",
      "D": "雷贝拉唑",
      "E": "法莫替丁"
    },
    "answer": "B",
    "explanation": "本题考查抗酸药的临床用药评价。长期大剂量服用氢氧化铝, 可致严重便秘、粪结块而引起肠梗阻, 长期便秘者慎用。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "d184ff125a21ccdb82dd62c3c90eca5d14f8ebd9",
    "section_no": 1,
    "section_title": "抑酸剂、抗酸药与胃黏膜保护药",
    "section_norm": "第一节 抑酸剂、抗酸药与胃黏膜保护药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第1节利尿药",
    "qtype": "综合分析题",
    "qno": 30,
    "stem": "可用于高血压危象，对某些呋塞米无效的病例仍可能有效的药物是",
    "options": {
      "A": "布美他尼",
      "B": "依他尼酸",
      "C": "甘露醇",
      "D": "氨苯蝶啶",
      "E": "氢氯噻嗪"
    },
    "answer": "A",
    "explanation": "②本题考查袢利尿药的临床用药评价。布美他尼属于高效利尿药, 利尿作用强, 可用于高血压危象、抗利尿激素分泌过多症、急性药物或毒物中毒等, 对某些呋塞米无效的病例仍可能有效。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "ff12bc230f30d78ac3719da25d84811c679416f1",
    "section_no": 1,
    "section_title": "利尿药",
    "section_norm": "第一节 利尿药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第1节抗血栓药",
    "qtype": "综合分析题",
    "qno": 34,
    "stem": "患者，男，63岁。非ST段抬高型急性冠脉综合征，经皮冠状动脉介入（PCI）治疗，术后为预防支架内血栓形成，常与阿司匹林联合使用的药物是",
    "options": {
      "A": "氯吡格雷",
      "B": "肝素",
      "C": "利伐沙班",
      "D": "氨甲环酸",
      "E": "阿替普酶"
    },
    "answer": "A",
    "explanation": "本题考查（ADP）P2Y12 受体拮抗剂的临床用药评价。氯吡格雷属于 P2Y12 受体拮抗剂, 其适应证包括: 急性冠脉综合征: ① 非 ST 段抬高型急性冠脉综合征, 包括接受经皮冠状动脉介入术置入支架的患者, 为预防支架内血栓形成, 常与阿司匹林合用; ② ST 段抬高型急性冠脉综合征, 与阿司匹林合用, 可合并在溶栓治疗中使用。故本题答案为 A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords) | explanation_range_detected",
    "question_id": "464e9484b45941eca359b4af5d3cdd2308f1db83",
    "section_no": 1,
    "section_title": "抗血栓药",
    "section_norm": "第一节 抗血栓药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于融合蛋白类抗风湿药的是",
    "options": {
      "A": "依那西普",
      "B": "泼尼松",
      "C": "来氟米特",
      "D": "双氯芬酸"
    },
    "answer": "A",
    "explanation": "本题考查抗风湿药的分类与代表药品。生物制剂及靶向改善病情的抗风湿药包括：①肿瘤坏死因子（TNF-α）抑制剂：a. 融合蛋白类：依那西普；b. 单克隆抗体类：阿达木单抗、英夫利西单抗；②IL-17（白细胞介素-17）抑制剂：司库奇尤单抗、依奇珠单抗；③JAK 抑制剂（小分子靶向抑制剂）：枸橼酸托法替布、巴瑞替尼。故本题答案为 A。来氟米特属于免疫制剂类抗风湿药。双氯芬酸属于非甾体抗炎药。泼尼松属于糖皮质激素。",
    "source_note": "explanation_range_detected",
    "question_id": "077b6804649680475e4e345207c234b562883aca",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "可用于环磷酰胺引起的出血性膀胱炎的祛痰药是",
    "options": {
      "A": "厄多司坦",
      "B": "溴己新",
      "C": "氨溴索",
      "D": "乙酰半胱氨酸",
      "E": "羧甲司坦"
    },
    "answer": "D",
    "explanation": "本题考查黏痰溶解剂的临床用药评价。乙酰半胱氨酸可用于环磷酰胺引起的出血性膀胱炎的治疗。故本题答案为D。",
    "source_note": "",
    "question_id": "2efacd427a5b8f0031fe5c7bd6a2df96a29943ef",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "对于迷走神经过度兴奋所致的窦房阻滞、房室阻滞等缓慢型心律失常可选用的药物是",
    "options": {
      "A": "甲氧氮普胺",
      "B": "阿托品",
      "C": "阿瑞匹坦",
      "D": "莫沙必利",
      "E": "曲美布汀"
    },
    "answer": "B",
    "explanation": "本题考查抗胆碱 M 受体药的临床用药评价。阿托品可兴奋心脏，使心率加快，可用于迷走神经过度兴奋所致的窦房阻滞、房室阻滞等缓慢型心律失常。故本题答案为 B。甲氧氯普胺和莫沙必利属于胃肠动力药。阿瑞匹坦属于止吐药。曲美布汀为功能性胃肠病治疗药。",
    "source_note": "",
    "question_id": "bf5a91566d50675f9d425a0ba6f2609b83608a2a",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "乙内酰脲类抗癫痫药通过减少钠离子内流而使神经细胞膜稳定，限制钠离子通道介导的发作性放电的扩散，属于该类的抗癫痫药物是",
    "options": {
      "A": "卡马西平",
      "B": "苯妥英钠",
      "C": "丙戊酸钠",
      "D": "苯巴比妥",
      "E": "氯硝西泮"
    },
    "answer": "B",
    "explanation": "本题考查抗癫痫药的分类与作用机制。苯妥英钠属于乙内酰脲类抗癫痫药，可减少钠离子内流而使神经细胞膜稳定，限制钠离子通道介导的发作性放电的扩散。故本题答案为 B。",
    "source_note": "",
    "question_id": "71562214a8d2ffb4457b697172dbdca5ae9b0417",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "抗高血压药物中同时具有利尿和降压作用的是",
    "options": {
      "A": "硝普钠",
      "B": "硝苯地平",
      "C": "利血平",
      "D": "呕唑嗪",
      "E": "吟达帕胺"
    },
    "answer": "E",
    "explanation": "本题考查抗高血压药的分类与代表药品。吲达帕胺属于中效利尿剂，可降低血容量，是临床广泛应用的利尿降压药。故本题答案为E。",
    "source_note": "",
    "question_id": "35972ab7ef1526db6794b3815d78535be6ad733c",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "是一种硬化剂，能使曲张静脉周围纤维化，压迫曲张静脉，达到止血目的药物是",
    "options": {
      "A": "酚磺乙胺",
      "B": "甲萘氢醌",
      "C": "聚桂醇",
      "D": "蛇毒血凝酶",
      "E": "艾曲泊帕乙醇胺"
    },
    "answer": "C",
    "explanation": "本题考查抗出血药的分类与代表药品。聚桂醇是一种硬化剂，能使曲张静脉周围纤维化，压迫曲张静脉，达到止血目的。静脉内注射后，可损伤血管内皮、促进血栓形成、阻塞血管，从而起到止血作用。故本题答案为 C。",
    "source_note": "",
    "question_id": "2bc65484149834e87896c038d28e68c6f86b257d",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第2节治疗男性勃起功能障碍药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于5型磷酸二酯酶抑制剂，可用于治疗男性勃起功能障碍合并良性前列腺增生的症状和体征的药物是",
    "options": {
      "A": "非那雄胺",
      "B": "他达拉非",
      "C": "坦索罗辛",
      "D": "索利那新",
      "E": "前列地尔"
    },
    "answer": "B",
    "explanation": "本题考查治疗男性勃起功能障碍药的分类与代表药品。5 型磷酸二酯酶（PDE-5）抑制剂包括西地那非、伐地那非、他达拉非、阿伐那非、爱地那非，是勃起功能障碍首选治疗药物，他达拉非还用于治疗勃起功能障碍合并前列腺增生，改善下尿路症状。故本题答案为 B。",
    "source_note": "",
    "question_id": "305390baf1c9e73580ee1c89e4c154c93abd5340",
    "section_no": 2,
    "section_title": "治疗男性勃起功能障碍药",
    "section_norm": "第二节 治疗男性勃起功能障碍药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "下列不属于糖皮质激素药理作用的是",
    "options": {
      "A": "抗休克",
      "B": "免疫抑制",
      "C": "抗病毒",
      "D": "抗炎",
      "E": "升高血糖"
    },
    "answer": "C",
    "explanation": "本题考查肾上腺糖皮质激素类药物的药理作用与临床应用。糖皮质激素的药理作用包括：①抗炎作用；②免疫抑制作用；③抗毒素作用（减轻细菌内毒素对机体的损害）；④抗休克作用；⑤兴奋中枢神经系统；⑥影响消化系统（促进胃酸、胃蛋白酶分泌）；⑦影响运动系统（可导致骨质疏松、肌肉萎缩）；⑧影响血液系统（升高血小板、红细胞、中性粒细胞、纤维蛋白原、血红蛋白；降低淋巴细胞、嗜酸性粒细胞）；⑨影响物质代谢（升高血糖，提高蛋白质的分解代谢，改变脂肪分布，保水保钠排钾排钙）。故本题答案为 C。",
    "source_note": "explanation_range_detected",
    "question_id": "06a695c069924f840e868ef9fd6faa2129ac073d",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于二氢叶酸还原酶抑制剂，主要用于治疗非小细胞肺癌和恶性胸膜间皮瘤的药物是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "氟尿嘧啶 卡培他滨",
      "C": "培美曲塞",
      "D": "阿糖胞苷"
    },
    "answer": "C",
    "explanation": "本题考查干扰核酸生物合成的药物（抗代谢药）的分类与临床用药评价。二氢叶酸还原酶抑制剂包括培美曲塞、甲氨蝶呤，其中培美曲塞主要用于非小细胞肺癌、恶性胸膜间皮瘤。甲氨蝶呤主要用于乳腺癌、绒毛膜癌、恶性葡萄胎、急性白血病、恶性淋巴瘤、非霍奇金淋巴瘤、蕈样肉芽肿、多发性骨髓瘤、卵巢癌、宫颈癌、睾丸癌、头颈部癌、支气管肺癌、软组织肉瘤、骨肉瘤等。故本题答案为 C。",
    "source_note": "",
    "question_id": "31a4e465484222aba4f9f75c7ca6ef3f686d1e35",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "为高效抗氧化剂，可用于防治坏血病、牙龈出血、各种急、慢性传染疾病及紫癜等的辅助治疗的维生素是",
    "options": {
      "A": "维生素 \\mathbf{B}_1",
      "B": "维生素 \\mathrm{B}_{2}",
      "C": "维生素 \\mathrm{B}_{6}",
      "D": "维生素 C",
      "E": "维生素A"
    },
    "answer": "D",
    "explanation": "本题考查水溶性维生素的临床用药评价。维生素C为高效抗氧化剂,可减轻抗坏血酸过氧化物酶基底的氧化应力。可用于防治坏血病、牙龈出血、各种急、慢性传染疾病及紫癜等的辅助治疗。故本题答案为D。",
    "source_note": "",
    "question_id": "524c380f14d466747b0085c3fb09f4392cf67950",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第2节耳鼻咽喉科用药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于肾上腺素 \\alpha 、 \\beta 受体激动药，可缓解鼻黏膜充血肿胀引起的鼻塞的药物是",
    "options": {
      "A": "利多卡因",
      "B": "左卡巴斯汀",
      "C": "麻黄碱",
      "D": "倍氯米松",
      "E": "度米芬"
    },
    "answer": "C",
    "explanation": "本题考查耳鼻咽喉科用药的分类与代表药品。肾上腺素 \\alpha 、 \\beta 受体激动药的代表药物有麻黄碱、呋麻滴鼻液（还可抑菌），可使外周血管收缩，缓解鼻黏膜充血肿胀引起的鼻塞，减轻鼻腔分泌物或鼻出血。故本题答案为C。利多卡因属于局部麻醉药。左卡巴斯汀属于H1受体拮抗剂，倍氯米松属于局部用糖皮质激素。度米芬属于阳离子型表面活性剂，用于治疗咽喉炎。",
    "source_note": "",
    "question_id": "f0db7fccb1a815118988a498fe17232edc2e1469",
    "section_no": 2,
    "section_title": "耳鼻咽喉科用药",
    "section_norm": "第二节 耳鼻咽喉科用药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第2节局部用抗真菌药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "可用于治疗深部和皮下真菌感染，属于多烯类的抗真菌药物是",
    "options": {
      "A": "克霉唑",
      "B": "特比萘芬",
      "C": "伏立康唑",
      "D": "两性霉素 B",
      "E": "灰黄霉素"
    },
    "answer": "D",
    "explanation": "本题考查局部用抗真菌药的分类与代表药品。两性霉素 B 抗真菌活性最强，是唯一可用于治疗深部和皮下真菌感染的多烯类药物。故本题答案为 D。克霉唑属于咪唑类抗真菌药物。特比萘芬属于丙烯胺类抗真菌药物。伏立康唑属于三唑类抗真菌药物。灰黄霉素属于非多烯类抗真菌药物。",
    "source_note": "",
    "question_id": "33be42fc0920d6bc3e231baab6267b515b4c6464",
    "section_no": 2,
    "section_title": "局部用抗真菌药",
    "section_norm": "第二节 局部用抗真菌药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "不属于传统合成改善病情的抗风湿药的是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "柳氮磺吡啶",
      "C": "羟氯喹",
      "D": "蒸普生"
    },
    "answer": "D",
    "explanation": "本题考查抗风湿药的分类与代表药品。萘普生属于非甾体抗炎药。常用的传统合成改善病情的抗风湿药（慢作用抗风湿药）包括甲氨蝶呤、柳氮磺吡啶、来氟米特、羟氯喹、双醋瑞因等。故本题答案为D。",
    "source_note": "",
    "question_id": "e6f80cb1c78f2c47ea68aa75900bd025422bb308",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "以下不属于阿托品适应证的是",
    "options": {
      "A": "胃溃疡",
      "B": "内脏绞痛",
      "C": "休克",
      "D": "强心苷中毒导致的缓慢型心律失常",
      "E": "解救有机磷酸酯类农药中毒"
    },
    "answer": "A",
    "explanation": "本题考查抗胆碱 M 受体药的临床用药评价。阿托品的临床适应证，包括 ① 各种内脏绞痛，如胃肠绞痛及膀胱刺激症状。对胆绞痛、肾绞痛的疗效较差 ② 全身麻醉前给药，严重盗汗和流涎症； ③ 迷走神经过度兴奋所致的窦房传导阻滞、房室传导阻滞等缓慢型心律失常； ④ 抗休克； ⑤ 解救有机磷酸酯类农药中毒。虽然大剂量阿托品可抑制胃液分泌，但副作用太多，不可用于治疗胃溃疡。故本题答案为 A。",
    "source_note": "explanation_range_detected",
    "question_id": "b78ff9d88ea3f39aea926ede140f7d75fd75340e",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "抗癫痫机制是促进氯离子内流的药物是",
    "options": {
      "A": "卡马西平",
      "B": "苯妥英钠",
      "C": "地西泮",
      "D": "苯巴比妥",
      "E": "丙戊酸钠"
    },
    "answer": "D",
    "explanation": "本题考查抗癫痫药的分类与作用机制。苯巴比妥可与 GABAA 受体结合, 延长 GABA 介导的 CI-通道开放时间, 从而增强 GABA 作用。该过程使跨膜的氯离子内流增加, 引起神经元超极化。故本题答案为 D。",
    "source_note": "",
    "question_id": "c4cc337babfe9624fc1ae663015e7cfad72cb873",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "属于非二氢吡啶类钙通道阻滞剂的药物是",
    "options": {
      "A": "利多卡因",
      "B": "胺碘酮",
      "C": "非洛地平",
      "D": "氨氯地平",
      "E": "地尔硫革"
    },
    "answer": "E",
    "explanation": "本题考查抗高血压药的分类与代表药品。钙通道阻滞剂（CCB）主要分为：①二氢吡啶类（主要作用于动脉）：硝苯地平、氨氯地平、非洛地平、拉西地平等；②非二氢吡啶类（对血管选择性差，对心脏具有负性变时、负性传导及负性变力作用）：维拉帕米、地尔硫草。故本题答案为E。利多卡因属于Ib类钠通道阻滞剂。胺碘酮属于钾通道阻滞剂。",
    "source_note": "explanation_range_detected",
    "question_id": "5166ca1a2b26ee57fddbc03f8221fa38f790ac2a",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第2节治疗男性勃起功能障碍药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "治疗男性勃起功能障碍首选的药物是",
    "options": {
      "A": "非那雄胺",
      "B": "苯丙酸诺龙",
      "C": "他莫昔芬",
      "D": "己烯雌酚",
      "E": "西地那非"
    },
    "answer": "E",
    "explanation": "本题考查5型磷酸二酯酶抑制剂的临床用药评价。西地那非为5型磷酸二酯酶抑制剂，是治疗男性勃起功能障碍的首选药物。故本题答案为E。",
    "source_note": "",
    "question_id": "032255440e5976aa290deec82946e091c4718e4d",
    "section_no": 2,
    "section_title": "治疗男性勃起功能障碍药",
    "section_norm": "第二节 治疗男性勃起功能障碍药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "下列属于糖皮质激素适应证的是",
    "options": {
      "A": "活动性肺结核",
      "B": "中毒性休克",
      "C": "严重精神病",
      "D": "活动性胃溃疡",
      "E": "严重高血压"
    },
    "answer": "B",
    "explanation": "本题考查肾上腺糖皮质激素类药物的药理作用与临床应用。肾上腺糖皮质激素的适应证包括：① 各种原因引起的休克（中毒性休克、心源性休克、低血容量性休克）；② 过敏性疾病：过敏性鼻炎、支气管哮喘；③ 血液系统疾病；④ 严重感染并发的毒血症；⑤ 急、慢性肾上腺皮质功能减退；⑥ 自身免疫性疾病；⑦ 缓解急性炎症的各种症状；⑧ 肌肉和关节劳损、剥脱性皮炎等。故本题答案为 B。",
    "source_note": "explanation_range_detected",
    "question_id": "869d8ce4022080bfd9532fb5444e8f91cb0cb2c3",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第2节青霉素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "青霉素类药物用药后可发生严重的过敏反应，以下针对青霉素类药物过敏反应的描述，不正确的是",
    "options": {
      "A": "过敏性休克为 I 型变态反应",
      "B": "使用之前必须做皮试，皮试阳性者禁止使用，皮试阴性者不会发生过敏反应",
      "C": "对青霉素 G 过敏的患者禁止使用阿莫西林",
      "D": "用药之前需询问过敏史及家族变态反应病史",
      "E": "过敏性休克一旦发生，立即肌内注射抢救药物，同时静脉滴注大剂量肾上腺糖皮质激素"
    },
    "answer": "B",
    "explanation": "本题考查青霉素类药物的临床用药评价。青霉素使用前必须做皮肤敏感试验，阳性反应者禁用，阴性者不能排除出现过敏反应的可能。故本题答案为 B。青霉素类药物导致的过敏性休克为 I 型变态反应。对一种青霉素过敏的患者，对其他青霉素类药物也过敏，对青霉胺或头孢菌素也可能过敏，故对青霉素 G 过敏的患者禁止使用阿莫西林。用药前需询问过敏史，个人或家族变态反应病史。青霉素过敏性休克发生率为 0.004\\% \\sim 0.015\\% ，如不及时抢救，病死率高，故一旦发生过敏反应就地抢救，立即肌内注射 0.1\\% 肾上腺素 0.5 \\sim 1 \\mathrm{ml}，必要时以 5\\% 葡萄糖注射液或氯化钠注射液稀释后静脉注射，同时静脉滴注大剂量肾上腺糖皮质激素。",
    "source_note": "",
    "question_id": "be7d0257377fabb5eed65236a9d88d20244dbe38",
    "section_no": 2,
    "section_title": "青霉素类抗菌药物",
    "section_norm": "第二节 青霉素类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "下列关于甲氨蝶呤药物相互作用的说法，错 误的是",
    "options": {
      "A": "氟尿嘧啶与甲氨蝶呤合用, 两者可产生协同作用",
      "B": "阿司匹林会使甲氨蝶呤血浆蛋白结合率下降, 游离型药物增加, 血浆浓度增加",
      "C": "丙磺舒竞争性抑制甲氨蝶呤的肾小管分泌, 减慢其排泄, 使其毒性增加",
      "D": "甲氨蝶呤与氨苯蝶啶、乙胺嘧啶等药物合用, 毒副作用增加",
      "E": "合用碳酸氢钠可减少甲氨蝶呤的排泄，增加毒性作用"
    },
    "answer": "E",
    "explanation": "本题考查干扰核酸生物合成的药物（抗代谢药）的临床用药评价。甲氨蝶呤属弱酸性药, 与弱酸性药 (如丙磺舒及水杨酸类) 合用, 可竞争性抑制甲氨蝶呤的肾小管分泌, 减慢其排泄, 易中毒; 与碳酸氢钠等碱性药物合用, 可促进其排泄, 减少毒性。故本题答案为 E。",
    "source_note": "",
    "question_id": "e1b53f8286a91d02bf0f1678916bb8f77ac91a32",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可构成血红蛋白，与红细胞的形成和成熟有关，有利于维持正常的造血功能的微量元素是",
    "options": {
      "A": "硒",
      "B": "锰",
      "C": "铁",
      "D": "钴",
      "E": "碘"
    },
    "answer": "C",
    "explanation": "本题考查常见微量元素的生理功能、临床监测及注意事项。铁可构成血红蛋白，与红细胞的形成和成熟有关，有利于维持正常的造血功能，铁缺乏者可出现贫血。故本题答案为 C。",
    "source_note": "",
    "question_id": "4b727ce018ad83002a0ab36c343b9a7bf205d3e7",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第2节耳鼻咽喉科用药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "不属于鼻部血管收缩药的是",
    "options": {
      "A": "麻黄碱滴鼻液",
      "B": "味麻滴鼻液",
      "C": "羟甲唑啉鼻喷剂",
      "D": "赛洛唑啉滴鼻液",
      "E": "布地奈德鼻喷剂"
    },
    "answer": "E",
    "explanation": "本题考查耳鼻咽喉科用药的分类与代表药品。血管收缩药可用于缓解鼻黏膜充血肿胀引起的鼻塞，代表药物有麻黄碱、呋麻滴鼻液、羟甲唑啉、赛洛唑啉。故本题答案为E。布地奈德属于鼻用抗过敏药。",
    "source_note": "",
    "question_id": "a1f78aa6cc5b6072b816da66baf883d4c887f1d5",
    "section_no": 2,
    "section_title": "耳鼻咽喉科用药",
    "section_norm": "第二节 耳鼻咽喉科用药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第2节局部用抗真菌药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可抑制角鲨烯环氧酶的活性，属于丙烯胺类抗真菌药的是",
    "options": {
      "A": "制霉菌素",
      "B": "联苯苄唑",
      "C": "特比萘芬",
      "D": "阿莫罗芬",
      "E": "环吡酮胺"
    },
    "answer": "C",
    "explanation": "本题考查局部用抗真菌药的分类与代表药品。丙烯胺类抗真菌药包括萘替芬和特比萘芬，为角鲨烯环氧酶的非竞争性、可逆性抑制剂。故本题答案为 C。",
    "source_note": "",
    "question_id": "224c453479d6a348cb473abcc07c22e7c86b8cb9",
    "section_no": 2,
    "section_title": "局部用抗真菌药",
    "section_norm": "第二节 局部用抗真菌药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "可刺激胃黏膜，引起轻微的恶心，反射性引起支气管黏膜腺体分泌增加的祛痰药是",
    "options": {
      "A": "溴己新",
      "B": "乙酰半胱氨酸",
      "C": "羧甲司坦",
      "D": "愈创甘油醚",
      "E": "喷托维林"
    },
    "answer": "D",
    "explanation": "本题考查祛痰药的分类与作用机制。恶心性和刺激性祛痰药可刺激胃黏膜, 引起轻微的恶心, 反射性引起支气管黏膜腺体分泌增加, 降低痰液黏性, 使痰液稀释而易于咳出, 代表药物有氯化铵、桉叶油、愈创甘油醚、愈创木酚磺酸钾。故本题答案为 D。溴己新、乙酰半胱氨酸、羧甲司坦为黏痰溶解剂。喷托维林属于镇咳药。",
    "source_note": "",
    "question_id": "0b6849ed6fa4ecaef70a88ac15ab85c92ea6aa45",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "左旋多巴、溴隐亭治疗帕金森病易引起恶心、呕吐等不良反应，为减少这些不良反应，首选的外周多巴胺受体拮抗剂是",
    "options": {
      "A": "东莨菪碱",
      "B": "莫沙必利",
      "C": "多潘立酮",
      "D": "托烷司琼",
      "E": "昂丹司琼"
    },
    "answer": "C",
    "explanation": "本题考查胃肠动力药的分类与作用机制。多潘立酮是外周多巴胺受体拮抗剂，直接拮抗胃肠道多巴胺D2受体及血-脑屏障外的化学感受器触发区的多巴胺受体，促使胃肠蠕动，使张力恢复正常，促使胃排空，增加胃窦和十二指肠运动，协调幽门的收缩，同时抑制恶心、呕吐，并有效防止胆汁反流。可用于功能性、器质性、感染性疾病以及放、化疗所引起的恶心和呕吐。故本题答案为C。",
    "source_note": "",
    "question_id": "c88df25617f33da567f54f9d40ab3f788efc5a28",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "卡托普利抗高血压的作用机制是",
    "options": {
      "A": "抑制肾素活性",
      "B": "抑制血管紧张素转换酶活性",
      "C": "增加血管紧张素 \\mathrm{II} 的生成",
      "D": "抑制羟甲基戊二酰辅酶A还原酶活性",
      "E": "拮抗血管紧张素受体"
    },
    "answer": "B",
    "explanation": "本题考查ACEI类的临床用药评价。卡托普利属于血管紧张素转换酶抑制剂，抑制血管紧张素转换酶活性从而发挥降压作用。故本题答案为B。",
    "source_note": "",
    "question_id": "70a03def73cb04e0b4c806e2142782a90468c257",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "艾曲泊帕乙醇胺用药期间需关注的不良反应是",
    "options": {
      "A": "血小板减少症",
      "B": "超敏反应",
      "C": "血栓形成",
      "D": "再生障碍性贫血",
      "E": "磺胺样过敏反应"
    },
    "answer": "C",
    "explanation": "本题考查促血小板生成药的临床用药评价。艾曲泊帕乙醇胺属于促血小板生成药，可诱导骨髓祖细胞增殖和分化，产生和血小板生成素类似的生理活性，升高血小板，严重不良反应为肝毒性和血栓形成。故本题答案为C。",
    "source_note": "",
    "question_id": "7fddd206dae68954db53eb9dd3df79837ea5695f",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第2节治疗男性勃起功能障碍药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "5型磷酸二酯酶抑制剂中起效最快的是",
    "options": {
      "A": "西地那非",
      "B": "伐地那非",
      "C": "他达拉非",
      "D": "阿伐那非",
      "E": "爱地那非"
    },
    "answer": "D",
    "explanation": "本题考查5型磷酸二酯酶抑制剂的临床用药评价。5型磷酸二酯酶抑 制剂中起效时间最快的是阿伐那非（15min），维持时间最长的是他达拉非（36h）。故本题答案为D。",
    "source_note": "",
    "question_id": "fe68d7376eebff1720b348fd617267a9d2bc417b",
    "section_no": 2,
    "section_title": "治疗男性勃起功能障碍药",
    "section_norm": "第二节 治疗男性勃起功能障碍药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "属于长效糖皮质激素，生物效应可维持 20 \\sim 36 小时的药物是",
    "options": {
      "A": "氢化可的松",
      "B": "泼尼松",
      "C": "曲安西龙",
      "D": "帕拉米松",
      "E": "地塞米松"
    },
    "answer": "E",
    "explanation": "本题考查肾上腺糖皮质激素类药物的分类与代表药品。糖皮质激素根据药代动力学特征及作用时间可分为: ① 短效 (8~12h): 氢化可的松、可的松; ② 中效 (12~24h): 泼尼松、泼尼松龙、甲泼尼龙、曲安西龙; ③ 长效 (20~36h): 地塞米松、 倍他米松；④关节腔内注射（36～72）：醋酸曲安奈德、醋酸甲泼尼龙、帕拉米松。故本题答案为E。",
    "source_note": "explanation_range_detected",
    "question_id": "f1b102c99a0be26a61ca14ab69889e9dececf488",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第2节青霉素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "可减少青霉素的肾小管分泌，延长青霉素的半衰期的药物是",
    "options": {
      "A": "链霉素",
      "B": "头孢他啶 四环素",
      "C": "肾上腺素",
      "D": "丙磺舒"
    },
    "answer": "D",
    "explanation": "本题考查青霉素类药物的临床用药评价。丙磺舒、阿司匹林、吲哚美辛、保泰松和磺胺类药物可减少青霉素类药物的肾小管分泌而延长其血浆半衰期。故本题答案为 D。",
    "source_note": "",
    "question_id": "2475d274c3e7fbbe97718493e79242737f3200be",
    "section_no": 2,
    "section_title": "青霉素类抗菌药物",
    "section_norm": "第二节 青霉素类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "属于嘌呤核苷酸合成酶抑制剂的是",
    "options": {
      "A": "他莫昔芬",
      "B": "疏嘌呤",
      "C": "紫杉醇",
      "D": "吉非替尼",
      "E": "异环磷酰胺"
    },
    "answer": "B",
    "explanation": "本题考查干扰核酸生物合成的药物（抗代谢药）的分类与代表药品。嘌呤核苷酸合成酶抑制剂的代表药品有巯嘌呤、硫鸟嘌呤。故本题答案为 B。",
    "source_note": "",
    "question_id": "4c02a05884e5941d7277443da5e535f08d3b1691",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "维生素A的适应证不包括",
    "options": {
      "A": "甲状旁腺功能不全引起的低钙血症",
      "B": "角膜软化",
      "C": "干眼病",
      "D": "夜盲症",
      "E": "皮肤角质粗糙"
    },
    "answer": "A",
    "explanation": "本题考查脂溶性维生素的临床用药评价。维生素A临床用于防治维生素A缺乏症, 如角膜软化、干眼病、夜盲症、皮肤角质粗糙等。故本题答案为A。",
    "source_note": "",
    "question_id": "731ddee084531e1a5580885c6db42d92adfa30ad",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第2节耳鼻咽喉科用药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "关于耳鼻咽喉科用药的说法，错误的是",
    "options": {
      "A": "左卡巴斯汀可消除组胺与 \\mathrm{H}_{1} 受体结合而产生的过敏症状",
      "B": "倍氯米松属于局部用糖皮质激素，发挥局部抗炎和抗过敏作用",
      "C": "赛洛唑啉可用于干燥性鼻炎和萎缩性鼻炎",
      "D": "氯霉素滴耳液可用于敏感菌引起的外耳炎、中耳炎",
      "E": "薄荷喉片可作用于黏膜冷觉感受器，收缩黏膜血管，减轻水肿，用于咽喉炎"
    },
    "answer": "C",
    "explanation": "本题考查耳鼻咽喉科用药的分类与代表药品。赛洛唑啉属于肾上腺素α1受体激动药，主要用于缓解鼻黏膜充血肿胀引起的鼻塞。故本题答案为C。",
    "source_note": "",
    "question_id": "2ac42a60629935c3096f92336e9f08a08e9ea506",
    "section_no": 2,
    "section_title": "耳鼻咽喉科用药",
    "section_norm": "第二节 耳鼻咽喉科用药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "用药期间避免与中枢性镇咳药同时服用的黏痰溶解剂是",
    "options": {
      "A": "氯化铵",
      "B": "可待因",
      "C": "愈创甘油醚",
      "D": "右美沙芬",
      "E": "氨溴索"
    },
    "answer": "E",
    "explanation": "本题考查祛痰药的分类与作用机制。黏痰溶解剂仅对咳痰症状有改善作用，在使用时应注意查明咳嗽、咳痰的原因，如使用7日后未见好转，应及时就医；用药期间避免与中枢性镇咳药（如右美沙芬）同时服用，以免稀化的痰液堵塞气道，代表药物有乙酰半胱氨酸、溴己新、氨溴索、桉柠蒎油、羧甲司坦等。故本题答案为E。氯化铵、愈创甘油醚属于恶心性和刺激性祛痰药。右美沙芬、可待因属于镇咳药。",
    "source_note": "",
    "question_id": "116c4cce41eca350c47697c624f03378e1dc07d5",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "易引起牙龈增生的药物是",
    "options": {
      "A": "苯妥英钠",
      "B": "卡马西平",
      "C": "地西泮",
      "D": "丙戊酸钠",
      "E": "唑吡坦"
    },
    "answer": "A",
    "explanation": "本题考查苯妥英钠的临床用药评价。苯妥英钠具有强碱性，局部刺激性大，口服可引起恶心、呕吐、胃痛等，宜饭后服用，长期应用可引起牙龈增生，多发生于儿童及青少年。故本题答案为 A。",
    "source_note": "",
    "question_id": "a271eaec885d75f5584a7e654c6c6438442872d6",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "抗高血压药物中，能够减少 Ang II 的生成，升高缓激肽水平的是",
    "options": {
      "A": "厄贝沙坦",
      "B": "美托洛尔",
      "C": "氨氮地平",
      "D": "依那普利",
      "E": "吟达帕胺"
    },
    "answer": "D",
    "explanation": "本题考查 ACEI 类的临床用药评价。依那普利为血管紧张素转换酶抑制剂 (ACEI), 通过抑制 ACE, 降低循环系统和血管组织 RAS 活性, 减少 Ang II 的生成, 同时抑制了缓激肽的降解, 使缓激肽水平升高。故本题答案为 D。厄贝沙坦为血管紧张素受体拮抗剂, 不影响缓激肽的降解。",
    "source_note": "",
    "question_id": "080f4571470ac48375124010dc31be12d888ce09",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "具有抗纤维蛋白溶解作用的抗出血药是",
    "options": {
      "A": "卡络磺钠",
      "B": "维生素 \\mathrm{K}_{1}",
      "C": "蛇毒血凝酶",
      "D": "鱼精蛋白",
      "E": "氨甲环酸"
    },
    "answer": "E",
    "explanation": "本题考查抗出血药的分类与代表药品。氨甲环酸、氨基己酸、氨基乙酸为抗纤维蛋白溶解药，能竞争性抑制纤维蛋白与纤溶酶的结合，阻断纤维蛋白凝块的溶解，从而产生止血作用。故本题答案为 E。",
    "source_note": "",
    "question_id": "a1d85c99b48ea7f2b14da09f5789483d8ee92a81",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第2节治疗男性勃起功能障碍药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "关于5型磷酸二酯酶抑制剂不良反应的说法，错误的是",
    "options": {
      "A": "可引起阴茎异常勃起",
      "B": "可引起低血压、反射性心动过速、鼻塞和眩晕，他达拉非和阿伐那非风险更低",
      "C": "可引起“蓝视”现象，他达拉非最易引起",
      "D": "可引起非动脉性缺血性视神经病变",
      "E": "可引起听力减退，西地那非、伐地那非和他达拉非可能引起突发性听力损失"
    },
    "answer": "C",
    "explanation": "本题考查5型磷酸二酯酶抑制剂的临床用药评价。5型磷酸二酯酶抑制剂可引起“蓝视”现象，除他达拉非外，西地那非、伐地那非和阿伐那非对视网膜上PDE-6有不同程度的抑制作用，大剂量使用或血药浓度过高时可致男性视觉异常，主要表现为眩光、蓝视。故本题答案为C。",
    "source_note": "",
    "question_id": "c3872439b13595e02d1ec29031d7ca956480d43b",
    "section_no": 2,
    "section_title": "治疗男性勃起功能障碍药",
    "section_norm": "第二节 治疗男性勃起功能障碍药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "关于肾上腺皮质激素的说法，错误的是",
    "options": {
      "A": "肾上腺皮质激素是一类非甾体激素",
      "B": "盐皮质激素由肾上腺皮质球状带分泌, 可调节水、电解质代谢",
      "C": "糖皮质激素由肾上腺皮质束状带分泌,可调节糖、蛋白质、脂肪代谢",
      "D": "氨皮质激素由肾上腺皮质网状带分泌,包括孕激素、雌激素和雄激素",
      "E": "人体分泌糖皮质激素具有昼夜节律性, 这是由ACTH分泌的昼夜节律所引起的"
    },
    "answer": "A",
    "explanation": "本题考查肾上腺皮质激素概述。肾上腺皮质激素为一类甾体激素。故本题答案为 A。根据肾上腺皮质激素分泌部位和主要作用可分为三类 ①由肾上腺皮质中层的束状带所分泌的可调节糖、蛋白质、脂肪代谢的糖皮质激素；②由肾上腺皮质的最外层的球状带所分泌的可调节水、电解质代谢的盐皮质激素；③由肾上腺皮质的网状带分泌的，作用于性器官的氮皮质激素，如孕激素、雌激性和雄激素。人体分泌糖皮质激素具有昼夜节律性，上午 8 点为分泌高潮，午夜 12 点为分泌低潮这是由 ACTH 分泌的昼夜节律所引起的。",
    "source_note": "explanation_range_detected",
    "question_id": "a4545a9a55bfa41a31d5cad31ae3e39abaac5b9c",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "下列药物中，与具有抗叶酸作用的氨苯蝶啶、乙胺嘧啶等药物同用，会导致毒副作用增加的是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "阿糖胞苷 疏嘌呤",
      "C": "羟基脲",
      "D": "四氢叶酸"
    },
    "answer": "A",
    "explanation": "本题考查干扰核酸生物合成的药物（抗代谢药）的临床用药评价。甲氨蝶呤为抗叶酸类抗肿瘤药, 与具有抗叶酸作用的氨苯蝶啶、乙胺嘧啶等药物同用, 毒副作用增加。故本题答案为 A。",
    "source_note": "",
    "question_id": "faff912bab90b2abc95e8f3cfdf520b2b7a502d5",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "不属于水溶性维生素的是",
    "options": {
      "A": "维生素 \\mathbf{B}_1",
      "B": "维生素 \\mathrm{B}_{6}",
      "C": "维生素 C",
      "D": "维生素E",
      "E": "叶酸"
    },
    "answer": "D",
    "explanation": "本题考查水溶性维生素的临床用药评价。常用的脂溶性维生素有维生素 A、D、E、K 等。常用的水溶性维生素包括维生素 B1、B2、B6、B12、烟酸、叶酸、泛酸、维生素 C 等。故本题答案为 D。",
    "source_note": "",
    "question_id": "25c6c2b3d02b122836da21143940e49666ecce4f",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第2节耳鼻咽喉科用药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "赛洛唑啉可用于缓解鼻黏膜充血肿胀引起的鼻塞，其作用的受体是",
    "options": {
      "A": "组胺 \\mathrm{H}_{1} 受体",
      "B": "组胺 \\mathrm{H}_{2} 受体",
      "C": "肾上腺素 \\alpha_{1} 受体",
      "D": "肾上腺素 \\beta_{1} 受体",
      "E": "乙酰胆碱M受体"
    },
    "answer": "C",
    "explanation": "本题考查耳鼻咽喉科用药的分类与代表药品。赛洛唑啉属于肾上腺素α1受体激动药，为血管收缩药，可使外周血管收缩，缓解鼻黏膜充血肿胀引起的鼻塞，减少鼻腔分泌物或鼻出血。故本题答案为C。",
    "source_note": "",
    "question_id": "40914a8a6d0938b7dac46c944091021d280b1a29",
    "section_no": 2,
    "section_title": "耳鼻咽喉科用药",
    "section_norm": "第二节 耳鼻咽喉科用药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "为巯基化合物，易被氧化，可与金属离子络合，储存期间应避免接触空气的药物是",
    "options": {
      "A": "氯化铵",
      "B": "右美沙芬",
      "C": "乙酰半胱氨酸",
      "D": "愈创甘油醚",
      "E": "桉叶油"
    },
    "answer": "C",
    "explanation": "本题考查黏痰溶解剂的临床用药评价。乙酰半胱氨酸为巯基化合物,易被氧化,可与金属离子络合,储存期间应避免接触空气、氧化剂、某些金属、橡胶。故本题答案为 C。",
    "source_note": "",
    "question_id": "f5d199841174d083e200b36fb764cb4b8f153d0f",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "下列药物中对中枢神经系统无抗胆碱能作用，不能用于晕动病的是",
    "options": {
      "A": "阿托品",
      "B": "东莨菪碱",
      "C": "异丙嗪",
      "D": "苯海拉明",
      "E": "丁溴东莨菪碱"
    },
    "answer": "E",
    "explanation": "本题考查抗胆碱 \\mathrm{M} 受体药的临床用药评价。丁溴东莨菪碱不易透过血-脑屏障, 没有中枢抗胆碱作用, 不能用于预防晕动病。故本题答案为 E。",
    "source_note": "",
    "question_id": "63d1708fe24e1199366acaa53ff2039f9a0fa2b7",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "为避免引起大面积中毒性表皮坏死松解症，服用前提倡做人体白细胞抗原等位基因（HLA-B1502）检测的抗癫痫药是",
    "options": {
      "A": "卡马西平",
      "B": "丙戊酸钠",
      "C": "氯硝西泮",
      "D": "托吡酯",
      "E": "加巴喷丁"
    },
    "answer": "A",
    "explanation": "本题考查卡马西平的临床用药评价。卡马西平的不良反应常见视物模糊、复视、眼球震颤、头痛。少见变态反应、史蒂文斯-约翰逊综合征或中毒性表皮坏死松解症、皮疹、荨麻疹、瘙痒、严重腹泻、稀释性低钠血症或水中毒、红斑狼疮样综合征, 对于亚裔患者, 推荐在开始卡马西平治疗前筛查患者是否携带 HLA-B*1502 等位基因。故本题答案为 A。",
    "source_note": "",
    "question_id": "5fcc86f3e1dd4e93d79f541232f90bb56f7a1746",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "起效快，作用维持时间较短，适用于高血压 急症的药物是",
    "options": {
      "A": "福辛普利",
      "B": "卡托普利",
      "C": "赖诺普利",
      "D": "厄贝沙坦",
      "E": "缘沙坦"
    },
    "answer": "B",
    "explanation": "本题考查ACEI类的临床用药评价。福辛普利、卡托普利和赖诺普利属于血管紧张素转换酶抑制剂（ACEI），多数ACEI类药物作用时间可维持24小时，但卡托普利起效快，作用维持时间短，适用于高血压急症。故本题答案为B。厄贝沙坦和缬沙坦属于血管紧张素受体拮抗剂（ARB），所有的ARB类药物起效时间在2h左右，作用持续时间在24小时以上。",
    "source_note": "",
    "question_id": "af9268aabaad35aaccd0fdaf51a484f0c29e988a",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "新生儿出血宜选用",
    "options": {
      "A": "维生素 \\mathbf{B}_{12}",
      "B": "肝素",
      "C": "香豆素类",
      "D": "维生素 \\mathrm{K}_{1}",
      "E": "阿司匹林"
    },
    "answer": "D",
    "explanation": "本题考查维生素K类的临床用药评价。维生素K1用于维生素K缺乏引起的出血，如梗阻性黄疸、胆瘘、慢性腹泻等所致出血，香豆素类、水杨酸钠等所致的低凝血酶原血症，新生儿出血以及长期应用广谱抗生素所致的体内维生素K缺乏。",
    "source_note": "",
    "question_id": "08ae7a8d78d0282f6eec989adeb534c23a663613",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第2节治疗男性勃起功能障碍药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "下列药物中，与西地那非无明显相互作用的是",
    "options": {
      "A": "阿司匹林",
      "B": "西咪替丁",
      "C": "克拉霉素",
      "D": "硝酸酯类",
      "E": "多沙唑嗪"
    },
    "answer": "A",
    "explanation": "本题考查 5 型磷酸二酯酶抑制剂的临床用药评价。5 型磷酸二酯酶抑制剂的药物相互作用: ①与硝酸酯类药合用, 由于两类都能引起血压降低, 联合使用,可发生严重的低血压; ②与 CYP3A4 抑制剂 (西咪替丁、红霉素、克拉霉素、伊曲康唑、利托那韦、茚地那韦、沙奎那韦等) 合用, 可影响该类药的肝脏代谢, 延长半衰期; ③与 α1 受体拮抗剂合用, 原则上可增加发生低血压的风险, 优选坦索罗辛和赛洛多辛 (无低血压或低血压较轻)。故本题答案为 A。",
    "source_note": "explanation_range_detected",
    "question_id": "a90987e571989e579bc32e960c809c735447755f",
    "section_no": 2,
    "section_title": "治疗男性勃起功能障碍药",
    "section_norm": "第二节 治疗男性勃起功能障碍药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "关于糖皮质激素药理作用的描述，错误的是",
    "options": {
      "A": "可抑制各种原因引起的炎症反应",
      "B": "可以减轻异体器官移植术后的排斥反应",
      "C": "可以减少内热原的释放, 对感染毒血症的高热有退热作用",
      "D": "可刺激骨髓造血, 升高红细胞、血红蛋白、淋巴细胞、嗜酸性粒细胞含量",
      "E": "可改变身体的脂肪分布，形成向心性肥胖"
    },
    "answer": "D",
    "explanation": "本题考查肾上腺糖皮质激素类药物的药理作用与临床应用。糖皮质激素可以刺激骨髓造血（升高血小板、红细胞、中性粒细胞、纤维蛋白原、血红蛋白含量), 降低淋巴细胞、嗜酸性粒细胞含量。故本题答案为 D。",
    "source_note": "",
    "question_id": "1182d90aae8a3e892b90db239f09f91ca9a934c8",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第2节耳鼻咽喉科用药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "可直接氧化和卤化菌体蛋白，用于治疗咽喉炎的药物是",
    "options": {
      "A": "度米芬",
      "B": "西地碘",
      "C": "氯霉素",
      "D": "复方薄荷油",
      "E": "克霉唑"
    },
    "answer": "B",
    "explanation": "本题考查耳鼻咽喉科用药的分类与代表药品。西地碘属于咽喉部用药,可直接氧化和卤化菌体蛋白，用于治疗咽喉炎及口腔溃疡等。故本题答案为 B。",
    "source_note": "",
    "question_id": "ffe74c825edffdb4f2a0a599428ae683977720c8",
    "section_no": 2,
    "section_title": "耳鼻咽喉科用药",
    "section_norm": "第二节 耳鼻咽喉科用药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "有轻度的镇咳、防腐作用，大剂量有平滑肌松弛作用的药物是",
    "options": {
      "A": "氯化铵",
      "B": "愈创甘油醚",
      "C": "溴己新",
      "D": "氨溴索",
      "E": "羧甲司坦"
    },
    "answer": "B",
    "explanation": "本题考查恶心性和刺激性祛痰药的临床用药评价。愈创甘油醚属于恶心性和刺激性祛痰药, 具有轻度的镇咳、防腐作用, 大剂量有平滑肌松弛作用。故本题答案为 B。",
    "source_note": "",
    "question_id": "c73055aad1c6327e0ce2cdd5f6d0afe9a74aa40e",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "多潘立酮的典型不良反应是",
    "options": {
      "A": "胆汁反流",
      "B": "高泌乳素血症",
      "C": "肝肾功能损害",
      "D": "恶心、呕吐",
      "E": "腹胀"
    },
    "answer": "B",
    "explanation": "本题考查胃肠动力药的临床用药评价。多潘立酮是外周多巴胺 D2 受体拮抗剂，可导致血清泌乳素水平升高、溢乳、男子乳房女性化、女性月经不调等，但停药后即可恢复正常。故本题答案为 B。",
    "source_note": "",
    "question_id": "b6621bd723af64f7b0354cc5be8ebafad0d4da25",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "不属于卡马西平典型不良反应的是",
    "options": {
      "A": "视物模糊、复视",
      "B": "史蒂文斯-约翰逊综合征",
      "C": "三叉神经痛",
      "D": "中毒性表皮坏死松解症",
      "E": "红斑狼疮样综合征"
    },
    "answer": "C",
    "explanation": "本题考查卡马西平的临床用药评价。卡马西平可引起视物模糊、复视、眼球震颤、头痛、变态反应、史蒂文斯-约翰逊综合征或中毒性表皮坏死松解症、皮疹、严重腹泻、稀释性低钠血症或水中毒、红斑狼疮样综合征等不良反应。故本题答案为 C。三叉神经痛为卡马西平的适应证。",
    "source_note": "",
    "question_id": "c3d1e55cfacb7dbea82637d815e14092cb0a4bd1",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "可能导致肾功能进一步损伤，因此不推荐与ARB类药物合用的是",
    "options": {
      "A": "硝酸酯类药物",
      "B": "利尿药",
      "C": "ACEI类药物",
      "D": "他汀类药物",
      "E": "CCB类药物"
    },
    "answer": "C",
    "explanation": "本题考查 ACEI 类的临床用药评价。不推荐 ACEI 类和 ARB 类药物联合应用，二者合用可能导致进一步的肾功能损害，包括可能发生急性肾功能衰竭，两药合用弊大于利。故本题答案为 C。",
    "source_note": "",
    "question_id": "774b7a73d2f30d67ee9d5729b98d3e9143eeb4ae",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "使用糖皮质激素治疗结缔组织病时，为遵循人体糖皮质激素的分泌昼夜节律性，给药时间为",
    "options": {
      "A": "上午 8 时",
      "B": "中午12时",
      "C": "下午2点",
      "D": "晚上8时",
      "E": "午夜12时"
    },
    "answer": "A",
    "explanation": "本题考查肾上腺糖皮质激素类药物的临床应用注意。人体糖皮质激素的分泌具有昼夜节律性，一日上午8时左右为分泌高潮，午夜12时为低潮，故糖皮质激素给药时间为上午8时。故本题答案为A。",
    "source_note": "",
    "question_id": "699e76fc4791517298baa5937c0101208f2d6197",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第2节耳鼻咽喉科用药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "属于阳离子型表面活性剂，可用于治疗咽炎的药物是",
    "options": {
      "A": "酮替芬",
      "B": "度米芬",
      "C": "氨溴索",
      "D": "环丙沙星",
      "E": "麻黄碱"
    },
    "answer": "B",
    "explanation": "本题考查耳鼻咽喉科用药的分类与代表药品。度米芬属于阳离子型表面活性剂，具有广谱杀菌作用，可用于治疗咽炎、鹅口疮和口腔溃疡等。故本题答案为B。酮替芬属于H1受体拮抗剂类鼻用抗过敏药。氨溴索属于黏痰溶解剂。环丙沙星属于喹诺酮类抗菌药物。麻黄碱属于血管收缩药。",
    "source_note": "",
    "question_id": "816dd0451c6fb419eb6689e0861391607cd87e7d",
    "section_no": 2,
    "section_title": "耳鼻咽喉科用药",
    "section_norm": "第二节 耳鼻咽喉科用药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "可为钡灌肠做准备，且对食管有刺激性，需整片吞服，切勿咀嚼或掰碎的药物是",
    "options": {
      "A": "曲美布汀",
      "B": "匹维溴铵",
      "C": "东莨菪碱",
      "D": "多潘立酮",
      "E": "屈他维林"
    },
    "answer": "B",
    "explanation": "本题考查匹维溴铵的临床用药评价。匹维溴铵可用于钡灌肠准备, 应于检查前 3 天开始用药, 本品对食管有刺激性, 需整片吞服, 切勿咀嚼或掰碎。故本题答案为 B。",
    "source_note": "",
    "question_id": "47bbeaaaacc8fbc0dabbfc026aefb1763ddad487",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "为脂肪酸衍生物，对多种癫痫类型都有效的广谱抗癫痫药是",
    "options": {
      "A": "乙琥胺",
      "B": "苯巴比妥",
      "C": "丙戊酸钠",
      "D": "苯妥英钠",
      "E": "地西泮"
    },
    "answer": "C",
    "explanation": "本题考查丙戊酸钠的临床用药评价。丙戊酸钠为脂肪酸衍生物, 可用于各种类型的癫痫, 包括全身性强直-阵挛性发作及部分性发作; 尚可用于双相情感障碍相关的躁狂发作。故本题答案为 C。",
    "source_note": "",
    "question_id": "d5ff405d1923ab1e9c4f4ae0ca8b73a88d826890",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "男，60岁，高血压病史近20年，经检查：心室肌肥厚，血压：170/100mmHg。最宜选用的降压药是",
    "options": {
      "A": "氢氯噻嗪",
      "B": "可乐定",
      "C": "卡托普利",
      "D": "维拉帕米",
      "E": "利多卡因"
    },
    "answer": "C",
    "explanation": "本题考查 ACEI 类的临床用药评价。血管紧张素转换酶抑制剂如卡托普利, 通过抑制 ACE, 减低循环系统和血管组织 RAS 活性, 减少 Ang II 的生成和升高缓激肽水平, 而在心脏方面预防与逆转心肌肥厚, 对缺血心肌具有保护作用, 且起效快, 适用于高血压急症。故本题答案为 C。",
    "source_note": "",
    "question_id": "de9b3e0d81c31223a4bfbe11ce67323ccd6e1de1",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第2节青霉素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "青霉素的抗菌谱不包括",
    "options": {
      "A": "脑膜炎奈瑟菌",
      "B": "肺炎链球菌",
      "C": "破伤风杆菌",
      "D": "伤寒杆菌",
      "E": "钩端螺旋体"
    },
    "answer": "D",
    "explanation": "本题考查青霉素类药物的临床用药评价。青霉素的抗菌谱包括革兰阳性球菌（如溶血性链球菌、肺炎链球菌、金黄色葡萄球菌等）、革兰阴性球菌（如脑膜炎奈瑟菌）、某些革兰阳性杆菌（如破伤风杆菌）、梅毒、钩端螺旋体等，不包括伤寒杆 菌（革兰阴性杆菌）。故本题答案为D。",
    "source_note": "",
    "question_id": "9358f8b4d0cf572e9abbd62da7ee55f9512024ca",
    "section_no": 2,
    "section_title": "青霉素类抗菌药物",
    "section_norm": "第二节 青霉素类抗菌药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第2节耳鼻咽喉科用药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "有抑菌、抑制痛觉神经和刺激腺体分泌作用的鼻黏膜保护药是",
    "options": {
      "A": "氨溴索",
      "B": "左卡巴斯汀",
      "C": "复方薄荷油",
      "D": "糖酸莫米松",
      "E": "麻黄碱"
    },
    "answer": "C",
    "explanation": "本题考查耳鼻咽喉科用药的分类与代表药品。复方薄荷油属于鼻黏膜保护药，具有抑菌、抑制痛觉神经、刺激腺体分泌及减轻鼻腔干燥作用。故本题答案为C。氨溴索为黏痰溶解剂。左卡巴斯汀、糠酸莫米松为鼻用抗过敏药。麻黄碱为血管收 缩药。",
    "source_note": "",
    "question_id": "ae5ffe6da9ab2c09fbd4ef3c5cd0cb6e08c1aeff",
    "section_no": 2,
    "section_title": "耳鼻咽喉科用药",
    "section_norm": "第二节 耳鼻咽喉科用药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第2节耳鼻咽喉科用药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "可消除组胺与 \\mathrm{H}_{1} 受体结合而产生的过敏症状，临床可用于季节性及常年性过敏性鼻炎的预防与治疗的药物是",
    "options": {
      "A": "羟甲唑啉",
      "B": "布地奈德",
      "C": "麻黄碱",
      "D": "桃金娘油",
      "E": "氮革斯汀"
    },
    "answer": "E",
    "explanation": "本题考查耳鼻咽喉科用药的分类与代表药品。氮草斯汀属于 H1 受体拮抗剂, 可消除组胺与 H1 受体结合而产生的过敏症状, 临床可用于季节性及常年性过敏性鼻炎的预防与治疗。故本题答案为 E。",
    "source_note": "",
    "question_id": "f999e281905413a49e83418e831d41008738493f",
    "section_no": 2,
    "section_title": "耳鼻咽喉科用药",
    "section_norm": "第二节 耳鼻咽喉科用药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "丙戊酸钠的典型不良反应是",
    "options": {
      "A": "肝功能损害",
      "B": "中毒性表皮坏死松解症",
      "C": "抑制呼吸",
      "D": "口干、皮肤干燥",
      "E": "低血钙"
    },
    "answer": "A",
    "explanation": "本题考查丙戊酸钠的临床用药评价。丙戊酸钠的典型不良反应包括体重增加、肝脏损害、肝脏中毒。故本题答案为 A。",
    "source_note": "",
    "question_id": "d48d8a64083f450b1a94b8de84906307fe4c3b2d",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "贝那普利常见的不良反应是",
    "options": {
      "A": "低血钾，低血压",
      "B": "刺激性干咳",
      "C": "多毛，多汗",
      "D": "阳痿，性欲减退",
      "E": "反射性心率加快"
    },
    "answer": "B",
    "explanation": "本题考查 ACEI 类的临床用药评价。ACEI 类最常见不良反应为干咳，多见于用药初期，症状较轻者可坚持服药，不能耐受者可改用 ARB 类。其他不良反应有低血压、皮疹。严重不良反应为血管神经性水肿。长期应用有可能导致血钾升高，应定期监测血钾和血肌酐水平。故本题答案为 B。",
    "source_note": "",
    "question_id": "8ae72799100f20ebb2385818132f9599a039cf39",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "关于糖皮质激素对物质代谢的影响，错误的是",
    "options": {
      "A": "升高血糖",
      "B": "分解蛋白质",
      "C": "改变脂肪分布",
      "D": "排钾",
      "E": "排钠"
    },
    "answer": "E",
    "explanation": "本题考查肾上腺糖皮质激素类药物的药理作用与临床应用。糖皮质激素可增强钠离子再吸收及钾、钙、磷的排泄。故本题答案为 E。",
    "source_note": "",
    "question_id": "e946b5238e34d18b9d1dd4d972b7284f921c716c",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第2节耳鼻咽喉科用药",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "麻黄碱滴鼻液临床主要用于",
    "options": {
      "A": "鼻腔干燥",
      "B": "过敏性鼻炎",
      "C": "萎缩性鼻炎",
      "D": "药物性鼻炎",
      "E": "鼻黏膜肿胀引起的鼻塞"
    },
    "answer": "E",
    "explanation": "本题考查耳鼻咽喉科用药的分类与代表药品。麻黄碱是 \\alpha 、 \\beta 受体激动剂, 属于血管收缩药, 临床可用于缓解鼻黏膜充血肿胀引起的鼻塞。故本题答案为 E。",
    "source_note": "",
    "question_id": "ade8b12bc7eaa32b393fa2fbfd5aae1745684d83",
    "section_no": 2,
    "section_title": "耳鼻咽喉科用药",
    "section_norm": "第二节 耳鼻咽喉科用药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "与抗菌药物亚胺培南合用，血药浓度降低，癫痫失控风险增加的药物是",
    "options": {
      "A": "卡马西平",
      "B": "拉莫三嗪",
      "C": "丙戊酸钠",
      "D": "左乙拉西坦",
      "E": "加巴喷丁"
    },
    "answer": "C",
    "explanation": "本题考查丙戊酸钠的临床用药评价。丙戊酸钠与亚胺培南、美罗培南、厄他培南、多立培南等抗生素合用, 本品血药浓度降低, 癫痫失控的风险增加。故本题答案为 C。",
    "source_note": "",
    "question_id": "84bf3578c44716525932cc765d5a36fc795befa1",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "关于肾上腺糖皮质激素类药物药理作用的说法，错误的是",
    "options": {
      "A": "抑制炎症细胞向炎症部位移动，阻止炎症介质释放，抑制炎症后组织损伤的修复",
      "B": "可降低血糖, 促进蛋白质合成, 减轻体重",
      "C": "可缓解过敏反应及自身免疫性疾病的症状",
      "D": "能提高机体对有害刺激的应激能力,减轻细菌内毒素对机体的损害",
      "E": "能解除小动脉痉挛，增强心肌收缩力，改善微循环"
    },
    "answer": "B",
    "explanation": "本题考查肾上腺糖皮质激素类药物的药理作用与临床应用。肾上腺糖皮质激素可增高肝糖原, 升高血糖; 提高蛋白质的分解代谢; 改变身体脂肪的分布,形成向心性肥胖, 增加体重。故本题答案为 B。",
    "source_note": "",
    "question_id": "bab5a04d7787a87010c489c44c89e054d2271484",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "关于抗癫痫药特殊人群用药的说法，正确的是",
    "options": {
      "A": "驾驶员在撤药后6个月无癫痫发作时可驾驶车辆",
      "B": "卡马西平致畸风险最高，孕妇禁用",
      "C": "左乙拉西坦禁用18岁以下青少年",
      "D": "抗癫痫治疗半年内无清醒发作方可驾驶小轿车",
      "E": "给予叶酸可以有效地预防抗癫痫药相关的新生儿出血风险"
    },
    "answer": "A",
    "explanation": "本题考查抗癫痫药的特殊人群用药。癫痫患者在驾驶前需经历一定时间的无发作期，已有半年至2年无发作才能驾驶车辆，具体时长依发作类型、用药情况而定；撤药期间不能驾车，需撤药后6个月再驾车。故本题答案为A。应用抗癫痫药有致畸风险，其中丙戊酸最高，其次是苯巴比妥和苯妥英，卡马西平和托吡酯居中，奥卡西平、拉莫三嗪和左乙拉西坦显示较高安全性。使用抗癫痫药的妇女，应在妊娠前、妊娠期补充叶酸（预防神经管缺陷），妊娠后期需补充维生素K（预防抗癫痫药相关的新生儿出血）。左乙拉西坦可辅助治疗儿童及成人癫痫患者的局灶性发作、12岁及12岁以上青少年肌阵挛性癫痫发作，6岁及6岁以上特发性全面性癫痫患者的原发性全面强直-阵挛性癫痫发作。",
    "source_note": "",
    "question_id": "842f1043ce7367cb9f508925aeafd653cb43a890",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "糖皮质激素联用呋塞米可导致",
    "options": {
      "A": "血钙升高",
      "B": "胃溃疡风险增加",
      "C": "钾过度流失",
      "D": "血糖降低",
      "E": "血压升高"
    },
    "answer": "C",
    "explanation": "本题考查肾上腺糖皮质激素类药物的药物相互作用。糖皮质激素可引起水钠潴留, 促进钾、钙、磷的排泄, 引起血钙和血钾降低, 增高肝糖原, 升高血压。呋塞米为排钾利尿药, 也会引起血钾过低, 两者合用会引起钾过度流失。故本题答案为 C。",
    "source_note": "",
    "question_id": "0bee6f06aadd77ef828875405f7c3d707d9a4b8c",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 12,
    "stem": "易引起反射性心动过速、心悸和头痛的短效CCB类药品是",
    "options": {
      "A": "左旋氨氯地平片",
      "B": "氨氯地平片",
      "C": "硝苯地平片",
      "D": "拉西地平片",
      "E": "乐卡地平片"
    },
    "answer": "C",
    "explanation": "本题考查三代钙通道阻滞剂（CCB）的对比。第一代钙通道阻滞剂（CCB）的代表药品为硝苯地平片，具有半衰期短、清除率高、作用持续时间短、生物利用度低、药物血浆浓度波动大，对血压的控制时间短的特点，易导致反射性心动过速、心悸、头痛。故本题答案为C。左旋氨氯地平片、氨氯地平片、拉西地平片、乐卡地平片为第三代钙通道阻滞剂（CCB），具有起效平缓、作用平稳、持续时间久、抗高血压谷峰比值高的特点，因此患者血压波动小，一日给药一次，长效平稳降压。",
    "source_note": "",
    "question_id": "d817a09f4338b025395678c0d5d36ae72b8bf70b",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 13,
    "stem": "扩张脑血管作用较强，能增加脑血流量，可用于缺血性脑血管病的钙通道阻滞剂是",
    "options": {
      "A": "氨氯地平",
      "B": "硝苯地平",
      "C": "维拉帕米",
      "D": "尼莫地平",
      "E": "地尔硫革"
    },
    "answer": "D",
    "explanation": "本题考查钙通道阻滞剂（CCB）的临床用药评价。氨氯地平、硝苯地平和尼莫地平属于二氢吡啶类钙通道阻滞剂，该类药物能明显舒张血管，其中尼莫地平舒张脑血管作用较强，能增加脑血流量，可用于缺血性脑血管病的治疗。故本题答案为D。维拉帕米、地尔硫草属于非二氢吡啶类钙通道阻滞剂，对窦房结、房室结处的钙通道具有选择性，但血管选择性较差，扩血管作用弱于二氢吡啶类，临床主要用于心律失常、心绞痛、高血压的治疗。",
    "source_note": "",
    "question_id": "f37d7ad7a46d1b920480c3733746c1009948a8f2",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "单项选择题",
    "qno": 13,
    "stem": "关于糖皮质激素用于特殊人群的说法，不正确的是",
    "options": {
      "A": "儿童使用需定期监测生长发育情况",
      "B": "有精神病史的患者避免使用",
      "C": "严重肝功能不全患者应使用泼尼松",
      "D": "妊娠早期妇女禁止使用",
      "E": "老年患者使用需预防骨质疏松和高血压"
    },
    "answer": "C",
    "explanation": "本题考查肾上腺糖皮质激素类药物的临床应用注意。可的松和泼尼松为前药，需在肝内分别转化为氢化可的松和泼尼松龙而生效，故严重肝功能不全者宜选择氢化可的松或泼尼松龙。故本题答案为C。",
    "source_note": "",
    "question_id": "29cf040843f1c6b46ff5a19b73dac2c357c0ab66",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 15,
    "stem": "可导致牙龈增生的抗高血压药是",
    "options": {
      "A": "硝苯地平",
      "B": "卡托普利",
      "C": "缢沙坦",
      "D": "普萘洛尔",
      "E": "硝普钠"
    },
    "answer": "A",
    "explanation": "本题考查钙通道阻滞剂（CCB）的临床用药评价。二氢吡啶类钙通道阻滞剂（如硝苯地平）常见不良反应包括：反射性交感神经激活导致心跳加快、面部潮红、脚踝部水肿、牙龈增生等。故本题答案为 A。",
    "source_note": "",
    "question_id": "939bc02abe02b9b7aedd43c4606e2a9fc83f8202",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 16,
    "stem": "参与非洛地平代谢的肝药酶是",
    "options": {
      "A": "CYP1A2",
      "B": "CYP2D6",
      "C": "CYP3A4",
      "D": "CYP2C9",
      "E": "CYP2C19"
    },
    "answer": "C",
    "explanation": "本题考查钙通道阻滞剂（CCB）的临床用药评价。非洛地平是CYP3A4的底物，受肝药酶诱导剂和抑制剂的影响。故本题答案为C。",
    "source_note": "",
    "question_id": "711645affd8e41e0ddb6ac2e9b601ee976e77e28",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 17,
    "stem": "关于二氢吡啶类钙通道阻滞剂的说法，错误的是",
    "options": {
      "A": "二氢吡啶类 CCB 主要扩张动脉, 对静脉影响较小",
      "B": "尼莫地平可用于既往有脑卒中病史的老年高血压患者",
      "C": "红霉素可显著增加非洛地平的生物利用度",
      "D": "硝苯地平主要作用于窦房结和房室结处的钙通道",
      "E": "氨氯地平可用于外周血管痉挛性疾病，改善大多数雷诺综合征患者的症状"
    },
    "answer": "D",
    "explanation": "本题考查钙通道阻滞剂 (CCB) 的临床用药评价。二氢吡啶类钙通道阻滞剂 (XX 地平) 主要作用于血管平滑肌上的 L 型钙通道, 发挥舒张血管和降压作用,而非二氢吡啶类钙通道阻滞剂（如维拉帕米、地尔硫草）对窦房结和房室结处的钙通道具有选择性。故本题答案为 D。",
    "source_note": "",
    "question_id": "6a3a68eed5bd993e69532e5a4b6a28c3d3f432b1",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "单项选择题",
    "qno": 18,
    "stem": "长期使用 \\beta 受体拮抗剂突然停药可发生反跳 现象，一般需逐步撤药，撤药时间至少",
    "options": {
      "A": "3 天",
      "B": "5 天",
      "C": "7 天",
      "D": "9 天",
      "E": "14天"
    },
    "answer": "A",
    "explanation": "本题考查 \\beta 受体拮抗剂的临床用药评价。长期应用 \\beta 受体拮抗剂突然停药可发生反跳现象, 即原有症状加重或出现新的表现, 称之为撤药综合征。如需停用 \\beta 受体拮抗剂应逐步撤药, 至少经过 3 天, 一般为 2 周。故本题答案为 A。",
    "source_note": "",
    "question_id": "4d2ab168d22cd7d67ddfc3146a0e65ece34e03fa",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 3,
    "stem": "既可用于治疗类风湿关节炎，又可用于治疗溃疡性结肠炎、克罗恩病的药物是",
    "options": {
      "A": "双氯芬酸",
      "B": "英夫利西单抗",
      "C": "来氟米特",
      "D": "双醋瑞因",
      "E": "司库奇尤单抗"
    },
    "answer": "B",
    "explanation": "本组题考查抗风湿药的临床用药评价。 ①英夫利昔单抗属于肿瘤坏死因子（TNF-α）抑制剂，可用于银屑病、强直性脊柱炎、克罗恩病、溃疡性结肠炎。故本题答案为B。",
    "source_note": "",
    "question_id": "d982e881bb166c62179380129905327920d4435d",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第2节局部用抗真菌药",
    "qtype": "配伍选择题",
    "qno": 3,
    "stem": "可干扰真菌细胞膜麦角固醇的合成，主要用于治疗皮肤癣菌病、念珠菌病，属于吗啉类药物的是",
    "options": {
      "A": "卡泊芬净",
      "B": "特比萘芬",
      "C": "阿莫罗芬",
      "D": "联苯苄唑",
      "E": "伊曲康唑"
    },
    "answer": "C",
    "explanation": "本组题考查局部用抗真菌药的分类与代表药品。 ①阿莫罗芬属于吗啉类抗真菌药, 通过干扰真菌细胞膜麦角固醇的合成而导致真菌死亡, 主要用于治疗皮肤癣菌病、皮肤念珠菌病等。故本题答案为 C。",
    "source_note": "",
    "question_id": "92565489496d46c90f1e19ef2cade5452ab3a880",
    "section_no": 2,
    "section_title": "局部用抗真菌药",
    "section_norm": "第二节 局部用抗真菌药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第2节局部用抗真菌药",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "主要用于治疗浅表皮肤真菌感染，如手癣、体癣，属于咪唑类抗真菌药物的是",
    "options": {
      "A": "卡泊芬净",
      "B": "特比萘芬",
      "C": "阿莫罗芬",
      "D": "联苯苄唑",
      "E": "伊曲康唑"
    },
    "answer": "D",
    "explanation": "本组题考查局部用抗真菌药的分类与代表药品。 ②联苯苄唑属于咪唑类抗真菌药物, 主要用于治疗浅表皮肤真菌感染, 如手癣、足癣、体癣、股癣等。故本题答案为 D。卡泊芬净属于棘白菌素类抗真菌药。特比萘芬属于丙烯胺类抗真菌药物。伊曲康唑属于三唑类抗真菌药。",
    "source_note": "",
    "question_id": "2866c19ab287a879da4795f8ae1ddfb532d60de0",
    "section_no": 2,
    "section_title": "局部用抗真菌药",
    "section_norm": "第二节 局部用抗真菌药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "既可用于治疗成人类风湿关节炎，又可用于治疗狼疮性肾炎的药物是",
    "options": {
      "A": "双氯芬酸",
      "B": "英夫利西单抗",
      "C": "来氟米特",
      "D": "双醋瑞因",
      "E": "司库奇尤单抗"
    },
    "answer": "C",
    "explanation": "本组题考查抗风湿药的临床用药评价。 ③来氟米特属于慢作用抗风湿药，主要抑制合成嘧啶的二氢乳清酸脱氢酶，使活化淋巴细胞的生长受抑制，适用于成人类风湿关节炎，也适用于狼疮性肾炎。故本题答案为C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "eecc90472ab7555d2dd345101cc5a167145471cc",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "属于二氢叶酸还原酶抑制剂的是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "羟基脲",
      "C": "替吉奥",
      "D": "氟尿嘧啶",
      "E": "吉西他滨"
    },
    "answer": "A",
    "explanation": "本组题考查干扰核酸生物合成的药物（抗代谢药）的分类与代表药品。 ①二氢叶酸还原酶抑制剂包括甲氨蝶呤、培美曲塞。故本题答案为A。",
    "source_note": "",
    "question_id": "54cc52d147e11f9dcc388e789446dd72da27534a",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "能降低血清胆固醇和三酰甘油浓度，升高高密度脂蛋白，具有明显调节血脂作用的维生素是",
    "options": {
      "A": "维生素 \\mathbf{B}_2",
      "B": "维生素 \\mathrm{B}_{6}",
      "C": "烟酸",
      "D": "维生素 \\mathrm{B}_{1}",
      "E": "叶酸"
    },
    "answer": "C",
    "explanation": "本组题考查水溶性维生素的临床用药评价。 ①烟酸缺乏时可影响细胞的正常呼吸和代谢而发生糙皮病，小剂量烟酸用于治疗糙皮病，大剂量具有明显调节血脂的作用，降低血清胆固醇和三酰甘油浓度，升高高密度脂蛋白，可用于混合型血脂异常。故本题答案为C。",
    "source_note": "",
    "question_id": "c643102c95b47146b201ebc43085981e4e85b40a",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "为骨关节炎白细胞介素-1(IL-1)的重要抑制剂，具有止痛、抗炎及退热作用的抗风湿药是",
    "options": {
      "A": "双氯芬酸",
      "B": "柳氮磺吡啶",
      "C": "双醋瑞因",
      "D": "甲氨蝶呤",
      "E": "来氟米特"
    },
    "answer": "C",
    "explanation": "本组题考查抗风湿药的临床用药评价。 ①双醋瑞因为骨关节炎 IL-1 的重要抑制剂, 可诱导软骨生成, 具有止痛、抗炎及退热作用, 但不抑制前列腺素合成。故本题答案为 C。",
    "source_note": "",
    "question_id": "132ca1a9db1a41a53a25738f413e78010d39c4aa",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "属于促血小板生成药，适用于治疗实体瘤化疗后所致的血小板减少症的是",
    "options": {
      "A": "酚磺乙胺",
      "B": "重组人凝血因子IX",
      "C": "重组人凝血因子VIII",
      "D": "重组人血小板生成素",
      "E": "艾曲泊帕乙醇胺"
    },
    "answer": "D",
    "explanation": "①本题考查促血小板生成药的临床用药评价。重组人血小板生成素、艾曲泊帕乙醇胺属于促血小板生成药, 重组人血小板生成素皮下注射用于治疗实体瘤化疗后所致的血小板减少症、特发性血小板减少性紫癜 (ITP); 艾曲泊帕乙醇胺适用于治疗成人和儿童免疫性血小板减少症、成人难治性重型再生障碍性贫血。故本题答案为 D。",
    "source_note": "",
    "question_id": "06d6673cd6d2d620fea304f890878a021311e6fa",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第2节治疗男性勃起功能障碍药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "获得FDA批准用于阴茎自行注射，作为勃起功能障碍治疗二线方案的药物是",
    "options": {
      "A": "十一酸睾酮",
      "B": "前列地尔",
      "C": "戊酸雌二醇",
      "D": "西地那非",
      "E": "非那雄胺"
    },
    "answer": "B",
    "explanation": "①本题考查治疗男性勃起功能障碍药的分类与代表药品。当勃起功能障碍患者口服药物无效时可以考虑阴茎自行注射作为治疗的二线方案，前列地尔是唯一获得FDA批准用于阴茎自行注射的药物。故本题答案为B。",
    "source_note": "",
    "question_id": "5e42d66a622cab13f1e07d6c721a4f665606913a",
    "section_no": 2,
    "section_title": "治疗男性勃起功能障碍药",
    "section_norm": "第二节 治疗男性勃起功能障碍药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "属于 DNA 多聚酶抑制剂的是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "羟基脲",
      "C": "替吉奥",
      "D": "氟尿嘧啶",
      "E": "吉西他滨"
    },
    "answer": "E",
    "explanation": "本组题考查干扰核酸生物合成的药物（抗代谢药）的分类与代表药品。 ②DNA多聚酶抑制剂包括阿糖胞苷、吉西他滨。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "4c00dd3f11d6bcd18a8863442a80c02bb9abd3af",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "通过抑制合成嘧啶的二氢乳清酸脱氢酶，使活化淋巴细胞的生长受抑制的抗风湿药是",
    "options": {
      "A": "双氯芬酸",
      "B": "柳氮磺吡啶",
      "C": "双醋瑞因",
      "D": "甲氨蝶呤",
      "E": "来氟米特"
    },
    "answer": "E",
    "explanation": "本组题考查抗风湿药的临床用药评价。 ②来氟米特主要通过抑制合成嘧啶的二氢乳清酸脱氢酶, 使活化淋巴细胞的生长受抑制, 适用于成人类风湿关节炎。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "18ceb195189311c7650c65a15a942d5e45e9a886",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "可作为对乙酰氨基酚中毒解救的祛痰药是",
    "options": {
      "A": "氨溴索",
      "B": "氯化铵",
      "C": "槟柠菜",
      "D": "可待因",
      "E": "乙酰半胱氨酸"
    },
    "answer": "E",
    "explanation": "①本题考查黏痰溶解剂的临床用药评价。乙酰半胱氨酸属于黏痰溶解剂, 具有较强的黏痰溶解作用, 除了可用于痰液黏稠引起的呼吸困难、咳痰困难者外, 还可用于对乙酰氨基酚中毒的解救, 以及治疗环磷酰胺引起的出血性膀胱炎。故本题答案为E。",
    "source_note": "",
    "question_id": "c71ed02cf32df245cd720fdc69649b6424dbe2a9",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "属于凝血因子，适用于甲型血友病治疗的药物是",
    "options": {
      "A": "酚磺乙胺",
      "B": "重组人凝血因子IX",
      "C": "重组人凝血因子VIII",
      "D": "重组人血小板生成素",
      "E": "艾曲泊帕乙醇胺"
    },
    "answer": "C",
    "explanation": "②本题考查凝血因子的临床用药评价。甲型血友病是一种由因子VIII活性水平降低引起的遗传性凝血障碍, 重组人凝血因子VIII对缺乏人凝血因子VIII所致的凝血功能障碍具有纠正作用, 主要用于防治甲型血友病和获得性凝血因子VIII缺乏而致的出血症状及这类患者的手术出血治疗。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "19f64b2867aaf53ea7768e263dc4ae75e70b9a6f",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第2节治疗男性勃起功能障碍药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "获得美国FDA批准治疗肺动脉高压的药物是",
    "options": {
      "A": "十一酸睾酮",
      "B": "前列地尔",
      "C": "戊酸雌二醇",
      "D": "西地那非",
      "E": "非那雄胺"
    },
    "answer": "D",
    "explanation": "②本题考查5型磷酸二酯酶抑制剂的临床用药评价。西地那非抑制5型磷酸二酯酶，还可以引起肺血管等其他血管的舒张，故用于改善缺氧性肺血管收缩，治疗肺动脉高压。尤其是严重且治疗不力的儿童患者。西地那非和他达拉非获得美国FDA批准治疗肺动脉高压。故本题答案为D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "6e6ab2cbe039ccedd156d938f20247521c4e3369",
    "section_no": 2,
    "section_title": "治疗男性勃起功能障碍药",
    "section_norm": "第二节 治疗男性勃起功能障碍药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "属于核苷酸还原酶抑制剂的是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "羟基脲",
      "C": "替吉奥",
      "D": "氟尿嘧啶",
      "E": "吉西他滨"
    },
    "answer": "B",
    "explanation": "本组题考查干扰核酸生物合成的药物（抗代谢药）的分类与代表药品。 ③羟基脲属于核苷酸还原酶抑制剂。故本题答案为B。替吉奥和氟尿嘧啶属于胸腺核苷酸合成酶抑制剂。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "86fd876214e4acfa39de318b12da5260300a7a47",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "使用维生素治疗咽喉炎和口角炎时，出现尿液呈黄色，该维生素是",
    "options": {
      "A": "维生素 A",
      "B": "维生素 \\mathrm{B}_{2}",
      "C": "维生素 C",
      "D": "维生素 K",
      "E": "维生素E"
    },
    "answer": "B",
    "explanation": "①本题考查水溶性维生素的临床用药评价。维生素B2主要用于口角炎、舌炎、唇炎、面部脂溢性皮炎的治疗, 大量服用后导致尿呈黄色。故本题答案为 B。",
    "source_note": "",
    "question_id": "3bf2c2667a162f28249071ac7ebd7c21d0ac9b72",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "通过抑制细胞内二氢叶酸还原酶，从而使嘌呤合成受阻，同时具有抗炎作用的药物是",
    "options": {
      "A": "双氯芬酸",
      "B": "柳氮磺吡啶",
      "C": "双醋瑞因",
      "D": "甲氨蝶呤",
      "E": "来氟米特"
    },
    "answer": "D",
    "explanation": "本组题考查抗风湿药的临床用药评价。 ③甲氨蝶呤通过抑制细胞内二氢叶酸还原酶, 使嘌呤合成受抑制, 同时具有抗炎作用。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "74fbc43c995ba87bcdd8f57eb0bcc25a9d96a7a0",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "属于毛细血管止血药，可以降低毛细血管壁的通透性，缩短凝血时间而止血的药物是",
    "options": {
      "A": "酚磺乙胺",
      "B": "重组人凝血因子IX",
      "C": "重组人凝血因子VIII",
      "D": "重组人血小板生成素",
      "E": "艾曲泊帕乙醇胺"
    },
    "answer": "A",
    "explanation": "③本题考查抗出血药的分类与代表药品。酚磺乙胺属于毛细血管止血药, 主要是通过降低毛细血管壁的通透性, 使毛细血管收缩, 增强血小板的功能及黏合力, 促进血小板释放凝血活性物质, 缩短凝血时间而止血。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "aec17fcee3587d753dc7ae53d8cf29734241f57d",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第2节青霉素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "对某些革兰阴性杆菌包括铜绿假单胞菌有抗菌活性的药物是",
    "options": {
      "A": "青霉素 G",
      "B": "芋星青霉素",
      "C": "阿莫西林",
      "D": "蒂夫西林",
      "E": "哔拉西林"
    },
    "answer": "E",
    "explanation": "①本题考查青霉素类药物的分类与作用机制。羧苄西林和哌拉西林属于抗铜绿假单胞菌青霉素类药物, 对革兰阳性菌的作用较天然青霉素或氨基青霉素差, 但对某些革兰阴性杆菌包括铜绿假单胞菌有抗菌活性。故本题答案为 E。",
    "source_note": "",
    "question_id": "bbdd8a3076e1bac2ee616edeb4d20007428c7337",
    "section_no": 2,
    "section_title": "青霉素类抗菌药物",
    "section_norm": "第二节 青霉素类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "使用大剂量甲氨蝶呤时，必须准备好的解救药物是",
    "options": {
      "A": "维生素 A",
      "B": "亚叶酸钙",
      "C": "乙酰半胱氨酸",
      "D": "维生素 \\mathrm{B}_{12}",
      "E": "烟酸"
    },
    "answer": "B",
    "explanation": "本组题考查干扰核酸生物合成的药物（抗代谢药）的临床用药评价。 ①甲氨蝶呤有肾毒性，使用大剂量甲氨蝶呤时，必须准备好解救药亚叶酸钙并需密切监测肾功能及充分水化、碱化尿液，预防肾损伤。故本题答案为B。",
    "source_note": "",
    "question_id": "5186baf092e3a01caf33646ee997862701da951c",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "使用维生素治疗牙龈出血时，需关注尿酸盐、半胱氨酸盐或草酸盐结石，该维生素是",
    "options": {
      "A": "维生素 A",
      "B": "维生素 \\mathrm{B}_{2}",
      "C": "维生素 C",
      "D": "维生素 K",
      "E": "维生素E"
    },
    "answer": "C",
    "explanation": "②本题考查水溶性维生素的临床用药评价。维生素C可用于防治坏血病、牙龈出血、各种急、慢性传染疾病及紫癜等的辅助治疗, 大量 (2g/d 以上) 应用可能引起尿酸盐、半胱氨酸盐或草酸盐结石。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "322f2e6325b57a295627d570f4737e95dc417e1e",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "可用于治疗骨关节炎，但应避免与氢氧化铝同服的药物是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "金诺芬",
      "C": "来氟米特",
      "D": "地塞米松",
      "E": "双醋瑞因"
    },
    "answer": "E",
    "explanation": "本组题考查抗风湿药的临床用药评价。 ①双醋瑞因为骨关节炎 IL-1 的重要抑制剂, 可诱导软骨生成, 具有止痛、抗炎及退热作用。为提高双醋瑞因的生物利用度, 应避免同时服用含有氢氧化铝和(或)氢氧化镁的药物。故本题答案为 E。",
    "source_note": "",
    "question_id": "51779e3ee536f8185a218ec945f9d616bd464e38",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "既可酸化尿液，用于代谢性碱中毒，又可用于干咳以及痰不易咳出者的药物是",
    "options": {
      "A": "氨溴索",
      "B": "氯化铵",
      "C": "槟柠菜",
      "D": "可待因",
      "E": "乙酰半胱氨酸"
    },
    "answer": "B",
    "explanation": "③本题考查恶心性和刺激性祛痰药的临床用药评价。氯化铵属于恶心性祛痰药, 可用于干咳及痰不易咳出者。氯化铵被吸收后, 氯离子进入血液和细胞外液, 使尿液酸化, 可纠正代谢性碱中毒, 但代谢性酸中毒患者忌用。故本题答案为B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c8e7cc6b5679c4242eeab9c9a786a68a5d58cab8",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "既可拮抗多巴胺 \\mathrm{D}_2 受体活性，又能抑制乙酰胆碱酯酶活性的药物是",
    "options": {
      "A": "莫沙必利",
      "B": "帕洛诺司琼",
      "C": "甲氧氯普胺",
      "D": "多潘立酮",
      "E": "伊托必利"
    },
    "answer": "E",
    "explanation": "本组题考查胃肠动力药的分类与作用机制。 ①伊托必利既可拮抗多巴胺D2受体活性,又能抑制乙酰胆碱酯酶活性。故本题答案为E。",
    "source_note": "",
    "question_id": "42391eb59d049e710e2eb7a9afd0c3a212bd3182",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "使用培美曲塞时，为减轻治疗相关的血液学毒性及胃肠道毒性，应肌内注射的维生素是",
    "options": {
      "A": "维生素 A",
      "B": "亚叶酸钙",
      "C": "乙酰半胱氨酸",
      "D": "维生素 \\mathrm{B}_{12}",
      "E": "烟酸"
    },
    "answer": "D",
    "explanation": "本组题考查干扰核酸生物合成的药物（抗代谢药）的临床用药评价。 ②为减轻治疗相关的血液学毒性及胃肠道毒性，使用培美曲塞期间应补充维生素，处理措施包括：口服叶酸和肌内注射维生素B12。故本题答案为D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "443a6fe4933dfad253b74fe724d0148105458ae7",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "使用维生素作为习惯性流产及不孕症的辅助治疗时，需注意出现血栓危险，该维生素是",
    "options": {
      "A": "维生素 A",
      "B": "维生素 \\mathrm{B}_{2}",
      "C": "维生素 C",
      "D": "维生素 K",
      "E": "维生素E"
    },
    "answer": "E",
    "explanation": "③本题考查脂溶性维生素的临床用药评价。维生素E可用于习惯性流产及不孕症的辅助治疗, 长期超量服用 (>800\\mathrm{mg / d}) 对维生素缺乏者可引起出血倾向, 改变内分泌代谢, 改变免疫功能, 影响性功能, 并出现血栓危险, 其中较严重的有血栓性静脉炎或肺栓塞, 或两者同时发生。故本题答案为 E。",
    "source_note": "",
    "question_id": "4b2e41147d3bb3df9081627ab5abdbf414dd8c52",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "类风湿关节炎首选的锚定药物是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "金诺芬",
      "C": "来氟米特",
      "D": "地塞米松",
      "E": "双醋瑞因"
    },
    "answer": "A",
    "explanation": "本组题考查抗风湿药的临床用药评价。 ②甲氨蝶呤属于传统合成改善病情的抗风湿药, 抑制细胞内二氢叶酸还原酶, 使嘌呤合成受抑制, 同时具有抗炎作用, 为类风湿关节炎首选的锚定药物。故本题答案为 A。",
    "source_note": "",
    "question_id": "0ea0514cf929cdf36be817e1ef8df75d69c3290c",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "口服后在小肠黏膜和肝脏存在首关效应，口服生物利用度极低（6\\% \\sim 10\\%）的祛痰药是",
    "options": {
      "A": "氯化铵",
      "B": "愈创甘油醚",
      "C": "羧甲司坦",
      "D": "乙酰半胱氨酸",
      "E": "氨溴索"
    },
    "answer": "D",
    "explanation": "①本题考查黏痰溶解剂的临床用药评价。乙酰半胱氨酸具有较强的黏痰溶解作用, 不仅能溶解白色黏痰, 也能溶解脓性痰, 雾化吸入祛痰效果显著优于氨溴索、溴己新、糜蛋白酶。口服吸收后在小肠黏膜和肝脏存在首关效应, 故口服生物利用度极低 (6\\% \\sim 10\\%) 。故本题答案为 D。",
    "source_note": "",
    "question_id": "b4e7f92d2007c1eafb6c93f4fa54f308c8cdfaab",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "兼有中枢和外周多巴胺 \\mathbf{D}_2 受体拮抗作用，可促进胃肠蠕动的药物是",
    "options": {
      "A": "莫沙必利",
      "B": "帕洛诺司琼",
      "C": "甲氧氯普胺",
      "D": "多潘立酮",
      "E": "伊托必利"
    },
    "answer": "C",
    "explanation": "本组题考查胃肠动力药的分类与作用机制。 ②甲氧氯普胺兼有中枢和外周多巴胺D2受体拮抗作用,能抑制中枢催吐化学感受区的多巴胺受体,提高该感受区的阈值,具有较强的中枢性镇吐作用,同时有胃肠道兴奋作用,可促进胃肠蠕动。故本题答案为C。",
    "source_note": "",
    "question_id": "2112ccb6f5301428738a5a9d7189606c20ae9ede",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第2节青霉素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "用于预防风湿热可每 2\\sim 4 周肌内注射1次的药物是",
    "options": {
      "A": "青霉素 G",
      "B": "芋星青霉素",
      "C": "阿莫西林",
      "D": "蒂夫西林",
      "E": "哔拉西林"
    },
    "answer": "B",
    "explanation": "③本题考查青霉素类药物的临床用药评价。苄星青霉素属于长效青霉素, 用于预防风湿热可每 2 \\sim 4 周肌内注射 1 次。故本题答案为 B。",
    "source_note": "",
    "question_id": "bce10f8c7f29eb8abdfdae92ce26ad3fdba6fc99",
    "section_no": 2,
    "section_title": "青霉素类抗菌药物",
    "section_norm": "第二节 青霉素类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "与别嘌醇存在药物相互作用，合用时需减量的药物是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "曲妥珠单抗",
      "C": "长春新碱",
      "D": "环磷酰胺",
      "E": "疏嘌呤"
    },
    "answer": "E",
    "explanation": "【 10 \\sim 11】 ①本题考查干扰核酸生物合成的药物（抗代谢药）的临床用药评价。巯嘌呤与别嘌醇同时服用时, 由于后者抑制巯嘌呤的代谢, 明显地增加巯嘌呤的效能与毒性, 因此在两药同时服用的过程中, 应仔细观察药物的不良反应, 并适当减少巯嘌呤的剂量至常用量的 1 / 4 \\sim 1 / 3 。故本题答案为 E。",
    "source_note": "",
    "question_id": "a5f73c7c4582f3223cd065941938e702dbf3fc23",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "参与甲状腺激素的合成，以促进生长发育，调节新陈代谢的微量元素是",
    "options": {
      "A": "锌",
      "B": "硒",
      "C": "碘",
      "D": "钴",
      "E": "铁"
    },
    "answer": "C",
    "explanation": "【 10 \\sim 11】本组题考查常见微量元素的生理功能、临床监测及注意事项。 ①碘的生理功能是通过甲状腺激素完成的, 碘可参与甲状腺激素的合成, 促进生长发育,参与脑发育, 调节新陈代谢。故本题答案为 C。",
    "source_note": "",
    "question_id": "108422ee3acf55b6dfbf3a3e39535a4898343952",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "可以控制疟疾症状，同时具有抗炎、调节免 疫作用的药物是",
    "options": {
      "A": "氯喹",
      "B": "柳氮磺吡啶",
      "C": "甲氨蝶呤",
      "D": "来氟米特",
      "E": "金诺芬"
    },
    "answer": "A",
    "explanation": "①本题考查抗风湿药的分类与代表药品。氯喹、羟氯喹属于抗疟药，可以控制疟疾症状，同时具有抗炎、调节免疫作用。故本题答案为A。",
    "source_note": "",
    "question_id": "cdc43696f70d97712f0d9bfb0f7e981bfa5b1739",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "可增加水钠排出，具有利尿作用的祛痰药是",
    "options": {
      "A": "氯化铵",
      "B": "愈创甘油醚",
      "C": "羧甲司坦",
      "D": "乙酰半胱氨酸",
      "E": "氨溴索"
    },
    "answer": "A",
    "explanation": "②本题考查恶心性和刺激性祛痰药的临床用药评价。氯化铵属于恶心性和刺激性祛痰药, 用药后可增加肾小管氯离子浓度, 增加水 钠排出，具有利尿作用。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "1bd56286ca97d969b3a5f5e2739f12d097542009",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "属于选择性 5 - \\mathrm{HT}_{4} 受体激动剂，可促进乙酰胆碱释放的药物是",
    "options": {
      "A": "莫沙必利",
      "B": "帕洛诺司琼",
      "C": "甲氧氯普胺",
      "D": "多潘立酮",
      "E": "伊托必利"
    },
    "answer": "A",
    "explanation": "本组题考查胃肠动力药的分类与作用机制。 ③莫沙必利为选择性5-HT4受体激动剂,通过兴奋胃肠道胆碱能中间神经元及肌间神经丛的5-HT4受体,促进乙酰胆碱释放,从而增强上消化道(胃和小肠)运动。故本题答案为A。帕洛诺司琼为长效的5-HT3受体拮抗剂。多潘立酮属于外周性 多巴胺受体拮抗剂，直接拮抗胃肠道多巴胺D2受体及血-脑屏障外的化学感受器触发区的多巴胺受体，促进胃肠蠕动。",
    "source_note": "",
    "question_id": "473f7ad41fb1e35e378464a2096fe61dfe72aac4",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "是维生素 \\mathsf{B}_{12} 的重要组成成分的微量元素是",
    "options": {
      "A": "锌",
      "B": "硒",
      "C": "碘",
      "D": "钴",
      "E": "铁"
    },
    "answer": "D",
    "explanation": "【 10 \\sim 11】本组题考查常见微量元素的生理功能、临床监测及注意事项。 ②钴是维生素 B12 的重要组成成分, 体内钴主要以维生素 12 的形式发挥作用。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "18dbb1d1113d4390de862bd0b83edd77514e820b",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "可抑制前列腺素合成和溶菌酶的释放，服用前应检查血、尿常规以及肝、肾功能的药物是",
    "options": {
      "A": "氯喹",
      "B": "柳氮磺吡啶",
      "C": "甲氨蝶呤",
      "D": "来氟米特",
      "E": "金诺芬"
    },
    "answer": "E",
    "explanation": "②本题考查抗风湿药的临床用药评价。金诺芬可抑制前列腺素合成和溶菌酶的释放，并与免疫球蛋白补体结合，阻断关节炎的发展，主要用于活动性类风湿关节炎，服用前应检查血、尿常规，血小板计数，肝、肾功能。故本题答案为E。",
    "source_note": "",
    "question_id": "ff79a8f11d17576ffaf94c916cb916c285730c9c",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "属于黏痰溶解剂的是",
    "options": {
      "A": "溴己新",
      "B": "愈创木酚磺酸钾",
      "C": "沙丁胺醇",
      "D": "曲尼司特",
      "E": "酮替芬"
    },
    "answer": "A",
    "explanation": "【 12 \\sim 13】本组题考查祛痰药的分类与作用机制。 ①黏痰溶解剂的代表药物有: 溴己新、氨溴索、乙酰半胱氨酸、桉柠蒎油、糜蛋白酶、厄多司坦、福多司坦、美司坦、羧甲司坦。故本题答案为 A。",
    "source_note": "",
    "question_id": "24e4f46a705c8702742de4c4e277382755fe0196",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "可透过血-脑屏障，易引起锥体外系反应的胃肠动力药是",
    "options": {
      "A": "东莨菪碱",
      "B": "昂丹司琼",
      "C": "多潘立酮",
      "D": "甲氧氯普胺",
      "E": "伊托必利"
    },
    "answer": "D",
    "explanation": "本组题考查胃肠动力药的临床用药评价。 ①甲氧氯普胺兼有中枢和外周多巴胺 D2 受体抑制作用, 易透过血-脑屏障, 故易引起锥体外系反应, 常见嗜睡和倦怠。故本题答案为 D。",
    "source_note": "",
    "question_id": "f0f83b86dedc0b686bd4d4b6d36246ecd05a4224",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "可用于治疗全身性原发性纤维蛋白溶解亢进引起的出血的药物是",
    "options": {
      "A": "重组人凝血因子VIII",
      "B": "艾曲泊帕乙醇胺",
      "C": "甲萘氢醌",
      "D": "醋硝香豆素",
      "E": "氨甲环酸"
    },
    "answer": "E",
    "explanation": "【 12\\sim 13 】 ① 本题考查抗纤维蛋白溶解药的临床用药评价。氨甲环酸为抗纤维蛋白溶解药，用于因原发性纤维蛋白溶解过度所引起的出血，以及内脏手术后的出血，术中早期用药或术前用药，可减少手术中渗血。故本题答案为E。",
    "source_note": "",
    "question_id": "630e76a08a8990d3ac6668a16b41ddd88dd0b87e",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "属于肿瘤坏死因子（TNF- \\alpha ）抑制剂的是",
    "options": {
      "A": "阿达木单抗",
      "B": "司库奇尤单抗",
      "C": "托法替布",
      "D": "来氟米特",
      "E": "甲氨蝶呤"
    },
    "answer": "A",
    "explanation": "本组题考查抗风湿药的分类与代表药品。 ①肿瘤坏死因子（TNF-\\alpha）抑制剂有：融合蛋白类：依那西普；单克隆抗体类：阿达木单抗、英夫利西单抗。 故本题答案为 A。",
    "source_note": "",
    "question_id": "2e1e5fa416cb6f00a8386b3752ccbeebdf711f18",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "属于恶心性和刺激性祛痰药的是",
    "options": {
      "A": "溴己新",
      "B": "愈创木酚磺酸钾",
      "C": "沙丁胺醇",
      "D": "曲尼司特",
      "E": "酮替芬"
    },
    "answer": "B",
    "explanation": "【 12 \\sim 13】本组题考查祛痰药的分类与作用机制。 ②恶心性和刺激性祛痰药的代表药物有: 氯化铵、桉叶油、愈创甘油醚、愈创木酚磺酸钾。故本题答案为 B。沙丁胺醇、曲尼司特、酮替芬为平喘药。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "489644d84e20232e1d89bd25fc5001cbdad4b2f3",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "禁止与红霉素或其他可能会延长Q-T间期的 CYP3A4酶强效抑制剂合用的胃肠动力药是",
    "options": {
      "A": "东莨菪碱",
      "B": "昂丹司琼",
      "C": "多潘立酮",
      "D": "甲氧氯普胺",
      "E": "伊托必利"
    },
    "answer": "C",
    "explanation": "本组题考查胃肠动力药的临床用药评价。 ②多潘立酮具有心脏毒性, 与显著抑制 CYP3A4 酶的药物合用可导致多潘立酮的血药浓度增加, 禁止与红霉素或其他可能会延长 Q-T 间期的 CYP3A4 酶强效抑制剂（如氟康唑、伏立康唑、克拉霉素、胺碘酮、伊曲康唑、泊沙康唑、利托那韦、沙奎那韦）合用。故本题答案为 C。",
    "source_note": "",
    "question_id": "9937f17cac260b6c3033dacecb13427e66976d63",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "可用于治疗长期使用头孢哌酮所致的出血的药物是",
    "options": {
      "A": "重组人凝血因子VIII",
      "B": "艾曲泊帕乙醇胺",
      "C": "甲萘氢醌",
      "D": "醋硝香豆素",
      "E": "氨甲环酸"
    },
    "answer": "C",
    "explanation": "【 12\\sim 13 】 ② 本题考查维生素K类的临床用药评价。甲萘氢醌属于维生素K类，适用于维生素K缺乏引起的出血：a.梗阻性黄疸、胆瘘、慢性腹泻等疾病导致的出血；b.香豆素类、水杨酸钠、长期应用广谱抗生素等药物导致的出血；c.新生儿出血。故本题答案为C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "d0eb95dd004117b4d51ba22d1cd58e9f967d854c",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "属于IL-17（白细胞介素-17）抑制剂的是",
    "options": {
      "A": "阿达木单抗",
      "B": "司库奇尤单抗",
      "C": "托法替布",
      "D": "来氟米特",
      "E": "甲氨蝶呤"
    },
    "answer": "B",
    "explanation": "本组题考查抗风湿药的分类与代表药品。 ②IL-17（白细胞介素-17）抑制剂有：司库奇尤单抗、依奇珠单抗。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "df1b3ee989fd43de7d1bcfa820ac94a6577adc9e",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "不引起便秘，无成瘾性，兼有中枢和外周镇咳作用的药物是",
    "options": {
      "A": "右美沙芬",
      "B": "苯丙哌林",
      "C": "桎柠蒎油",
      "D": "氨溴索",
      "E": "羧甲司坦"
    },
    "answer": "B",
    "explanation": "【 14\\sim 15 】 ①本题考查镇咳药的分类与作用机制。苯丙哌林兼有中枢性和外周性两种镇咳作用，镇咳作用较强，为可待因的 2\\sim 4 倍。无麻醉作用，不抑制呼吸，不引起胆道和十二指肠痉挛，不引起便秘，无成瘾性，未发现耐受性。故本题答案为B。",
    "source_note": "",
    "question_id": "fe0dc08445ec50b6fc0b100e4b8f7dd3ac77b110",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "属于肝素拮抗剂的是",
    "options": {
      "A": "罗普司亭",
      "B": "氨甲环酸",
      "C": "硫酸鱼精蛋白",
      "D": "聚桂醇",
      "E": "垂体后叶"
    },
    "answer": "C",
    "explanation": "【 14\\sim 16 】本组题考查抗出血药的分类与代表药品。 ①硫酸鱼精蛋白属于肝 素拮抗剂，可用于肝素过量所致出血。故本题答案为 C。",
    "source_note": "",
    "question_id": "9ede3010e2e6054bdf8d6072e95e818f1b82fe34",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "属于短效糖皮质激素，生物效应维持 8\\sim 12h 的是",
    "options": {
      "A": "地夫可特、泼尼松龙",
      "B": "地塞米松、倍他米松",
      "C": "氢化可的松、可的松",
      "D": "曲安西龙、氟氢可的松",
      "E": "醋酸曲安奈德、帕拉米松"
    },
    "answer": "C",
    "explanation": "本组题考查肾上腺糖皮质激素药物的分类与代表药品。 ① 短效糖皮质激素: 氢化可的松、可的松, 生物效应维持 8 \\sim 12 \\mathrm{~h} 。故本题答案为 C。",
    "source_note": "",
    "question_id": "98d71c5079cd3c193217348543d285a242cc1b1f",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "属于JAK抑制剂的是",
    "options": {
      "A": "阿达木单抗",
      "B": "司库奇尤单抗",
      "C": "托法替布",
      "D": "来氟米特",
      "E": "甲氨蝶呤"
    },
    "answer": "C",
    "explanation": "本组题考查抗风湿药的分类与代表药品。 ③JAK 抑制剂（小分子靶向抑制剂）有：枸橼酸托法替布、巴瑞替尼。故本题答案为 C。来氟米特与甲氨蝶呤属于免疫制剂类抗风湿药。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "dfe2baecb071d5b39c2e93ede508028aad73de76",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "具有黏痰溶解和抗炎作用，还可用于支气管造影术后促进造影剂排出的药物是",
    "options": {
      "A": "右美沙芬",
      "B": "苯丙哌林",
      "C": "桎柠蒎油",
      "D": "氨溴索",
      "E": "羧甲司坦"
    },
    "answer": "C",
    "explanation": "【 14\\sim 15 】 ②本题考查黏痰溶解剂的临床用药评价。桉柠蒎油除促进黏痰溶解外，还有抗炎作用，可减轻支气管黏膜肿胀、扩张支气管，并可用于支气管造影术后促进造影剂排出。故本题答案为C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "3697e4d508c6f213f8000e289b2c6b28c38688ff",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "属于小分子拟肽类血小板生成素受体激动剂的是",
    "options": {
      "A": "罗普司亭",
      "B": "氨甲环酸",
      "C": "硫酸鱼精蛋白",
      "D": "聚桂醇",
      "E": "垂体后叶"
    },
    "answer": "A",
    "explanation": "【 14\\sim 16 】本组题考查抗出血药的分类与代表药品。 ②促血小板生成药包括：a. 重组人血小板生成素、人白介素-11；b. 口服血小板生成素受体激动剂：艾曲泊帕乙醇胺、海曲泊帕乙醇胺、阿伐曲泊帕、芦曲泊帕；c. 小分子拟肽类血小板生成素受体激动剂：罗普司亭。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "e68691513a25617c0a33343041cf61feb53c9df0",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "属于中效糖皮质激素，生物效应维持12\\sim 16h 的是",
    "options": {
      "A": "地夫可特、泼尼松龙",
      "B": "地塞米松、倍他米松",
      "C": "氢化可的松、可的松",
      "D": "曲安西龙、氟氢可的松",
      "E": "醋酸曲安奈德、帕拉米松"
    },
    "answer": "A",
    "explanation": "本组题考查肾上腺糖皮质激素药物的分类与代表药品。 ② 中效糖皮质激素: a. 泼尼松、泼尼松龙、甲泼尼龙、地夫可特, 生物效应维持 12 \\sim 16 \\mathrm{~h}; b. 曲安西龙、氟氢可的松, 生物效应维持 12 \\sim 24 \\mathrm{~h} 。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "8f223fc95792bae139254ef088b50b12012fc8a4",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第2节抗出血药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "属于收缩血管药的是",
    "options": {
      "A": "罗普司亭",
      "B": "氨甲环酸",
      "C": "硫酸鱼精蛋白",
      "D": "聚桂醇",
      "E": "垂体后叶"
    },
    "answer": "E",
    "explanation": "【 14\\sim 16 】本组题考查抗出血药的分类与代表药品。 ③垂体后叶（注射液）、特利加压素属于收缩血管药。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "1e5f320da4183b094721486f5341594ce5307e89",
    "section_no": 2,
    "section_title": "抗出血药",
    "section_norm": "第二节 抗出血药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "属于关节腔内注射糖皮质激素，生物效应维持 36 \\sim 72 \\mathrm{~h} 的是",
    "options": {
      "A": "地夫可特、泼尼松龙",
      "B": "地塞米松、倍他米松",
      "C": "氢化可的松、可的松",
      "D": "曲安西龙、氟氢可的松",
      "E": "醋酸曲安奈德、帕拉米松"
    },
    "answer": "E",
    "explanation": "本组题考查肾上腺糖皮质激素药物的分类与代表药品。 ③ 关节腔内注射糖皮质激素: 醋酸曲安奈德、醋酸甲泼尼龙、帕拉米松, 生物效应维持 36 \\sim 72 \\mathrm{~h} 。故本题答案为 E。长效糖皮质激素: 地塞米松、倍他米松; 生物效应维持 20 \\sim 36 \\mathrm{~h} 。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "4f2ad186f270927e1c66017a76075272a92c30bb",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "冲击治疗适用于",
    "options": {
      "A": "中毒性休克",
      "B": "结核性脑膜炎",
      "C": "肾病综合征",
      "D": "原发性或继发性慢性肾上腺皮质功能减退症",
      "E": "急性肾上腺皮质功能不全及肾上腺危象糖皮质激素治疗不同疾病的治疗方案及过程不同"
    },
    "answer": "A",
    "explanation": "本组题考查糖皮质激素类药物的治疗方案及疗程。 ①冲击治疗: 大部分适用于危重患者的抢救, 如重度感染、中毒性休克、过敏性休克、严重哮喘持续状态、过敏性喉头水肿等。故本题答案为 A。",
    "source_note": "",
    "question_id": "9828364ab2e8f82f5140f6860e373ba6659426f7",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "长程治疗适用于",
    "options": {
      "A": "中毒性休克",
      "B": "结核性脑膜炎",
      "C": "肾病综合征",
      "D": "原发性或继发性慢性肾上腺皮质功能减退症",
      "E": "急性肾上腺皮质功能不全及肾上腺危象糖皮质激素治疗不同疾病的治疗方案及过程不同"
    },
    "answer": "C",
    "explanation": "本组题考查糖皮质激素类药物的治疗方案及疗程。 ②长程治疗: 适用于预防和治疗器官移植后排斥反应及反复发作的多器官受累的慢性系统性自身免疫性疾病, 如系统性红斑狼疮、类风湿关节炎、血小板减少性紫癜、溶血性贫血、肾病综合征等。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "a8468931a6f38e8aa76d461ef9ee72966b21e058",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "属于非选择性 \\beta 受体拮抗剂的抗高血压药物是",
    "options": {
      "A": "拉贝洛尔",
      "B": "阿罗洛尔",
      "C": "卡维地洛",
      "D": "普萘洛尔",
      "E": "比索洛尔"
    },
    "answer": "D",
    "explanation": "【 19 \\sim 20】本组题考查抗高血压药的分类与代表药品。 ①普萘洛尔属于非选择性 \\beta 受体拮抗剂。故本题答案为 D。",
    "source_note": "",
    "question_id": "92cc19b0a6218ef736f98582076fa56673e5aa18",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "应急替代方案适用于",
    "options": {
      "A": "中毒性休克",
      "B": "结核性脑膜炎",
      "C": "肾病综合征",
      "D": "原发性或继发性慢性肾上腺皮质功能减退症",
      "E": "急性肾上腺皮质功能不全及肾上腺危象糖皮质激素治疗不同疾病的治疗方案及过程不同"
    },
    "answer": "E",
    "explanation": "本组题考查糖皮质激素类药物的治疗方案及疗程。 ③替代 治疗：包括长程替代方案（适用于原发或继发性慢性肾上腺皮质功能减退症）、应急替代方案（急性肾上腺皮质功能不全及肾上腺危象）、抑制替代方案（先天性肾上腺皮质增生症）。故本题答案为E。短程治疗：适用于应激性治疗，或感染及变态反应类疾病所致的机体严重器质性损伤，如结核性脑膜炎及胸膜炎、剥脱性皮炎或器官移植急性排斥反应等。中程治疗：适用于病程较长且多器官受累性疾病，如风湿热等。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "4fc5286ea2f4161658faeb5dd5bf3cd47b415829",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 20,
    "stem": "属于选择性 \\beta_{1} 受体拮抗剂的抗高血压药物是",
    "options": {
      "A": "拉贝洛尔",
      "B": "阿罗洛尔",
      "C": "卡维地洛",
      "D": "普萘洛尔",
      "E": "比索洛尔"
    },
    "answer": "E",
    "explanation": "【 19 \\sim 20】本组题考查抗高血压药的分类与代表药品。 ②属于选择性 \\beta 1 受体拮抗剂的有比索洛尔、美托洛尔、阿替洛尔。故本题答案为 E。拉贝洛尔、阿罗洛尔、卡维地洛属于 \\alpha 1 和 \\beta 受体拮抗剂。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "3bc7903bc09e204a562893e71b8dbc2a42dc4dc8",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 23,
    "stem": "肾功能不全时无需调整剂量的血管紧张素转换酶抑制剂是",
    "options": {
      "A": "福辛普利",
      "B": "赖诺普利",
      "C": "培哚普利",
      "D": "替米沙坦",
      "E": "氯沙坦"
    },
    "answer": "A",
    "explanation": "①本题考查ACEI类的临床用药评价。福辛普利、赖诺普利、培哚普利属于血管紧张素转换酶抑制剂（ACEI）。大部分ACEI及其代谢产物主要经肾排泄，故肾功能异常时（肌酐清除率≤30ml/min，部分<60ml/min）需要调小剂量或禁止使用。福辛普利经肝和肾排泄，肾功能不全时无需调整剂量，赖诺普利、培哚普利肝功能损害无需调整剂量。故本题答案为A。",
    "source_note": "",
    "question_id": "512eb50aa291af02f40b2dbf999c9d798af63750",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 24,
    "stem": "具有活性代谢产物的血管紧张素受体拮抗剂是",
    "options": {
      "A": "福辛普利",
      "B": "赖诺普利",
      "C": "培哚普利",
      "D": "替米沙坦",
      "E": "氯沙坦"
    },
    "answer": "E",
    "explanation": "②本题考查ARB类的临床用药评价。氯沙坦、坎地沙坦酯、奥美沙坦酯是仅有的三个有活性代谢物的血管紧张素受体拮抗剂（ARB）。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "2f54c51348f287ae4c0bce8b802d05ff5bbbecd7",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 25,
    "stem": "直接通过抑制肾素的活性而发挥降压作用的药物是",
    "options": {
      "A": "依那普利",
      "B": "厄贝沙坦",
      "C": "呕唑嗪",
      "D": "普萘洛尔",
      "E": "阿利吉仑"
    },
    "answer": "E",
    "explanation": "①本题考查抗高血压药的分类与代表药品。阿利吉仑属于肾素抑制药, 通过抑制肾素的活性, 抑制血管紧张素原转变为血管紧张素 I , 从而降低血管紧张素 I 、II 水平, 发挥降压作用, 对血管紧张素转化酶几乎无亲和力, 同时也不增加缓激肽和 P 物质水平。故本题答案为 E。",
    "source_note": "",
    "question_id": "5edc00f52053cb898173e374ace5e4b3bedf371d",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 26,
    "stem": "能够阻断 ACE 途径和糜酶途径生成的 Ang II 与受体 \\mathrm{AT}_{1} 结合，发挥降压作用的药物是",
    "options": {
      "A": "依那普利",
      "B": "厄贝沙坦",
      "C": "呕唑嗪",
      "D": "普萘洛尔",
      "E": "阿利吉仑"
    },
    "answer": "B",
    "explanation": "②本题考查 ARB 类的临床用药评价。厄贝沙坦属于血管紧张素受体拮抗剂, 能够阻断 ACE 途径和糜酶途径生成的 Ang II 与 AT1 结合,从而避免由于 AT1 受体激活而对心血管产生的损害作用。故本题答案为 B。依那普利属于血管紧张素转换酶抑制剂, 通过抑制血管紧张素转化酶, 减少 Ang II 的生成和升高缓激肽水平发挥降压作用。哌唑嗪属于 α 1 受体拮抗剂。普萘洛尔属于 β 受体拮抗剂。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "372f118daaff8be82e459c7efcfa62076e45a319",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 31,
    "stem": "高血压合并慢性阻塞性肺疾病不宜选用",
    "options": {
      "A": "普萘洛尔",
      "B": "卡托普利",
      "C": "氢氯噻嗪",
      "D": "硝苯地平",
      "E": "利血平"
    },
    "answer": "A",
    "explanation": "本组题考查 \\beta 受体拮抗剂的临床用药评价。 ①普萘洛尔为非选择性 \\beta 受体拮抗药, 可拮抗支气管平滑肌 \\beta 2 受体, 收缩支气管平滑肌, 增加呼吸道阻力。用药后可加重慢性阻塞性肺病。故本题答案为 A。",
    "source_note": "",
    "question_id": "cf46f79be6958485b3e026f3360e5b26a10a4924",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 32,
    "stem": "高血压合并三度房室传导阻滞者不宜选用",
    "options": {
      "A": "普萘洛尔",
      "B": "卡托普利",
      "C": "氢氯噻嗪",
      "D": "硝苯地平",
      "E": "利血平"
    },
    "answer": "A",
    "explanation": "本组题考查 \\beta 受体拮抗剂的临床用药评价。 ②普萘洛尔可拮抗心脏 \\beta 1 受体, 降低心输出量, 减慢窦性节律, 延缓房和房室结的传导, II、III度房室传导阻滞、病态窦房结综合征患者禁用。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "f101bcaac2c2750bd7db1e4e35ae395fdabb8106",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 33,
    "stem": "高血压合并变异型心绞痛不宜选用",
    "options": {
      "A": "普萘洛尔",
      "B": "卡托普利",
      "C": "氢氯噻嗪",
      "D": "硝苯地平",
      "E": "利血平"
    },
    "answer": "A",
    "explanation": "本组题考查 \\beta 受体拮抗剂的临床用药评价。 ③高血压合并变异型心绞痛患者不宜使用 \\beta 受体拮抗药, 因拮抗 \\beta 受体, \\alpha 受体相对占优势, 易致冠状动脉收缩。故本题答案为 A。",
    "source_note": "",
    "question_id": "7bc11da8cd8e122e5b9943db456d538ffb257d17",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 34,
    "stem": "肾功能不全应用超过 48 \\sim 72 \\mathrm{~h} 者，每日须测定血浆中氰化物或硫氰酸盐浓度的药物是",
    "options": {
      "A": "硝普钠",
      "B": "美托洛尔",
      "C": "氨氯地平",
      "D": "贝那普利",
      "E": "氢氯噻嗪"
    },
    "answer": "A",
    "explanation": "①本题考查其他抗高血压药的临床用药评价。硝普钠代谢产物为硫氰酸盐, 肾功能不良者容易中毒, 应用超过 48 \\sim 72 \\mathrm{~h} 者, 每日须测定血浆中氰化物或硫氰酸盐, 保持硫氰酸盐不超过 100 \\mu \\mathrm{g} / \\mathrm{ml}; 氰化物不超过 3 \\mu \\mathrm{mol} / \\mathrm{ml} 。故本题答案为 A。",
    "source_note": "",
    "question_id": "53b297eb009e84d3d19318419e0984d851ae353c",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 35,
    "stem": "可导致下肢及踝部水肿的降压药物是",
    "options": {
      "A": "硝普钠",
      "B": "美托洛尔",
      "C": "氨氯地平",
      "D": "贝那普利",
      "E": "氢氯噻嗪"
    },
    "answer": "C",
    "explanation": "②本题考查钙通道阻滞剂 (CCB) 的临床用药评价。CCB 类药物 (如氨氯地平) 可导致下肢及踝部水肿。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "b8f47e3d066d4b6656b8ee432c26934f400a5a0e",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 36,
    "stem": "宜现配现用，溶液的保存与应用不应超过24h，且遇光易变质的抗高血压药是",
    "options": {
      "A": "阿利吉仑",
      "B": "硝苯地平",
      "C": "福辛普利",
      "D": "硝普钠",
      "E": "普萘洛尔"
    },
    "answer": "D",
    "explanation": "①本题考查其他抗高血压药的临床用药评价。硝普钠溶液的保存与应用不应超过 24h, 溶液遇光易变质, 需在避光输液瓶中静脉滴注, 不可静脉注射,应缓慢静滴或使用微量输液泵。故本题答案为 D。",
    "source_note": "",
    "question_id": "a8ae13ccf8af3c4d911a80ce6c0c3b388b8d076e",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "配伍选择题",
    "qno": 37,
    "stem": "长期使用突然停药可发生反跳现象的抗高血压药是",
    "options": {
      "A": "阿利吉仑",
      "B": "硝苯地平",
      "C": "福辛普利",
      "D": "硝普钠",
      "E": "普萘洛尔"
    },
    "answer": "E",
    "explanation": "②本题考查 \\beta 受体拮抗剂的临床用药评价。长期应用 \\beta 受体拮抗剂突然停药可发生反跳现象, 即原有症状加重或出现新的表现, 称之为撤药综合征。如需停用 \\beta 受体拮抗剂应逐步撤药, 至少经过 3 天, 一般为 2 周。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "34a23e4e50cd9ec317aec5820728a90c3fa53881",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "伴有较多痰液的咳嗽患者宜选用的祛痰药是",
    "options": {
      "A": "苯丙哌林",
      "B": "右美沙芬",
      "C": "可待因",
      "D": "地塞米松",
      "E": "羧甲司坦"
    },
    "answer": "E",
    "explanation": "本题考查祛痰药的分类与作用机制。祛痰药有: ① 恶心性和刺激性祛痰药: 氯化铵、桉叶油、愈创甘油醚、愈创木酚磺酸钾; ② 黏痰溶解剂: 溴己新、桉柠蒎油、标准桃金娘油、糜蛋白酶、氨溴索、乙酰半胱氨酸、羧甲司坦、厄多司坦、福多司坦、美司坦。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords) | explanation_range_detected",
    "question_id": "c69b1bafb47b54a31d19d856b167aa7175b94520",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第2节抗风湿药",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "可以用于治疗类风湿关节炎，但溃疡性结肠炎、克罗恩病患者慎用的药物是",
    "options": {
      "A": "双氯芬酸",
      "B": "英夫利西单抗",
      "C": "来氟米特",
      "D": "双醋瑞因",
      "E": "司库奇尤单抗"
    },
    "answer": "E",
    "explanation": "本组题考查抗风湿药的临床用药评价。 ②司库奇尤单抗属于IL-17（白细胞介素-17）抑制剂，可用于类风湿关节炎，但可加重溃疡性结肠炎、克罗恩病，故溃疡性结肠炎、克罗恩病患者慎用。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "724b87162d9f64aba9cf528258e5dbfe99cddb2c",
    "section_no": 2,
    "section_title": "抗风湿药",
    "section_norm": "第二节 抗风湿药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "患者，男，因腹部阵发性疼痛就医，诊断为胃肠道平滑肌痉挛，医生处方消旋山茛蓉碱 片。该药的不良反应不包括",
    "options": {
      "A": "口干",
      "B": "排尿困难",
      "C": "视物模糊",
      "D": "心率减慢",
      "E": "便秘"
    },
    "answer": "D",
    "explanation": "本题考查抗胆碱 M 受体药的临床用药评价。消旋山莨菪碱为抗胆碱 M 受体药。可使心率加快, 导致心悸; 可使腺体分泌减少, 导致口干、皮肤干燥; 可使膀胱平滑肌的兴奋性降低, 导致尿潴留、排尿困难; 可使瞳孔扩大, 导致视物模糊、眼内压升高; 可使胃肠道平滑肌的兴奋性降低, 导致便秘。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "92547732eded451b5527600f072901d2fd8c21f8",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第2节青霉素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "青霉素过敏性休克，病死率高，可立即给患者肌内注射用于抢救的药物是",
    "options": {
      "A": "麻黄碱",
      "B": "去甲肾上腺素",
      "C": "地塞米松",
      "D": "肾上腺素",
      "E": "异丙肾上腺素"
    },
    "answer": "D",
    "explanation": "本题考查青霉素类药物的临床用药评价。青霉素类可引起严重的过敏反应, 如过敏性休克, 一旦发生, 必须就地抢救, 立即给患者肌内注射肾上腺素。因肾上腺素具有兴奋心肌、升高血压、松弛支气管等作用, 可缓解过敏性休克的心跳微弱、血压下降、呼吸困难等症状。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "bb13caee763c50130ea6fa7b1b15125f5c23428d",
    "section_no": 2,
    "section_title": "青霉素类抗菌药物",
    "section_norm": "第二节 青霉素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第2节青霉素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 5,
    "stem": "患者诊断为感染性心内膜炎，血液细菌培养为草绿色链球菌，可选择与青霉素G联合应用的药物是",
    "options": {
      "A": "阿莫西林",
      "B": "红霉素",
      "C": "链霉素",
      "D": "四环素",
      "E": "羧苄西林"
    },
    "answer": "C",
    "explanation": "本题考查青霉素类药物的临床用药评价。青霉素与氨基糖苷类药物（如链霉素）联合用于治疗草绿色链球菌引起的心内膜炎。故本题答案为C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "dda2b53a9d90880c9c18e84499b30dac5786b029",
    "section_no": 2,
    "section_title": "青霉素类抗菌药物",
    "section_norm": "第二节 青霉素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第2节青霉素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 6,
    "stem": "患者，女，诊断为十二指肠溃疡，幽门螺杆菌 (+) 。可与质子泵抑制剂（PPI）联合用于根除幽门螺杆菌的抗生素是",
    "options": {
      "A": "双氯西林",
      "B": "芋星青霉素",
      "C": "万古霉素",
      "D": "阿莫西林",
      "E": "羧苄西林"
    },
    "answer": "D",
    "explanation": "本题考查青霉素类药物的临床用药评价。阿莫西林与克拉霉素、质子泵抑制剂联合口服用药可根除胃、十二指肠幽门螺杆菌感染，降低消化道溃疡复发率。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "e52fadaaac2c4488a194c1537812b3270dcc9e1f",
    "section_no": 2,
    "section_title": "青霉素类抗菌药物",
    "section_norm": "第二节 青霉素类抗菌药物"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第2节微量元素与维生素",
    "qtype": "综合分析题",
    "qno": 6,
    "stem": "能降低同型半胱氨酸水平，改善内皮细胞功能，发挥对高血压患者靶器官保护作用的维生素是",
    "options": {
      "A": "维生素 \\mathbf{B}_2",
      "B": "维生素 \\mathrm{B}_{6}",
      "C": "烟酸",
      "D": "维生素 \\mathrm{B}_{1}",
      "E": "叶酸"
    },
    "answer": "E",
    "explanation": "本组题考查水溶性维生素的临床用药评价。 ②同型半胱氨酸水平升高与高血压和妊娠期高血压疾病的发病机制密切相关，补充叶酸和维生素B12能使同型半胱氨酸下降超过 20\\% ，进而使脑卒中风险显著下降 25\\% 。叶酸还可直接改善内皮细胞功能，对抗氧化，发挥对高血压患者靶器官保护作用。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "295242056d96adea25c281141d778bc67d3e1ca1",
    "section_no": 2,
    "section_title": "微量元素与维生素",
    "section_norm": "第二节 微量元素与维生素"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第2节祛痰药",
    "qtype": "综合分析题",
    "qno": 8,
    "stem": "黏痰溶解作用强，适用于大量黏痰阻塞而引起的呼吸困难，支气管哮喘患者慎用的药物是",
    "options": {
      "A": "氨溴索",
      "B": "氯化铵",
      "C": "槟柠菜",
      "D": "可待因",
      "E": "乙酰半胱氨酸"
    },
    "answer": "E",
    "explanation": "②本题考查黏痰溶解剂的临床用药评价。乙酰半胱氨酸具有较强的黏痰溶解作用, 不仅能溶解白色黏痰, 也能溶解脓性痰, 适用于大量黏痰阻塞而引起的呼吸困难; 其对呼吸道黏膜有刺激作用, 故有时可引起呛咳或支气管痉挛, 支气管哮喘患者慎用。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "9c07e500694de876ecf522313c761ede8a0496b0",
    "section_no": 2,
    "section_title": "祛痰药",
    "section_norm": "第二节 祛痰药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第2节解痉药、胃肠动力药与功能性胃肠病治疗药",
    "qtype": "综合分析题",
    "qno": 8,
    "stem": "患者，女，22岁，近日出现间断性腹泻与便秘、腹痛，腹痛多于排便后缓解，考虑为肠易激综合征，宜选择的治疗药物是",
    "options": {
      "A": "奥美拉唑",
      "B": "山莨菪碱",
      "C": "曲美布汀",
      "D": "美沙拉秦",
      "E": "铝碳酸镁"
    },
    "answer": "C",
    "explanation": "本题考查曲美布汀的临床用药评价。曲美布汀可抑制运动功能亢进肌群的运动，同时也可增进运动功能低下肌群的运动，可用于：①改善胃肠道运动功能紊乱引起的食欲不振、恶心、呕吐、嗳气、腹胀、腹痛、腹泻、便秘等症状；②肠易激综合征。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords) | explanation_range_detected",
    "question_id": "ffb6087fe44ffd6b36f94149a03d080fdc2a2efe",
    "section_no": 2,
    "section_title": "解痉药、胃肠动力药与功能性胃肠病治疗药",
    "section_norm": "第二节 解痉药、胃肠动力药与功能性胃肠病治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第2节抗癫痫药",
    "qtype": "综合分析题",
    "qno": 8,
    "stem": "患者，女，34岁，自述最近服用了某种药物后体重增加，该女士可能服用的药物是",
    "options": {
      "A": "苯巴比妥",
      "B": "丙戊酸钠",
      "C": "卡马西平",
      "D": "苯妥英钠",
      "E": "扑米酮"
    },
    "answer": "B",
    "explanation": "本题考查丙戊酸钠的临床用药评价。丙戊酸钠的典型不良反应包括体重增加、肝脏损害、肝脏中毒。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "6319bdc40ece899f74f97b7794bfcea357b0d089",
    "section_no": 2,
    "section_title": "抗癫痫药",
    "section_norm": "第二节 抗癫痫药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "综合分析题",
    "qno": 8,
    "stem": "患者，女，58岁，血糖升高10年，口服二甲双胍治疗，高血压病史5年，未规律治疗，近期查体：血压 158 / 95\\mathrm{mmHg}，尿常规示蛋白尿 (+++)，适宜该患者使用的降压药物是",
    "options": {
      "A": "硝苯地平",
      "B": "普萘洛尔",
      "C": "甲基多巴",
      "D": "依那普利",
      "E": "特拉唑嗪"
    },
    "answer": "D",
    "explanation": "本题考查 ACEI 类的临床用药评价。依那普利属于血管紧张素转换酶抑制剂（ACEI）类抗高血压药，可同时改善糖尿病患者多蛋白尿或微量蛋白尿，延缓肾脏损害。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "da84ee95573667c007053637cc05dc3be9113d4c",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第2节肾上腺糖皮质激素类药物",
    "qtype": "综合分析题",
    "qno": 8,
    "stem": "患者，男，45岁。初始诊断肾病综合征合并严重肝功能不全，宜选用的糖皮质激素是",
    "options": {
      "A": "氟替卡松",
      "B": "泼尼松",
      "C": "可的松",
      "D": "波尼松龙",
      "E": "布地奈德"
    },
    "answer": "D",
    "explanation": "本题考查肾上腺糖皮质激素类药物的临床应用注意。可的松和泼尼松为前药，需在肝内分别转化为氢化可的松和泼尼松龙而生效，故严重肝功能不全者宜选择氢化可的松或泼尼松龙。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "ae5a0e942053ee645df3c5763f316f193455dbdf",
    "section_no": 2,
    "section_title": "肾上腺糖皮质激素类药物",
    "section_norm": "第二节 肾上腺糖皮质激素类药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第2节青霉素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 9,
    "stem": "即使患者存在严重肾功能衰竭，也不需要调整给药剂量的药物是",
    "options": {
      "A": "青霉素 G",
      "B": "芋星青霉素",
      "C": "阿莫西林",
      "D": "蒂夫西林",
      "E": "哔拉西林"
    },
    "answer": "D",
    "explanation": "②本题考查青霉素类药物的临床用药评价。萘夫西林、苯唑西林、双氯西林都主要经非肾途径清除,即使患者存在严重的肾功能障碍, 也不需要调整给药剂量。故本题答案为 D。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "c9fba7a61ccbb8be88e69297014c2bef53722c99",
    "section_no": 2,
    "section_title": "青霉素类抗菌药物",
    "section_norm": "第二节 青霉素类抗菌药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "综合分析题",
    "qno": 10,
    "stem": "患者，男，65岁。高血压病史8年，血压峰值 180 / 110\\mathrm{mmHg}，冠心病史5年，双侧肾动脉狭窄，不宜选用的抗高血压药是",
    "options": {
      "A": "普萘洛尔",
      "B": "氨氯地平",
      "C": "吟达帕胺",
      "D": "赖诺普利",
      "E": "特拉唑嗪"
    },
    "answer": "D",
    "explanation": "本题考查 ACEI 类的临床用药评价。血管紧张素转换酶抑制剂（如赖诺普利）的禁忌证包括：双侧肾动脉狭窄、高钾血症、妊娠期妇女。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "1b6ac751502abe7273ca6f2b2e1c0e94e745cebe",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "综合分析题",
    "qno": 11,
    "stem": "适用于伴有糖尿病肾病，且不能耐受因ACEI所导致严重干咳的高血压患者的药物是",
    "options": {
      "A": "氯沙坦",
      "B": "甲基多巴",
      "C": "阿利吉仑",
      "D": "利血平",
      "E": "硝苯地平"
    },
    "answer": "A",
    "explanation": "本题考查ARB类的临床用药评价。ARB类（如氯沙坦）一般无咳嗽、血管神经性水肿的不良反应，尤其适用于不能耐受ACEI引起咳嗽的患者。故本题答案为A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "4f236859570005805d9f59700a63afc0541a9650",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第2节干扰核酸生物合成的药物（抗代谢药）",
    "qtype": "综合分析题",
    "qno": 11,
    "stem": "急性白血病患者接受化疗期间出现了手指、足趾麻木、腱反射迟钝等不良反应，最有可能导致上述症状的药物是",
    "options": {
      "A": "甲氨蝶呤",
      "B": "曲妥珠单抗",
      "C": "长春新碱",
      "D": "环磷酰胺",
      "E": "疏嘌呤"
    },
    "answer": "C",
    "explanation": "【 10 \\sim 11】 ②本题考查长春碱类的临床用药评价。长春新碱主要用于急性白血病、急性和慢性淋巴细胞白血病, 其神经毒性表现为手指、足趾麻木、腱反射迟钝或消失、外周神经炎, 为剂量限制性毒性, 其他不良反应包括骨髓抑制、消化道反应、脱发。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "89dcd1af5a8c982daf31d9b05d3e3a260bb31ede",
    "section_no": 2,
    "section_title": "干扰核酸生物合成的药物（抗代谢药）",
    "section_norm": "第二节 干扰核酸生物合成的药物（抗代谢药）"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "综合分析题",
    "qno": 14,
    "stem": "对伴有支气管哮喘的心绞痛患者更适用的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "呕唑嗪",
      "C": "硝苯地平",
      "D": "卡托普利",
      "E": "美托洛尔"
    },
    "answer": "C",
    "explanation": "本题考查钙通道阻滞剂（CCB）的临床用药评价。钙通道阻滞剂对支气管平滑肌的松弛作用较为明显, 因此可用于伴有支气管哮喘的心绞痛。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "9e8af82f27eabfeca0faffe8560d6cecf67dd963",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "综合分析题",
    "qno": 29,
    "stem": "患者，男，76岁。因“高血压危象”入院，血压 203 / 110\\mathrm{mmHg}，宜首选的降压药物是",
    "options": {
      "A": "硝普钠",
      "B": "美托洛尔",
      "C": "氨氯地平",
      "D": "贝那普利",
      "E": "氢氯噻嗪"
    },
    "answer": "A",
    "explanation": "①本题考查其他抗高血压药的临床用药评价。硝普钠可用于治疗高血压急症, (高血压危象、高血压脑病、恶性高血压、嗜铬细胞瘤手术前后阵发性高血压、外科麻醉期间进行控制性降压), 急性心力衰竭, 急性肺水肿。故本题答案为 A。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "4da45614f36ff9cc983ddfd41d61807cf5e2f24a",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "综合分析题",
    "qno": 30,
    "stem": "患者，女，45岁。诊断为高血压合并甲状腺功能亢进，心率过快，宜选用的抗高血压药是",
    "options": {
      "A": "硝普钠",
      "B": "美托洛尔",
      "C": "氨氯地平",
      "D": "贝那普利",
      "E": "氢氯噻嗪"
    },
    "answer": "B",
    "explanation": "②本题考查 \\beta 受体拮抗剂的临床用药评价。美托洛尔属于 \\beta 受体拮抗剂, 可用于治疗高血压, 还可减慢窦性节律, 减慢心房和房室结的传导, 延长房室结的功能性不应期,因此也可用于治疗心律失常, 以及用于控制甲状腺功能亢进症的心率加快。故本题答案 为B。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "4e7072083659979c4f5b15b88b87917329f13115",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "综合分析题",
    "qno": 38,
    "stem": "患者，男，65岁，良性前列腺增生症病史3年，最近出现明显头晕、耳鸣，查体：血压165/100mmHg，拟进行降压治疗，宜选用的抗高血压药是",
    "options": {
      "A": "氨氯地平",
      "B": "氢氯噻嗪",
      "C": "普萘洛尔",
      "D": "特拉唑嗪",
      "E": "卡托普利"
    },
    "answer": "D",
    "explanation": "本组题考查常用降压药种类的临床选择。 ①特拉唑嗪属于 \\alpha 1 受体拮抗药, 对前列腺和外周血管平滑肌上的 \\alpha 1 受体都有拮抗作用, 可降低血压, 还可松弛前列腺平滑肌, 缓解膀胱梗阻的动力性因素, 减轻下尿路症状, 适用于高血压合并良性前列腺增生症患者。故本题答案为 D。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "20024c8a69c73b0d240898aa9b16492d9df41d3b",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "综合分析题",
    "qno": 39,
    "stem": "患者，男，41岁，既往有痛风病史，新诊断为高血压，查体：血压 150 / 110\\mathrm{mmHg} 血尿酸 450\\mu \\mathrm{mol} / \\mathrm{L}，不宜选用的抗高血压药是",
    "options": {
      "A": "氨氯地平",
      "B": "氢氯噻嗪",
      "C": "普萘洛尔",
      "D": "特拉唑嗪",
      "E": "卡托普利"
    },
    "answer": "B",
    "explanation": "本组题考查常用降压药种类的临床选择。 ②氢氯噻嗪为一线抗高血压药, 用药早期通过利尿、减少血容量而降压, 长期用药则通过扩张外周血管而产生降压作用。但可干扰肾小管排泄尿酸, 导致高尿酸血症, 甚至诱发痛风发作, 高尿酸血症或痛风患者不宜使用。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "bcfcead0254b95246bd7a60d69590e14c5dd2a4e",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第2节抗高血压药",
    "qtype": "综合分析题",
    "qno": 40,
    "stem": "患者，女，57岁，既往有支气管哮喘病史，反复咳嗽、喘息，新诊断为高血压，血压160/110mmHg，应避免使用的抗高血压药是",
    "options": {
      "A": "氨氯地平",
      "B": "氢氯噻嗪",
      "C": "普萘洛尔",
      "D": "特拉唑嗪",
      "E": "卡托普利"
    },
    "answer": "C",
    "explanation": "本组题考查常用降压药种类的临床选择。 ③普萘洛尔为非选择性 \\beta 受体拮抗剂, 可拮抗支气管平滑肌的 \\beta 2 受体, 引起支气管平滑肌收缩, 这一作用对正常人作用弱, 对支气管哮喘者作用强。因此支气管哮喘者禁用普萘洛尔, 应用选择性 \\beta 1 受体拮抗剂也需慎重。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "33136805ce5bef8b06b83f347e8e10236ec1c888",
    "section_no": 2,
    "section_title": "抗高血压药",
    "section_norm": "第二节 抗高血压药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "与丙磺舒合用，可提高降尿酸作用的药物是",
    "options": {
      "A": "氯化铵",
      "B": "碳酸氢钠",
      "C": "氯化钠",
      "D": "氯化钾",
      "E": "碳酸钙"
    },
    "answer": "B",
    "explanation": "本题考查抗痛风药的分类与作用机制。碳酸氢钠可碱化尿液, 与促进尿酸排泄药（如丙磺舒）合用, 可提高降尿酸效果。碳酸钙属于难吸收的抗酸药, 只中和胃酸, 难以吸收入血, 不可碱化尿液。故本题答案为 B。",
    "source_note": "",
    "question_id": "d772153d8473571ec8853d6b5ca4444d5c8a077a",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第3节止吐药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于抗胆碱能药物，易通过血-脑屏障，能有效预防晕动病的药物是",
    "options": {
      "A": "东莨菪碱",
      "B": "甲氧氮普胺",
      "C": "帕洛诺司琼",
      "D": "地塞米松",
      "E": "劳拉西泮"
    },
    "answer": "A",
    "explanation": "本题考查止吐药的临床用药评价。东莨菪碱属于抗胆碱能药物，易通过血-脑屏障，能有效预防晕动病，可抗晕车、晕船。故本题答案为A。甲氧氯普胺为多巴胺受体拮抗剂。帕洛诺司琼属于5-HT3受体拮抗剂。地塞米松属于糖皮质激素。劳拉西泮属于苯二氮草类药物。",
    "source_note": "",
    "question_id": "a97ba778587ce8101038c63a807eaf7741cf3213",
    "section_no": 3,
    "section_title": "止吐药",
    "section_norm": "第三节 止吐药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第3节抗抑郁药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "可增加 NE 和 5-HT 的间接释放，增强中枢 NE 能及 5-HT 能神经的功能，并拮抗 5\\mathrm{-HT}_{2}、5\\mathrm{-HT}_{3} 受体以调节 5\\mathrm{-HT}_{1} 功能，从而达到抗抑郁作用的药物是",
    "options": {
      "A": "米氮平",
      "B": "吗氯贝胺",
      "C": "帕罗西汀",
      "D": "舍曲林",
      "E": "文拉法辛"
    },
    "answer": "A",
    "explanation": "本题考查抗抑郁药的分类与作用机制。米氮平属于去甲肾上腺素能及特异性 5-HT 能抗抑郁药，可能是中枢突触前抑制性 \\alpha 肾上腺素受体拮抗药，增加 NE 和 5-HT 的间接释放，增强中枢 NE 能及 5-HT 能神经的功能，并拮抗 5-HT2、5-HT3 受体以调节 5-HT1 功能，从而达到抗抑郁作用。故本题答案为 A。",
    "source_note": "",
    "question_id": "c1a4c126532d319c5ace8d44c3ab3a6ec1dd40ac",
    "section_no": 3,
    "section_title": "抗抑郁药",
    "section_norm": "第三节 抗抑郁药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "可降低动脉粥样硬化风险的脂蛋白是",
    "options": {
      "A": "乳糜微粒（CM）",
      "B": "极低密度脂蛋白（VLDL）",
      "C": "低密度脂蛋白（LDL）",
      "D": "中间密度脂蛋白（IDL）",
      "E": "高密度脂蛋白（HDL）"
    },
    "answer": "E",
    "explanation": "本题考查脂蛋白的分类与功能。脂蛋白按其组成、密度和特性等差异分为：乳糜微粒（CM）、极低密度脂蛋白（VLDL）、中间密度脂蛋白（IDL）、低密度脂蛋白（LDL）和高密度脂蛋白（HDL）等。其中HDL的主要功能是从血液中将胆固醇带回到肝脏，由肝脏进行分解代谢，从而降低血液中的胆固醇含量，可以降低动脉粥样硬化的风险。故本题答案为E。",
    "source_note": "",
    "question_id": "a2d2bfd7f09773c56528ccf6a5255c7ca8935bf2",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第3节抗贫血药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "关于叶酸的描述，错误的是",
    "options": {
      "A": "属于水溶性维生素",
      "B": "可用于预防胎儿先天性神经管畸形",
      "C": "可用于巨幼红细胞性贫血",
      "D": "恶性贫血及疑有维生素 \\mathrm{B}_{12} 缺乏的患者,不单独用叶酸",
      "E": "营养性巨幼红细胞性贫血常合并缺铁， 应同时补充铁，无需补充B族维生素"
    },
    "answer": "E",
    "explanation": "本题考查叶酸的临床用药评价。营养性巨幼红细胞性贫血常合并缺铁，应同时补充铁，并补充蛋白质及其他B族维生素。故本题答案为E。",
    "source_note": "",
    "question_id": "74541f07f21aba134b75e3c596acda8c232da4dc",
    "section_no": 3,
    "section_title": "抗贫血药",
    "section_norm": "第三节 抗贫血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "较少发生直立性低血压的 \\alpha_{1} 受体拮抗剂是",
    "options": {
      "A": "酚苄明",
      "B": "坦索罗辛",
      "C": "特拉唑嗪",
      "D": "非那雄胺",
      "E": "西地那非"
    },
    "answer": "B",
    "explanation": "本题考查 \\alpha 1 受体拮抗药的临床用药评价。坦索罗辛和赛洛多辛对前列腺上 \\alpha 1 \\mathrm{~A} 受体具有高选择性, 而对外周血管平滑肌 \\alpha 1 \\mathrm{~B} 受体则几乎无影响, 因此在使用过程中很少发生低血压。故本题答案为 B。",
    "source_note": "",
    "question_id": "d83e8dd4fa32a2a4965b605bf6c763c2e4164792",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "关于左甲状腺素作用特点的描述，错误的是",
    "options": {
      "A": "每日口服1次，不必分次服用",
      "B": "由乳汁分泌甚微，哺乳期妇女适量服用对婴儿无不良影响",
      "C": "通常首选早餐后 30 \\sim 60 分钟服用，次选睡前服用",
      "D": "妊娠期需规律监测甲状腺功能",
      "E": "服用后起效较慢，几周后才能达到最高疗效"
    },
    "answer": "C",
    "explanation": "本题考查甲状腺激素类药物的临床用药评价。含大豆物质、高纤维素和高蛋白的食物可能会降低左甲状腺素在肠道中的吸收量。口服左甲状腺素时, 通常首选早餐前 30 \\sim 60 分钟服用, 次选睡前服用, 空腹服药后至少 30 \\mathrm{~min} 后才能进食。故本题答案为 C。",
    "source_note": "",
    "question_id": "d1766d84e9302151b2051a498c18310b80dc1f00",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "化学结构中没有甲硫四氮唑侧链和甲硫三嗪侧链，不会导致双硫仑样反应的药物是",
    "options": {
      "A": "头孢孟多",
      "B": "头孢尼西",
      "C": "头孢曲松",
      "D": "头孢甲肟",
      "E": "头孢他啶"
    },
    "answer": "E",
    "explanation": "本题考查头孢菌素类药物的临床用药评价。化学结构中没有甲硫四氮唑侧链和甲硫三嗪侧链，不会导致双硫仑样反应的药物有头孢拉定、头孢氨苄、头孢呋辛酯、头孢克洛、头孢丙烯、头孢噻肟、头孢他啶、头孢唑肟、头孢克肟、头孢地尼、头孢他美酯、头孢吡肟等。故本题答案为 E。头孢孟多、头孢替安、头孢曲松、头孢尼西、头孢哌酮、头孢甲肟、头孢匹胺等会导致双硫仑样反应。",
    "source_note": "",
    "question_id": "90a63712dc892e6de01220506639582afe196e73",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第3节干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "具有典型心脏毒性，在每个化疗周期前应该进行心电图或超声心动检查，排除心脏病变的是",
    "options": {
      "A": "疏嘌呤",
      "B": "卡铂",
      "C": "多柔比星",
      "D": "奥沙利铂",
      "E": "甲氨蝶呤"
    },
    "answer": "C",
    "explanation": "本题考查葱环类抗肿瘤抗生素的临床用药评价。葱环类抗肿瘤抗生素（柔红霉素、多柔比星、表柔比星、吡柔比星）的迟发毒性反应有骨髓抑制、心脏毒性（剂量限制性毒性）、胃炎、脱发。严重器质性心脏病和心功能异常禁用。故本题答案为 C。",
    "source_note": "",
    "question_id": "0eba0a9c41a180fe0e145628810a1ac09c480cdb",
    "section_no": 3,
    "section_title": "干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "section_norm": "第三节 干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第3节肠内营养药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "下列关于肠内营养药临床应用注意的说法，错误的是",
    "options": {
      "A": "冲调好的肠内营养粉剂（TP）应该立即服用或加盖冰箱保存，在24h内服完",
      "B": "肠内营养粉剂（TP）应正确混合防止插管堵塞",
      "C": "肠内营养乳剂（TPF-D）可管饲和注射给药",
      "D": "肠内营养乳剂（TPF-D）使用前摇匀，25^{\\circ} \\mathrm{C} 以下密闭保存，不可冰冻",
      "E": "肠内营养乳剂（TPF-D）开启后最多可在冰箱内（2～10℃）保存24h"
    },
    "answer": "C",
    "explanation": "本题考查肠内营养药的临床应用注意。肠内营养是指经消化道给以营养素，根据给予肠内营养（EN）途径的不同，分为口服和管饲，不能注射给药。故本题答案为C。",
    "source_note": "",
    "question_id": "bb333dd853594ce245b73a15ccf5625b96649f58",
    "section_no": 3,
    "section_title": "肠内营养药",
    "section_norm": "第三节 肠内营养药"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第3节口腔科用药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "口腔治疗控制疼痛最常用的药物是",
    "options": {
      "A": "利多卡因",
      "B": "可待因",
      "C": "双氯芬酸钠",
      "D": "吗啡",
      "E": "曲马多"
    },
    "answer": "A",
    "explanation": "本题考查口腔科用药的分类与代表药品。口腔治疗控制疼痛最常用的药物是局部麻醉药，代表药物有利多卡因、复方盐酸阿替卡因、普鲁卡因、甲哌卡因。故本题的正确答案为 A。",
    "source_note": "",
    "question_id": "f282d876cf31dfcfdc7d4be5967328a1552469f0",
    "section_no": 3,
    "section_title": "口腔科用药",
    "section_norm": "第三节 口腔科用药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第3节痔疮治疗药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "可用于治疗重度痤疮（尤其是结节囊肿型痤疮），但妊娠期妇女避免使用的药物是",
    "options": {
      "A": "克拉霉素",
      "B": "过氧苯甲酰",
      "C": "异维A酸",
      "D": "克罗米通",
      "E": "莫匹罗星"
    },
    "answer": "C",
    "explanation": "本题考查抗角化药的临床用药评价。异维 A 酸对严重的结节囊肿型痤疮有高效作用, 妊娠期妇女服后可致自发性流产及胎儿发育畸形, 妊娠期妇女禁用。故本题答案为 C。",
    "source_note": "",
    "question_id": "4996ba293e086923035c5803826aaebd47e0b4de",
    "section_no": 3,
    "section_title": "痔疮治疗药",
    "section_norm": "第三节 痔疮治疗药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "缓解 COPD 支气管痉挛的首选药是",
    "options": {
      "A": "沙美特罗",
      "B": "茶碱",
      "C": "沙丁胺醇",
      "D": "塞托溴铵",
      "E": "奥马珠单抗"
    },
    "answer": "C",
    "explanation": "本题考查β2受体激动剂的临床用药评价。短效β2受体激动剂吸入给药起效快，在3～5分钟内起效，疗效可维持4～6小时，是缓解轻至中度哮喘急性症状、COPD支气管痉挛的首选药物。故本题答案为C。",
    "source_note": "",
    "question_id": "a60955801bdc39150e6330ddd49e1e1af24bbbe9",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第3节抗抑郁药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "下列药物中可引起体重增加的是",
    "options": {
      "A": "二甲双胍",
      "B": "辛伐他汀",
      "C": "米氮平",
      "D": "阿司匹林",
      "E": "硝酸甘油"
    },
    "answer": "C",
    "explanation": "本题考查米氮平的临床用药评价。米氮平常见体重增加、困倦, 还有三环类抗抑郁药也可见体重增加。故本题答案为 C。二甲双胍可使体重下降。",
    "source_note": "",
    "question_id": "cfbbe14fe8b7186d7b665c9d4cabdc6424b9daee",
    "section_no": 3,
    "section_title": "抗抑郁药",
    "section_norm": "第三节 抗抑郁药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "下列药物中不属于调血脂药物的是",
    "options": {
      "A": "瑞舒伐他汀",
      "B": "非诺贝特",
      "C": "依折麦布",
      "D": "血脂康",
      "E": "米力农"
    },
    "answer": "E",
    "explanation": "本题考查调节血脂药的分类与代表药品。瑞舒伐他汀属于羟甲基戊二酰辅酶A还原酶抑制剂类调节血脂药。非诺贝特属于贝丁酸类调节血脂药。依折麦布属于胆固醇吸收抑制剂类调节血脂药。血脂康的主要成分为13种天然复合他汀，有调血脂作用。故本题答案为E。米力农为抗心力衰竭药。",
    "source_note": "",
    "question_id": "d9aef683a57eb5ceb65c819f96f5e8ff1ca9d3cd",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第3节抗贫血药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "重组人促红素的适应证是",
    "options": {
      "A": "缺铁性贫血",
      "B": "巨幼红细胞性贫血",
      "C": "血小板减少性紫癜",
      "D": "中性粒细胞减少症",
      "E": "肾功能不全所致贫血"
    },
    "answer": "E",
    "explanation": "本题考查重组人促红素的临床用药评价。重组人促红素为红细胞生成刺激剂，其适应证包括 ① 肾功能不全所致贫血，包括透析及非透析患者； ② 外科围手术期的红细胞动员。故本题答案为 E。缺铁性贫血常用铁剂治疗。巨幼红细胞性贫血常用叶酸和维生素 B12 治疗。血小板减少性紫癜常用糖皮质激素治疗。先天性、特发性中性粒细胞减少症常用重组人粒细胞刺激因子治疗。",
    "source_note": "explanation_range_detected",
    "question_id": "e12c1f5852a8ffcfe6109a3b940a2b33ac961d36",
    "section_no": 3,
    "section_title": "抗贫血药",
    "section_norm": "第三节 抗贫血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "特拉唑嗪的作用机制是",
    "options": {
      "A": "抑制逼尿肌收缩",
      "B": "缩小前列腺体积",
      "C": "拮抗雄激素受体",
      "D": "抑制前列腺增生",
      "E": "松弛前列腺平滑肌"
    },
    "answer": "E",
    "explanation": "本题考查治疗良性前列腺增生用药的分类与作用机制。特拉唑嗪属于 \\alpha 1. 受体拮抗剂, 通过阻滞分布在前列腺和膀胱颈部平滑肌细胞表面的 \\alpha 1 受体, 松弛前列腺平滑肌, 达到缓解膀胱出口动力性梗阻的作用。故本题答案为 E。",
    "source_note": "",
    "question_id": "d658343e139321b209d990dc78a49fbedd9b0a32",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "关于甲状腺激素生理活性的说法，错误的是",
    "options": {
      "A": "四碘甲状腺原氨酸是主要的生理活性物质",
      "B": "促进代谢和增加产热",
      "C": "成人严重缺乏可引起黏液性水肿",
      "D": "先天性甲状腺功能不足可引起呆小病",
      "E": "提高交感肾上腺系统的感受性"
    },
    "answer": "A",
    "explanation": "本题考查甲状腺激素的生理活性。甲状腺激素包括四碘甲状腺原氨酸（T4）和三碘甲状腺原氨酸（T3）。T3是主要的生理活性物质，T4要转变为T3才能发挥作用。故本题答案为A。甲状腺素主要作用为：①维持正常生长发育，先天性甲状腺功能不足可引起呆小病，成人甲状腺功能不全时，则引起黏液性水肿；②促进代谢和增加产热；③提高交感肾上腺系统的感受性。",
    "source_note": "explanation_range_detected",
    "question_id": "7512076e0203b65afdbdf80206b140acd9fe4bb8",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "头孢菌素类药物的抗菌作用机制是",
    "options": {
      "A": "与细菌细胞内膜上主要的青霉素结合蛋白（PBP）结合，使细菌细胞壁合成过程中的交叉连接不能形成，导致细菌细胞壁合成障碍",
      "B": "与细菌的30S核糖体结合，影响蛋白质合成过程的多个环节，使蛋白质的合成受阻",
      "C": "与细菌的50S核糖体亚基的供位相结合，竞争性阻断了肽链延伸过程中的肽基转移作用或移位作用，从而终止蛋白质的合成",
      "D": "选择性干扰细菌 DNA 旋转酶或拓扑异构酶 IV, 抑制 DNA 的合成和复制而导致细菌死亡",
      "E": "作用于二氢叶酸合成酶, 干扰细菌叶酸代谢"
    },
    "answer": "A",
    "explanation": "本题考查头孢菌素类药物的作用机制。头孢菌素类抗菌药物的抗菌作用机制与青霉素类药物相同，与细菌细胞内膜上主要的青霉素结合蛋白（PBP）结合，使细菌细胞壁合成过程中的交叉连接不能形成，导致细菌细胞壁合成障碍。故本题答案为 A。",
    "source_note": "",
    "question_id": "77bf81f69669e009308934de16c0118b61caef3c",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第3节干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可作为急性白血病的二线用药，还可作为恶性淋巴瘤中的霍奇金淋巴瘤的首选药之一的是",
    "options": {
      "A": "柔红霉素",
      "B": "阿那曲唑",
      "C": "吉西他滨",
      "D": "多柔比星",
      "E": "长春地辛"
    },
    "answer": "D",
    "explanation": "本题考查蒽环类抗肿瘤抗生素的临床用药评价。多柔比星作为急性白血病的二线用药，用于一线药物耐药时；也是治疗恶性淋巴瘤中霍奇金淋巴瘤及非霍奇金淋巴瘤的首选药之一。故本题答案为 D。",
    "source_note": "",
    "question_id": "136a5588337bf67c3441c1bb86a214108e2ac0a0",
    "section_no": 3,
    "section_title": "干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "section_norm": "第三节 干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）"
  },
  {
    "chapter": "第十二章 眼科用药、耳鼻咽喉科用药及口腔科用药",
    "section": "第3节口腔科用药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可用于牙菌斑造成的牙周病、龋齿，误服可导致局部腐蚀的药物是",
    "options": {
      "A": "复方硼砂溶液",
      "B": "利多卡因",
      "C": "四环素",
      "D": "制霉菌素",
      "E": "曲安奈德"
    },
    "answer": "A",
    "explanation": "本题考查口腔科用药的分类与代表药品。复方硼砂溶液属于消毒防腐药，可用于牙菌斑造成的牙周病、龋齿，误服后可引起局部组织腐蚀，吸收后可发生急性中毒。故本题的正确答案为A。",
    "source_note": "",
    "question_id": "0dc99135a7f222997ffad51da2eb215a7c5a0891",
    "section_no": 3,
    "section_title": "口腔科用药",
    "section_norm": "第三节 口腔科用药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第3节痔疮治疗药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "常用的痤疮治疗药不包括",
    "options": {
      "A": "特比萘芬",
      "B": "过氧苯甲酰",
      "C": "维 A 酸",
      "D": "阿达帕林",
      "E": "异维A酸"
    },
    "answer": "A",
    "explanation": "本题考查痤疮治疗药的分类与代表药品。特比萘芬属于皮肤真菌感染治疗药，可用于手癣、足癣、体癣、股癣等。故本题答案为 A。常用的痤疮治疗药包括 ① 非抗生素类抗菌药：过氧苯甲酰、壬二酸；② 抗生素类抗菌药：红霉素、林可霉素、克林霉素、夫西地酸、氯霉素；③ 抗角化药：维 A 酸、异维 A 酸、阿达帕林；④ 其他类：氨苯砜、二硫化硒、硫黄、水杨酸。",
    "source_note": "explanation_range_detected",
    "question_id": "73010214d1d28382189f6f957bd0a55b818dfda8",
    "section_no": 3,
    "section_title": "痔疮治疗药",
    "section_norm": "第三节 痔疮治疗药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "痛风急性发作期禁用别嘌醇的原因是",
    "options": {
      "A": "可引起超敏反应综合征",
      "B": "起效较慢, 2 \\sim 4 周方显效",
      "C": "促使组织内尿酸结晶重新溶解",
      "D": "使尿酸盐沉积到肾脏, 形成结石",
      "E": "可引起骨髓造血功能抑制"
    },
    "answer": "C",
    "explanation": "本题考查抑制尿酸生成药的临床用药评价。别嘌醇是抑制尿酸生成药,本身不能控制痛风的急性炎症症状, 不能作为抗炎药使用, 因可促使组织内尿酸结晶重新溶解, 再次诱发和加重痛风急性期症状, 故痛风急性发作期禁用。故本题答案为 C。",
    "source_note": "",
    "question_id": "09df044eb578259a8388ac2ec05aac370f613dd1",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第3节止吐药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "可减轻地塞米松所致的焦虑和甲氧氯普胺所致的静坐不能，作为CINV辅助治疗药物的是",
    "options": {
      "A": "昂丹司琼",
      "B": "劳拉西泮",
      "C": "阿瑞匹坦",
      "D": "莫沙必利",
      "E": "东莨菪碱"
    },
    "answer": "B",
    "explanation": "本题考查止吐药的临床用药评价。苯二氮草类药物单独应用时止吐作用相对较弱，最常用的是劳拉西泮和阿普唑仑，主要作为辅助药物，用于减轻地塞米松所致焦虑和甲氧氯普胺所致静坐不能，也可用于减少预期性的CINV。故本题答案为B。",
    "source_note": "",
    "question_id": "41f4b4a18a135b372ce42e906e394dfc9f475818",
    "section_no": 3,
    "section_title": "止吐药",
    "section_norm": "第三节 止吐药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第3节抗抑郁药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "关于抗抑郁药氟西汀作用特点的说法，错误的是",
    "options": {
      "A": "属于选择性 5-HT 再摄取抑制剂",
      "B": "可用于治疗强迫症以及神经性贪食症",
      "C": "需停药2周才能换用单胺氧化酶抑制剂",
      "D": "存在首关效应, 血浆蛋白结合率较高",
      "E": "妊娠期妇女长期用药，新生儿可出现戒断反应"
    },
    "answer": "C",
    "explanation": "本题考查抗抑郁药的使用注意事项。氟西汀需停药5周才能换用单胺氧化酶抑制剂，其他5-HT再摄取抑制剂需2周。故本题答案为C。",
    "source_note": "",
    "question_id": "51cec2424c849726772d03c31e037ef917c66519",
    "section_no": 3,
    "section_title": "抗抑郁药",
    "section_norm": "第三节 抗抑郁药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "水溶性他汀类药物能够选择性抑制肝脏胆固醇合成，而对肾上腺、性腺、心脏、大脑等部位的胆固醇合成影响极低，既有效降低了血清胆固醇水平，又减少了肝脏以外组织不良反应的发生。水溶性较强的他汀类药物是",
    "options": {
      "A": "洛伐他汀",
      "B": "普伐他汀 阿托伐他汀",
      "C": "辛伐他汀",
      "D": "匹伐他汀"
    },
    "answer": "B",
    "explanation": "本题考查羟甲基戊二酰辅酶A还原酶抑制剂的临床用药评价。他汀类药物按照其亲脂亲水特性，可分为：①水溶性较强：普伐他汀、瑞舒伐他汀；②脂溶性：洛伐他汀、辛伐他汀；③兼具有水溶性和脂溶性：氟伐他汀、阿托伐他汀、匹伐他汀。水溶性较强的他汀能够选择性抑制肝脏胆固醇合成，而对肾上腺、性腺、心脏、大脑等部位的胆固醇合成影响极低，既可有效降低血清胆固醇水平，又可减少肝脏以外组织不良反应的发生。故本题答案为B。",
    "source_note": "explanation_range_detected",
    "question_id": "c86d1996cc0edb01adfe8916bda12ed5d090e6ee",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第3节抗贫血药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "关于铁剂临床用药评价的说法，错误的是",
    "options": {
      "A": "口服铁剂 7 \\sim 10 日, 在血红蛋白恢复正常后, 需及时停药防止出现慢性铁中毒",
      "B": "空腹口服有利于铁吸收，若空腹不能耐受，可改为餐后服用",
      "C": "注射铁剂常见过敏反应，表现为皮肤瘙痒、呼吸困难、面部潮红等",
      "D": "酸性条件促进铁剂的吸收, 可与维生素 C 以及果汁一起服用",
      "E": "与磷酸盐类、四环素类及鞣酸等同服，可妨碍铁剂的吸收"
    },
    "answer": "A",
    "explanation": "本题考查铁剂的临床用药评价。通常口服铁剂后 4 \\sim 5 日, 血液中网织红细胞数即可上升, 7 \\sim 12 日达峰。在血红蛋白恢复正常后, 仍需继续服用铁剂 3 \\sim 6 个月, 以补充缺失的贮存铁量。故本题答案为 A。空腹口服有利于铁吸收, 若空腹不能耐受, 可改为餐后服用。注射铁剂常见过敏反应, 表现为皮肤瘙痒、呼吸困难、面部潮红等。酸性条件可以促进铁剂的吸收, 因此铁剂可以和维生素 C 以及果汁一起服用, 维生素 C 与去铁胺合用, 可促进后者与铁的络合, 从而使尿铁排出增加。与磷酸盐类、四环素类及鞣酸等同服, 可妨碍铁剂的吸收。",
    "source_note": "",
    "question_id": "947cbc2cfe1334b94ef3e9fc9fbfa5e0a3e3cfc9",
    "section_no": 3,
    "section_title": "抗贫血药",
    "section_norm": "第三节 抗贫血药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "下列关于大剂量的碘剂的描述，错误的是",
    "options": {
      "A": "有抗甲状腺的作用, 可用于甲状腺危象的治疗",
      "B": "甲亢外科手术前使用可减少甲状腺血供, 硬化甲状腺腺体",
      "C": "作用时间短暂，最多维持2周",
      "D": "可用于治疗单纯性甲状腺肿",
      "E": "不能作为常规的抗甲状腺药"
    },
    "answer": "D",
    "explanation": "本题考查碘化钾的临床用药评价。碘剂剂量不同, 作用不同; ①小剂量碘剂: 可用于治疗单纯性甲状腺肿/地方性甲状腺肿; ②大剂量碘剂: 有抗甲状腺的作用, 但由于其作用时间短暂（最多维持 2 周），且服用时间过长时，不仅作用消失，且可使病情加重，因此不能作为常规的抗甲状腺药，可用于甲状腺危象和甲亢术前准备。故本题答案为 D。",
    "source_note": "explanation_range_detected",
    "question_id": "8d079d8c53c94bfeb97210b243bb08b004807f9e",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "属于第五代头孢菌素的是",
    "options": {
      "A": "头孢唑林",
      "B": "头孢他啶",
      "C": "头孢洛林",
      "D": "头孢吡肟",
      "E": "头孢呋辛"
    },
    "answer": "C",
    "explanation": "本题考查头孢菌素类药物的分类与代表药物。第五代头孢菌素类药物包括: 头孢洛林、头孢吡普。故本题答案为 C。头孢唑林为第一代头孢菌素。头孢他啶为第三代头孢菌素。头孢吡肟为第四代头孢菌素。头孢呋辛为第二代头孢菌素。",
    "source_note": "",
    "question_id": "30dc2bb83d3e9147546d0c6e11f8d99169a12142",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第3节干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "与多柔比星存在交叉耐药性的抗肿瘤药物是",
    "options": {
      "A": "氟尿嘧啶",
      "B": "柔红霉素",
      "C": "阿糖胞苷",
      "D": "L-门冬酰胺酶",
      "E": "多西他赛"
    },
    "answer": "B",
    "explanation": "本题考查蒽环类抗肿瘤抗生素的临床用药评价。多柔比星与柔红霉素、长春新碱和放线菌素 D 呈现交叉耐药性。故本题答案为 B。",
    "source_note": "",
    "question_id": "3a73d1ec0f9dc50d8311498208164b1cec11997b",
    "section_no": 3,
    "section_title": "干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "section_norm": "第三节 干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第3节痔疮治疗药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "关于过氧苯甲酰药理作用和临床应用的说法，错误的是",
    "options": {
      "A": "通过释放新生态氧而发挥杀菌除臭作用",
      "B": "可用于治疗寻常痤疮，每日早晚各1次",
      "C": "用药后可出现过敏性接触性皮炎和干燥现象",
      "D": "可漂白头发，不宜用在有毛发的部位",
      "E": "皮肤急性炎症或破溃处，需一日多次使用"
    },
    "answer": "E",
    "explanation": "本题考查非抗生素类抗菌药（过氧苯甲酰）的临床用药评价。过氧苯甲酰用药后可出现过敏性接触性皮炎和干燥现象，皮肤急性炎症或破溃者禁用。故本题答案为 E。",
    "source_note": "",
    "question_id": "97207ec6d55c26a96caffdeb7548364aeb3d5ed9",
    "section_no": 3,
    "section_title": "痔疮治疗药",
    "section_norm": "第三节 痔疮治疗药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "可抑制粒细胞浸润和白细胞趋化，用于痛风急性期的药物是",
    "options": {
      "A": "非布司他",
      "B": "秋水仙碱",
      "C": "丙磺舒",
      "D": "双氯芬酸",
      "E": "来氟米特"
    },
    "answer": "B",
    "explanation": "本题考查秋水仙碱的临床用药评价。秋水仙碱属于抑制粒细胞浸润炎症反应药, 可通过抑制粒细胞浸润和白细胞趋化、抑制磷脂酶 A2、抑制局部细胞产生 IL-1 等, 从而抑制关节局部疼痛、肿胀和炎症反应, 适用于治疗痛风性关节炎急性发作和预防复发性痛风性关节炎的急性发作。故本题答案为 B。",
    "source_note": "",
    "question_id": "3e7f3cb8e8c9972af11299ca0c33357902ea9671",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "平喘药从治疗目的分为控制症状类药物和缓解症状类药物，属于缓解症状类药物的是",
    "options": {
      "A": "吸入型肾上腺糖皮质激素",
      "B": "短效 \\beta_{2} 受体激动剂",
      "C": "缓释茶碱",
      "D": "白三烯受体拮抗剂",
      "E": "抗 IgE 单克隆抗体"
    },
    "answer": "B",
    "explanation": "本题考查平喘药的治疗目的。从治疗目的来分平喘药可分为两类 ①控 制症状类药物：即每日需要使用并长时间维持应用的药物，主要通过其抗炎作用使哮喘维持在临床控制状态，包括吸入型肾上腺糖皮质激素、全身型肾上腺糖皮质激素、白三烯受体拮抗剂、长效β2受体激动剂、缓释茶碱、抗IgE单克隆抗体；②缓解症状类药物（又称急救药物），急性发作时可按需使用，主要通过迅速解除支气管痉挛从而缓解患者哮喘症状，包括速效吸入和短效口服β2受体激动剂、吸入型肾上腺糖皮质激素与福莫特罗复方制剂、吸入型抗胆碱能药物、短效茶碱、全身型肾上腺糖皮质激素。故本题答案为B。",
    "source_note": "explanation_range_detected",
    "question_id": "26d0f1f9a2fccc5671904a7be58989e6400a8b0d",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第3节抗抑郁药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "关于抗抑郁药使用注意事项的说法，正确的是",
    "options": {
      "A": "选药时应因人而异，须全面考虑患者症状特点、年龄、躯体状况、药物的耐受性、有无合并症，予以个体化合理用药",
      "B": "为尽快达到有效治疗浓度，应从大剂量开始，逐渐减量，以提高患者服药依从性",
      "C": "米氮平起效缓慢, 需 4 ~ 6 周显效, 切忌频繁换药",
      "D": "突然停用选择性 5-HT 再摄取抑制剂, 最常见胃肠道反应",
      "E": "以单胺氧化酶抑制剂替换氟西汀时，应该间隔2周时间"
    },
    "answer": "A",
    "explanation": "本题考查抗抑郁药的使用注意事项。抗抑郁药的应用因人而异，须全面考虑患者症状特点、年龄、躯体状况、药物的耐受性、有无合并症，予以个体化合理用药。故本题答案为 A。使用抗抑郁药时，应从小剂量开始，逐增剂量，尽可能采用最小有效量，使不良反应减至最少，以提高服药依从性。抗抑郁药起效缓慢，一般 4 \\sim 6 周方显效，即便是起效较快的抗抑郁药（如米氮平、文拉法辛）也需要 1 周左右的时间，因此要有足够的耐心，切忌频繁换药。选择性 5-HT 再摄取抑制剂如迅速停药，可出现胃肠功能紊乱、头晕、感觉障碍、睡眠障碍、恶心、出汗、激惹、震颤、意识模糊等。其中，出汗是突然停药或大剂量减药的最常见症状，建议在停止治疗前逐渐减量。氟西汀需停药 5 周才能换用单胺氧化酶抑制剂。",
    "source_note": "",
    "question_id": "0ebc0cdd5091b256baa58f96bb90f8f05d74303f",
    "section_no": 3,
    "section_title": "抗抑郁药",
    "section_norm": "第三节 抗抑郁药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "丙硫氧嘧啶起效慢的主要原因是",
    "options": {
      "A": "口服吸收缓慢",
      "B": "首过效应明显",
      "C": "肾脏排泄速度快",
      "D": "待储备的甲状腺激素耗竭后才能生效",
      "E": "为前药，需游离出甲巯咪唑而发挥作用"
    },
    "answer": "D",
    "explanation": "本题考查硫脲类药物的临床用药评价。丙硫氧嘧啶不能直接对抗甲状腺激素, 待储备的甲状腺激素耗竭后才能生效, 作用较慢。故本题答案为 D。",
    "source_note": "",
    "question_id": "d735f05342fd7571689f265c170271ec265540de",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第3节干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "下列药物中，不属于蒽环类抗肿瘤抗生素的是",
    "options": {
      "A": "柔红霉素",
      "B": "多柔比星",
      "C": "表柔比星",
      "D": "罗红霉素",
      "E": "阿克拉阿霉素"
    },
    "answer": "D",
    "explanation": "本题考查蒽环类抗肿瘤抗生素的临床用药评价。蒽环类抗肿瘤抗生素的代表药物有柔红霉素、多柔比星、表柔比星、吡柔比星、阿克拉阿霉素。罗红霉素是大环内酯类抗菌药物, 应与柔红霉素区分。故本题答案为 D。",
    "source_note": "",
    "question_id": "3329b11f6708ff74801432ec676b47ff91d708e0",
    "section_no": 3,
    "section_title": "干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "section_norm": "第三节 干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第3节痔疮治疗药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "为炎性痤疮首选外用抗菌药的是",
    "options": {
      "A": "过氧苯甲酰",
      "B": "壬二酸",
      "C": "红霉素",
      "D": "维 A 酸",
      "E": "莫匹罗星"
    },
    "answer": "A",
    "explanation": "本题考查非抗生素类抗菌药（过氧苯甲酰）的临床用药评价。过氧苯甲酰为强氧化剂, 极易分解, 遇有机物分解出新生态氧而发挥杀菌除臭作用, 可杀灭痤疮丙酸杆菌, 为炎性痤疮首选外用抗菌用药。故本题答案为 A。",
    "source_note": "",
    "question_id": "70c3249426eed1734b52ed108a3b124cd3819bf3",
    "section_no": 3,
    "section_title": "痔疮治疗药",
    "section_norm": "第三节 痔疮治疗药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "关于孟鲁司特临床应用的说法，错误的是",
    "options": {
      "A": "作用较弱，相当于色甘酸钠",
      "B": "抗炎作用强，可单独用于中、重度哮喘的治疗",
      "C": "老年人、肾功能不全者无需调整剂量",
      "D": "1 \\sim 5 岁儿童使用孟鲁司特的剂量为一次 4 \\mathrm{mg}",
      "E": "不宜用于治疗急性哮喘发作"
    },
    "answer": "B",
    "explanation": "本题考查白三烯受体拮抗剂的临床用药评价。孟鲁司特是除吸入型肾上腺糖皮质激素外可单独应用的长期控制性药物之一, 但是其抗炎作用不如吸入型糖皮质激素, 可作为轻度哮喘的替代治疗药物和中、重度哮喘的联合用药。故本题答案为 B。孟鲁司特起效慢, 作用较弱, 相当于色甘酸钠, 不能控制哮喘急性症状。老年人、肾功能不全、轻至中度肝损伤者使用孟鲁司特无需调整剂量。孟鲁司特的用法用量: ① 1 \\sim 5 岁儿童患者, 一次 4 \\mathrm{mg}; ② 6 \\sim 14 岁儿童患者, 一次 5 \\mathrm{mg}; ③15 岁及 15 岁以上患者, 一次 10 \\mathrm{mg} 。",
    "source_note": "explanation_range_detected",
    "question_id": "320d27ebaa0d558d6f57453968a912c6d4d8e0f5",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "他汀类药具有肌毒性，需要监测的临床指标是",
    "options": {
      "A": "乳酸脱氢酶",
      "B": "尿淀粉酶",
      "C": "碱性磷酸酶",
      "D": "肌酸激酶",
      "E": "谷丙转氨酶"
    },
    "answer": "D",
    "explanation": "本题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。服用他 汀类调节血脂药可发生横纹肌溶解症，因此，服用者应定期监测肌酸激酶（CK）。故本题答案为 D。",
    "source_note": "",
    "question_id": "fea0392147fc9d6460a2791ce2643fa893e14829",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "为 I 型、II 型 5\\alpha 还原酶抑制剂的药物是",
    "options": {
      "A": "坦索罗辛",
      "B": "非那雄胺",
      "C": "度他雄胺",
      "D": "托特罗定",
      "E": "特拉唑嗪"
    },
    "answer": "C",
    "explanation": "本题考查治疗良性前列腺增生用药的分类与作用机制。非那雄胺和依立雄胺（爱普列特）为 II 型 5 \\alpha 还原酶抑制剂, 度他雄胺为 I 型、II 型 5 \\alpha 还原酶抑制剂 (双重抑制剂)。故本题答案为 C。坦索罗辛、特拉唑嗪为 \\alpha 1 受体拮抗剂。托特罗定为 M 胆碱受体拮抗剂。",
    "source_note": "",
    "question_id": "9db8017a467b96c23a39ac155622c4cc7583ba4c",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "妊娠前和妊娠早期优先选用的抗甲状腺药是",
    "options": {
      "A": "甲巯咪唑",
      "B": "丙硫氧嘧啶",
      "C": "卡比马唑",
      "D": "碘化钾",
      "E": "放射性碘"
    },
    "answer": "B",
    "explanation": "本题考查硫脲类药物的临床用药评价。妊娠前和妊娠早期优先选择丙硫氧嘧啶，哺乳期用药权衡利弊，应当在每次哺乳后服用低至中等剂量丙硫氧嘧啶和甲巯咪唑。故本题答案为B。",
    "source_note": "",
    "question_id": "a971a8835faf32693ef1f835d21cdb721d1b419e",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "对革兰阳性菌、革兰阴性菌、厌氧菌等的作用均很强的头孢菌素类药物是",
    "options": {
      "A": "第一代头孢菌素",
      "B": "第二代头孢菌素",
      "C": "第三代头孢菌素",
      "D": "第四代头孢菌素",
      "E": "单环 \\beta -内酰胺类"
    },
    "answer": "D",
    "explanation": "本题考查各代头孢菌素类抗菌药物的对比。第四代头孢菌素对革兰阳性菌、革兰阴性菌、厌氧菌显示广谱抗菌活性。故本题答案为D。第一代头孢菌素对革兰阳性菌作用较第二代略强、显著超过第三代；对革兰阴性菌杆菌作用较第二、三代弱。第二代头孢菌素对革兰阳性菌作用较第一代略差或相仿，对革兰阴性菌作用较第一代强，较第三代弱，对厌氧菌有一定作用。第三代头孢菌素对革兰阳性菌作用较第一、第二代弱，对革兰阴性菌作用较第一、二代强，对厌氧菌及铜绿假单胞菌有较强作用。氨曲南属于单环β-内酰胺类药物，仅对需氧革兰阴性菌包括铜绿假单胞菌有效，对革兰阳性菌和厌氧菌作用差。",
    "source_note": "",
    "question_id": "6d4f093318e363e612e5774ebcfebf550f9d70aa",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "常见尿道刺激的抗痛风药是",
    "options": {
      "A": "秋水仙碱",
      "B": "丙磺舒 苯溴马隆",
      "C": "非布司他",
      "D": "别嘌醇"
    },
    "answer": "A",
    "explanation": "本题考查秋水仙碱的临床用药评价。秋水仙碱常见尿道刺激症状, 如尿频、尿急、尿痛、血尿, 严重者可致死; 晚期中毒症状有血尿、少尿、肾衰竭。长期应用可引起骨髓造血功能抑制, 如粒细胞和血小板计数减少、再生障碍性贫血等。故本 题答案为A。",
    "source_note": "",
    "question_id": "fa9cbffcff4b5914bf204a6ff3a33e0d962f0e0b",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "属于肥大细胞膜稳定剂的是",
    "options": {
      "A": "特布他林",
      "B": "色甘酸钠",
      "C": "布地奈德",
      "D": "孟鲁司特",
      "E": "多索茶碱"
    },
    "answer": "B",
    "explanation": "本题考查平喘药的分类与代表药品。肥大细胞膜稳定剂的代表药物有: 色甘酸钠、曲尼司特。故本题答案为 B。特布他林为短效 \\beta 2 受体激动剂, 布地奈德为吸入型肾上腺糖皮质激素, 孟鲁司特为白三烯受体拮抗剂, 多索茶碱为黄嘌呤类药物。",
    "source_note": "",
    "question_id": "ab5a88af32259d23e9538c299ee9d4077cf66724",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "需要他汀类和贝丁酸类药物联合应用治疗时，可考虑使用的贝丁酸类药物是",
    "options": {
      "A": "非诺贝尔",
      "B": "贝诺酯",
      "C": "雷贝拉唑",
      "D": "吉非贝齐",
      "E": "厄贝沙坦"
    },
    "answer": "A",
    "explanation": "本题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。他汀类与烟酸、贝丁酸类合用, 肌毒性升高; 若要联合用药 (禁用吉非贝齐), 晨起服用贝特类 (如非诺贝特), 晚间睡前服用他汀类, 也可隔日分别交替使用。故本题答案为 A。",
    "source_note": "",
    "question_id": "9cebb5c22dae9af8ef5bcfa0cf7f9ee5d14526a2",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "治疗良性前列腺增生症用药中，起效较慢，不适于需要尽快解决急性症状的是",
    "options": {
      "A": "坦索罗辛",
      "B": "阿夫唑嗪",
      "C": "非那雄胺",
      "D": "托拉塞米",
      "E": "索利那新"
    },
    "answer": "C",
    "explanation": "本题考查 5 \\alpha 还原酶抑制剂的临床用药评价。非那雄胺属于 5 \\alpha 还原酶抑制剂, 起效相对较慢, 不适于需要尽快解决急性症状的患者。临床试验研究显示, 该类药物使用 3 \\sim 6 个月后见效, 获得最大疗效则需要 6 \\sim 12 个月, 度他雄胺起效相对较快。故本题答案为 C。",
    "source_note": "",
    "question_id": "d6d67ad536b20a8f967218fba89b7d02c92f8232",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "硫脲类抗甲状腺药最严重的不良反应是",
    "options": {
      "A": "关节痛",
      "B": "甲状腺功能减退",
      "C": "中性粒细胞胞浆抗体相关性血管炎",
      "D": "粒细胞缺乏症",
      "E": "胰岛素自身免疫综合征"
    },
    "answer": "D",
    "explanation": "本题考查硫脲类药物的临床用药评价。硫脲类抗甲状腺药最严重的不良反应为粒细胞缺乏症, 用药期间应定期监测血常规。故本题答案为 D。",
    "source_note": "",
    "question_id": "82da4be9511abf3e822834903add1ca9121986c4",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "与多种药物存在配伍禁忌，应该单独给药的是",
    "options": {
      "A": "头孢羟氨苄",
      "B": "头孢西丁",
      "C": "拉氧头孢",
      "D": "头孢曲松",
      "E": "头孢匹罗"
    },
    "answer": "D",
    "explanation": "本题考查头孢菌素类药物的临床用药评价。头孢曲松与多种药物存在配伍禁忌, 如红霉素、四环素、氟康唑、万古霉素、两性霉素 B、环丙沙星、苯妥英钠、氯丙嗪、氨茶碱、维生素 B、维生素 C, 并可与金属形成络合物, 故一般应单独给药。故本题答案为 D。",
    "source_note": "",
    "question_id": "6f811a261de4ec67021d8d9e2fdc148b5e2f89ed",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第3节干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "心脏毒性为剂量限制性毒性的抗肿瘤药是",
    "options": {
      "A": "柔红霉素",
      "B": "长春新碱",
      "C": "顺铂",
      "D": "博来霉素",
      "E": "环磷酰胺"
    },
    "answer": "A",
    "explanation": "本题考查蒽环类抗肿瘤抗生素的临床用药评价。柔红霉素属于蒽环类抗肿瘤抗生素, 不良反应主要是骨髓抑制和心脏毒性, 其中心脏毒性为其剂量限制性毒性。故本题答案为 A。",
    "source_note": "",
    "question_id": "d0ea62708280b40b3f356a69b76e039813eed382",
    "section_no": 3,
    "section_title": "干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "section_norm": "第三节 干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "关于丙磺舒临床用药评价的描述，不正确的是",
    "options": {
      "A": "与阿司匹林合用可增加丙磺舒的排酸作用",
      "B": "治疗期间应保持摄入足量水",
      "C": "适当补充碳酸氢钠",
      "D": "维持尿道畅通",
      "E": "禁用于急性痛风发作期"
    },
    "answer": "A",
    "explanation": "本题考查促进尿酸排泄药的临床用药评价。丙磺舒属于促尿酸排泄药,与水杨酸盐和阿司匹林合用可抑制丙磺舒的排酸作用。故本题答案为 A。",
    "source_note": "",
    "question_id": "aad1dd717cdd45924a4e03666dd01a2daf1b11f5",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "下列药物中长期使用易产生耐受性的是",
    "options": {
      "A": "M胆碱受体拮抗剂",
      "B": "白三烯拮抗剂",
      "C": "\\beta_{2} 受体激动剂",
      "D": "黄嘌呤类药物",
      "E": "吸入型肾上腺糖皮质激素"
    },
    "answer": "C",
    "explanation": "本题考查 \\beta 2 受体激动剂的临床用药评价。长期、单一应用 \\beta 2 受体激动剂可造成细胞膜 \\beta 2 受体的向下调节, 表现出耐受性, 导致药效降低, 使支气管痉挛不易缓解, 哮喘加重。故本题答案为 C。",
    "source_note": "",
    "question_id": "4be9da0391209f5e616435588338c03f00943bce",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "参与氟伐他汀代谢的主要肝药酶是",
    "options": {
      "A": "CYP1A2",
      "B": "CYP2D6",
      "C": "CYP3A4",
      "D": "CYP2C9",
      "E": "CYP2C19"
    },
    "answer": "D",
    "explanation": "本题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。氟伐他汀的主要代谢酶是 CYP2C9。故本题答案为 D。",
    "source_note": "",
    "question_id": "edf8863ccb6a3d28788abd15728566f7f6d8da3b",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "可导致男性胎儿外生殖器发育畸形，妊娠期或备孕期妇女不宜接触其破碎制剂的药物是",
    "options": {
      "A": "非那雄胺",
      "B": "赛洛多辛",
      "C": "特拉唑嗪",
      "D": "西地那非",
      "E": "坦索罗辛"
    },
    "answer": "A",
    "explanation": "本题考查 5 \\mathrm{a} 还原酶抑制剂的临床用药评价。 5 \\mathrm{a} 还原酶抑制剂（如非那雄胺）在 FDA 妊娠用药安全类别中属于 X 类, 可导致男性胎儿外生殖器发育畸形, 妊娠期妇女或备孕期妇女不宜接触破碎非那雄胺片。故本题答案为 A。",
    "source_note": "",
    "question_id": "7832efec11e1223b7ebf881125507aacb3064057",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "甲亢术前准备的正确给药方法是",
    "options": {
      "A": "只服用硫脲类",
      "B": "只服用碘化物",
      "C": "先服用碘化物, 术前两周再服用硫脲类",
      "D": "先服用硫脲类, 术前两周再服用碘化物",
      "E": "同时服用碘化物和硫脲类"
    },
    "answer": "D",
    "explanation": "本题考查硫脲类药物的临床用药评价。甲亢术前准备：先服用一段时间硫脲类，使甲状腺功能恢复到正常，减少麻醉和术后并发症；术前两周加服大剂量碘剂，使组织缩小变硬，血流减少，利于手术。故本题答案为 D。",
    "source_note": "",
    "question_id": "d945da18cd211c0e2cfceeefeaf3b9961b8ff569",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第3节干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "与β受体拮抗剂合用，可增加心脏毒性的是",
    "options": {
      "A": "替吉奥",
      "B": "博来霉素",
      "C": "多柔比星",
      "D": "长春新碱",
      "E": "阿糖胞苷"
    },
    "answer": "C",
    "explanation": "本题考查葱环类抗肿瘤抗生素的临床用药评价。多柔比星属于葱环类抗肿瘤抗生素，与 \\beta 受体拮抗剂合用，可能增加心脏毒性。故本题答案为 C。",
    "source_note": "",
    "question_id": "0905a5edba4f57bf86f070de1e0cf2a5ad79ae70",
    "section_no": 3,
    "section_title": "干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "section_norm": "第三节 干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "仅皮下注射，不适用于哮喘急性发作和哮喘持续状态的治疗的平喘药是",
    "options": {
      "A": "塞托溴铵",
      "B": "奥马珠单抗 布地奈德",
      "C": "氨茶碱",
      "D": "特布他林"
    },
    "answer": "B",
    "explanation": "本题考查过敏介质阻释剂（奥马珠单抗）的临床用药评价。奥马珠单抗仅可皮下注射，不得静脉注射或肌内注射，应至少使用 12 \\sim 16 周以判断其有效性，不适用于哮喘急性发作和哮喘持续状态的治疗。故本题答案为 B。",
    "source_note": "",
    "question_id": "ad31831155ba086890f0e849fd612f04d7f0bfc8",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "可降低胆固醇合成与促进胆固醇分解，降低胆固醇水平，且具有显著的抗氧化作用的药物是",
    "options": {
      "A": "普罗布考",
      "B": "依折麦布",
      "C": "辛伐他汀",
      "D": "非诺贝尔特",
      "E": "阿昔莫司"
    },
    "answer": "A",
    "explanation": "本题考查其他调血脂药的临床用药评价。普罗布考通过降低胆固醇合成与促进胆固醇分解, 使血胆固醇和低密度脂蛋白降低, 具有显著的抗氧化作用, 延缓动脉粥样硬化斑块的形成, 消退已形成的动脉粥样硬化斑块。故本题答案为 A。",
    "source_note": "",
    "question_id": "3c20a38ffc97abfb07f225652597f9bdb9d9a486",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "不属于左甲状腺素的适应证的是",
    "options": {
      "A": "甲状腺功能减退",
      "B": "甲状腺功能正常者非毒性的甲状腺肿",
      "C": "甲状腺危象",
      "D": "甲状腺癌患者甲状腺切除后的替代治疗",
      "E": "甲状腺抑制试验"
    },
    "answer": "C",
    "explanation": "本题考查甲状腺激素类药物的临床用药评价。左甲状腺素的适应证包括：①治疗非毒性的甲状腺肿（甲状腺功能正常）；②甲状腺肿切除术后服用，以预防甲状腺肿复发；③治疗各种原因引起的甲状腺功能减退；④甲状腺功能亢进症患者，药物治疗甲状腺功能正常时联合应用本药；⑤甲状腺癌患者甲状腺切除术后；⑥用于甲状腺抑制实验。故本题答案为C。治疗甲状腺危象应使用抗甲状腺药。",
    "source_note": "explanation_range_detected",
    "question_id": "4af3ec015d31f5ab754395f8eb3bcb7018cf8cba",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "对于轻、中度敏感菌感染，可一天1次给药的药物是",
    "options": {
      "A": "头孢呋辛",
      "B": "头孢他啶",
      "C": "头孢米诺",
      "D": "头孢唑林",
      "E": "头孢曲松"
    },
    "answer": "E",
    "explanation": "本题考查头孢菌素类药物的临床用药评价。头孢曲松半衰期较长，对于轻、中度敏感菌感染，可一天1次给药。故本题答案为E。",
    "source_note": "",
    "question_id": "5ee0b9e78e190cb958c20753fba926600afab696",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "药粉误入眼内可能引起闭角型青光眼、眼睛疼痛、结膜充血的药物是",
    "options": {
      "A": "噻托溴铵",
      "B": "沙丁胺醇",
      "C": "氨茶碱",
      "D": "沙美特罗",
      "E": "特布他林"
    },
    "answer": "A",
    "explanation": "本题考查 M 胆碱受体拮抗剂的临床用药评价。噻托溴铵属于 M 胆碱受体拮抗剂, 使用中如不慎污染眼睛, 可引起或加重闭角型青光眼、眼睛疼痛或不适、 视物模糊、结膜充血和角膜水肿的症状。故本题答案为 A。",
    "source_note": "",
    "question_id": "0393d5cea471ab5d9a08261cc1604276e179f641",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "可降低胆固醇浓度，对甘油三酯浓度无影响或使之轻度升高的药物是",
    "options": {
      "A": "依折麦布",
      "B": "普罗布考",
      "C": "考来烯胺",
      "D": "匹伐他汀",
      "E": "非诺贝特"
    },
    "answer": "C",
    "explanation": "本题考查其他调血脂药的临床用药评价。胆酸螯合剂（考来烯胺）可降低胆固醇浓度，对甘油三酯浓度无影响或使之轻度升高，如果甘油三酯在基线升高，胆酸螯合剂不能作为一线治疗。故本题答案为 C。",
    "source_note": "",
    "question_id": "4984c3511b4276ed9c3c1bd10fc1fefb79743420",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "关于丙硫氧嘧啶临床用药评价的叙述，错误的是",
    "options": {
      "A": "若出现粒细胞缺乏应立即停药",
      "B": "若出现甲状腺功能减退可酌情加用左甲状腺素",
      "C": "肾功能不全者用药无需调整剂量",
      "D": "服药期间避免摄入高碘食物或含碘药物",
      "E": "活性代谢产物有肝毒性, 注意监测肝功能"
    },
    "answer": "C",
    "explanation": "本题考查硫脲类药物的临床用药评价。老年人尤其是肾功能减退者,应用丙硫氧嘧啶须减量, 肾功能不全者用甲巯咪唑无需调整剂量。故本题答案为 C。",
    "source_note": "",
    "question_id": "b01ef13f46bef0151727cacee501f054e6048dba",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "属于 M 胆碱受体拮抗剂，尤其适用于因用 \\beta 受体激动剂产生肌肉震颤、心动过速而不能耐受的支气管哮喘者的是",
    "options": {
      "A": "沙丁胺醇",
      "B": "曲尼司特",
      "C": "孟鲁司特",
      "D": "异丙托溴铵",
      "E": "色甘酸钠"
    },
    "answer": "D",
    "explanation": "本题考查 M 胆碱受体拮抗剂的临床用药评价。异丙托溴铵属于 M 胆碱受体拮抗剂, 尤其适用于因用 \\beta 受体激动剂产生肌肉震颤、心动过速而不能耐受此类药物的患者。故本题答案为 D。沙丁胺醇为短效 \\beta 2 受体激动剂, 曲尼司特与色甘酸钠为过敏介质阻释剂, 孟鲁司特为白三烯受体拮抗剂。",
    "source_note": "",
    "question_id": "816dd5fb2578cb80b5c2a0c732e52e1cf93d1540",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "属于 B 族维生素的调血脂药是",
    "options": {
      "A": "烟酸",
      "B": "洛伐他汀",
      "C": "考来烯胺",
      "D": "非诺贝尔特",
      "E": "依折麦布"
    },
    "answer": "A",
    "explanation": "本题考查其他调血脂药的临床用药评价。烟酸属于 B 族维生素, 当用量超过作为维生素作用的剂量时, 可有明显的调节血脂作用。故本题答案为 A。",
    "source_note": "",
    "question_id": "8628f457ab23caf236ee2f2b0c8dcb15297aef65",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "奏效快，代谢慢，维持时间长的抗甲状腺药是",
    "options": {
      "A": "甲状腺片",
      "B": "左甲状腺素",
      "C": "甲巯咪唑",
      "D": "丙硫氧嘧啶",
      "E": "卡比马唑"
    },
    "answer": "C",
    "explanation": "本题考查硫脲类药物的临床用药评价。硫脲类药物包括甲巯咪唑、丙硫氧嘧啶和卡比马唑, 其中甲巯咪唑作用较丙硫氧嘧啶强, 且奏效快而代谢慢, 维持时间长, 肾功能不全者无需调整剂量。故本题答案为 C。卡比马唑属于前药, 需游离出 甲巯咪唑才发挥作用，作用开始较慢，但维持时间长。甲状腺片和左甲状腺素属于甲状腺激素类药物。",
    "source_note": "",
    "question_id": "49e03438b6645997278ebf4e4b518483db0e20a2",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "与含钙药品同时静脉给药，可在肺或肾中形成沉淀，造成致命性危害的药物是",
    "options": {
      "A": "头孢曲松",
      "B": "头孢克洛",
      "C": "头孢吡肟",
      "D": "头孢他啶",
      "E": "头孢匹罗"
    },
    "answer": "A",
    "explanation": "本题考查头孢菌素类药物的临床用药评价。为避免在肺或肾中形成 头孢曲松-钙盐沉淀，造成致命性危害，禁止头孢曲松与含钙的药品（包括胃肠外营养液）同时进行静脉给药。如前后使用，两者之间应有其他静脉输液间隔，新生儿应有48小时以上的时间间隔。故本题答案为A。",
    "source_note": "",
    "question_id": "a0d3f59af9b0b4d36b12ebc3bf91da876e7a8cb6",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "属于抗 IgE 单克隆抗体，可抑制肥大细胞来源的炎性介质释放的药物是",
    "options": {
      "A": "特布他林",
      "B": "倍氯米松",
      "C": "茶碱",
      "D": "色甘酸钠",
      "E": "奥马珠单抗"
    },
    "answer": "E",
    "explanation": "本题考查平喘药的分类与代表药品。抗IgE单克隆抗体可抑制肥大细胞来源的炎性介质释放，减少炎症细胞在气道的募集、组织重塑和肺功能的恶化，代表药物为奥马珠单抗。故本题答案为E。特布他林属于短效β2受体激动剂。倍氯米松属于吸入型肾上腺糖皮质激素。茶碱属于黄嘌呤类药物。色甘酸钠属于肥大细胞膜稳定剂。",
    "source_note": "",
    "question_id": "56221b5932ca301e407618ec9ce3d63b3c4f5e5d",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "下列对阿昔莫司的描述，错误的是",
    "options": {
      "A": "是烟酸类药",
      "B": "可降低甘油三酯",
      "C": "可引起皮肤潮红",
      "D": "可升高胆固醇水平",
      "E": "可升高尿酸水平"
    },
    "answer": "D",
    "explanation": "本题考查其他调血脂药的临床用药评价。阿昔莫司属于烟酸类药，可使甘油三酯和胆固醇水平降低。故本题答案为 D。烟酸类最常见的不良反应是颜面潮红，其他不良反应有皮肤瘙痒、皮疹、肝脏损害、高尿酸血症、高血糖、棘皮症和消化道不适等。",
    "source_note": "",
    "question_id": "407b49f4e41e6bf8ef29fc906c8696875904afe5",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "通过抑制过氧化酶系统，抑制甲状腺激素的生成；在甲状腺外，还能抑制外周 \\mathrm{T}_{4} 转化为 \\mathrm{T}_{3} 的药物是",
    "options": {
      "A": "卡比马唑",
      "B": "甲巯咪唑",
      "C": "丙硫氧嘧啶",
      "D": "碘化钾",
      "E": "左甲状腺素"
    },
    "answer": "C",
    "explanation": "本题考查硫脲类药物的临床用药评价。硫脲类抗甲状腺药有丙硫氧嘧啶、甲巯咪唑、卡比马唑。这类药物能抑制过氧化酶系统，使摄入到甲状腺细胞内的碘化物不能氧化成活性碘，酪氨酸不能碘化；一碘酪氨酸和二碘酪氨酸的缩合过程受阻，以致不能生成甲状腺激素。其中丙硫氧嘧啶还能在甲状腺外能抑制T4转化为T3。故本题答案为C。",
    "source_note": "",
    "question_id": "d583d64663effb4afd4aac1d64ff48d8572dacfe",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "单项选择题",
    "qno": 12,
    "stem": "应用噻托溴铵应监护的不良反应不包括",
    "options": {
      "A": "口干",
      "B": "便秘",
      "C": "瞳孔散大",
      "D": "眼压降低",
      "E": "排尿困难"
    },
    "answer": "D",
    "explanation": "本题考查M胆碱受体拮抗剂的临床用药评价。应用M胆碱受体拮抗剂应注意监护抗胆碱药的不良反应，如口干、便秘、瞳孔散大、视物模糊、眼睑炎、眼压升高、排尿困难、心悸。故本题答案为D。",
    "source_note": "",
    "question_id": "2a3fb83260d5e7b1f103c54a05f4c9ea9801e112",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 12,
    "stem": "可降低胆固醇和甘油三酯水平，主要升高高 密度脂蛋白的调节血脂药是",
    "options": {
      "A": "瑞舒伐他汀",
      "B": "依折麦布",
      "C": "阿昔莫司",
      "D": "考来烯胺",
      "E": "苯扎贝特"
    },
    "answer": "C",
    "explanation": "本题考查其他调血脂药的临床用药评价。烟酸类（烟酸、阿昔莫司）是“较为全效”的调节血脂药, 主要升高高密度脂蛋白胆固醇 (HDL-C), 降低甘油三酯 (TG) 及低密度脂蛋白胆固醇 (LDL-C)。故本题答案为 C。",
    "source_note": "",
    "question_id": "793e34be41bbe8cb9196d8e9a7838ca46a0821cb",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 13,
    "stem": "属于前蛋白转化酶枯草溶菌素9（PCSK9）抑制剂的调节血脂药是",
    "options": {
      "A": "依洛尤单抗",
      "B": "血脂康 阿昔莫司",
      "C": "阿托伐他汀",
      "D": "依折麦布"
    },
    "answer": "A",
    "explanation": "本题考查调节血脂药的分类与代表药品。依洛尤单抗属于前蛋白转化酶枯草溶菌素 9 (PCSK9) 抑制剂。故本题答案为 A。",
    "source_note": "",
    "question_id": "7a579b2a49aa0fe42a4a1049c76c376205458b55",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 14,
    "stem": "HMG-CoA还原酶抑制剂的不良反应不包括",
    "options": {
      "A": "肝毒性",
      "B": "高铁血红蛋白血症",
      "C": "消化系统不良反应",
      "D": "肌毒性",
      "E": "神经系统不良反应"
    },
    "answer": "B",
    "explanation": "本题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。HMG-CoA 还原酶抑制剂（他汀类）的不良反应包括: ①肌毒性 (肌痛、肌病、横纹肌溶解); ②肝毒性: 肝脏氨基转移酶 AST、ALT 升高; ③增加新发糖尿病风险; ④消化系统不良反应: 恶心、腹泻、腹痛、消化不良; ⑤神经系统不良反应: 失眠、头痛、抑郁。他汀类药物不会引起高铁血红蛋白血症。故本题答案为 B。",
    "source_note": "explanation_range_detected",
    "question_id": "e47c3f379889479c302ffd9355e35278a80a70a0",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "单项选择题",
    "qno": 15,
    "stem": "关于他汀类药物的说法，错误的是",
    "options": {
      "A": "他汀类药物的代谢和生物利用度受 P-糖蛋白影响",
      "B": "有广泛的首过肝摄取, 主要由有机阴离子 OATP1B1 调节",
      "C": "他汀类药物剂量倍增时, LDL-C 进一步降低幅度仅约 6\\%",
      "D": "他汀类药物宜早晨空腹服用",
      "E": "可用于动脉粥样硬化、急性冠脉综合征"
    },
    "answer": "D",
    "explanation": "本题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。他汀类药物中除了阿托伐他汀、瑞舒伐他汀半衰期长, 可以在一日内任何时间给药外, 其他半衰期较短 (1~4h) 的他汀类药物在晚餐或晚餐后服药有助于提高疗效。故本题答案为 D。",
    "source_note": "",
    "question_id": "6e33a1334b7abd78445a0144f0b732aebba87045",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第3节肠内营养药",
    "qtype": "配伍选择题",
    "qno": 3,
    "stem": "适用于成人、4岁及以上儿童使用的标准型肠内营养药是",
    "options": {
      "A": "肠内营养粉剂（TP）",
      "B": "肠内营养乳剂（TPF-D）",
      "C": "复方氨基酸注射液（18AA）",
      "D": "赖氨酸注射液",
      "E": "丙氨酰谷氨酰胺注射液"
    },
    "answer": "A",
    "explanation": "本组题考查肠内营养药的分类与代表药品。 ② 肠内营养粉剂（TP）为标准型肠内营养药。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "189cb906fca2243369862972c40f7224e268f9e1",
    "section_no": 3,
    "section_title": "肠内营养药",
    "section_norm": "第三节 肠内营养药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第3节止吐药",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "属于长效的 5\\mathrm{-HT}_3 受体拮抗剂，不推荐七日内重复给药的止吐药是",
    "options": {
      "A": "昂丹司琼",
      "B": "苯海拉明",
      "C": "氯丙嗪",
      "D": "帕洛诺司琼",
      "E": "阿瑞匹坦"
    },
    "answer": "D",
    "explanation": "①本题考查止吐药的临床用药评价。昂丹司琼和帕洛诺司琼属于 5-HT3 受体拮抗剂, 其中帕洛诺司琼属于长效的 5-HT3 受体拮抗剂, 半衰期约 40 小时, 因对频繁 (每日连续或隔日交替) 给药的安全性和有效性未评价, 因此不推荐七日内重复给药。故本题答案为 D。",
    "source_note": "",
    "question_id": "0f2f5de811819d468c455b0928136266f4dc277c",
    "section_no": 3,
    "section_title": "止吐药",
    "section_norm": "第三节 止吐药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第3节抗贫血药",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "可用于恶性贫血的是",
    "options": {
      "A": "硫酸亚铁",
      "B": "小檗胺",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "罗特西普",
      "E": "十一酸睾酮"
    },
    "answer": "C",
    "explanation": "本组题考查抗贫血药的分类与适应证。 ①叶酸与维生素 B12 主要用于巨幼红细胞性贫血, 其中维生素 B12 可用于由内因子缺乏导致的恶性贫血。故本题答案为 C。",
    "source_note": "",
    "question_id": "e7ade32ce133ffbe7427237d245f2f2c0e6d07f2",
    "section_no": 3,
    "section_title": "抗贫血药",
    "section_norm": "第三节 抗贫血药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第3节止吐药",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "属于多巴胺受体拮抗剂的止吐药是",
    "options": {
      "A": "昂丹司琼",
      "B": "苯海拉明",
      "C": "氯丙嗪",
      "D": "帕洛诺司琼",
      "E": "阿瑞匹坦"
    },
    "answer": "C",
    "explanation": "②本题考查止吐药的分类与代表药品。氯丙嗪为多巴胺受体 拮抗剂，主要拮抗脑内多巴胺受体，小剂量抑制延脑催吐化学感受区的多巴胺受体，大剂量时直接抑制呕吐中枢。故本题答案为C。",
    "source_note": "",
    "question_id": "bba2a2e445af1cb443ab8de477f9203cd7e6e388",
    "section_no": 3,
    "section_title": "止吐药",
    "section_norm": "第三节 止吐药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第3节抗贫血药",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "可用于再生障碍性贫血的是",
    "options": {
      "A": "硫酸亚铁",
      "B": "小檗胺",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "罗特西普",
      "E": "十一酸睾酮"
    },
    "answer": "E",
    "explanation": "本组题考查抗贫血药的分类与适应证。 ②十一酸睾酮对正常造血细胞有兴奋作用, 可以增强红细胞生成素的产生及作用, 对干细胞转变成红细胞也有直接的刺激作用。可用于再生障碍性贫血的辅助治疗。 故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "31b45444f533f2d5810b485d29bac4ad4559d3de",
    "section_no": 3,
    "section_title": "抗贫血药",
    "section_norm": "第三节 抗贫血药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第3节止吐药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "可透过血-脑屏障，占领脑内NK-1受体，可用于预防高度致吐性化疗药物所致恶心和呕吐的药物是",
    "options": {
      "A": "昂丹司琼",
      "B": "苯海拉明",
      "C": "氯丙嗪",
      "D": "帕洛诺司琼",
      "E": "阿瑞匹坦"
    },
    "answer": "E",
    "explanation": "③本题考查止吐药的临床用药评价。阿瑞匹坦属于神经激肽-1（NK-1）受体拮抗剂，可与其他止吐药物联合给药，用于预防高度致吐性抗肿瘤化疗的初次和重复治疗过程中出现的急性和迟发性恶心和呕吐。故本题答案为E。苯海拉明属于抗组胺药物。",
    "source_note": "",
    "question_id": "1bcb2b680f4b37a84d2855e53f2911d8c58ebb1c",
    "section_no": 3,
    "section_title": "止吐药",
    "section_norm": "第三节 止吐药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第3节抗贫血药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "可用于 \\beta -地中海贫血的是",
    "options": {
      "A": "硫酸亚铁",
      "B": "小檗胺",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "罗特西普",
      "E": "十一酸睾酮"
    },
    "answer": "D",
    "explanation": "本组题考查抗贫血药的分类与适应证。 ③罗特西普可调控红细胞成熟过程，适用于输血依赖型β-地中海贫血的成人患者。故本题答案为D。硫酸亚铁用于防治各种原因（如慢性失血、营养不良、妊娠、儿童发育期等）引起的缺铁性贫血。小檗胺属于升白细胞药物，可用于防治放化疗患者白细胞减少。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "7ca6ef2051a3eaf8a38b6fbde87744a74e5b1e3f",
    "section_no": 3,
    "section_title": "抗贫血药",
    "section_norm": "第三节 抗贫血药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第3节止吐药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "高度致吐性化疗药所引起恶心呕吐的治疗应选用",
    "options": {
      "A": "化疗前用三药方案，包括单剂量 5 - \\mathrm{HT}_{3} 受体拮抗剂、地塞米松和NK-1受体拮抗剂",
      "B": "第1日采用 5 - \\mathrm{HT}_{3} 受体拮抗剂联合地塞米松，第2和第3日继续使用地塞米松",
      "C": "单一药物, 如地塞米松、 5 - \\mathrm{HT}_{3} 受体拮抗剂或甲氧氯普胺预防呕吐",
      "D": "奥美拉唑联合口服地塞米松",
      "E": "不必在化疗前常规给予止吐药物"
    },
    "answer": "A",
    "explanation": "本组题考查依据化疗药的催吐性选用止吐药。 ①高度催吐性化疗,推荐化疗前用三药方案, 包括单剂量 5-HT3 受体拮抗剂、地塞米松和 NK-1 受体拮抗剂。故本题答案为 A。",
    "source_note": "",
    "question_id": "f1ce0d027febf744f58a3d847780e8d450cf1d7b",
    "section_no": 3,
    "section_title": "止吐药",
    "section_norm": "第三节 止吐药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第3节抗贫血药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "胃肠道吸收有自限现象，正常人的吸收率为 10\\% ，贫血者为 30\\% 的药物是",
    "options": {
      "A": "重组人促红素",
      "B": "叶酸",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "环孢素",
      "E": "硫酸亚铁"
    },
    "answer": "E",
    "explanation": "①本题考查铁剂的临床用药评价。口服铁剂常用二价铁盐如硫酸亚铁, 口服铁剂胃肠道吸收有自限现象, 即铁的吸收与体内储存量有关, 正常人的吸收率为 10\\%, 贫血者为 30\\% 。故本题答案为 E。",
    "source_note": "",
    "question_id": "62c5b74e440331543ccdde0adc059c93e5bffdda",
    "section_no": 3,
    "section_title": "抗贫血药",
    "section_norm": "第三节 抗贫血药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "可抑制近端肾小管对尿酸盐的重吸收，使尿酸排出增加的药物是",
    "options": {
      "A": "非布司他",
      "B": "秋水仙碱",
      "C": "丙磺舒",
      "D": "碳酸氢钠",
      "E": "来氟米特"
    },
    "answer": "C",
    "explanation": "本组题考查抗痛风药的分类与作用机制。 ①丙磺舒属于促进尿酸排泄药, 可抑制近端肾小管对尿酸盐的重吸收, 使尿酸排出增加, 从而降低血尿酸浓度,减少尿酸沉积。故本题答案为 C。",
    "source_note": "",
    "question_id": "8accd2a7ba5b1f2c31055f7f9ee54acca735ceae",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第3节止吐药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "中度致吐性化疗药所引起恶心呕吐的治疗应选用",
    "options": {
      "A": "化疗前用三药方案，包括单剂量 5 - \\mathrm{HT}_{3} 受体拮抗剂、地塞米松和NK-1受体拮抗剂",
      "B": "第1日采用 5 - \\mathrm{HT}_{3} 受体拮抗剂联合地塞米松，第2和第3日继续使用地塞米松",
      "C": "单一药物, 如地塞米松、 5 - \\mathrm{HT}_{3} 受体拮抗剂或甲氧氯普胺预防呕吐",
      "D": "奥美拉唑联合口服地塞米松",
      "E": "不必在化疗前常规给予止吐药物"
    },
    "answer": "B",
    "explanation": "本组题考查依据化疗药的催吐性选用止吐药。 ②中度催吐性化疗, 推荐第 1 日采用 5-HT3 受体拮抗剂联合地塞米松, 第 2 和第 3 日继续使用地塞米松。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "3b1379d05286302c8e78e448fdb5bedc2af24bb1",
    "section_no": 3,
    "section_title": "止吐药",
    "section_norm": "第三节 止吐药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第3节抗贫血药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "单独使用纠正巨幼红细胞性贫血时可导致神经损害的药物是",
    "options": {
      "A": "重组人促红素",
      "B": "叶酸",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "环孢素",
      "E": "硫酸亚铁"
    },
    "answer": "B",
    "explanation": "②本题考查叶酸的临床用药评价。叶酸服用后可迅速纠正巨幼红细胞性贫血的异常现象, 改善贫血, 但不能阻止因维生素 B12 缺乏所致的神经损害, 若仍大剂量服用叶酸, 由于造血旺盛而消耗维生素 B12, 则可使神经损害向不可逆方向发展。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "9afe72228e1dbabbeae996b285a26c84307c1bea",
    "section_no": 3,
    "section_title": "抗贫血药",
    "section_norm": "第三节 抗贫血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "易引起直立性低血压、鼻塞、反射性心动过速的药物是",
    "options": {
      "A": "普适泰",
      "B": "多沙唑嗪",
      "C": "非那雄胺",
      "D": "赛洛多辛",
      "E": "西地那非"
    },
    "answer": "B",
    "explanation": "【 8 \\sim 9】 ①本题考查 a 1 受体拮抗药的临床用药评价。非选择性 a 1 受体拮抗药（多沙唑嗪）不良反应包括直立性低血压、反射性心动过速、鼻塞、抑制射精、增 加水钠潴留和血容量。赛洛多辛属于选择性 \\alpha 1 \\mathrm{~A} 受体拮抗药，很少发生低血压。故本题答案为 B。",
    "source_note": "",
    "question_id": "1c81728e894710df3a8356ef1b3121cb07cd47d3",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第3节干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "属于 DNA 多聚酶抑制剂，可用于慢性粒细胞白血病的急变期，亦适用于恶性淋巴瘤的药物是",
    "options": {
      "A": "阿糖胞苷",
      "B": "疏嘌呤",
      "C": "丝裂霉素",
      "D": "阿克拉阿霉素",
      "E": "柔红霉素"
    },
    "answer": "A",
    "explanation": "【 8 \\sim 9】 ①本题考查干扰核酸生物合成的药物（抗代谢药）的分类与临床用 药评价。阿糖胞苷属于 DNA 多聚酶抑制剂，主要用于治疗急性淋巴细胞及非淋巴细胞白血病的诱导缓解期及维持巩固期、慢性粒细胞白血病的急变期，亦适用于恶性淋巴瘤。故本题答案为 A。",
    "source_note": "",
    "question_id": "cf445cf6824e0bb42ffb2a70ee220146f5844926",
    "section_no": 3,
    "section_title": "干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "section_norm": "第三节 干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "可抑制黄嘌呤氧化酶，阻止次黄嘌呤和黄嘌呤代谢为尿酸，从而减少尿酸生成的药物是",
    "options": {
      "A": "非布司他",
      "B": "秋水仙碱",
      "C": "丙磺舒",
      "D": "碳酸氢钠",
      "E": "来氟米特"
    },
    "answer": "A",
    "explanation": "本组题考查抗痛风药的分类与作用机制。 ②非布司他属于抑制尿酸生成药, 可抑制黄嘌呤氧化酶, 阻止次黄嘌呤和黄嘌呤代谢为尿酸, 从而减少尿酸的生成, 降低血尿酸和尿尿酸含量。故本题答案为 A。秋水仙碱属于抑制粒细胞浸润炎症反应药。碳酸氢钠具有碱化尿液作用, 临床上与促进尿酸排泄药合用, 提高降尿酸效果。来氟米特属于慢作用抗风湿药。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "99940f7eb7994c5065d0629ddbf260366d391944",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第3节止吐药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "低度致吐性化疗药所引起恶心呕吐的治疗应选用",
    "options": {
      "A": "化疗前用三药方案，包括单剂量 5 - \\mathrm{HT}_{3} 受体拮抗剂、地塞米松和NK-1受体拮抗剂",
      "B": "第1日采用 5 - \\mathrm{HT}_{3} 受体拮抗剂联合地塞米松，第2和第3日继续使用地塞米松",
      "C": "单一药物, 如地塞米松、 5 - \\mathrm{HT}_{3} 受体拮抗剂或甲氧氯普胺预防呕吐",
      "D": "奥美拉唑联合口服地塞米松",
      "E": "不必在化疗前常规给予止吐药物"
    },
    "answer": "C",
    "explanation": "本组题考查依据化疗药的催吐性选用止吐药。 ③低度催吐性化疗, 建议用单一药物, 如地塞米松、5-HT3 受体拮抗剂或多巴胺受体拮抗剂（如甲氧氯普胺）预防呕吐。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "51366368d2d075cc6dcb1710c70d67fc49db0565",
    "section_no": 3,
    "section_title": "止吐药",
    "section_norm": "第三节 止吐药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第3节抗抑郁药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "属于四环类抗抑郁药，不可与单胺氧化酶抑制剂合并使用的药物是",
    "options": {
      "A": "氟西汀",
      "B": "舍曲林",
      "C": "马普替林",
      "D": "多塞平",
      "E": "米氮平"
    },
    "answer": "C",
    "explanation": "本组题考查抗抑郁药的分类与临床用药评价。 ①四环类抗抑郁药（马普替林）与单胺氧化酶抑制剂合用易引起 5-HT 综合征, 两药不可合并使用。故本题答案为 C。",
    "source_note": "",
    "question_id": "aad91182f627a58c85c43c807b528f56cbc25924",
    "section_no": 3,
    "section_title": "抗抑郁药",
    "section_norm": "第三节 抗抑郁药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第3节抗贫血药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "可用于神经炎的辅助治疗，用药期间应检查血钾浓度的药物是",
    "options": {
      "A": "重组人促红素",
      "B": "叶酸",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "环孢素",
      "E": "硫酸亚铁"
    },
    "answer": "C",
    "explanation": "③本题考查维生素 B12 的临床用药评价。维生素 B12 可用于因内因子缺乏所致的巨幼红细胞性贫血, 也可用于亚急性联合变性神经系统病变, 如神经炎的辅助治疗。可导致血钾降低, 用药期间宜查血钾, 以防发生低钾血症。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "ed3e49159c03c29beb92c689e5d64fb906bc125c",
    "section_no": 3,
    "section_title": "抗贫血药",
    "section_norm": "第三节 抗贫血药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "易引起性欲减退、阳痿、射精障碍、射精量减少等不良反应的是",
    "options": {
      "A": "普适泰",
      "B": "多沙唑嗪",
      "C": "非那雄胺",
      "D": "赛洛多辛",
      "E": "西地那非"
    },
    "answer": "C",
    "explanation": "【 8 \\sim 9】 ②本题考查 5 \\mathrm{a} 还原酶抑制剂的临床用药评价。 5 \\mathrm{a} 还原酶抑制剂（非那雄胺）可引起性欲减退、阳痿、射精量减少，偶见男性乳房女性化、睾丸痛、皮疹和唇肿胀。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "ff9a761f6133820530ccc42feed5b137187cb3a7",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第3节干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "属于第二代蒽环类抗肿瘤药物，具有亲脂性，有疗效高、心脏毒性低、可口服等优点的是",
    "options": {
      "A": "阿糖胞苷",
      "B": "疏嘌呤",
      "C": "丝裂霉素",
      "D": "阿克拉阿霉素",
      "E": "柔红霉素"
    },
    "answer": "D",
    "explanation": "【 8 \\sim 9】 ②本题考查蒽环类抗肿瘤抗生素的临床用药评价。阿克拉阿霉素属于第二代蒽环类抗肿瘤药物，具有亲脂性，易迅速进入细胞并维持较高浓度，有疗效高、心脏毒性低，可口服的优点。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "a7283e94cb6f2c79b3ad7d00b72c87b3b2498f5b",
    "section_no": 3,
    "section_title": "干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）",
    "section_norm": "第三节 干扰转录过程和阻止RNA合成的药物（作用于核酸转录药物）"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "可降低血尿酸含量，而升高尿尿酸含量的抗痛风药是",
    "options": {
      "A": "非布司他",
      "B": "苯溴马隆",
      "C": "秋水仙碱",
      "D": "别嘌醇",
      "E": "阿司匹林"
    },
    "answer": "B",
    "explanation": "【 10 \\sim 11 】 ①本题考查促进尿酸排泄药的临床用药评价。促进尿酸排泄药如丙磺舒、苯溴马隆, 可使血尿酸降低、尿尿酸升高。故本题答案为 B。",
    "source_note": "",
    "question_id": "b6574aff465399855af73c5ff0844ddd6d52a26e",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第3节抗抑郁药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "属于选择性5-羟色胺再摄取抑制剂，口服吸收缓慢的药物是",
    "options": {
      "A": "氟西汀",
      "B": "舍曲林",
      "C": "马普替林",
      "D": "多塞平",
      "E": "米氮平"
    },
    "answer": "B",
    "explanation": "本组题考查抗抑郁药的分类与临床用药评价。 ③在选择性 5-HT 再摄取抑制剂中, 除舍曲林口服吸收缓慢, 其余药物口服吸收均良好。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "ff7ff3e8cd811f9689259409c68d830036498030",
    "section_no": 3,
    "section_title": "抗抑郁药",
    "section_norm": "第三节 抗抑郁药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "可致类磺胺过敏反应，长期服用还可能导致 尿酸盐在泌尿道形成结石的药物是",
    "options": {
      "A": "秋水仙碱",
      "B": "非布司他",
      "C": "丙磺舒",
      "D": "别嘌醇",
      "E": "塞来昔布"
    },
    "answer": "C",
    "explanation": "①本题考查促进尿酸排泄药的临床用药评价。丙磺舒、苯溴马隆为促进尿酸排泄药, 可使血尿酸降低、尿尿酸升高, 长期服用可能导致尿酸盐在泌尿道形成结石, 在治疗过程中应碱化尿液和多饮水, 其中丙磺舒还可导致类磺胺过敏反应。故本题答案为 C。",
    "source_note": "",
    "question_id": "61b028beac6ff9c22bf6edec44e788046ed901d9",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "作为有过直立性低血压的良性前列腺增生症合并高血压者的首选药物的是",
    "options": {
      "A": "奥昔布宁",
      "B": "赛洛多辛",
      "C": "非那雄胺",
      "D": "特拉唑嗪",
      "E": "托拉塞米"
    },
    "answer": "B",
    "explanation": "①本题考查 α 1 受体拮抗药的临床用药评价。特拉唑嗪属于第二代 α 1 受体拮抗药, 对前列腺和外周血管平滑肌上的 α 1 受体都有拮抗作用, 使用过程中容易出现直立性低血压、眩晕, 甚至有 “首剂效应” 和出现晕厥。赛洛多辛属于第三代 α 1 受体拮抗药, 对前列腺平滑肌上的 α 1A 受体具有高选择性, 对血管平滑肌上的 α 1B 受体影响较少, 较少发生低血压, 可作为有过直立性低血压的良性前列腺增生症合并高血压者的首选药物。故本题答案为 B。",
    "source_note": "",
    "question_id": "992f717ab7e55655ed84d6c0fc48fc194a021f4a",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "可改善甲亢所致的交感神经活性增强症状的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "甲巯咪唑",
      "C": "胺碘酮",
      "D": "放射性碘",
      "E": "左甲状腺素"
    },
    "answer": "A",
    "explanation": "【 12\\sim 14 】 ① 本题考查 \\beta 受体拮抗剂的临床用药评价。普萘洛尔主要通过其拮抗 \\beta 受体的作用而改善甲亢所致的心率、心收缩力增加等交感神经活性增强的症状，同时还能抑制外周T4向T3转化。故本题答案为A。",
    "source_note": "",
    "question_id": "0f68aacc53a5257e41fa7bda22274aee8f4ad580",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "可致超敏反应综合征，建议应用前做基因（HLA-B*5801）筛查，长期服用还可能出现黄嘌呤肾病的药物是",
    "options": {
      "A": "秋水仙碱",
      "B": "非布司他",
      "C": "丙磺舒",
      "D": "别嘌醇",
      "E": "塞来昔布"
    },
    "answer": "D",
    "explanation": "②本题考查抑制尿酸生成药的临床用药评价。别嘌醇为抑制尿酸生成药, 可抑制黄嘌呤氧化酶, 长期服用可能出现黄嘌呤肾病, 还可引起超敏反应综合征,尤其是 HLA-B*5801 基因阳性者。故本题答案为 D。",
    "source_note": "",
    "question_id": "7ddc07d72233b3e91e32b0a5e0ffb1a6fe266e8b",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "长期吸入给药可能引起口腔、咽喉部的念珠菌感染，吸入后应立即漱口的药物是",
    "options": {
      "A": "布地奈德",
      "B": "沙丁胺醇",
      "C": "塞托溴铵",
      "D": "孟鲁司特",
      "E": "西替利嗪"
    },
    "answer": "A",
    "explanation": "①本题考查吸入型肾上腺糖皮质激素的临床用药评价。布地奈德属于吸入型肾上腺糖皮质激素, 长期吸入给药可能引起口腔、咽喉部的念珠菌感染, 表现为声音嘶哑、咽部不适, 吸药后用水漱口及局部应用抗霉菌药物可降低发生率。故本题答案为 A。",
    "source_note": "",
    "question_id": "526df1aa467ec7eb9a6df82cff5a2b3b302f3092",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "通过抑制过氧化酶，从而抑制甲状腺激素合成的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "甲巯咪唑",
      "C": "胺碘酮",
      "D": "放射性碘",
      "E": "左甲状腺素"
    },
    "answer": "B",
    "explanation": "【 12\\sim 14 】 ② 本题考查硫脲类药物的临床用药评价。甲巯咪唑属于硫脲类抗甲状腺药，可抑制甲状腺过氧化物酶活性，从而抑制甲状腺激素合成。故本题答案为B。",
    "source_note": "",
    "question_id": "941c6dc024e83482dec740b9d89f607198fcf537",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "属于第二代头孢菌素类药物，可用于预防手术后切口感染的是",
    "options": {
      "A": "头孢唑林",
      "B": "头孢呋辛",
      "C": "头孢曲松",
      "D": "头孢他啶",
      "E": "头孢吡肟"
    },
    "answer": "B",
    "explanation": "本组题考查头孢菌素类药物的分类与各代头孢菌素类抗菌药物的对比。 ①头孢呋辛属于第二代头孢菌素类药物, 临床上可用于预防手术后切口感染和敏感菌导致的下呼吸道感染和尿路感染等。故本题答案为 B。",
    "source_note": "",
    "question_id": "4030452d9bb91aea919905a3d3220af3667959ad",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "可致可逆性的维生素 \\mathsf{B}_{12} 吸收不良，长期使用还可引起骨髓造血功能抑制的药物是",
    "options": {
      "A": "秋水仙碱",
      "B": "非布司他",
      "C": "丙磺舒",
      "D": "别嘌醇",
      "E": "塞来昔布"
    },
    "answer": "A",
    "explanation": "③本题考查秋水仙碱的临床用药评价。秋水仙碱可致可逆性的维生素 B12 吸收不良, 长期使用还可引起骨髓造血功能抑制。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "1184dac099c7ee4fe40a6797d0a03eaface954cc",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "可引起虹膜松弛综合征，增加术中及术后疼痛，延长恢复时间，降低视力改善的预期的药物是",
    "options": {
      "A": "非那雄胺",
      "B": "托特罗定",
      "C": "度他雄胺",
      "D": "坦索罗辛",
      "E": "奥昔布宁"
    },
    "answer": "D",
    "explanation": "①本题考查 \\alpha 1 受体拮抗药的临床用药评价。坦索罗辛、多沙唑嗪、赛洛多辛可导致虹膜松弛综合征, 该不良反应可增加术中及术后疼痛, 延长恢复时间, 降低视力改善的预期。故本题答案为 D。",
    "source_note": "",
    "question_id": "38b5dd5a30bbdca1b62745e0a4697f5980cdcb70",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "用于甲状腺素缺乏的替代治疗的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "甲巯咪唑",
      "C": "胺碘酮",
      "D": "放射性碘",
      "E": "左甲状腺素"
    },
    "answer": "E",
    "explanation": "【 12\\sim 14 】 ③ 本题考查甲状腺激素类药物的临床用药评价。甲状腺激素类药（甲状腺片、左甲状腺素、碘塞罗宁）主要用于治疗甲减、单纯性甲状腺肿及甲状腺癌手术后导致甲减的辅助治疗。故本题答案为E。",
    "source_note": "",
    "question_id": "412853366f7c25ebe7201c10b237a34a2ba1b2c2",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "属于第四代头孢菌素类药物，可用于治疗中性粒细胞减少伴发热的是",
    "options": {
      "A": "头孢唑林",
      "B": "头孢呋辛",
      "C": "头孢曲松",
      "D": "头孢他啶",
      "E": "头孢吡肟"
    },
    "answer": "E",
    "explanation": "本组题考查头孢菌素类药物的分类与各代头孢菌素类抗菌药物的对比。 ②头孢吡肟属于第四代头孢菌素类药物, 常用于治疗中性粒细胞减少伴发热。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "28736ae3601391f48731f0ed96cc6f340f9e1b58",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "对白三烯受体有高度的亲和力，起效慢，一般连续应用4周方显效的平喘药是",
    "options": {
      "A": "噻托溴铵",
      "B": "沙丁胺醇",
      "C": "茶碱",
      "D": "氯雷他定",
      "E": "孟鲁司特"
    },
    "answer": "E",
    "explanation": "①本题考查白三烯受体拮抗剂的临床用药评价。孟鲁司特为白三烯受体拮抗剂, 对白三烯受体有高度的亲和力和选择性, 起效慢, 一般需要连续应用 4 周。故本题答案为 E。",
    "source_note": "",
    "question_id": "282b1298706987c98587b838f138a15df4482a81",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "需要停药 6 个月以后方可献血的药物是",
    "options": {
      "A": "非那雄胺",
      "B": "托特罗定",
      "C": "度他雄胺",
      "D": "坦索罗辛",
      "E": "奥昔布宁"
    },
    "answer": "C",
    "explanation": "②本题考查 5 \\alpha 还原酶抑制剂的临床用药评价。非那雄胺、度他雄胺为 5 \\alpha 还原酶抑制剂, 可降低 PSA 水平、缩小增大的前列 腺体积, 对前列腺体积较大和 (或) 血清 PSA 水平较高的患者治疗效果更好。服用度他雄胺者需要停药 6 个月以后方可献血, 服用非那雄胺的患者需要停药 1 个月后方可献血。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "5618a1b216103c73ff5f5abe44489dff2f9f5696",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "起效缓慢，需要在体内游离出有活性的甲巯咪唑才能发挥作用的药物是",
    "options": {
      "A": "碘化钾",
      "B": "卡比马唑",
      "C": "普萘洛尔",
      "D": "左甲状腺素",
      "E": "丙硫氧嘧啶"
    },
    "answer": "B",
    "explanation": "①本题考查硫脲类药物的临床用药评价。卡比马唑在体内逐渐水解, 游离出甲巯咪唑而发挥作用, 作用开始较慢、维持时间较长。故本题答案为 B。",
    "source_note": "",
    "question_id": "9b13f950487532b975272a10a2c60c6bc25498c9",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "肾毒性严重，且对血-脑屏障穿透性较差，不宜用于中枢神经系统感染的头孢菌素类药物是",
    "options": {
      "A": "头孢呋辛",
      "B": "头孢唑林",
      "C": "亚胺培南",
      "D": "氨曲南",
      "E": "头孢曲松"
    },
    "answer": "B",
    "explanation": "本组题考查各代头孢菌素类抗菌药物的对比。 ①头孢唑林属于第一代头孢菌素类药物, 肾毒性较严重, 避免与具有肾毒性的药物联合使用, 且对血-脑屏障穿透性较差, 不宜用于中枢神经系统感染。故本题答案为 B。",
    "source_note": "",
    "question_id": "403b7c31562d92e4743a9d74e864a71c9e9f54fa",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "可用于缓解喘息症状，治疗窗窄，易发生中毒，用药期间需监测血药浓度的平喘药是",
    "options": {
      "A": "噻托溴铵",
      "B": "沙丁胺醇",
      "C": "茶碱",
      "D": "氯雷他定",
      "E": "孟鲁司特"
    },
    "answer": "C",
    "explanation": "②本题考查黄嘌呤类药物的临床用药评价。茶碱为黄嘌呤类药物, 可用于支气管哮喘、喘息性支气管炎、阻塞性肺气肿等缓解喘息症状, 药物治疗窗 窄，易发生中毒，用药期间需监测茶碱血药浓度来调整剂量，既能保证疗效又可防止毒性反应的发生。故本题答案为 C。",
    "source_note": "",
    "question_id": "31abd0956d15edf4ae71be763477464c939c36e8",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "属于烟酸类的调血脂药是",
    "options": {
      "A": "考来烯胺",
      "B": "瑞舒伐他汀",
      "C": "阿昔莫司",
      "D": "非诺贝特",
      "E": "依折麦布"
    },
    "answer": "C",
    "explanation": "本组题考查调节血脂药的分类与代表药品。 ①阿昔莫司属于烟酸类药物。故本题答案为 C。",
    "source_note": "",
    "question_id": "8b5c215fbe5ede5259a2a05f424732ac58b59f73",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "可促进头发生长，临床上用于治疗男性雄激素性脱发的药物是",
    "options": {
      "A": "托特罗定",
      "B": "奥昔布宁",
      "C": "非那雄胺",
      "D": "坦索罗辛",
      "E": "普适泰"
    },
    "answer": "C",
    "explanation": "【 16\\sim 17 】 ①本题考查 5a 还原酶抑制剂的临床用药评价。小剂量非那雄胺能够促进头发生长，临床上用于治疗男性雄激素性脱发。故本题答案为C。",
    "source_note": "",
    "question_id": "d60c52915d1a3f9545c8dfe1eb039df719179bf8",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "可减少甲状腺供血及术中出血，硬化甲状腺腺体，术前2周使用的药物是",
    "options": {
      "A": "碘化钾",
      "B": "卡比马唑",
      "C": "普萘洛尔",
      "D": "左甲状腺素",
      "E": "丙硫氧嘧啶"
    },
    "answer": "A",
    "explanation": "②本题考查碘化钾的临床用药评价。甲亢外科手术治疗前使用大剂量碘剂, 如碘化钾溶液、饱和碘化钾溶液或无机碘, 可减少甲状腺供血及术中出血, 硬化甲状腺腺体, 以便于手术操作。故本题答案为 A。",
    "source_note": "",
    "question_id": "65c5290f2e718e901dd5ce9a097b6bc4df94816b",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "基本无肾毒性，可用于病原未明感染的经验性治疗的头孢菌素类药物是",
    "options": {
      "A": "头孢呋辛",
      "B": "头孢唑林",
      "C": "亚胺培南",
      "D": "氨曲南",
      "E": "头孢曲松"
    },
    "answer": "E",
    "explanation": "本组题考查各代头孢菌素类抗菌药物的对比。 ②头孢曲松属于第三代头孢菌素类药物, 基本无肾毒性, 临床用于严重革兰阴性菌及敏感革兰阳性菌的感染,病原未明感染的经验性治疗及院内感染。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "5ed5bbfefa7ae1c8f9c73062baa0609a12bb865b",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "个体差异较大，血药浓度维持在 10 \\sim 20\\mu \\mathrm{g} / \\mathrm{ml} 范围内有效且比较安全的药物是",
    "options": {
      "A": "多索茶碱",
      "B": "噻托溴铵",
      "C": "奥马珠单抗",
      "D": "沙丁胺醇",
      "E": "孟鲁司特"
    },
    "answer": "A",
    "explanation": "①本题考查黄嘌呤类药物的临床用药评价。多索茶碱个体差异较大, 剂量要视个体病情变化选择最佳剂量和用药方法, 必要时监测血药浓度, 维持在 10 \\sim 20 \\mu \\mathrm{g} / \\mathrm{ml} 范围内有效且比较安全。故本题答案为 A。",
    "source_note": "",
    "question_id": "2c63e52176098e804cc1bba34bc8ce6099c7c096",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "属于胆固醇吸收抑制剂的调血脂药是",
    "options": {
      "A": "考来烯胺",
      "B": "瑞舒伐他汀",
      "C": "阿昔莫司",
      "D": "非诺贝特",
      "E": "依折麦布"
    },
    "answer": "E",
    "explanation": "本组题考查调节血脂药的分类与代表药品。 ②依折麦布属于胆固醇吸收抑制剂。故本题答案为 E。",
    "source_note": "",
    "question_id": "2737b9ffdec1b5f35493af6102f917812f510242",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "属于植物制剂，可用于治疗慢性、非细菌性前列腺炎的药物是",
    "options": {
      "A": "托特罗定",
      "B": "奥昔布宁",
      "C": "非那雄胺",
      "D": "坦索罗辛",
      "E": "普适泰"
    },
    "answer": "E",
    "explanation": "【 16\\sim 17 】 ②本题考查治疗良性前列腺增生用药的分类与作用机制。普适泰作为裸麦花粉提炼出来的一种植物制剂，可阻碍睾酮转化为二氢睾酮及抑制白三烯、前列腺素合成，用于治疗良性前列腺增生和慢性、非细菌性前列腺炎。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "42ea058167af9a612611721283a148624e79e46e",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "作用慢而持久，口服吸收后在外周转化为 \\mathrm{T}_{3}，通过结合 \\mathrm{T}_{3} 受体而发挥作用的药物是",
    "options": {
      "A": "碘化钾",
      "B": "丙硫氧嘧啶",
      "C": "甲巯咪唑",
      "D": "左甲状腺素",
      "E": "碘塞罗宁"
    },
    "answer": "D",
    "explanation": "【 17 \\sim 18】 ①本题考查甲状腺激素类药物的临床用药评价。左甲状腺素是人工合成的四碘甲状腺原氨酸, 作用慢而持久, 口服吸收后在外周转化为 T3, 通过结合 T3 受体发挥其特定作用。碘塞罗宁为人工合成的 T3, 作用快而强, 维持时间短。故本题答案为 D。",
    "source_note": "",
    "question_id": "34fa45350b312bb1fd48eec78d7575adc4f1142e",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "具有一定肾毒性，在脑脊液中有一定浓度，可用于敏感菌所致脑膜炎治疗的头孢菌素类药物是",
    "options": {
      "A": "头孢呋辛",
      "B": "头孢唑林",
      "C": "亚胺培南",
      "D": "氨曲南",
      "E": "头孢曲松"
    },
    "answer": "A",
    "explanation": "本组题考查各代头孢菌素类抗菌药物的对比。 ③头孢呋辛属于第二代头孢菌素类药物, 在脑脊液中有一定浓度, 可用于敏感菌所致脑膜炎治疗。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "6c03d7a0cc78203a3a6e681d1f42caff36b84a63",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "可抑制肝脏P450酶，竞争性抑制茶碱的代谢，导致茶碱血药浓度升高的药物是",
    "options": {
      "A": "多索茶碱",
      "B": "噻托溴铵",
      "C": "奥马珠单抗",
      "D": "沙丁胺醇",
      "E": "孟鲁司特"
    },
    "answer": "E",
    "explanation": "②本题考查白三烯受体拮抗剂的临床用药评价。白三烯受体拮抗剂（如孟鲁司特）可抑制肝脏 P450 酶, 竞争性抑制茶碱的代谢, 导致茶碱血药浓度升高, 联合用药需监测茶碱的血药浓度。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c517ecbfaa93897f29b1cc66b252ba232935aa7a",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "属于贝丁酸类的调血脂药是",
    "options": {
      "A": "考来烯胺",
      "B": "瑞舒伐他汀",
      "C": "阿昔莫司",
      "D": "非诺贝特",
      "E": "依折麦布"
    },
    "answer": "D",
    "explanation": "本组题考查调节血脂药的分类与代表药品。 ③非诺贝特属于贝丁酸类药物。故本题答案为 D。考来烯胺属于胆酸螯合剂。瑞舒伐他汀属于羟甲基戊二酰辅酶 A 还原酶抑制剂。",
    "source_note": "",
    "question_id": "434c2b2de03387a3d757fd2c887699c400023664",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "大剂量时有抗甲状腺的作用，但作用时间短暂，且服用时间过长时，不仅作用消失，且可使病情加重的药物",
    "options": {
      "A": "碘化钾",
      "B": "丙硫氧嘧啶",
      "C": "甲巯咪唑",
      "D": "左甲状腺素",
      "E": "碘塞罗宁"
    },
    "answer": "A",
    "explanation": "【 17 \\sim 18】 ②本题考查碘化钾的临床用药评价。大剂量的碘有抗甲状腺的作用, 但由于其作用时间短暂 (最多维持 2 周), 且服用时间过长时, 不仅作用消失, 且可使病情加重, 因此不能作为常规的抗甲状腺药。故本题答案为 A。",
    "source_note": "",
    "question_id": "e1127c932e43061176d11dda140518f0f685c45a",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "属于第一代头孢菌素类药物，常用于围手术期预防术后切口感染的药物是",
    "options": {
      "A": "头孢他啶",
      "B": "头孢吡肟",
      "C": "头孢曲松",
      "D": "头孢孟多",
      "E": "头孢唑林"
    },
    "answer": "E",
    "explanation": "本组题考查头孢菌素类药物的分类与各代头孢菌素类抗菌药物的对比。 ①头孢唑林属于第一代头孢菌素类药物, 可用于敏感菌感染引起的呼吸道、尿道等感染, 也常用于预防手术后切口感染。故本题答案为 E。",
    "source_note": "",
    "question_id": "2511576546b9a2fa1f823b8609041b1ace8848f1",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "属于快速起效药，起效最快，可作为哮喘缓解药物按需使用的是",
    "options": {
      "A": "福莫特罗",
      "B": "苗达特罗",
      "C": "沙美特罗",
      "D": "维兰特罗",
      "E": "奥达特罗 长效 \\beta_{2} 受体拮抗药可分为快速起效药和缓慢起效药。"
    },
    "answer": "A",
    "explanation": "本组题考查 \\beta 2 受体激动剂的临床用药评价。长效 \\beta 2 受体激动剂可分为快速起效药和缓慢起效药。 ①快速起效药的代表药物有福莫特罗、茚达特罗、维兰特罗及奥达特罗, 其中福莫特罗起效最快, 也可作为哮喘缓解药物按需使用。故本题答案为 A。",
    "source_note": "",
    "question_id": "aff49e7659f0b49790dfb30ae34e782893e3e233",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "不经过肝脏细胞色素 P450 酶系代谢的调节血脂药是",
    "options": {
      "A": "洛伐他汀",
      "B": "瑞舒伐他汀",
      "C": "辛伐他汀",
      "D": "阿托伐他汀",
      "E": "普伐他汀"
    },
    "answer": "E",
    "explanation": "【 19 \\sim 20】本组题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。 ①他汀类药物主要代谢的 CYP450 酶如下: a.CYP3A4: 洛伐他汀、辛伐他汀、阿托伐他汀; b.CYP2C9: 氟伐他汀、瑞舒伐他汀、匹伐他汀; c.普伐他汀不经细胞色素 P450 酶代谢。故本题答案为 E。",
    "source_note": "",
    "question_id": "8de2d23b1a5dc494f3ff63f0df238a387989918c",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "可引起胰岛素自身免疫综合征的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "碘化钾",
      "C": "甲巯咪唑",
      "D": "左甲状腺素",
      "E": "丙硫氧嘧啶"
    },
    "answer": "C",
    "explanation": "【 19\\sim 21 】 ①本题考查硫脲类药物的临床用药评价。甲巯咪唑可引起胰岛素自身免疫综合征，诱发产生胰岛素自身抗体，进而诱发低血糖反应。故本题答案为C。",
    "source_note": "",
    "question_id": "8eb8ae0850bbb69b10ead35f3644a004628e65f9",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "属于第三代头孢菌素类药物，尤其适合用于铜绿假单胞菌感染的药物是",
    "options": {
      "A": "头孢他啶",
      "B": "头孢吡肟",
      "C": "头孢曲松",
      "D": "头孢孟多",
      "E": "头孢唑林"
    },
    "answer": "A",
    "explanation": "本组题考查头孢菌素类药物的分类与各代头孢菌素类抗菌药物的对比。 ②头孢他啶属于第三代头孢菌素类药物, 适用于敏感革兰阴性杆菌, 尤其是铜绿假单胞菌所致感染。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "85c6ffa280698f40fbcfde60f3fc3507a5dd9d0b",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 20,
    "stem": "属于缓慢起效药，不适用于急性哮喘、重度或危重哮喘发作者的是",
    "options": {
      "A": "福莫特罗",
      "B": "苗达特罗",
      "C": "沙美特罗",
      "D": "维兰特罗",
      "E": "奥达特罗 长效 \\beta_{2} 受体拮抗药可分为快速起效药和缓慢起效药。"
    },
    "answer": "C",
    "explanation": "本组题考查 \\beta 2 受体激动剂的临床用药评价。长效 \\beta 2 受体激动剂可分为快速起效药和缓慢起效药。 ②缓慢起效药为沙美特罗, 起效较慢, 故不适用于急性哮喘发作、重度或危重哮喘发作患者。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "86a211cf230b3c2cf8e4d196f912644da0eb17a9",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 20,
    "stem": "经肾排泄较少，肾功能不全者使用不会影响血药浓度和疗效的调节血脂药是",
    "options": {
      "A": "洛伐他汀",
      "B": "瑞舒伐他汀",
      "C": "辛伐他汀",
      "D": "阿托伐他汀",
      "E": "普伐他汀"
    },
    "answer": "D",
    "explanation": "【 19 \\sim 20】本组题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。 ②阿托伐他汀经肾排泄较少, 肾功能不全者使用不会对本品的血浆浓度产生影响, 也不会对降脂效果产生影响, 因此无需调整剂量。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "723e387eee1572e112728501fee91b12146391c3",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 20,
    "stem": "可引起中性粒细胞胞浆抗体相关性血管炎的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "碘化钾",
      "C": "甲巯咪唑",
      "D": "左甲状腺素",
      "E": "丙硫氧嘧啶"
    },
    "answer": "E",
    "explanation": "【 19\\sim 21 】 ②本题考查硫脲类药物的临床用药评价。丙硫氧嘧啶可引起中性粒细胞胞浆抗体相关性血管炎。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "33b96b83cc49ddae5228e4cfd319375915a54877",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 21,
    "stem": "为抗IL-5单克隆抗体，可用于成人和12岁以上青少年重度嗜酸性粒细胞性哮喘的维持治疗的药物是",
    "options": {
      "A": "西替利嗪",
      "B": "茶碱",
      "C": "美泊利珠单抗",
      "D": "特布他林",
      "E": "氟替卡松"
    },
    "answer": "C",
    "explanation": "①本题考查平喘药的分类和代表药品。美泊利珠单抗属于抗IL-5单克隆抗体，是中国首个用于成人和12岁及以上青少年重度嗜酸粒细胞性哮喘的维持治疗的靶向人源抗IL-5单克隆抗体，是重度嗜酸粒细胞性哮喘患者的治疗新选择。故本题答案为C。",
    "source_note": "",
    "question_id": "b2868baa64e5233a741fded34f54b9532474a4fa",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 21,
    "stem": "属于脂溶性他汀，主要经肝药酶CYP3A4代谢的药物是",
    "options": {
      "A": "匹伐他汀",
      "B": "普伐他汀",
      "C": "阿托伐他汀",
      "D": "瑞舒伐他汀",
      "E": "洛伐他汀"
    },
    "answer": "E",
    "explanation": "本组题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。 ① 辛伐他汀、洛伐他汀属于脂溶性他汀, 为内酯环型前药, 须在肝脏中水解成开环 \\beta-羟基酸型才有药理活性, 主要代谢酶为 CYP3A4。故本题答案为 E。",
    "source_note": "",
    "question_id": "f4295ee21c36a20b7f257e0e1f6c2af9ad2b31cd",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 21,
    "stem": "可能引起心悸、心绞痛发作的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "碘化钾",
      "C": "甲巯咪唑",
      "D": "左甲状腺素",
      "E": "丙硫氧嘧啶"
    },
    "answer": "D",
    "explanation": "【 19\\sim 21 】 ③本题考查甲状腺激素类药物的临床用药评价。左甲状腺素治疗开始可能出现心动过速、心悸、心绞痛、心律失常、月经紊乱、体重减轻、骨骼肌痉挛、肌无力等症状，过量给药可出现甲状腺功能亢进症、甲状腺肿大，重复给药可引起抗体形成、促甲状腺素假性升高或对以后给予的促甲状腺素产生抗药性。故本题答案为D。",
    "source_note": "",
    "question_id": "47174eb6019ae46141e40e1e4f0459c0161a372c",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 22,
    "stem": "心源性肺水肿引起的哮喘宜使用的药物是",
    "options": {
      "A": "西替利嗪",
      "B": "茶碱",
      "C": "美泊利珠单抗",
      "D": "特布他林",
      "E": "氟替卡松"
    },
    "answer": "B",
    "explanation": "②本题考查黄嘌呤类药物的临床用药评价。茶碱属于黄嘌呤类药物，可用于心源性肺水肿引起的哮喘。故本题答案为B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "1df381013035b0f473bb929a7d809f488464238b",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 22,
    "stem": "属于水溶性他汀，主要经肝药酶CYP2C9代谢的药物是",
    "options": {
      "A": "匹伐他汀",
      "B": "普伐他汀",
      "C": "阿托伐他汀",
      "D": "瑞舒伐他汀",
      "E": "洛伐他汀"
    },
    "answer": "D",
    "explanation": "本组题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。 ② 普伐他汀、瑞舒伐他汀为水溶性他汀, 其中普伐他汀不经细胞色素 P450 酶代谢, 瑞舒伐他汀的主要代谢 酶为 CYP2C9。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c56223ecd6004322fbc8898093c4db9bee69caf0",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 22,
    "stem": "为人工合成的三碘甲状腺原氨酸，作用快而强，维持时间短，可用于黏液性水肿昏迷的药物是",
    "options": {
      "A": "左甲状腺素",
      "B": "碘塞罗宁",
      "C": "碘化钾",
      "D": "丙硫氧嘧啶",
      "E": "卡比马唑"
    },
    "answer": "B",
    "explanation": "①本题考查甲状腺激素类药物的临床用药评价。左甲状腺素、碘塞罗宁、甲状腺片为甲状腺激素类药，主要用于治疗甲减、单纯性甲状腺肿及甲状腺癌手术后甲减的辅助治疗，亦可用于诊断甲状腺功能亢进的抑制试验。其中碘塞罗宁为人工合成的三碘甲状腺原氨酸，作用快而强，维持时间短，适用于黏液性水肿昏迷的抢救。左甲状腺素是人工合成的四碘甲状腺原氨酸，作用慢而持久。故本题答案为B。",
    "source_note": "",
    "question_id": "7a538a2669db6e87d2de0f2a569d052c2f04af2c",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 23,
    "stem": "属于水、脂双溶性他汀，主要经肝药酶 CYP2C9 代谢的药物是",
    "options": {
      "A": "匹伐他汀",
      "B": "普伐他汀",
      "C": "阿托伐他汀",
      "D": "瑞舒伐他汀",
      "E": "洛伐他汀"
    },
    "answer": "A",
    "explanation": "本组题考查羟甲基戊二酰辅酶 A 还原酶抑制剂的临床用药评价。 ③氟伐他汀、阿托伐他汀、匹伐他汀兼具水溶性和脂溶性, 其中阿托伐他汀的主要代谢酶为 CYP3A4, 氟伐他汀、匹伐他汀的主要代谢酶为 CYP2C9。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "b6229be073ae30eb1d4040e697e3032f94c6bcb6",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 23,
    "stem": "通过抑制过氧化物酶活性，使酪氨酸碘化缩合过程受阻，可用于甲状腺危象的治疗以及甲状腺术前准备的药物是",
    "options": {
      "A": "左甲状腺素",
      "B": "碘塞罗宁",
      "C": "碘化钾",
      "D": "丙硫氧嘧啶",
      "E": "卡比马唑"
    },
    "answer": "D",
    "explanation": "②本题考查硫脲类药物的临床用药评价。丙硫氧嘧啶、甲巯咪唑、卡比马唑为硫脲类抗甲状腺药，通过抑制过氧化物酶活性，使酪氨酸碘化缩合过程受阻，减少甲状腺激素的生成。丙硫氧嘧啶还能抑制外周组织T4转化为T3，可用于甲状腺危象的治疗。卡比马唑为前药，需游离出甲巯咪唑而发挥作用，起效慢，维持时间长，不适用于甲状腺危象。故本题答案为D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "cd9264633d5035864c76ee0594186a115880859a",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 24,
    "stem": "12岁以上确诊为IgE介导的，经吸入型肾上腺糖皮质激素和长效 \\beta_{2} 受体激动剂不能控制的",
    "options": {
      "A": "奥马珠单抗",
      "B": "孟鲁司特",
      "C": "沙美特罗",
      "D": "多索茶碱",
      "E": "布地奈德"
    },
    "answer": "A",
    "explanation": "②本题考查过敏介质阻释剂（奥马珠单抗）的临床用药评价。奥马珠单抗可与 IgE 特异性结合, 剂量依赖性降低游离 IgE 水平, 减少炎性介质释放, 阻断过敏性哮喘的炎症级联反应, 适用于 12 岁及以上确诊为 IgE 介导的, 经吸入型肾上腺糖皮质激素和吸入长效 \\beta 2 受体激动剂不能控制的中、重度持续性过敏性哮喘患者。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "7d9005d4a5f8829282c01d81b32470f4af08d9b9",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "配伍选择题",
    "qno": 24,
    "stem": "通过抑制过氧化酶系统，从而抑制甲状腺激素生成的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "丙硫氧嘧啶",
      "C": "胺碘酮",
      "D": "放射性碘",
      "E": "左甲状腺素"
    },
    "answer": "B",
    "explanation": "①本题考查硫脲类药物的临床用药评价。丙硫氧嘧啶能抑制过氧化酶系统, 使摄入到甲状腺细胞内的碘化物不能氧化成活性碘, 酪氨酸不能碘化, 一碘酪氨酸和二碘酪氨酸的缩合过程受阻, 以致不能生成甲状腺激素。故本题答案为 B。",
    "source_note": "",
    "question_id": "3cc462fabf72ddd96be690e996ecd4567d28a22d",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "配伍选择题",
    "qno": 25,
    "stem": "属于黄嘌呤类药物的平喘药是",
    "options": {
      "A": "沙美特罗",
      "B": "氟替卡松",
      "C": "美泊利珠单抗",
      "D": "异丙托溴铵",
      "E": "多索茶碱"
    },
    "answer": "E",
    "explanation": "本组题考查平喘药的分类与代表药品。 ①黄嘌呤类药物的代表药物有多索茶碱、茶碱、氨茶碱、二羟丙茶碱。故本题答案为E。",
    "source_note": "",
    "question_id": "7616e7060466feda3ef3bf5318b29571b1a10269",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第3节甲状腺激素类药物与抗甲状腺药物",
    "qtype": "综合分析题",
    "qno": 25,
    "stem": "可用于诊断甲状腺功能亢进的抑制试验的药物是",
    "options": {
      "A": "普萘洛尔",
      "B": "丙硫氧嘧啶",
      "C": "胺碘酮",
      "D": "放射性碘",
      "E": "左甲状腺素"
    },
    "answer": "E",
    "explanation": "②本题考查甲状腺激素类药的临床用药评价。甲状腺激素类药（甲状腺片、左甲状腺素、碘塞罗宁）主要用于治疗甲减、单纯性甲状腺肿及甲状腺癌手术后甲减的辅助治疗, 亦可用于诊断甲状腺功能亢进的抑制试验。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "qtype_raw": "配伍选择题",
    "question_id": "47aed4930932f14fd1c4cad314a5dd34fdae82bd",
    "section_no": 3,
    "section_title": "甲状腺激素类药物与抗甲状腺药物",
    "section_norm": "第三节 甲状腺激素类药物与抗甲状腺药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 26,
    "stem": "为碱性阴离子交换树脂，可阻断肠道内胆汁酸中胆固醇重吸收的药物是 抑制饮食和胆汁胆固醇在肠道吸收的药物是",
    "options": {
      "A": "普伐他汀",
      "B": "普罗布考",
      "C": "考来烯胺",
      "D": "依折麦布",
      "E": "苯扎贝特"
    },
    "answer": "C",
    "explanation": "本组题考查其他调血脂药的临床用药评价。 ①考来烯胺属于胆酸螯合剂, 为碱性阴离子交换树脂, 可阻断肠道内胆汁酸中胆固醇的重吸收。故本题答案为 C。",
    "source_note": "",
    "question_id": "c677614f4312113808f394ae5ba45f3bb97e1711",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 27,
    "stem": "在肠道刷状缘水平与NPC1L1发生相互作用，",
    "options": {
      "A": "普伐他汀",
      "B": "普罗布考",
      "C": "考来烯胺",
      "D": "依折麦布",
      "E": "苯扎贝特"
    },
    "answer": "D",
    "explanation": "本组题考查其他调血脂药的临床用药评价。 ②依折麦布属于胆固醇吸收抑制剂, 在肠道刷状缘水平通过与 NPC1L1 相互作用从而抑制饮食和胆汁胆固醇在肠道的吸收, 降低 TC、LDL-C 和 ApoB 水平。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "969f86932430d2220c885e07239aba742c84c7d1",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "配伍选择题",
    "qno": 28,
    "stem": "激动过氧化物酶体增殖物激活受体 \\alpha (PPAR\\alpha), 显著增加LPL活性, 减少AopC III合成的药物是",
    "options": {
      "A": "普伐他汀",
      "B": "普罗布考",
      "C": "考来烯胺",
      "D": "依折麦布",
      "E": "苯扎贝特"
    },
    "answer": "E",
    "explanation": "本组题考查其他调血脂药的临床用药评价。 ③苯扎贝特属于贝丁酸类药物, 是过氧化物酶体增殖物激活受体 α (PPAR α) 的激动剂, 能显著增加 LPL 活性, 同时减少 AopCIII 的合成, 促进血清 TG 脂解及 VLDL 清除。故本题答案为 E。",
    "source_note": "",
    "question_id": "89ddbc4f5a1d88b8f162a7317ac4441f2a13794f",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，男，42岁，支气管哮喘病史2年，近日因劳累过度导致哮喘急性发作，该患者宜使用的药物是",
    "options": {
      "A": "沙美特罗氟替卡松粉吸入剂",
      "B": "多索茶碱口服液",
      "C": "孟鲁司特钠咀嚼片",
      "D": "噻托溴铵吸入粉雾剂",
      "E": "沙丁胺醇气雾剂"
    },
    "answer": "E",
    "explanation": "本题考查β2受体激动剂的临床用药评价。短效β2受体激动剂（如沙丁胺醇、特布他林）吸入给药后在3~5min内起效，是缓解轻、中度急性哮喘症状、COPD支气管痉挛的首选药。故本题答案为E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "c8d03b185d15a14f4dfc835a5bbed5bccbd82426",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "适用于痛风患者高尿酸血症长期治疗的药物是",
    "options": {
      "A": "布洛芬",
      "B": "秋水仙碱",
      "C": "非布司他",
      "D": "来氟米特",
      "E": "可的松"
    },
    "answer": "C",
    "explanation": "本题考查抑制尿酸生成药的临床用药评价。非布司他属于抑制尿酸生成药, 适用于痛风患者高尿酸血症的长期治疗, 但不推荐用于无临床症状的高尿酸血症。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "2dd5b5222cb953307b91d2e765882c33380d966a",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第3节止吐药",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "先天性Q-T间期延长综合征患者应避免使用的止吐药是",
    "options": {
      "A": "昂丹司琼",
      "B": "氢氧化铝",
      "C": "地塞米松",
      "D": "莫沙必利",
      "E": "地西泮"
    },
    "answer": "A",
    "explanation": "本题考查止吐药的临床用药评价。昂丹司琼属于 5-HT3 受体拮抗剂，可延长 Q-T 间期，并具有剂量依赖性，先天性 Q-T 间期延长综合征患者应避免使用。故本题答案为 A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "1e89616070f38c7133faff4f54332c41a58f34dd",
    "section_no": 3,
    "section_title": "止吐药",
    "section_norm": "第三节 止吐药"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第3节肠内营养药",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "适用于糖尿病患者的肠内营养药是",
    "options": {
      "A": "肠内营养粉剂（TP）",
      "B": "肠内营养乳剂（TPF-D）",
      "C": "复方氨基酸注射液（18AA）",
      "D": "赖氨酸注射液",
      "E": "丙氨酰谷氨酰胺注射液"
    },
    "answer": "B",
    "explanation": "本组题考查肠内营养药的分类与代表药品。 ① 肠内营养乳剂（TPF-D）为糖尿病型肠内营养乳剂。故本题答案为 B。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "6b88ad8a363e9039b21a54aae8715f5550309650",
    "section_no": 3,
    "section_title": "肠内营养药",
    "section_norm": "第三节 肠内营养药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "对接受洋地黄治疗的患者，应用沙美特罗替卡松吸入粉雾剂控制哮喘，应告诫患者可引起的不良反应是",
    "options": {
      "A": "口喉刺激",
      "B": "瘙痒",
      "C": "肌肉痉挛",
      "D": "骨折",
      "E": "心律不齐"
    },
    "answer": "E",
    "explanation": "本题考查 \\beta 2 受体激动剂的临床用药评价。 \\beta 2 受体激动剂可引起低钾血症, 而血钾降低一般是暂时的, 通常不需要补充, 但需告诫患者有诱发低血钾而造成心律不齐的可能性, 特别是联用洋地黄类药物患者。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "3247962a75d1fa70dac41d47c37b61037760dd3e",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "能缓解前列腺增生患者急性症状，为中度良性前列腺增生患者的一线治疗药物的是",
    "options": {
      "A": "非那雄胺",
      "B": "依立雄胺",
      "C": "度他雄胺",
      "D": "普适泰",
      "E": "赛洛多辛"
    },
    "answer": "E",
    "explanation": "本题考查 \\alpha 1 受体拮抗药的临床用药评价。\\alpha 1 受体拮抗药（如赛洛多辛）是中度良性前列腺增生患者的一线治疗药物或重度良性前列腺增生患者在术前的临时治疗措施。故本题答案为 E。5a 还原酶抑制剂起效较慢，不能缓解急性症状。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "01c8f932364842a63a6bbeaafc88a4067fcce29d",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "患者，男，54岁，因骨关节感染，使用头孢哌酮治疗，为防止低凝血酶原血症，应补充的维生素是",
    "options": {
      "A": "维生素 \\mathrm{B}_{1}",
      "B": "维生素 \\mathrm{B}_{6}",
      "C": "维生素 K",
      "D": "维生素 C",
      "E": "维生素D"
    },
    "answer": "C",
    "explanation": "本题考查头孢菌素类药物的临床用药评价。头孢菌素类药物可导致肠道菌群改变, 造成维生素 B 和维生素 K 合成受阻, 缺乏维生素 K 可导致低凝血酶原血症、凝血酶原时间延长等出血风险, 可补充维生素 K 纠正。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "2d5f4f3ce4167176e9869732db6b92bb66be2c1f",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第3节抗抑郁药",
    "qtype": "综合分析题",
    "qno": 5,
    "stem": "患者，女，35岁，服用单胺氧化酶抑制剂，近期欲换用艾司西酞普兰，该患者需停药的时间至少为",
    "options": {
      "A": "7 天",
      "B": "14 天",
      "C": "21 天",
      "D": "28 天",
      "E": "35天"
    },
    "answer": "B",
    "explanation": "本题考查抗抑郁药的使用注意事项。艾司西酞普兰属于选择性 5-HT 再摄取抑制剂, 单胺氧化酶抑制剂在停用 14 天后才能换用 5-HT 再摄取抑制剂。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "17906dd763c47e1664bbbd47ab081ce9736bc4ec",
    "section_no": 3,
    "section_title": "抗抑郁药",
    "section_norm": "第三节 抗抑郁药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 7,
    "stem": "应用头孢吡肟期间出现腹泻考虑为抗生素相关性腹泻，中、重度患者用甲硝唑口服治疗，无效时考虑使用的药物是",
    "options": {
      "A": "万古霉素",
      "B": "替加环素",
      "C": "磷霉素",
      "D": "林可霉素",
      "E": "奥硝唑"
    },
    "answer": "A",
    "explanation": "本题考查头孢菌素类药物的临床用药评价。应用头孢吡肟期间出现腹泻, 考虑为抗生素相关性腹泻, 对轻症患者, 停用头孢吡肟即可缓解; 中、重度患者用甲硝唑口服, 无效时考虑用万古霉素或去甲万古霉素口服。故本题答案为 A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "1f4d3d08220c7c94c8a5123fd158d919456416e2",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第3节抗抑郁药",
    "qtype": "综合分析题",
    "qno": 10,
    "stem": "属于三环类抗抑郁药，伴有青光眼的抑郁症患者不宜选用的药物是",
    "options": {
      "A": "氟西汀",
      "B": "舍曲林",
      "C": "马普替林",
      "D": "多塞平",
      "E": "米氮平"
    },
    "answer": "D",
    "explanation": "本组题考查抗抑郁药的分类与临床用药评价。 ②三环类抗抑郁药（多塞平、阿米替林、丙米嗪、氯米帕明）常见抗胆碱能效应, 如口干、出汗减少、便秘、尿潴留、排尿困难、视物模糊、眼内压升高、心动过速, 故青光眼、尿潴留患者禁用。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "3472b779f11839b5a98dbb724a6988196b90c830",
    "section_no": 3,
    "section_title": "抗抑郁药",
    "section_norm": "第三节 抗抑郁药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "综合分析题",
    "qno": 10,
    "stem": "对前列腺平滑肌上 \\alpha_{\\mathrm{1A}} 受体具有高选择性，松弛前列腺平滑肌，减轻良性前列腺增生症患者下尿路症状，使尿流通畅的药物是",
    "options": {
      "A": "索利那新",
      "B": "赛洛多辛",
      "C": "非那雄胺",
      "D": "特拉唑嗪",
      "E": "西地那非"
    },
    "answer": "B",
    "explanation": "①本题考查 α 1 受体拮抗药的临床用药评价。常用于治疗前列腺增生症的 α 1 受体拮抗药包括第二代（哌唑嗪、特拉唑嗪等）和第三代（坦索罗辛、赛洛多辛等），可以通过拮抗 α 1 受体，使前列腺平滑肌松弛，缓解膀胱出口梗阻的动力性因素，减轻下尿路症状，尿流通畅。其中第二代药物对前列腺和外周血管平滑肌上的 α 1 受体都有拮抗作用，而第三代药物对前列腺上 α 1A 受体具有高选择性，而对外周血管平滑肌 α 1B 受体则几乎无影响。故本题答案为 B。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "978bf6b38346ca533c196c23ba2293b03d7fac69",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "综合分析题",
    "qno": 11,
    "stem": "患者，男，55岁，既往有冠心病、高尿酸血症，患者诉昨晚8点起右大脚趾关节处疼痛难忍，宜使用的药物是",
    "options": {
      "A": "非布司他",
      "B": "苯溴马隆",
      "C": "秋水仙碱",
      "D": "别嘌醇",
      "E": "阿司匹林"
    },
    "answer": "C",
    "explanation": "【 10 \\sim 11 】 ②本题考查秋水仙碱的临床用药评价。秋水仙碱属于抑制粒细胞浸润炎症反应药, 可抑制关节局部疼痛、肿胀和炎症反应, 适用于治疗痛风性关节炎急性发作和预防复发性痛风性关节炎的急性发作。故本题答案为 C。非布司他与别嘌醇为抑制尿酸生成药, 不能用于痛风急性发作,可降低血尿酸和尿尿酸。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "126a87c01e2248ad56d5fe7e9dc7227e5c0d5d57",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "综合分析题",
    "qno": 11,
    "stem": "可缩小前列腺的体积，降低PSA水平，能够降低良性前列腺增生症患者发生急性尿潴留风险的药物是",
    "options": {
      "A": "索利那新",
      "B": "赛洛多辛",
      "C": "非那雄胺",
      "D": "特拉唑嗪",
      "E": "西地那非"
    },
    "answer": "C",
    "explanation": "②本题考查 5α 还原酶抑制剂的临床用药评价。非那雄胺为 5α 还原酶抑制剂，通过降低前列腺内双氢睾酮的含量，抑制前列腺的增生，缩小前列腺体积，还可降低血清前列腺特异性抗原（PSA）水平，长期服用可降低良性前列腺增生/下尿路症状患者发生急性尿潴留和需要手术治疗的风险，延缓疾病进展。故本题答案为 C。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "2cc77962ce81b5d5a2f34892b484b4888733cf50",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 11,
    "stem": "患者，男，57岁。既往有癫痫病史，伴肾功能不全，因重度肺炎用药治疗后患者癫痫复发，推断该患者所用的抗菌药物可能是",
    "options": {
      "A": "头孢呋辛",
      "B": "头孢曲松",
      "C": "头孢氨苄",
      "D": "头孢吡肟",
      "E": "头孢丙烯"
    },
    "answer": "D",
    "explanation": "本组题考查头孢菌素类药物的临床用药评价。 ①头孢吡肟用于肾功能不全患者而未调整给药剂量时, 可能出现脑病、肌痉挛、癫痫等神经系统反应。故本题答案为 D。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "cb4e069d9e9bb19457aa97ab46de7e1bb31dfa36",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第3节头孢菌素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 12,
    "stem": "患者，男，67岁。因肺炎链球菌导致脑膜炎入院，肌酐清除率 29\\mathrm{mL} / \\mathrm{min}，宜选用的无需根据肾功能调整剂量的抗菌药物是",
    "options": {
      "A": "头孢呋辛",
      "B": "头孢曲松",
      "C": "头孢氨苄",
      "D": "头孢吡肟",
      "E": "头孢丙烯"
    },
    "answer": "B",
    "explanation": "本组题考查头孢菌素类药物的临床用药评价。 ②对于重度肾衰竭患者, 除了使用头孢曲松以外, 其他的头孢菌素类药物都需要调整给药剂量。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "f995dae06633e3580b4fefc1b5b6b5f64a1d6da2",
    "section_no": 3,
    "section_title": "头孢菌素类抗菌药物",
    "section_norm": "第三节 头孢菌素类抗菌药物"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第3节治疗良性前列腺增生用药",
    "qtype": "综合分析题",
    "qno": 13,
    "stem": "作为有性生活要求的男性患者治疗良性前列腺增生症的二线药物的是",
    "options": {
      "A": "奥昔布宁",
      "B": "赛洛多辛",
      "C": "非那雄胺",
      "D": "特拉唑嗪",
      "E": "托拉塞米"
    },
    "answer": "C",
    "explanation": "②本题考查 5α 还原酶抑制剂的临床用药评价。非那雄胺属于 5α 还原酶抑制剂, 可降低双氢睾酮含量, 常见性欲减退、阳痿的不良反应, 作为有性生活要求的男性患者治疗良性前列腺增生症的二线药物。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "adb6053ecdfbc07a9129ede7373310556e933fd0",
    "section_no": 3,
    "section_title": "治疗良性前列腺增生用药",
    "section_norm": "第三节 治疗良性前列腺增生用药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "综合分析题",
    "qno": 14,
    "stem": "起效慢，可引起尿潴留、排尿困难，前列腺增生患者慎用的平喘药是",
    "options": {
      "A": "布地奈德",
      "B": "沙丁胺醇",
      "C": "塞托溴铵",
      "D": "孟鲁司特",
      "E": "西替利嗪"
    },
    "answer": "C",
    "explanation": "②本题考查 M 胆碱受体拮抗剂的临床用药评价。噻托溴铵属于 M 胆碱受体拮抗剂, 起效慢, 不作为支气管痉挛急性发作的抢救治疗药物, 常见抗胆碱能效应 (口干、便秘、尿潴留、排尿困难、瞳孔扩大、眼压增高、视物模糊), 前列腺增生、闭角型青光眼患者慎用。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "f9234153c46fa6cfca3b9d295e8d59509bc7b3e7",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "综合分析题",
    "qno": 15,
    "stem": "适用于痛风性关节炎的缓解期，肾结石患者禁用的药物是",
    "options": {
      "A": "秋水仙碱",
      "B": "碳酸氢钠",
      "C": "别嘌醇",
      "D": "苯溴马隆",
      "E": "甲氨蝶呤"
    },
    "answer": "D",
    "explanation": "①本题考查促进尿酸排泄药的临床用药评价。苯溴马隆属于促进尿酸排泄药, 适用于原发性和继发性高尿酸血症、各种原因引起的痛风以及痛风性关节炎的非急性发作期; 痛风性关节炎急性期, 有中、重度肾功能不全或肾结石者禁用。故本题答案为 D。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "ec96fcb5844f57be5e4b6096f12a6480c4ba6c35",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第二章 解热、镇痛、抗炎、抗风湿及抗痛风药",
    "section": "第3节抗痛风药",
    "qtype": "综合分析题",
    "qno": 16,
    "stem": "适用于血尿酸和24小时尿尿酸过多患者，长期使用可致黄嘌呤肾病的药物是",
    "options": {
      "A": "秋水仙碱",
      "B": "碳酸氢钠",
      "C": "别嘌醇",
      "D": "苯溴马隆",
      "E": "甲氨蝶呤"
    },
    "answer": "C",
    "explanation": "②本题考查抑制尿酸生成药的临床用药评价。别嘌醇属于抑制尿酸生成药, 适用于血尿酸和 24 小时尿尿酸过多患者或有痛风结石、肾结石、泌尿系统结石、不宜应用促进尿酸排出药者, 长期使用可出现黄嘌呤肾病。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "d1eb9a3561b80e0fa207c236ccc655c20d8df057",
    "section_no": 3,
    "section_title": "抗痛风药",
    "section_norm": "第三节 抗痛风药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第3节平喘药",
    "qtype": "综合分析题",
    "qno": 23,
    "stem": "推荐与吸入型肾上腺糖皮质激素联合使用，尤其适合于中、重度持续哮喘患者长期治疗的药物是 中、重度持续性过敏性哮喘宜使用的药物是",
    "options": {
      "A": "奥马珠单抗",
      "B": "孟鲁司特",
      "C": "沙美特罗",
      "D": "多索茶碱",
      "E": "布地奈德"
    },
    "answer": "C",
    "explanation": "①本题考查 \\beta 2 受体激动剂的临床用药评价。长效 \\beta 2 受体激动剂与吸入型肾上腺糖皮质激素联合使用, 两者具有协同抗炎和平喘作用, 联合用药可获得相当于加倍剂量的吸入型肾上腺糖皮质激素, 并可增加患者的用药依从性, 减少大剂量吸入型肾上腺糖皮质激素的不良反应, 尤其适合中、重度持续哮喘者的长期治疗。故本题答案为 C。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "1e2c1f110da2be7174e1df735f01f0d1b20ec378",
    "section_no": 3,
    "section_title": "平喘药",
    "section_norm": "第三节 平喘药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "综合分析题",
    "qno": 24,
    "stem": "患者，男，65岁。体检结果：甘油三酯（TG）",
    "options": {
      "A": "依折麦布",
      "B": "非诺贝特",
      "C": "辛伐他汀",
      "D": "氟伐他汀",
      "E": "瑞舒伐他汀"
    },
    "answer": "B",
    "explanation": "本组题考查其他调血脂药的临床用药评价。 ①该患者的TG值高于正常范围, 需要调节血脂, 贝丁酸类药 (如非诺贝特) 是降低TG为治疗目标时的首选药。故本题答案为B。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "98f3aaf31759f867a66e7c98219d7d526ce3871b",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第3节调节血脂药",
    "qtype": "综合分析题",
    "qno": 25,
    "stem": "患者，女，55岁。经皮冠状动脉介入治疗(PCI)术后一直服用他汀类药物，但是低密度脂蛋白胆固醇（LDL-C）未达标，医师增加了他汀类药物的剂量后，患者的ALT升至120U/L，故医师拟恢复原他汀类药物的剂量，并联用其他调血脂药，该患者宜联用的药物是",
    "options": {
      "A": "依折麦布",
      "B": "非诺贝特",
      "C": "辛伐他汀",
      "D": "氟伐他汀",
      "E": "瑞舒伐他汀"
    },
    "answer": "A",
    "explanation": "本组题考查其他调血脂药的临床用药评价。 ②依折麦布属于胆固醇吸收抑制剂, 可单独服用或与他汀联合应用, 降低TC、LDL-C、ApoB水平。故本题答案为A。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "760ae093b96fe04cb0cecb490aaa56b9f46abe99",
    "section_no": 3,
    "section_title": "调节血脂药",
    "section_norm": "第三节 调节血脂药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第4节特发性肺纤维化的治疗药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "轻、中度肺功能障碍的特发性肺纤维化宜使用的药物是",
    "options": {
      "A": "吡非尼酮",
      "B": "沙丁胺醇",
      "C": "特布他林",
      "D": "格隆溴铵",
      "E": "奥马珠单抗"
    },
    "answer": "A",
    "explanation": "本题考查特发性肺纤维化的治疗药物的临床用药评价。吡非尼酮、尼达尼布可显著延缓用力肺活量下降速率，适用于轻到中度肺功能障碍的特发性肺纤维化患者。故本题答案为 A。沙丁胺醇、特布他林、格隆溴铵、奥马珠单抗属于平喘药。",
    "source_note": "",
    "question_id": "bf10da4365d12dfb1fafd3a1dcd6002b7248279c",
    "section_no": 4,
    "section_title": "特发性肺纤维化的治疗药物",
    "section_norm": "第四节 特发性肺纤维化的治疗药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于肝细胞膜修复保护剂的是",
    "options": {
      "A": "谷胱甘肽",
      "B": "甘草酸二铵",
      "C": "多烯磷脂酰胆碱",
      "D": "联苯双酯",
      "E": "腺苷蛋氨酸"
    },
    "answer": "C",
    "explanation": "本题考查肝脏疾病用药的分类与代表药品。肝细胞膜修复保护剂（必需磷脂类）化学结构上与肝细胞膜的天然成分一致, 可增加肝细胞膜的完整性、稳定性和流动性, 促进肝细胞膜再生, 起到稳定、保护、修复细胞膜的作用。代表性药物是多烯磷脂酰胆碱。故本题答案为 C。",
    "source_note": "",
    "question_id": "02be9006471235d9e30a7fe5cbdf444148ff683d",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第4节抗记忆障碍及改善神经功能药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "下列属于酰胺类的脑功能改善及抗记忆障碍药的是",
    "options": {
      "A": "奥拉西坦",
      "B": "胞磷胆碱钠",
      "C": "利斯的明",
      "D": "多奈哌齐",
      "E": "艾地苯醌"
    },
    "answer": "A",
    "explanation": "本题考查抗记忆障碍及改善神经功能药的分类与作用机制。酰胺类中枢兴奋药的代表药物有吡拉西坦、茴拉西坦、奥拉西坦等。故本题答案为 A。",
    "source_note": "",
    "question_id": "3dca650cbc8584be95b1ca862ccb60edffb70345",
    "section_no": 4,
    "section_title": "抗记忆障碍及改善神经功能药",
    "section_norm": "第四节 抗记忆障碍及改善神经功能药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第4节抗心绞痛药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "心绞痛急性发作的首选治疗措施是",
    "options": {
      "A": "口服硝苯地平控释片",
      "B": "舌下含服硝酸甘油片",
      "C": "静脉注射硝普钠",
      "D": "口服单硝酸异山梨酯片",
      "E": "左胸前区贴敷硝酸异山梨酯"
    },
    "answer": "B",
    "explanation": "本题考查硝酸酯类药物的临床用药评价。硝酸甘油舌下含服吸收迅速完全，起效最快，2 \\sim 3 分钟起效，5分钟达最大效应，作用持续时间也最短，约 20 \\sim 30 分钟，是心绞痛急性发作的首选治疗药物。故本题答案为 B。",
    "source_note": "",
    "question_id": "52c84e7b8d54db0f373dd3ac427dd9b3e709cd2f",
    "section_no": 4,
    "section_title": "抗心绞痛药",
    "section_norm": "第四节 抗心绞痛药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第4节治疗膀胱过度活动症用药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "目前已知人体有5种M受体亚型 (\\mathsf{M}_1\\sim \\mathsf{M}_5) ，其中直接参与膀胱收缩的重要受体是",
    "options": {
      "A": "\\mathbf{M}_{1} 受体",
      "B": "{\\mathrm{M}}_{5} 受体",
      "C": "{\\mathrm{M}}_{3} 受体",
      "D": "{\\mathrm{M}}_{4} 受体"
    },
    "answer": "C",
    "explanation": "本题考查 M 受体拮抗药的临床用药评价。目前已知人体有 5 种 M 受体亚型 (M1~M5), 其中 M3 受体在膀胱中是唯一直接参与膀胱收缩的重要受体。故本题答案为 C。",
    "source_note": "",
    "question_id": "7c6f548563b3d7b355784a84772ddcd70a7d8502",
    "section_no": 4,
    "section_title": "治疗膀胱过度活动症用药",
    "section_norm": "第四节 治疗膀胱过度活动症用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "不属于胰岛素适应证的是",
    "options": {
      "A": "1型糖尿病",
      "B": "酮症酸中毒",
      "C": "纠正细胞内缺钾",
      "D": "2 型糖尿病",
      "E": "低血糖昏迷"
    },
    "answer": "E",
    "explanation": "本题考查胰岛素和胰岛素类似物的临床用药评价。低血糖者禁用胰岛素。故本题答案为 E。",
    "source_note": "",
    "question_id": "6b4ba0eb6f7bc862d9f97ec535c7b24385cd2165",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第4节\\beta-内酰胺酶抑制剂及其与\\beta-内酰胺类抗生素配伍的复方制剂",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "为青霉烷砜类 \\beta-内酰胺酶抑制剂，对 \\beta-内酰胺酶产生不可逆地抑制作用的药物是",
    "options": {
      "A": "阿维巴坦",
      "B": "舒巴坦",
      "C": "雷利巴坦",
      "D": "法硼巴坦",
      "E": "克拉霉素"
    },
    "answer": "B",
    "explanation": "本题考查 \\beta -内酰胺酶抑制剂的临床用药评价。克拉维酸、舒巴坦和他唑巴坦为 \\beta -内酰胺酶不可逆抑制剂，其中舒巴坦和他唑巴坦属于青霉烷砜类结构。故本题答案为B。阿维巴坦、雷利巴坦、法硼巴坦属于非 \\beta -内酰胺结构的可逆的 \\beta -内酰胺酶抑制剂。克拉霉素属于大环内酯类药物。",
    "source_note": "",
    "question_id": "e3a5f7e95d9f50a05973f30d872cbca1e69d6a6e",
    "section_no": 4,
    "section_title": "\\beta-内酰胺酶抑制剂及其与\\beta-内酰胺类抗生素配伍的复方制剂",
    "section_norm": "第四节 \\beta-内酰胺酶抑制剂及其与\\beta-内酰胺类抗生素配伍的复方制剂"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第4节干扰有丝分裂药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "易发生超敏反应，用药前常规给予地塞米松、苯海拉明和西咪替丁加以预防的抗肿瘤药是",
    "options": {
      "A": "注射用柔红霉素",
      "B": "注射用硫酸长春新碱",
      "C": "紫杉醇注射液",
      "D": "注射用盐酸博来霉素",
      "E": "注射用环磷酰胺"
    },
    "answer": "C",
    "explanation": "本题考查紫杉醇类的临床用药评价。紫杉醇注射液的过敏反应可能与赋形剂聚氧乙烯蓖麻油有关, 应在治疗前 12 \\mathrm{~h} 及 6 \\mathrm{~h} 口服地塞米松 20 \\mathrm{mg}, 治疗前 30 \\sim 60 \\mathrm{~min} 肌内注射苯海拉明 50 \\mathrm{mg} 并静脉注射西咪替丁 300 \\mathrm{mg} 或雷尼替丁 50 \\mathrm{mg} 预防过敏反应。故本题答案为 C。",
    "source_note": "",
    "question_id": "9baecb7d33bf206e69854fc9ec086dd9a3df91e5",
    "section_no": 4,
    "section_title": "干扰有丝分裂药物",
    "section_norm": "第四节 干扰有丝分裂药物"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第4节肠外营养药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "不属于疾病特异型氨基酸制剂的是",
    "options": {
      "A": "复方氨基酸注射液（18AA）",
      "B": "复方氨基酸注射液（6AA）",
      "C": "复方氨基酸注射液（3AA）",
      "D": "赖氨酸注射液",
      "E": "复方氨基酸注射液（9AA）"
    },
    "answer": "A",
    "explanation": "本题考查肠外营养药的分类与代表药品。复方氨基酸注射液（18AA）属于平衡型氨基酸制剂。故本题答案为 A。疾病特异型氨基酸制剂：①用于肾病的氨基酸制剂：复方氨基酸注射液（9AA）；②用于肝病的氨基酸制剂：复方氨基酸注射液（3AA）、复方氨基酸注射液（6AA）、复方氨基酸注射液（20AA）；③用于颅脑损伤的氨基酸制剂：赖氨酸注射液；④免疫调节型氨基酸注射液：丙氨酰谷氨酰胺注射液。⑤用于创伤（应激）的氨基酸制剂。",
    "source_note": "explanation_range_detected",
    "question_id": "7ce11636dd43079747badd61f26f5348d2977e02",
    "section_no": 4,
    "section_title": "肠外营养药",
    "section_norm": "第四节 肠外营养药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第4节外用糖皮质激素",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "长期、大面积使用可出现库欣综合征的药物是",
    "options": {
      "A": "丙酸氯倍他索",
      "B": "过氧苯甲酰",
      "C": "维 A 酸",
      "D": "咪康唑",
      "E": "硫黄"
    },
    "answer": "A",
    "explanation": "本题考查外用糖皮质激素的临床用药评价。长期、大面积外用强效、极强效糖皮质激素（如丙酸氯倍他索），由于经皮吸收累积量增加，部分患者可出现库欣综合征等不良反应。故本题答案为 A。",
    "source_note": "",
    "question_id": "65c0a08d40ed65c6de233b561d391646cf426e0d",
    "section_no": 4,
    "section_title": "外用糖皮质激素",
    "section_norm": "第四节 外用糖皮质激素"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "属于肝脏解毒类药的是",
    "options": {
      "A": "联苯双酯",
      "B": "硫普罗宁",
      "C": "甘草酸二铵",
      "D": "多烯磷脂酰胆碱",
      "E": "熊去氧胆酸"
    },
    "answer": "B",
    "explanation": "本题考查肝脏疾病用药的分类与代表药品。肝脏解毒类药可以提供巯基或葡糖醛酸，增强解毒功能。代表性药物有谷胱甘肽、乙酰半胱氨酸、硫普罗宁、葡醛内酯。故本题答案为 B。",
    "source_note": "",
    "question_id": "00e577e538b0abb474092f068ecbb845032bd375",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第4节抗记忆障碍及改善神经功能药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "多奈哌齐的作用机制是",
    "options": {
      "A": "抑制中枢单胺氧化酶, 使脑内 DA 降解减少",
      "B": "抑制中枢胆碱酯酶, 使脑内 Ach 含量增加",
      "C": "激动中枢M胆碱受体, 使中枢胆碱能神经功能加强",
      "D": "抑制中枢 GABA 氨基转移酶, 使脑内 GABA 分解减少",
      "E": "抑制外周单胺氧化酶, 使肾上腺素分解减少"
    },
    "answer": "B",
    "explanation": "本题考查抗记忆障碍及改善神经功能药的分类与作用机制。多奈哌齐通过抑制胆碱酯酶活性, 阻止乙酰胆碱的水解, 提高脑内乙酰胆碱的含量, 从而缓解因胆碱能神经功能缺陷所引起的记忆和认知功能障碍。故本题答案为 B。",
    "source_note": "",
    "question_id": "a2432dad8139daec85f710141cf972f05ea29cb0",
    "section_no": 4,
    "section_title": "抗记忆障碍及改善神经功能药",
    "section_norm": "第四节 抗记忆障碍及改善神经功能药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第4节抗心绞痛药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "单硝酸异山梨酯缓释片用于冠心病长期治疗的给药方式是",
    "options": {
      "A": "晨起服药，一日1次",
      "B": "每 5min 含服 1 片, 15 \\mathrm{~min} 内需服 3 片",
      "C": "晨起服药，一日2次",
      "D": "一日 2 \\sim 3 次",
      "E": "睡前服药，一日1次"
    },
    "answer": "A",
    "explanation": "本题考查硝酸酯类药物的临床用药评价。单硝酸异山梨酯缓释片剂、缓释胶囊剂，晨服，初始剂量一次 50\\mathrm{mg} 或 60\\mathrm{mg}，一日1次，需个体化给药。故本题答案为A。",
    "source_note": "",
    "question_id": "d554c9188dd4762bc94cf04e7396ff5abce812d3",
    "section_no": 4,
    "section_title": "抗心绞痛药",
    "section_norm": "第四节 抗心绞痛药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第4节升白细胞药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "不属于升白细胞药的是",
    "options": {
      "A": "肌苷",
      "B": "利可君",
      "C": "鲨肝醇",
      "D": "维生素 \\mathrm{B}_{4}",
      "E": "小檗碱"
    },
    "answer": "E",
    "explanation": "本题考查升白细胞药的代表药品与临床用药评价。升白细胞药包括 ① 刺激因子类（人粒细胞刺激因子、人粒细胞巨噬细胞刺激因子）；② 其他升白细胞药：肌苷、利可君、维生素B4（腺嘌呤）、小檗胺、鲨肝醇、脱氧核苷酸钠。故本题答案为E。小檗碱为肠道抗感染药。",
    "source_note": "explanation_range_detected",
    "question_id": "ab77d3bce755431400e5111ff9ac026547a15cec",
    "section_no": 4,
    "section_title": "升白细胞药",
    "section_norm": "第四节 升白细胞药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第4节治疗膀胱过度活动症用药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可用于治疗膀胱过度活动症的 M 受体拮抗药是",
    "options": {
      "A": "托吡卡胺",
      "B": "噻托溴铵",
      "C": "喷托维林",
      "D": "索利那新",
      "E": "苯海索"
    },
    "answer": "D",
    "explanation": "本题考查治疗膀胱过度活动症用药的分类与作用机制。治疗膀胱过度活动症用药主要包括: ①M 受体拮抗药: 奥昔布宁、托特罗定、黄酮哌酯、索利那新、曲司氯铵、丙哌维林; ②β3肾上腺素受体激动剂: 米拉贝隆; ③A型肉毒毒素。故本题答案为D。托吡卡胺为散瞳药。噻托溴铵为平喘药。喷托维林为镇咳药。苯海索为抗帕金森病药。",
    "source_note": "explanation_range_detected",
    "question_id": "e90885653fe4dbf82cbee416f5b3e2bbfc510a06",
    "section_no": 4,
    "section_title": "治疗膀胱过度活动症用药",
    "section_norm": "第四节 治疗膀胱过度活动症用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "胰岛素常见不良反应是",
    "options": {
      "A": "骨髓抑制",
      "B": "酮症酸中毒",
      "C": "高钾血症",
      "D": "低血糖反应",
      "E": "乳酸血症"
    },
    "answer": "D",
    "explanation": "本题考查胰岛素和胰岛素类似物的临床用药评价。胰岛素常见低血糖反应，一般于注射后发生，首先出现心慌、出汗、并有面色苍白、饥饿感、虚弱、震颤、反应迟钝、视力或听力异常、意识障碍、头痛、眩晕、抑郁、心悸、神经过敏、复视、言语障碍、运动失调，甚至昏迷。故本题答案为 D。",
    "source_note": "",
    "question_id": "5255a6733271632bb6feb58faf2c5d26ac853d01",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第4节\\beta-内酰胺酶抑制剂及其与\\beta-内酰胺类抗生素配伍的复方制剂",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "β-内酰胺酶抑制剂的抑酶活性由弱到强的顺序是",
    "options": {
      "A": "他唑巴坦 < 克拉维酸 < 舒巴坦",
      "B": "舒巴坦 < 克拉维酸 < 他唑巴坦",
      "C": "他唑巴坦 < 舒巴坦 < 克拉维酸",
      "D": "舒巴坦 < 他唑巴坦 < 克拉维酸",
      "E": "克拉维酸 < 舒巴坦 < 他唑巴坦"
    },
    "answer": "B",
    "explanation": "本题考查 \\beta-内酰胺酶抑制剂的临床用药评价。舒巴坦的抑酶活性比克拉维酸低, 但稳定性强。他唑巴坦的抑酶谱广度和活性都强于克拉维酸和舒巴坦。它们三者之间抑酶活性由弱到强的顺序为舒巴坦 < 克拉维酸 < 他唑巴坦。故本题答案为 B。",
    "source_note": "",
    "question_id": "ba7e4b687b4558b24835bf264a8be594f5d2e343",
    "section_no": 4,
    "section_title": "\\beta-内酰胺酶抑制剂及其与\\beta-内酰胺类抗生素配伍的复方制剂",
    "section_norm": "第四节 \\beta-内酰胺酶抑制剂及其与\\beta-内酰胺类抗生素配伍的复方制剂"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第4节干扰有丝分裂药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "对神经系统有明显毒性的抗肿瘤药是",
    "options": {
      "A": "柔红霉素",
      "B": "环磷酰胺",
      "C": "伊立替康",
      "D": "博来霉素",
      "E": "长春新碱"
    },
    "answer": "E",
    "explanation": "本题考查长春碱类的临床用药评价。神经系统毒性为长春碱类药物的剂量限制性毒性，主要表现为四肢麻木、腱反射迟钝或消失、外周神经炎。故本题答案为 E。",
    "source_note": "",
    "question_id": "2ef78dac7d822a3972046915a00d74442bea7aad",
    "section_no": 4,
    "section_title": "干扰有丝分裂药物",
    "section_norm": "第四节 干扰有丝分裂药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第4节外用糖皮质激素",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "属于极强效的外用糖皮质激素是",
    "options": {
      "A": "醋酸氢化可的松",
      "B": "醋酸地塞米松",
      "C": "丙酸氯倍他索",
      "D": "醋酸曲安奈德",
      "E": "哈西奈德"
    },
    "answer": "C",
    "explanation": "本题考查外用糖皮质激素的分类与代表药品。外用糖皮质激素按药理作用强度大致可分为弱效、中效、强效和极强效四类 ① 极强效外用糖皮质激素有 0.05\\% 卤米松、0.1\\% 氟轻松、0.05\\% 丙酸氯倍他索；② 强效外用糖皮质激素有 0.1\\% 糖酸莫米松、0.025\\% 丙酸倍氯米松、0.1\\% 哈西奈德；③ 中效外用糖皮质激素有 0.05\\% 醋酸地塞米松、0.1\\% 丁酸氢化可的松、0.1\\% 曲安奈德、0.05\\% 丙酸氟替卡松；④ 弱效外用糖皮质激素有 1.0\\% 醋酸氢化可的松、0.01\\% 醋酸氟轻松。故本题答案为 C。",
    "source_note": "explanation_range_detected",
    "question_id": "15f548cdaa01c5e4f5866bca875530154696ae28",
    "section_no": 4,
    "section_title": "外用糖皮质激素",
    "section_norm": "第四节 外用糖皮质激素"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "降酶速度快、降幅大，对多种化学毒物引起的ALT升高均有明显降低作用的药物是",
    "options": {
      "A": "甘草酸二铵",
      "B": "硫普罗宁",
      "C": "多烯磷脂酰胆碱",
      "D": "熊去氧胆酸",
      "E": "联苯双酯"
    },
    "answer": "E",
    "explanation": "本题考查肝脏疾病用药的临床用药评价。联苯双酯为抗氧化药，对多种化学毒物引起的ALT升高均有明显的降低作用，并且降酶速度快、降幅大，短期作用较好。故本题答案为E。",
    "source_note": "",
    "question_id": "582d68c367e66a9d12c40d64e2aaa2ad21c4631e",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第4节抗记忆障碍及改善神经功能药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "为新型组胺类药物，可增加前毛细血管微循环血流量，主要用于治疗内耳眩晕症的药物是",
    "options": {
      "A": "倍他司汀",
      "B": "利斯的明",
      "C": "丁苯酞",
      "D": "尼麦角林",
      "E": "胞磷胆碱钠"
    },
    "answer": "A",
    "explanation": "本题考查抗记忆障碍及改善神经功能药的临床用药评价。倍他司汀为新型组胺类药物，选择性作用于 H1 受体，具有扩张毛细血管、舒张前毛细血管括约肌、增加前毛细血管微循环血流量的作用，也具有降低内耳静脉压、促进内耳淋巴吸收、增加内耳动脉血流量的作用。临床主要用于内耳眩晕症，亦可用于脑动脉硬化、缺血性脑血管疾病及高血压所致体位性眩晕、耳鸣。故本题答案为 A。",
    "source_note": "",
    "question_id": "b7c506c42d80a5874ae27f3cfba23a8dfd65ace1",
    "section_no": 4,
    "section_title": "抗记忆障碍及改善神经功能药",
    "section_norm": "第四节 抗记忆障碍及改善神经功能药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第4节抗心绞痛药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "硝酸甘油的不良反应中与扩血管作用无关的是",
    "options": {
      "A": "心率加快",
      "B": "搏动性头痛",
      "C": "体位性低血压",
      "D": "面部潮红",
      "E": "耐受性"
    },
    "answer": "E",
    "explanation": "本题考查硝酸酯类药物的临床用药评价。硝酸酯类药物（如硝酸甘油）的不良反应：①舒张血管作用：搏动性头痛、面部潮红或有烧灼感、血压降低、反射性心率加快、晕厥、血硝酸盐升高等；②连续使用易产生耐受性。故本题答案为E。",
    "source_note": "explanation_range_detected",
    "question_id": "87c80781f3ccb4175fc859fc794c9e7f74e315ee",
    "section_no": 4,
    "section_title": "抗心绞痛药",
    "section_norm": "第四节 抗心绞痛药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第4节升白细胞药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "称为腺嘌呤，具有刺激骨髓白细胞增生作用的药物是",
    "options": {
      "A": "维生素 \\mathrm{B}_{4}",
      "B": "维生素 \\mathrm{B}_{6}",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "维生素 C",
      "E": "维生素 \\mathrm{B}_{2}"
    },
    "answer": "A",
    "explanation": "本题考查升白细胞药的代表药品与临床用药评价。维生素B4又称腺嘌呤，具有刺激骨髓白细胞增生的作用，可用于防治各种原因引起的白细胞减少症、急 性粒细胞减少症，尤其是防治肿瘤放化疗引起的白细胞减少症。故本题答案为A。",
    "source_note": "",
    "question_id": "c8b7f3a52d0675819e9600c1606efa5c3d37d116",
    "section_no": 4,
    "section_title": "升白细胞药",
    "section_norm": "第四节 升白细胞药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第4节治疗膀胱过度活动症用药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "属于 \\beta_{3} 肾上腺素受体激动剂，可用于治疗膀胱过度活动症的药物是",
    "options": {
      "A": "托特罗定",
      "B": "黄酮哌酯",
      "C": "特布他林",
      "D": "米拉贝隆",
      "E": "非那雄胺"
    },
    "answer": "D",
    "explanation": "本题考查治疗膀胱过度活动症用药的分类与作用机制。β 3 肾上腺素受体激动剂的代表药品是米拉贝隆。故本题答案为 D。托特罗定、黄酮哌酯属于 M 受体拮抗药。特布他林属于 β 2 肾上腺素受体激动药。非那雄胺属于 5 \\alpha 还原酶抑制剂。",
    "source_note": "",
    "question_id": "e9203e67a81587e6dd6f910abe5fc91d3b2d5892",
    "section_no": 4,
    "section_title": "治疗膀胱过度活动症用药",
    "section_norm": "第四节 治疗膀胱过度活动症用药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第4节\\beta-内酰胺酶抑制剂及其与\\beta-内酰胺类抗生素配伍的复方制剂",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "克拉维酸与阿莫西林配伍应用主要是因为前者可",
    "options": {
      "A": "抑制 \\beta- 内酰胺酶",
      "B": "延缓阿莫西林经肾小管的分泌",
      "C": "提高阿莫西林的生物利用度",
      "D": "减少阿莫西林的不良反应",
      "E": "增强阿莫西林对铜绿假单胞菌的抗菌活性"
    },
    "answer": "A",
    "explanation": "本题考查 \\beta-内酰胺酶抑制剂的临床用药评价。\\beta-内酰胺酶抑制剂包括克拉维酸、舒巴坦等, 与青霉素类组成复方制剂, 保护不耐酶的药物结构免受破坏,从而提高抗菌活性和效果。故本题答案为 A。",
    "source_note": "",
    "question_id": "6d6688990b1a8dd1c4b9aff38ed1d006c2ab444f",
    "section_no": 4,
    "section_title": "\\beta-内酰胺酶抑制剂及其与\\beta-内酰胺类抗生素配伍的复方制剂",
    "section_norm": "第四节 \\beta-内酰胺酶抑制剂及其与\\beta-内酰胺类抗生素配伍的复方制剂"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第4节外用糖皮质激素",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "外用糖皮质激素作用强度的比较，正确的是",
    "options": {
      "A": "醋酸地塞米松 > 糖酸莫米松 > 卤米松",
      "B": "卤米松 > 醋酸地塞米松 > 糖酸莫米松",
      "C": "醋酸地塞米松 > 卤米松 > 糖酸莫米松",
      "D": "卤米松 > 糖酸莫米松 > 醋酸地塞米松",
      "E": "糠酸莫米松 > 卤米松 > 醋酸地塞米松"
    },
    "answer": "D",
    "explanation": "本题考查外用糖皮质激素的分类与代表药品。醋酸地塞米松为中效外用糖皮质激素, 糖酸莫米松为强效外用糖皮质激素, 卤米松为极强效外用糖皮质激素,作用强度比较为卤米松 > 糖酸莫米松 > 醋酸地塞米松。故本题答案为 D。",
    "source_note": "",
    "question_id": "d5b03fbdfdf4d9ab83fc10954abd2d3e8e63af51",
    "section_no": 4,
    "section_title": "外用糖皮质激素",
    "section_norm": "第四节 外用糖皮质激素"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "可促进肝细胞膜再生，增强细胞膜的防御能力，临床用于以肝细胞膜损害为主的急慢性 肝炎的药物是",
    "options": {
      "A": "甘草酸二铵",
      "B": "多烯磷脂酰胆碱",
      "C": "联苯双酯",
      "D": "熊去氧胆酸",
      "E": "门冬氨酸钾镁"
    },
    "answer": "B",
    "explanation": "本题考查肝脏疾病用药的临床用药评价。多烯磷脂酰胆碱为肝细胞膜修复保护剂（必需磷脂类），可增加肝细胞膜的完整性、稳定性和流动性，促进肝细胞 膜再生，起到稳定、保护、修复细胞膜的作用，临床用于以肝细胞膜损害为主的急慢性肝炎、药物性肝炎、酒精性肝病、中毒性肝炎等。故本题答案为B。",
    "source_note": "",
    "question_id": "2b5b668c8504971c09d84b9c4981480ccd33d2bf",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第4节抗记忆障碍及改善神经功能药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "与左旋芹菜甲素具有相同的化学结构，可用于治疗轻、中度急性缺血性脑卒中的药物是",
    "options": {
      "A": "尼麦角林",
      "B": "丁苯酞",
      "C": "倍他司汀",
      "D": "奥拉西坦",
      "E": "利斯的明"
    },
    "answer": "B",
    "explanation": "本题考查抗记忆障碍及改善神经功能药的临床用药评价。丁苯酞为我国开发的一类新药，能促进中枢神经功能改善和恢复，主要用于治疗轻、中度急性缺血性脑卒中。禁用于对芹菜过敏者（芹菜中所含的左旋芹菜甲素与本药的化学结构相同）以及有严重出血倾向者。故本题答案为 B。",
    "source_note": "",
    "question_id": "7809d6eae753538fa223116822f0aaf464597852",
    "section_no": 4,
    "section_title": "抗记忆障碍及改善神经功能药",
    "section_norm": "第四节 抗记忆障碍及改善神经功能药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第4节抗心绞痛药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "与硝酸酯类药物合用可引起严重的低血压，用药期间禁止联合使用的是",
    "options": {
      "A": "坎利酮",
      "B": "西地那非",
      "C": "味塞米",
      "D": "丙酸睾酮",
      "E": "非那雄胺"
    },
    "answer": "B",
    "explanation": "本题考查硝酸酯类药物的临床用药评价。硝酸酯类与 5 型磷酸二酯酶抑制剂（如西地那非）合用，可显著增强硝酸酯类的舒张血管作用，从而发生显著性低血压，禁止联合使用。故本题答案为 B。",
    "source_note": "",
    "question_id": "b3c2fd13e7e715de2fb0e90337988021c8b39363",
    "section_no": 4,
    "section_title": "抗心绞痛药",
    "section_norm": "第四节 抗心绞痛药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第4节治疗膀胱过度活动症用药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "为非选择性M受体拮抗药，有较强抗胆碱作用的药物是",
    "options": {
      "A": "奥昔布宁",
      "B": "黄酮哌酯",
      "C": "托特罗定",
      "D": "索利那新",
      "E": "丙哌维林"
    },
    "answer": "A",
    "explanation": "本题考查 M 受体拮抗药的临床用药评价。奥昔布宁是非选择性 M 受体拮抗药, 具有较强的抗胆碱作用, 不良反应较严重; 黄酮哌酯具有与奥昔布宁相同的作用特点, 只是抗胆碱作用很弱; 托特罗定和索利那新是高选择性的 M3 受体拮抗药, 对中枢神经系统中的 M1 受体影响极小; 丙哌维林同时具有抗胆碱和钙拮抗作用, 副作 用较小。故本题答案为A。",
    "source_note": "",
    "question_id": "40317d5df8e71d58635ae655381e33c37039c4b4",
    "section_no": 4,
    "section_title": "治疗膀胱过度活动症用药",
    "section_norm": "第四节 治疗膀胱过度活动症用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "下列药物中可引起乳酸血症和口中金属味等不良反应的是",
    "options": {
      "A": "瑞格列奈",
      "B": "罗格列酮",
      "C": "胰岛素",
      "D": "伏格列波糖",
      "E": "二甲双胍"
    },
    "answer": "E",
    "explanation": "本题考查双胍类药物的临床用药评价。双胍类药物的不良反应包括胃胀、乏力、口苦、口中有金属味、轻度厌食、恶心、稀便或腹泻等消化道不良反应。由于双胍类药增强糖的无氧酵解, 抑制肝糖原生成, 少数患者可出现乳酸性血症。故本题答案为 E。",
    "source_note": "",
    "question_id": "54be1f3f44de7c063770203affa2fbac0102f547",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "注射液严禁用",
    "options": {
      "A": "复方甘草甜素",
      "B": "乙酰半胱氨酸",
      "C": "多烯磷脂酰胆碱",
      "D": "水飞蓟素",
      "E": "联苯双酯"
    },
    "answer": "C",
    "explanation": "本题考查肝脏疾病用药的临床用药评价。多烯磷脂酰胆碱主要用于以肝细胞膜损害为主的急慢性肝炎。其注射液严禁用电解质溶液（0.9%氯化钠溶液、林格液等）稀释, 如需稀释, 只能用 5%、10%葡萄糖溶液或木糖醇注射液。故本题答案为 C。",
    "source_note": "",
    "question_id": "8ee4614ffd987f34b377a2eda910785619446210",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第4节抗记忆障碍及改善神经功能药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "可拮抗 \\alpha 受体, 扩张血管增加血氧及能量供应, 增强神经传导, 改善脑功能不足的是",
    "options": {
      "A": "尼麦角林",
      "B": "加兰他敏 胞磷胆碱钠",
      "C": "苯海索",
      "D": "丁苯酞"
    },
    "answer": "A",
    "explanation": "本题考查抗记忆障碍及改善神经功能药的分类与作用机制。尼麦角林为半合成的麦角衍生物, 可拮抗 \\alpha 受体, 具有扩张血管作用, 增加血氧及能量供应, 增强神经传导, 改善脑功能不足。故本题答案为 A。",
    "source_note": "",
    "question_id": "a6cb0a7862e37bfa6c8de3048018ab4a8cd809a0",
    "section_no": 4,
    "section_title": "抗记忆障碍及改善神经功能药",
    "section_norm": "第四节 抗记忆障碍及改善神经功能药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "属于二肽基肽酶-4抑制剂的药物是",
    "options": {
      "A": "达格列净",
      "B": "多格列艾汀",
      "C": "罗格列酮",
      "D": "艾塞那肽",
      "E": "西格列汀"
    },
    "answer": "E",
    "explanation": "本题考查口服降糖药与肠促胰素类降糖药的分类与代表药品。二肽基肽酶-4（DPP-4）抑制剂代表药品有西格列汀、阿格列汀等。故本题答案为E。",
    "source_note": "",
    "question_id": "1043fc1dcc09f7007e50a8738e77043639a4a073",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第4节干扰有丝分裂药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "主要作用于M期，可与微管蛋白结合，抑制微管聚合，使有丝分裂停止于中期的是",
    "options": {
      "A": "紫杉醇",
      "B": "高三尖杉酯碱",
      "C": "L-门冬酰胺酶",
      "D": "依托泊苷",
      "E": "长春新碱"
    },
    "answer": "E",
    "explanation": "本题考查干扰有丝分裂药物的分类与作用机制。长春碱类作用机制为 与微管蛋白结合，抑制微管聚合，从而使纺锤丝不能形成，细胞有丝分裂停止于中期，属细胞周期特异性药物，主要作用于M期细胞。故本题答案为E。紫杉醇类作用机制为促进微管聚合，同时抑制微管的解聚，使纺锤体失去正常功能，细胞有丝分裂停止，属于细胞周期特异性药物。",
    "source_note": "",
    "question_id": "729c71b5337b177cda522dd1e092df684a7ba28b",
    "section_no": 4,
    "section_title": "干扰有丝分裂药物",
    "section_norm": "第四节 干扰有丝分裂药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "下列药物注射液中含有苯甲醇，禁用于新生儿和早产儿的是",
    "options": {
      "A": "熊去氧胆酸",
      "B": "异甘草酸镁",
      "C": "葡醛内酯",
      "D": "多烯磷脂酰胆碱",
      "E": "硫普罗宁"
    },
    "answer": "D",
    "explanation": "本题考查肝脏疾病用药的临床用药评价。多烯磷脂酰胆碱是肝细胞膜修复保护剂 (必需磷脂类), 注射液含苯甲醇, 可导致致命性的 “喘息综合征”, 新生儿和早产儿禁用。故本题答案为 D。",
    "source_note": "",
    "question_id": "99ec33391a8b466436295a2688ceb1cad7291e51",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第4节抗心绞痛药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "易产生耐受性的药物是",
    "options": {
      "A": "卡托普利",
      "B": "硝苯地平",
      "C": "呕唑嗪",
      "D": "氯沙坦",
      "E": "硝酸甘油"
    },
    "answer": "E",
    "explanation": "本题考查硝酸酯类药物的临床用药评价。以硝酸甘油为代表的硝酸酯类, 连续、反复和大剂量应用易产生耐受性。故本题答案为 E。",
    "source_note": "",
    "question_id": "610f9b00afb7072bb6edc643f1cd16d5499ab483",
    "section_no": 4,
    "section_title": "抗心绞痛药",
    "section_norm": "第四节 抗心绞痛药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "空腹血糖较高者宜选用的磺酰脲类促胰岛素分泌药是",
    "options": {
      "A": "格列吡嗪",
      "B": "格列齐特",
      "C": "格列喹酮",
      "D": "瑞格列奈",
      "E": "罗格列酮"
    },
    "answer": "B",
    "explanation": "本题考查磺酰脲类促胰岛素分泌药的临床用药评价。磺酰脲类的辩证用药: ①空腹血糖高: 选格列齐特和格列美脲; ②餐后血糖高: 选用格列吡嗪、格列喹酮; ③对轻、中度肾功能不全者, 宜选用格列喹酮; ④对既往发生心肌梗死或存在心血管疾病高危因素者, 宜选用格列美脲、格列吡嗪, 不宜选择格列本脲; 对急性心肌梗死者,急性期可使用胰岛素, 急性期后再选择磺酰脲类药; ⑤格列本脲降糖作用强, 持续时间长, 一旦出现低血糖, 纠正起来很困难; ⑥应激状态换胰岛素治疗。故本题答案为 B。",
    "source_note": "explanation_range_detected",
    "question_id": "70fc14a47065845c01cf7ec0d05a3fb36c250db4",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第4节干扰有丝分裂药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "影响氨基酸供应, 使肿瘤细胞生长受抑制的是",
    "options": {
      "A": "多西他赛",
      "B": "门冬氨酸钾镁",
      "C": "高三尖杉酯碱",
      "D": "长春瑞滨",
      "E": "L-门冬酰胺酶"
    },
    "answer": "E",
    "explanation": "本题考查干扰有丝分裂药物的分类与作用机制。L-门冬酰胺酶可将血清门冬酰胺水解而使肿瘤细胞缺乏门冬酰胺供应, 生长受到抑制。故本题答案为E。",
    "source_note": "",
    "question_id": "6ff38672b68baf9d7cd4b95b281182e9eb6c42a7",
    "section_no": 4,
    "section_title": "干扰有丝分裂药物",
    "section_norm": "第四节 干扰有丝分裂药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "在体内可与含羟基或羧基的毒物结合，形成低毒或无毒结合物排出体外，起到解毒和保护肝脏的作用，用于急、慢性肝炎治疗的药物是",
    "options": {
      "A": "葡醛内酯",
      "B": "腺苷蛋氨酸",
      "C": "多烯磷脂酰胆碱",
      "D": "复方甘草酸苷",
      "E": "双环醇"
    },
    "answer": "A",
    "explanation": "本题考查肝脏疾病用药的临床用药评价。葡醛内酯属于肝脏解毒类药,在体内可与含有羟基或羧基的毒物结合, 形成低毒或无毒结合物, 由尿排出体外, 保护肝脏和解毒, 用于急慢性肝炎的辅助治疗。故本题答案为 A。",
    "source_note": "",
    "question_id": "288c667e9cf1b436368c7f4073c5bd9d63cfa8c9",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "关于磺酰脲类药物的描述，不正确的是",
    "options": {
      "A": "对空腹血糖较高者宜选用格列美脲",
      "B": "对轻、中度肾功能不全者可选用格列喹酮",
      "C": "对既往发生心肌梗死的患者可选用格列本脲",
      "D": "使用格列本脲需防止过量出现持久低血糖",
      "E": "应激状态下需要换成胰岛素治疗"
    },
    "answer": "C",
    "explanation": "本题考查磺酰脲类促胰岛素分泌药的临床用药评价。对既往发生心肌梗死或存在心血管疾病高危因素者, 宜选用格列美脲、格列吡嗪, 不宜选用格列本脲, 因格列本脲对缺血的心肌有害。故本题答案为 C。",
    "source_note": "",
    "question_id": "15e2d070e90319abd03611600095d22885db8608",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第4节干扰有丝分裂药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "关于长春新碱的说法，错误的是",
    "options": {
      "A": "属于细胞周期特异性药物",
      "B": "输注时避免日光直接照射",
      "C": "可引起尿酸升高",
      "D": "与苯妥英钠合用, 降低苯妥英钠吸收",
      "E": "可以口服、静脉输注"
    },
    "answer": "E",
    "explanation": "本题考查长春碱类的临床用药评价。长春新碱仅用于静脉注射。故本题答案为E。",
    "source_note": "",
    "question_id": "32a9daf5607d836cb2ca8717ef67d6754e04a6f7",
    "section_no": 4,
    "section_title": "干扰有丝分裂药物",
    "section_norm": "第四节 干扰有丝分裂药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "甘草酸二铵可用于",
    "options": {
      "A": "严重低钾血症者",
      "B": "高钠血症者",
      "C": "心力衰竭者",
      "D": "肾衰竭者",
      "E": "ALT 升高的急、慢性肝炎"
    },
    "answer": "E",
    "explanation": "本题考查肝脏疾病用药的临床用药评价。严重低钾血症、高钠血症、高血压、心力衰竭和肾衰竭患者禁用甘草酸二铵。故本题答案为 E。",
    "source_note": "",
    "question_id": "84bb363518e72e6d57bffc88f77f1ec4da5c197a",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "单纯饮食控制及锻炼不能有效控制血糖的2型糖尿病宜首选的药物是",
    "options": {
      "A": "二甲双胍",
      "B": "格列喹酮",
      "C": "胰岛素",
      "D": "罗格列酮",
      "E": "利拉鲁肽"
    },
    "answer": "A",
    "explanation": "本题考查双胍类药物的临床用药评价。二甲双胍首选用于单纯饮食控制及体育锻炼治疗无效的 2 型糖尿病, 特别是肥胖的 2 型糖尿病。故本题答案为 A。",
    "source_note": "",
    "question_id": "83ca34109d7ba90fa5213975d34f112c6d8b51cd",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "可中效、稳定的降低糖化血红蛋白，临床需监测胰腺炎风险的药物是",
    "options": {
      "A": "阿卡波糖",
      "B": "西格列汀",
      "C": "二甲双胍",
      "D": "吡格列酮",
      "E": "格列齐特"
    },
    "answer": "B",
    "explanation": "本题考查二肽基肽酶-4 抑制剂的临床用药评价。二肽基肽酶-4 抑制剂为一类作用强度中等的降糖药, 代表药物有西格列汀、维格列汀、沙格列汀等, 可中效、稳定地降低糖化血红蛋白。注意 DPP-4 抑制剂可能诱发急性坏死性胰腺炎, 因此, 有必要密切观察。故本题答案为 B。",
    "source_note": "",
    "question_id": "25b03da7fc18ab2529abdbd586002f71b4aad8d8",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "不属于胰岛素不良反应的是",
    "options": {
      "A": "低血糖反应",
      "B": "高钾血症",
      "C": "皮下脂肪萎缩",
      "D": "体重增加",
      "E": "过敏反应"
    },
    "answer": "B",
    "explanation": "本题考查胰岛素和胰岛素类似物的临床用药评价。胰岛素可促使钾从细胞外液进入组织细胞内，纠正细胞内缺钾，可能导致低钾血症。故本题答案为 B。胰岛素的不良反应包括：①低血糖反应，一般于注射后发生，首先出现心慌、出汗，并有面色苍白、饥饿感、虚弱、反应迟钝、视力或听力异常、意识障碍、头痛、眩晕、抑郁、心悸、言语障碍、运动失调甚至昏迷；②过敏反应，表现有荨麻疹、紫癜、低血压、血管神经性水肿、支气管痉挛甚至过敏性休克或死亡；局部反应表现为注射部位红肿、灼热、瘙痒、皮疹、水疱或皮下硬结；③使用纯度不高的动物胰岛素易出现注射部位皮下脂肪萎缩；④引起体重增加。",
    "source_note": "explanation_range_detected",
    "question_id": "09e1660a0d3d97433e6616abc74ba107ddae389c",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 12,
    "stem": "胰岛素临床应用非常广泛，关于其注意事项的叙述，错误的是",
    "options": {
      "A": "混悬型胰岛素注射液禁止静脉注射",
      "B": "长效胰岛素类似物可一日注射 1 次",
      "C": "未开瓶使用胰岛素应在 10 \\sim 20^{\\circ} \\mathrm{C} 保存",
      "D": "冷冻后的胰岛素不可使用",
      "E": "酒精能直接导致低血糖, 应避免酗酒"
    },
    "answer": "C",
    "explanation": "本题考查胰岛素和胰岛素类似物的临床用药评价。尚未开瓶使用的胰岛素应在 2 \\sim 8^{\\circ} \\mathrm{C} 冷处保存。长效胰岛素可一日注射一次。冷冻后的胰岛素不可使用。酒精能直接导致低血糖, 应避免酗酒和空腹饮酒。故本题答案为 C。",
    "source_note": "",
    "question_id": "99077bed565c3aed4423f95ee990ad42725fa71f",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 13,
    "stem": "格列本脲的降糖作用机制是",
    "options": {
      "A": "减少胰高血糖素的分泌，中枢性抑制食欲",
      "B": "增加靶细胞对胰岛素的敏感性, 促进葡萄糖的利用",
      "C": "作用于胰岛 \\beta 细胞上 ATP 敏感的钾离子通道, 刺激胰岛素分泌",
      "D": "抑制 \\alpha- 葡萄糖苷酶, 减少葡萄糖的吸收",
      "E": "减少肾小管对葡萄糖的重吸收, 促进葡萄糖的排泄"
    },
    "answer": "C",
    "explanation": "本题考查磺酰脲类促胰岛素分泌药的临床用药评价。格列本脲属于磺酰脲类促胰岛素分泌药，该类药的受体是胰岛β细胞上ATP敏感的钾离子通道（K+-ATP通道）的一部分。K+-ATP通道调控胰岛β细胞释放胰岛素。磺酰脲类药物结合受体使此类通道受到抑制，从而改变细胞的静息电位，使钙离子内流，刺激胰岛素分泌。故本题 答案为C。",
    "source_note": "",
    "question_id": "b907ac6d501f90c463657a9d3461393664fbecdd",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 14,
    "stem": "避免与含碘造影剂合用的口服降糖药是",
    "options": {
      "A": "二甲双胍",
      "B": "格列喹酮",
      "C": "米格列醇",
      "D": "精蛋白人胰岛素",
      "E": "罗格列酮"
    },
    "answer": "A",
    "explanation": "本题考查双胍类药物的临床用药评价。二甲双胍要避免与含碘造影剂、甲氧氯普胺合用。故本题答案为 A。",
    "source_note": "",
    "question_id": "5a57402c81f2b33bf767c98897dd9f09de9cfd4f",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 15,
    "stem": "关于阿卡波糖作用特点的描述，不正确的是",
    "options": {
      "A": "口服吸收很少",
      "B": "发生急性低血糖时, 应用蔗糖纠正",
      "C": "在缓解餐后高血糖方面优于磺酰脲类药",
      "D": "适合以碳水化合物为主食的亚洲人群",
      "E": "拉平昼夜血糖曲线，特别适用于老年人"
    },
    "answer": "B",
    "explanation": "本题考查 \\alpha-葡萄糖苷酶抑制剂的临床用药评价。阿卡波糖可使蔗糖分解为果糖和葡萄糖的速度更加缓慢, 因此如果发生急性的低血糖, 不宜使用蔗糖, 而应该使用葡萄糖纠正低血糖反应。故本题答案为 B。",
    "source_note": "",
    "question_id": "9f3aefd134ef4e2983d606d72b6b4d78dc83f26d",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 16,
    "stem": "关于噻唑烷二酮类胰岛素增敏剂的说法，错 误的是",
    "options": {
      "A": "罗格列酮是单纯的 PPAR- \\gamma 受体激动剂",
      "B": "会导致患者出现液体潴留",
      "C": "会导致女性患者骨折风险增加",
      "D": "单独使用不导致低血糖",
      "E": "能够抑制 \\alpha- 葡萄糖苷酶, 减慢淀粉等多糖分解为双糖和单糖"
    },
    "answer": "E",
    "explanation": "本题考查胰岛素增敏剂的临床用药评价。α-葡萄糖苷酶抑制剂阿卡波糖、伏格列波糖等能够抑制双糖类水解酶α-葡萄糖苷酶的活性而减慢淀粉等多糖分解为双糖（如蔗糖）和单糖（如葡萄糖），延缓单糖的吸收，降低餐后血糖峰值。故本题答案为E。",
    "source_note": "",
    "question_id": "a74d955246754fcf8180d7f8907a0d56fdfd43d9",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 17,
    "stem": "适合中国及亚洲人群的饮食谱（以碳水化合物为主）的口服降糖药是",
    "options": {
      "A": "二甲双胍",
      "B": "格列本脲",
      "C": "那格列奈",
      "D": "米格列醇",
      "E": "卡格列净"
    },
    "answer": "D",
    "explanation": "本题考查 α - 葡萄糖苷酶抑制剂的临床用药评价。α - 葡萄糖苷酶抑制剂可抑制 α - 葡萄糖苷酶 (双糖类水解酶), 减少淀粉等多糖分解为双糖 (如蔗糖) 和单糖 (如葡萄糖), 延缓单糖的吸收, 降低餐后血糖峰值, 适合中国及亚洲人群以碳水化合物为主的饮食谱。故本题答案为 D。",
    "source_note": "",
    "question_id": "5ceeff451d3193419a897570d68cc99c5c40b11d",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 19,
    "stem": "精蛋白人胰岛素属于",
    "options": {
      "A": "超短效胰岛素类似物",
      "B": "短效胰岛素",
      "C": "中效胰岛素",
      "D": "混合胰岛素",
      "E": "长效胰岛素类似物"
    },
    "answer": "C",
    "explanation": "本题考查胰岛素和胰岛素类似物的分类与代表药品。精蛋白人胰岛素属于中效胰岛素。故本题答案为 C。",
    "source_note": "",
    "question_id": "7c951cbbf7795c363d20935b53e5c5dce1da2ae6",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 20,
    "stem": "具有速/短效和长效胰岛素的作用，又称之为“双时相胰岛素”的是",
    "options": {
      "A": "短效胰岛素",
      "B": "超短效胰岛素类似物",
      "C": "混合胰岛素",
      "D": "长效胰岛素",
      "E": "长效胰岛素类似物"
    },
    "answer": "C",
    "explanation": "本题考查胰岛素和胰岛素类似物的临床用药评价。混合胰岛素即 “双时相胰岛素”, 是指含有两种不同时效的胰岛素或胰岛素类似物的混合物, 可同时具有速/短效胰岛素和长效胰岛素的作用。故本题答案为 C。",
    "source_note": "",
    "question_id": "69c04eddc76194f358d2e6c0b501640080176be0",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 21,
    "stem": "皮下注射起效迅速，持续时间短，若餐前给药，15min内要立即进食的胰岛素/胰岛素类似物是",
    "options": {
      "A": "普通胰岛素",
      "B": "地特胰岛素",
      "C": "德谷胰岛素",
      "D": "谷赖胰岛素",
      "E": "精蛋白人胰岛素"
    },
    "answer": "D",
    "explanation": "本题考查胰岛素和胰岛素类似物的临床用药评价。谷赖胰岛素属于超短（速）效胰岛素类似物，皮下注射吸收较人胰岛素快，起效迅速，持续时间短，能有效控制餐后血糖，若餐前给药 15 \\mathrm{~min} 内要进食碳水化合物，预防低血糖。故本题答案为 D。",
    "source_note": "",
    "question_id": "9b7e889b6380bb9715a9624834ed04d63a71db42",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 22,
    "stem": "对鱼精蛋白过敏者，禁止使用的胰岛素是",
    "options": {
      "A": "门冬胰岛素",
      "B": "赖脯胰岛素",
      "C": "普通胰岛素",
      "D": "地特胰岛素",
      "E": "精蛋白锌胰岛素"
    },
    "answer": "E",
    "explanation": "本题考查胰岛素和胰岛素类似物的临床用药评价。精蛋白锌胰岛素和低精蛋白锌胰岛素含有鱼精蛋白, 对鱼精蛋白过敏者禁用。故本题答案为 E。",
    "source_note": "",
    "question_id": "dadb9c1b938deb2ca4ace1cc543f85207c9d266a",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 23,
    "stem": "关于胰岛素或胰岛素类似物作用特点的描述，正确的是",
    "options": {
      "A": "德谷门冬双胰岛素注射液属于混合人胰岛素",
      "B": "门冬胰岛素可作为基础胰岛素控制基础血糖",
      "C": "赖脯胰岛素可以静脉注射给药",
      "D": "地特胰岛素作用时间长达 42 \\mathrm{~h}, 无血药峰浓度",
      "E": "精蛋白人胰岛素注射液属于短效胰岛素"
    },
    "answer": "C",
    "explanation": "本题考查胰岛素和胰岛素类似物的临床用药评价。只有可溶性胰岛素，如短效胰岛素、门冬胰岛素和赖脯胰岛素等可以静脉注射给药。故本题答案为 C。德谷门冬双胰岛素注射液属于双胰岛素类似物。门冬胰岛素属于超短（速）效胰岛素类似物，起效快，持续时间短，可有效地控制餐后血糖。甘精胰岛素、地特胰岛素和德谷胰岛素是利用重组 DNA 技术，延长了胰岛素的治疗时效。地特胰岛素作用时间可长达 24 小时；甘精胰岛素 U100 作用持续时间可长达 30 小时；甘精胰岛素 U300 作用持续时间为 36 小时；德谷胰岛素作用持续时间为 42 小时。德谷胰岛素和甘精胰岛素无血药峰浓度。精蛋白人胰岛素属于中效胰岛素。",
    "source_note": "",
    "question_id": "3e88d5691e0f66438e8752e50c07be0d0c61b750",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 24,
    "stem": "降糖效果受肾小球滤过的葡萄糖负荷影响的药物是",
    "options": {
      "A": "艾塞那肽",
      "B": "达格列净",
      "C": "利拉鲁肽",
      "D": "罗格列酮",
      "E": "阿卡波糖"
    },
    "answer": "B",
    "explanation": "本题考查钠-葡萄糖协同转运蛋白 2 抑制剂的临床用药评价。达格列净属于钠-葡萄糖协同转运蛋白 2 抑制剂, 降低血糖的能力受肾小球滤过的葡萄糖负荷的限制。降糖作用不依赖于胰岛 \\beta 细胞功能及胰岛素的敏感性。故本题答案为 B。",
    "source_note": "",
    "question_id": "5ce6181554e5072800d3c7c098e5f61eb7fd8c4a",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 25,
    "stem": "属于超长效制剂，一般一周1次皮下注射的是",
    "options": {
      "A": "贝那鲁肽",
      "B": "艾塞那肽",
      "C": "利司那肽",
      "D": "利拉鲁肽",
      "E": "度拉糖肽"
    },
    "answer": "E",
    "explanation": "本题考查肠促胰素类降糖药的临床用药评价。司美格鲁肽、度拉糖肽、艾塞那肽周制剂及洛塞那肽为超长效制剂, 一般一周 1 次皮下注射。故本题答案为 E。利拉鲁肽为长效制剂, 需要一日 1 次皮下注射。贝那鲁肽、艾塞那肽及利司那肽为短效制剂, 一般需要一日 1 \\sim 3 次皮下注射。",
    "source_note": "",
    "question_id": "b9b0d81f771913223b4729b69cbbda2c994f4c56",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "单项选择题",
    "qno": 27,
    "stem": "西格列汀的降糖作用机制是",
    "options": {
      "A": "高选择性抑制胃肠二肽基肽酶-4 (DPP-4)",
      "B": "抑制肠内水解多糖、双糖的 \\alpha- 葡萄糖苷酶",
      "C": "激动肠道的胰高血糖素样肽-1(GLP-1)",
      "D": "激活过氧化物酶体增殖因子受体 -\\gamma (PPAR-\\gamma)",
      "E": "抑制肾小管钠-葡萄糖协同转运蛋白-2 (SGLT-2)"
    },
    "answer": "A",
    "explanation": "本题考查二肽基肽酶-4 抑制剂的临床用药评价。西格列汀属于二肽基肽酶-4 抑制剂, 其作用机制是抑制二肽基肽酶-4 (DPP-4), 减少胰高血糖素样肽-1 (GLP-1) 的降解, 使胰岛素分泌增加。故本题答案为 A。",
    "source_note": "",
    "question_id": "619f1f3e443512f53bc80d56512df82443ba51c2",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第4节特发性肺纤维化的治疗药物",
    "qtype": "配伍选择题",
    "qno": 2,
    "stem": "为多效性的吡啶化合物，不良反应可导致光敏反应的药物是",
    "options": {
      "A": "吡非尼酮",
      "B": "孟鲁司特",
      "C": "沙美特罗",
      "D": "塞托溴铵",
      "E": "尼达尼布"
    },
    "answer": "A",
    "explanation": "本组题考查特发性肺纤维化的治疗药物的临床用药评价。 ①吡非尼酮是一种多效性的吡啶化合物, 具有抗炎、抗纤维化和抗氧化特性, 不良反应可导致光过敏、乏力、皮疹、胃部不适和厌食。故本题答案为 A。",
    "source_note": "",
    "question_id": "3f1d0474fc13c4a3fc035b432ff8fa03a92aec14",
    "section_no": 4,
    "section_title": "特发性肺纤维化的治疗药物",
    "section_norm": "第四节 特发性肺纤维化的治疗药物"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第4节肠外营养药",
    "qtype": "配伍选择题",
    "qno": 2,
    "stem": "治疗肝性脑病、慢性迁延性肝炎、慢性活动性肝炎引起的氨基酸代谢紊乱的药物是",
    "options": {
      "A": "赖氨酸注射液",
      "B": "复方氨基酸注射液（18AA）",
      "C": "复方氨基酸注射液（9AA）",
      "D": "丙氨酰谷氨酰胺注射液",
      "E": "复方氨基酸注射液（6AA）"
    },
    "answer": "E",
    "explanation": "本组题考查肠外营养药的分类与代表药品。 ①复方氨基酸注射液（6AA）为用于肝病的氨基酸制剂，可用于治疗肝性脑病、慢性迁延性肝炎、慢性活动性肝炎及亚急性与慢性重型肝炎引起的氨基酸代谢紊乱。故本题答案为E。",
    "source_note": "",
    "question_id": "8a1d21fa389483ceac2989e75673ccdeba509d99",
    "section_no": 4,
    "section_title": "肠外营养药",
    "section_norm": "第四节 肠外营养药"
  },
  {
    "chapter": "第三章 呼吸系统用药",
    "section": "第4节特发性肺纤维化的治疗药物",
    "qtype": "配伍选择题",
    "qno": 3,
    "stem": "为多靶点酪氨酸激酶抑制剂，不良反应常见腹泻的药物是",
    "options": {
      "A": "吡非尼酮",
      "B": "孟鲁司特",
      "C": "沙美特罗",
      "D": "塞托溴铵",
      "E": "尼达尼布"
    },
    "answer": "E",
    "explanation": "本组题考查特发性肺纤维化的治疗药物的临床用药评价。 ②尼达尼布是多靶点酪氨酸激酶抑制剂, 具有抗纤维化和抗炎活性, 不良反应常见腹泻, 无严重不良反应发生。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "f992ee108feb9fd81d402beff14cd6db9fccaa26",
    "section_no": 4,
    "section_title": "特发性肺纤维化的治疗药物",
    "section_norm": "第四节 特发性肺纤维化的治疗药物"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第4节升白细胞药",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "可刺激白细胞的增生，用于防治肿瘤放化疗引起的白细胞减少症的药物是",
    "options": {
      "A": "维生素 \\mathrm{B}_{4}",
      "B": "维生素 \\mathrm{B}_{6}",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "维生素C",
      "E": "维生素K"
    },
    "answer": "A",
    "explanation": "①本题考查升白细胞药的代表药品与临床用药评价。维生素 B4 又称腺嘌呤, 具有刺激骨髓白细胞增生的作用, 可用于防治各种原因引起的白细胞减少症、急性粒细胞减少症, 尤其是防治肿瘤放化疗引起的白细胞减少症。故本题答案为 A。",
    "source_note": "",
    "question_id": "f31b02e6363297fdce708746490565de1e31532f",
    "section_no": 4,
    "section_title": "升白细胞药",
    "section_norm": "第四节 升白细胞药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第4节升白细胞药",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "可促进红细胞的成熟，用于因内因子缺乏所致的巨幼红细胞性贫血的药物是",
    "options": {
      "A": "维生素 \\mathrm{B}_{4}",
      "B": "维生素 \\mathrm{B}_{6}",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "维生素C",
      "E": "维生素K"
    },
    "answer": "C",
    "explanation": "②本题考查维生素 B12 的临床用药评价。维生素 B12 又称为钴胺素, 是体内唯一的一种需要内因子辅助吸收的维生素, 可用于因内因子缺乏所致的巨幼红细胞性贫血和神经炎的辅助治疗。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "9c6aab834f82f8c07e3708b69d9a09eedac899c6",
    "section_no": 4,
    "section_title": "升白细胞药",
    "section_norm": "第四节 升白细胞药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第4节抗记忆障碍及改善神经功能药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "属于核苷类衍生物，可改善脑组织代谢，促进大脑功能恢复、促进苏醒的是",
    "options": {
      "A": "吡拉西坦",
      "B": "多奈哌齐",
      "C": "胞磷胆碱钠",
      "D": "硫辛酸",
      "E": "艾地苯醌"
    },
    "answer": "C",
    "explanation": "本组题考查抗记忆障碍及改善神经功能药的分类与作用机制。 ①胞磷胆碱钠为核苷类衍生物, 可改善脑组织代谢, 促进大脑功能恢复、促进苏醒。故本题答案为 C。",
    "source_note": "",
    "question_id": "98f48ad63acc5a0b513abb5bb5c94794de5dd374",
    "section_no": 4,
    "section_title": "抗记忆障碍及改善神经功能药",
    "section_norm": "第四节 抗记忆障碍及改善神经功能药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第4节升白细胞药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "可促进凝血因子合成，用于治疗新生儿低凝血酶原血症的药物是",
    "options": {
      "A": "维生素 \\mathrm{B}_{4}",
      "B": "维生素 \\mathrm{B}_{6}",
      "C": "维生素 \\mathrm{B}_{12}",
      "D": "维生素C",
      "E": "维生素K"
    },
    "answer": "E",
    "explanation": "③本题考查维生素 K 类的临床用药评价。维生素 K 是凝血因子 II 、 VII 、 IX 、 X 合成必不可少的辅因子, 可用于治疗新生儿低凝血酶原血症。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "6a0d2cffa1b8a4587b0d3219207c04ee0df69ca8",
    "section_no": 4,
    "section_title": "升白细胞药",
    "section_norm": "第四节 升白细胞药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第4节抗记忆障碍及改善神经功能药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "为其他改善神经功能类药，可促进神经传导和髓鞘的形成，用于治疗糖尿病多发性周围神经病变的是",
    "options": {
      "A": "吡拉西坦",
      "B": "多奈哌齐",
      "C": "胞磷胆碱钠",
      "D": "硫辛酸",
      "E": "艾地苯醌"
    },
    "answer": "D",
    "explanation": "本组题考查抗记忆障碍及改善神经功能药的分类与作用机制。 ②硫辛酸为其他改善神经功能类药, 可促进神经传导和髓鞘的形成, 用于治疗糖尿病多发性周围神经病变。故本题答案为 D。",
    "source_note": "",
    "question_id": "2fa4b9f5259d339dc38904a8d109af6b9f262689",
    "section_no": 4,
    "section_title": "抗记忆障碍及改善神经功能药",
    "section_norm": "第四节 抗记忆障碍及改善神经功能药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第4节抗心绞痛药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "生物利用度接近 100\\% ，无首关效应的硝酸酯类药物是",
    "options": {
      "A": "硝普钠",
      "B": "硝酸甘油",
      "C": "硝酸异山梨酯",
      "D": "单硝酸异山梨酯",
      "E": "硝苯地平"
    },
    "answer": "D",
    "explanation": "本组题考查硝酸酯类药物的临床用药评价。 ①单硝酸异山梨酯作为较新的一代硝酸酯药已经大量使用, 其片剂和缓释剂型在胃肠道吸收完全, 生物利用度 100\\%, 无首关效应。故本题答案为 D。",
    "source_note": "",
    "question_id": "2ae583a0353747ac6af42154fe3849fe5aa035ff",
    "section_no": 4,
    "section_title": "抗心绞痛药",
    "section_norm": "第四节 抗心绞痛药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第4节抗心绞痛药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "主要药理作用源于其活性代谢产物 5-单硝酸异山梨酯的药物是",
    "options": {
      "A": "硝普钠",
      "B": "硝酸甘油",
      "C": "硝酸异山梨酯",
      "D": "单硝酸异山梨酯",
      "E": "硝苯地平"
    },
    "answer": "C",
    "explanation": "本组题考查硝酸酯类药物的临床用药评价。 ②硝酸异山梨酯属于中效药, 作用持续时间 2 \\sim 6h, 普通片剂口服起效时间 15 \\sim 40 \\mathrm{~min}, 主要药理作用源于其肝脏的活性代谢产物 5-单硝酸异山梨酯。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "fdb96f6286a2db8fcbb096d90f645903df92bb15",
    "section_no": 4,
    "section_title": "抗心绞痛药",
    "section_norm": "第四节 抗心绞痛药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第4节治疗膀胱过度活动症用药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "治疗膀胱过度活动症的二线用药是",
    "options": {
      "A": "\\alpha_{1} 受体拮抗药",
      "B": "5 \\alpha 还原酶抑制剂",
      "C": "M受体拮抗药",
      "D": "\\beta_{3} 肾上腺素受体激动剂",
      "E": "A型肉毒毒素"
    },
    "answer": "D",
    "explanation": "【8 \\sim 9】本组题考查治疗膀胱过度活动症用药的分类与作用机制。 ① \\beta 3 肾上腺素受体激动剂为治疗膀胱过度活动症的二线用药。故本题答案为 D。",
    "source_note": "",
    "question_id": "1ee216d2f6343a2ca98c854efbb1226c9ce856d5",
    "section_no": 4,
    "section_title": "治疗膀胱过度活动症用药",
    "section_norm": "第四节 治疗膀胱过度活动症用药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第4节治疗膀胱过度活动症用药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "治疗膀胱过度活动症的三线用药是",
    "options": {
      "A": "\\alpha_{1} 受体拮抗药",
      "B": "5 \\alpha 还原酶抑制剂",
      "C": "M受体拮抗药",
      "D": "\\beta_{3} 肾上腺素受体激动剂",
      "E": "A型肉毒毒素"
    },
    "answer": "E",
    "explanation": "【8 \\sim 9】本组题考查治疗膀胱过度活动症用药的分类与作用机制。 ② A 型肉毒毒素为治疗膀胱过度活动症的三线用药。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "ccecf4dd12ce9060393ddf586fb976f28e7825b0",
    "section_no": 4,
    "section_title": "治疗膀胱过度活动症用药",
    "section_norm": "第四节 治疗膀胱过度活动症用药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第4节干扰有丝分裂药物",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "可促进微管聚合，同时抑制微管的解聚，使细胞有丝分裂停止的药物是",
    "options": {
      "A": "三尖杉酯碱",
      "B": "表柔比星",
      "C": "长春新碱",
      "D": "多西他赛",
      "E": "甲氨蝶呤"
    },
    "answer": "D",
    "explanation": "本组题考查干扰有丝分裂药的分类与作用机制。 ①紫杉醇类（紫杉醇、紫杉醇脂质体、白蛋白结合型紫杉醇、多西他赛）属于微管蛋白活性抑制药，可促进微管聚合，同时抑制微管的解聚，使纺锤体失去正常功能，细胞有丝分裂停止。故本题答案为D。",
    "source_note": "",
    "question_id": "33db42b5d678312676ca501e4d6a7f5a1f0aab44",
    "section_no": 4,
    "section_title": "干扰有丝分裂药物",
    "section_norm": "第四节 干扰有丝分裂药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "通过各种机制发挥抗炎作用，可用于治疗急、慢性肝炎的药物是",
    "options": {
      "A": "熊去氧胆酸",
      "B": "双环醇",
      "C": "硫普罗宁",
      "D": "甘草酸二铵",
      "E": "多烯磷脂酰胆碱"
    },
    "answer": "D",
    "explanation": "【 11 \\sim 13 】 ①本题考查肝脏疾病用药的临床用药评价。肝脏抗炎药可通过各种机制发挥抗炎作用, 还具有保护肝细胞膜及改善肝功能的作用, 可用于急、慢性肝 炎的治疗, 代表药物有甘草酸二铵、复方甘草甜素、异甘草酸镁。故本题答案为 D。",
    "source_note": "",
    "question_id": "3d26e5b31e995b62f265af193885b056c495f164",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第4节干扰有丝分裂药物",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "可抑制蛋白质合成的起始阶段，并使核糖体分解，释出新生肽链的药物是",
    "options": {
      "A": "三尖杉酯碱",
      "B": "表柔比星",
      "C": "长春新碱",
      "D": "多西他赛",
      "E": "甲氨蝶呤"
    },
    "answer": "A",
    "explanation": "本组题考查干扰有丝分裂药的分类与作用机制。 ②高三尖杉酯碱类（三尖杉酯碱、高三尖杉酯碱）属于干扰核糖体功能的药物，可抑制蛋白质合成的起始阶段，并使核糖体分解，释出新生肽链。故本题答案为A。长春碱类属于微管蛋白活性抑制药，与微管蛋白结合，抑制微管聚合，使纺锤丝不能形成，细胞有丝分裂停止于中期。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "9936f2bbd401c84259bec6c1f0bc512b9d0e6a58",
    "section_no": 4,
    "section_title": "干扰有丝分裂药物",
    "section_norm": "第四节 干扰有丝分裂药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "可促进胆汁分泌，减轻胆汁淤积，用于治疗胆汁淤积性肝病的药物是",
    "options": {
      "A": "熊去氧胆酸",
      "B": "双环醇",
      "C": "硫普罗宁",
      "D": "甘草酸二铵",
      "E": "多烯磷脂酰胆碱"
    },
    "answer": "A",
    "explanation": "【 11 \\sim 13 】 ②本题考查胆疾病用药的临床用药评价。熊去氧胆酸可促进胆汁分泌, 减轻胆汁淤积, 用于治疗胆汁淤积性肝病。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "bd9daf83e2a874642572291cb22275a0d2c6293c",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "可提供巯基，具有解毒、抗组胺、清除自由基和保护肝细胞作用的药物是",
    "options": {
      "A": "熊去氧胆酸",
      "B": "双环醇",
      "C": "硫普罗宁",
      "D": "甘草酸二铵",
      "E": "多烯磷脂酰胆碱"
    },
    "answer": "C",
    "explanation": "【 11 \\sim 13 】 ③本题考查肝脏疾病用药的临床用药评价。硫普罗宁为肝脏解毒类药, 可提供巯基, 具有解毒保护肝细胞作用。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "fce58921603fa1c4a313aadcd7c18b5fcb7ed0d9",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "参与体内三羧酸循环及糖代谢，能改善肝脏的合成，有解毒、灭活激素等功能的药物是",
    "options": {
      "A": "葡醛内酯",
      "B": "谷胱甘肽",
      "C": "多烯磷脂酰胆碱",
      "D": "甘草酸二铵",
      "E": "奥德昔巴特"
    },
    "answer": "B",
    "explanation": "②本题考查肝脏疾病用药的临床用药评价。谷胱甘肽是一种广泛存在于身体细胞内, 含 \\gamma 一酰胺键和巯基的三肽 (由谷氨酸、半胱氨酸及甘氨酸组成), 参与体内三羧酸循环及糖代谢, 能改善肝脏的合成, 有解毒、灭活激素等功能。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "dd98e222f8e30444413caa29afec06d16e03c5cc",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 28,
    "stem": "按作用时间分类，属于超短效胰岛素类似物的是",
    "options": {
      "A": "地特胰岛素",
      "B": "赖脯胰岛素",
      "C": "精蛋白人胰岛素",
      "D": "人胰岛素",
      "E": "甘精胰岛素"
    },
    "answer": "B",
    "explanation": "本组题考查胰岛素和胰岛素类似物的分类与代表药品。 ①超短（速）效胰岛素类似物的代表药物有赖脯胰岛素、门冬胰岛素、谷赖胰岛素。故本题答案为B。",
    "source_note": "",
    "question_id": "fc712ed5348a4278bfcec8698267e862f56d66b0",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 29,
    "stem": "按作用时间分类，属于短效胰岛素的是",
    "options": {
      "A": "地特胰岛素",
      "B": "赖脯胰岛素",
      "C": "精蛋白人胰岛素",
      "D": "人胰岛素",
      "E": "甘精胰岛素"
    },
    "answer": "D",
    "explanation": "本组题考查胰岛素和胰岛素类似物的分类与代表药品。 ②短效胰岛素的代表药物有动物胰岛素（猪胰岛素、牛胰岛素）、人胰岛素。故本题答案为D。地特胰岛素、甘精胰岛素属于长效胰岛素类似物。精蛋白人胰岛素属于中效胰岛素。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "06c9b4aba68c66520fbaf6f69a45531e7fe05b02",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 30,
    "stem": "皮下注射应在餐前 30\\mathrm{min} 给药，静脉注射可用于抢救糖尿病酮症酸中毒的胰岛素或胰岛素类似物是",
    "options": {
      "A": "人胰岛素",
      "B": "甘精胰岛素",
      "C": "地特胰岛素",
      "D": "门冬胰岛素",
      "E": "长效胰岛素"
    },
    "answer": "A",
    "explanation": "本组题考查胰岛素和胰岛素类似物的临床用药评价。 ①普通胰岛素属于短效胰岛素, 应在餐前 30min 皮下注射给药, 静脉注射可用于抢救糖尿病酮症酸中毒和高血糖高渗性昏迷。故本题答案为 A。",
    "source_note": "",
    "question_id": "572d49922e5890813bb675878cbdf7e5754efbbd",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 31,
    "stem": "既可餐前 5 \\sim 10 \\mathrm{~min} 皮下注射给药，也可餐后立即给药的胰岛素或胰岛素类似物是",
    "options": {
      "A": "人胰岛素",
      "B": "甘精胰岛素",
      "C": "地特胰岛素",
      "D": "门冬胰岛素",
      "E": "长效胰岛素"
    },
    "answer": "D",
    "explanation": "本组题考查胰岛素和胰岛素类似物的临床用药评价。 ②门冬胰岛素属于超短（速）效胰岛素类似物, 起效快, 作用时间短, 既可餐前 5 \\sim 10 \\mathrm{~min} 皮下注射给药, 也可餐后立即给药。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "a08ad98dee87b750267af29d3c69ee8e20da8d70",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 32,
    "stem": "每日1次固定时间给药，作用持续时间超过24h，血浆浓度无明显峰值的胰岛素或胰岛素类似物是",
    "options": {
      "A": "人胰岛素",
      "B": "甘精胰岛素",
      "C": "地特胰岛素",
      "D": "门冬胰岛素",
      "E": "长效胰岛素"
    },
    "answer": "B",
    "explanation": "本组题考查胰岛素和胰岛素类似物的临床用药评价。 ③甘精胰岛素属于长效胰岛素类似物, 每日 1 次固定时间给药, 作用持续时间超过 24h, 无明显峰值时间。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "ddd1cc898628deb624934cd41f83ba2383cf83a4",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 35,
    "stem": "属于促胰岛素分泌药的是",
    "options": {
      "A": "阿卡波糖",
      "B": "瑞格列奈",
      "C": "米格列醇",
      "D": "达格列净",
      "E": "艾塞那肽"
    },
    "answer": "B",
    "explanation": "【 35\\sim 37 】本组题考查口服降糖药与肠促胰素类降糖药的分类与代表药品。 ① 促胰岛素分泌药包括：a.磺酰脲类：格列本脲、格列美脲、格列喹酮、格列齐特等；b.格列奈(非磺酰脲)类瑞格列奈、那格列奈、米格列奈。故本题答案为B。",
    "source_note": "",
    "question_id": "8b86b4e95bf0152e8f2214236260ea5b4424b519",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 36,
    "stem": "属于 GLP-1 受体激动剂的是",
    "options": {
      "A": "阿卡波糖",
      "B": "瑞格列奈",
      "C": "米格列醇",
      "D": "达格列净",
      "E": "艾塞那肽"
    },
    "answer": "E",
    "explanation": "【 35\\sim 37 】本组题考查口服降糖药与肠促胰素类降糖药的分类与代表药品。 ② 胰高血糖素样肽-1（GLP-1）受体激动剂包括：艾塞那肽、利拉鲁肽、贝那鲁肽等。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "17a8fd817129eb39b268512cbe48194155d0307b",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 37,
    "stem": "属于SGLT-2抑制剂的是",
    "options": {
      "A": "阿卡波糖",
      "B": "瑞格列奈",
      "C": "米格列醇",
      "D": "达格列净",
      "E": "艾塞那肽"
    },
    "answer": "D",
    "explanation": "【 35\\sim 37 】本组题考查口服降糖药与肠促胰素类降糖药的分类与代表药品。 ③钠-葡萄糖协同转运蛋白-2（SGLT-2）抑制剂包括：达格列净、恩格列净、卡格列净等。故本题答案为D。米格列醇、阿卡波糖属于α-葡萄糖苷酶抑制剂。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "cadc2a6b4dac33ca4f809de10cdcbfa86dff2a04",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 38,
    "stem": "磺酰脲类降糖药中，轻度、中度肾功能不全者适宜选用的药物是",
    "options": {
      "A": "瑞格列奈",
      "B": "艾塞那肽",
      "C": "二甲双胍",
      "D": "格列美脲",
      "E": "格列喹酮"
    },
    "answer": "E",
    "explanation": "①本题考查磺酰脲类促胰岛素分泌药的临床用药评价。对轻度、中度肾功能不全者, 宜选用格列喹酮。糖尿病合并严重肾功能不全时, 应改用胰岛素治疗。故本题答案为 E。",
    "source_note": "",
    "question_id": "207108e9bdbd14df6d35f356aafbbaa011337c4c",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 39,
    "stem": "既可降低空腹血糖，又可降低餐后血糖，被称为“餐时血糖调节剂”的降糖药是",
    "options": {
      "A": "瑞格列奈",
      "B": "艾塞那肽",
      "C": "二甲双胍",
      "D": "格列美脲",
      "E": "格列喹酮"
    },
    "answer": "A",
    "explanation": "②本题考查格列奈类促胰岛素分泌药的临床用药评价。格列奈类促胰岛素分泌药既可降低空腹血糖、又可降低餐后血糖, 称为 “餐时血糖调节剂”, 代表药物有那格列奈、瑞格列奈等。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "5e610db9fbb242f9c738ddaeee687662e80aa9f4",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 40,
    "stem": "不良反应会增加女性骨折风险，且体重增加的口服降糖药是",
    "options": {
      "A": "利拉鲁肽",
      "B": "达格列净",
      "C": "西格列汀",
      "D": "阿卡波糖",
      "E": "罗格列酮"
    },
    "answer": "E",
    "explanation": "①本题考查胰岛素增敏剂的临床用药评价。胰岛素增敏剂（如罗格列酮）典型不良反应常见贫血、血红蛋白降低、血容量增加、血细胞比容降低、血红蛋白降低, 在开始治疗后 4~12 周更为明显; 与胰岛素、促胰岛素分泌剂联合应用,可增加低血糖发生的风险; 骨关节系统中常见背痛、肌痛、肌酸激酶增高; 并可增加女性骨折的风险; 体重增加和水肿。故本题答案为 E。",
    "source_note": "",
    "question_id": "e9fda5634c48ceec9ab3bece24e61388fc255dfb",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 41,
    "stem": "不良反应常见生殖泌尿道感染，且体重减轻的口服降糖药是",
    "options": {
      "A": "利拉鲁肽",
      "B": "达格列净",
      "C": "西格列汀",
      "D": "阿卡波糖",
      "E": "罗格列酮"
    },
    "answer": "B",
    "explanation": "②本题考查钠-葡萄糖协同转运蛋白-2 抑制剂的临床用药评价。钠-葡萄糖协同转运蛋白-2 抑制剂（如达格列净）的常见不良反应为生殖泌尿道感染; 还可降低血压、减轻体重。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "7ce82cbe57836cd1d7025c8f1c36bd49f7656497",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 42,
    "stem": "不良反应常见胃胀、腹胀、排气增加、肠鸣响的口服降糖药是",
    "options": {
      "A": "利拉鲁肽",
      "B": "达格列净",
      "C": "西格列汀",
      "D": "阿卡波糖",
      "E": "罗格列酮"
    },
    "answer": "D",
    "explanation": "③本题考查 α - 葡萄糖苷酶抑制剂的临床用药评价。α - 葡萄糖苷酶抑制剂（如阿卡波糖）的常见不良反应为胃肠道反应, 最常见胃胀、腹胀、排气增加、腹痛、胃肠痉挛性疼痛、肠鸣响。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "65b36a6412eb80670bcc1901891f4eb2e21528a6",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 43,
    "stem": "辅料中添加沙波立沙钠，现已有口服制剂的药物是",
    "options": {
      "A": "瑞格列奈",
      "B": "司美格鲁肽",
      "C": "胰岛素",
      "D": "二甲双胍",
      "E": "吡格列酮"
    },
    "answer": "B",
    "explanation": "①本题考查肠促胰素类降糖药的临床用药评价。司美格鲁肽属于胰高血糖素样肽-1 受体激动剂, 此类药物是多肽结构, 主要局限于注射给药, 但司美格鲁肽的口服片剂添加辅料有沙波立沙钠 (SNAC), 可保护司美格鲁肽免受酶降解解。故本题答案为 B。",
    "source_note": "",
    "question_id": "a7aaadbb24d6bde86495c90afa0280f9a118666f",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 45,
    "stem": "维生素 \\mathrm{B}_{12} 、叶酸和铁缺乏者禁用的药物是",
    "options": {
      "A": "瑞格列奈",
      "B": "司美格鲁肽",
      "C": "胰岛素",
      "D": "二甲双胍",
      "E": "吡格列酮"
    },
    "answer": "D",
    "explanation": "③本题考查双胍类药物的临床用药评价。二甲双胍禁用于维生素 B12、叶酸和铁缺乏者。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "1000fc95466767ec3844ccabc70126a5630561f3",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 46,
    "stem": "通过减慢肠道内多糖水解为双糖和单糖，延缓单糖的吸收，从而降低餐后血糖峰值的药物是",
    "options": {
      "A": "达格列净",
      "B": "罗格列酮",
      "C": "瑞格列奈",
      "D": "格列本脲",
      "E": "米格列醇"
    },
    "answer": "E",
    "explanation": "①本题考查α-葡萄糖苷酶抑制剂的临床用药评价。米格列醇属于α-葡萄糖苷酶抑制剂，通过竞争性抑制双糖类水解酶α-葡萄糖苷酶的活性而减慢多 糖分解为双糖和单糖,延缓单糖的吸收,从而降低餐后血糖峰值。故本题答案为 E。",
    "source_note": "",
    "question_id": "a57ebc80aeb58082e895c52579679413f0da81e1",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 47,
    "stem": "通过激动PPAR-γ受体，提高细胞对葡萄糖的利用，可明显降低空腹血糖及胰岛素和C肽水平的药物是",
    "options": {
      "A": "达格列净",
      "B": "罗格列酮",
      "C": "瑞格列奈",
      "D": "格列本脲",
      "E": "米格列醇"
    },
    "answer": "B",
    "explanation": "②本题考查胰岛素增敏剂的临床用药评价。罗格列酮为胰岛素增敏剂，通过激动 PPAR- \\gamma 受体，增加脂肪、肌肉及肝脏等对胰岛素敏感性，从而增加葡萄糖利用，可明显降低空腹血糖及胰岛素和 C 肽水平。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "63b9df1afdaff7b26c32a34499f70fb6d53198dd",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 48,
    "stem": "可激动胰高血糖素样肽-1（GLP-1）受体，增加胰岛素的分泌，一日1次给药且不受进食影响的药物是",
    "options": {
      "A": "利拉鲁肽",
      "B": "艾塞那肽",
      "C": "西格列汀",
      "D": "瑞格列奈",
      "E": "格列喹酮"
    },
    "answer": "A",
    "explanation": "①本题考查肠促胰素类降糖药的临床用药评价。利拉鲁肽、艾塞那肽为 GLP-1 受体激动剂, 可激动 GLP-1 受体, 增加胰岛素的分泌, 利拉鲁肽一日 1 次皮下注射, 注射时间与进食无关, 艾塞那肽一日 2 次皮下注射, 于早餐和晚餐前 60 分钟内给药, 餐后不可给药。故本题答案为 A。",
    "source_note": "",
    "question_id": "ca284688ffba3b99fec0a928ad4b117287ac0474",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 49,
    "stem": "可抑制胰高血糖素样肽-1（GLP-1）降解，延长其活性，在联合用药上更加随机、方便的药物是",
    "options": {
      "A": "利拉鲁肽",
      "B": "艾塞那肽",
      "C": "西格列汀",
      "D": "瑞格列奈",
      "E": "格列喹酮"
    },
    "answer": "C",
    "explanation": "②本题考查二肽基肽酶-4 抑制剂的临床用药评价。西格列汀为二肽基肽酶-4 抑制剂, 可减少 GLP-1 的降解, 延长其活性, GLP-1 以葡萄糖浓度依赖的方式增强胰岛素分泌, 抑制胰高血糖素分泌, 并能减少肝葡萄糖的合成, 单药或联合应用可控制对胰岛素敏感的糖尿病者的血糖水平。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "77ea0d535d834fb1178c6f35144ffea7f060f525",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 50,
    "stem": "与磺酰脲受体的结合与解离的速度均较迅速，促进胰岛素分泌的作用快而短，降糖起效迅速的药物是",
    "options": {
      "A": "利拉鲁肽",
      "B": "艾塞那肽",
      "C": "西格列汀",
      "D": "瑞格列奈",
      "E": "格列喹酮"
    },
    "answer": "D",
    "explanation": "③本题考查格列奈类促胰岛素分泌药的临床用药评价。瑞格列奈为非磺酰脲类促胰岛素分泌药, 与磺酰脲受体的结合与解离的速度均较迅速, 促进胰岛素分泌的作用快而短, 降糖起效迅速, 口服吸收快。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "f0167c66437e6d7c6d25cf9f0cef77634509d172",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 51,
    "stem": "属于葡萄糖依赖性促胰岛素多肽（GIP）/GLP-1双受体激动剂的是",
    "options": {
      "A": "司美格鲁肽",
      "B": "替尔泊肽",
      "C": "西格列他钠",
      "D": "西格列汀",
      "E": "多格列艾汀"
    },
    "answer": "B",
    "explanation": "本组题考查口服降糖药与肠促胰素类降糖药的分类与代表药品。 ①葡萄糖依赖性促胰岛素多肽（GIP）/GLP-1 双受体激动剂的代表药品为替尔泊肽。胰高血糖素样肽-1 受体激动剂（GLP-1RA）的代表药品有艾塞那肽、利拉鲁肽、贝那鲁肽、利司那肽、司美格鲁肽、度拉糖肽、洛塞那肽。故本题答案为 B。",
    "source_note": "",
    "question_id": "85f36a6f1f03591d9b2ef818743df58626f60d5a",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 52,
    "stem": "属于葡萄糖激酶激活剂的是",
    "options": {
      "A": "司美格鲁肽",
      "B": "替尔泊肽",
      "C": "西格列他钠",
      "D": "西格列汀",
      "E": "多格列艾汀"
    },
    "answer": "E",
    "explanation": "本组题考查口服降糖药与肠促胰素类降糖药的分类与代表药品。 ②葡萄糖激酶激活剂的代表药品为多格列艾汀。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "3709fce243f576220685ee62e204e9458ea90f04",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "配伍选择题",
    "qno": 53,
    "stem": "属于过氧化物酶体增殖物激活受体（PPAR）泛激动剂的是",
    "options": {
      "A": "司美格鲁肽",
      "B": "替尔泊肽",
      "C": "西格列他钠",
      "D": "西格列汀",
      "E": "多格列艾汀"
    },
    "answer": "C",
    "explanation": "本组题考查口服降糖药与肠促胰素类降糖药的分类与代表药品。 ③过氧化物酶体增殖物激活受体（PPAR）泛激动剂的代表药品为西格列他钠。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "528f185096fb55831d5e3dc9a8cd92389a39a408",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第4节升白细胞药",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "癌症患者在接受化疗后，由于白细胞减少而出现继发感染，为避免因白细胞减少造成免疫功能降低，适宜该患者使用的药物是",
    "options": {
      "A": "重组人血小板生成素",
      "B": "重组人促红素",
      "C": "重组人尿激酶原",
      "D": "重组人凝血因子IX",
      "E": "重组人粒细胞巨噬细胞刺激因子"
    },
    "answer": "E",
    "explanation": "本题考查升白细胞药的代表药品与临床用药评价。化疗、放疗对骨髓造血功能都有不同程度的抑制作用，表现为白细胞计数减少，抗感染能力降低，容易继发感染。若化疗期间出现白细胞降低，常使用升白细胞的药物，如重组人粒细胞刺激因子、重组人粒细胞巨噬细胞刺激因子、肌苷、利可君、腺嘌呤、小檗胺、鲨肝醇、脱氧核苷酸钠等。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "132b82e96f028d04a183060efd6c97a30a5ede69",
    "section_no": 4,
    "section_title": "升白细胞药",
    "section_norm": "第四节 升白细胞药"
  },
  {
    "chapter": "第十一章 调节水、电解质、酸碱平衡与营养用药",
    "section": "第4节肠外营养药",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "作为大手术、外伤或脓毒血症引起的严重肾功能衰竭以及急慢性肾功能衰竭患者肠外营养支持的药物是",
    "options": {
      "A": "赖氨酸注射液",
      "B": "复方氨基酸注射液（18AA）",
      "C": "复方氨基酸注射液（9AA）",
      "D": "丙氨酰谷氨酰胺注射液",
      "E": "复方氨基酸注射液（6AA）"
    },
    "answer": "C",
    "explanation": "本组题考查肠外营养药的分类与代表药品。 ②复方氨基酸注射液（9AA）为用于肾病的氨基酸制剂，可作为大手术、外伤或脓毒血症引起的严重肾功能衰竭以及急慢性肾功能衰竭患者的肠外营养药。故本题答案为C。赖氨酸注射液为用于颅脑损伤的氨基酸制剂。复方氨基酸注射液（18AA）为平衡型氨基酸制剂，可用于蛋白质摄入不足、吸收障碍等氨基酸不能满足机体代谢需要的患者，亦可用于改善术后患者的营养状况。丙氨酰谷氨酰胺注射液为免疫调节型氨基酸注射液。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "1d0646a13323eece42ccc2095d97982f2535771e",
    "section_no": 4,
    "section_title": "肠外营养药",
    "section_norm": "第四节 肠外营养药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第4节干扰有丝分裂药物",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "已反复采用蒽环类抗生素治疗的患者要避免应用，以免增加心脏毒性的抗肿瘤药是",
    "options": {
      "A": "高三尖杉酯碱",
      "B": "羟喜树碱",
      "C": "依托泊苷",
      "D": "奥沙利铂",
      "E": "L-门冬酰胺酶"
    },
    "answer": "A",
    "explanation": "本题考查三尖杉酯碱类的临床用药评价。高三尖杉酯碱静脉滴注速度过快或长期持续或重复给药时，会产生心脏毒性，应避免对已反复采用多柔比星或柔红霉素等蒽醌类抗生素治疗的患者应用高三尖杉酯碱，以免增加心脏毒性的可能。故本题答案为 A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "8bc5ab78623111c9e50498276db9a85b83c0ba3d",
    "section_no": 4,
    "section_title": "干扰有丝分裂药物",
    "section_norm": "第四节 干扰有丝分裂药物"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第4节治疗膀胱过度活动症用药",
    "qtype": "综合分析题",
    "qno": 5,
    "stem": "属于选择性 \\mathsf{M}_3 受体拮抗药，对中枢神经系统影响小，适用于痴呆和认知功能减退患者的药物是",
    "options": {
      "A": "奥昔布宁",
      "B": "索利那新",
      "C": "曲司氯铵",
      "D": "黄酮哌酯",
      "E": "米拉贝隆"
    },
    "answer": "B",
    "explanation": "本题考查 M 受体拮抗药的临床用药评价。索利那新属于选择性 M3 受体拮抗药, 对中枢神经系统影响小, 适用于痴呆和认知功能减退的患者。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "d9474b535cf0f8e328a4921697c2d238ee916dce",
    "section_no": 4,
    "section_title": "治疗膀胱过度活动症用药",
    "section_norm": "第四节 治疗膀胱过度活动症用药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第4节治疗膀胱过度活动症用药",
    "qtype": "综合分析题",
    "qno": 6,
    "stem": "患者，女，62岁，体型肥胖。尿急、尿频、夜尿3年，症状加重伴有急迫性尿失禁1年，宜首选的治疗药物是",
    "options": {
      "A": "坦索罗辛",
      "B": "非那雄胺 伐地那非",
      "C": "A型肉毒毒素",
      "D": "索利那新"
    },
    "answer": "D",
    "explanation": "本题考查 M 受体拮抗药的临床用药评价。膀胱过度活动症是以尿急症为核心, 可伴有尿频、夜尿和急迫性尿失禁的症候群。对其治疗的药物包括 M 受体拮抗药 (一线)、β3 肾上腺素受体激动剂 (二线) 和 A 型肉毒杆菌毒素注射剂 (三线)。索利那新是选择性 M3 受体拮抗剂, 适用于膀胱过度兴奋引起的尿频、尿急、急迫性尿失禁症状的治疗。故本题答案为 D。坦索罗辛、非那雄胺用于治疗良性前列腺增生。伐地那非可用于治疗男性勃起功能障碍。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "d6446b92a56903a78b3f71ffdc380379497964bf",
    "section_no": 4,
    "section_title": "治疗膀胱过度活动症用药",
    "section_norm": "第四节 治疗膀胱过度活动症用药"
  },
  {
    "chapter": "第七章 泌尿系统用药",
    "section": "第4节治疗膀胱过度活动症用药",
    "qtype": "综合分析题",
    "qno": 7,
    "stem": "同时具有抗胆碱和钙拮抗作用，副作用较小，可用于对其他M受体拮抗药不耐受患者的药物是",
    "options": {
      "A": "奥昔布宁",
      "B": "曲司氯铵",
      "C": "托特罗定",
      "D": "索利那新",
      "E": "丙哌维林"
    },
    "answer": "E",
    "explanation": "本题考查 M 受体拮抗药的临床用药评价。丙哌维林同时具有抗胆碱和钙拮抗作用, 副作用较小, 可用于对其他 M 受体拮抗药不耐受的患者。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "b9c90aaf0f8dd3ff3f0c7163bad9eb494f8183cf",
    "section_no": 4,
    "section_title": "治疗膀胱过度活动症用药",
    "section_norm": "第四节 治疗膀胱过度活动症用药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "综合分析题",
    "qno": 10,
    "stem": "患者，女，47岁，诊断为固醇性胆囊结石，宜使用的促进结石溶解的药物是",
    "options": {
      "A": "考来烯胺",
      "B": "熊去氧胆酸",
      "C": "多烯磷脂酰胆碱",
      "D": "异甘草酸镁",
      "E": "双环醇"
    },
    "answer": "B",
    "explanation": "本题考查胆疾病用药的临床用药评价。牛磺熊去氧胆酸、鹅去氧胆酸、熊去氧胆酸、去氢胆酸可治疗固醇性胆囊结石症, 均可促进胆汁酸分泌, 使其在胆汁中的含量升高, 还可抑制胆固醇在肠道内的重吸收, 并通过抑制胆固醇向胆汁中分泌,从而降低胆汁中胆固醇的饱和度, 使胆固醇结石逐渐溶解、脱落排出。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "4f72f680800f4adee3407ec732e2d8df4c268136",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第4节肝胆疾病用药",
    "qtype": "综合分析题",
    "qno": 14,
    "stem": "为回肠胆汁酸转运蛋白抑制剂，可通过抑制回肠远端胆汁酸的再摄取，增加胆汁酸通过结肠的清除，降低血清中胆汁酸的浓度，减轻患者的痛痒症状的药物是",
    "options": {
      "A": "葡醛内酯",
      "B": "谷胱甘肽",
      "C": "多烯磷脂酰胆碱",
      "D": "甘草酸二铵",
      "E": "奥德昔巴特"
    },
    "answer": "E",
    "explanation": "①本题考查胆疾病用药的分类与代表药品。奥德昔巴特为回肠胆汁酸转运蛋白抑制剂, 可通过抑制回肠远端胆汁酸的再摄取, 增加胆汁酸通过结肠的清除, 降低血清中胆汁酸的浓度, 减轻患者的痛痒症状。故本题答案为 E。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "0dba61c58c86ad4b0dad79a87a3a812276a6b1b2",
    "section_no": 4,
    "section_title": "肝胆疾病用药",
    "section_norm": "第四节 肝胆疾病用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "综合分析题",
    "qno": 18,
    "stem": "能够促进肾脏对葡萄糖的排泄，轻度降低2型糖尿病患者血糖水平的是",
    "options": {
      "A": "艾塞那肽",
      "B": "卡格列净",
      "C": "西格列汀",
      "D": "吡格列酮",
      "E": "格列吡嗪"
    },
    "answer": "B",
    "explanation": "本题考查钠-葡萄糖协同转运蛋白 2 抑制剂的临床用药评价。钠-葡萄糖协同转运蛋白 2 (SGLT-2) 抑制剂可促进肾脏对葡萄糖的排泄, 因此可轻度降低 2 型糖尿病患者升高的血糖水平, 代表药物有达格列净、恩格列净和卡格列净。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "156a17dd3d7d8ba74ec209e5189ffcb98a9ad06d",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "综合分析题",
    "qno": 26,
    "stem": "患者，男，65岁，2型糖尿病病史2年，心力衰竭病史1年，避免使用的降糖药物是",
    "options": {
      "A": "罗格列酮",
      "B": "达格列净",
      "C": "瑞格列奈",
      "D": "西格列汀",
      "E": "利拉鲁肽"
    },
    "answer": "A",
    "explanation": "本题考查胰岛素增敏剂的临床用药评价。罗格列酮属于噻唑烷二酮类胰岛素增敏剂, 可导致心力衰竭, 禁用于心功能III级和IV级的心力衰竭者, 或有心力衰竭史者。故本题答案为A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "9c95250a715d2e219e506ca640e98a41c638e2dd",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "综合分析题",
    "qno": 33,
    "stem": "患者，男，16岁，体重 60\\mathrm{kg}，诊断为“1型糖尿病”，宜选用的降糖药物是",
    "options": {
      "A": "二甲双胍",
      "B": "罗格列酮 阿卡波糖",
      "C": "瑞格列奈",
      "D": "胰岛素"
    },
    "answer": "D",
    "explanation": "①本题考查胰岛素和胰岛素类似物的临床用药评价。1 型糖尿病的主要病因是胰岛素分泌的绝对缺乏, 必须用胰岛素终身治疗来维持生命, 同时也须使用胰岛素控制血糖而减少糖尿病并发症发生的风险。故本题答案为 D。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "26b41a1c9a4b0f7257be58699d88a2c4e10d0df3",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "综合分析题",
    "qno": 34,
    "stem": "患者，男，60岁，BMI 27\\mathrm{kg} / \\mathrm{m}^2 ，诊断为“2型糖尿病”，首选的降糖药物是",
    "options": {
      "A": "二甲双胍",
      "B": "罗格列酮 阿卡波糖",
      "C": "瑞格列奈",
      "D": "胰岛素"
    },
    "answer": "A",
    "explanation": "②本题考查双胍类药物的临床用药评价。二甲双胍作为 2 型糖尿病患者控制高血糖的一线用药和药物联合中的基本用药, 首选用于单纯饮食控制及体育锻炼治疗无效的 2 型糖尿病, 尤其是肥胖的 2 型糖尿病。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "1db6e28869e3bb2d3bf271dfca48757d8fa79675",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第4节胰岛素与其他影响血糖的药物",
    "qtype": "综合分析题",
    "qno": 44,
    "stem": "糖尿病酮症酸中毒患者宜选用的药物是",
    "options": {
      "A": "瑞格列奈",
      "B": "司美格鲁肽",
      "C": "胰岛素",
      "D": "二甲双胍",
      "E": "吡格列酮"
    },
    "answer": "C",
    "explanation": "②本题考查胰岛素和胰岛素类似物的临床用药评价。胰岛素能促进脂肪的合成, 抑制脂肪分解, 使酮体生成减少, 纠正酮症酸血症的各种症状。故本题答案为 C。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "4161153852e2aee5343c71edca6c60e73be4c5bb",
    "section_no": 4,
    "section_title": "胰岛素与其他影响血糖的药物",
    "section_norm": "第四节 胰岛素与其他影响血糖的药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第5节中枢镇痛药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "对于轻度疼痛者，应首选",
    "options": {
      "A": "羟考酮",
      "B": "呼替啶",
      "C": "阿司匹林",
      "D": "芬太尼",
      "E": "可待因"
    },
    "answer": "C",
    "explanation": "本题考查镇痛药的临床应用注意。轻度疼痛患者，首选非甾体抗炎药，如阿司匹林。故本题答案为 C。中度疼痛患者应选弱阿片类药，如可待因。对重度疼痛患者选用强阿片类药，如吗啡、哌替丁、芬太尼。",
    "source_note": "",
    "question_id": "69ff2f372d858773806126d663d6c65b4d58db75",
    "section_no": 5,
    "section_title": "中枢镇痛药",
    "section_norm": "第五节 中枢镇痛药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "不属于心衰治疗药物的是",
    "options": {
      "A": "阿司匹林",
      "B": "沙库巴曲缬沙坦钠",
      "C": "地高辛",
      "D": "托拉塞米",
      "E": "比索洛尔"
    },
    "answer": "A",
    "explanation": "本题考查抗心力衰竭药的分类与代表药品。目前心力衰竭的治疗药物主要包括以下几类：强心苷类（如地高辛）、利尿药（如托拉塞米）、ACEI、ARB、醛固酮受体拮抗剂、β受体拮抗剂（如比索洛尔）、血管紧张素受体脑啡肽酶抑制剂（沙库巴曲缬沙坦钠）、钠-葡萄糖协同转运蛋白2（SGLT-2i）抑制剂（达格列净）、伊伐布雷定、维立西呱。故本题答案为A。阿司匹林属于非甾体抗炎药，既可以解热、镇痛、抗炎，小剂量阿司匹林又可以预防血栓形成，作为心脑血管事件一、二级预防的基石。",
    "source_note": "",
    "question_id": "27452d1bf1424ab101ae542fb7e22d3ea10bcd02",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "长期服用钙剂可导致",
    "options": {
      "A": "腹泻",
      "B": "低钠血症",
      "C": "便秘、嗳气",
      "D": "骨质疏松",
      "E": "肝功能异常"
    },
    "answer": "C",
    "explanation": "本题考查钙剂的临床用药评价。长期服用钙剂可引起嗳气、便秘、腹部不适等，大剂量服用或用药过量可出现高钙血症，表现为畏食、恶心、呕吐、便秘、腹痛、肌无力、心律失常。故本题答案为 C。",
    "source_note": "",
    "question_id": "2e714a3a804f4409970d1eb6d3295ca943ce885d",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于抗雄激素类药，适用于晚期前列腺癌的药物是",
    "options": {
      "A": "甲羟孕酮",
      "B": "炔雌醇",
      "C": "他莫昔芬",
      "D": "氟他胺",
      "E": "托瑞米芬"
    },
    "answer": "D",
    "explanation": "本题考查抗雄激素类（氟他胺）的临床用药评价。氟他胺属于抗雄激素类药，与雄激素竞争肿瘤部位的雄激素受体，抑制肿瘤细胞对雄激素的摄取，抑制雄激素与靶器官的结合。适用于晚期前列腺癌患者。故本题答案为 D。甲羟孕酮属于孕激素类。炔雌醇属于雌激素类。他莫昔芬和托瑞米芬属于雌激素受体拮抗剂。",
    "source_note": "",
    "question_id": "6e566604b0ca75a43d5fcffcfc8b18964a4567ba",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第5节治疗白癜风药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于补骨脂素及其衍生物的治疗白癜风药是",
    "options": {
      "A": "过氧苯甲酰",
      "B": "他扎罗汀",
      "C": "甲氧沙林",
      "D": "煤焦油",
      "E": "曲安奈德"
    },
    "answer": "C",
    "explanation": "本题考查治疗白癜风药的分类与代表药品。补骨脂素及其衍生物的代表药品有甲氧沙林、三甲沙林。故本题答案为 C。",
    "source_note": "",
    "question_id": "1db76924cb9f70c460657c772ee02c02ac047ad8",
    "section_no": 5,
    "section_title": "治疗白癜风药",
    "section_norm": "第五节 治疗白癜风药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可用于治疗便秘和肝性脑病的药物是",
    "options": {
      "A": "多库酯钠",
      "B": "硫酸镁 普芦卡必利",
      "C": "利那洛肽",
      "D": "乳果糖"
    },
    "answer": "D",
    "explanation": "本题考查泻药和便秘治疗药的临床用药评价。乳果糖口服后几乎不被吸收，以原型到达结肠，被肠道菌群分解为有机酸，导致肠道内 \\mathsf{pH} 下降，发挥渗透效应，并通过保留水分，增加粪便体积，从而发挥导泻治疗便秘的作用；同时可促进肠道嗜酸菌（如乳酸杆菌）的生长，抑制蛋白分解菌，改善肠道细菌氨代谢，可用于治疗肝性脑病。故本题答案为D。",
    "source_note": "",
    "question_id": "65a1fea8c9061df7095e7160f3e57323e1edd8b1",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第5节中枢镇痛药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "关于镇痛药使用注意事项的说法，错误的是",
    "options": {
      "A": "呕替啶的代谢产物具有神经毒性",
      "B": "口服给药，尽量避免创伤性给药，尤其是强阿片类药",
      "C": "“按时”给药，而不是“按需”给药",
      "D": "按阶梯给药，对于中度疼痛者应选用弱阿片类药",
      "E": "为避免严重不良反应，晚期癌痛患者应严格限制用量"
    },
    "answer": "E",
    "explanation": "本题考查镇痛药的临床应用注意。哌替啶在体内可转变为毒性代谢产物去甲哌替啶，产生神经系统毒性，表现为震颤、抽搐、癫痫大发作。镇痛药的使用原则：①口服给药，尽量避免创伤性给药，尤其是对于强阿片类药；②“按时”给药，而不是“按需”给药，以达到最低血浆药物浓度、峰值与谷值比；③按阶梯给药，对于轻度疼痛患者首选非甾体抗炎药；对于中度疼痛者应选用弱阿片类药；对于重度疼痛者应选用强阿片类药；④用药应个体化，剂量根据患者需要由小到大，直至患者疼痛消失，不应对药量限制过严，导致用药不足，应注意患者的实际疗效。故本题答案为E。",
    "source_note": "explanation_range_detected",
    "question_id": "16f51ebcbec27d4b22d303b2b24c4e4b4875d8af",
    "section_no": 5,
    "section_title": "中枢镇痛药",
    "section_norm": "第五节 中枢镇痛药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第5节骨髓保护药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "关于曲拉西利临床应用的描述，正确的是",
    "options": {
      "A": "用于乳腺癌患者接受内分泌治疗时预防骨转移",
      "B": "用于多发性骨髓瘤患者接受蛋白酶体抑制剂治疗时减少周围神经病变",
      "C": "用于非小细胞肺癌患者接受免疫治疗前预防骨髓抑制",
      "D": "用于既往接受过多次化疗的广泛期小细胞肺癌患者以增强化疗疗效",
      "E": "用于既往未接受过系统性化疗的广泛期小细胞肺癌患者，在接受含铂类药物联合依托泊苷方案治疗前预防性给药，降低骨髓抑制风险"
    },
    "answer": "E",
    "explanation": "本题考查骨髓保护药的分类与临床用药评价。曲拉西利是细胞周期蛋白依赖性激酶（CDK）4和6选择性抑制剂，适用于既往未接受过系统性化疗的广泛期小细胞肺癌患者，在接受含铂类药物联合依托泊苷方案治疗前预防性给药，降低化疗引起的骨髓抑制的发生率。故本题答案为E。",
    "source_note": "",
    "question_id": "4b8e4e1f8b906a3a4d814e319597ce9904a034e8",
    "section_no": 5,
    "section_title": "骨髓保护药",
    "section_norm": "第五节 骨髓保护药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第5节碳青霉烯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "为防止亚胺培南在近端肾小管中被正常人类肾脱氢肽酶I灭活，需联合使用的药物是",
    "options": {
      "A": "甲氧苄啶",
      "B": "西司他丁",
      "C": "克拉维酸",
      "D": "舒巴坦",
      "E": "他唑巴坦"
    },
    "answer": "B",
    "explanation": "本题考查碳青霉烯类药物的临床用药评价。亚胺培南在近端肾小管中被正常人类肾脱氢肽酶 I 灭活，西司他丁是肾脱氢肽酶 I 的特异性抑制剂，故联合西司他丁可防止亚胺培南灭活。故本题答案为 B。",
    "source_note": "",
    "question_id": "8a66dcd82b29649c1e7663d8120c00bbd779a11c",
    "section_no": 5,
    "section_title": "碳青霉烯类抗菌药物",
    "section_norm": "第五节 碳青霉烯类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "为目前临床上最常用的内分泌治疗药，主要用于治疗乳腺癌（雌激素受体阳性者，绝经前、后均可使用）的药物是",
    "options": {
      "A": "曲妥珠单抗",
      "B": "氟他胺 来曲唑",
      "C": "阿那曲唑",
      "D": "他莫昔芬"
    },
    "answer": "D",
    "explanation": "本题考查抗雌激素类的临床用药评价。他莫昔芬是目前临床上最常用的内分泌治疗药，主要用于治疗乳腺癌（雌激素受体阳性者，绝经前、后均可使用）、化疗无效的晚期卵巢癌和晚期子宫内膜癌。故本题答案为D。曲妥珠单抗属于生物靶向治疗药物。氟他胺临床适用于晚期前列腺癌。阿那曲唑和来曲唑属于芳香氨酶抑制剂，由于不能抑制卵巢功能，故不能用于绝经前乳腺癌患者，可用于绝经后乳腺癌患者。",
    "source_note": "",
    "question_id": "1e21948fd192d917d950343a91b2634886254964",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第5节治疗白癜风药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "治疗白癜风药分为4类，下列药物中不属于治疗白癜风药的是",
    "options": {
      "A": "肾上腺糖皮质激素类",
      "B": "钙调神经磷酸酶抑制剂",
      "C": "补骨脂素及其衍生物",
      "D": "维生素 \\mathrm{D}_{3} 衍生物",
      "E": "丙烯胺类"
    },
    "answer": "E",
    "explanation": "本题考查治疗白癜风药的分类与代表药品。治疗白癜风药分为 4 类,包括 ① 补骨脂素类及其衍生物: 甲氧沙林、三甲沙林; ② 肾上腺糖皮质激素类; ③ 钙调神经磷酸酶抑制剂: 他克莫司、吡美莫司; ④ 维生素 D3 衍生物: 卡泊三醇、他卡西醇。故本题答案为 E。丙烯胺类属于局部用抗真菌药。",
    "source_note": "explanation_range_detected",
    "question_id": "0bcfeb78f5fca066151cf2fc7ea854dca64ac5ae",
    "section_no": 5,
    "section_title": "治疗白癜风药",
    "section_norm": "第五节 治疗白癜风药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "为线性长链聚合物，通过氢键固定水分子，增加粪便含水量并软化粪便，从而改善便秘症状的是",
    "options": {
      "A": "聚乙二醇",
      "B": "乳果糖",
      "C": "聚卡波非钙",
      "D": "甘油",
      "E": "比沙可啶"
    },
    "answer": "A",
    "explanation": "本题考查泻药和便秘治疗药的临床用药评价。聚乙二醇为线性长链聚合物, 可通过氢键固定水分子, 使水分保留在结肠内, 增加粪便含水量并软化粪便, 恢复粪便体积和重量至正常, 从而改善便秘症状。故本题答案为 A。",
    "source_note": "",
    "question_id": "4ca2797eb94f14a9aa659c4176712a079dd67614",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第5节中枢镇痛药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "吗啡的适应证不包括是",
    "options": {
      "A": "癌性剧痛",
      "B": "胆绞痛及肾绞痛",
      "C": "严重战伤",
      "D": "急性锐痛",
      "E": "颅内压升高引起的头痛"
    },
    "answer": "E",
    "explanation": "本题考查吗啡的临床用药评价。吗啡属于强阿片类镇痛药，适用于其他镇痛药无效的急性锐痛，如严重创伤、战伤、烧伤、晚期癌症等疼痛，与阿托品合用，可缓解胆绞痛和肾绞痛。但吗啡可导致颅内压增高，颅内压升高引起的头痛者禁用吗啡。故本题答案为E。",
    "source_note": "",
    "question_id": "f9cf68ab8eece5631f0380ae3796c276a3ed1558",
    "section_no": 5,
    "section_title": "中枢镇痛药",
    "section_norm": "第五节 中枢镇痛药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "主要通过增强心肌收缩力而改善心功能的药物是",
    "options": {
      "A": "卡维地洛",
      "B": "硝酸异山梨酯",
      "C": "洋地黄毒苷",
      "D": "依他尼酸",
      "E": "依那普利"
    },
    "answer": "C",
    "explanation": "本题考查强心苷类药物的临床用药评价。洋地黄毒苷属于强心苷类正性肌力药, 主要是通过抑制衰竭心肌细胞膜上 \\mathrm{Na}+, \\mathrm{K}+-ATP 酶, 使细胞内 \\mathrm{Na}+ 水平升高, 促进 \\mathrm{Na}+-\\mathrm{Ca}2+ 交换, 提高细胞内 \\mathrm{Ca}2+ 水平, 从而发挥正性肌力作用。故本题答案为 C。",
    "source_note": "",
    "question_id": "99814d171963fb5cf444c9d74194d67b4c76dbad",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第5节碳青霉烯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "肝功能不全者无需调整剂量的碳青霉烯类药物是",
    "options": {
      "A": "亚胺培南",
      "B": "厄他培南",
      "C": "美罗培南",
      "D": "比阿培南",
      "E": "氨曲南"
    },
    "answer": "C",
    "explanation": "本题考查碳青霉烯类药物的临床用药评价。碳青霉烯类药物的代表药 为亚胺培南、美罗培南、厄他培南、比阿培南。其中美罗培南肝功能不全者无需调整剂量。故本题答案为 C。",
    "source_note": "",
    "question_id": "c1317b0164767af35e0c4dcba7a4e256f909d529",
    "section_no": 5,
    "section_title": "碳青霉烯类抗菌药物",
    "section_norm": "第五节 碳青霉烯类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "属于芳香氨酶抑制剂的药物是",
    "options": {
      "A": "依西美坦",
      "B": "丙酸睾酮",
      "C": "氟维司群",
      "D": "亮丙瑞林"
    },
    "answer": "A",
    "explanation": "本题考查调节体内激素平衡的药物的分类与代表药品。依西美坦属于芳香氨酶抑制剂。氟他胺属于抗雄激素类。氟维司群属于雌激素受体拮抗剂。亮丙瑞林属于促性腺激素释放激素（GnRH）激动剂/抑制剂。丙酸睾酮属于雄激素类。故本题答案为A。",
    "source_note": "",
    "question_id": "c7e24486336b106334d79dd9877369d15f10135f",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "属于容积性泻药，通过滞留粪便中的水分，增加粪便含水量和粪便体积起到通便作用的药物是",
    "options": {
      "A": "比沙可啶",
      "B": "乳果糖",
      "C": "聚乙二醇 4000",
      "D": "聚卡波非钙",
      "E": "多库酯钠"
    },
    "answer": "D",
    "explanation": "本题考查泻药和便秘治疗药的分类与代表药品。容积性泻药通过滞留 粪便中的水分，增加粪便含水量和粪便体积起到通便作用，常用药物包括欧车前、聚卡波非钙等。故本题答案为 D。",
    "source_note": "",
    "question_id": "560d839349b74ef59471418b92ab4c56ffb3e332",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "属于促性腺激素释放激素类似物，通过调节体内激素平衡，既能治疗前列腺癌，又能治疗乳腺癌的药物是",
    "options": {
      "A": "依西美坦",
      "B": "氟他胺",
      "C": "他莫昔芬",
      "D": "丙酸睾酮",
      "E": "戈舍瑞林"
    },
    "answer": "E",
    "explanation": "本题考查调节体内激素平衡的药物的分类与代表药品。戈舍瑞林属于促性腺激素释放激素类似物，通过调节体内激素平衡，临床主要用于可用激素治疗的前列腺癌，可用激素治疗的绝经前期及围绝经期妇女的乳腺癌以及缓解子宫内膜异位症症状，包括减轻疼痛并减少子宫内膜损伤的大小和数目。故本题答案为E。",
    "source_note": "",
    "question_id": "c24164a76ae30efa1c756d4f860c8b8267a16eb9",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "激动鸟苷酸环化酶 C，增强肠液分泌，促进排便的药物是",
    "options": {
      "A": "乳果糖",
      "B": "利那洛肽",
      "C": "多库酯钠",
      "D": "聚卡波非钙",
      "E": "聚乙二醇 4000"
    },
    "answer": "B",
    "explanation": "本题考查泻药和便秘治疗药的临床用药评价。利那洛肽属于促分泌药类泻药, 是一种鸟苷酸环化酶 C (GC-C) 激动剂, 可使小肠液分泌增加和结肠转运速度增快, 促进排便。故本题答案为 B。",
    "source_note": "",
    "question_id": "ab453999ec0e42f8fd3f4d0468e15ff0df89291a",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "属于中效强心苷，生物利用度约为 80\\% ，不经肝脏代谢的药物是",
    "options": {
      "A": "洋地黄毒苷",
      "B": "米力农",
      "C": "西地兰",
      "D": "毒毛花苷 K",
      "E": "地高辛"
    },
    "answer": "E",
    "explanation": "本题考查强心苷类药物的临床用药评价。地高辛是一种中效强心苷。其剂型多样, 口服地高辛的起效时间为 1 \\sim 2 \\mathrm{~h}, 血浆浓度达峰时间 2 \\sim 3 \\mathrm{~h}, 消除半衰期为 36 \\mathrm{~h}, 生物利用度约为 80 \\%, 主要以原形药物从尿液中排出。故本题答案为 E。",
    "source_note": "",
    "question_id": "efdf0f035d6b6b086c848315e98aff6a07c74d3a",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "可导致高血钙，服用洋地黄类药物期间应谨慎制定用量的药物是",
    "options": {
      "A": "鲤降钙素",
      "B": "雷洛昔芬",
      "C": "骨化三醇",
      "D": "阿仑膦酸钠",
      "E": "地舒单抗"
    },
    "answer": "C",
    "explanation": "本题考查维生素 D 及其活性代谢物的临床用药评价。骨化三醇较普通维生素 D 更易引起高钙血症, 因可诱导洋地黄类药物中毒, 对正在进行洋地黄类药物治疗的患者, 应谨慎制定维生素 D 及活性维生素 D 的用量。故本题答案为 C。",
    "source_note": "",
    "question_id": "e69e13de65b600051cd3b85523f3f10a30a7d807",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "对骨髓无抑制作用的药物是",
    "options": {
      "A": "氟尿嘧啶",
      "B": "甲氨蝶呤",
      "C": "环磷酰胺",
      "D": "疏嘌呤",
      "E": "他莫昔芬"
    },
    "answer": "E",
    "explanation": "本题考查抗雌激素类的临床用药评价。他莫昔芬属于调节体内激素平衡药, 无骨髓抑制的不良反应。故本题答案为 E。环磷酰胺、氟尿嘧啶、甲氨蝶呤和巯嘌呤均为细胞毒类抗肿瘤药, 对增殖较快的正常组织如骨髓等有毒性作用。",
    "source_note": "",
    "question_id": "12eaf0c1850cc06e5de4248cde519dad83f8acd5",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "为一种阴离子表面活性剂，口服后基本不吸收，通过物理性润滑肠道排便的是",
    "options": {
      "A": "比沙可啶",
      "B": "伊托必利",
      "C": "多库酯钠",
      "D": "聚卡波非钙",
      "E": "硫酸镁"
    },
    "answer": "C",
    "explanation": "本题考查泻药和便秘治疗药的临床用药评价。多库酯钠为一种阴离子表面活性剂，口服后基本不吸收，通过物理性润滑肠道排便，主要用于慢性功能性便秘。故本题答案为 C。",
    "source_note": "",
    "question_id": "186b29b53567e8f185fdbb417cbd6b5c0719e80d",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "地高辛中毒的易感因素不包括",
    "options": {
      "A": "肾功能损害",
      "B": "肝功能不全",
      "C": "低钾血症",
      "D": "高钙血症",
      "E": "老年患者"
    },
    "answer": "B",
    "explanation": "本题考查强心苷类药物的临床用药评价。地高辛以原型经肾脏排出,肝功能不全者可以选用。故本题答案为 B。地高辛中毒的易感因素: ①肾功能损害; ②电解质紊乱尤其是低钾血症、低镁血症、高钙血症可加大地高辛中毒的危险, 发生心律失常; ③老年患者伴随年龄的增加, 分布容积加大, 消除半衰期延长。",
    "source_note": "explanation_range_detected",
    "question_id": "34910bda24a3738f14a485d5d3bed0761499cf90",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "可导致手部潮红、咽喉部薄荷样爽快感、指端麻木、哮喘发作的药物是",
    "options": {
      "A": "唑来膦酸",
      "B": "雷洛昔芬",
      "C": "特立帕肽",
      "D": "鲤降钙素",
      "E": "维生素D"
    },
    "answer": "D",
    "explanation": "本题考查降钙素的临床用药评价。降钙素的不良反应有: ①面部、手部潮红; ②诱发哮喘; ③咽喉部薄荷样爽快感、低钠血症、全身乏力、指端麻木; ④过敏性休克。故本题答案为 D。",
    "source_note": "explanation_range_detected",
    "question_id": "fd88569525258d2981afd4b73de02d4a664a7a7f",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "主要经肝脏代谢，受肾功能影响小，体内消除缓慢，有蓄积性的强心苷类药物是",
    "options": {
      "A": "毒毛花苷 K",
      "B": "去乙酰毛花苷",
      "C": "维立西呱",
      "D": "洋地黄毒苷",
      "E": "地高辛"
    },
    "answer": "D",
    "explanation": "本题考查强心苷类药物的临床用药评价。洋地黄毒苷属于长效强心苷, 半衰期为 7 日以上, 体内消除缓慢, 有蓄积性, 主要经肝脏代谢, 受肾功能影响小, 可用于肾功能不全者。故本题答案为 D。毒毛花苷 K、去乙酰毛花苷为速效强心苷。维立西呱为可溶性鸟苷酸环化酶 (sGC) 刺激剂。地高辛是一种中效强心苷, 主要以原型药物从尿液中排出, 可用于肝功能不全者。",
    "source_note": "",
    "question_id": "ab7e775fb7a740d1da5aee628f50ee9825d2c3fa",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "可导致出汗、潮红、下肢痛性痉挛、类流感样综合征的不良反应，治疗初始时4个月内发生静脉血栓的危险性高的药物是",
    "options": {
      "A": "依替膦酸二钠",
      "B": "骨化三醇",
      "C": "生长因子",
      "D": "鲑降钙素",
      "E": "雷洛昔芬"
    },
    "answer": "E",
    "explanation": "本题考查雌激素受体调节剂的临床用药评价。雷洛昔芬属于雌激素受体调节剂，典型不良反应有：外周水肿、出汗、潮热、下肢痛性痉挛、头痛、血压升高、类流感样综合征、治疗初始时4个月内发生静脉血栓事件的危险性高。故本题答案为E。",
    "source_note": "",
    "question_id": "1d71ea625cdfb08a4792144fd8731e28468130f1",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "不属于氟维司群不良反应的是",
    "options": {
      "A": "男性乳房女性化",
      "B": "肝脏转氨酶 AST 及 ALT 升高",
      "C": "血栓栓塞",
      "D": "碱性磷酸酶升高",
      "E": "骨质疏松"
    },
    "answer": "A",
    "explanation": "本题考查抗雌激素类的临床用药评价。氟维司群属于抗雌激素类药, 不良反应包括: 血栓栓塞风险、注射部位反应、无力、恶心、肝脏转氨酶 AST 及 ALT 升高、碱性磷酸酶升高、骨质疏松的潜在风险等, 不会导致男性乳房女性化。故本题答案为 A。",
    "source_note": "",
    "question_id": "05b484d23bbe6edffaefe5d7c981452014dca326",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "可单纯降低心率，且特异性对窦房结起作用，对心房、房室或者心室传导时间未见明显影响的药物是",
    "options": {
      "A": "伊伐布雷定",
      "B": "地高辛",
      "C": "依那普利",
      "D": "沙库巴曲缬沙坦钠",
      "E": "米力农"
    },
    "answer": "A",
    "explanation": "本题考查伊伐布雷定的临床用药评价。伊伐布雷定是一种单纯降低心率的药物, 只特异性对窦房结起作用, 适用于窦性心律且心率 \\geqslant 75 次/分、伴有心脏收缩功能障碍的 NYHA II ～IV级慢性心力衰竭患者。故本题答案为 A。",
    "source_note": "",
    "question_id": "5a29eedbcb2e905addb69b7e0fbddb80899eee81",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "属于抗雌激素类药物的是",
    "options": {
      "A": "氟他胺、戈舍瑞林",
      "B": "他莫昔芬、氟他胺",
      "C": "托瑞米芬、来曲唑",
      "D": "阿那曲唑、戈舍瑞林",
      "E": "来曲唑、氟他胺"
    },
    "answer": "C",
    "explanation": "本题考查调节体内激素平衡的药物的分类与代表药品。抗雌激素类药物包括: ①雌激素受体拮抗剂: 托瑞米芬、他莫昔芬、氟维司群; ②芳香氨酶抑制剂: 来曲唑、阿那曲唑、依西美坦; ③孕激素类: 甲羟孕酮、甲地孕酮。故本题答案为 C。",
    "source_note": "explanation_range_detected",
    "question_id": "fab33767f7869fb3ac6c3896d26f46ec8d185760",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "属于人内源性甲状旁腺激素的活性片段，可用于治疗骨质疏松的是",
    "options": {
      "A": "鲤降钙素",
      "B": "依诺肝素",
      "C": "特立帕肽",
      "D": "雷洛昔芬",
      "E": "地舒单抗"
    },
    "answer": "C",
    "explanation": "本题考查特立帕肽的临床用药评价。特立帕肽属于人内源性甲状旁腺 激素的活性片段，可用于治疗骨质疏松。故本题答案为 C。",
    "source_note": "",
    "question_id": "cbf46eb022dc8c714955f495ab665ab2a5f1b470",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "体内生物活性最强的钙吸收调节剂是",
    "options": {
      "A": "骨化三醇",
      "B": "阿法骨化醇 降钙素",
      "C": "艾地骨化醇",
      "D": "维生素 D"
    },
    "answer": "A",
    "explanation": "本题考查维生素 D 及其活性代谢物的临床用药评价。骨化三醇是体内生物活性最强的钙吸收调节剂。故本题答案为 A。",
    "source_note": "",
    "question_id": "413ee10a379b393f74e57d726614eb373d702a33",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "可直接刺激可溶性鸟苷酸环化酶（sGC），改善心肌重构和肾脏血流的药物是",
    "options": {
      "A": "米力农",
      "B": "螺内酯",
      "C": "维立西呱",
      "D": "达格列净",
      "E": "卡维地洛"
    },
    "answer": "C",
    "explanation": "本题考查抗心力衰竭药的分类与代表药品。维立西呱是一种口服可溶性鸟苷酸环化酶（sGC）刺激剂，直接刺激 sGC，改善心肌重构和肾脏血流，降低近期发生心衰加重事件的慢性 HFrEF 患者的心血管死亡或心衰住院风险。故本题答案为 C。",
    "source_note": "",
    "question_id": "316dd5fa3d9d565f2e66d4089716cb1558988436",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "可导致“类流感样”反应的药物是",
    "options": {
      "A": "唑来膦酸钠",
      "B": "葡萄糖酸钙",
      "C": "阿法骨化醇",
      "D": "降钙素",
      "E": "糖皮质激素"
    },
    "answer": "A",
    "explanation": "本题考查双膦酸盐类药物的临床用药评价。注射用唑来膦酸钠可致“类流感样”反应, 表现为高热、肌肉酸痛等症状, 可以给予对乙酰氨基酚以解热镇痛治疗。故本题答案为 A。",
    "source_note": "",
    "question_id": "bd955eed615ec19063af25bd0d383264c1563036",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "单项选择题",
    "qno": 13,
    "stem": "下列对阿仑膦酸钠临床应用注意的描述，错误的是",
    "options": {
      "A": "可引起无症状性血钙降低, 应同时补钙",
      "B": "早餐前至少 30\\mathrm{min} 用 200\\mathrm{ml} 温开水送服",
      "C": "服后 30 \\mathrm{~min} 内不宜进食和卧床",
      "D": "不宜喝牛奶、咖啡、茶",
      "E": "治疗前须纠正钙代谢紊乱、维生素D缺乏"
    },
    "answer": "A",
    "explanation": "本题考查双膦酸盐类药物的临床用药评价。由于双膦酸盐会促进钙元素在骨骼中矿化沉积，增加血钙向骨钙的转移，应用双膦酸盐治疗可能会引发低钙血症，因此接受双膦酸盐类药物治疗前需要纠正低钙血症；确保维生素D和元素钙的摄入充分，但需要注意口服双膦酸盐制剂应避免和钙剂同一时间服用，以避免口服钙剂影响双膦酸盐在胃肠道的吸收。故本题答案为A。",
    "source_note": "",
    "question_id": "95d009b147d329e21a4ffa6b31d9d0aeec0fa17e",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "单项选择题",
    "qno": 14,
    "stem": "下列调节骨代谢药物中，属于 RANKL 抑制剂的药物是",
    "options": {
      "A": "雷洛昔芬",
      "B": "阿仑膦酸钠",
      "C": "地舒单抗",
      "D": "生长激素",
      "E": "鲤降钙素"
    },
    "answer": "C",
    "explanation": "本题考查调节骨代谢药的分类与代表药品。调节骨代谢的药物可分为 ①钙剂（如碳酸钙）、维生素D及其活性代谢物（如骨化三醇、阿法骨化醇）；②抑制骨吸收药：双膦酸盐类（如阿仑膦酸钠）、替勃龙、雌激素类、RANKL抑制剂（如地舒单抗）、雷洛昔芬、降钙素等；③刺激骨形成药：氟制剂、甲状旁腺激素、生长激素、骨生长因子等。故本题答案为C。",
    "source_note": "explanation_range_detected",
    "question_id": "27f798066bf5bcee40eb0b9ce711d6b73fa7df3c",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第5节中枢镇痛药",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "根据止痛强度分类，属于弱阿片类药物的是",
    "options": {
      "A": "呕替啶",
      "B": "吗啡",
      "C": "双氢可待因",
      "D": "芬太尼",
      "E": "喷他佐辛"
    },
    "answer": "C",
    "explanation": "①本题考查阿片类镇痛药的止痛强度。根据阿片类镇痛药的止痛强度分为弱、强阿片类药。弱阿片类药如可待因、双氢可待因, 主要用于轻、中度疼痛和癌性疼痛的治疗。故本题答案为 C。",
    "source_note": "",
    "question_id": "2b394d1eed055752daa13667e73263b8293d2fea",
    "section_no": 5,
    "section_title": "中枢镇痛药",
    "section_norm": "第五节 中枢镇痛药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第5节中枢镇痛药",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "根据来源分类，属于阿片生物碱类的药物是",
    "options": {
      "A": "呕替啶",
      "B": "吗啡",
      "C": "双氢可待因",
      "D": "芬太尼",
      "E": "喷他佐辛"
    },
    "answer": "B",
    "explanation": "②本题考查镇痛药的分类与代表药品。麻醉性镇痛药依来源可分为三类: 阿片生物碱 (吗啡、可待因)、半合成吗啡样镇痛药 (双氢可待因、丁丙诺啡、氢吗啡酮等)、合成阿片类镇痛药 (芬太尼、舒芬太尼、阿芬太尼、美沙酮、左啡诺、布托啡诺、喷他佐辛等)。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "6d16fb7edc97ef0da4dd23911fa816beae0541a8",
    "section_no": 5,
    "section_title": "中枢镇痛药",
    "section_norm": "第五节 中枢镇痛药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第5节碳青霉烯类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "西司他丁和亚胺培南组成复方制剂的原因是",
    "options": {
      "A": "两种药物会形成复合物沉淀",
      "B": "诱导细菌对前者的耐药",
      "C": "易发生交叉过敏反应",
      "D": "促进前者在肝脏的代谢",
      "E": "阻止后者在肾脏被灭活"
    },
    "answer": "E",
    "explanation": "本组题考查碳青霉烯类药物的临床用药评价。 ①亚胺培南在近端肾小管中被正常人类肾脱氢肽酶I灭活，西司他丁是肾脱氢肽酶的特异性抑制剂，故联用西司他丁可防止亚胺培南在肾脏被灭活。故本题答案为E。",
    "source_note": "",
    "question_id": "b5e1dcefa60c54be6ff775e091ce139e5f80a593",
    "section_no": 5,
    "section_title": "碳青霉烯类抗菌药物",
    "section_norm": "第五节 碳青霉烯类抗菌药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第5节中枢镇痛药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "根据结构分类，属于苯并吗啡烷类的药物是",
    "options": {
      "A": "呕替啶",
      "B": "吗啡",
      "C": "双氢可待因",
      "D": "芬太尼",
      "E": "喷他佐辛"
    },
    "answer": "E",
    "explanation": "③本题考查镇痛药的分类与代表药品。合成阿片类镇痛药根据化学结构不同分为四类: 苯哌啶类 (芬太尼、舒芬太尼、阿芬太尼、哌替啶)、二苯甲烷类 (美沙酮)、吗啡烷类 (左啡诺、布托啡诺)、苯并吗啡烷类 (喷他佐辛)。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "7340fa21cd0f346422a14aed4cf4c1aaa0607a56",
    "section_no": 5,
    "section_title": "中枢镇痛药",
    "section_norm": "第五节 中枢镇痛药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "起效快、效果好，但长期使用会破坏肠道水电解质平衡和维生素吸收的刺激性泻药是",
    "options": {
      "A": "多库酯钠",
      "B": "比沙可啶",
      "C": "利那洛肽",
      "D": "普芦卡必利",
      "E": "聚乙二醇 4000"
    },
    "answer": "B",
    "explanation": "本组题考查泻药和便秘治疗药的临床用药评价。 ①刺激性泻药包括比沙可啶、蒽醌类药物（如大黄、番泻叶）和蓖麻油，这类药物虽起效快、效果好，但长期使用会影响肠道水电解质平衡和维生素吸收，也会损害肠神经系统，导致大肠肌无力、药物依赖等。故本题答案为B。",
    "source_note": "",
    "question_id": "6ab0cd2b36be046ac094512eba2f9a6e300741b0",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第5节中枢镇痛药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "阿片类药物与阿托品合用可能出现的不良反应是",
    "options": {
      "A": "便秘、尿潴留",
      "B": "呼吸抑制、低血压",
      "C": "毒物排出缓慢，痊愈延迟",
      "D": "昏迷、惊厥、高热",
      "E": "针尖样瞳孔"
    },
    "answer": "A",
    "explanation": "本组题考查镇痛药的临床应用注意。 ①阿片类镇痛药与抗胆碱药尤其是阿托品合用, 不仅加重便秘, 还可增加麻痹性肠梗阻和尿潴留危险。故本题答案为 A。",
    "source_note": "",
    "question_id": "f376979296900bba676bf39ed3caeeb69707ac29",
    "section_no": 5,
    "section_title": "中枢镇痛药",
    "section_norm": "第五节 中枢镇痛药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "可在肠内形成高渗状态，吸收水分，增加粪便体积，刺激肠道蠕动，用于成人及8岁以上儿童便秘的药物是",
    "options": {
      "A": "多库酯钠",
      "B": "比沙可啶",
      "C": "利那洛肽",
      "D": "普芦卡必利",
      "E": "聚乙二醇 4000"
    },
    "answer": "E",
    "explanation": "本组题考查泻药和便秘治疗药的临床用药评价。 ②聚乙二醇4000属于渗透性泻药，可在肠内形成高渗状态，吸收水分，增加粪便体积，刺激肠道蠕动，临床用于成人及8岁以上儿童便秘。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "125d8ffb3c834cf58715321ba5b4a3e6038ec0f7",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第5节中枢镇痛药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "阿片类药物与硫酸镁合用可能出现的不良反应应是",
    "options": {
      "A": "便秘、尿潴留",
      "B": "呼吸抑制、低血压",
      "C": "毒物排出缓慢，痊愈延迟",
      "D": "昏迷、惊厥、高热",
      "E": "针尖样瞳孔"
    },
    "answer": "B",
    "explanation": "本组题考查镇痛药的临床应用注意。 ②硫酸镁与阿片类镇痛药合用可增强中枢抑制, 增加呼吸抑制和低血压风险。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "04ffab7c7e34e315b0bd3a2485e0c34b164ac95a",
    "section_no": 5,
    "section_title": "中枢镇痛药",
    "section_norm": "第五节 中枢镇痛药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第5节中枢镇痛药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "广谱抗生素引起严重水泻时，与阿片类药物合用可能出现的不良反应是",
    "options": {
      "A": "便秘、尿潴留",
      "B": "呼吸抑制、低血压",
      "C": "毒物排出缓慢，痊愈延迟",
      "D": "昏迷、惊厥、高热",
      "E": "针尖样瞳孔"
    },
    "answer": "C",
    "explanation": "本组题考查镇痛药的临床应用注意。 ③广谱抗生素如头孢菌素、青霉素或林可霉素、克林霉素等诱发的伪膜性肠炎, 出现严重的水泻时, 不宜应用阿片类镇痛药, 易引起毒物自肠腔排出缓慢, 痔愈延迟。故本题答案为 C。单胺氧化酶抑制剂与阿片类镇痛药尤其是吗啡、哌替啶合用可产生严重的, 甚至致死的不良反应, 包括躁狂、多汗、僵直、呼吸抑制、昏迷、惊厥和高热。针尖样瞳孔是阿片类药物中毒的征兆。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "5accc904192e8f9a04b0df8544c8183d73fde1fb",
    "section_no": 5,
    "section_title": "中枢镇痛药",
    "section_norm": "第五节 中枢镇痛药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "可通过细胞膜，与雌激素竞争性结合胞质内的雌激素受体，抑制雌激素依赖性蛋白质的结合，从而抑制乳腺癌细胞增殖的药物是",
    "options": {
      "A": "雷洛普芬",
      "B": "托瑞米芬",
      "C": "丙酸睾酮",
      "D": "阿那曲唑",
      "E": "氟他胺"
    },
    "answer": "B",
    "explanation": "【 9 \\sim 10】 ①本题考查抗雌激素类的临床用药评价。托瑞米芬属于雌激素受体拮抗剂, 可通过细胞膜, 与雌激素竞争性结合胞质内的雌激素受体, 抑制雌激素依赖性蛋白质的结合, 从而抑制乳腺癌细胞增殖。故本题答案为 B。",
    "source_note": "",
    "question_id": "2874dd2b4b2d363dbcfbcda152ea1d0c52a77e66",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "可与雄激素竞争肿瘤部位的雄激素受体，抑 制组织细胞对雄激素的摄取，抑制雄激素与靶器官的结合的药物是",
    "options": {
      "A": "雷洛普芬",
      "B": "托瑞米芬",
      "C": "丙酸睾酮",
      "D": "阿那曲唑",
      "E": "氟他胺"
    },
    "answer": "E",
    "explanation": "【 9 \\sim 10】 ②本题考查抗雄激素类的临床用药评价。氟他胺属于抗雄激素类药, 一种非甾体的雄激素拮抗剂, 可与雄激素竞争肿瘤部位的雄激素受体, 抑制组织细胞对雄激素的摄取, 抑制雄激素与靶器官的结合。故本题答案为 E。",
    "source_note": "",
    "question_id": "4086517335c0ed176ba44efe02b0d39cdca56023",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "通过抑制衰竭心肌细胞膜上 \\mathrm{Na}^{+}, \\mathrm{K}^{+}-ATP酶,提高细胞内 \\mathrm{Ca}^{2+} 水平, 从而发挥正性肌力作用的药物是",
    "options": {
      "A": "沙库巴曲缬沙坦钠",
      "B": "伊伐布雷定",
      "C": "达格列净",
      "D": "洋地黄毒苷",
      "E": "米力农"
    },
    "answer": "D",
    "explanation": "【 12 \\sim 13】 ①本题考查强心苷类药物的临床用药评价。强心苷类药物通过抑制衰竭心肌细胞膜上 \\mathrm{Na}+, \\mathrm{K}+-ATP 酶, 提高细胞内 \\mathrm{Ca} 2+ 水平, 从而发挥正性肌力作用,代表药品有去乙酰毛花苷、地高辛、洋地黄毒苷、毒毛花苷 \\mathrm{K} 。故本题答案为 \\mathrm{D} 。",
    "source_note": "",
    "question_id": "2c29e0707adce46c520d2552dbca3d454f7f50ee",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "通过抑制脑啡肽酶，同时拮抗血管紧张素Ⅱ的1型受体（\\mathrm{AT}_{1}）而发挥作用的药物是",
    "options": {
      "A": "沙库巴曲缬沙坦钠",
      "B": "伊伐布雷定",
      "C": "达格列净",
      "D": "洋地黄毒苷",
      "E": "米力农"
    },
    "answer": "A",
    "explanation": "【 12 \\sim 13】 ②本题考查沙库巴曲缬沙坦钠的临床用药评价。沙库巴曲缬沙坦钠属于血管紧张素受体脑啡肽酶抑制剂, 通过抑制脑啡肽酶, 同时拮抗血管紧张素 II 的 1 型受体 (AT1) 而发挥药理效应。故本题答案为 \\mathrm{A} 。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "a10cfc0f780a3b46a44abd610b5dcf59c1c63fb0",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "需至少餐前30分钟直立位服用，用200ml左右温开水送服，服药后30分钟内不宜卧 床的药物是",
    "options": {
      "A": "地舒单抗",
      "B": "特立帕肽",
      "C": "雷洛昔芬",
      "D": "唑来膦酸",
      "E": "利塞膦酸钠"
    },
    "answer": "E",
    "explanation": "本组题考查双膦酸盐类药物的临床用药评价。 ①和阿仑膦酸钠类似, 利塞膦酸钠口服用药, 需至少餐前 30 分钟直立位服用, 一杯 (200ml 左右) 温开水送服, 服药后 30 分钟内不宜卧床。故本题答案为 E。",
    "source_note": "",
    "question_id": "70649952939886e2a37e36b32c5d5b16863c9f1a",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "治疗骨质疏松可每年一次静脉给药，通常连续治疗3年后停药的药物是",
    "options": {
      "A": "地舒单抗",
      "B": "特立帕肽",
      "C": "雷洛昔芬",
      "D": "唑来膦酸",
      "E": "利塞膦酸钠"
    },
    "answer": "D",
    "explanation": "本组题考查双膦酸盐类药物的临床用药评价。 ②唑来膦酸治疗骨质疏松可每年一次静脉给药, 通常连续治疗 3 年后停药。故本题答案为 D。",
    "source_note": "",
    "question_id": "99cb432518ef90d372560f9124f75a893a24ec63",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "可用于治疗恶性肿瘤溶骨性骨转移引起的骨痛和高钙血症的药物是",
    "options": {
      "A": "雷洛昔芬",
      "B": "唑来膦酸",
      "C": "骨化三醇",
      "D": "依普黄酮",
      "E": "特立帕肽"
    },
    "answer": "B",
    "explanation": "本组题考查双膦酸盐类药物的临床用药评价。 ①唑来膦酸可用于: 恶性肿瘤溶骨性骨转移引起的骨痛、多发性骨髓瘤引起的骨骼损害、恶性肿瘤引起的高钙血症、绝经后妇女骨质疏松症、变形性骨炎。故本题答案为 B。",
    "source_note": "",
    "question_id": "098bc429f8fe620840c3c36cf33827f368403c29",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "可导致颌骨坏死，治疗期间应保持良好的口腔卫生的药物是",
    "options": {
      "A": "雷洛昔芬",
      "B": "唑来膦酸",
      "C": "骨化三醇",
      "D": "依普黄酮",
      "E": "特立帕肽"
    },
    "answer": "B",
    "explanation": "本组题考查双膦酸盐类药物的临床用药评价。 ②唑来膦酸在治疗期间可导致颌骨坏死, 接受双膦酸盐类药物治疗期间, 应保持良好的口腔卫生, 接受常规的口腔检查。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "4cbfb3beb2e3d2f3bc38d71c359c53de93dd6ea0",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "配伍选择题",
    "qno": 19,
    "stem": "可促进肠细胞的钙转运，使肠钙吸收入血，缓解甲状旁腺功能低下所致的低血钙及其临床症状的药物是",
    "options": {
      "A": "碳酸钙",
      "B": "降钙素",
      "C": "特立帕肽",
      "D": "骨化三醇"
    },
    "answer": "D",
    "explanation": "①本题考查维生素 D 及其活性代谢物的临床用药评价。骨化三醇是食物或药物中的钙在肠道中被主动吸收的调节剂, 通过与肠壁细胞内的胞浆受体结合, 可促进细胞大量合成钙结合蛋白, 从而促进肠细胞的钙转运, 使肠钙吸收入血, 纠正低血钙, 可缓解甲状旁腺功能低下所致的低血钙及其临床症状。故本题答案为 D。",
    "source_note": "",
    "question_id": "e42a664e1ca6deb4c271344350ab5f13c57d23d1",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "配伍选择题",
    "qno": 21,
    "stem": "因没有“药物假期”，不会在骨基质中沉积，抑制骨转换的作用具有可逆性，停用后会在相对较短时间内导致骨丢失，骨折风险升高，故不应随意停药的是",
    "options": {
      "A": "唑来膦酸",
      "B": "地舒单抗",
      "C": "鲤降钙素",
      "D": "雷洛昔芬",
      "E": "特立帕肽"
    },
    "answer": "B",
    "explanation": "①本题考查地舒单抗的临床用药评价。地舒单抗不会在骨基质中沉积, 其抑制骨转换的作用具有可逆性, 停用后会在相对较短时间内导致骨丢失, 骨折风险升高, 因此地舒单抗没有“药物假期”的概念, 不应随意停药。故本题答案为 B。",
    "source_note": "",
    "question_id": "1a5bc7e7a082d9a7dfbc0c2cbaf8994d50c0023b",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "可损害肠神经系统，导致大肠肌无力、药物依赖和大便失禁，故不建议便秘患者，尤其是老年人长期使用的药物是",
    "options": {
      "A": "聚乙二醇 4000",
      "B": "乳果糖",
      "C": "比沙可啶",
      "D": "普芦卡必利",
      "E": "硫酸镁"
    },
    "answer": "C",
    "explanation": "本题考查泻药和便秘治疗药的临床用药评价。比沙可啶为刺激性泻药，可刺激结肠收缩和蠕动，缩短结肠转运时间，刺激肠液分泌；通便起效快，但长期使用可损害肠神经系统，导致大肠肌无力、药物依赖和大便失禁，故不建议便秘患者，尤其是老年人长期使用。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "1095385028e7897d760e104a84308fbaa22403ed",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "患者，男，80岁，因慢性心功能不全、同时伴有双下肢水肿住院。下列药物中能充分控制该心衰患者的液体潴留的是",
    "options": {
      "A": "血管紧张素转换酶抑制剂",
      "B": "利尿药",
      "C": "肾素抑制剂",
      "D": "\\beta 受体拮抗剂",
      "E": "强心苷"
    },
    "answer": "B",
    "explanation": "本题考查抗心力衰竭药的分类与代表药品。利尿药可促进水钠排出，缓解心力衰竭症状（呼吸困难、水肿等），改善运动耐量，降低住院风险。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "8e50d2ddeb9b33be97bd31e9b6ef5d7409949ebc",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第六章 血液系统用药",
    "section": "第5节骨髓保护药",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "适用于激素受体阳性、人表皮生长因子受体2阴性的局部晚期乳腺癌患者的药物是",
    "options": {
      "A": "曲妥珠单抗",
      "B": "瑞波西利",
      "C": "帕妥珠单抗",
      "D": "艾曲泊帕乙醇胺",
      "E": "重组链激酶"
    },
    "answer": "B",
    "explanation": "本题考查骨髓保护药的分类与临床用药评价。瑞波西利是CDK4/6抑制剂，可阻滞肿瘤细胞从G1进入S期，减少雌激素受体阳性乳腺癌细胞系的细胞增殖作用，用于激素受体阳性、人表皮生长因子受体2阴性的局部晚期或转移性乳腺癌。故本题答案为B。曲妥珠单抗和帕妥珠单抗为针对人表皮生长因子受体2阳性乳腺癌的靶向药物。艾曲泊帕乙醇胺为促血小板生成药。重组链激酶为溶栓药。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "4d1324428061014418277c728927f67274486aef",
    "section_no": 5,
    "section_title": "骨髓保护药",
    "section_norm": "第五节 骨髓保护药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "患者，女，56岁，绝经7年后出现骨质疏松，医生给予药物治疗，并提醒，应于早餐前空腹服用，且服用时必须保持坐位或立位，服后 30\\mathrm{min} 内不宜进食和卧床，该患者使用的药物是",
    "options": {
      "A": "碳酸钙",
      "B": "阿仑膦酸钠",
      "C": "鲤降钙素",
      "D": "雷洛昔芬",
      "E": "特立帕肽"
    },
    "answer": "B",
    "explanation": "本题考查双膦酸盐类的临床用药评价。口服阿仑膦酸钠可导致食管溃疡，故为避免对食管的刺激，宜在早餐前空腹用 200\\mathrm{ml} 温开水送服，服药后 30\\mathrm{min} 内不宜进食和卧床，持续活动或保持上身直立 30\\mathrm{min} 后才可以躺卧。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "24f4fa856d232b1c22405eb3472966f646bf34f4",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "属于雌激素受体调节剂，用于预防绝经后妇女的骨质疏松症，不适用于男性患者的药物是",
    "options": {
      "A": "鲤降钙素",
      "B": "阿仑膦酸钠",
      "C": "地舒单抗",
      "D": "雷洛昔芬",
      "E": "特立帕肽"
    },
    "answer": "D",
    "explanation": "本题考查雌激素受体调节剂的临床用药评价。雷洛昔芬属于雌激素受体调节剂，仅用于预防绝经后妇女的骨质疏松症，不适用于男性患者。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "eb340e26a75becbe0f06df917d794543f96ca736",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第5节碳青霉烯类抗菌药物",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "用于既往有癫痫病史患者可引发癫痫，应避免使用丙戊酸钠抗癫痫治疗的β-内酰胺类药物是",
    "options": {
      "A": "拉氧头孢",
      "B": "青霉素",
      "C": "头孢西丁",
      "D": "亚胺培南"
    },
    "answer": "D",
    "explanation": "本题考查碳青霉烯类药物的临床用药评价。碳青霉烯类药与丙戊酸钠合用时，可促进丙戊酸钠代谢，导致其血浆药物浓度降低至有效浓度以下，甚至引发癫痫。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "107035db6063f778be8befeda214a2d01799d21f",
    "section_no": 5,
    "section_title": "碳青霉烯类抗菌药物",
    "section_norm": "第五节 碳青霉烯类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第5节碳青霉烯类抗菌药物",
    "qtype": "综合分析题",
    "qno": 6,
    "stem": "服用丙戊酸钠的癫痫患者合用美罗培南后，可能引起癫痫发作的机制是",
    "options": {
      "A": "两种药物会形成复合物沉淀",
      "B": "诱导细菌对前者的耐药",
      "C": "易发生交叉过敏反应",
      "D": "促进前者在肝脏的代谢",
      "E": "阻止后者在肾脏被灭活"
    },
    "answer": "D",
    "explanation": "本组题考查碳青霉烯类药物的临床用药评价。 ②碳青霉烯类药与丙戊酸钠合用时，可促进丙戊酸代谢，导致其血浆药物浓度降低至有效浓度以下，甚至引发癫痫发作。故本题答案为D。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "6e760915e3bf4c4e5edf87d371ab23fa9403600e",
    "section_no": 5,
    "section_title": "碳青霉烯类抗菌药物",
    "section_norm": "第五节 碳青霉烯类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第5节调节体内激素平衡的药物",
    "qtype": "综合分析题",
    "qno": 6,
    "stem": "可用于雌激素受体阳性，经他莫昔芬治疗后病情仍有进展的绝经后晚期乳腺癌患者的药物是",
    "options": {
      "A": "依西美坦",
      "B": "氟他胺",
      "C": "甲羟孕酮",
      "D": "丙酸睾酮",
      "E": "甲地孕酮"
    },
    "answer": "A",
    "explanation": "本题考查抗雌激素类的临床用药评价。依西美坦主要用于经他莫昔芬辅助治疗 2 \\sim 3 年后，绝经后雌激素受体阳性的妇女的早期浸润性乳腺癌的辅助治疗，直至完成总共5年的辅助内分泌治疗，以及经他莫昔芬治疗后，其病情仍有进展的自然或人工绝经后妇女的晚期乳腺癌。故本题答案为A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "8cfb68fc96d92e2ea616e7cd2126e5441726fdf3",
    "section_no": 5,
    "section_title": "调节体内激素平衡的药物",
    "section_norm": "第五节 调节体内激素平衡的药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "综合分析题",
    "qno": 9,
    "stem": "选择性激动 5\\mathrm{-HT}_{4} 受体，增强肠道蠕动，可用于治疗成年女性患者中通过轻泻剂难以充分缓解的慢性便秘症状的药物是",
    "options": {
      "A": "多库酯钠",
      "B": "比沙可啶",
      "C": "利那洛肽",
      "D": "普芦卡必利",
      "E": "聚乙二醇 4000"
    },
    "answer": "D",
    "explanation": "本组题考查泻药和便秘治疗药的临床用药评价。 ③普芦卡必利为促动力药，属于5-HT4受体激动剂，可通过激动5-HT4受体，增强肠动力活性，可用于治疗成年女性患者中通过轻泻剂难以充分缓解的慢性便秘症状。故本题答案为D。多库酯钠属于润滑性泻药。利那洛肽属于促分泌药。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "6bc006d4ba7df6641c028e440657911c96138d71",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第五章 心血管系统用药",
    "section": "第5节抗心力衰竭药",
    "qtype": "综合分析题",
    "qno": 9,
    "stem": "患者，男，55岁，慢性心力衰竭，目前使用沙库巴曲缬沙坦钠、美托洛尔、螺内酯治疗，其中美托洛尔已达到目标剂量，但心率仍\\geqslant 80 次/分钟，该患者宜联用的药物是",
    "options": {
      "A": "依那普利",
      "B": "厄贝沙坦",
      "C": "伊伐布雷定",
      "D": "米力农",
      "E": "味塞米"
    },
    "answer": "C",
    "explanation": "本题考查伊伐布雷定的临床用药评价。伊伐布雷定是一种单纯降低心率的药物，主要用于：①已使用ACEI/ARB/ARNI、β受体拮抗剂、醛固酮受体拮抗剂，β受体拮抗剂已达到目标剂量或最大耐受剂量，心率仍≥70次/分钟；②心率≥70次/分钟，对β受体拮抗剂禁忌或不能耐受者。故本题答案为C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords) | explanation_range_detected",
    "question_id": "0c17cb9e9c0a4bf2e4a5197762148fe2db9d7e70",
    "section_no": 5,
    "section_title": "抗心力衰竭药",
    "section_norm": "第五节 抗心力衰竭药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "综合分析题",
    "qno": 12,
    "stem": "患者，女，28岁，孕30周。诊断为轻度便秘，宜选用的渗透性泻药是",
    "options": {
      "A": "聚卡波非钙",
      "B": "普芦卡必利",
      "C": "硫酸镁",
      "D": "聚乙二醇",
      "E": "利那洛肽"
    },
    "answer": "D",
    "explanation": "【 12 \\sim 13 】 ①本题考查泻药和便秘治疗药的特殊人群用药。妊娠期便秘的治疗首先建议患者改变生活方式, 其次某些渗透性泻药 (如聚乙二醇、乳果糖) 的安全性好、作用缓和且对胎儿无不良影响, 可作为妊娠期便秘患者的首选泻药。故本题答案为 D。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "6da22a93c7825261990a560f6d52725e5040d6bd",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "综合分析题",
    "qno": 12,
    "stem": "维生素D依赖性佝偻病患者宜采用的治疗方案是",
    "options": {
      "A": "肌内注射降钙素",
      "B": "口服碳酸钙",
      "C": "口服骨化三醇",
      "D": "口服阿仑膦酸钠",
      "E": "口服雷洛昔芬"
    },
    "answer": "C",
    "explanation": "本题考查维生素 D 及其活性代谢物的临床用药评价。维生素 D 依赖性佝偻病患者, 血中骨化三醇水平降低或缺失, 由肾脏合成的内源性骨化三醇不足, 使用骨化三醇作为替代治疗。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "373db84abe3ba88824d00437fffb8893689ab13c",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第5节泻药与便秘治疗药",
    "qtype": "综合分析题",
    "qno": 13,
    "stem": "患者，男，45岁，既往有甲状旁腺依赖性高钙血症，近日出现便秘，不宜选择的药物是",
    "options": {
      "A": "聚卡波非钙",
      "B": "普芦卡必利",
      "C": "硫酸镁",
      "D": "聚乙二醇",
      "E": "利那洛肽"
    },
    "answer": "A",
    "explanation": "【 12 \\sim 13 】 ②本题考查泻药和便秘治疗药的临床用药评价。聚卡波非钙在肠道脱钙, 可发生 高钙血症，高钙血症患者禁用。故本题答案为A。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "b02c3621fd5b5f6490fffdff1360ead9fc3a6fad",
    "section_no": 5,
    "section_title": "泻药与便秘治疗药",
    "section_norm": "第五节 泻药与便秘治疗药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第5节调节骨代谢药物",
    "qtype": "综合分析题",
    "qno": 22,
    "stem": "一日皮下注射 20\\mu \\mathrm{g}，总共治疗最长时间为24个月，患者终身仅可接受一次为期24个月的治疗的药物是",
    "options": {
      "A": "唑来膦酸",
      "B": "地舒单抗",
      "C": "鲤降钙素",
      "D": "雷洛昔芬",
      "E": "特立帕肽"
    },
    "answer": "E",
    "explanation": "②本题考查特立帕肽的临床用药评价。特立帕肽适用于有骨折高风险的绝经后骨质疏松症, 一日皮下注射 20 \\mu \\mathrm{g}, 总共治疗的最长时间为 24 个月, 患者终身仅可接受一次为期 24 个月的治疗。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "e4ff6ccf3a7b9f74d2f596e7cfb8402e3eb2e2a4",
    "section_no": 5,
    "section_title": "调节骨代谢药物",
    "section_norm": "第五节 调节骨代谢药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第6节抗帕金森病药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "本身无药理活性，可通过血-脑脊液屏障，在脑内芳香族L-氨基酸脱羧酶作用下脱羧形成多巴胺后发挥药理作用的抗帕金森病药物是",
    "options": {
      "A": "左旋多巴",
      "B": "恩他卡朋",
      "C": "苯海索",
      "D": "司来吉兰",
      "E": "卡比多巴"
    },
    "answer": "A",
    "explanation": "本题考查左旋多巴的临床用药评价。左旋多巴为多巴胺（DA）的前体，本身并无药理活性，可通过血-脑脊液屏障，在脑内芳香族L-氨基酸脱羧酶作用下脱羧形成多巴胺后发挥药理作用。故本题答案为A。恩他卡朋为儿茶酚胺氧位甲基转移酶抑制 剂。苯海索为中枢抗胆碱药。司来吉兰为单胺氧化酶-B抑制剂。卡比多巴为外周多巴脱羧酶抑制剂。",
    "source_note": "",
    "question_id": "c26145af00a9654a74cfadf1a53d6842e5bd63dc",
    "section_no": 6,
    "section_title": "抗帕金森病药",
    "section_norm": "第六节 抗帕金森病药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "主要用于CD20阳性的非霍奇金淋巴瘤的单克隆抗体是",
    "options": {
      "A": "曲妥珠单抗",
      "B": "利妥昔单抗",
      "C": "贝伐珠单抗",
      "D": "西妥昔单抗",
      "E": "英夫利西单抗"
    },
    "answer": "B",
    "explanation": "本题考查靶向抗肿瘤药的适应证。利妥昔单抗用于复发或耐药的滤泡性中央型淋巴瘤，CD20 阳性的非霍奇金淋巴瘤。故本题答案为 B。",
    "source_note": "",
    "question_id": "9ad792ca971789f14925af07b55807a5dda17a0a",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第6节治疗银屑病药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "以下不属于银屑病治疗药的是",
    "options": {
      "A": "依那西普",
      "B": "地蒽酚",
      "C": "壬二酸",
      "D": "他扎罗汀",
      "E": "卡泊三醇"
    },
    "answer": "C",
    "explanation": "本题考查治疗银屑病药的分类与代表药品。治疗银屑病药物包括；煤焦油、地蒽酚、卡泊三醇、他卡西醇、他克莫司、维A酸、他扎罗汀、依那西普、英夫利西单抗、阿达木单抗、乌司奴单抗、古塞奇尤单抗、司库奇尤单抗、依奇珠单抗、阿普米司特、托法替布、乌帕替尼。故本题答案为C。壬二酸属于非抗生素类抗菌药，用于治疗痤疮。",
    "source_note": "",
    "question_id": "21a13092921a1b85e5912234d8a0a1dabfef0dcd",
    "section_no": 6,
    "section_title": "治疗银屑病药",
    "section_norm": "第六节 治疗银屑病药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第6节抗帕金森病药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "PD对症治疗最有效的药物是",
    "options": {
      "A": "司来吉兰",
      "B": "金刚烷胺",
      "C": "苎丝肼",
      "D": "左旋多巴",
      "E": "恩他卡朋"
    },
    "answer": "D",
    "explanation": "本题考查左旋多巴的临床用药评价。帕金森病（PD）对症治疗最有效的药物是左旋多巴，若症状明显，尤其是运动徐缓相关症状显著的话，应首选左旋多巴。故本题答案为 D。",
    "source_note": "",
    "question_id": "b2f3a8d733002200c01ea6ef504a5b83d3a3ffcd",
    "section_no": 6,
    "section_title": "抗帕金森病药",
    "section_norm": "第六节 抗帕金森病药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第6节减重药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "关于奥利司他临床用药评价的描述，错误的是",
    "options": {
      "A": "不推荐体重指数 \\mathrm{BMI} \\leqslant 24 \\mathrm{~kg} / \\mathrm{m}^{2} 的人群使用",
      "B": "肝肾功能不全者，无需调整给药剂量",
      "C": "常见胃肠道反应，如油性斑点、大便紧急感、脂肪泻等",
      "D": "适用于甲状腺功能减退引起的器质性肥胖患者",
      "E": "胆汁淤积性肝炎患者避免使用"
    },
    "answer": "D",
    "explanation": "本题考查奥利司他的临床用药评价。奥利司他禁止用于慢性吸收不良综合征、胆汁淤积患者、器质性肥胖患者（如甲状腺功能减退）。故本题答案为D。",
    "source_note": "",
    "question_id": "632442c213bd18e142699134918443b9a1343554",
    "section_no": 6,
    "section_title": "减重药",
    "section_norm": "第六节 减重药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第6节其他β-内酰胺类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "因其肾毒性低，可作为氨基糖苷类药物替代品的药物是",
    "options": {
      "A": "西司他丁",
      "B": "亚胺培南",
      "C": "舒巴坦",
      "D": "头孢美唑",
      "E": "氨曲南"
    },
    "answer": "E",
    "explanation": "本题考查其他β-内酰胺类抗菌药物的临床用药评价。因氨曲南抗菌谱与氨基糖苷类药物相似，且氨曲南具有肾毒性低、免疫原性弱等优点，可用于替代氨基糖苷类药物，作为联合用药之一治疗肾功能损害患者的需氧革兰阴性菌感染。故本题答案为E。",
    "source_note": "",
    "question_id": "d02e5982159539991a30d7a5d50a75b3a5a28f7f",
    "section_no": 6,
    "section_title": "其他β-内酰胺类抗菌药物",
    "section_norm": "第六节 其他β-内酰胺类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "可引起免疫相关性不良反应的单克隆抗体类药物是",
    "options": {
      "A": "曲妥珠单抗",
      "B": "西妥昔单抗",
      "C": "利妥昔单抗",
      "D": "信迪利单抗",
      "E": "贝伐珠单抗"
    },
    "answer": "D",
    "explanation": "本题考查单克隆抗体的临床用药评价。信迪利单抗为免疫哨点抑制剂，可引起免疫相关性不良反应。故本题答案为 D。",
    "source_note": "",
    "question_id": "b277b86f57ecc38dd5461c406fde4a7a4dbdaf57",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第6节其他β-内酰胺类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "不能渗入脑脊液，不能用于治疗脑膜炎的药物是",
    "options": {
      "A": "磺胺嘧啶",
      "B": "氨曲南 异烟肼",
      "C": "氯霉素",
      "D": "氟康唑"
    },
    "answer": "B",
    "explanation": "本题考查其他β-内酰胺类抗菌药物的临床用药评价。氨曲南不能渗入脑脊液，不能用于治疗脑膜炎。故本题答案为B。磺胺嘧啶可用于奈瑟球菌脑膜炎的治疗。氯霉素可用于肺炎链球菌脑膜炎、奈瑟菌脑膜炎、敏感的革兰阴性杆菌脑膜炎等的 治疗。氟康唑可用于隐球菌性脑膜炎的治疗。异烟肼可以用于结核性脑膜炎的治疗。",
    "source_note": "",
    "question_id": "5e7cb1ac0ca26deb0aaaf91566dba8ea886c630a",
    "section_no": 6,
    "section_title": "其他β-内酰胺类抗菌药物",
    "section_norm": "第六节 其他β-内酰胺类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第6节治疗银屑病药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "属于维A酸类，可用于治疗斑块型银屑病及寻常痤疮，因有致畸作用，在治疗前、治疗期间和停止治疗后一段时间，必须避孕的药物是",
    "options": {
      "A": "过氧乙酸",
      "B": "他扎罗汀",
      "C": "过氧苯甲酰",
      "D": "卡泊三醇",
      "E": "甲氧沙林"
    },
    "answer": "B",
    "explanation": "本题考查治疗银屑病药的临床用药评价。他扎罗汀属于维 A 酸类药物,可用于治疗斑块型银屑病及寻常痤疮,但对严重的银屑病无效;不良反应有致畸作用,在治疗前、治疗期间和停止治疗后一段时间,必须避孕。故本题答案为 B。",
    "source_note": "",
    "question_id": "8f55b22d31b3dd477606437f07e1076aba823b55",
    "section_no": 6,
    "section_title": "治疗银屑病药",
    "section_norm": "第六节 治疗银屑病药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "对消化道内的病毒、病菌及其产生的毒素有固定、抑制作用，可用于成人及儿童急、慢性腹泻的药物是",
    "options": {
      "A": "洛哌丁胺",
      "B": "消旋卡多曲",
      "C": "蒙脱石散",
      "D": "复方地芬诺酯",
      "E": "乳果糖"
    },
    "answer": "C",
    "explanation": "本题考查止泻药的临床用药评价。蒙脱石散属于吸附剂，对消化道内的病毒、病菌及其产生的毒素有固定、抑制作用。故本题答案为 C。洛哌丁胺、复方地芬诺酯为抗动力药。消旋卡多曲为抗分泌药。乳果糖为渗透性泻药，可用来治疗便秘。",
    "source_note": "",
    "question_id": "e89bf1b4d08c8be05f7c56a2913d564730b1344e",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第6节其他β-内酰胺类抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "抗菌活性与第三代头孢菌素中的头孢噻肟相似的药物是",
    "options": {
      "A": "青霉素 V",
      "B": "亚胺培南 头孢吡肟",
      "C": "氨曲南",
      "D": "拉氧头孢"
    },
    "answer": "D",
    "explanation": "本题考查其他 \\beta-内酰胺类抗菌药物的临床用药评价。氧头孢烯类代表药物为拉氧头孢和氟氧头孢等, 抗菌谱广, 抗菌活性与第三代头孢菌素中的头孢噻肟相似, 对多种革兰阴性菌及厌氧菌有较强作用, 对 \\beta-内酰胺酶稳定。故本题答案为 D。",
    "source_note": "",
    "question_id": "57ba83ff815d2f800612b411a6cb2eae302b56fa",
    "section_no": 6,
    "section_title": "其他β-内酰胺类抗菌药物",
    "section_norm": "第六节 其他β-内酰胺类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "只对癌细胞起作用而对正常细胞几乎无毒性作用的抗肿瘤药是",
    "options": {
      "A": "多柔比星",
      "B": "甲氨蝶呤",
      "C": "利妥昔单抗",
      "D": "环磷酰胺",
      "E": "丝裂霉素"
    },
    "answer": "C",
    "explanation": "本题考查单克隆抗体的临床用药评价。利妥昔单抗属于单克隆抗体靶向药物，能特异性地与靶细胞表面或循环中的配体结合，选择性杀伤特定细胞，只对癌细胞起作用而对正常体细胞几乎没有伤害，有效地抑制癌细胞的增长和扩散，并大幅度降低毒副作用。故本题答案为 C。",
    "source_note": "",
    "question_id": "04ec512e32bd809109dfa34077af3f74d939c01f",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "下列关于复方地芬诺酯的说法，错误的是",
    "options": {
      "A": "属于阿片受体激动剂",
      "B": "含有地芬诺酯和阿托品",
      "C": "可以减少肠蠕动",
      "D": "可用于急、慢性功能性腹泻",
      "E": "可用作细菌性腹泻的基础治疗药物"
    },
    "answer": "E",
    "explanation": "本题考查止泻药的临床用药评价。复方地芬诺酯含地芬诺酯和阿托品，属于抗动力药。可以降低肠道动力，延长胃肠传输时间，可延长细菌性腹泻的病程，因此抗动力药不能用作细菌性腹泻的基础治疗药物。细菌感染性腹泻需要使用抗生素进行特异性治疗。故本题答案为E。",
    "source_note": "",
    "question_id": "c91cf11f854e9f5690ce4a8422637cf47aeac2a9",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第6节其他β-内酰胺类抗菌药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "对大多数超广谱 \\beta 内酰胺酶（ESBL）稳定，用药期间和停药之后 5\\sim 7 天应避免饮酒的药物是",
    "options": {
      "A": "头孢吡肟",
      "B": "头孢美唑",
      "C": "亚胺培南",
      "D": "氨曲南",
      "E": "头孢唑林"
    },
    "answer": "B",
    "explanation": "本题考查其他 \\beta-内酰胺类抗菌药物的临床用药评价。头孢美唑属于头霉素类抗菌药物, 对大多数超广谱 \\beta-内酰胺酶 (ESBL) 稳定, 可导致 “双硫仑样” 反应,用药期间和停药之后 5 \\sim 7 天应避免饮酒或服用含有乙醇的食物和药物。故本题答案为 B。",
    "source_note": "",
    "question_id": "7ebd307823f96e470cf308588726ffd11451c944",
    "section_no": 6,
    "section_title": "其他β-内酰胺类抗菌药物",
    "section_norm": "第六节 其他β-内酰胺类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "属于生物靶向治疗药物的是",
    "options": {
      "A": "昂丹司琼",
      "B": "紫杉醇",
      "C": "吉非替尼",
      "D": "多柔比星",
      "E": "氟尿嘧啶"
    },
    "answer": "C",
    "explanation": "本题考查生物靶向治疗药物的分类与代表药品。生物靶向治疗药物包括生物反应调节剂、单克隆抗体、抗体药物偶联物、小分子靶向药物（酪氨酸激酶抑制剂）等。酪氨酸激酶抑制剂的代表药物有吉非替尼、厄洛替尼等。故本题答案为 C。",
    "source_note": "",
    "question_id": "8461baba5aa0cb38691b4d5adbaf1198735c49be",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "可有效治疗由非侵袭性大肠埃希菌菌株引起的旅行者腹泻的是",
    "options": {
      "A": "利福昔明",
      "B": "柳氮磺吡啶",
      "C": "洛哌丁胺",
      "D": "消旋卡多曲",
      "E": "复方地芬诺酯"
    },
    "answer": "A",
    "explanation": "本题考查肠道抗感染药的临床用药评价。利福昔明属于非吸收性的利福霉素类药物, 可有效治疗由非侵袭性大肠埃希菌菌株引起的旅行者腹泻。故本题答案为 A。",
    "source_note": "",
    "question_id": "7fabdc1d518fb2cc10ca8f52550223b14cc1614c",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "通过抑制酪氨酸激酶活性，特异性地阻断肿瘤生长、增殖过程中所必需的信号传导通路的药物是",
    "options": {
      "A": "紫杉醇",
      "B": "来曲唑",
      "C": "依托泊苷",
      "D": "西妥昔单抗",
      "E": "伊马替尼"
    },
    "answer": "E",
    "explanation": "本题考查酪氨酸激酶抑制剂的临床用药评价。酪氨酸激酶抑制剂通过抑制酪氨酸激酶活性, 特异性地阻断肿瘤生长、增殖过程中所必需的信号传导通路, 从而达到抑制肿瘤细胞增殖和转移的作用。常见药物有吉非替尼、厄洛替尼、伊马替尼等。故本题答案为 E。",
    "source_note": "",
    "question_id": "fecf080f25c788894baf5b253d3b00d7133a0bf8",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "妊娠期妇女严重腹泻需要应用抗菌药物时，首选",
    "options": {
      "A": "左氧氟沙星",
      "B": "阿奇霉素",
      "C": "四环素",
      "D": "利福昔明",
      "E": "柳氮磺吡啶"
    },
    "answer": "B",
    "explanation": "本题考查肠道抗感染药的临床用药评价。在特定的情况下，严重腹泻患者有必要应用抗菌药物，如每日排泄4次以上不成形大便、发热或便中带血、脓或黏液。一般而言，氟喹诺酮类药物因其有效性和耐受性是首选的抗生素，阿奇霉素是妊娠期妇女及儿童首选的药物。故本题答案为B。",
    "source_note": "",
    "question_id": "3bea5d3f5b3d3ee80753acf640e0b56f1cef0816",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "连续用药不能超过7日，可能导致尿液呈粉红色的是",
    "options": {
      "A": "左氧氟沙星",
      "B": "阿奇霉素",
      "C": "四环素",
      "D": "利福昔明",
      "E": "柳氮磺吡啶"
    },
    "answer": "D",
    "explanation": "本题考查肠道抗感染药的临床用药评价。利福昔明连续服用不能超过 7 日, 长期大剂量用药或肠黏膜损伤时, 有极少量被吸收, 导致尿液呈粉红色。故本题答案为 D。",
    "source_note": "",
    "question_id": "0927f4403ca0579efe7f0e5df12040a70d99da94",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "克罗恩病(CD)是一种病因不明的炎症性疾病，可累及从口腔到肛周区域的任一部分消化道。下列药物中可用于治疗克罗恩病的是",
    "options": {
      "A": "蒙脱石",
      "B": "美沙拉秦",
      "C": "乳酶生",
      "D": "洛哌丁胺",
      "E": "普芦卡必利"
    },
    "answer": "B",
    "explanation": "本题考查肠道抗炎药的代表药品。克罗恩病的治疗药物包括：美沙拉秦、柳氮磺吡啶、糖皮质激素、免疫调节剂（如硫唑嘌呤、巯嘌呤、甲氨蝶呤）、生物制剂（如英夫利西单抗、阿达木单抗、乌司奴单抗、利生奇珠单抗、维得利珠单抗）、JAK 抑制剂（如乌帕替尼）。故本题答案为 B。",
    "source_note": "",
    "question_id": "269f2f21ae2a39103b3b54e64c4f750c3bcc6932",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "既可治疗类风湿关节炎，又可治疗溃疡性结肠炎的是",
    "options": {
      "A": "柳氮磺吡啶",
      "B": "美沙拉秦",
      "C": "利福昔明",
      "D": "消旋卡多曲",
      "E": "多库酯钠"
    },
    "answer": "A",
    "explanation": "本题考查肠道抗炎药的临床用药评价。柳氮磺吡啶临床可用于溃疡性结肠炎、克罗恩病、类风湿关节炎、强直性脊柱炎等。故本题答案为A。",
    "source_note": "",
    "question_id": "ecedba00d59f67c097d8c6632dd52f2eefc37019",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "单项选择题",
    "qno": 11,
    "stem": "通过破坏IL-12和IL-23介导的信号传导和细胞炎症因子级联反应，从而治疗克罗恩病的生物制剂是",
    "options": {
      "A": "美沙拉秦",
      "B": "英夫利西单抗",
      "C": "乌司奴单抗",
      "D": "维得利珠单抗",
      "E": "乌帕替尼"
    },
    "answer": "C",
    "explanation": "本题考查肠道抗炎药的分类与代表药品。乌司奴单抗属于IL-12/IL-23抑制剂，可特异性的结合IL-12和IL-23的p40蛋白亚单位，阻断其与淋巴细胞表面的IL-12Rβ1受体结合，从而破坏IL-12和IL-23介导的信号传导和细胞炎症因子级联反应。故本题答案为C。英夫利西单抗属于TNF-α抑制剂。维得利珠单抗属于α4β7整合素抑制剂。",
    "source_note": "",
    "question_id": "f6118ad96c1b7abb9a46736929a27f5dc3146d41",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第6节减重药",
    "qtype": "配伍选择题",
    "qno": 3,
    "stem": "是长效和强效的特异性胃肠道脂肪酶抑制剂,使胃和小肠腔内脂肪酶失活, 不能将食物中的脂肪水解为可吸收的游离脂肪酸和单酰基甘油, 从而减少热量摄入, 控制体重的药物是",
    "options": {
      "A": "奥利司他",
      "B": "二甲双胍",
      "C": "艾塞那肽",
      "D": "司美格鲁肽",
      "E": "替尔泊肽"
    },
    "answer": "A",
    "explanation": "①本题考查奥利司他的临床用药评价。奥利司他是长效和强效的特异性胃肠道脂肪酶抑制剂, 通过与胃和小肠腔内胃脂肪酶和胰脂肪酶的活性丝氨酸部位形成共价键使酶失活而发挥治疗作用, 失活的酶不能将食物中的脂肪 (主要是甘油三酯)水解为可吸收的游离脂肪酸和单酰基甘油。未消化的甘油三酯不能被身体吸收, 从而减少热量摄入, 控制体重。故本题答案为 A。",
    "source_note": "",
    "question_id": "fde897365644d0d1d19cdfd2f9f18878ba0fbbcb",
    "section_no": 6,
    "section_title": "减重药",
    "section_norm": "第六节 减重药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第6节减重药",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "是目前唯一的葡萄糖依赖性促胰岛素多肽（GIP）受体和GLP-1受体的双靶点激动剂，可通过调节食欲来减少食物摄入、降低体重和减少脂肪量的药物是",
    "options": {
      "A": "奥利司他",
      "B": "二甲双胍",
      "C": "艾塞那肽",
      "D": "司美格鲁肽",
      "E": "替尔泊肽"
    },
    "answer": "E",
    "explanation": "②本题考查减重药的分类与代表药品。替尔泊肽是首个且目前唯一的葡萄糖依赖性促胰岛素多肽 (GIP) 受体和 GLP-1 受体的双靶点激动剂 (GIP/GLP-1 受体激动剂)。可通过调节食欲来减少食物摄入、降低体重和减少脂肪量。故本题答案为 E。",
    "source_note": "",
    "question_id": "849491f174c2729733c664f7722640d64eee64da",
    "section_no": 6,
    "section_title": "减重药",
    "section_norm": "第六节 减重药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第6节抗帕金森病药",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "选择性地抑制脑内的单胺氧化酶B（MAO-B），可用于治疗帕金森病的药物是",
    "options": {
      "A": "司来吉兰",
      "B": "恩他卡朋",
      "C": "卡比多巴",
      "D": "苯海索",
      "E": "金刚烷胺"
    },
    "answer": "A",
    "explanation": "①本题考查单胺氧化酶 B（MAO-B）抑制剂的临床用药评价。司来吉兰属于单胺氧化酶 B（MAO-B）抑制剂，可选择性地抑制脑内的单胺氧化酶 B（MAO-B），还能抑制突触前膜对多巴胺的再摄取，从而提高多巴胺的活性，改善帕金森病的相关症状。故本题答案为 A。",
    "source_note": "",
    "question_id": "f45aa060dcef87465c94e65bc9774c3d1432d55f",
    "section_no": 6,
    "section_title": "抗帕金森病药",
    "section_norm": "第六节 抗帕金森病药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第6节抗帕金森病药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "为儿茶酚胺氧位甲基转移酶（COMT）抑制剂，可延长和稳定左旋多巴对帕金森病治疗作用的药物是",
    "options": {
      "A": "司来吉兰",
      "B": "恩他卡朋",
      "C": "卡比多巴",
      "D": "苯海索",
      "E": "金刚烷胺"
    },
    "answer": "B",
    "explanation": "②本题考查恩他卡朋的临床用药评价。恩他卡朋是儿茶酚胺氧位甲基转移酶（COMT）的选择性、可逆性抑制药。与左旋多巴/卡比多巴合用，可阻止 3-O-甲基多巴的形成，降低 3-O-甲基多巴的血浆浓度，增加左旋多巴进入脑组织的药量，延长左旋多巴的消除半衰期，延长和稳定左旋多巴对帕金森病的治疗作用。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c35ee0fc2a16f7057b2e1b4d716ab964a70f3303",
    "section_no": 6,
    "section_title": "抗帕金森病药",
    "section_norm": "第六节 抗帕金森病药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第6节其他β-内酰胺类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "属于单环 \\beta-内酰胺类药物的是",
    "options": {
      "A": "头孢美唑",
      "B": "氨曲南 拉氧头孢",
      "C": "氨苄西林",
      "D": "头孢唑林"
    },
    "answer": "B",
    "explanation": "本组题考查其他 \\beta-内酰胺类抗菌药物的分类与作用机制。 ①氨曲南属于单环 \\beta-内酰胺类药物, 抗菌谱窄, 仅对需氧革兰阴性菌包括铜绿假单胞菌有效, 对革兰阳性菌和厌氧菌作用差。故本题答案为 B。",
    "source_note": "",
    "question_id": "e024b73f0bc9c829af8aff446d4f516ee090b54f",
    "section_no": 6,
    "section_title": "其他β-内酰胺类抗菌药物",
    "section_norm": "第六节 其他β-内酰胺类抗菌药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第6节抗帕金森病药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "能抑制左旋多巴在外周脱羧成多巴胺，使血中更多的左旋多巴进入中枢的药物是",
    "options": {
      "A": "司来吉兰",
      "B": "恩他卡朋",
      "C": "卡比多巴",
      "D": "苯海索",
      "E": "金刚烷胺"
    },
    "answer": "C",
    "explanation": "③本题考查抗帕金森病药的分类与代表药品。外周多巴脱羧酶抑制剂（如卡比多巴、苄丝肼）能抑制左旋多巴在外周脱羧成多巴胺，使血中更多的左旋多巴进入中枢脱羧成多巴胺，可减轻左旋多巴恶心、呕吐等副作用，并使其在治疗上发挥更大的效应。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "bd6719f08ad32bb05481c363e110fe4730101f25",
    "section_no": 6,
    "section_title": "抗帕金森病药",
    "section_norm": "第六节 抗帕金森病药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第6节其他β-内酰胺类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "属于头霉素类药物的是",
    "options": {
      "A": "头孢美唑",
      "B": "氨曲南 拉氧头孢",
      "C": "氨苄西林",
      "D": "头孢唑林"
    },
    "answer": "A",
    "explanation": "本组题考查其他 \\beta-内酰胺类抗菌药物的分类与作用机制。 ②头孢美唑属于头霉素类药物, 抗菌谱与第二代头孢菌素相似。故本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "8bd83268d5b9f44b7ab8bb5376c96a6e1ba5462c",
    "section_no": 6,
    "section_title": "其他β-内酰胺类抗菌药物",
    "section_norm": "第六节 其他β-内酰胺类抗菌药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第6节抗帕金森病药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "溴隐亭治疗帕金森病的作用机制是",
    "options": {
      "A": "激动中枢的多巴胺受体",
      "B": "阻滞中枢的胆碱受体",
      "C": "抑制多巴胺的再摄取",
      "D": "激动中枢胆碱受体",
      "E": "补充纹状体多巴胺的不足"
    },
    "answer": "A",
    "explanation": "【 8 \\sim 9】本组题考查抗帕金森病药的分类与代表药品。 ①溴隐亭属于中枢 DA 受体激动剂，可激动中枢的 DA 受体。故本题答案为 A。",
    "source_note": "",
    "question_id": "52e83688b7eedb0cef260b3f7ec26a765c7d7d3d",
    "section_no": 6,
    "section_title": "抗帕金森病药",
    "section_norm": "第六节 抗帕金森病药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "治疗转移性结直肠癌和晚期、转移性或复发性非小细胞肺癌宜选用的单克隆抗体是",
    "options": {
      "A": "曲妥珠单抗",
      "B": "利妥昔单抗",
      "C": "贝伐珠单抗",
      "D": "信迪利单抗",
      "E": "西妥昔单抗"
    },
    "answer": "C",
    "explanation": "本组题考查靶向抗肿瘤药的适应证。 ①贝伐珠单抗主要用于转移性结直肠癌和晚期、转移性或复发性非小细胞肺癌。故本题答案为C。",
    "source_note": "",
    "question_id": "ba12269d41e59035e822cf875c8f2b0365944bd1",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第6节抗帕金森病药",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "苯海索治疗帕金森病的作用机制是",
    "options": {
      "A": "激动中枢的多巴胺受体",
      "B": "阻滞中枢的胆碱受体",
      "C": "抑制多巴胺的再摄取",
      "D": "激动中枢胆碱受体",
      "E": "补充纹状体多巴胺的不足"
    },
    "answer": "B",
    "explanation": "【 8 \\sim 9】本组题考查抗帕金森病药的分类与代表药品。 ②苯海索属于中枢抗胆碱药，可阻滞神经中枢（纹状体）的胆碱受体。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "05ce446b7da137fd6db8fd4a59dd09d30793e054",
    "section_no": 6,
    "section_title": "抗帕金森病药",
    "section_norm": "第六节 抗帕金森病药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "治疗人表皮生长因子受体-2过度表达的转移性乳腺癌宜选用的单克隆抗体是",
    "options": {
      "A": "曲妥珠单抗",
      "B": "利妥昔单抗",
      "C": "贝伐珠单抗",
      "D": "信迪利单抗",
      "E": "西妥昔单抗"
    },
    "answer": "A",
    "explanation": "本组题考查靶向抗肿瘤药的适应证。 ②曲妥珠单抗可用于人表皮生长因子受体-2过度表达的转移性乳腺癌、已接受过1个或多个化疗方案的转移性乳腺癌、联合紫杉醇类药治疗未接受过化疗的转移性乳腺癌。故本题答案为A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "9ae95fca1c3d442491939ab79a99ece2dec518f8",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第6节其他β-内酰胺类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "仅对需氧革兰阴性菌有良好抗菌活性，属于窄谱抗菌药的是",
    "options": {
      "A": "氨曲南",
      "B": "拉氧头孢",
      "C": "头孢曲松",
      "D": "头孢西丁",
      "E": "亚胺培南"
    },
    "answer": "A",
    "explanation": "本组题考查其他 \\beta-内酰胺类抗菌药物的临床用药评价。 ②氨曲南对需氧革兰阴性菌有效, 对革兰阳性菌和厌氧菌作用差, 属于窄谱抗菌药。故本题答案为 A。",
    "source_note": "",
    "question_id": "e7a8405d00a5ab7a56c79c128b311268c4457d0e",
    "section_no": 6,
    "section_title": "其他β-内酰胺类抗菌药物",
    "section_norm": "第六节 其他β-内酰胺类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "属于生物反应调节剂的是",
    "options": {
      "A": "舒尼替尼",
      "B": "曲妥珠单抗",
      "C": "白细胞介素",
      "D": "吉非替尼",
      "E": "恩美曲妥珠单抗"
    },
    "answer": "C",
    "explanation": "本组题考查生物靶向治疗药物的分类与代表药品。 ①生物反应调节剂有干扰素、白细胞介素（IL）、肿瘤坏死因子（TNF）、卡介苗、香菇多糖、胸腺素类。故本题答案为C。",
    "source_note": "",
    "question_id": "82d0f1a2a89043e5db88c04999ea882e593c7ac0",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "属于酪氨酸激酶抑制剂，作用靶点为血管内皮生长因子受体（VEGFR）的是",
    "options": {
      "A": "舒尼替尼",
      "B": "曲妥珠单抗",
      "C": "白细胞介素",
      "D": "吉非替尼",
      "E": "恩美曲妥珠单抗"
    },
    "answer": "A",
    "explanation": "本组题考查生物靶向治疗药物的分类与代表药品。 ②舒尼替尼、吉非替尼属于酪氨酸激酶抑制剂，舒尼替尼作用靶点为血管内皮生长因子受体（VEGFR），吉非替尼作用靶点为表皮生长因子受体（EGFR）。故 本题答案为 A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "d1964be15616e53c0042c2b8a03a9799096d4606",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "可用于控制急、慢性腹泻的症状，2岁以下儿童禁用的止泻药是 可用于1个月以上婴儿急性腹泻的药物是",
    "options": {
      "A": "美沙拉秦",
      "B": "消旋卡多曲",
      "C": "蒙脱石散",
      "D": "洛哌丁胺",
      "E": "地衣芽孢杆菌活菌"
    },
    "answer": "D",
    "explanation": "【 12 \\sim 13】本组题考查止泻药的临床用药评价。 ①洛哌丁胺为阿片受体激动剂, 可降低肠道动力, 用于控制急、慢性腹泻的症状, 禁用于 2 岁以下儿童。故本题答案为 D。",
    "source_note": "",
    "question_id": "fc0d6ced10760371ae37edbe2ed21c651cf42949",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "属于抗体药物偶联物的是",
    "options": {
      "A": "舒尼替尼",
      "B": "曲妥珠单抗",
      "C": "白细胞介素",
      "D": "吉非替尼",
      "E": "恩美曲妥珠单抗"
    },
    "answer": "E",
    "explanation": "本组题考查生物靶向治疗药物的分类与代表药品。 ③恩美曲妥珠单抗属于抗体药物偶联物。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "08ada47c415b7182d87d124e3d90010fcd6c235b",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "是一种脑啡肽酶抑制剂，具有抑制分泌的作用，",
    "options": {
      "A": "美沙拉秦",
      "B": "消旋卡多曲",
      "C": "蒙脱石散",
      "D": "洛哌丁胺",
      "E": "地衣芽孢杆菌活菌"
    },
    "answer": "B",
    "explanation": "【 12 \\sim 13】本组题考查止泻药的临床用药评价。 ②消旋卡多曲是一种脑啡肽酶抑制剂, 具有抑制分泌的作用, 能减少大便的量并缩短腹泻持续时间, 可用于 1 个月以上婴儿和儿童以及成人急性腹泻。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "6eece4ca1a9f94731d20360d82a9fcf744f23ab5",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "属于微生态制剂的止泻药物是",
    "options": {
      "A": "利生奇珠单抗",
      "B": "阿达木单抗",
      "C": "洛哌丁胺",
      "D": "消旋卡多曲",
      "E": "地衣芽孢杆菌活菌"
    },
    "answer": "E",
    "explanation": "【 14\\sim 16 】 ① 本题考查止泻药的分类与代表药品。微生态制剂类止泻药包括芽孢杆菌、双歧杆菌、嗜酸乳杆菌、粪肠球菌等活菌。故本题答案为E。",
    "source_note": "",
    "question_id": "7ce062794153381359a73c5bcd05e2a3b6f13f58",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "配伍选择题",
    "qno": 15,
    "stem": "属于 TNF- \\alpha 抑制剂的肠道抗炎药物是",
    "options": {
      "A": "利生奇珠单抗",
      "B": "阿达木单抗",
      "C": "洛哌丁胺",
      "D": "消旋卡多曲",
      "E": "地衣芽孢杆菌活菌"
    },
    "answer": "B",
    "explanation": "【 14\\sim 16 】 ② 本题考查肠道抗炎药的分类与代表药品。阿达木单抗属于TNF- \\alpha 抑制剂。故本题答案为B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "bd59d5da7fb887b2f3e3831cc22d436367da7139",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "配伍选择题",
    "qno": 16,
    "stem": "属于抗动力药的是",
    "options": {
      "A": "利生奇珠单抗",
      "B": "阿达木单抗",
      "C": "洛哌丁胺",
      "D": "消旋卡多曲",
      "E": "地衣芽孢杆菌活菌"
    },
    "answer": "C",
    "explanation": "【 14\\sim 16 】 ③ 本题考查止泻药的分类与代表药品。抗动力药有洛哌丁胺、复方地芬诺酯。故本题答案为C。利生奇珠单抗属于IL-23抑制剂。消旋卡多曲属于抗分泌药。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "e5913b6d54b33410ecce5c7ba20d4cb7773e0ce4",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "配伍选择题",
    "qno": 17,
    "stem": "预防和治疗腹泻引起的轻、中度脱水应选用",
    "options": {
      "A": "口服补液盐",
      "B": "硫酸镁",
      "C": "洛哌丁胺",
      "D": "甘油",
      "E": "地衣芽孢杆菌活菌"
    },
    "answer": "A",
    "explanation": "本组题考查止泻药的临床用药评价。 ①补液盐能有效纠正腹泻引起的液体和电解质丢失, 临床可用于预防和治疗腹泻引起的轻、中度脱水, 并可用于补充钠、钾、氯。故本题答案为 A。",
    "source_note": "",
    "question_id": "fa4ccb5460a6fe3bb94483c509d53ee697e6851f",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "配伍选择题",
    "qno": 18,
    "stem": "治疗细菌或真菌感染引起的急、慢性肠炎、腹泻应选用",
    "options": {
      "A": "口服补液盐",
      "B": "硫酸镁",
      "C": "洛哌丁胺",
      "D": "甘油",
      "E": "地衣芽孢杆菌活菌"
    },
    "answer": "E",
    "explanation": "本组题考查止泻药的临床用药评价。 ②地衣芽孢杆菌活菌可用于细菌或真菌感染引起的急、慢性肠炎、腹泻。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "e2a8d19a667c216a92f26fb0c38127f3365afebf",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第6节减重药",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "当 \\mathrm{BMI} \\geqslant 28 \\mathrm{~kg} / \\mathrm{m}^{2} 时，定义为肥胖，目前国内获准用于治疗肥胖症患者减重治疗的首选口服减肥药是",
    "options": {
      "A": "奥司他韦",
      "B": "奥利司他",
      "C": "二甲双胍",
      "D": "替尔泊肽",
      "E": "司美格鲁肽"
    },
    "answer": "B",
    "explanation": "本题考查奥利司他的临床用药评价。目前国内共有 5 种药物获得国家药品监督管理局批准用于成年原发性肥胖症患者减重治疗，包括奥利司他、利拉鲁肽、 贝那鲁肽、司美格鲁肽及替尔泊肽。其中奥利司他是目前首选的口服减肥药。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "62bb4a7dbfcb224d715bffc8c61c9d9af9d0827a",
    "section_no": 6,
    "section_title": "减重药",
    "section_norm": "第六节 减重药"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第6节止泻药、肠道抗感染药、肠道抗炎药",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "患者，女，6岁，因食用海鲜后出现呕吐、腹痛、水样便腹泻，考虑为肠胃炎，医生处方阿奇霉素、蒙脱石散、地衣芽孢杆菌活菌治疗。关于地衣芽孢杆菌活菌临床应用的描述，错误的是",
    "options": {
      "A": "应置于冰箱中冷藏保存",
      "B": "溶解时水温不宜超过 40^{\\circ} \\mathrm{C}",
      "C": "避免与抗酸药同服",
      "D": "与铋剂、鞣酸分开服用",
      "E": "可用于胃肠道菌群失调的防治"
    },
    "answer": "A",
    "explanation": "本题考查止泻药的临床用药评价。地衣芽孢杆菌活菌无需冷藏，室温贮藏即可。故本题答案为 A。地衣芽孢杆菌为活菌制剂，溶解时水温不宜超过 40^{\\circ} \\mathrm{C} 。抗酸药、抗菌药与活菌制剂合用可减弱其疗效，避免同服；铋剂、鞣酸、活性炭、酊剂等能抑制、吸附或杀灭活菌，故应错时分开服用，一般需要间隔 2 \\sim 3 小时。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "578e30ff9a988f0de41e8de75e295d351371a88a",
    "section_no": 6,
    "section_title": "止泻药、肠道抗感染药、肠道抗炎药",
    "section_norm": "第六节 止泻药、肠道抗感染药、肠道抗炎药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第6节治疗银屑病药",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "治疗银屑病药中，大剂量应用前和使用中需监测尿钙，高钙血症患者禁用的药物是",
    "options": {
      "A": "煤焦油",
      "B": "卡泊三醇",
      "C": "他莫昔芬",
      "D": "他扎罗汀",
      "E": "地蒽酚"
    },
    "answer": "B",
    "explanation": "本题考查治疗银屑病药的临床用药评价。卡泊三醇为维生素D3的衍生物，大剂量使用乳膏剂或搽剂，在应用前和使用中需监测尿钙升高的情况，高钙血症患者禁用。故本题答案为B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "e1ba96bb75452f348525249cac282a4edf29aa1a",
    "section_no": 6,
    "section_title": "治疗银屑病药",
    "section_norm": "第六节 治疗银屑病药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第6节抗帕金森病药",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "为促多巴胺释放药，毒性小，治疗较年轻的早期或轻度的帕金森病患者最有用的药物是",
    "options": {
      "A": "苯海索",
      "B": "司来吉兰",
      "C": "左旋多巴",
      "D": "恩他卡朋",
      "E": "金刚烷胺"
    },
    "answer": "E",
    "explanation": "本题考查抗帕金森病药的分类与代表药品。金刚烷胺为促多巴胺释放药，是作用相对较弱的抗帕金森病药，毒性小，治疗较年轻的早期或轻度的帕金森病患者最有用。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "78f8ca3ba95b0a08cb71689ff8e4043281f8bab9",
    "section_no": 6,
    "section_title": "抗帕金森病药",
    "section_norm": "第六节 抗帕金森病药"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第6节生物靶向治疗药物",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "用药前，必须对患者进行人表皮生长因子受体-2基因筛查，且易导致心肌病的药物是",
    "options": {
      "A": "利妥昔单抗",
      "B": "曲妥珠单抗",
      "C": "西妥昔单抗",
      "D": "贝伐珠单抗",
      "E": "伊马替尼"
    },
    "answer": "B",
    "explanation": "本题考查单克隆抗体的临床用药评价与靶向抗肿瘤药的适应证。曲妥珠单抗可用于人表皮生长因子受体-2过度表达的转移性乳腺癌的治疗，用药前，必须对 患者进行人表皮生长因子受体-2基因筛查。本品可导致心肌病亚临床和临床心力衰竭，治疗期间需进行心脏功能评估。故本题答案为B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "d5df94564936e78e8012e60af57f89be7e8b8b58",
    "section_no": 6,
    "section_title": "生物靶向治疗药物",
    "section_norm": "第六节 生物靶向治疗药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第6节抗帕金森病药",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "年龄在70岁以下、有震颤问题困扰、不伴明显运动徐缓及步态障碍的PD患者，作为单一疗法最有用的药物是",
    "options": {
      "A": "左旋多巴",
      "B": "苯海索",
      "C": "恩他卡朋",
      "D": "司来吉兰",
      "E": "卡比多巴"
    },
    "answer": "B",
    "explanation": "本题考查苯海索的临床用药评价。对于年龄在 70 岁以下、有震颤问题困扰、不伴明显运动徐缓及步态障碍的 PD 患者, 抗胆碱能药物 (苯海索) 作为单一疗法最有用。故本题答案为 B。左旋多巴是 PD 对症治疗最有效的药物, 症状明显, 尤其是运动徐缓相关症状显著的患者, 应首选左旋多巴。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "44fcc0fee1b68ba39594beaf0d4cd84a77c102d5",
    "section_no": 6,
    "section_title": "抗帕金森病药",
    "section_norm": "第六节 抗帕金森病药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第6节其他β-内酰胺类抗菌药物",
    "qtype": "综合分析题",
    "qno": 9,
    "stem": "与青霉素类及头孢菌素类无交叉过敏反应，在严密监测下可用于对青霉素类、头孢菌素类过敏患者的药物是",
    "options": {
      "A": "氨曲南",
      "B": "拉氧头孢",
      "C": "头孢曲松",
      "D": "头孢西丁",
      "E": "亚胺培南"
    },
    "answer": "A",
    "explanation": "本组题考查其他 \\beta-内酰胺类抗菌药物的临床用药评价。 ①氨曲南属于单环 \\beta-内酰胺类抗菌药, 与青霉素类及头孢菌素类无交叉过敏反应, 在严密监测下可用于对青霉素类、头孢菌素类过敏的患者。故本题答案为 A。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "5be65ea8360ba6bb82df0ec77158423a37be8c05",
    "section_no": 6,
    "section_title": "其他β-内酰胺类抗菌药物",
    "section_norm": "第六节 其他β-内酰胺类抗菌药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第7节助消化药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "具有促进消化和止泻作用，可用于消化不良、腹胀及小儿饮食失调所引起的腹泻、绿便的药物是",
    "options": {
      "A": "乳酶生",
      "B": "胰酶",
      "C": "蒙脱石散",
      "D": "利福昔明",
      "E": "美沙拉秦"
    },
    "answer": "A",
    "explanation": "本题考查助消化药的临床用药评价。乳酶生为活菌制剂，在肠内分解糖类生成乳酸，使肠内酸度增高，从而抑制腐败菌的生长繁殖，并防止肠内发酵，减少产气，因而有促进消化和止泻作用。临床可用于消化不良、腹胀及小儿饮食失调所引起的腹泻、绿便等。故本题答案为A。",
    "source_note": "",
    "question_id": "2c98d73b88f680f6081e777aabc0d6762b43b3ee",
    "section_no": 7,
    "section_title": "助消化药",
    "section_norm": "第七节 助消化药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第7节抗精神病药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "为5-HT-DA系统稳定剂的抗精神病药是",
    "options": {
      "A": "利培酮",
      "B": "碳酸锂",
      "C": "阿立哌唑",
      "D": "氯氮平",
      "E": "氯丙嗪"
    },
    "answer": "C",
    "explanation": "本题考查抗精神病药的分类与作用机制。阿立哌唑为 5-HT-DA 系统稳定剂, 对多巴胺 D2 受体具有弱激动作用, 对 5-HT2A 受体具有拮抗作用, 有助于 5-HT 与 DA 系统功能的协调并具有平衡作用, 提高抗精神病的疗效。故本题答案为 C。",
    "source_note": "",
    "question_id": "222f87785f11bf1d4dc17872294242eb6e2e0c7b",
    "section_no": 7,
    "section_title": "抗精神病药",
    "section_norm": "第七节 抗精神病药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于天然雌激素的是",
    "options": {
      "A": "炔雌醇",
      "B": "戊酸雌二醇",
      "C": "雌二醇",
      "D": "己烯雌酚",
      "E": "地屈孕酮"
    },
    "answer": "C",
    "explanation": "本题考查性激素的分类与代表药品。女性激素有雌激素类药物和孕激素类药物。雌激素类药物包括 ①天然雌激素：雌二醇、雌酮、雌三醇；②雌激素合成衍生物：炔雌醇、戊酸雌二醇；③全合成雌激素：己烯雌酚。孕激素类药物包括：黄体酮（孕酮）、甲羟孕酮、地屈孕酮。故本题答案为 C。",
    "source_note": "explanation_range_detected",
    "question_id": "1fa163981c9ff3b259dc3b8eadc57a38628ca355",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第7节其他抗肿瘤药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "可用于晚期原发性肝癌的细胞分化诱导剂是",
    "options": {
      "A": "依西美坦",
      "B": "香菇多糖",
      "C": "索拉非尼",
      "D": "干扰素",
      "E": "亚砷酸"
    },
    "answer": "E",
    "explanation": "本题考查细胞分化诱导剂的代表药品与临床用药评价。亚砷酸属于细胞分化诱导剂，可用于治疗急性早幼粒细胞性白血病、晚期原发性肝癌。故本题答案为E。",
    "source_note": "",
    "question_id": "a2218975d3e882ade40a83c579cef03479743abf",
    "section_no": 7,
    "section_title": "其他抗肿瘤药物",
    "section_norm": "第七节 其他抗肿瘤药物"
  },
  {
    "chapter": "第四章 消化系统用药",
    "section": "第7节助消化药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "在肠液中可消化淀粉、蛋白质和脂肪，能使食物中不同的成分被充分消化为可吸收的小分子片段的药物是",
    "options": {
      "A": "雷尼替丁",
      "B": "东莨菪碱",
      "C": "胰酶",
      "D": "多潘立酮",
      "E": "地衣芽孢杆菌"
    },
    "answer": "C",
    "explanation": "本题考查助消化药的临床用药评价。胰酶为助消化药，是来自猪、羊或牛胰腺中提取的多种酶的混合物，主要为胰蛋白酶、胰淀粉酶与胰脂肪酶，在肠液中可消化淀粉、蛋白质和脂肪，能使食物中的不同成分被充分消化为可吸收的小分子片段。故本题答案为 C。",
    "source_note": "",
    "question_id": "f9b09ae2e38c6499be05951047096e9ba04df01a",
    "section_no": 7,
    "section_title": "助消化药",
    "section_norm": "第七节 助消化药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第7节抗精神病药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "具有较高的 5\\mathrm{-HT}_{2} 受体拮抗作用，对中脑边缘系统的作用比对纹状体系统更具有选择性，较少发生锥体外系反应的抗精神病药是",
    "options": {
      "A": "氯丙嗪",
      "B": "舒必利",
      "C": "奥氮平",
      "D": "氟哌啶醇",
      "E": "氟哌噻吨"
    },
    "answer": "C",
    "explanation": "本题考查第二代抗精神病药的临床用药评价。奥氮平属于第二代抗精神病药，与第一代抗精神病药相比，其具有较高的 5-HT2 受体拮抗作用，对中脑边缘系统的作用比对纹状体系统更具有选择性，较少发生锥体外系反应。故本题答案为 C。",
    "source_note": "",
    "question_id": "3f4c9a8f3342733b91d5ad3e030c60f03c720f47",
    "section_no": 7,
    "section_title": "抗精神病药",
    "section_norm": "第七节 抗精神病药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "下列关于雌激素用药注意和不良反应的描述，不正确的是",
    "options": {
      "A": "长期或大量使用雌激素者，当停药或减量时须逐步减量",
      "B": "雌激素治疗可能增加乳腺癌的发生风险",
      "C": "雌激素治疗可减少血栓的发生风险",
      "D": "雌激素治疗可能诱发不规则阴道流血",
      "E": "雌激素治疗可能增加子宫内膜癌的风险"
    },
    "answer": "C",
    "explanation": "本题考查雌激素类的临床用药评价。雌激素治疗可能增加血栓栓塞性事件, 曾伴有血栓性静脉炎或血栓栓塞史者禁用。故本题答案为 C。长期或大量使用雌 激素者，当停药或减量时须逐步减量；雌激素治疗可能增加乳腺癌和子宫内膜癌的风险，已知或怀疑患有乳腺癌、雌激素依赖性肿瘤者禁用；雌激素治疗可能诱发不规则阴道流血，未明确诊断的阴道不规则流血者禁用。",
    "source_note": "",
    "question_id": "3cca85a28e5a3b6f0340d6d57a8f5675f0662704",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第7节氨基糖苷类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "属于氨基糖苷类抗菌药物的是",
    "options": {
      "A": "阿奇霉素",
      "B": "替加环素",
      "C": "多黏菌素 B",
      "D": "阿米卡星"
    },
    "answer": "D",
    "explanation": "本题考查氨基糖苷类药物的分类与代表药品。氨基糖苷类药物包括庆大霉素、卡那霉素、链霉素、妥布霉素、大观霉素、依替米星、异帕米星、阿米卡星、奈替米星。故本题答案为 D。阿奇霉素为大环内酯类抗菌药。阿莫西林为青霉素类抗菌药。多黏菌素 B 为多黏菌素类抗菌药。替加环素为四环素类抗菌药。",
    "source_note": "",
    "question_id": "e7e19d4d7095cf53b794fea0c51d4919a4cc022e",
    "section_no": 7,
    "section_title": "氨基糖苷类抗菌药物",
    "section_norm": "第七节 氨基糖苷类抗菌药物"
  },
  {
    "chapter": "第十章 抗肿瘤药",
    "section": "第7节其他抗肿瘤药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "亚砷酸的适应证的是",
    "options": {
      "A": "韦尼克脑病",
      "B": "白细胞过多综合征",
      "C": "多发性神经炎",
      "D": "急性早幼粒细胞性白血病",
      "E": "CD20 阳性的非霍奇金淋巴瘤"
    },
    "answer": "D",
    "explanation": "本题考查细胞分化诱导剂的临床用药评价。亚砷酸适用于急性早幼粒细胞性白血病、晚期原发性肝癌。故本题答案为 D。亚砷酸不良反应有: ①韦尼克脑病; ②白细胞过多综合征; ③多发性神经炎和多发性神经根炎。CD20 阳性的非霍奇金淋巴瘤宜选用利妥昔单抗。",
    "source_note": "explanation_range_detected",
    "question_id": "cee79a6db820d80c8c5c3164940e18d50af44fb6",
    "section_no": 7,
    "section_title": "其他抗肿瘤药物",
    "section_norm": "第七节 其他抗肿瘤药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第7节妇科外用药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "可直接卤化菌体蛋白质，可用于化脓性皮炎、细菌性阴道炎、痔疮的消毒防腐药是",
    "options": {
      "A": "聚维酮碘",
      "B": "聚甲酚磺醛 雌三醇",
      "C": "甲硝唑",
      "D": "硝呋太尔"
    },
    "answer": "A",
    "explanation": "本题考查妇科外用药的临床用药评价。聚维酮碘是碘与表面活性剂聚乙烯吡咯烷酮经反应生成的复合物, 从载体中释出碘, 可直接卤化菌体蛋白质, 是广谱强效杀菌药, 可用于化脓性皮炎、细菌性阴道炎、痔疮。故本题答案为 A。",
    "source_note": "",
    "question_id": "6f10338be5d2aee25705554a332974eced130f01",
    "section_no": 7,
    "section_title": "妇科外用药",
    "section_norm": "第七节 妇科外用药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第7节抗精神病药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "对躁狂和抑郁交替发作的双相情感性精神障碍有很好的治疗和预防复发作用，但用药期间应监测血药浓度的药物是",
    "options": {
      "A": "硫酸镁",
      "B": "碳酸锂",
      "C": "胶体果胶铋",
      "D": "氯氮平",
      "E": "氨茶碱"
    },
    "answer": "B",
    "explanation": "本题考查碳酸锂的临床用药评价。锂盐的治疗指数低, 治疗量和中毒量较接近, 应对血锂浓度进行监测, 帮助调节治疗量及维持量, 及时发现急性中毒。故本题答案为 B。",
    "source_note": "",
    "question_id": "567bd7b549241c6b66ee05a67730f4c50c2e7896",
    "section_no": 7,
    "section_title": "抗精神病药",
    "section_norm": "第七节 抗精神病药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "下列药物中不属于孕激素的是",
    "options": {
      "A": "地屈孕酮",
      "B": "黄体酮",
      "C": "炔诺酮",
      "D": "甲羟孕酮",
      "E": "炔雌醇"
    },
    "answer": "E",
    "explanation": "本题考查性激素药的分类与代表药品。炔雌醇属于雌激素。临床上常用的孕激素有黄体酮、甲羟孕酮、炔孕酮、环丙孕酮、地屈孕酮、屈螺酮。故本题答案为 E。",
    "source_note": "",
    "question_id": "635bce86bbc091a6725eec265dd1bc986549815b",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第7节氨基糖苷类抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "氨基糖苷类药物的抗菌作用机制是",
    "options": {
      "A": "影响细菌叶酸代谢",
      "B": "抑制细菌的拓扑异构酶",
      "C": "抑制细菌细胞壁的合成",
      "D": "抑制细菌蛋白质的合成",
      "E": "促进细菌细胞膜合成"
    },
    "answer": "D",
    "explanation": "本题考查氨基糖苷类药物的作用机制。氨基糖苷类药物的作用机制主要是抑制细菌蛋白质的合成, 还可影响细菌细胞膜屏障功能, 导致细胞死亡。故本题答案为 D。",
    "source_note": "",
    "question_id": "c9635f9fcc6e7910c7409572802e8473007ab22b",
    "section_no": 7,
    "section_title": "氨基糖苷类抗菌药物",
    "section_norm": "第七节 氨基糖苷类抗菌药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "下列选项中属于雌二醇的适应证的是",
    "options": {
      "A": "子宫颈癌",
      "B": "绝经期前乳腺癌",
      "C": "前列腺癌",
      "D": "子宫内膜癌",
      "E": "结肠癌"
    },
    "answer": "C",
    "explanation": "本题考查雌激素类的临床用药评价。雌二醇主要用于卵巢功能不全或卵巢激素不足引起的各种症状, 如功能性子宫出血、原发性闭经、绝经期综合征及前列腺癌等。故本题答案为 C。",
    "source_note": "",
    "question_id": "c3a14b349b7df04c2c0ff87727d590e448f3bdcf",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "不属于地屈孕酮的适应证的是",
    "options": {
      "A": "绝经后乳腺癌",
      "B": "功能失调性子宫出血",
      "C": "子宫内膜异位症",
      "D": "痛经",
      "E": "孕激素缺乏所致的习惯性流产"
    },
    "answer": "A",
    "explanation": "本题考查孕激素类的临床用药评价。地屈孕酮的适应证包括 ① 痛经; ② 子宫内膜异位症; ③ 功能失调性子宫出血; ④ 孕激素缺乏所致先兆流产或习惯性流产; ⑤ 黄体功能不全所致不孕症; ⑥ 继发性闭经; ⑦ 月经周期不规则; ⑧ 经前期紧张综合征。故本题答案为 A。",
    "source_note": "explanation_range_detected",
    "question_id": "bd8247a7c755c930c21a1b3cb27c21c16fb72a7b",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第7节氨基糖苷类抗菌药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "与氨基糖苷类药物合用可能加重肾毒性的是",
    "options": {
      "A": "头孢唑林",
      "B": "头孢他啶 克林霉素",
      "C": "克拉维酸",
      "D": "四环素"
    },
    "answer": "A",
    "explanation": "本题考查氨基糖苷类药物的临床用药评价。氨基糖苷类有肾毒性, 与第一代头孢菌素（如头孢唑林）合用可加重肾毒性。故本题答案为 A。",
    "source_note": "",
    "question_id": "43071447e775a73f75b0a9f932e2e57e08e94bf7",
    "section_no": 7,
    "section_title": "氨基糖苷类抗菌药物",
    "section_norm": "第七节 氨基糖苷类抗菌药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "以下不属于长效避孕药的是",
    "options": {
      "A": "复方己酸羟孕酮注射液",
      "B": "左炔诺孕酮炔雌醚片",
      "C": "复方庚酸炔诺酮注射液",
      "D": "左炔诺孕酮埋植剂",
      "E": "去氧孕烯炔雌醇片"
    },
    "answer": "E",
    "explanation": "本题考查性激素类避孕药的分类与代表药品。长效避孕药多为孕激素与长效雌激素配伍或通过剂型改变而达到长效避孕的目的，包括：①口服长效避孕药：左炔诺孕酮、氯地孕酮与炔雌醚配伍，均可作为每月口服一次的长效避孕药；②注射长效避孕针：复方己酸羟孕酮注射液、复方庚酸炔诺酮注射液均为每月一次的避孕药；③埋植剂：左炔诺孕酮埋植剂以低量恒定缓慢释药，有效期5年；④含药阴道环：左炔诺孕酮避孕环和甲硅环亦为低量恒定缓慢释放的剂型，有效期3～12个月；⑤含药宫内节育器：孕酮节育器是一种缓释系统，能提高避孕有效率，降低脱落率，有效期5年。去氧孕烯炔雌醇片为短效口服避孕药。故本题答案为E。",
    "source_note": "explanation_range_detected",
    "question_id": "969ef6648ce81115dc2ab5c403f1d4862e27f0c1",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第7节氨基糖苷类抗菌药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "氨基糖苷类药物中具有抗结核分枝杆菌作用的是",
    "options": {
      "A": "链霉素",
      "B": "异烟肼",
      "C": "庆大霉素",
      "D": "吡嗪酰胺",
      "E": "卡那霉素"
    },
    "answer": "A",
    "explanation": "本题考查氨基糖苷类药物的临床用药评价。氨基糖苷类药物中链霉素、阿米卡星对结核分枝杆菌和其他分枝杆菌属有良好作用。异烟肼、吡嗪酰胺属于抗结核药物, 不属于氨基糖苷类药物。故本题答案为 A。",
    "source_note": "",
    "question_id": "4fa757385320c17ec61b79e7c4257072c201b8d4",
    "section_no": 7,
    "section_title": "氨基糖苷类抗菌药物",
    "section_norm": "第七节 氨基糖苷类抗菌药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "下列避孕药中无孕激素活性的是",
    "options": {
      "A": "孕二烯酮",
      "B": "羟孕酮",
      "C": "左炔诺孕酮",
      "D": "米非司酮"
    },
    "answer": "D",
    "explanation": "本题考查性激素类避孕药的临床用药评价。米非司酮无孕激素、雌激素、雄激素和抗雌激素活性; 但能与孕酮受体结合, 对子宫内膜孕酮受体亲和力比黄体酮强 5 倍。主要通过影响子宫内膜着床期的正常生理变化, 干扰孕卵着床过程, 降低着床率, 避免妊娠, 临床作为事后避孕药用于紧急避孕。故本题答案为 D。",
    "source_note": "",
    "question_id": "fe5c869ef359cdf7b0b82d568ba5506547717eb9",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第7节氨基糖苷类抗菌药物",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "可致前庭、耳蜗神经功能障碍，妊娠期妇女和新生儿禁用的抗菌药物是",
    "options": {
      "A": "林可霉素类",
      "B": "酰胺醇类",
      "C": "四环素类",
      "D": "氨基糖苷类",
      "E": "喹诺酮类"
    },
    "answer": "D",
    "explanation": "本题考查氨基糖苷类药物的临床用药评价。氨基糖苷类常见不良反应是耳毒性, 包括前庭和耳蜗神经功能障碍, 禁用于妊娠期妇女和新生儿。故本题答案为 D。",
    "source_note": "",
    "question_id": "12c7c07bb057127210a326df938156801f7ef8d5",
    "section_no": 7,
    "section_title": "氨基糖苷类抗菌药物",
    "section_norm": "第七节 氨基糖苷类抗菌药物"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "单项选择题",
    "qno": 10,
    "stem": "与前列腺素药物序贯合并使用，可用于终止停经49日内的妊娠的是",
    "options": {
      "A": "左炔诺孕酮",
      "B": "米非司酮",
      "C": "雌二醇",
      "D": "庚酸炔诺酮",
      "E": "黄体酮"
    },
    "answer": "B",
    "explanation": "本题考查性激素类避孕药的临床用药评价。米非司酮与前列腺素类药物序贯合并使用, 可用于终止停经 49 日内的妊娠。故本题答案为 B。",
    "source_note": "",
    "question_id": "62fa89b46658628488e1f9543b295dc9adc4926f",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第7节抗精神病药",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "第一代抗精神病药中诱发癫痫风险最高的是",
    "options": {
      "A": "垄硫平",
      "B": "氯丙嗪",
      "C": "氯哌噻吨",
      "D": "氟哌啶醇",
      "E": "奥氮平"
    },
    "answer": "B",
    "explanation": "本组题考查第一代抗精神病药的临床用药评价。 ①第一代抗精神病药物中诱发癫痫风险最高是氯丙嗪。故本题答案为 B。",
    "source_note": "",
    "question_id": "fde66b3fa72d9f84a0f72b877a911e225e8d52e5",
    "section_no": 7,
    "section_title": "抗精神病药",
    "section_norm": "第七节 抗精神病药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第7节抗精神病药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "第一代抗精神病药中诱发癫痫风险最低的是",
    "options": {
      "A": "垄硫平",
      "B": "氯丙嗪",
      "C": "氯哌噻吨",
      "D": "氟哌啶醇",
      "E": "奥氮平"
    },
    "answer": "D",
    "explanation": "本组题考查第一代抗精神病药的临床用药评价。 ②第一代抗精神病药物中诱发癫痫风险最低的是氟哌啶醇。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "61bbb0a84d441e58aeaf9855cadba285bf1dcd16",
    "section_no": 7,
    "section_title": "抗精神病药",
    "section_norm": "第七节 抗精神病药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第7节抗精神病药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "第一代抗精神病药物最常见，而第二代抗精神病药物较少引起的不良反应是",
    "options": {
      "A": "锥体外系不良反应",
      "B": "代谢紊乱",
      "C": "高泌乳素血症",
      "D": "Q-T间期延长",
      "E": "外周抗胆碱能反应"
    },
    "answer": "A",
    "explanation": "【7 \\sim 8】 ①本题考查第一代抗精神病药的临床用药评价。高效价的第一代抗精神病药物最容易引起锥体外系反应, 而第二代抗精神病药物较少引起此不良反应, 且 药物之间存在比较大的差异。故本题答案为A。",
    "source_note": "",
    "question_id": "1ebf8795a9a92792fdc58cfad9c0bf2eb1cd25b0",
    "section_no": 7,
    "section_title": "抗精神病药",
    "section_norm": "第七节 抗精神病药"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第7节抗精神病药",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "与第一代抗精神病药物相比，第二代抗精神病药物常见的不良反应是",
    "options": {
      "A": "锥体外系不良反应",
      "B": "代谢紊乱",
      "C": "高泌乳素血症",
      "D": "Q-T间期延长",
      "E": "外周抗胆碱能反应"
    },
    "answer": "B",
    "explanation": "【7 \\sim 8】 ②本题考查第二代抗精神病药的临床用药评价。抗精神病药物引起的体重增加及糖脂代谢异常等代谢综合征的症状目前已成为药物治疗中需要重视的问题，也是第二代抗精神病药物常见的不良反应，严重影响患者服药的依从性，同时在很大程度上增加了心血管疾病和糖尿病的风险。第二代抗精神病药物比第一代抗精神病药物更易引起代谢综合征。故本题答案为B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "61eaca12be36d911cd631b104bdc492767e85077",
    "section_no": 7,
    "section_title": "抗精神病药",
    "section_norm": "第七节 抗精神病药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "采用微粒化工艺后，克服了原口服剂型在肝脏内很快失活的缺点，用于治疗月经失调和先兆流产的药物是",
    "options": {
      "A": "左炔诺孕酮",
      "B": "地屈孕酮",
      "C": "甲羟孕酮",
      "D": "黄体酮",
      "E": "羟孕酮"
    },
    "answer": "D",
    "explanation": "本组题考查孕激素类的临床用药评价。 ①黄体酮口服后迅速经胃肠道吸收, 在肝脏内很快失活, 故以往不能口服。近来已有经微粒化后的产品, 克服了原口服剂型在肝脏内很快失活的缺点, 可以口服, 可用于治疗月经失调和先兆流产。故本题答案为 D。",
    "source_note": "",
    "question_id": "2b675405e793bb5e4ccf77696a6bac35d17aede3",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "注射剂可用于治疗月经不调、绝经期后乳腺癌、子宫内膜癌的药物是",
    "options": {
      "A": "左炔诺孕酮",
      "B": "地屈孕酮",
      "C": "甲羟孕酮",
      "D": "黄体酮",
      "E": "羟孕酮"
    },
    "answer": "C",
    "explanation": "本组题考查孕激素类的临床用药评价。 ②甲羟孕酮可用于月经不调、功能失调性子宫出血及子宫内膜异位症等。注射液可用作长效避孕药, 亦可用于绝经期后乳腺癌及子宫内膜癌。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "77c54d8410bbc00687de2c6a363c4b77acf3bcce",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "育龄女性在无防护的性生活或避孕失误72小时内宜使用的口服紧急避孕药是",
    "options": {
      "A": "米非司酮",
      "B": "左炔诺孕酮",
      "C": "双炔失碳酯",
      "D": "黄体酮",
      "E": "复方左炔诺孕酮"
    },
    "answer": "B",
    "explanation": "本组题考查性激素类避孕药的临床用药评价。 ①左炔诺孕酮单方制剂可作为紧急避孕药，在无防护的性生活或避孕失败72小时内尽快口服，不宜作为常规避孕药。故本题答案为B。",
    "source_note": "",
    "question_id": "79238c06b575b163a7d5caeaecdebae9b29178ff",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "配伍选择题",
    "qno": 14,
    "stem": "育龄妇女避孕失败，意外妊娠，距上次经期结束40天，医生可开具的抗早孕药是",
    "options": {
      "A": "米非司酮",
      "B": "左炔诺孕酮",
      "C": "双炔失碳酯",
      "D": "黄体酮",
      "E": "复方左炔诺孕酮"
    },
    "answer": "A",
    "explanation": "本组题考查性激素类避孕药的临床用药评价。 ②米非司酮为强抗孕激素，对受孕动物各期妊娠均有引产效应，可作为非手术性抗早孕药。与前列腺素药物序贯合并使用，可用于终止停经49日内的妊娠。故本题答案为A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "ff20c888c3e814fc548651eba59576f3f0ca5850",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第7节氨基糖苷类抗菌药物",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，男，56岁，由于铜绿假单胞菌感染导致脑膜炎，医生处方庆大霉素治疗，治疗期间需关注的不良反应是",
    "options": {
      "A": "双硫仑样反应",
      "B": "耳、肾毒性",
      "C": "肌腱断裂",
      "D": "再生障碍性贫血",
      "E": "肝毒性、牙齿黄染"
    },
    "answer": "B",
    "explanation": "本题考查氨基糖苷类药物的临床用药评价。庆大霉素属于氨基糖苷类药物, 典型不良反应包括: ①耳毒性: 前庭、耳蜗神经功能障碍; ②肾毒性: 损害近曲小管上皮细胞, 引起肾小管肿胀, 甚至坏死; ③神经-肌肉接头处传递阻断: 引起心肌 抑制、血压下降、肢体瘫痪、呼吸肌麻痹；④过敏反应。故本题答案为B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords) | explanation_range_detected",
    "question_id": "71ad69ea175b1899210e988af16bafa0b8d4c9c3",
    "section_no": 7,
    "section_title": "氨基糖苷类抗菌药物",
    "section_norm": "第七节 氨基糖苷类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第7节妇科外用药",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，女，32岁。诊断为慢性宫颈炎症、柱状上皮外移，使用聚甲酚磺醛栓治疗。关于该药物临床用药评价的说法，错误的是",
    "options": {
      "A": "治疗期间避免性交",
      "B": "月经期间暂停治疗",
      "C": "有广谱抗菌作用",
      "D": "有刺激性, 注意避免接触到眼睛",
      "E": "用药后若出现大片白色坏死组织从病灶处脱落，应及时就医"
    },
    "answer": "E",
    "explanation": "本题考查妇科外用药的临床用药评价。聚甲酚磺醛为消毒防腐药，用药后若出现大片白色坏死组织从病灶处脱落，为正常现象。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "e41e8e1f1ceba291ab4bda021e5f2c8cad1d5c54",
    "section_no": 7,
    "section_title": "妇科外用药",
    "section_norm": "第七节 妇科外用药"
  },
  {
    "chapter": "第八章 内分泌系统用药",
    "section": "第7节性激素类",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "可能引起所分娩女婴出现生殖道异常，罕见病例在育龄期发生阴道癌或宫颈癌的药物是",
    "options": {
      "A": "他莫昔芬",
      "B": "炔雌醇",
      "C": "雌三醇",
      "D": "雌二醇",
      "E": "己烯雌酚"
    },
    "answer": "E",
    "explanation": "本题考查雌激素类的临床用药评价。妊娠早期使用己烯雌酚可能引起所分娩女婴出现生殖道异常, 罕见病例在育龄期发生阴道癌或宫颈癌。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "8415bbf5631bca5616a7a173d6d1eb68329367ee",
    "section_no": 7,
    "section_title": "性激素类",
    "section_norm": "第七节 性激素类"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第7节氨基糖苷类抗菌药物",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "患者，男，36岁，肾功能正常。因长期住院导致院内感染，经实验室检测为铜绿假单胞菌感染，医生处方庆大霉素肌内注射。静脉快速注射庆大霉素引起呼吸抑制的原因是",
    "options": {
      "A": "庆大霉素引起的过敏性休克",
      "B": "庆大霉素引起的神经-肌肉接头阻滞",
      "C": "庆大霉素加重患者原有疾病",
      "D": "庆大霉素引起的耳毒性",
      "E": "庆大霉素引起的肾毒性"
    },
    "answer": "B",
    "explanation": "本题考查氨基糖苷类药物的临床用药评价。庆大霉素可阻滞神经-肌肉接头传递, 引起呼吸抑制, 故不可快速静脉注射给药。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "c8ef784fc5a59a16eb770153a79831a273f67672",
    "section_no": 7,
    "section_title": "氨基糖苷类抗菌药物",
    "section_norm": "第七节 氨基糖苷类抗菌药物"
  },
  {
    "chapter": "第一章 精神与中枢神经系统用药",
    "section": "第7节抗精神病药",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "不推荐作为首发精神分裂症患者一线治疗选择的药物是",
    "options": {
      "A": "阿立哌唑",
      "B": "奥氮平",
      "C": "喹硫平",
      "D": "齐拉西酮",
      "E": "氯氮平"
    },
    "answer": "E",
    "explanation": "本题考查第二代抗精神病药的临床用药评价。第二代抗精神病药物 (SGAs): 阿立哌唑、氨磺必利、奥氮平、喹硫平、帕利哌酮、利培酮和齐拉西酮等 SGAs 已经作为首发患者的一线用药选择, 具体选择何种抗精神病药作为首选治疗用药, 应根据个体化评估结果和临床治疗学原理做出抉择。鉴于治疗中安全性和严重不良反应等因素, 原则上不推荐氯氮平作为首发精神分裂症患者的一线治疗选择。故本题答案为 E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "b247d135db66870a77824323b826a8d23456eab8",
    "section_no": 7,
    "section_title": "抗精神病药",
    "section_norm": "第七节 抗精神病药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第8节四环素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "为第三代四环素类药物，与细菌核糖体30S亚基结合点的亲和力更强的药物是",
    "options": {
      "A": "多西环素",
      "B": "金霉素",
      "C": "替加环素",
      "D": "四环素",
      "E": "米诺环素"
    },
    "answer": "C",
    "explanation": "本题考查四环素类抗菌药物的代表药品与临床用药评价。替加环素属于第三代四环素类药物，其作用机制与四环素类似，但与细菌核糖体 30S 亚基结合位点的亲和力是四环素的 5 倍。故本题答案为 C。多西环素和米诺环素属于第二代四环素类药物。金霉素和四环素属于第一代四环素类药物。",
    "source_note": "",
    "question_id": "f36b287d6f660f570f37bfa97f19cb1b2075c3a3",
    "section_no": 8,
    "section_title": "四环素类抗菌药物",
    "section_norm": "第八节 四环素类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第8节消毒防腐药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "关于消毒防腐药使用注意事项的说法，不正确的是",
    "options": {
      "A": "误服戊二醛后应洗胃和使用催吐剂",
      "B": "聚维酮碘与过氧化氢混合可引起爆炸",
      "C": "氯己定含漱液不宜长期使用, 以免引起牙齿着色",
      "D": "依沙吖啶仅供外用, 且见光易分解, 颜色加深, 不可再用",
      "E": "高浓度苯酚会导致皮肤烧伤并有腐蚀性"
    },
    "answer": "A",
    "explanation": "本题考查消毒防腐药的代表药物与临床用药评价。误服戊二醛后避免洗胃和使用催吐剂, 可服用水、牛奶、活性炭。故本题答案为 A。",
    "source_note": "",
    "question_id": "1f30cb9d03e0bcb97dddf9b04ea6cbec07eb609d",
    "section_no": 8,
    "section_title": "消毒防腐药",
    "section_norm": "第八节 消毒防腐药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第8节四环素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "四环素类抗菌药物属于快速抑菌剂，且抗菌谱广，抗菌范围不包括",
    "options": {
      "A": "支原体",
      "B": "衣原体",
      "C": "立克次体",
      "D": "革兰阳性菌",
      "E": "铜绿假单胞菌"
    },
    "answer": "E",
    "explanation": "本题考查四环素类抗菌药物的临床用药评价。四环素类抗菌药物属于广谱抗菌药物，抗菌谱包括：革兰阳性菌、立克次体、支原体、衣原体、螺旋体、诺卡菌、放线菌、布鲁菌、兔热病、惠普尔病和疟疾等，但对铜绿假单胞菌无作用。故本题答案为 E。",
    "source_note": "",
    "question_id": "671ece265125bab1d2b145efcd91ff5c33d5f779",
    "section_no": 8,
    "section_title": "四环素类抗菌药物",
    "section_norm": "第八节 四环素类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第8节消毒防腐药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "不属于消毒防腐药的是",
    "options": {
      "A": "味喃西林",
      "B": "高锰酸钾",
      "C": "过氧化氢",
      "D": "阿达帕林",
      "E": "过氧苯甲酰"
    },
    "answer": "D",
    "explanation": "本题考查消毒防腐药的代表药物与临床用药评价。消毒防腐药包括：苯酚、高锰酸钾、过氧化氢、过氧苯甲酰、环氧乙烷、聚维酮碘、氯己定、乙醇、戊二醛、硼酸、硝酸银、磺胺嘧啶银、氧化锌、呋喃西林等。故本题答案为 D。阿达帕林为抗角化药。",
    "source_note": "",
    "question_id": "14139be476614d8224245f2f0ef4249506d5b5b2",
    "section_no": 8,
    "section_title": "消毒防腐药",
    "section_norm": "第八节 消毒防腐药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第8节四环素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "可能引起前庭功能失调（眩晕）的药物是",
    "options": {
      "A": "头孢曲松",
      "B": "氨苄西林",
      "C": "氯霉素",
      "D": "克林霉素",
      "E": "米诺环素"
    },
    "answer": "E",
    "explanation": "本题考查四环素类抗菌药物的临床用药评价。米诺环素可引起眩晕、耳鸣等前庭功能紊乱，用药期间禁止从事高空作业、驾车以及操作具有危险性的机械。故本题答案为 E。",
    "source_note": "",
    "question_id": "12ca208308d14ee897ef5c80ecedcd03b2732c8f",
    "section_no": 8,
    "section_title": "四环素类抗菌药物",
    "section_norm": "第八节 四环素类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第8节消毒防腐药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "对消毒防腐药苯酚耐药的病原微生物是",
    "options": {
      "A": "球菌",
      "B": "杆菌",
      "C": "双球菌",
      "D": "真菌",
      "E": "病毒"
    },
    "answer": "E",
    "explanation": "本题考查消毒防腐药的代表药物与临床用药评价。病原微生物对消毒防腐药的敏感性不相同, 苯酚对病毒无效。故本题答案为 E。",
    "source_note": "",
    "question_id": "bdb43fbeb7193f4fd520db9f2c296f2cb7dca5b6",
    "section_no": 8,
    "section_title": "消毒防腐药",
    "section_norm": "第八节 消毒防腐药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第8节四环素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "与核糖体30S亚基结合，抑制细菌蛋白质合成的药物是",
    "options": {
      "A": "四环素",
      "B": "克林霉素",
      "C": "万古霉素",
      "D": "氯霉素",
      "E": "青霉素"
    },
    "answer": "A",
    "explanation": "本题考查四环素类抗菌药物的代表药品与作用机制。四环素类药物进入细胞后, 与细菌核糖体的 30S 亚基结合, 阻止蛋白质合成始动复合物, 并抑制氨基酰-tRNA 与 mRNA-核糖体复合物结合, 从而抑制肽链延长和细菌蛋白质的合成。故本题答案为 A。",
    "source_note": "",
    "question_id": "7bd5214fecd8eb2656585145d5bf64356e91f364",
    "section_no": 8,
    "section_title": "四环素类抗菌药物",
    "section_norm": "第八节 四环素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第8节四环素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "与钙离子形成的螯合物在体内呈黄色，沉积在牙齿和骨骼中，造成牙齿黄染，不可用于8岁以下患儿的药物是",
    "options": {
      "A": "青霉素 V",
      "B": "头孢哌酮",
      "C": "阿奇霉素",
      "D": "四环素",
      "E": "林可霉素"
    },
    "answer": "D",
    "explanation": "本题考查四环素类抗菌药物的临床用药评价。四环素类抗菌药物可引起牙齿永久性变色，牙釉质发育不良，并抑制骨骼发育，8岁以下儿童禁用。故本题答案为D。",
    "source_note": "",
    "question_id": "d26ca162d80a2dde95863cd3e5a60f765d1e5986",
    "section_no": 8,
    "section_title": "四环素类抗菌药物",
    "section_norm": "第八节 四环素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第8节四环素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "受四环素类两大耐药机制影响小，也不受 \\beta- 内酰胺酶影响，体内和体外均具有广谱抗菌活性的药物是",
    "options": {
      "A": "米诺环素",
      "B": "四环素",
      "C": "多西环素",
      "D": "替加环素",
      "E": "土霉素"
    },
    "answer": "D",
    "explanation": "本题考查四环素类抗菌药物的临床用药评价。替加环素属于广谱甘氨 酰环素类药物，为第三代四环素类药物，受四环素类两大耐药机制（核糖体保护和外排机制）的影响较小，也不受 \\beta-内酰胺酶（包括超广谱 \\beta-内酰胺酶）、靶位修饰、大环内酯类外排泵或酶靶位改变（如旋转酶/拓扑异构酶）等耐药机制的影响，体内和体外均具有广谱抗菌活性。故本题答案为 D。",
    "source_note": "",
    "question_id": "bde4ab4636559d7ead65bfde2c88f8f15e9c6393",
    "section_no": 8,
    "section_title": "四环素类抗菌药物",
    "section_norm": "第八节 四环素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第8节四环素类抗菌药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "关于替加环素的说法，错误的是",
    "options": {
      "A": "仅限于治疗其他抗生素不适用的复杂感染",
      "B": "8岁以下儿童禁用",
      "C": "抗菌谱广, 可用于铜绿假单胞菌",
      "D": "可导致急性胰腺炎",
      "E": "可发生轻度至威胁生命的假膜性肠炎"
    },
    "answer": "C",
    "explanation": "本题考查四环素类抗菌药物的临床用药评价。替加环素属于四环素类抗菌药，抗菌谱广，但对铜绿假单胞菌无抗菌活性。故本题答案为 C。",
    "source_note": "",
    "question_id": "4ea15dca16326e49f4ab046d4b24fe4e767bbca2",
    "section_no": 8,
    "section_title": "四环素类抗菌药物",
    "section_norm": "第八节 四环素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第8节四环素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "与多价金属离子如铝、钙、铁、镁、铋等形成不溶性络合物，口服吸收率减少的药物是",
    "options": {
      "A": "四环素",
      "B": "克林霉素",
      "C": "氯霉素",
      "D": "青霉素",
      "E": "庆大霉素"
    },
    "answer": "A",
    "explanation": "①本题考查四环素类抗菌药物的临床用药评价。四环素类的代表药物有四环素、多西环素、米诺环素等, 其可以与多价阳离子 (铝、钙、铁、镁、铋) 形成不溶性络合物, 导致口服吸收率减少。故本题答案为 A。",
    "source_note": "",
    "question_id": "d9e55f8a740b30275e7f79a470f376640820d313",
    "section_no": 8,
    "section_title": "四环素类抗菌药物",
    "section_norm": "第八节 四环素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第8节四环素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "可引起可逆性肾功能损害，导致肾小管肿胀，甚至坏死的药物是",
    "options": {
      "A": "四环素",
      "B": "克林霉素",
      "C": "氯霉素",
      "D": "青霉素",
      "E": "庆大霉素"
    },
    "answer": "E",
    "explanation": "②本题考查氨基糖苷类药物的临床用药评价。氨基糖苷类代表药物 (如庆大霉素) 可导致可逆性肾功能损害, 损害近曲小管上皮细胞, 引起肾小管肿胀, 甚至坏死。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "f17bfff224cec2883bf3f02234983d42745cb148",
    "section_no": 8,
    "section_title": "四环素类抗菌药物",
    "section_norm": "第八节 四环素类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于第二代抗组胺药物的是",
    "options": {
      "A": "氯苯那敏",
      "B": "去氯羟嗪",
      "C": "塞曲司特",
      "D": "苯海拉明",
      "E": "氯雷他定"
    },
    "answer": "E",
    "explanation": "本题考查抗过敏药的分类与代表药品。第二代抗组胺药物有：特非那定、非索非那定、氯雷他定、地氯雷他定、奥洛他定、卢帕他定、阿伐斯汀、贝他斯汀、依巴斯汀、依美斯汀、西替利嗪、左西替利嗪等。故本题答案为 E。",
    "source_note": "",
    "question_id": "ad1e106250a4307f1745f3c068deb26146340a0f",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "红霉素与辛伐他汀联合使用，可增加横纹肌溶解的危险性，原因是",
    "options": {
      "A": "红霉素属于肝药酶抑制剂",
      "B": "红霉素属于肝药酶诱导剂",
      "C": "红霉素具有肌毒性",
      "D": "红霉素属于 P 糖蛋白诱导剂",
      "E": "辛伐他汀增加红霉素的肌毒性"
    },
    "answer": "A",
    "explanation": "本题考查大环内酯类药物的临床用药评价。红霉素属于肝药酶抑制剂，可抑制 CYP3A4，导致辛伐他汀、洛伐他汀和阿托伐他汀血药浓度升高，增加横纹肌溶解的危险性。故本题答案为 A。",
    "source_note": "",
    "question_id": "8be44028c79530e308c6a98a877f99c8920e9f4b",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "严重影响驾驶安全，或导致伤害，驾驶员和从事机械操作、精密仪器操作人员避免使用的药物是",
    "options": {
      "A": "西替利嗪",
      "B": "咪唑斯汀",
      "C": "氯雷他定",
      "D": "氯苯那敏"
    },
    "answer": "B",
    "explanation": "本题考查抗过敏药的临床用药评价。国际酒精药品和交通安全委员会（ICADTS）针对驾驶员和从事机械操作、精密仪器操作人员，将抗组胺药总结为三类，第III类为严重影响驾驶安全，或导致伤害，服药期间不能从事驾驶或操作，且停药后需再次评估药物后续影响，再决定何时恢复驾驶或操作。属于第III类药物的均为第一代抗组胺药，药物包括：苯海拉明、氯马斯汀、异丙嗪、曲普利啶。故本题答案为B。",
    "source_note": "",
    "question_id": "45c84acdddfde281daddb16f0c57485bf1f2df53",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "下列不属于大环内酯类抗菌药物的是",
    "options": {
      "A": "交沙霉素",
      "B": "泰利霉素",
      "C": "阿奇霉素",
      "D": "克林霉素",
      "E": "克拉霉素"
    },
    "answer": "D",
    "explanation": "本题考查大环内酯类药物的分类与代表药品。大环内酯类抗生素是一类具有 14\\sim 16 碳内酯环的抗菌药物，其代表药物有红霉素、罗红霉素、交沙霉素、乙 酰螺旋霉素、麦迪霉素、克拉霉素、阿奇霉素、泰利霉素等。克林霉素属于林可霉素类抗菌药物。故本题答案为 D。",
    "source_note": "",
    "question_id": "1917bfba4d73cf4395f09e7e2ea81be2781dccdd",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "对革兰阳性菌和非典型致病菌如军团菌、肺炎支原体、衣原体等有良好抗菌作用的药物是",
    "options": {
      "A": "红霉素",
      "B": "阿莫西林",
      "C": "多黏菌素 B",
      "D": "阿米卡星",
      "E": "味喃唑酮"
    },
    "answer": "A",
    "explanation": "本题考查大环内酯类药物的临床用药评价。红霉素属于大环内酯类药物, 抗菌谱包括革兰阳性球菌、革兰阴性球菌、部分革兰阴性杆菌、非典型致病菌（军团菌、肺炎支原体、立克次体、衣原体）和厌氧消化球菌。故本题答案为 A。",
    "source_note": "",
    "question_id": "8ea6adcfb2577d2f6ea5602b11ff1267946ed58d",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "与 50s 核糖体亚基的供位相结合，竞争性阻断了肽链延伸过程中的肽基转移作用与移位作用，从而抑制蛋白质的合成的药物是",
    "options": {
      "A": "克拉霉素",
      "B": "呼拉西林",
      "C": "两性霉素 B",
      "D": "链霉素",
      "E": "呋喃西林"
    },
    "answer": "A",
    "explanation": "本题考查大环内酯类药物的分类与作用机制。大环内酯类药物的代表药物有红霉素、克拉霉素、阿奇霉素、罗红霉素、泰利霉素，其作用机制是与细菌核糖体50S亚基结合，抑制细菌蛋白质的合成。故本题答案为A。",
    "source_note": "",
    "question_id": "bbe3fe113fc366a959d8ae4e43750779464bb3f8",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "为十五元环类大环内酯类抗菌药物的是",
    "options": {
      "A": "阿奇霉素",
      "B": "罗红霉素",
      "C": "吉他霉素",
      "D": "麦迪霉素",
      "E": "交沙霉素"
    },
    "answer": "A",
    "explanation": "本题考查大环内酯类药物的临床用药评价。大环内酯类抗菌药因结构母核上含碳数目不同，可分为十四元、十五元和十六元环，其中红霉素及其酯类衍生物如琥乙红霉素、依托红霉素、罗红霉素、克拉霉素、地红霉素以及泰利霉素属于十四元环类；阿奇霉素为十五元环类；吉他霉素、麦迪霉素、螺旋霉素、交沙霉素等属于十六元环类。故本题答案为 A。",
    "source_note": "",
    "question_id": "412f82103c74a063f89d09a0978c00a292fef7cb",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "可与 PPI、铋剂联合使用治疗幽门螺杆菌感染的药物是",
    "options": {
      "A": "克拉霉素",
      "B": "替考拉宁",
      "C": "美罗培南",
      "D": "大观霉素",
      "E": "氯霉素"
    },
    "answer": "A",
    "explanation": "本题考查大环内酯类药物的临床用药评价。克拉霉素为大环内酯类抗菌药物，可与 PPI、铋剂联合使用治疗幽门螺杆菌感染。故本题答案为 A。",
    "source_note": "",
    "question_id": "e3942011f9b85d7bb718b61920d5bd1ff064dca7",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "阿奇霉素在组织和细胞内渗透性好，能广泛分布的组织和体液不包括",
    "options": {
      "A": "肝脏",
      "B": "肾脏",
      "C": "脑组织",
      "D": "胆汁",
      "E": "脾脏"
    },
    "answer": "C",
    "explanation": "本题考查大环内酯类药物的临床用药评价。克拉霉素、阿奇霉素和泰利霉素的血清半衰期更长, 并且在组织和细胞内渗透性更好, 广泛分布于除脑组织和脑脊液外的各种组织和体液中。故本题答案为 C。",
    "source_note": "",
    "question_id": "d8ff867daedfed1c606aab2ea2942d54fe0d9b60",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "单项选择题",
    "qno": 9,
    "stem": "红霉素与林可霉素合用，可以",
    "options": {
      "A": "扩大抗菌谱",
      "B": "产生拮抗作用 增加毒性",
      "C": "增强抗菌活性",
      "D": "降低毒性"
    },
    "answer": "B",
    "explanation": "本题考查大环内酯类药物的临床用药评价。红霉素与林可霉素或氯霉素合用因竞争核糖体 50S 亚基而发生拮抗作用。故本题答案为 B。",
    "source_note": "",
    "question_id": "6285fb8e38edae2a0a31302003acaad0b8979018",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "下列药物中具有中枢性镇咳作用的有",
    "options": {
      "A": "可待因",
      "B": "右美沙芬",
      "C": "喷托维林",
      "D": "福尔可定",
      "E": "那可丁"
    },
    "answer": "D",
    "explanation": "②本题考查抗过敏药的分类与代表药品。塞曲司特为血栓素 A2 受体拮抗剂, 能有效地拮抗血栓素 A2 引起的支气管收缩及气道高反应性。故本题答案为 D。",
    "source_note": "",
    "question_id": "97f271323d01b3baa326ada679d07cbf9c83ac25",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "作为对青霉素过敏的白喉带菌者的替代选用药的是",
    "options": {
      "A": "红霉素",
      "B": "舒巴坦",
      "C": "阿莫西林",
      "D": "氯霉素",
      "E": "林可霉素"
    },
    "answer": "A",
    "explanation": "【 10 \\sim 11】 ①本题考查大环内酯类药物的临床用药评价。红霉素可作为青霉素过敏患者溶血性链球菌、肺炎链球菌等所致急性扁桃体炎、急性咽炎、鼻窦炎; 溶 血性链球菌所致猩红热、蜂窝织炎；白喉及白喉带菌者；气性坏疽、炭疽、破伤风；放线菌病；梅毒；李斯特菌病等替代选用药。故本题答案为 A。",
    "source_note": "",
    "question_id": "2c272a0c4a534bffb8685319883f82684d3295a4",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "与头孢哌酮组成复方制剂，用于需要抗菌药物广覆盖的感染的药物是",
    "options": {
      "A": "红霉素",
      "B": "舒巴坦",
      "C": "阿莫西林",
      "D": "氯霉素",
      "E": "林可霉素"
    },
    "answer": "B",
    "explanation": "【 10 \\sim 11】 ②本题考查 \\beta-内酰胺酶抑制剂的临床用药评价。舒巴坦属于 \\beta-内酰胺酶抑制剂，可与头孢哌酮组成复方制剂，用于需要抗菌药物广覆盖的感染。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "3241840e9f36949ec6a81f167bb5e9371e208b8e",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 1,
    "stem": "关于非甾体抗炎药(NSAIDs)作用特点的说法，正确的有",
    "options": {
      "A": "通过抑制合成前列腺素所需的环氧化酶而发挥解热、镇痛、抗炎作用",
      "B": "解热作用部位主要是中枢, 只能使发热者的体温下降, 而对正常体温无影响",
      "C": "镇痛作用部位主要是中枢, 可产生中等程度的镇痛作用",
      "D": "大多数的 NSAIDs 具有抗炎作用, 但对乙酰氨基酚几乎没有抗炎作用",
      "E": "可抑制血小板中的血栓素 \\mathrm{A}_{2}\\left(\\mathrm{TXA}_{2}\\right) 的合成, 减少血小板聚集"
    },
    "answer": "ABDE",
    "explanation": "本题考查解热、镇痛、抗炎药的临床用药评价。①非甾体抗炎药（NSAIDs）通过抑制合成前列腺素所需的环氧化酶而发挥解热、镇痛、抗炎、抗风湿作用；②非甾体抗炎药通过抑制中枢前列腺素的合成发挥解热作用，这类药物只能使发热者的体温下降，而对正常体温没有影响；③非甾体抗炎药（NSAIDs）可产生中等程度的镇痛作用，镇痛作用部位主要在外周。对慢性疼痛，如头痛、关节肌肉疼痛、牙痛等效果较好；④大多数的NSAIDs具有抗炎作用，但对乙酰氨基酚几乎没有抗炎作用；⑤NSAIDs可抑制血小板中的血栓素A2（TXA2）的合成，减少血小板聚集。故本题答案为ABDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABDE) | explanation_range_detected",
    "question_id": "6618f75f28863391763c18a2fb3a17765c53478c",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 2,
    "stem": "属于生物制剂及靶向改善病情的抗风湿药有",
    "options": {
      "A": "阿达木单抗",
      "B": "羟氯喹",
      "C": "托法替布",
      "D": "巴瑞替尼",
      "E": "来氟米特"
    },
    "answer": "ACD",
    "explanation": "本题考查抗风湿药的分类与代表药品。生物制剂及靶向改善病情的抗风湿药有：①肿瘤坏死因子（TNF-α）抑制剂：a.融合蛋白类：依那西普；b.单克隆抗体类：阿达木单抗、英夫利西单抗；②IL-17（白细胞介素-17）抑制剂：司库奇尤单抗、依奇珠单抗；③JAK抑制剂（小分子靶向抑制剂）：枸橼酸托法替布、巴瑞替尼。故本题答案为ACD。来氟米特、羟氯喹属于传统合成改善病情的抗风湿药（慢作用抗风湿药）。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ACD) | explanation_range_detected",
    "question_id": "8ec3d3f737cac4773a1b06f3a29cb157448ddad4",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 6,
    "stem": "关于平喘药临床用药评价的描述，正确的有",
    "options": {
      "A": "沙丁胺醇属于短效 \\beta_{2} 受体激动剂, 吸入给药在 3 \\sim 5 \\mathrm{~min} 内起效",
      "B": "异丙托溴铵属于长效M胆碱受体拮抗剂,能选择性拮抗 \\mathrm{M}_{3} 受体, 扩张支气管平滑肌,缓解哮喘症状",
      "C": "特布他林的前体药班布特罗作用维持时间可达24小时，适用于有夜间哮喘症状的患者",
      "D": "白三烯受体拮抗剂起效慢, 作用弱, 仅适用于轻、中度哮喘和稳定期的控制",
      "E": "孟鲁司特可出现严重神经系统不良反应"
    },
    "answer": "ACDE",
    "explanation": "本题考查平喘药的临床用药评价。①沙丁胺醇属于短效β2受体激动剂, 吸入给药可快速起效 (3 \\sim 5 \\mathrm{~min}), 具有速效、短效、高选择性特点; ②异丙托溴铵属于短效M胆碱受体拮抗剂, 能选择性拮抗M3受体, 扩张支气管平滑肌, 缓解哮喘症状; ③特 布他林的前体药班布特罗作用维持时间可达24小时，适用于有夜间哮喘症状的患者；④白三烯受体拮抗剂起效慢，作用弱，仅适用于轻、中度哮喘和稳定期的控制；⑤孟鲁司特可出现严重神经系统不良反应，精神疾病史的患者使用孟鲁司特时应密切关注该药引起的精神异常现象。故本题答案为ACDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ACDE) | explanation_range_detected",
    "question_id": "83d4e06a071140613f831d6a76e578040cc841a0",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 7,
    "stem": "下列药物中属于选择性 \\beta_{2} 受体激动剂的是",
    "options": {
      "A": "普萘洛尔",
      "B": "沙丁胺醇",
      "C": "沙美特罗",
      "D": "特布他林",
      "E": "美托洛尔"
    },
    "answer": "BCD",
    "explanation": "本题考查平喘药的分类与代表药品。选择性 \\beta 2 受体激动剂有: ① 短效 \\beta 2 受体激动剂: 沙丁胺醇、特布他林; ② 长效 \\beta 2 受体激动剂: 福莫特罗、沙美特罗、丙卡特罗。普萘洛尔、美托洛尔为 \\beta 受体拮抗剂。故本题答案为 BCD。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BCD) | explanation_range_detected",
    "question_id": "a4f16a6aec138468e5a7a1b69bb0de633ff182f8",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 8,
    "stem": "关于奥美拉唑临床用药评价的说法，正确的有",
    "options": {
      "A": "为前药, 代谢主要受 CYP2C19 主导, 可影响氯吡格雷代谢为活性产物",
      "B": "激动 \\mathrm{H}^{+}, \\mathrm{K}^{+}-ATP 酶的活性, 阻断了胃酸分泌的最后步骤",
      "C": "对质子泵的抑制作用是不可逆的, 单次抑酸作用时间可维持 12 \\mathrm{~h} 以上",
      "D": "与阿莫西林和克拉霉素联合使用治疗幽门螺杆菌感染",
      "E": "长期使用可导致维生素 \\mathrm{B}_{12} 吸收障碍"
    },
    "answer": "ACDE",
    "explanation": "本题考查质子泵抑制剂（PPI）的临床用药评价。①奥美拉唑为前药，在体内主要经 CYP2C19 代谢。氯吡格雷为前药，需经 CYP2C19 代谢为有抗血小板活性的代谢物，而奥美拉唑和艾司奥美拉唑能明显抑制 CYP2C19 活性，影响氯吡格雷的抗血小板药效，因此氯吡格雷应避免与奥美拉唑和艾司奥美拉唑合用；②质子泵抑制剂直接抑制 H+，K+-ATP 酶的活性，使壁细胞内的 H+不能转运到胃腔中，阻断了胃酸分泌的最后步骤；③PPI 对质子泵的抑制作用是不可逆的，单次抑酸作用时间可维持 12h 以上；④奥美拉唑可与抗菌药物（如阿莫西林、克拉霉素）合用治疗幽门螺杆菌（Hp）相关性消化性溃疡；⑤PPI 长期使用时，骨质疏松（和骨折）和低镁血症发生风险增加，也可能引起维生素 B12 吸收障碍。故本题答案为 ACDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ACDE) | explanation_range_detected",
    "question_id": "a6e08d9cea631db2a119a4352388adbc7365a38a",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 10,
    "stem": "莪若碱类解痉药可引起的不良反应有",
    "options": {
      "A": "心动过缓",
      "B": "胃肠动力亢进",
      "C": "排尿困难",
      "D": "视物模糊",
      "E": "皮肤潮红"
    },
    "answer": "CDE",
    "explanation": "本题考查抗胆碱 M 受体药的临床用药评价。茛菪碱类药物可引起抗胆碱能效应，包括便秘、排尿困难、视物模糊、皮肤潮红、口鼻咽喉干燥、出汗减少、瞳孔散大、眼睑炎、眼压升高、心悸、体温升高、胃肠动力低下、胃食管反流等。故本题答案为 CDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=CDE)",
    "question_id": "9e9491a48f66e6942d6fe33f8fe526ba54e01a05",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 11,
    "stem": "关于多烯磷脂酰胆碱临床用药评价的说法，正确的有",
    "options": {
      "A": "临床用于以肝细胞膜损害为主的急慢性肝炎",
      "B": "属于肝细胞膜修复保护剂",
      "C": "注射液含有苯甲醇, 新生儿和早产儿禁用",
      "D": "注射液可以用电解质溶液稀释",
      "E": "可增加肝细胞膜的完整性、稳定性和流动性"
    },
    "answer": "ABCE",
    "explanation": "本题考查肝脏疾病用药的临床用药评价。①多烯磷脂酰胆碱作为细胞 膜的重要组分，可促进肝细胞膜再生，临床主要用于治疗肝细胞膜损伤为主的急慢性肝炎等；②多烯磷脂酰胆碱属于肝细胞膜修复保护剂；③多烯磷脂酰胆碱注射液含有苯甲醇，新生儿和早产儿禁用，以免出现致命的“喘息综合征”；④多烯磷脂酰胆碱注射液严禁用电解质溶液（0.9%氯化钠、林格液等）稀释，如需稀释，只能用5%、10%葡萄糖溶液或木糖醇注射液；⑤多烯磷脂酰胆碱化学结构上与肝细胞膜的天然成分一致，可增加肝细胞膜的完整性、稳定性和流动性。故本题答案为ABCE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCE) | explanation_range_detected",
    "question_id": "fd9fe297a4d776ca2802858f8a478d93e2185646",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 12,
    "stem": "关于泻药和便秘治疗药特殊人群用药的说法，正确的有",
    "options": {
      "A": "聚乙二醇是便秘患儿的一线治疗药物",
      "B": "老年人便秘的药物治疗首选硫酸镁",
      "C": "乳果糖的安全性好、作用缓和，且对胎儿无不良影响，可用于妊娠期便秘",
      "D": "对于糖尿病患者便秘的顽固性病例，可尝试使用普芦卡必利",
      "E": "阿片类引起的便秘（OIC）的治疗药物包括容积性泻药、渗透性泻药、刺激性泻药"
    },
    "answer": "ACDE",
    "explanation": "本题考查泻药和便秘治疗药的特殊人群用药。①聚乙二醇属于渗透性泻药, 是便秘患儿的一线治疗药物; ②老年人便秘的药物治疗首选容积性和渗透性泻药 (乳果糖、聚乙二醇), 但同为渗透性泻药的盐类泻药 (硫酸镁) 过量应用可导致电解质紊乱, 建议慎用; ③乳果糖属于渗透性泻药, 其安全性好、作用缓和, 且对胎儿无不良影响, 可用于妊娠期便秘; ④糖尿病患者便秘可使用容积性泻药、渗透性泻药、刺激性泻药。对于顽固性病例, 可尝试使用新型通便药物, 如普芦卡必利、芦比前列酮和利那洛肽; ⑤阿片类引起的便秘 (OIC) 的治疗药物包括容积性、渗透性、刺激性泻药。故本题答案为 ACDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ACDE) | explanation_range_detected",
    "question_id": "eefa84379a3e1c1eb52c912632de35c39c11ba8a",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 14,
    "stem": "关于抗抑郁药米氮平的说法，错误的有",
    "options": {
      "A": "属于5-羟色胺及去甲肾上腺素再摄取抑制剂",
      "B": "可与单胺氧化酶抑制剂同时合用治疗抑郁症",
      "C": "可导致体重减轻、可逆性的粒细胞缺乏症",
      "D": "为新型抗抑郁药，用药后1天左右起效",
      "E": "对组胺 \\mathrm{H}_{1} 受体有较高亲和力，具有镇静作用，可用于治疗广泛焦虑障碍和伴有紧张型头痛的抑郁症"
    },
    "answer": "ABCD",
    "explanation": "本题考查米氮平的临床用药评价。①米氮平属于去甲肾上腺素能及特异性 5-HT 能抗抑郁药; ②米氮平与单胺氧化酶抑制剂合用可导致严重的不良反应, 两者不应合用; ③米氮平常见体重增加、困倦, 严重不良反应有急性骨髓功能抑制, 可引起可逆性的粒细胞缺乏症, 应注意, 一旦发现患者有发热、喉痛或其他感染症状, 应立即停药, 并进行血常规检查; ④抗抑郁药起效缓慢, 一般 4 \\sim 6 周显效, 即便是起效较快的抗抑郁药（如米氮平、文拉法辛）也需要 1 周左右的时间; ⑤米氮平对组胺 H1 受 体亲和力较高，因此还具有特异性的镇静作用，临床广泛用于治疗中性抑郁、广泛焦虑障碍和伴有紧张型头痛的抑郁症。故本题答案为ABCD。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCD) | explanation_range_detected",
    "question_id": "a389cb808bc3ca4265626ce79f95431b07b47667",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 15,
    "stem": "关于左旋多巴作用特点的说法，正确的有",
    "options": {
      "A": "是PD对症治疗最有效的药物",
      "B": "运动徐缓相关症状显著的 PD 患者，应首选左旋多巴",
      "C": "单独使用，进入中枢神经系统的药物不到 1\\% ，须与外周多巴脱羧酶抑制剂合用",
      "D": "是多巴胺（DA）的前体，本身无药理活性",
      "E": "严重不良反应可能导致眼睑痉挛、高血压、溶血性贫血等"
    },
    "answer": "ABCDE",
    "explanation": "本题考查左旋多巴的临床用药评价。①PD 对症治疗最有效的药物是左旋多巴; ②PD 症状明显, 尤其是运动徐缓相关症状显著的话, 应首选左旋多巴; ③左旋多巴大多在脑外脱羧变成多巴胺, 仅少部分 (约 1\\% ) 进入脑内, 须与外周多巴脱羧酶抑制剂（如卡比多巴、苄丝肼）合用, 可改善帕金森病的症状; ④左旋多巴是多巴胺 (DA) 等的前体, 本身并无药理活性, 可通过血-脑脊液屏障, 在脑内经芳香族 L-氨基酸脱羧酶作用下脱羧形成多巴胺后发挥药理作用; ⑤左旋多巴常见不良反应: 严重或连续的恶心、呕吐, 以及食欲缺乏等, 多能逐渐耐受; 严重不良反应: 眼睑痉挛、高血压、极度疲劳或无力、溶血性贫血等。故本题答案为 ABCDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCDE) | explanation_range_detected",
    "question_id": "31bff582a05e5a944ef24543ec30cd9fc4c807ca",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 16,
    "stem": "关于抗精神病药氯氮平不良反应的说法，正确的有",
    "options": {
      "A": "可损害肝功能",
      "B": "无恶性综合征的不良反应",
      "C": "较少引起锥体外系不良反应",
      "D": "有抗胆碱能作用, 表现为口干、视物模糊、便秘和尿潴留症状",
      "E": "与第一代药物相比, 更易引起代谢综合征, 应定期检查血糖"
    },
    "answer": "ACDE",
    "explanation": "本题考查第二代抗精神病药的临床用药评价。①氯氮平、奥氮平、氯丙嗪等常见肝功能损害的不良反应；②恶性综合征（NMS）是一种严重的抗精神病药物不良反应，几乎所有的抗精神病药物均可引起；③第一代抗精神病药物容易引起锥体外系反应，而第二代抗精神病药物较少引起此不良反应；④氯丙嗪、硫利达嗪、氯氮平、奥氮平等有外周抗胆碱能反应，表现为口干、视物模糊、便秘和尿潴留等；⑤第二代抗精神病药物（如氯氮平）可引起体重增加及糖脂代谢异常等代谢综合征的不良反应，应定期检查血糖，避免发生糖尿病或酮症酸中毒。故本题答案为ACDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ACDE) | explanation_range_detected",
    "question_id": "e9981a158c1d3be492866f5f74a9a866bb1db10b",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 17,
    "stem": "属于钠通道阻滞剂的抗心律失常药有",
    "options": {
      "A": "普鲁卡因胺",
      "B": "利多卡因",
      "C": "普罗帕酮",
      "D": "地尔硫革",
      "E": "索他洛尔"
    },
    "answer": "ABC",
    "explanation": "本题考查抗心律失常药的分类与作用机制。抗心律失常药包括：（1）钠通道阻滞剂：① Ia 类适度（中等）阻滞钠通道：奎尼丁、普鲁卡因胺；② Ib 类轻度（较弱）阻滞钠通道：利多卡因、苯妥英钠、美西律；③ Ic 类明显（较强）阻滞钠通道：普罗帕酮。（2）钾通道阻滞剂（III类抗心律失常药）：胺碘酮、索他洛尔。（3）钙通道阻滞剂（IV类抗心律失常药）：维拉帕米、地尔硫草。（4）β 受体拮抗剂（II 类抗心律失常药）：阿替洛尔、美托洛尔等。故本题答案为 ABC。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABC) | explanation_range_detected",
    "question_id": "5a1761ae14ac5875545b7af47ae9f7d656b651db",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 19,
    "stem": "属于二氢吡啶类 CCB 的药物有",
    "options": {
      "A": "维拉帕米",
      "B": "硝苯地平",
      "C": "尼莫地平",
      "D": "氨氮地平",
      "E": "地尔硫草"
    },
    "answer": "BCD",
    "explanation": "本题考查抗高血压药的分类与代表药品。L 型钙通道阻滞剂可分为二氢吡啶类 CCB 和非二氢吡啶类 CCB。其中属于二氢吡啶类 CCB 药物的有硝苯地平、氨氯地平、尼莫地平、非洛地平等; 属于非二氢吡啶类的药物有地尔硫草和维拉帕米。故本题答案为 BCD。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BCD)",
    "question_id": "393540e8ca4cb800978d2709c85af0b6e2d58162",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 20,
    "stem": "关于硝普钠临床应用注意的说法，正确的有",
    "options": {
      "A": "滴注溶液应新鲜配制并迅速将输液瓶用黑纸或铝箔包裹避光",
      "B": "新配溶液为淡棕色，如变为暗棕色、橙色或蓝色，应弃去",
      "C": "维生素 \\mathrm{B}_{12} 缺乏、肝肾功能不全者慎用",
      "D": "药液有局部刺激性, 谨防外漏",
      "E": "半衰期较短，须采用静脉注射"
    },
    "answer": "ABCD",
    "explanation": "本题考查其他抗高血压药的临床用药评价。①硝普钠对光敏感, 溶液稳定性较差, 滴注溶液应新鲜配制并迅速将输液瓶用黑纸或铝箔包裹避光; ②硝普钠新配溶液为淡棕色, 如变为暗棕色、橙色或蓝色, 应弃去; ③甲减、肺功能不全、维生素 B12 缺乏、肝肾功能不全、脑血管或冠脉供血不足、脑病或其他颅内压增高者慎用硝普钠; ④硝普钠药液有局部刺激性, 谨防外漏; ⑤硝普钠半衰期仅为几分钟, 不可静脉注射, 应缓慢静滴或使用微量输液泵。故本题答案为 ABCD。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCD) | explanation_range_detected",
    "question_id": "f1dcf4318c422893aad81628e89da18663c6da9c",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 23,
    "stem": "硝酸酯类药物具有起效快、疗效确切、经济和方便等优点，是缓解心绞痛的常用药物，适用于各类心绞痛的治疗。其具体药理作用 包括",
    "options": {
      "A": "扩张静脉为主，降低前负荷，降低心肌耗氧量",
      "B": "轻微扩张动脉，降低后负荷，降低心肌耗氧量",
      "C": "直接扩张冠状动脉，增加缺血区血液供应",
      "D": "保护心肌细胞, 减轻缺血性损伤",
      "E": "轻微的抗血小板作用"
    },
    "answer": "ABCDE",
    "explanation": "本题考查硝酸酯类药物的临床用药评价。硝酸酯类药物进入机体部分经肝脏代谢后，在血管平滑肌内经谷胱甘肽转移酶催化释放一氧化氮（NO），对血管平滑肌有直接松弛作用。此类药以扩张静脉为主，减低前负荷，兼有轻微的扩张动脉的作用，使心肌耗氧量减少，同时也可直接扩张冠状动脉。改变心肌血液的分布，增加缺血区血液供应。还可保护心肌细胞，减轻缺血性损伤。并具有轻微的抗血小板作用。故本题答案为ABCDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCDE)",
    "question_id": "df65248dcc9690ac28f29a9e52a0e0abe46c99b8",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 24,
    "stem": "关于抗血栓药过量引起出血的解救方法，正确的有",
    "options": {
      "A": "华法林过量引起的严重出血可静脉注射维生素 \\mathbb{K}_1",
      "B": "肝素过量可通过缓慢输注硫酸鱼精蛋白中和",
      "C": "达比加群酯的解救药为依达赛珠单抗",
      "D": "利伐沙班和阿哌沙班国内外都没有特效的解救药，需要等待药物自然清除",
      "E": "氨甲环酸可用作链激酶及尿激酶的拮 抗物, 用于溶栓过量所致的严重出血"
    },
    "answer": "ABCE",
    "explanation": "本题考查抗血栓药的临床用药评价。①华法林用药过程中若发生轻度出血, 或凝血酶原时间已显著延长至正常的 2.5 倍以上, 应立即减量或停药; 严重出血可静脉注射维生素 K1, 用以控制出血, 必要时可输全血、血浆或凝血酶原复合物。②鱼精蛋白能中和肝素的作用, 当临床情况 (出血) 需要逆转肝素化时可通过缓慢输注硫酸鱼精蛋白中和肝素钠; ③依达赛珠单抗结合达比加群及其酰基葡萄糖醛酸代谢产物的亲和力, 高于达比加群结合凝血酶的亲和力, 并可中和其抗凝作用, 可作为达比加群酯的解救药; ④Andexanet alfa, 国外已上市, 国内尚在新药申请中。Andexanet alfa 是 Xa 因子抑制剂的逆转剂, 是重组的 Xa 转基因变体, 能够替代 Xa 与利伐沙班、阿哌沙班和艾多沙班结合, 恢复 Xa 的正常凝血功能; ⑤氨甲环酸为抗纤维蛋白溶解药, 可用作链激酶及尿激酶的拮抗物, 用于溶栓过量所致的严重出血。故本题答案为 ABCE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCE) | explanation_range_detected",
    "question_id": "5a852ae7da192b887a88acf666c22b9e892db623",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 25,
    "stem": "属于 \\mathrm{P2Y_{12}} 受体拮抗剂的药物有",
    "options": {
      "A": "氯吡格雷",
      "B": "双嘧达莫",
      "C": "替罗非班",
      "D": "替格瑞洛",
      "E": "利伐沙班"
    },
    "answer": "AD",
    "explanation": "本题考查抗血栓药的分类与代表药品。P2Y12受体拮抗剂的代表药品有噻氯匹定、氯吡格雷、替格瑞洛。双嘧达莫属于磷酸二酯酶抑制剂。替罗非班属于血小板糖蛋白（GP）IIb/IIIa受体拮抗剂。利伐沙班属于直接Xa因子抑制剂。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=AD)",
    "question_id": "3f4fe6439d9cd6d7a881f3ec4278b090558a187c",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 26,
    "stem": "属于抗凝药的有",
    "options": {
      "A": "华法林",
      "B": "蒂莫司他",
      "C": "依替巴肽",
      "D": "达比加群酯",
      "E": "利伐沙班"
    },
    "answer": "ABDE",
    "explanation": "本题考查抗血栓药的分类与代表药品。抗凝药包括：①维生素K拮抗剂：华法林钠；②肝素类：肝素（肝素钠、肝素钙）、低分子量肝素（达肝素钠、那屈肝素钙、依诺肝素钠）；③直接凝血酶抑制剂：达比加群酯、水蛭素、重组水蛭素、比伐芦定、阿加曲班；④直接Xa因子抑制剂：利伐沙班、阿哌沙班、艾多沙班；⑤丝氨酸蛋白酶抑制剂：萘莫司他。故本题答案为ABDE。依替巴肽属于抗血小板药。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABDE) | explanation_range_detected",
    "question_id": "4a3dbb18c2757becbcacb8f4fd13bd6c0d278c31",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 27,
    "stem": "能竞争性抑制纤溶酶原与纤维蛋白之间的吸附，阻断纤维蛋白凝块溶解的药物有",
    "options": {
      "A": "替奈普酶",
      "B": "氨基己酸",
      "C": "卡络磺钠",
      "D": "氨甲环酸",
      "E": "阿替普酶"
    },
    "answer": "BD",
    "explanation": "本题考查抗出血药的分类与代表药品。抗纤维蛋白溶解药（氨基己酸、氨甲环酸）能竞争性抑制纤溶酶原与纤维蛋白之间的吸附，阻断纤维蛋白凝块的溶解。用于预防及治疗血纤维蛋白溶解亢进引起的各种出血。故本题答案为BD。替奈普酶、阿替普酶为纤溶酶原激活剂，可激活纤溶酶原，加速血栓溶解。卡络磺钠为毛细血管止血药，可降低毛细血管的通透性，缩短凝血时间而止血。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BD)",
    "question_id": "a7db5aee596a50a6d41d801c63c2868a106037e1",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 29,
    "stem": "直接抑制远曲小管近端腔壁上的 \\mathrm{Na}^{+}-\\mathrm{Cl}^{-}共转运体功能的利尿药有",
    "options": {
      "A": "氢氯噻嗪",
      "B": "依他尼酸",
      "C": "阿米洛利",
      "D": "氯噻酮",
      "E": "弓达帕胺"
    },
    "answer": "ADE",
    "explanation": "本题考查利尿药的分类与作用部位。中效利尿药包括 ① 噻嗪类（氢氯噻嗪、氯噻嗪）和类噻嗪类（吲达帕胺、氯噻酮），直接抑制远曲小管近端腔壁上的 \\mathrm{Na} + -\\mathrm{Cl}-共转运体的功能，由此减少了肾小管上皮细胞对 \\mathrm{Na} + 和 \\mathrm{Cl}-的再吸收，促进肾小管液中 \\mathrm{Na} + 、 \\mathrm{Cl}-和水的排出。故本题答案为 ADE。依他尼酸属于强效利尿药（袢利尿药），作用于肾小管髓袢升支粗段的 \\mathrm{Na} + -\\mathrm{K} + -2\\mathrm{Cl}-共转运体而发挥利尿作用。阿米洛利属于低效利尿药（留钾利尿药），作用于远曲小管远端和集合管腔膜上的 \\mathrm{Na} + 通道。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ADE)",
    "question_id": "ab4d6c217a93845bd65f7f86e0aa5ea986f3d434",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 30,
    "stem": "长期使用可使血钾水平降低的药物有",
    "options": {
      "A": "氨苯蝶啶",
      "B": "氢氯噻嗪",
      "C": "引达帕胺",
      "D": "味塞米",
      "E": "螺内酯"
    },
    "answer": "BCD",
    "explanation": "本题考查利尿药的临床用药评价。可引起血钾降低的利尿药有强效利尿药（如呋塞米、托拉塞米、依他尼酸、布美他尼）、中效利尿药（如氢氯噻嗪、吲达帕胺）。故本题答案为BCD。氨苯蝶啶、螺内酯为低效利尿药，属于留钾利尿药，可引起血钾水平升高。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BCD)",
    "question_id": "4c35d3fb011aa2328103a996765f71ee3649322c",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 31,
    "stem": "以下关于利尿药的说法，正确的有",
    "options": {
      "A": "甘露醇应静脉滴注给药，若析出结晶，则不可再使用",
      "B": "托伐普坦可以在不损失电解质的情况下增加水的排泄",
      "C": "螺内酯为留钾利尿药中作用最强的药物",
      "D": "味塞米可作为原发性高血压的一线用药",
      "E": "氢氯噻嗪可导致血钙升高"
    },
    "answer": "BE",
    "explanation": "本题考查利尿药的临床用药评价。①除作肠道准备用, 甘露醇应静脉滴注给药, 若遇冷析出结晶, 可置热水中或用力振荡, 待结晶完全溶解后再使用; ②托伐普坦是 V2 选择性拮抗药, 也被称为排水利尿药, 可以在不损失电解质的情况下增加水的排泄 (脱水); ③阿米洛利为留钾利尿药中作用最强的药物; ④与噻嗪类利尿药相比, 由于疗效差, 半衰期短, 味塞米不作为原发性高血压的一线用药, 仅当噻嗪类药物疗效不佳, 尤其伴有肾功能不全时或出现高血压危象时, 可使用袢利尿药; ⑤氢氯噻嗪可 促进钙离子重吸收回血液，导致血钙升高。故本题答案为BE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BE) | explanation_range_detected",
    "question_id": "7c0dbd6d328889252bc24106339ea728c28fb335",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 32,
    "stem": "关于坦索罗辛药理作用及作用特点的说法，正确的有",
    "options": {
      "A": "排除前列腺癌诊断之后才可使用",
      "B": "能缩小增生的前列腺体积",
      "C": "能降低血清前列腺特异性抗原（PSA）水平",
      "D": "能松弛前列腺平滑肌",
      "E": "能减少急性尿潴留的发生"
    },
    "answer": "AD",
    "explanation": "本题考查 \\alpha 1 受体拮抗药的临床用药评价。①排除前列腺癌诊断之后才可使用坦索罗辛；② \\alpha 1 受体拮抗剂通过松弛尿道、膀胱颈及前列腺部位平滑肌而达到治疗目的，适用于需要尽快改善急性症状的患者；③ \\alpha 1 受体拮抗剂不能缩小增生的前列腺体积，也不降低血清前列腺特异性抗原（PSA）水平，也不能减少急性尿潴留的发生。故本题答案为AD。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=AD) | explanation_range_detected",
    "question_id": "1a2f2cba59076c3aabd4c962fb27ece5084dfabf",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 35,
    "stem": "关于糖皮质激素使用方法的说法，正确的有",
    "options": {
      "A": "危重患者的抢救如重度感染、中毒性休克，应采用冲击治疗",
      "B": "急性肾上腺皮质功能不全及肾上腺危象, 应采用长程替代方案",
      "C": "原发或继发性慢性肾上腺皮质功能减退症, 应采用抑制替代方案",
      "D": "反复发作的多器官受累的慢性系统性自身免疫性疾病，应采用长程治疗",
      "E": "冲击治疗使用期间必须配合其他有效治疗措施，因疗程短可迅速停药"
    },
    "answer": "ADE",
    "explanation": "本题考查糖皮质激素的治疗方案及疗程。①危重患者的抢救如重度感染、中毒性休克，应采用冲击治疗；②急性肾上腺皮质功能不全及肾上腺危象，应采用应急替代方案；③原发或继发性慢性肾上腺皮质功能减退症，应采用长程替代方案；④反复发作的多器官受累的慢性系统性自身免疫性疾病，应采用长程治疗；⑤冲击治疗使用期间必须配合其他有效治疗措施，因疗程短可迅速停药。故本题答案为ADE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ADE) | explanation_range_detected",
    "question_id": "9881aa25e2a5fc7854663e980df01764dc459ede",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 37,
    "stem": "属于抗甲状腺药的有",
    "options": {
      "A": "左甲状腺素",
      "B": "甲巯咪唑",
      "C": "碘塞罗宁",
      "D": "丙硫氧嘧啶",
      "E": "卡比马唑"
    },
    "answer": "BDE",
    "explanation": "本题考查抗甲状腺药的代表药品。临床上常用的抗甲状腺药有丙硫 氧嘧啶、甲巯咪唑、卡比马唑及甲硫氧嘧啶。故本题答案为BDE。左甲状腺素和碘塞罗宁属于甲状腺激素类药。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BDE)",
    "question_id": "b33c88dba1e33ac49a0d7107396c42e7cce89edb",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 39,
    "stem": "关于磺酰脲类促胰岛素分泌药临床用药评价的描述，正确的有",
    "options": {
      "A": "适用于2型糖尿病患者，禁用于1型糖尿病",
      "B": "格列吡嗪、格列本脲、格列齐特、格列美脲属于第二代磺酰脲类",
      "C": "空腹血糖高应选用格列齐特, 餐后血糖高宜选用格列吡嗪",
      "D": "轻、中度肾功能不全者，宜选用格列喹酮",
      "E": "格列本脲作用时间长, 可用于存在心肌梗死高危因素者, 但一旦出现低血糖,纠正困难"
    },
    "answer": "ABCD",
    "explanation": "本题考查磺酰脲类促胰岛素分泌药的临床用药评价。①磺酰脲类促胰岛素分泌药与胰岛β细胞上ATP敏感的钾离子通道结合，刺激胰岛素分泌，适用于2型糖尿病患者，1型糖尿病禁用；②格列吡嗪、格列本脲、格列齐特、格列美脲属于第二代磺酰脲类；③空腹血糖较高选用长效的格列齐特、格列美脲；餐后血糖升高选用格列吡嗪、格列喹酮；④对轻、中度肾功能不全者，选用格列喹酮；⑤格列本脲对缺血的心肌可能有害，对既往发生心肌梗死或存在心血管疾病高危因素患者宜选用格列美脲和格列吡嗪，不宜使用格列本脲；格列本脲降糖作用强，持续时间长，一旦出现低血糖，纠正起来困难。故本题答案为ABCD。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCD) | explanation_range_detected",
    "question_id": "881313998870347479d728698fed4dc3fdb11627",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 40,
    "stem": "不属于促进骨形成的药物有",
    "options": {
      "A": "特立帕肽",
      "B": "骨化三醇",
      "C": "唑来膦酸",
      "D": "雷洛昔芬",
      "E": "地舒单抗"
    },
    "answer": "BCDE",
    "explanation": "本题考查调节骨代谢药的分类与代表药品。调节骨代谢的药物可分为 ①钙剂（如碳酸钙）、维生素D及其活性代谢物（如骨化三醇、阿法骨化醇）； ②抑制骨吸收药：双膦酸盐类（如阿仑膦酸钠、唑来膦酸）、替勃龙、雌激素类、RANKL抑制剂（如地舒单抗）、雷洛昔芬、降钙素等； ③刺激骨形成药：氟制剂、甲状旁腺激素（特立帕肽）、生长激素、骨生长因子等。故本题答案为BCDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BCDE) | explanation_range_detected",
    "question_id": "ebe2d764b2cd5b6fdf0a38147c31b2b57f3e0f86",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 41,
    "stem": "属于黄体酮适应证的有",
    "options": {
      "A": "功能失调性子宫出血",
      "B": "孕激素依赖性肿瘤",
      "C": "与雌激素联合用于激素替代疗法",
      "D": "经前期紧张综合征",
      "E": "用作宫内节育器缓释孕激素"
    },
    "answer": "ACDE",
    "explanation": "本题考查孕激素类的临床用药评价。黄体酮的适应证包括 ①用于月经失调，如闭经和功能失调性子宫出血、黄体功能不全、先兆流产和习惯性流产及经前期紧张综合征的治疗；②用于激素替代疗法时应与雌激素联合应用；③也用于宫内节育器缓释孕激素药物。故本题答案为 ACDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ACDE) | explanation_range_detected",
    "question_id": "d2611de4bb5650d8085af7108cc141d2425a5ab4",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 42,
    "stem": "可以与炔雌醇组成复方制剂作为短效避孕药的有",
    "options": {
      "A": "甲羟孕酮",
      "B": "孕二烯酮",
      "C": "米非司酮",
      "D": "去氧孕烯",
      "E": "左炔诺孕酮"
    },
    "answer": "BDE",
    "explanation": "本题考查性激素类避孕药的分类与代表药品。孕二烯酮、去氧孕烯、 左炔诺孕酮等可以与炔雌醇组成复方制剂作为短效避孕药。故本题答案为BDE。甲羟孕酮适用于月经不调、功能失调性子宫出血及子宫内膜异位症等。注射液可用作长效避孕药，亦可用于绝经期后乳腺癌及子宫内膜癌。米非司酮可作为非手术性抗早孕药，与前列腺素药物序贯合并使用，用于终止停经49日内的妊娠。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BDE)",
    "question_id": "cca32cc083cc1a795b37a402ce9694a3a152ac67",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 43,
    "stem": "经肝、肾双途径清除的抗菌药物有",
    "options": {
      "A": "美洛西林",
      "B": "利福平",
      "C": "莫西沙星",
      "D": "头孢曲松",
      "E": "头孢他啶"
    },
    "answer": "ACD",
    "explanation": "本题考查常见抗菌药物的清除途径。主要经肝、肾双途径清除的药物有美洛西林、哌拉西林、头孢哌酮、头孢曲松、头孢噻肟、氨曲南、环丙沙星、莫西沙星等。故本题答案为 ACD。利福平主要经肝脏清除。头孢他啶主要经肾脏清除。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ACD)",
    "question_id": "bad2182548758586675e5ff03888bb87bc7f28ba",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 44,
    "stem": "通过抑制蛋白质合成而发挥抗菌作用的药物有",
    "options": {
      "A": "红霉素",
      "B": "青霉素",
      "C": "替加环素",
      "D": "环丙沙星",
      "E": "氯霉素"
    },
    "answer": "ACE",
    "explanation": "本题考查抗菌药物的分类与作用机制。影响细菌蛋白质合成的药物有：①与核糖体的30S亚基结合的药物：四环素类（四环素、多西环素、美他环素、替加环素）、氨基糖苷类（链霉素、阿米卡星等）；②与核糖体的50S亚基结合的药物：大环内酯类（红霉素、阿奇霉素、罗红霉素、泰利霉素等）、林可霉素类（林可霉素、克林霉素）、酰胺醇类（氯霉素、甲砜霉素）、利奈唑胺。故本题答案为ACE。青霉素是影响细菌细胞壁合成的药物。环丙沙星影响细菌DNA合成。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ACE) | explanation_range_detected",
    "question_id": "d38f79ea90baabc9f194b5b65741c7fb4467e585",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 45,
    "stem": "关于病原微生物耐药性的说法，正确的有",
    "options": {
      "A": "可分为天然耐药性和获得性耐药性",
      "B": "经质粒介导的耐药性在自然界中最为多见",
      "C": "经质粒介导的耐药性在自然界中最重要",
      "D": "临床上抗菌药物治疗失败与钝化酶或灭活酶的形成有关",
      "E": "代谢拮抗药的增加可导致耐药性的产生"
    },
    "answer": "ABCDE",
    "explanation": "本题考查病原微生物的耐药性。①病原微生物的耐药性可分为天然耐药性和获得性耐药性两种，前者系遗传特征，一般不会改变；后者系由病原微生物体内脱氧核糖核（DNA）的改变而产生；②经质粒介导的耐药性在自然界中最为多见、也最重要；③钝化酶或灭活酶（如β-内酰胺酶、氨基糖苷类钝化酶、氯霉素乙酰转移酶）的形成，是临床上抗感染药治疗失败的原因之一；④代谢拮抗药的增加或细菌酶系的变化也属于耐药性发生的机制。故本题答案为ABCDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCDE) | explanation_range_detected",
    "question_id": "904ff487a09fc0dc21b73f7bcc08c615790de359",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 46,
    "stem": "下列属于第三代头孢菌素的有",
    "options": {
      "A": "头孢呋辛",
      "B": "头孢哌酮",
      "C": "头孢他啶",
      "D": "头孢噻肟",
      "E": "头孢克洛"
    },
    "answer": "BCD",
    "explanation": "本题考查头孢菌素类药物的分类与代表药品。头孢呋辛、头孢克洛属于第二代头孢菌素。头孢哌酮、头孢他啶、头孢噻肟属于第三代头孢菌素。故本题答案为BCD。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BCD)",
    "question_id": "ee3203fdd9fe24924fd6d56f2fd8c267f7aee0fb",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 47,
    "stem": "下列药物中属于 \\beta 内酰胺酶抑制剂的有",
    "options": {
      "A": "克拉维酸",
      "B": "舒巴坦",
      "C": "苯唑西林",
      "D": "他唑巴坦",
      "E": "双氯西林"
    },
    "answer": "ABD",
    "explanation": "本题考查β-内酰胺酶抑制剂的代表药品。β-内酰胺酶抑制剂包括克拉维酸、舒巴坦、他唑巴坦、阿维巴坦、雷利巴坦、法硼巴坦。故本题答案为ABD。苯唑西林和双氯西林属于耐青霉素酶类青霉素。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABD)",
    "question_id": "aae567002c88a0b6665279957836292d2d956346",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 54,
    "stem": "以下属于抗艾滋病病毒药物的有",
    "options": {
      "A": "替诺福韦",
      "B": "西多福韦",
      "C": "拉米夫定",
      "D": "多替拉韦",
      "E": "阿扎那韦"
    },
    "answer": "BEE",
    "explanation": "本题考查利奈唑胺的临床用药评价。利奈唑胺与细菌核糖体50S亚基结合，抑制mRNA与核糖体连接，阻止70S起始复合物的形成，抑制细菌蛋白质的合成。故本题答案为B。【55】本题考查利奈唑胺的临床用药评价。在应用利奈唑胺的患者中可出现骨髓抑制（包括血小板减少、贫血、白细胞减少和全血细胞减少），风险与疗程相关。应每周进行血小板和全血细胞计数的检查，尤其是用药超过2周、用药前已有骨髓抑制，或合并应用能导致骨髓抑制的其他药物的患者。故本题答案为E。【56】本题考查利奈唑胺的临床用药评价。利奈唑胺对葡萄球菌属、肠球菌属、链球菌属均显示良好的抗菌作用，对厌氧菌亦具抗菌活性，对艰难梭菌的作用与万古霉素相似，对支原体属和衣原体属、结核分枝杆菌、鸟分枝杆菌亦有一定抑制作用。但对革兰阴性菌（如军团菌）作用差。故本题答案为E。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=BEE)",
    "question_id": "ff8c321f5bdd5dfbfdcf62770dee8d211de82001",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "多项选择题",
    "qno": 57,
    "stem": "酪氨酸激酶抑制剂可引起的不良反应有",
    "options": {
      "A": "出血性膀胱炎",
      "B": "Q-T间期延长",
      "C": "皮疹",
      "D": "腹泻",
      "E": "男性乳房发育"
    },
    "answer": "ACDB",
    "explanation": "本题考查葱环类抗肿瘤抗生素的临床用药评价。干扰转录过程和阻止RNA合成的药物有柔红霉素、多柔比星、表柔比星、吡柔比星、阿克拉阿霉素。故本题答案为A。【58】本题考查葱环类抗肿瘤抗生素的临床用药评价。多柔比星的禁忌证包括：骨髓功能抑制、心肺功能失代偿、严重心脏病、重症感染、妊娠及哺乳期妇女、电解质或酸碱平衡失调、胃肠道梗阻、肝功能损害、水痘或带状疱疹。骨肉瘤属于多柔比星的适应证。故本题答案为C。【59】本题考查干扰有丝分裂的药物的分类与作用机制。干扰有丝分裂的药物包括：①微管蛋白活性抑制药：长春碱类（如长春新碱）和紫杉醇类（如多西他赛）；②干扰核糖体功能的药物：高三尖杉酯碱类；③影响氨基酸供应的药物：L-门冬酰胺酶。故本题答案为D。【60】本题考查直接影响DNA结构和功能的药物的分类与作用机制。直接影响DNA结构和功能的药物包括：①破坏DNA的烷化剂：氮芥、环磷酰胺、塞替派、白消安、替莫唑胺；②破坏DNA的铂类化合物：顺铂、卡铂、奥沙利铂；③破坏DNA的抗生素：丝裂霉素、博来霉素；④拓扑异构酶抑制剂：羟喜树碱、伊立替康、拓扑替康、依托泊苷、替尼泊苷。故本题答案为B。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ACDB) | explanation_range_detected",
    "question_id": "3e29095ad5d5c6f92f8ac9a5380fbae363ad9984",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第9节大环内酯类抗菌药物",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，男，24岁，有青霉素过敏史，用红霉素替代治疗溶血性链球菌感染，可能出现的不良反应是",
    "options": {
      "A": "尖端扭转型室性心动过速",
      "B": "跟腱断裂",
      "C": "牙齿永久性变色",
      "D": "结晶尿",
      "E": "吉-海反应"
    },
    "answer": "A",
    "explanation": "本题考查大环内酯类药物的临床用药评价。大环内酯类药物（红霉素、克拉霉素、阿奇霉素、泰利霉素）的不良反应包括胃肠道反应、肝毒性（肝肿大、AST/ALT升高）、心脏毒性（心律失常、尖端扭转型室性心动过速等）、耳毒性（耳蜗神经损伤的耳聋、耳鸣、前庭神经功能损害）。故本题答案为 A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "d8973d7a4df8a53942a7023b42850d929ef6a76e",
    "section_no": 9,
    "section_title": "大环内酯类抗菌药物",
    "section_norm": "第九节 大环内酯类抗菌药物"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "综合分析题",
    "qno": 22,
    "stem": "患者，男，66岁，BMI 24\\mathrm{kg} / \\mathrm{m}^2 ，高血压病史15年，冠心病病史3年，目前规律服用阿司匹林、贝那普利、美托洛尔、阿托伐他汀、单硝酸异山梨酯治疗。昨日饮酒饱餐后出现胸闷，心前区疼痛，自服1片硝酸甘油症状不能缓解，可能的原因有",
    "options": {
      "A": "患者对硝酸酯类药物产生耐受性",
      "B": "硝酸甘油片被吞服",
      "C": "硝酸甘油片已经过期",
      "D": "硝酸甘油片单次剂量不足, 次数不足",
      "E": "硝酸甘油片未密闭遮光保存，药品变质失效"
    },
    "answer": "ABCDE",
    "explanation": "本题考查硝酸酯类药物的临床用药评价。①患者长期应用单硝酸异山梨酯, 若连续使用 24h 可能出现耐受性; ②硝酸甘油存在首关效应, 心绞痛急性发作时需舌下含服, 不能吞服; ③服药时应有麻刺烧灼感或头胀感, 这是硝酸甘油起效的标志之一, 如未出现, 说明药品已失效; ④硝酸甘油舌下含服, 一次 0.25 \\sim 0.5 \\mathrm{mg}, 每 5min 可重复 1 片, 如 15 \\mathrm{~min} 内总量达 3 片后疼痛持续存在, 应立即就医; ⑤硝酸甘油见光易分解, 须避光、密封、阴凉处保存。故本题答案为 ABCDE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCDE) | Auto: 多项选择题 -> 综合分析题 (stem keywords) | explanation_range_detected",
    "qtype_raw": "综合分析题",
    "question_id": "1e7a7e84c99b112273bfdbeddef80276f3423f58",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "综合分析题",
    "qno": 33,
    "stem": "患者，男，45岁，近期出现排尿起始延缓，排尿时间延长，射程不远，尿线细而无力，诊断为良性前列腺增生症，处方特拉唑嗪治疗，用药后可发生的不良反应有",
    "options": {
      "A": "体位性低血压",
      "B": "心悸",
      "C": "性欲减退",
      "D": "脱发",
      "E": "鼻塞"
    },
    "answer": "ABE",
    "explanation": "本题考查 \\alpha 1 受体拮抗药的临床用药评价。\\alpha 1 受体拮抗药如特拉唑嗪、哌唑嗪等对前列腺和外周血管平滑肌上的 \\alpha 1 受体都有拮抗作用, 因此, 在使用过程中易发生直立性低血压、眩晕、心悸、鼻塞等不良反应。故本题答案为 ABE。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABE) | Auto: 多项选择题 -> 综合分析题 (stem keywords)",
    "qtype_raw": "综合分析题",
    "question_id": "3ac771a2435b014c73bce664b1c7197869c71079",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第十三章 皮肤用药及抗过敏用药",
    "section": "第9节抗过敏药",
    "qtype": "综合分析题",
    "qno": 36,
    "stem": "患者，女，28岁，孕7周，诊断为甲状腺功能减退症，使用左甲状腺素钠片治疗，对该患者的用药指导，正确的有",
    "options": {
      "A": "服用期间如出现心悸、多汗或体重下降，应及时就诊",
      "B": "妊娠期使用应监测甲状腺功能",
      "C": "起效较慢, 几周后才能达到最高疗效",
      "D": "口服初始剂量: 25 \\sim 50 \\mu \\mathrm{g}, 一日 1 次",
      "E": "含铝药物、铁剂、碳酸钙可增强左甲状腺素的作用"
    },
    "answer": "ABCD",
    "explanation": "本题考查甲状腺激素类药物的临床用药评价。①孕期甲减可能对胎儿造成不良影响，服药期间应监测甲功，如出现心悸、多汗或体重下降，应及时就诊；②妊娠期使用应监测甲状腺功能；③左甲状腺素属于人工合成的四碘甲状腺原氨酸（L-T4），在体内转变为T3后发挥作用，故起效慢，几周后才能达到最高疗效；④左甲状腺素成人口服初始剂量：25\\sim 50\\mu \\mathrm{g}，一日1次，随后每2周以 25\\mu \\mathrm{g} 调整至适宜剂量；⑤含铝药物、铁剂、碳酸钙降低左甲状腺素的作用。故本题答案为ABCD。",
    "source_note": "Auto: 配伍选择题 -> 多项选择题 (answer=ABCD) | Auto: 多项选择题 -> 综合分析题 (stem keywords) | explanation_range_detected",
    "qtype_raw": "综合分析题",
    "question_id": "71c5cc1c37d783aa2c4325ae5c6aa9249e990d40",
    "section_no": 9,
    "section_title": "抗过敏药",
    "section_norm": "第九节 抗过敏药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第10节林可霉素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "可与林可霉素呈完全交叉耐药的是",
    "options": {
      "A": "头孢曲松",
      "B": "万古霉素",
      "C": "阿莫西林",
      "D": "克林霉素",
      "E": "庆大霉素"
    },
    "answer": "D",
    "explanation": "本组题考查林可霉素类药物的临床用药评价。 ①克林霉素与林可霉素可呈完全交叉耐药。故本题答案为 D。",
    "source_note": "",
    "question_id": "6446b23acd867e2dbc31a8d4fb7a31af402658a6",
    "section_no": 10,
    "section_title": "林可霉素类抗菌药物",
    "section_norm": "第十节 林可霉素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第10节林可霉素类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "可与大环内酯类药竞争细菌核糖体的结合部位而相互抵抗的药物是",
    "options": {
      "A": "头孢曲松",
      "B": "万古霉素",
      "C": "阿莫西林",
      "D": "克林霉素",
      "E": "庆大霉素"
    },
    "answer": "D",
    "explanation": "本组题考查林可霉素类药物的临床用药评价。 ②克林霉素可与氯霉素、大环内酯类药竞争细菌核糖体的结合部位而相互抵抗, 不宜合用。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "f5bcbbd0249e9a86c1c12d51e2e4c76b007d0fa1",
    "section_no": 10,
    "section_title": "林可霉素类抗菌药物",
    "section_norm": "第十节 林可霉素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第10节林可霉素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，女，32岁，由于金黄色葡萄球菌感染，引起急慢性骨髓炎及关节感染，可作为首选的治疗药物是",
    "options": {
      "A": "万古霉素",
      "B": "克林霉素",
      "C": "甲硝唑",
      "D": "利奈唑胺",
      "E": "替加环素"
    },
    "answer": "B",
    "explanation": "本题考查林可霉素类药物的临床用药评价。林可霉素类药物（林可霉素、克林霉素）是治疗金黄色葡萄球菌引起的急慢性骨髓炎及关节感染的首选药。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "80553ac0731eb9e3e24c5ec75b4a1bb03ba6dac6",
    "section_no": 10,
    "section_title": "林可霉素类抗菌药物",
    "section_norm": "第十节 林可霉素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第10节林可霉素类抗菌药物",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "骨髓炎患者使用克林霉素治疗期间需关注的不良反应是",
    "options": {
      "A": "低血糖反应",
      "B": "肺纤维化",
      "C": "神经 - 肌肉阻断",
      "D": "耳蜗神经损害",
      "E": "蛋白尿"
    },
    "answer": "C",
    "explanation": "本题考查林可霉素类药物的临床用药评价。林可霉素类药物的典型不良反应包括过敏反应、血管神经性水肿、肠道菌群失调和抗生素相关性腹泻、神经-肌肉阻断作用。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "550f3beeb70e456c83543c392c0d54e3909f798c",
    "section_no": 10,
    "section_title": "林可霉素类抗菌药物",
    "section_norm": "第十节 林可霉素类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第11节酰胺醇类抗菌药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "患儿，男，日龄2天，突发严重脑膜炎，为防止发生“灰婴综合征”，禁用的药品是",
    "options": {
      "A": "甲硝唑",
      "B": "味喃唑酮",
      "C": "氯霉素",
      "D": "克拉霉素",
      "E": "阿莫西林"
    },
    "answer": "C",
    "explanation": "本题考查酰胺醇类抗菌药物的临床用药评价。氯霉素可透过血-胎盘屏障，新生儿剂量达 140\\sim 160\\mathrm{mg / (kg\\cdot d)} ，可致致死性的灰婴综合征，故新生儿禁用。故本题答案为C。",
    "source_note": "",
    "question_id": "d052550f0bda3a84a444a32908b68cb08c658adc",
    "section_no": 11,
    "section_title": "酰胺醇类抗菌药物",
    "section_norm": "第十一节 酰胺醇类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第11节酰胺醇类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "关于酰胺醇类药物的描述，不正确的是",
    "options": {
      "A": "可用于敏感菌所致伤寒、副伤寒",
      "B": "可抑制肝药酶活性",
      "C": "可拮抗维生素 \\mathrm{B}_{6} 和维生素 \\mathrm{B}_{12} 的作用, 导致贫血或周围神经炎的发生",
      "D": "长期使用可导致维生素K合成受阻而出血",
      "E": "产生耐药性主要原因是细菌产生 \\beta -内酰胺酶"
    },
    "answer": "E",
    "explanation": "本题考查酰胺醇类抗菌药物的临床用药评价。细菌对氯霉素有缓慢的耐药性，主要是产生乙酰转移酶，通过质粒传递而获得。故本题答案为 E。",
    "source_note": "",
    "question_id": "25118bcc8e1630539beb8c91f41943fb48b8082a",
    "section_no": 11,
    "section_title": "酰胺醇类抗菌药物",
    "section_norm": "第十一节 酰胺醇类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第11节酰胺醇类抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "可抑制骨髓造血功能，导致再生障碍性贫血的药物是",
    "options": {
      "A": "四环素",
      "B": "青霉素",
      "C": "氯霉素",
      "D": "左氧氟沙星",
      "E": "卡那霉素"
    },
    "answer": "C",
    "explanation": "本题考查酰胺醇类抗菌药物的临床用药评价。氯霉素可引起严重的骨髓抑制、再生障碍性贫血及灰婴综合征等严重不良反应。故本题答案为 C。",
    "source_note": "",
    "question_id": "797b658ee19195a9b7f2c0a7a319638d6bc79629",
    "section_no": 11,
    "section_title": "酰胺醇类抗菌药物",
    "section_norm": "第十一节 酰胺醇类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第11节酰胺醇类抗菌药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "氯霉素的典型不良反应不包括",
    "options": {
      "A": "再生障碍性贫血",
      "B": "骨髓抑制",
      "C": "视神经炎",
      "D": "灰婴综合征",
      "E": "红人综合征"
    },
    "answer": "E",
    "explanation": "本题考查酰胺醇类抗菌药物的临床用药评价。氯霉素的典型不良反应包括: ①骨髓造血功能障碍: 血细胞减少, 严重者出现再生障碍性贫血; ②神经系统: 拮抗维生素 B6 和维生素 B12, 引起周围神经炎、视神经炎, 肌内注射可引起坐骨神经麻痹而造成下肢瘫痪; ③灰婴综合征: 新生儿剂量达 140 \\sim 160 \\mathrm{mg} /\\left(\\mathrm{kg} \\cdot \\mathrm{d}\\right), 可致致死性的灰婴综合征等。故本题答案为 E。快速静脉滴注万古霉素和去甲万古霉素时, 可出现血压降低、呼吸困难、上部躯体发红 (红人综合征)。",
    "source_note": "explanation_range_detected",
    "question_id": "252fe81b50c43c1ac759df09699314f1512bcc51",
    "section_no": 11,
    "section_title": "酰胺醇类抗菌药物",
    "section_norm": "第十一节 酰胺醇类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第11节酰胺醇类抗菌药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "下列药物中属于酰胺醇类抗菌药物的是",
    "options": {
      "A": "万古霉素",
      "B": "替考拉宁",
      "C": "保泰松",
      "D": "甲砜霉素",
      "E": "红霉素"
    },
    "answer": "D",
    "explanation": "本题考查酰胺醇类抗菌药物的代表药品与作用机制。酰胺醇类抗菌药物包括氯霉素、甲砜霉素及无味氯霉素。故本题答案为 D。",
    "source_note": "",
    "question_id": "1f454ff9ff78bf698e9ca64da29e374df567bd26",
    "section_no": 11,
    "section_title": "酰胺醇类抗菌药物",
    "section_norm": "第十一节 酰胺醇类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第11节酰胺醇类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "先天缺乏葡萄糖-6-磷酸脱氢酶者使用后可能出现溶血性贫血的药物是",
    "options": {
      "A": "青霉素",
      "B": "四环素",
      "C": "氯霉素",
      "D": "红霉素",
      "E": "头孢曲松"
    },
    "answer": "C",
    "explanation": "【7 \\sim 8】 ①本题考查酰胺醇类抗菌药物的临床用药评价。先天缺乏葡萄糖-6-磷酸脱氢酶者使用氯霉素后, 可导致溶血性贫血。故本题答案为C。",
    "source_note": "",
    "question_id": "1cdc93b49f15bff83a04078c4b3fc8292e7299f2",
    "section_no": 11,
    "section_title": "酰胺醇类抗菌药物",
    "section_norm": "第十一节 酰胺醇类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第11节酰胺醇类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "用药后可与钙离子螯合，沉积于牙齿与骨骼中，造成牙齿黄染的药物是",
    "options": {
      "A": "青霉素",
      "B": "四环素",
      "C": "氯霉素",
      "D": "红霉素",
      "E": "头孢曲松"
    },
    "answer": "B",
    "explanation": "【7 \\sim 8】 ②本题考查四环素类抗菌药物的临床用药评价。四环素类药物与钙离子形成的螯合物在体内呈黄色, 沉积在牙齿和骨骼中, 造成牙齿黄染, 并影响胎儿、新生儿和婴幼儿骨骼正常发育。故本题答 案为B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "1aad04ce980f4a90e5df10acff6073a8380c22fd",
    "section_no": 11,
    "section_title": "酰胺醇类抗菌药物",
    "section_norm": "第十一节 酰胺醇类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第12节喹诺酮类抗菌药物",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "属于第四代喹诺酮类抗菌药物，被称为呼吸喹诺酮类，对肺部感染的常见致病菌起到良好杀菌作用的药物是",
    "options": {
      "B": "诺氟沙星",
      "C": "环丙沙星",
      "D": "莫西沙星",
      "E": "吡哌酸",
      "A": "左氧氟沙星"
    },
    "answer": "D",
    "explanation": "本题考查喹诺酮类抗菌药物的分类与临床用药评价。莫西沙星属于第四代喹诺酮类药物，在肺组织的浓度较高，且对肺部感染的常见致病菌能起到良好的杀菌作用，故称为呼吸喹诺酮类。故本题答案为 D。左氧氟沙星、诺氟沙星、环丙沙星属于第三代喹诺酮类。吡哌酸属于第二代喹诺酮类药物。",
    "source_note": "",
    "question_id": "c298737cce87b1e75f0976c2d64443fed63e2247",
    "section_no": 12,
    "section_title": "喹诺酮类抗菌药物",
    "section_norm": "第十二节 喹诺酮类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第12节喹诺酮类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "使用后需注意避免直接暴露于阳光或紫外线下，且女性用药后比男性更容易出现眩晕、耳鸣等前庭功能紊乱的不良反应的药物是",
    "options": {
      "A": "万古霉素",
      "B": "多西环素",
      "C": "米诺环素",
      "D": "环丙沙星",
      "E": "利奈唑胺"
    },
    "answer": "C",
    "explanation": "【 9 \\sim 10 】 ①本题考查四环素类抗菌药物的临床用药评价。米诺环素使用后,患者可能在日晒时出现光敏现象, 引起皮肤色素沉着, 服药后避免直接暴露于阳光或紫外线下, 一旦皮肤出现红斑立即停药; 其脂溶性高, 有很好的组织渗透性, 还可引起眩晕、耳鸣、共济失调伴恶心、呕吐等前庭功能紊乱, 常发生于用药 3 日后, 且女性发生率高于男性。故本题答案为 C。",
    "source_note": "",
    "question_id": "ae4dbc09ac20bc86edc14b9bdd0c52dcc7f5b4e4",
    "section_no": 12,
    "section_title": "喹诺酮类抗菌药物",
    "section_norm": "第十二节 喹诺酮类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第12节喹诺酮类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "使用时应避免过度日光或人工紫外线照射，且肾功能不全者未调整给药剂量，易发生抽搐、癫痫样发作的药物是",
    "options": {
      "A": "万古霉素",
      "B": "多西环素",
      "C": "米诺环素",
      "D": "环丙沙星",
      "E": "利奈唑胺"
    },
    "answer": "D",
    "explanation": "【 9 \\sim 10 】 ②本题考查喹诺酮类抗菌药物的临床用药评价。环丙沙星属于喹诺酮类药物, 偶见光敏反应, 用药时应避免过度日光或人工紫外线照射。肾功能不全者未调整给药剂量, 易发生抽搐、癫痫样发作等中枢神经系统反应。故本题答案为 D。",
    "source_note": "",
    "question_id": "213d669a8387eeb239ade498de672965ddb62335",
    "section_no": 12,
    "section_title": "喹诺酮类抗菌药物",
    "section_norm": "第十二节 喹诺酮类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第12节喹诺酮类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "喹诺酮类抗菌药物与糖皮质激素类药物联用，可能增加的风险是",
    "options": {
      "A": "消化道出血",
      "B": "牙龈增生",
      "C": "肌腱断裂",
      "D": "Q-T间期延长",
      "E": "间质性肺炎"
    },
    "answer": "C",
    "explanation": "本组题考查喹诺酮类抗菌药物的临床用药评价。 ①喹诺酮类抗菌药物可引起关节病变, 60 岁以上患者, 合用甾体类药物 (如糖皮质激素类药物), 肾脏、心脏或肺移植, 类风湿关节炎等有肌腱障碍史, 用药后参加体力活动或是紧张, 肌腱断裂的风险均可能增加。故本题答案为 C。",
    "source_note": "",
    "question_id": "83f0e237f1c0ae3f74e8f66bbfd7f4193f6555b1",
    "section_no": 12,
    "section_title": "喹诺酮类抗菌药物",
    "section_norm": "第十二节 喹诺酮类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第12节喹诺酮类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "喹诺酮类抗菌药物与三环类抗抑郁药联用，可能增加的风险是",
    "options": {
      "A": "消化道出血",
      "B": "牙龈增生",
      "C": "肌腱断裂",
      "D": "Q-T间期延长",
      "E": "间质性肺炎"
    },
    "answer": "D",
    "explanation": "本组题考查喹诺酮类抗菌药物的临床用药评价。 ②喹诺酮类抗菌药物可能会使心电图 Q-T 间期延长, 不宜与已知可使 Q-T 间期延长的抗心律失常药 (奎尼丁、普鲁卡因胺、胺碘酮、索洛地尔)、红霉素、三环类抗抑郁药等药物合用。故本题答案为 D。",
    "source_note": "",
    "question_id": "158c0c8f9fb3a0ea5a485114f55aca6819fdc3a6",
    "section_no": 12,
    "section_title": "喹诺酮类抗菌药物",
    "section_norm": "第十二节 喹诺酮类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第12节喹诺酮类抗菌药物",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，男，53岁，既往有2型糖尿病病史5年，因尿路感染使用环丙沙星治疗，治疗期间可能出现的不良反应是",
    "options": {
      "A": "低血糖反应",
      "B": "肺纤维化",
      "C": "神经 - 肌肉阻断",
      "D": "耳蜗神经损害",
      "E": "蛋白尿"
    },
    "answer": "A",
    "explanation": "本题考查喹诺酮类抗菌药物的临床用药评价。喹诺酮类药物用药期间可能出现血糖升高或降低, 使用降糖药物或胰岛素的糖尿病患者需严密监测血糖。故本题答案为 A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "b5537caf875a014d3f40146054e8448c52068234",
    "section_no": 12,
    "section_title": "喹诺酮类抗菌药物",
    "section_norm": "第十二节 喹诺酮类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第13节磺胺类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "下列药物中可导致新生儿出现药物性黄疸的是",
    "options": {
      "A": "罗红霉素",
      "B": "阿莫西林",
      "C": "林可霉素",
      "D": "磺胺嘧啶",
      "E": "头孢他啶"
    },
    "answer": "D",
    "explanation": "本题考查磺胺类抗菌药物的临床用药评价。磺胺类药物（如磺胺嘧啶） 与胆红素竞争蛋白结合部位，可致游离胆红素增高。新生儿肝功能不完善，故较易发生高胆红素血症和新生儿黄疸，偶可发生核黄疸。故本题答案为D。",
    "source_note": "",
    "question_id": "dc01ef25425c4c701589c515a1c3fd61ff08e8fc",
    "section_no": 13,
    "section_title": "磺胺类抗菌药物",
    "section_norm": "第十三节 磺胺类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第13节磺胺类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "可与对氨基苯甲酸竞争性抑制二氢叶酸合成 酶，阻碍叶酸合成的药物是",
    "options": {
      "A": "磺胺嘧啶",
      "B": "氧氟沙星",
      "C": "利福平",
      "D": "两性霉素",
      "E": "红霉素"
    },
    "answer": "A",
    "explanation": "本题考查磺胺类抗菌药物的临床用药评价。磺胺类药物 (如磺胺嘧啶) 可与对氨基苯甲酸竞争性抑制二氢叶酸合成酶, 阻止细菌二氢叶酸的合成, 继而使二氢叶酸和四氢叶酸合成减少, RNA 和 DNA 合成受阻, 最终抑制细菌生长繁殖。故本题答案为 A。",
    "source_note": "",
    "question_id": "7bbfdcb56f9dacaec89f39a892af8280a33d189a",
    "section_no": 13,
    "section_title": "磺胺类抗菌药物",
    "section_norm": "第十三节 磺胺类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第13节磺胺类抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "可抑制二氢叶酸还原酶的药物是",
    "options": {
      "A": "克拉霉素",
      "B": "庆大霉素",
      "C": "甲氧苄啶",
      "D": "磺胺嘧啶",
      "E": "氧氟沙星"
    },
    "answer": "C",
    "explanation": "本题考查磺胺类抗菌药物的临床用药评价。甲氧苄啶可抑制细菌二氢叶酸还原酶, 导致四氢叶酸生成减少, 阻止细菌核酸合成。故本题答案为 C。",
    "source_note": "",
    "question_id": "47af2e9d2c48df18ccce4c8220ddc2b578a9bee8",
    "section_no": 13,
    "section_title": "磺胺类抗菌药物",
    "section_norm": "第十三节 磺胺类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第13节磺胺类抗菌药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "目前治疗肺孢子菌病的首选药物是",
    "options": {
      "A": "磺胺嘧啶",
      "B": "复方磺胺甲噁唑",
      "C": "柳氮磺吡啶",
      "D": "莫西沙星",
      "E": "氯霉素"
    },
    "answer": "B",
    "explanation": "本题考查磺胺类抗菌药物的临床用药评价。复方磺胺甲噁唑为目前治疗肺孢子菌病的首选药物, 亦可用作艾滋病患者及中性粒细胞缺乏患者的肺孢子菌病的预防用药。故本题答案为 B。",
    "source_note": "",
    "question_id": "1f0576c62cec48296da3b5ed4b6e915ad0dd96b5",
    "section_no": 13,
    "section_title": "磺胺类抗菌药物",
    "section_norm": "第十三节 磺胺类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第13节磺胺类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "应用期间应多饮水，防止结晶尿和结石的发生，必要时服用碳酸氢钠的是",
    "options": {
      "A": "磺胺嘧啶",
      "B": "甲氧苄啶",
      "C": "万古霉素",
      "D": "氨苄西林",
      "E": "美罗培南"
    },
    "answer": "A",
    "explanation": "本组题考查磺胺类抗菌药物的临床用药评价。 ①应用磺胺药期间应多饮水, 保持正常尿量, 以防止结晶尿和结石的发生, 必要时亦可服碱化尿液的药物。故本题答案为 A。",
    "source_note": "",
    "question_id": "8399384d5f772faefba9da94170b3233d99ab8a9",
    "section_no": 13,
    "section_title": "磺胺类抗菌药物",
    "section_norm": "第十三节 磺胺类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第13节磺胺类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "与磺胺甲噁唑合用具有协同作用，属于抗菌增效剂的是",
    "options": {
      "A": "磺胺嘧啶",
      "B": "甲氧苄啶",
      "C": "万古霉素",
      "D": "氨苄西林",
      "E": "美罗培南"
    },
    "answer": "B",
    "explanation": "本组题考查磺胺类抗菌药物的临床用药评价。 ②甲氧苄啶与磺胺类药合用时, 两者双重阻断细菌四氢叶酸的合成而产生显著的协同抑菌效应, 属于抗菌增效剂。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "4f0a35397f763c9a3d8313db849dec98d9045075",
    "section_no": 13,
    "section_title": "磺胺类抗菌药物",
    "section_norm": "第十三节 磺胺类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第13节磺胺类抗菌药物",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，男，59岁，为蚕豆病（葡萄糖-6-磷酸脱氢酶缺乏症）患者，使用复方磺胺甲噁唑后，可能引发的药源性疾病是",
    "options": {
      "A": "痛风发作",
      "B": "溶血性贫血",
      "C": "高血压",
      "D": "周围神经炎",
      "E": "类流感样综合征"
    },
    "answer": "B",
    "explanation": "本题考查磺胺类抗菌药物的临床用药评价。缺乏葡萄糖-6-磷酸脱氢酶者应用复方磺胺甲噁唑后易发生溶血性贫血, 该反应为剂量依赖性。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "fe6da54036086d079e923483125af552ca936437",
    "section_no": 13,
    "section_title": "磺胺类抗菌药物",
    "section_norm": "第十三节 磺胺类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "属于糖肽类抗菌药物的是",
    "options": {
      "A": "甲砜霉素",
      "B": "替考拉宁",
      "C": "利奈唑胺",
      "D": "磷霉素",
      "E": "甲氧苄啶"
    },
    "answer": "B",
    "explanation": "本题考查糖肽类抗菌药物的代表药品与作用机制。糖肽类抗菌药物由 链霉菌或放线菌产生，结构为线性多肽，代表药品有万古霉素、去甲万古霉素和替考拉宁。故本题答案为B。",
    "source_note": "",
    "question_id": "729636899966708ac3d3d178fd7341bed47fa0dd",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "万古霉素的抗菌作用机制是",
    "options": {
      "A": "作用于细菌核糖体30S亚基",
      "B": "作用于细菌核糖体 50S 亚基",
      "C": "抑制细菌细胞壁合成",
      "D": "抑制二氢叶酸合成酶",
      "E": "抑制 DNA 旋转酶"
    },
    "answer": "C",
    "explanation": "本题考查糖肽类抗菌药物的作用机制。万古霉素的作用机制为与细菌细胞壁前体肽聚糖末端的 D-丙氨酰-D-丙氨酸形成复合物, 干扰甘氨酸五肽的连接, 从而抑制细菌细胞壁的合成。故本题答案为 C。",
    "source_note": "",
    "question_id": "1ed50e7ed316d96cc096f096e7a6d8b8a2bc8c9b",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "万古霉素静脉滴注速度过快可发生的不良反应是",
    "options": {
      "A": "高血压危象",
      "B": "血糖异常",
      "C": "急性肝衰竭",
      "D": "红人综合征",
      "E": "出血"
    },
    "answer": "D",
    "explanation": "本题考查糖肽类抗菌药物的临床用药评价。快速静脉输注万古霉素和去甲万古霉素时，出现血压降低、呼吸困难、上部躯体发红（红人综合征，主要由嗜碱性粒细胞和肥大细胞释放组胺引起，用苯海拉明和减慢滴注速度可避免）、胸背部肌肉痉挛等。故本题答案为 D。",
    "source_note": "",
    "question_id": "d6c27626ac25ed8b5be36f402cbc64b7f8e06deb",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "关于万古霉素的描述，错误的是",
    "options": {
      "A": "为长 PAE 的时间依赖性抗菌药物",
      "B": "对 \\mathrm{G}^{-}菌作用强大, 对 \\mathrm{G}^{+}菌作用弱",
      "C": "对肠球菌的抗菌活性不如替考拉宁",
      "D": "具有耳毒性、肾毒性",
      "E": "与碱性溶液有配伍禁忌, 遇重金属可发生沉淀"
    },
    "answer": "B",
    "explanation": "本题考查糖肽类抗菌药物的临床用药评价。糖肽类药物对 \\mathrm{G}+ 菌具有强大的抗菌活性，对 \\mathrm{G}- 菌作用弱。故本题答案为B。",
    "source_note": "",
    "question_id": "cf9bb7c1a8daaaa7b8744862c7d58e737e43369b",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "治疗耐甲氧西林的金黄色葡萄球菌 (MRSA) 严重感染宜选用的药物是",
    "options": {
      "A": "四环素",
      "B": "克林霉素",
      "C": "万古霉素",
      "D": "林可霉素",
      "E": "克拉霉素"
    },
    "answer": "C",
    "explanation": "本题考查糖肽类抗菌药物的临床用药评价。万古霉素可用于耐药革兰阳性菌所致严重感染，特别是甲氧西林耐药的金黄色葡萄球菌感染。故本题答案为 C。",
    "source_note": "",
    "question_id": "9fdd1ba6c5ce10dd084535f8b662fcd8d82ec7d2",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "万古霉素与氨基糖苷类药物联合使用，可增加的不良反应是",
    "options": {
      "A": "双硫仑样反应",
      "B": "肾毒性",
      "C": "灰婴综合征",
      "D": "红人综合征",
      "E": "特异质反应"
    },
    "answer": "B",
    "explanation": "本题考查糖肽类抗菌药物的临床用药评价。万古霉素具有肾毒性和耳毒性，与同样具有肾毒性和耳毒性的药物（如氨基糖苷类、两性霉素B等）联合使用，可增加耳毒性及肾毒性。故本题答案为B。",
    "source_note": "",
    "question_id": "a05aefc37f1ab546abff09cb43e3bd606b4d138b",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "引起“红人综合征”不良反应明显较同类药物少见的是",
    "options": {
      "A": "红霉素",
      "B": "替考拉宁",
      "C": "克拉霉素",
      "D": "克林霉素",
      "E": "万古霉素"
    },
    "answer": "B",
    "explanation": "【 9 \\sim 10】 ①本题考查糖肽类药物的临床用药评价。糖肽类药物（如万古霉素、替考拉宁）快速滴注时可出现血压降低, 甚至心跳骤停, 以及喘鸣、呼吸困难、上部躯体发红等红人综合征反应, 但替考拉宁引起 “红人综合征” 明显较万古霉素少见。故本题答案为 B。",
    "source_note": "",
    "question_id": "1afb17d46f65162b9a876df6fdd96a71d20693a3",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "不耐酸，口服易被胃酸破坏的大环内酯类药物是",
    "options": {
      "A": "红霉素",
      "B": "替考拉宁",
      "C": "克拉霉素",
      "D": "克林霉素",
      "E": "万古霉素"
    },
    "answer": "A",
    "explanation": "【 9 \\sim 10】 ②本题考查大环内酯类药物的临床用药评价。红霉素易被胃酸破坏, 口服吸收很少，故临床一般采用其肠溶衣片或酯化物制剂。故本题答案为A。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "ce5a777883fcccb562f7a51b52c86addd2eb146e",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，男，53岁，由于严重肺炎住院，经实验室检查为耐甲氧西林的金黄色葡萄球菌感染，医生给予万古霉素治疗，为避免发生“红人综合征”，滴注速度应该维持在",
    "options": {
      "A": "10min 以上",
      "B": "30min 以上",
      "C": "30 \\mathrm{~min} 以下",
      "D": "60min 以上",
      "E": "60min以下"
    },
    "answer": "D",
    "explanation": "本题考查糖肽类抗菌药物的临床用药评价。万古霉素和去甲万古霉素在快速滴注时可能出现血压降低，心跳停止，上部躯干发红的不良反应，滴注速度应缓慢，滴注时间至少在60min以上。故本题答案为D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "2aa77188ff0285c176796bb1bc4eb3492e34d38c",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第14节糖肽类抗菌药物",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "口服可用于艰难梭菌所致假膜性肠炎患者的 药物是",
    "options": {
      "A": "多西环素",
      "B": "味喃唑酮",
      "C": "万古霉素",
      "D": "红霉素",
      "E": "阿莫西林"
    },
    "answer": "C",
    "explanation": "本题考查糖肽类抗菌药物的临床用药评价。口服万古霉素可用于经甲硝唑治疗无效的艰难梭菌所致假膜性肠炎患者。故本题答案为C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "c0f539c449fe09206d8dda4bf0457ed36a36abe1",
    "section_no": 14,
    "section_title": "糖肽类抗菌药物",
    "section_norm": "第十四节 糖肽类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "治疗耐万古霉素的屎肠球菌感染可选用",
    "options": {
      "A": "磷霉素",
      "B": "利奈唑胺",
      "C": "替加环素",
      "D": "庆大霉素",
      "E": "头孢他啶"
    },
    "answer": "B",
    "explanation": "本题考查利奈唑胺的临床用药评价。利奈唑胺可用于万古霉素耐药的尿肠球菌感染, 包括伴发的菌血症。故本题答案为 B。",
    "source_note": "",
    "question_id": "421f604ba9da1f9a638a01684efa4d22a20b332f",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "通过与核糖体的30S亚单位结合、阻止氨酰化tRNA分子进入核糖体A位而抑制细菌蛋白质合成的药物是",
    "options": {
      "A": "多黏菌素E",
      "B": "磷霉素",
      "C": "利奈唑胺",
      "D": "替加环素",
      "E": "两性霉素 B"
    },
    "answer": "D",
    "explanation": "①本题考查四环素类抗菌药物的临床用药评价。替加环素通过与核糖体的 30S 亚单位结合、阻止氨酰化 tRNA 分子进入核糖体 A 位而抑制细菌蛋白质合成。故本题答案为 D。",
    "source_note": "",
    "question_id": "4786fe67e2f5ea50ac51831d2d71342a12457da4",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "与催化肽聚糖合成的磷酸烯醇丙酮酸转移酶不可逆性结合，灭活该酶，阻断细菌细胞壁合成，导致细菌死亡的药物是",
    "options": {
      "A": "多黏菌素E",
      "B": "磷霉素",
      "C": "利奈唑胺",
      "D": "替加环素",
      "E": "两性霉素 B"
    },
    "answer": "B",
    "explanation": "②本题考查磷霉素的临床用药评价。磷霉素与催化肽聚糖合成的磷酸烯醇丙酮酸转移酶不可逆性结合, 灭活该酶, 阻断细菌细胞壁合成, 导致细菌死亡。故本题答案为 B。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "4db505006fdef4e7a9c6a385c39646df009d499a",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "通过与核糖体50S亚单位结合，抑制mRNA与核糖体连接，阻止70S起始复合物的形成，抑制细菌蛋白质合成的药物是",
    "options": {
      "A": "多黏菌素E",
      "B": "磷霉素",
      "C": "利奈唑胺",
      "D": "替加环素",
      "E": "两性霉素 B"
    },
    "answer": "C",
    "explanation": "③本题考查利奈唑胺的临床用药评价。利奈唑胺通过与核糖体 50S 亚单位结合, 抑制 mRNA 与核糖体连接, 阻止 70S 起始复合物的形成, 抑制细菌蛋白质的合成。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "eae521a534cf871fcc91d8464eebfd7f05b2d90b",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "具有单胺氧化酶抑制剂作用，且对结核分枝杆菌有一定抑制作用的药物是",
    "options": {
      "A": "多黏菌素",
      "B": "奥硝唑",
      "C": "磷霉素",
      "D": "利奈唑胺",
      "E": "替加环素"
    },
    "answer": "D",
    "explanation": "①本题考查利奈唑胺的临床用药评价。利奈唑胺具有单胺氧化酶抑制剂作用, 对支原体属和衣原体属、结核分枝杆菌、鸟分枝杆菌亦有一定抑制作用。故本题答案为 D。",
    "source_note": "",
    "question_id": "6c9725437b367fdc201e548a530da6f4c7e78b94",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "配伍选择题",
    "qno": 9,
    "stem": "可引起周围神经病和乳酸性酸中毒的药物是",
    "options": {
      "A": "多黏菌素",
      "B": "奥硝唑",
      "C": "磷霉素",
      "D": "利奈唑胺",
      "E": "替加环素"
    },
    "answer": "D",
    "explanation": "②本题考查利奈唑胺的临床用药评价。利奈唑胺可引起骨髓抑制（包括血小板减少、贫血、白细胞减少和全血细胞减少）、周围神经病和视神经病变、乳酸性酸中毒。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "d3d5d1b90e6111db980fecac7addace4af7853f0",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "可导致牙齿永久性变色及急性胰腺炎的药物是",
    "options": {
      "A": "多黏菌素",
      "B": "奥硝唑",
      "C": "磷霉素",
      "D": "利奈唑胺",
      "E": "替加环素"
    },
    "answer": "E",
    "explanation": "③本题考查四环素类抗菌药物的临床用药评价。替加环素可导致牙齿永久性变色及急性胰腺炎。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c37cd5478df57ecc5da6ea360c5889eebb51555c",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，男，23岁，由于铜绿假单胞菌引起肺部感染，用抗菌药物进行治疗，治疗期间出现肾功能减退和神经毒性，患者使用的药物可能是",
    "options": {
      "A": "甲硝唑",
      "B": "青霉素",
      "C": "多黏菌素E",
      "D": "头孢他啶",
      "E": "林可霉素"
    },
    "answer": "C",
    "explanation": "本题考查多黏菌素的临床用药评价。多黏菌素类药物对铜绿假单胞菌有较强的抗菌活性, 主要不良反应是肾毒性和神经毒性。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "8e962c911c0f207954685dd874e9b900c4c4d0e1",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "综合分析题",
    "qno": 2,
    "stem": "患者，男，56岁，既往有青霉素过敏史，因重症肺炎在ICU治疗，肺泡灌洗液培养提示为耐甲氧西林金黄色葡萄球菌（MRSA），宜选用的治疗药物是",
    "options": {
      "A": "磺胺嘧啶",
      "B": "羧苄西林",
      "C": "利奈唑胺",
      "D": "链霉素",
      "E": "复方磺胺甲噁唑"
    },
    "answer": "C",
    "explanation": "本题考查利奈唑胺的临床用药评价。利奈唑胺对耐甲氧西林的金黄色葡萄球菌有良好抗菌作用，可用于耐甲氧西林的金黄色葡萄球菌引起的院内获得性肺炎、复杂性皮肤和皮肤软组织感染及耐万古霉素的屎肠球菌感染，包括伴发的菌血症的治疗。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "bd5ea69cd960485cb1d20c9be6149655c0a3e446",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第15节其他抗菌药物",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "患者，男，50岁，诊断为耐甲氧西林的金黄色葡萄球菌所致社区获得性肺炎，使用利奈唑胺治疗，在用药期间需关注的不良反应是",
    "options": {
      "A": "红人综合征",
      "B": "溶血性贫血",
      "C": "血小板减少",
      "D": "跟腱炎",
      "E": "牙齿黄染"
    },
    "answer": "C",
    "explanation": "本题考查利奈唑胺的临床用药评价。利奈唑胺可导致骨髓抑制，包括出现血小板减少、贫血、白细胞减少等风险，长时间应用还可能出现周围神经炎和视神经病变、乳酸性酸中毒。故本题答案为 C。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "0d04efa4cff20f9c86e07dcb27b91ff8a5712a31",
    "section_no": 15,
    "section_title": "其他抗菌药物",
    "section_norm": "第十五节 其他抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第16节硝基呋喃类抗菌药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "应用6个月或以上可发生弥漫性间质性肺炎或肺纤维化的药物是",
    "options": {
      "A": "甲硝唑",
      "B": "亚胺培南",
      "C": "味喃妥因",
      "D": "磺胺嘧啶",
      "E": "利奈唑胺"
    },
    "answer": "C",
    "explanation": "本题考查硝基呋喃类抗菌药物的临床用药评价。长期应用呋喃妥因 6 个月或以上者可发生弥漫性间质性肺炎或肺纤维化，故不宜长期预防用药。故本题答案为 C。",
    "source_note": "",
    "question_id": "12594d407678d32e4a2b42e5fde3b69d0f998804",
    "section_no": 16,
    "section_title": "硝基呋喃类抗菌药物",
    "section_norm": "第十六节 硝基呋喃类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第16节硝基呋喃类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "酸性尿液中药效增强，主要用于急性单纯性下尿路感染和反复发作性尿路感染的预防的药物是",
    "options": {
      "A": "异烟肼",
      "B": "他唑巴坦",
      "C": "磺胺嘧啶",
      "D": "味喃妥因",
      "E": "两性霉素 B"
    },
    "answer": "D",
    "explanation": "本题考查硝基呋喃类抗菌药物的临床用药评价。呋喃妥因属于硝基呋喃类抗菌药物，在酸性尿液中活性可增强，可用于急性单纯性下尿路感染和反复发作性尿路感染的预防。故本题答案为 D。",
    "source_note": "",
    "question_id": "6a78c4eecc0ab563a70992a604a7e8e0a09b006d",
    "section_no": 16,
    "section_title": "硝基呋喃类抗菌药物",
    "section_norm": "第十六节 硝基呋喃类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第16节硝基呋喃类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "仅外用的硝基呋喃类抗菌药物是",
    "options": {
      "A": "味喃妥因",
      "B": "味喃唑酮",
      "C": "味喃西林",
      "D": "甲硝唑",
      "E": "替硝唑"
    },
    "answer": "C",
    "explanation": "本题考查硝基呋喃类抗菌药物的代表药品与作用机制。硝基呋喃类药物属广谱抗菌药, 口服吸收差, 血浆药物浓度低, 包括呋喃妥因、呋喃唑酮、呋喃西林, 其中呋喃西林目前仅作外用。故本题答案为 C。",
    "source_note": "",
    "question_id": "8c1f598bd94db7a3286859a09a09a89bb5d82562",
    "section_no": 16,
    "section_title": "硝基呋喃类抗菌药物",
    "section_norm": "第十六节 硝基呋喃类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第16节硝基呋喃类抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "葡萄糖-6-磷酸脱氢酶缺乏者使用后可导致溶血性贫血的抗菌药物是",
    "options": {
      "A": "庆大霉素",
      "B": "味喃妥因",
      "C": "芋星青霉素",
      "D": "甲硝唑",
      "E": "左氧氟沙星"
    },
    "answer": "B",
    "explanation": "本题考查硝基呋喃类抗菌药物的临床用药评价。呋喃妥因用于葡萄糖-6-磷酸脱氢酶缺乏者可导致溶血性贫血。故本题答案为B。",
    "source_note": "",
    "question_id": "1bdc8a153f43b53f08ea4320d3bbdafd10fd6eb8",
    "section_no": 16,
    "section_title": "硝基呋喃类抗菌药物",
    "section_norm": "第十六节 硝基呋喃类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第16节硝基呋喃类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "注射给药可用于敏感菌所致尿路感染，但5岁以下儿童禁用的是",
    "options": {
      "A": "甲氧苄啶",
      "B": "红霉素",
      "C": "磷霉素",
      "D": "味喃唑酮",
      "E": "味喃妥因"
    },
    "answer": "C",
    "explanation": "①本题考查磷霉素的临床用药评价。磷霉素口服可用于治疗敏感菌所致急性单纯性下尿路感染和肠道感染, 注射剂可用于治疗敏感菌所致呼吸道感染、尿路感染、皮肤软组织感染等, 但 5 岁以下儿童禁用本品的注射剂型。故本题答案为 C。",
    "source_note": "",
    "question_id": "eb1b18d4fa35793aeaccf3d393cb236e20c2760f",
    "section_no": 16,
    "section_title": "硝基呋喃类抗菌药物",
    "section_norm": "第十六节 硝基呋喃类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第16节硝基呋喃类抗菌药物",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "仅用于治疗难以根除的幽门螺杆菌感染的药物是",
    "options": {
      "A": "甲氧苄啶",
      "B": "红霉素",
      "C": "磷霉素",
      "D": "味喃唑酮",
      "E": "味喃妥因"
    },
    "answer": "D",
    "explanation": "②本 题考查硝基呋喃类抗菌药物的临床用药评价。呋喃唑酮仅用于治疗难以根除的幽门螺杆菌感染。故本题答案为 D。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "b36e182c179b67036344279f8f822bcb17525b5b",
    "section_no": 16,
    "section_title": "硝基呋喃类抗菌药物",
    "section_norm": "第十六节 硝基呋喃类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第17节硝基咪唑类抗菌药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于硝基咪唑类抗菌药物的是",
    "options": {
      "A": "甲硝唑",
      "B": "磺胺甲噁唑",
      "C": "味喃妥因",
      "D": "夫西地酸",
      "E": "磺胺米隆"
    },
    "answer": "A",
    "explanation": "本题考查硝基咪唑类抗菌药物的代表药品。硝基咪唑类的代表药物有甲硝唑、替硝唑、奥硝唑、左奥硝唑、塞克硝唑、二甲硝咪唑、异丙硝唑等。故本题答案为 A。",
    "source_note": "",
    "question_id": "b16beee4a6268dc74bf3ad1ab594dd0cfa1a3140",
    "section_no": 17,
    "section_title": "硝基咪唑类抗菌药物",
    "section_norm": "第十七节 硝基咪唑类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第17节硝基咪唑类抗菌药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "属于甲硝唑典型不良反应的是",
    "options": {
      "A": "骨髓抑制",
      "B": "耳毒性",
      "C": "肾毒性",
      "D": "口腔金属味",
      "E": "间质性肺炎"
    },
    "answer": "D",
    "explanation": "本题考查硝基咪唑类抗菌药物的临床用药评价。硝基咪唑类不良反应有: ①胃肠道反应最为常见, 表现为恶心、呕吐、食欲缺乏、腹部不适和腹泻等; ②口腔金属味; ③头痛; ④深色尿 (对人体无害); ⑤外周神经痛; 注射部位静脉炎等。故本题答案为 D。",
    "source_note": "explanation_range_detected",
    "question_id": "4a4777ac0382779af99a4f6a05a24b9574f279fa",
    "section_no": 17,
    "section_title": "硝基咪唑类抗菌药物",
    "section_norm": "第十七节 硝基咪唑类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第17节硝基咪唑类抗菌药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "关于甲硝唑临床用药评价的说法，错误的是",
    "options": {
      "A": "为治疗需氧菌感染的重要选择药物",
      "B": "口服可用于艰难梭菌所致的伪膜性肠炎",
      "C": "可用于肠道及肠外阿米巴病",
      "D": "用药期间避免饮酒, 以防发生双硫仑样反应",
      "E": "可导致深色尿"
    },
    "answer": "A",
    "explanation": "本题考查硝基咪唑类抗菌药物的临床用药评价。硝基咪唑类药物（如甲硝唑）是治疗原虫和厌氧菌感染的重要选择药物, 对所有需氧菌无抗菌活性。故本题答案为 A。",
    "source_note": "",
    "question_id": "d03c37a7accfc97d0ec9fe537527fefcdf09d9fe",
    "section_no": 17,
    "section_title": "硝基咪唑类抗菌药物",
    "section_norm": "第十七节 硝基咪唑类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第17节硝基咪唑类抗菌药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "不可用于治疗幽门螺杆菌感染的抗菌药物是",
    "options": {
      "A": "阿莫西林",
      "B": "克拉霉素",
      "C": "味喃唑酮",
      "D": "甲硝唑",
      "E": "头孢唑林"
    },
    "answer": "E",
    "explanation": "本题考查抗菌药物的适应证。可根治幽门螺杆菌感染的抗菌药物有：阿莫西林、克拉霉素、四环素类、左氧氟沙星、呋喃唑酮、甲硝唑等。故本题答案为 E。",
    "source_note": "",
    "question_id": "93629452f390f4ff2ee42277cf94c837594e6722",
    "section_no": 17,
    "section_title": "硝基咪唑类抗菌药物",
    "section_norm": "第十七节 硝基咪唑类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第17节硝基咪唑类抗菌药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "不会导致双硫仑样反应的抗菌药物是",
    "options": {
      "A": "甲硝唑",
      "B": "替硝唑",
      "C": "奥硝唑",
      "D": "头孢孟多",
      "E": "头孢美唑"
    },
    "answer": "C",
    "explanation": "本题考查硝基咪唑类抗菌药物的临床用药评价。甲硝唑、替硝唑与乙醇合用可发生双硫仑样反应, 奥硝唑对乙醛脱氢酶无抑制作用, 不会导致双硫仑样反应。头孢菌素类中头孢孟多、头孢哌酮、头孢甲肟、头孢替安、头孢尼西、头孢曲松、头孢匹胺可导致双硫仑样反应, 头霉素类药物 (如头孢美唑、头孢米诺、头孢替坦) 也可导致双硫仑样反应。故本题答案为 C。",
    "source_note": "",
    "question_id": "afa27031d49a377aed81ee13600acb3716a0c49f",
    "section_no": 17,
    "section_title": "硝基咪唑类抗菌药物",
    "section_norm": "第十七节 硝基咪唑类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第17节硝基咪唑类抗菌药物",
    "qtype": "综合分析题",
    "qno": 6,
    "stem": "患者，男，54岁，既往有青霉素过敏史，因肺炎链球菌所致心内膜炎使用万古霉素治疗，滴注期间患者出现血压降低、呼吸困难、上部躯体发红，此不良反应是",
    "options": {
      "A": "溶血性贫血",
      "B": "双硫仑样反应",
      "C": "灰婴综合征",
      "D": "过敏性休克",
      "E": "红人综合征"
    },
    "answer": "E",
    "explanation": "①本题考查糖肽类抗菌药物的临床用药评价。万古霉素和去甲万古霉素快速滴注时可出现血压降低，甚至心跳骤停，以及喘鸣、呼吸困难、上部躯干发红等红人综合征的表现，故滴注速度应缓慢。故本题答案为E。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "9c6dc4d265d94108f3acfa9880f54a70d9540e56",
    "section_no": 17,
    "section_title": "硝基咪唑类抗菌药物",
    "section_norm": "第十七节 硝基咪唑类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第17节硝基咪唑类抗菌药物",
    "qtype": "综合分析题",
    "qno": 7,
    "stem": "患者，女，29岁，因阴道滴虫病口服甲硝唑治疗，用药期间聚会饮酒后出现面部潮红、头痛、头晕、胸闷等症状，此不良反应是",
    "options": {
      "A": "溶血性贫血",
      "B": "双硫仑样反应",
      "C": "灰婴综合征",
      "D": "过敏性休克",
      "E": "红人综合征"
    },
    "answer": "B",
    "explanation": "②本题考查硝基咪唑类抗菌药物的临床用药评价。服用甲硝唑期间或之后5～7日内饮酒、服用含有乙醇的药物、食物以及外用乙醇，可抑制乙醛脱氢酶活性，使乙醛代谢为乙酸的路径受阻，从而导致乙醛在体内蓄积，引起双硫仑样反应，临床可表现为颜面潮红、头痛、头晕、胸闷、呼吸困难等症状。故本题答案为B。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "a389f252b50620348fcb99baf9d53dae248cf475",
    "section_no": 17,
    "section_title": "硝基咪唑类抗菌药物",
    "section_norm": "第十七节 硝基咪唑类抗菌药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "异烟肼的典型不良反应是",
    "options": {
      "A": "神经 - 肌肉接头阻滞",
      "B": "中枢抑制",
      "C": "耳毒性",
      "D": "视神经炎",
      "E": "周围神经炎"
    },
    "answer": "E",
    "explanation": "本题考查异烟肼的临床用药评价。异烟肼可导致肝毒性、神经系统毒性（如周围神经炎）、变态反应、胃肠道反应。故本题答案为 E。",
    "source_note": "",
    "question_id": "19ba98a292fd3c07f87de4c8a2e746bd8ced702d",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "可诱导肝药酶活性的抗结核药是",
    "options": {
      "A": "异烟肼",
      "B": "利福平",
      "C": "吡嗪酰胺",
      "D": "乙胺丁醇",
      "E": "链霉素"
    },
    "answer": "B",
    "explanation": "本题考查利福平的临床用药评价。利福平为肝药酶诱导剂。故本题答案为 B。",
    "source_note": "",
    "question_id": "0cec38e74f41ef112e2fbf658dfa358ebb360db1",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "利福平抗结核分枝杆菌的作用机制是",
    "options": {
      "A": "抑制 RNA 合成",
      "B": "抑制蛋白质合成",
      "C": "抑制分枝菌酸合成",
      "D": "抑制二氢叶酸合成酶",
      "E": "抑制二氢叶酸还原酶"
    },
    "answer": "A",
    "explanation": "本题考查利福平的临床用药评价。利福平的抗菌作用机制是与依赖于DNA的RNA多聚酶的β亚单位牢固结合，抑制细菌RNA的合成。故本题答案为A。",
    "source_note": "",
    "question_id": "647bb54ce4515a2fec69c95a9ee3be94a26bcc01",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "结核病化学治疗应遵循的基本原则不包括",
    "options": {
      "A": "全程",
      "B": "联合",
      "C": "早期",
      "D": "足量",
      "E": "规律"
    },
    "answer": "D",
    "explanation": "本题考查抗结核药的基本原则。结核病化学治疗遵循早期、联合、适量、规律、全程5项基本原则。故本题答案为D。",
    "source_note": "",
    "question_id": "2731f3d15873e6987ea1ad613762e91c684db66d",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "下列抗结核药物中也可以用于治疗麻风病的是",
    "options": {
      "A": "对氨基水杨酸",
      "B": "异烟肼",
      "C": "利福平",
      "D": "吡嗪酰胺",
      "E": "乙胺丁醇"
    },
    "answer": "C",
    "explanation": "本题考查利福平的临床用药评价。利福平对革兰阳性和阴性细菌，部分非结核分枝杆菌、麻风杆菌和某些病毒均有抑制作用。故本题答案为 C。",
    "source_note": "",
    "question_id": "94d548bb01d59225ea78f33f7b1cb8bc3484175d",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "会引起球后视神经炎，不推荐小于13岁的儿童使用的药物是",
    "options": {
      "A": "阿米卡星",
      "B": "吡嗪酰胺",
      "C": "四环素",
      "D": "磺胺异噁唑",
      "E": "乙胺丁醇"
    },
    "answer": "E",
    "explanation": "【 10 \\sim 11 】 ①本题考查乙胺丁醇的临床用药评价。乙胺丁醇可导致球后视神经炎, 导致视物模糊、眼痛、红绿色盲或视力减退、视野缩小等, 在幼儿中不易监测视力变化, 故乙胺丁醇不推荐用于 13 岁以下儿童。故本题答案为 E。",
    "source_note": "",
    "question_id": "636aa608ff0698fa6396450116936414eb02cfc4",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "会增加新生儿黄疸的发生风险，小于2个月的婴儿禁用的药物是",
    "options": {
      "A": "阿米卡星",
      "B": "吡嗪酰胺",
      "C": "四环素",
      "D": "磺胺异噁唑",
      "E": "乙胺丁醇"
    },
    "answer": "D",
    "explanation": "【 10 \\sim 11 】 ②本题考查磺胺类抗菌药物的临床用药评价。磺胺类药物可与胆红素竞争在血浆蛋白上的结合部位, 而新生儿的乙酰转移酶系统未发育完善, 磺胺游离血药浓度增高, 增加了核黄疸的发生风险,故新生儿及 2 个月以下婴儿禁止使用。故本题答案为 D。",
    "source_note": "",
    "question_id": "97847b8c152fe3a60aeee17e0ff73fa8dc911f70",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "配伍选择题",
    "qno": 12,
    "stem": "对各型结核分枝杆菌都有高度选择性，是目前杀菌作用最强的抗结核药，对其他细菌无作用的是",
    "options": {
      "A": "异烟肼",
      "B": "阿米卡星",
      "C": "吡嗪酰胺",
      "D": "乙胺丁醇"
    },
    "answer": "A",
    "explanation": "【 12 \\sim 13】 ①本题考查异烟肼的临床用药评价。异烟肼对各型结核分枝杆菌都有高度选择性抗菌作用, 是目前抗结核药物中具有最强杀菌作用的合成抗菌药物, 对其他细菌无作用。故本题答案为 A。",
    "source_note": "",
    "question_id": "4ed7ebb7f51d19d72f90c3c848a8e6f0df99166a",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "配伍选择题",
    "qno": 13,
    "stem": "对细胞外及在中性或碱性环境中的结核分枝杆菌无效，又称之为“半杀菌药”的是",
    "options": {
      "A": "异烟肼",
      "B": "阿米卡星",
      "C": "吡嗪酰胺",
      "D": "乙胺丁醇"
    },
    "answer": "C",
    "explanation": "【 12 \\sim 13】 ②本题考查吡嗪酰胺的临床用药评价。吡嗪酰胺对静止期缓慢生长或巨噬细胞内及干酪病灶内的结核菌有杀灭作用, 因对细胞外及在中性或碱性环境中的结核菌无效, 又称为 “半杀菌药”。故本题答案为 C。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "06d2952eaea0d69ad1d80b100fdbc72fc506a5e7",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第18节抗结核分枝杆菌药",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "患者，男，65岁，因肺结核，长期使用异烟肼治疗，为防止周围神经炎的发生，应补充的维生素是",
    "options": {
      "A": "维生素 \\mathrm{B}_{1}",
      "B": "维生素 \\mathrm{B}_{6}",
      "C": "维生素K",
      "D": "维生素 C",
      "E": "维生素D"
    },
    "answer": "B",
    "explanation": "本题考查异烟肼的临床用药评价。异烟肼可拮抗维生素 B6 或增加维生素 B6 经肾排泄，引起周围神经炎，每日服用维生素 \\mathrm{B} 6 10 \\sim 50 \\mathrm{mg} 可以预防或缓解周围神经炎的发生。故本题答案为 B。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "ddfb78b4cae3d88a359431d2a03abad3c7e5eb18",
    "section_no": 18,
    "section_title": "抗结核分枝杆菌药",
    "section_norm": "第十八节 抗结核分枝杆菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第19节抗真菌药",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "主要用于诊断已经确立的深部真菌感染，但不宜用于皮肤、黏膜真菌感染的药物是",
    "options": {
      "A": "氟康唑",
      "B": "卡泊芬净",
      "C": "氟胞嘧啶",
      "D": "两性霉素 B",
      "E": "克霉唑"
    },
    "answer": "D",
    "explanation": "本题考查两性霉素B的临床用药评价。两性霉素B主要用于治疗已经 确诊的深部真菌病，且病情危重呈进行性发展者，但不宜用于皮肤、黏膜真菌感染，如免疫功能正常者的口腔念珠菌病、阴道念珠菌病和食道念珠菌病。故本题答案为D。",
    "source_note": "",
    "qtype_raw": "单项选择题",
    "question_id": "d2b38bca1ffaeccf8c19a874416057c5e6757005",
    "section_no": 19,
    "section_title": "抗真菌药",
    "section_norm": "第十九节 抗真菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第19节抗真菌药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "极易产生耐药性，治疗隐球菌性脑膜炎时通常与两性霉素B合用的药物是",
    "options": {
      "A": "氟胞嘧啶",
      "B": "卡泊芬净",
      "C": "伏立康唑",
      "D": "伊曲康唑",
      "E": "氟康唑"
    },
    "answer": "A",
    "explanation": "本题考查氟胞嘧啶的临床用药评价。氟胞嘧啶极易产生耐药性，故极少单独应用，常与两性霉素 B 合用治疗隐球菌性、念珠菌性脑膜炎；与氟康唑或伊曲康唑联合治疗艾滋病合并急性隐球菌脑病。故本题答案为 A。",
    "source_note": "",
    "question_id": "72508f7702ae54fcb5bee112bcedfc02a40c655e",
    "section_no": 19,
    "section_title": "抗真菌药",
    "section_norm": "第十九节 抗真菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第19节抗真菌药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "两性霉素B具有广谱抗真菌活性和强大的杀真菌作用，但不良反应较多。关于两性霉素B的说法，错误的是",
    "options": {
      "A": "可用于隐球菌、毛霉菌属和组织胞浆菌病，但对土曲霉无效",
      "B": "权衡利弊情况下可用于妊娠期女性",
      "C": "不可用氯化钠注射液稀释",
      "D": "可致神经系统毒性, 严重者可发生下肢截瘫",
      "E": "与肾上腺糖皮质激素联合使用, 可减轻低血钾风险"
    },
    "answer": "E",
    "explanation": "本题考查两性霉素 B 的临床用药评价。两性霉素 B 和肾上腺糖皮质激素均可导致低血钾, 二者合用可加重低钾血症风险。故本题答案为 E。",
    "source_note": "",
    "question_id": "e3d5eee887176e3819f6e2118145123dd46b219c",
    "section_no": 19,
    "section_title": "抗真菌药",
    "section_norm": "第十九节 抗真菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第19节抗真菌药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "不同剂型药动学特点有所差异，适应证不完全相同，胶囊剂型广泛用于浅部真菌病的治 疗，是甲癣的一线治疗药物的是",
    "options": {
      "A": "氟康唑",
      "B": "伊曲康唑",
      "C": "泊沙康唑",
      "D": "艾沙康唑",
      "E": "伏立康唑"
    },
    "answer": "B",
    "explanation": "本题考查三唑类的临床用药评价。伊曲康唑包括胶囊、口服液和注射液等剂型，不同剂型药动学特点有所差异，适应证亦不完全相同。伊曲康唑胶囊脂溶性高，可广泛用于浅部真菌病的治疗，是甲癣的一线治疗药物。口服液剂型的暴露量大于胶囊，可作为伊曲康唑注射液治疗的序贯疗法，是过敏性支气管肺曲霉病的一线治疗药物。故本题答案为 B。",
    "source_note": "",
    "question_id": "b60e61709a246d2d642d58692ace7f1b12400d52",
    "section_no": 19,
    "section_title": "抗真菌药",
    "section_norm": "第十九节 抗真菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第19节抗真菌药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "静脉给药与口服剂型的药动学特征相似，主要经肾脏清除或以原型排至尿液中，可用于泌尿系统真菌感染的药物是",
    "options": {
      "A": "伊曲康唑",
      "B": "伏立康唑",
      "C": "泊沙康唑",
      "D": "艾沙康唑",
      "E": "氟康唑"
    },
    "answer": "E",
    "explanation": "本题考查三唑类的临床用药评价。氟康唑静脉给药与口服剂型的药动学特征相似, 主要经肾脏清除或以原型排至尿液中, 可用于泌尿系统真菌感染。故本题答案为 E。伊曲康唑不同剂型药动学特点有所差异, 适应证亦不完全相同, 且尿液中仅有少量伊曲康唑, 故不用于尿路感染的治疗。伏立康唑进入尿液的药量很少, 一般不用于治疗尿路感染。泊沙康唑代谢产物经胆汁和粪便排泄, 不用于治疗尿路感染。艾沙康唑在尿液中药物浓度很低, 不用于泌尿系统真菌感染。",
    "source_note": "",
    "question_id": "5e4c0ba7bb0b4e1919a2464c7b9008eaa4b772cb",
    "section_no": 19,
    "section_title": "抗真菌药",
    "section_norm": "第十九节 抗真菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第19节抗真菌药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "抗菌谱广，尤其对毛霉目真菌有较好活性的药物是",
    "options": {
      "A": "泊沙康唑",
      "B": "卡泊芬净",
      "C": "伊曲康唑",
      "D": "氟康唑",
      "E": "伏立康唑"
    },
    "answer": "A",
    "explanation": "本题考查三唑类的临床用药评价。泊沙康唑、艾沙康唑抗菌谱广，尤其对毛霉目真菌有较好活性。故本题答案为 A。毛霉菌属不推荐使用卡泊芬净、米卡芬净、氟康唑、伊曲康唑及伏立康唑治疗。",
    "source_note": "",
    "question_id": "e0abc66ddeb0cbae85ea940d5a2efb37f543ef1a",
    "section_no": 19,
    "section_title": "抗真菌药",
    "section_norm": "第十九节 抗真菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第19节抗真菌药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "抗菌谱较氟康唑广，对土曲霉具有良好抗菌活性的药物是",
    "options": {
      "A": "两性霉素 B",
      "B": "伊曲康唑",
      "C": "卡泊芬净",
      "D": "米卡芬净",
      "E": "伏立康唑"
    },
    "answer": "E",
    "explanation": "本题考查三唑类的临床用药评价。伏立康唑较氟康唑抗菌谱广, 增加了对烟曲霉、土曲霉、黄曲霉等活性。故本题答案为 E。",
    "source_note": "",
    "question_id": "93d2bdb1093b6146632b747e2ceda30369abfa16",
    "section_no": 19,
    "section_title": "抗真菌药",
    "section_norm": "第十九节 抗真菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第19节抗真菌药",
    "qtype": "配伍选择题",
    "qno": 10,
    "stem": "属于三唑类药物，可治疗隐球菌病和念珠菌病，但曲霉菌属对其耐药的是",
    "options": {
      "A": "咪康唑",
      "B": "酮康唑",
      "C": "氟康唑",
      "D": "伊曲康唑",
      "E": "艾沙康唑"
    },
    "answer": "C",
    "explanation": "本组题考查三唑类的临床用药评价。 ①氟康唑属于三唑类抗真菌药, 可用于隐球菌病和念珠菌病的治疗和预防, 但曲霉菌属对其耐药。故本题答案为 C。",
    "source_note": "",
    "question_id": "d8b27af59fc42eb6d2b8c2d0900176661b0da037",
    "section_no": 19,
    "section_title": "抗真菌药",
    "section_norm": "第十九节 抗真菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第19节抗真菌药",
    "qtype": "配伍选择题",
    "qno": 11,
    "stem": "属于三唑类药物，抗菌谱可覆盖毛霉菌属的是",
    "options": {
      "A": "咪康唑",
      "B": "酮康唑",
      "C": "氟康唑",
      "D": "伊曲康唑",
      "E": "艾沙康唑"
    },
    "answer": "E",
    "explanation": "本组题考查三唑类的临床用药评价。 ②氟康唑、伊曲康唑和艾沙康唑属于三唑类药物, 其中艾沙康唑抗菌谱可覆盖毛霉菌属。氟康唑主要用于念珠菌属和隐球菌属。伊曲康唑抗菌谱拓展至曲霉属。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "d4bb782f8e777face0bf7d540b3ee2f7306de94f",
    "section_no": 19,
    "section_title": "抗真菌药",
    "section_norm": "第十九节 抗真菌药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第20节抗疱疹病毒药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "为核苷酸类似物，主要用于治疗巨细胞病毒感染，但口服生物利用度差，需静脉给药的是",
    "options": {
      "A": "阿昔洛韦",
      "B": "腈甲酸钠",
      "C": "西多福韦",
      "D": "泛普洛韦",
      "E": "缘更昔洛韦"
    },
    "answer": "C",
    "explanation": "本题考查抗疱疹病毒药的分类与临床用药评价。西多福韦为核苷酸类似物, 主要用于治疗巨细胞病毒感染, 但对广泛的疱疹病毒也具有活性, 但其口服生物利用度差, 需静脉给药。故本题答案为 C。",
    "source_note": "",
    "question_id": "4e9fcd67581b11bfb620fd212ebc0bf48eae1ae6",
    "section_no": 20,
    "section_title": "抗疱疹病毒药物",
    "section_norm": "第二十节 抗疱疹病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第20节抗疱疹病毒药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "对巨细胞病毒（CMV）几乎无效的药物是",
    "options": {
      "A": "阿昔洛韦",
      "B": "更昔洛韦",
      "C": "缀更昔洛韦",
      "D": "西多福韦",
      "E": "膦甲酸钠"
    },
    "answer": "A",
    "explanation": "本题考查抗疱疹病毒药的临床用药评价。阿昔洛韦是单纯疱疹病毒（HSV）、水痘-带状疱疹病毒（VZV）和EB病毒的高选择性且强效的抑制剂，但在治疗人巨细胞病毒感染无效。故本题答案为A。更昔洛韦对HSV和VZV有活性，治疗CMV比阿昔洛韦更加有效，可用于治疗危及生命或视觉的免疫缺陷患者的巨细胞病毒感染。缬更昔洛韦在肠和肝内迅速水解为更昔洛韦，可用于治疗巨细胞病毒感染。西多福韦是胞嘧啶的磷酸核苷酸类似物，主要用于治疗巨细胞病毒感染。膦甲酸钠能有效抑制疱疹病毒，包括CMV。",
    "source_note": "",
    "question_id": "ef127c9d035b3e32cab722dde32d6855721ae318",
    "section_no": 20,
    "section_title": "抗疱疹病毒药物",
    "section_norm": "第二十节 抗疱疹病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第20节抗疱疹病毒药物",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "为喷昔洛韦的前药，生物利用度为 77\\% 的药物是 物是",
    "options": {
      "A": "阿昔洛韦",
      "B": "泛普洛韦",
      "C": "伐昔洛韦",
      "D": "喷昔洛韦",
      "E": "缘更昔洛韦"
    },
    "answer": "B",
    "explanation": "本组题考查抗疱疹病毒药的临床用药评价。 ①泛昔洛韦属于喷昔洛韦的前药, 经肠和肝迅速去乙酰化和氧化为喷昔洛韦, 口服吸收良好, 生物利用度为 77 \\% 。故本题答案为 B。",
    "source_note": "",
    "question_id": "5f665f75c87c453ef0bea9c2347685350932933c",
    "section_no": 20,
    "section_title": "抗疱疹病毒药物",
    "section_norm": "第二十节 抗疱疹病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第20节抗疱疹病毒药物",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "为更昔洛韦的前药，生物利用度为 60\\% 的药",
    "options": {
      "A": "阿昔洛韦",
      "B": "泛普洛韦",
      "C": "伐昔洛韦",
      "D": "喷昔洛韦",
      "E": "缘更昔洛韦"
    },
    "answer": "E",
    "explanation": "本组题考查抗疱疹病毒药的临床用药评价。 ②缬更昔洛韦属于更昔洛韦的前药, 口服后在肠道和肝脏中水解为更昔洛韦, 生物利用度为 60 \\% 。故本题答案为 E。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "c1b5c43dd0cef4026692dbfd839a91b56f0c08ff",
    "section_no": 20,
    "section_title": "抗疱疹病毒药物",
    "section_norm": "第二十节 抗疱疹病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第20节抗疱疹病毒药物",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "对大多数对更昔洛韦耐药的巨细胞病毒（CMV）具有活性，还对HIV有活性的药物是",
    "options": {
      "A": "阿昔洛韦",
      "B": "膦甲酸钠 喷昔洛韦",
      "C": "更昔洛韦",
      "D": "伐昔洛韦"
    },
    "answer": "B",
    "explanation": "本组题考查抗疱疹病毒药的临床用药评价。 ① 膦甲酸钠不需通过磷酸化发挥作用, 对胸腺嘧啶激酶缺乏而引起阿昔洛韦耐药的单纯疱疹病毒 (HSV) 和水痘-带状疱疹病毒 (VZV) 以及大多数对更昔洛韦耐药的巨细胞病毒 (CMV) 具有活性还可抑制 HIV 的逆转录酶, 并在体内对 HIV 有活性。故本题答案为 B。",
    "source_note": "",
    "question_id": "6f5fbcf917401e228b48d91fe6335691b1a88937",
    "section_no": 20,
    "section_title": "抗疱疹病毒药物",
    "section_norm": "第二十节 抗疱疹病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第20节抗疱疹病毒药物",
    "qtype": "配伍选择题",
    "qno": 8,
    "stem": "为阿昔洛韦的前体酯化物，较阿昔洛韦有更好的口服生物利用度的药物是",
    "options": {
      "A": "阿昔洛韦",
      "B": "膦甲酸钠 喷昔洛韦",
      "C": "更昔洛韦",
      "D": "伐昔洛韦"
    },
    "answer": "D",
    "explanation": "本组题考查抗疱疹病毒药的临床用药评价。 ② 伐昔洛韦是阿昔洛韦的前体酯化物, 口服后经肠和肝水解, 转化为阿昔洛韦, 与口服阿昔洛韦相比, 伐昔洛韦具有药代动力学优势, 有更好的口服生物利用度, 比阿昔洛韦给药频次低。故本题答案为 D。",
    "source_note": "",
    "question_id": "a6f2e68f6c6f68a97a7ae8b8b75bcf5ffa5b6f83",
    "section_no": 20,
    "section_title": "抗疱疹病毒药物",
    "section_norm": "第二十节 抗疱疹病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第20节抗疱疹病毒药物",
    "qtype": "综合分析题",
    "qno": 1,
    "stem": "关于阿昔洛韦临床用药评价的描述，错误的是 A. 适用于治疗危及生命或视觉的免疫缺陷患者的巨细胞病毒感染 B. 属于核苷类似物, 通过抑制 DNA 聚合酶来干扰病毒复制而发挥抗疱疹病毒作用 C. 静脉注射可引起肾毒性, 用药前或用药期间应检查肾功能 D. 使用期间应摄入充足的水分，防止药物沉积于肾小管 E. 不提倡作为生殖器疱疹的预防用药或孕期的治疗用药",
    "options": {
      "A": "阿昔洛韦",
      "B": "绸更昔洛韦",
      "C": "膦甲酸钠",
      "D": "更昔洛韦",
      "E": "西多福韦"
    },
    "answer": "A",
    "explanation": "本题考查抗疱疹病毒药的临床用药评价。阿昔洛韦主要用于急性带状疱疹、初发和复发的生殖器疱疹、水痘，而对人巨细胞病毒无效，不用于预防和治疗 HIV 感染者巨细胞病毒视网膜炎。更昔洛韦适用于治疗危及生命或视觉的免疫缺陷患者的巨细胞病毒感染。故本题答案为 A。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "9b3134affd4d8230c88e0b0b6ac3f762715b37a2",
    "section_no": 20,
    "section_title": "抗疱疹病毒药物",
    "section_norm": "第二十节 抗疱疹病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第21节抗流感病毒药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于神经氨酸酶抑制剂的抗流感病毒药是",
    "options": {
      "A": "金刚乙胺",
      "B": "阿比多尔",
      "C": "利巴韦林",
      "D": "玛巴洛沙韦",
      "E": "扎那米韦"
    },
    "answer": "E",
    "explanation": "本题考查抗流感病毒药的分类与代表药品。扎那米韦属于神经氨酸酶抑制剂。故本题答案为E。",
    "source_note": "",
    "question_id": "7d2bf247cad72b58375f1c4b9ad5a357c188a705",
    "section_no": 21,
    "section_title": "抗流感病毒药",
    "section_norm": "第二十一节 抗流感病毒药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第21节抗流感病毒药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "关于玛巴洛沙韦临床用药评价的描述，不正确的是",
    "options": {
      "A": "应在症状出现后48小时内服用",
      "B": "适用于既往健康的成人和5岁及以上儿童单纯性甲型和乙型流感患者",
      "C": "不适用于存在流感相关并发症高风险的患者",
      "D": "除对流感病毒以外的其他病原体引起的疾病无效",
      "E": "避免与含多价阳离子制剂同服"
    },
    "answer": "C",
    "explanation": "本题考查RNA聚合酶抑制剂的临床用药评价。玛巴洛沙韦属于RNA 聚合酶抑制剂，适用于既往健康的成人和5岁以上儿童单纯性甲型和乙型流感患者，或存在流感相关并发症高风险的成人和12岁及以上儿童流感患者，对除流感病毒以外的其他病原体引起的疾病无效。故本题答案为C。",
    "source_note": "",
    "question_id": "3617886f70165c79d36fec0ae69020c8ec754b75",
    "section_no": 21,
    "section_title": "抗流感病毒药",
    "section_norm": "第二十一节 抗流感病毒药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第21节抗流感病毒药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "关于奥司他韦使用方法的描述，不正确的是",
    "options": {
      "A": "使用减毒活流感疫苗 2 周内不应服用奥司他韦",
      "B": "服用奥司他韦后2周内不应使用减毒活流感疫苗",
      "C": "三价灭活流感疫苗可以在服用奥司他韦前后的任何时间使用",
      "D": "老年人、轻度或中度肝损伤患者无需调整奥司他韦的使用剂量",
      "E": "患者应在首次出现流感症状48小时以内使用奥司他韦"
    },
    "answer": "B",
    "explanation": "本题考查神经氨酸酶抑制剂的临床用药评价。奥司他韦与疫苗存在相互作用，在服用奥司他韦后48h内不应使用减毒活流感疫苗；使用减毒活流感疫苗2周内不应服用奥司他韦；三价灭活流感疫苗可以在服用奥司他韦前后的任何时间使用。故本题答案为B。",
    "source_note": "",
    "question_id": "780f059feb9a17a570808078a6398767bed8f6eb",
    "section_no": 21,
    "section_title": "抗流感病毒药",
    "section_norm": "第二十一节 抗流感病毒药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第21节抗流感病毒药",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "属于血细胞凝聚素抑制剂的是",
    "options": {
      "A": "奥司他韦",
      "B": "金刚烷胺",
      "C": "阿比多尔",
      "D": "玛巴洛沙韦",
      "E": "法维拉韦"
    },
    "answer": "C",
    "explanation": "本组题考查抗流感病毒药物的分类和代表药品。 ①阿比多尔属于血细胞凝聚素抑制剂，通过阻止病毒进入细胞，抑制包膜病毒膜融合，在细胞内吞过程中加强病毒糖蛋白与宿主膜的相互作用，达到抑制病毒的作用，临床上用于甲或乙型流感病毒的预防和治疗。故本题答案为C。",
    "source_note": "",
    "question_id": "a22b87c61a72e30cf0d27579a591b13596d80216",
    "section_no": 21,
    "section_title": "抗流感病毒药",
    "section_norm": "第二十一节 抗流感病毒药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第21节抗流感病毒药",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "属于 \\mathbf{M}_2 离子通道阻滞剂的是",
    "options": {
      "A": "奥司他韦",
      "B": "金刚烷胺",
      "C": "阿比多尔",
      "D": "玛巴洛沙韦",
      "E": "法维拉韦"
    },
    "answer": "B",
    "explanation": "本组题考查抗流感病毒药物的分类和代表药品。 ②M2离子通道阻滞剂的代表药品有金刚烷胺、金刚乙胺。故本题答案为B。奥司他韦属于神经氨酸酶抑制剂。玛巴洛沙韦和法维拉韦属于RNA聚合酶抑制剂。",
    "source_note": "",
    "question_id": "3f6e06ec0ce8fe8bcbe1360a2c5a458ed39fe539",
    "section_no": 21,
    "section_title": "抗流感病毒药",
    "section_norm": "第二十一节 抗流感病毒药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第21节抗流感病毒药",
    "qtype": "配伍选择题",
    "qno": 6,
    "stem": "为 RNA 聚合酶抑制剂，属于前药，通过水解转化为活性代谢产物发挥抗流感病毒作用的药物是",
    "options": {
      "A": "扎那米韦",
      "B": "玛巴洛沙韦",
      "C": "阿比多尔",
      "D": "金刚烷胺",
      "E": "奥司他韦"
    },
    "answer": "B",
    "explanation": "本组题考查抗流感病毒药物的分类与临床用药评价。 ①玛巴洛沙韦属于RNA聚合酶抑制剂，为前药，通过水解转化为活性代谢产物巴洛沙韦，发挥抗流感病毒活性。故本题答案为B。",
    "source_note": "",
    "question_id": "e3084681d38be85fad630c9d70d2af41fd206a74",
    "section_no": 21,
    "section_title": "抗流感病毒药",
    "section_norm": "第二十一节 抗流感病毒药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第21节抗流感病毒药",
    "qtype": "配伍选择题",
    "qno": 7,
    "stem": "为神经氨酸酶抑制剂，属于前药，通过肝脏代谢为活性代谢产物发挥抗流感病毒作用的药物是",
    "options": {
      "A": "扎那米韦",
      "B": "玛巴洛沙韦",
      "C": "阿比多尔",
      "D": "金刚烷胺",
      "E": "奥司他韦"
    },
    "answer": "E",
    "explanation": "本组题考查抗流感病毒药物的分类与临床用药评价。 ②奥司他韦为神经氨酸酶抑制剂，属于前药，通过肝酯酶快速转化为活性形式奥司他韦羧酸酯发挥抗流感病毒作用。故本题答案为E。",
    "source_note": "",
    "question_id": "44889ff7496fb220cb60bf27c2f489b89185b6de",
    "section_no": 21,
    "section_title": "抗流感病毒药",
    "section_norm": "第二十一节 抗流感病毒药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第22节抗新型冠状病毒药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "属于抗新型冠状病毒药的是",
    "options": {
      "A": "奥司他韦",
      "B": "阿兹夫定",
      "C": "阿昔洛韦",
      "D": "利巴韦林",
      "E": "膦甲酸钠"
    },
    "answer": "B",
    "explanation": "本题考查抗新型冠状病毒药的分类与代表药品。抗新型冠状病毒药包括：①小分子药物：莫诺拉韦、瑞德西韦、阿兹夫定、奈玛特韦/利托那韦、先诺特韦/利托那韦等；②单克隆抗体：贝特洛韦单抗、安巴韦单抗/罗米司韦单抗。故本题答案为 B。",
    "source_note": "explanation_range_detected",
    "question_id": "004c4102cb219a70790c0405ffdf969ee05e5793",
    "section_no": 22,
    "section_title": "抗新型冠状病毒药",
    "section_norm": "第二十二节 抗新型冠状病毒药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第22节抗新型冠状病毒药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "不属于小分子药物的抗新型冠状病毒药的是",
    "options": {
      "A": "莫诺拉韦",
      "B": "奈玛特韦/利托那韦",
      "C": "贝特洛韦单抗",
      "D": "先诺特韦 / 利托那韦",
      "E": "瑞德西韦"
    },
    "answer": "C",
    "explanation": "本题考查抗新型冠状病毒药的分类与代表药品。抗新型冠状病毒药包括：①小分子药物：莫诺拉韦、瑞德西韦、阿兹夫定、奈玛特韦/利托那韦、先诺特韦/利托那韦等；②单克隆抗体：贝特洛韦单抗、安巴韦单抗/罗米司韦单抗。故本题答案为 C。",
    "source_note": "explanation_range_detected",
    "question_id": "b1cdb9ff16d0aae207f732f153b14c8b4d3ed91a",
    "section_no": 22,
    "section_title": "抗新型冠状病毒药",
    "section_norm": "第二十二节 抗新型冠状病毒药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第23节抗肝炎病毒药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "为复方制剂，可用于治疗成人慢性丙型肝炎病毒感染，且不需要与利巴韦林联合使用的药物是",
    "options": {
      "A": "达芦那韦 / 考比司他",
      "B": "聚乙二醇干扰素 \\alpha - 2a",
      "C": "聚乙二醇干扰素 \\alpha - 2 \\mathrm{~b}",
      "D": "索磷布韦 - 维帕他韦",
      "E": "阿德福韦酯"
    },
    "answer": "D",
    "explanation": "本题考查治疗慢性丙型肝炎药的临床用药评价。索磷布韦-维帕他韦属于复方制剂，为治疗慢性丙型肝炎病毒感染药物，可用于初治和复治的非肝硬化及肝硬化患者，不需与利巴韦林联合使用。故本题答案为D。达芦那韦/考比司他属于抗艾滋病病毒药物。聚乙二醇干扰素α-2a和聚乙二醇干扰素α-2b不属于复方制剂，而且聚乙二醇干扰素α-2a用于治疗丙型肝炎时最好与利巴韦林联合使用。阿德福韦酯为治疗慢性乙型肝炎药。",
    "source_note": "",
    "question_id": "52186c875be306a0f5ac56cea3d5387a398b0612",
    "section_no": 23,
    "section_title": "抗肝炎病毒药物",
    "section_norm": "第二十三节 抗肝炎病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第23节抗肝炎病毒药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "以下不属于抗肝炎病毒药的是",
    "options": {
      "A": "阿德福韦酯",
      "B": "干扰素",
      "C": "阿兹夫定",
      "D": "恩替卡韦",
      "E": "索磷布韦-维帕他韦"
    },
    "answer": "C",
    "explanation": "本题考查抗肝炎病毒药物的分类与代表药品。抗肝炎病毒药物包括 ① 核苷（酸）类药：拉米夫定、恩替卡韦、阿德福韦酯、替诺福韦酯；② 干扰素：聚乙二醇干扰素 a 2a、聚乙二醇干扰素 a 2b；③ 治疗慢性丙型肝炎药物：干扰素、利巴韦林、索磷布韦-维帕他韦。阿兹夫定为抗艾滋病病毒药物，也可治疗新型冠状病毒感染。故本题答案为 C。",
    "source_note": "explanation_range_detected",
    "question_id": "8185e23cdcb50be9e82a72a9d8f0ecd466e7d39b",
    "section_no": 23,
    "section_title": "抗肝炎病毒药物",
    "section_norm": "第二十三节 抗肝炎病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第23节抗肝炎病毒药物",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "可用于治疗5岁及以上人群慢性乙型肝炎的药物是",
    "options": {
      "A": "聚乙二醇干扰素 \\alpha - 2a",
      "B": "索磷布韦 - 维帕他韦",
      "C": "特拉匹韦",
      "D": "替诺福韦",
      "E": "阿昔洛韦"
    },
    "answer": "A",
    "explanation": "本题考查干扰素的临床用药评价。聚乙二醇干扰素α-2a可用于治疗5岁及以上儿童慢性乙型肝炎。而我国已批准富马酸丙酚替诺福韦用于12岁及以上且体重大于等于35kg青少年的慢性乙型肝炎。故本题答案为A。索磷布韦-维帕他韦、特拉 匹韦为治疗慢性丙型肝炎药。阿昔洛韦属于抗疱疹病毒药。",
    "source_note": "",
    "question_id": "237596f470bb6540547f0a66f4ceb1360997c563",
    "section_no": 23,
    "section_title": "抗肝炎病毒药物",
    "section_norm": "第二十三节 抗肝炎病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第23节抗肝炎病毒药物",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "属于直接抗病毒药，临床可用于治疗丙型肝炎的是",
    "options": {
      "A": "阿舒瑞韦",
      "B": "利巴韦林",
      "C": "聚乙二醇干扰素 \\alpha - 2 \\mathrm{a}",
      "D": "替比夫定",
      "E": "替诺福韦酯"
    },
    "answer": "A",
    "explanation": "本题考查抗肝炎病毒药物的分类和代表药品。治疗慢性丙型肝炎药物: ① 干扰素: 聚乙二醇干扰素 \\alpha-2a、聚乙二醇干扰素 \\alpha-2b; ② 其他类: 利巴韦林、索磷布韦-维帕他韦; ③ 直接抗病毒药物: 达拉他韦、阿舒瑞韦; ④ 蛋白酶抑制剂: 波普瑞韦、特拉匹韦。故本题答案为 A。",
    "source_note": "explanation_range_detected",
    "question_id": "1b0c64abb2a9e742b8a673a46e32fb0e6ba58a93",
    "section_no": 23,
    "section_title": "抗肝炎病毒药物",
    "section_norm": "第二十三节 抗肝炎病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第23节抗肝炎病毒药物",
    "qtype": "综合分析题",
    "qno": 7,
    "stem": "妊娠期首次诊断为慢性乙型肝炎者及哺乳期可选用的抗肝炎病毒药物是",
    "options": {
      "A": "恩替卡韦",
      "B": "拉米夫定",
      "C": "聚乙二醇干扰素 \\alpha - 2 \\mathrm{a}",
      "D": "阿德福韦酯",
      "E": "替诺福韦酯"
    },
    "answer": "E",
    "explanation": "本题考查核苷（酸）类药物的临床用药评价。妊娠期首次诊断为慢性乙型肝炎者，可选用替诺福韦酯治疗，哺乳期也可选用替诺福韦酯治疗。故本题答案为E。",
    "source_note": "",
    "qtype_raw": "单项选择题",
    "question_id": "7436f9ba49d77b13a88ae3b935835dee960e067e",
    "section_no": 23,
    "section_title": "抗肝炎病毒药物",
    "section_norm": "第二十三节 抗肝炎病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第23节抗肝炎病毒药物",
    "qtype": "综合分析题",
    "qno": 8,
    "stem": "抗病毒治疗期间意外妊娠的患者，若正在服用恩替卡韦，可不终止妊娠，建议更换为",
    "options": {
      "A": "拉米夫定（LAM）",
      "B": "替比夫定（LdT）",
      "C": "恩替卡韦（ETV）",
      "D": "阿德福韦酯（ADV）",
      "E": "替诺福韦酯（TDF）"
    },
    "answer": "E",
    "explanation": "本组题考查核苷（酸）类药物的临床用药评价。 ①抗病毒治疗期间意外妊娠的患者，若正在服用TDF，建议继续妊娠；若正在服用恩替卡韦，可不终止妊娠，建议更换为TDF继续治疗。故本题答案为E。",
    "source_note": "Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "09e20ad20e00c6348699997b708f6f256f32277a",
    "section_no": 23,
    "section_title": "抗肝炎病毒药物",
    "section_norm": "第二十三节 抗肝炎病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第23节抗肝炎病毒药物",
    "qtype": "综合分析题",
    "qno": 9,
    "stem": "若正在接受IFNa治疗的乙肝患者意外妊娠，建议向妊娠妇女和家属充分告知风险，由其决定是否继续妊娠，若决定继续妊娠，则治疗药物要换为",
    "options": {
      "A": "拉米夫定（LAM）",
      "B": "替比夫定（LdT）",
      "C": "恩替卡韦（ETV）",
      "D": "阿德福韦酯（ADV）",
      "E": "替诺福韦酯（TDF）"
    },
    "answer": "E",
    "explanation": "本组题考查核苷（酸）类药物的临床用药评价。 ②若正在接受IFN-α治疗的乙肝患者意外妊娠，建议向妊娠期妇女和家属充分告知风险，由其决定是否继续妊娠，若决定继续妊娠则要换用TDF治疗。故本题答案为E。",
    "source_note": "Stem split from same-line multiple questions in timu. | Auto: 配伍选择题 -> 综合分析题 (stem keywords)",
    "question_id": "9eed43e539e16e639207f30031dbedd0868a23c0",
    "section_no": 23,
    "section_title": "抗肝炎病毒药物",
    "section_norm": "第二十三节 抗肝炎病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第24节抗艾滋病病毒药物",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "以下均属于抗艾滋病病毒药物的是",
    "options": {
      "A": "膦甲酸钠、西多福韦",
      "B": "奥司他韦、阿巴卡韦",
      "C": "齐多夫定、拉替拉韦",
      "D": "拉米夫定、特拉匹韦",
      "E": "多拉韦林、扎那米韦"
    },
    "answer": "C",
    "explanation": "本题考查抗艾滋病病毒药物的分类和代表药品。抗艾滋病病毒药物有：①核苷类逆（反）转录酶抑制药：齐多夫定、拉米夫定、阿巴卡韦、恩曲他滨、阿兹夫定、替诺福韦；②非核苷类逆（反）转录酶抑制药：奈韦拉平、利匹韦林、艾诺韦林、依非韦伦、多拉韦林；③蛋白酶抑制药：洛匹那韦/利托那韦、达芦那韦/考比司他、阿 扎那韦；④整合酶抑制剂：拉替拉韦、多替拉韦等；⑤融合抑制剂：艾博韦泰。故本题答案为C。膦甲酸钠、西多福韦属于抗疱疹病毒药物。奥司他韦、扎那米韦属于抗流感病毒药物。特拉匹韦属于抗肝炎病毒药物。",
    "source_note": "explanation_range_detected",
    "question_id": "ef8c0ee13450f0024e326e7b2263f62844090291",
    "section_no": 24,
    "section_title": "抗艾滋病病毒药物",
    "section_norm": "第二十四节 抗艾滋病病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第24节抗艾滋病病毒药物",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "阿巴卡韦属于",
    "options": {
      "A": "抗艾滋病病毒药",
      "B": "抗疱疹病毒药",
      "C": "抗流感病毒药",
      "D": "抗乙型肝炎病毒药",
      "E": "抗丙型肝炎病毒药"
    },
    "answer": "A",
    "explanation": "本题考查抗艾滋病病毒药物的分类和代表药品。核苷类逆（反）转录酶抑制药：齐多夫定、拉米夫定、阿巴卡韦、恩曲他滨、阿兹夫定、替诺福韦。故本题答案为 A。",
    "source_note": "",
    "question_id": "09e02730aa2e19a430341c5ae7d7297ccbbab559",
    "section_no": 24,
    "section_title": "抗艾滋病病毒药物",
    "section_norm": "第二十四节 抗艾滋病病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第24节抗艾滋病病毒药物",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "对于感染HIV高风险人群，在知情同意及依 从性好的前提下提供抗病毒药物进行暴露前预防和暴露后预防。对于明确HIV暴露后72小时内的人群，首选的阻断方案为",
    "options": {
      "A": "每日服用恩曲他滨/替诺福韦（FTC/TDF）",
      "B": "每日服用恩曲他滨/替诺福韦艾拉酚胺(FTC/TAF)",
      "C": "臀部肌内注射长效卡替拉韦",
      "D": "恩曲他滨 / 替诺福韦（FTC/TDF）联合多替拉韦",
      "E": "恩曲他滨/替诺福韦（FTC/TDF）联合利托那韦"
    },
    "answer": "D",
    "explanation": "本题考查抗艾滋病病毒药物的临床用药评价。对于明确HIV暴露后72小时内的人群，首选的阻断方案为恩曲他滨/替诺福韦（FTC/TDF）联合INSTI（多替拉韦或比克替拉韦或拉替拉韦）。故本题答案为D。",
    "source_note": "",
    "question_id": "09805f854303f12d1d5020b07252a27e64c934b4",
    "section_no": 24,
    "section_title": "抗艾滋病病毒药物",
    "section_norm": "第二十四节 抗艾滋病病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第24节抗艾滋病病毒药物",
    "qtype": "配伍选择题",
    "qno": 4,
    "stem": "属于蛋白酶抑制药类抗艾滋病病毒药物的是",
    "options": {
      "A": "奥司他韦",
      "B": "洛匹那韦 / 利托那韦",
      "C": "阿昔洛韦",
      "D": "多替拉韦",
      "E": "利巴韦林"
    },
    "answer": "B",
    "explanation": "本组题考查抗艾滋病病毒药物的分类和代表药品。 ①蛋白酶抑制药的代表药物有洛匹那韦/利托那韦、达芦那韦/考比司他、阿扎那韦。故本题答案为B。",
    "source_note": "",
    "question_id": "ca8163df4c3760a9cf4dd68976561a6a9d369e32",
    "section_no": 24,
    "section_title": "抗艾滋病病毒药物",
    "section_norm": "第二十四节 抗艾滋病病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第24节抗艾滋病病毒药物",
    "qtype": "配伍选择题",
    "qno": 5,
    "stem": "属于整合酶抑制剂类抗艾滋病病毒药物的是",
    "options": {
      "A": "奥司他韦",
      "B": "洛匹那韦 / 利托那韦",
      "C": "阿昔洛韦",
      "D": "多替拉韦",
      "E": "利巴韦林"
    },
    "answer": "D",
    "explanation": "本组题考查抗艾滋病病毒药物的分类和代表药品。 ②整合酶抑制剂的代表药物有拉替拉韦、多替拉韦、卡替拉韦。故本题答案为D。奥司他韦属于抗流感病毒药物。阿昔洛韦属于抗疱疹病毒药物，主要用于单纯疱疹病毒及带状疱疹的治疗。利巴韦林属于抗丙型肝炎病毒药物。",
    "source_note": "Stem split from same-line multiple questions in timu.",
    "question_id": "ba5d83b9e84b30d57425a31cfda837668e9cb0d2",
    "section_no": 24,
    "section_title": "抗艾滋病病毒药物",
    "section_norm": "第二十四节 抗艾滋病病毒药物"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第25节抗原虫药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "为较好的病因性预防药，大剂量使用可出现巨幼红细胞性贫血的药物是",
    "options": {
      "A": "伯氨喹",
      "B": "乙胺嘧啶",
      "C": "青蒿素",
      "D": "奎宁",
      "E": "氯喹"
    },
    "answer": "B",
    "explanation": "本题考查抗疟药的临床用药评价。乙胺嘧啶属于二氢叶酸还原酶抑制剂，作用于红内期，主要作用于成熟形态，用于疟疾的预防，是较好的病因性预防药。不良反应包括巨幼红细胞性贫血、全血细胞减少、肺内渗血等。故本题答案为 B。",
    "source_note": "",
    "question_id": "bea18cdcfd534e967070898035f7fe9e71b4acee",
    "section_no": 25,
    "section_title": "抗原虫药",
    "section_norm": "第二十五节 抗原虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第25节抗原虫药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "临床作为控制疟疾复发和阻止疟疾传播首选药的是",
    "options": {
      "A": "双氢青蒿素",
      "B": "伯氨喹",
      "C": "磺胺多辛",
      "D": "吡喹酮",
      "E": "羟氯喹"
    },
    "answer": "B",
    "explanation": "本题考查抗疟药的临床用药评价。伯氨喹可杀灭间日疟、三日疟、恶性疟和卵形疟组织期的虫株, 尤以间日疟为著, 也可杀灭各种疟原虫的配子体, 对恶性疟的作用尤强, 临床作为控制复发和阻止疟疾传播的首选药。故本题答案为 B。",
    "source_note": "",
    "question_id": "bf6203dfdca2d31bfcd866ae827758561705d4a0",
    "section_no": 25,
    "section_title": "抗原虫药",
    "section_norm": "第二十五节 抗原虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第25节抗原虫药",
    "qtype": "单项选择题",
    "qno": 3,
    "stem": "甲硝唑的适应证不包括",
    "options": {
      "A": "滴虫病",
      "B": "阿米巴病",
      "C": "贾第虫病",
      "D": "血吸虫病",
      "E": "小袋纤毛虫病"
    },
    "answer": "D",
    "explanation": "本题考查抗原虫药的临床用药评价。甲硝唑可用于阿米巴病、小袋纤毛虫病、贾第虫病、滴虫病, 也广泛应用于抗厌氧菌感染。故本题答案为 D。",
    "source_note": "",
    "question_id": "5c5e1bc69d22d5604a92cd45496621600b50e8e3",
    "section_no": 25,
    "section_title": "抗原虫药",
    "section_norm": "第二十五节 抗原虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第25节抗原虫药",
    "qtype": "单项选择题",
    "qno": 6,
    "stem": "属于治疗阿米巴肝脓肿的首选药物的是",
    "options": {
      "A": "甲硝唑",
      "B": "乙胺嘧啶",
      "C": "巴龙霉素",
      "D": "氯喹"
    },
    "answer": "A",
    "explanation": "本题考查抗原虫的临床用药评价。甲硝唑是治疗阿米巴肝脓肿的首选药物, 但不能根除包囊, 故患者还应接受肠道内抗阿米巴药物的全疗程治疗。故本题答案为 A。",
    "source_note": "",
    "question_id": "ee2ad25839940ecd7e1f2c85bfb4a1ce60285b68",
    "section_no": 25,
    "section_title": "抗原虫药",
    "section_norm": "第二十五节 抗原虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第25节抗原虫药",
    "qtype": "单项选择题",
    "qno": 7,
    "stem": "抗疟药物不包括",
    "options": {
      "A": "乙胺嘧啶",
      "B": "复方蒿甲醚",
      "C": "巴龙霉素",
      "D": "伯氨喹",
      "E": "氯喹"
    },
    "answer": "C",
    "explanation": "本题考查抗疟药的分类与代表药品。抗疟药包括: 乙胺嘧啶、伯氨喹、氯喹、青蒿素、复方蒿甲醚。故本题答案为 C。巴龙霉素属于抗阿米巴病药。",
    "source_note": "",
    "question_id": "2d5db928843750b2b42705e8aa7595fefad311f1",
    "section_no": 25,
    "section_title": "抗原虫药",
    "section_norm": "第二十五节 抗原虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第25节抗原虫药",
    "qtype": "单项选择题",
    "qno": 8,
    "stem": "可用于无症状携带者的阿米巴病治疗，还适用于贾第虫病、利什曼病的药物是",
    "options": {
      "A": "双碘喹啉",
      "B": "吡喹酮",
      "C": "甲硝唑",
      "D": "阿苯达唑"
    },
    "answer": "B",
    "explanation": "本题考查抗原虫药的临床用药评价。巴龙霉素属于抗阿米巴病药，可用于无症状携带者的阿米巴病治疗，还适用于贾第虫病、利什曼病。故本题答案为 B。",
    "source_note": "",
    "question_id": "861831aaffba80a620f41fa68b35de5d3af5c6fc",
    "section_no": 25,
    "section_title": "抗原虫药",
    "section_norm": "第二十五节 抗原虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第25节抗原虫药",
    "qtype": "综合分析题",
    "qno": 4,
    "stem": "伯氨喹主要用于根治间日疟和控制疟疾传播，葡萄糖-6-磷酸脱氢酶缺乏症患者使用可能引发的药源性疾病是",
    "options": {
      "A": "金鸡纳反应",
      "B": "灰婴综合征",
      "C": "耳蜗神经损害",
      "D": "Q-T间期延长",
      "E": "急性溶血性贫血"
    },
    "answer": "E",
    "explanation": "本题考查抗疟药的临床用药评价。葡萄糖-6-磷酸脱氢酶缺乏者服用伯氨喹可发生急性溶血性贫血和高铁血红蛋白血症，出现发绀、胸闷等症状，葡萄糖-6-磷酸脱氢酶缺乏者禁用。故本题答案为E。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "16eddea7c543647ed815769c8fcb88e98cf0d052",
    "section_no": 25,
    "section_title": "抗原虫药",
    "section_norm": "第二十五节 抗原虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第26节抗蠕虫药",
    "qtype": "单项选择题",
    "qno": 1,
    "stem": "为高效、低毒的广谱驱虫药，可用于蛔虫病、 蛇虫病的药物是",
    "options": {
      "A": "甲硝唑",
      "B": "阿苯达唑",
      "C": "吡唑酮",
      "D": "伊维菌素",
      "E": "双碘喹啉"
    },
    "answer": "B",
    "explanation": "本题考查抗肠道线虫药的临床用药评价。阿苯达唑是一种高效、低毒的广谱驱虫药，可用于蛔虫病、钩虫病、粪类圆线虫病、鞭虫病、蛲虫病治疗。故本题答案为 B。甲硝唑可用于阿米巴病、小袋纤毛虫病、贾第虫病、滴虫病，也广泛应用于抗厌氧菌感染。吡喹酮属于抗血吸虫药。伊维菌素是防治盘尾丝虫病的首选药物。双碘喹啉属于抗阿米巴病药。",
    "source_note": "",
    "question_id": "75149adc75fbe9cdcdb60a54fec99212ad04dfb2",
    "section_no": 26,
    "section_title": "抗蠕虫药",
    "section_norm": "第二十六节 抗蠕虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第26节抗蠕虫药",
    "qtype": "单项选择题",
    "qno": 2,
    "stem": "为一种口服有效的微丝杀菌剂，是防治盘尾丝虫病的首选药物的是",
    "options": {
      "A": "乙胺嘧啶",
      "B": "伊维菌素 吡唑酮",
      "C": "甲苯咪唑",
      "D": "阿苯达唑"
    },
    "answer": "B",
    "explanation": "本题考查抗肠道线虫药的临床用药评价。伊维菌素是由阿维链霉菌产生的十六元环大环内酯类抗菌药物, 为一种口服有效的微丝杀菌剂, 是防治盘尾丝虫病的首选药物。故本题答案为 B。",
    "source_note": "",
    "question_id": "4ec8095fe4dcb2e86fbfd636a1ac30a09e4e09bc",
    "section_no": 26,
    "section_title": "抗蠕虫药",
    "section_norm": "第二十六节 抗蠕虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第26节抗蠕虫药",
    "qtype": "单项选择题",
    "qno": 4,
    "stem": "既可作为血吸虫病的首选药物，还可用于治疗绦虫病的药物是",
    "options": {
      "A": "阿苯达唑",
      "B": "甲苯咪唑",
      "C": "伊维菌素",
      "D": "乙胺嘧啶",
      "E": "吡喹酮"
    },
    "answer": "E",
    "explanation": "本题考查吡喹酮的临床用药评价。吡喹酮为广谱抗吸虫和绦虫药物,为血吸虫病的首选药物, 还可用于治疗绦虫病。故本题答案为 E。",
    "source_note": "",
    "question_id": "0389763c1efd47c3a96b8615a889809a96edc8f5",
    "section_no": 26,
    "section_title": "抗蠕虫药",
    "section_norm": "第二十六节 抗蠕虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第26节抗蠕虫药",
    "qtype": "单项选择题",
    "qno": 5,
    "stem": "属于苯并咪唑类衍生物，为广谱驱虫药，通过直接抑制肠道寄生虫对葡萄糖的摄入，导致虫体内糖原耗竭，使其无法生存而死亡的药物是",
    "options": {
      "A": "双碘喹啉",
      "B": "甲苯咪唑",
      "C": "巴龙霉素",
      "D": "氯喹",
      "E": "替硝唑"
    },
    "answer": "B",
    "explanation": "本题考查抗肠道线虫药的临床用药评价。甲苯咪唑属于苯并咪唑类衍生物, 是广谱的驱虫药物, 可直接抑制肠道寄生虫对葡萄糖的摄入, 导致虫体内糖原耗竭, 使其无法生存而死亡。故本题答案为 B。",
    "source_note": "",
    "question_id": "03e212d671e955d9e2322a3d63c98797f0671671",
    "section_no": 26,
    "section_title": "抗蠕虫药",
    "section_norm": "第二十六节 抗蠕虫药"
  },
  {
    "chapter": "第九章 抗感染药物",
    "section": "第26节抗蠕虫药",
    "qtype": "综合分析题",
    "qno": 3,
    "stem": "患者，女，36岁，因发热、腹痛、腹泻、乏力1周就诊，查体：肝脾肿大，粪便检查可见血吸虫虫卵，诊断为血吸虫病，宜选用的治疗药物是",
    "options": {
      "A": "甲苯咪唑",
      "B": "甲硝唑",
      "C": "乙胺嘧啶",
      "D": "吡喹酮",
      "E": "伊维菌素"
    },
    "answer": "D",
    "explanation": "本题考查吡喹酮的临床用药评价。吡喹酮为广谱抗吸虫和绦虫药物,适用于各种血吸虫病、华支睾吸虫病、肺吸虫病、姜片虫病以及绦虫病和囊虫病。故本题答案为 D。",
    "source_note": "Auto: 单项选择题 -> 综合分析题 (stem keywords)",
    "question_id": "4142669febcc21bd82731033ba8eefb4f7f64846",
    "section_no": 26,
    "section_title": "抗蠕虫药",
    "section_norm": "第二十六节 抗蠕虫药"
  }
]